,Tweet content,date,symbol,increase
0,"RT @StocksThatDoubl: Want alerts for momentum stocks? SUBSCRIBE: https://t.co/uAcamNRUPt  https://t.co/GTBX9iaGPR $PM $GILD $CMCSA $C $IBM ‚Ä¶Want alerts for momentum stocks? SUBSCRIBE: https://t.co/uAcamNRUPt  https://t.co/GTBX9iaGPR $PM $GILD $CMCSA $C $IBM $STRT @tgtxdough: Key upcoming clinical catalysts $GILD $CELG $IBB $KITE $FGEN $ESPR $JUNO https://t.co/dpo9XuEu70$GILD:

Gilead Sciences Adds 2% After Leerink Says Co Continues to ‚Ä¶:

https://t.co/KMl8gzf92yRT @StocksThatDoubl: https://t.co/uAcamNRUPt subscribers alerted to 10-1800% gain stocks. JOIN NOW Promo https://t.co/OQCNEb9p9K $PM $GILD ‚Ä¶RT @HumbleBioTrader: The biggest obstacle in biotech now is the politics of pricing. Great companies like $GILD being questioned by politic‚Ä¶Nasdaq100 #Stocks Performance $MAR $DLTR $NFLX $VIAB $MNST $SPLS $GILD $TSLA $YHOO $SIRI $SBUX $NVDA $AAL  more@ https://t.co/YdSIjFJqHfhttps://t.co/uAcamNRUPt subscribers alerted to 10-1800% gain stocks. JOIN NOW Promo https://t.co/OQCNEb9p9K $PM $GILD $CMCSA $C $IBM $STS&amp;P100 #Stocks Performance $TWX $MET $GD $GILD $MO $GE $MMM $SBUX $ALL $TGT $DIS $COST $AIG $SPG $BLK $MON more@ https://t.co/cKkr8cKsju$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/sUTPu7mnUP https://t.co/crvW9qemPFThe biggest obstacle in biotech now is the politics of pricing. Great companies like $GILD being questioned by political hacks/both parties.Lizard Bearish https://t.co/9zfLathYet $GILD $WGO $WTFC $CETV $ABCO $PNK $CSH $BOND $SCHR $ATNY $FJP@bradloncar Nothing will happen here. It would set a template to go after a lot of drugs. Will be same outcome as $GILD. NothingRT @FiercePharma: Merck's $200M damages in Gilead hep C case falls far short of expectations https://t.co/cZFoF4tjQi $MRK $GILD #pharma by ‚Ä¶Scan results - Shooting Star Candlestick today: $CNL $WGO $WTFC $HIMX $ABCO $PNK $CSH $DATA $GILD $LNT ... https://t.co/vjKWPmNMvWGILD Summary
See Here ---&gt; https://t.co/MG3r7SVZZd

$GILD $PAAS $PATK #investWould $GILD benefit from acquiring $CELG? Only time will tell... https://t.co/i1EtAowVbr by @SeekingAlpha https://t.co/sPUETULkpERT @tgtxdough: MS $GILD On capital deployment, (1) mgt. is focused on liver diseases outside HCV, especially NASH, inflammation and oncologyRT @adamfeuerstein: Leerink‚Äôs G. Porges says $MRK Zepatier launch worse than $ABBV Viekira Pak at same time point. $GILD maintains HepC dom‚Ä¶Gilead Sciences, Inc. $GILD Stake Boosted by Robshaw &amp; Julian Associates Inc. https://t.co/9gBwi9V434@Lilac I liked your post, but I'm not really happy about it, RED everywhere. I had a few up, $GILD, $SYN and $AMDA, but didn't $FIT suck!Checchi Capital Advisers LLC Has $1,513,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/9gzCfR2i9UGilead Sciences, Inc. $GILD Stake Boosted by Robshaw &amp; Julian Associates Inc. https://t.co/dKJggiY8bP$REGN double bottom waiting for mean reversion  bounce
#healthcare $ALDR $MNKD $GILD https://t.co/eXYAvjv7j8BRIEF#GileadSciences says CEO John C. Martin's 2015 total compensation $18.8 mln  SEC Filing. Read more: https://t.co/8Z0UE0jk4U $GILDGilead Sciences, Inc. $GILD Position Maintained by Cabot Wellington LLC https://t.co/8AAEbrQ0HDChecchi Capital Advisers LLC Has $1,513,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/kkjHgAfVehGilead Sciences, Inc. $GILD Position Maintained by Cabot Wellington LLC https://t.co/IwIInO8tCxChecchi Capital Advisers LLC Has $1,513,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/jub3UIFMKIGilead Sciences, Inc. $GILD Position Maintained by Cabot Wellington LLC https://t.co/SM2EDXJZmbPictet North America Advisors SA Boosts Position in Gilead Sciences, Inc. $GILD https://t.co/5UcQIoA2VGRT @iviewmarkets: Sector Performers: $RRC $DO $MOS $SWN $AA $PVH $KHC $XRAY $GILD $GD $GE $TWX $DLTR $NFLX $NWSA $DG $CSC $TDC $MSI https:/‚Ä¶RT @jonathanrockoff: Think the increasing competition may be getting to $GILD 's hepatitis C franchise? Think again, Leerink says. https://‚Ä¶Sector Performers: $RRC $DO $MOS $SWN $AA $PVH $KHC $XRAY $GILD $GD $GE $TWX $DLTR $NFLX $NWSA $DG $CSC $TDC $MSI https://t.co/Fad3eemSSqRT @Tootix: #GENFIT The definition of Biotech Stock Picking #NASH #Elafibranor $GNFT $ICPT $GILD $SAN  https://t.co/3pXWZr01Kf https://t.co‚Ä¶@FiercePharma @TracyStaton @RNAiAnalyst ok, ongoing Sovaldi/harvoni marketing costs $GILD, but why would R&amp;D affect forward $MRK royalties??RT @RebeccaDRobbins: How many remaining hep C patients can $GILD still reach? That's a big question for the co. My @statnews analysis: http‚Ä¶BRIEF-#GileadSciences says CEO John C. Martin's 2015 total compensation $18.8 mln - SEC Fil... Read more: https://t.co/6XU4rnLzOe $GILDRECAP 3/28 Puts:
$XLNX May 47 P
$OHRP Oct 2.5 P
$PYPL Apr 35.5 P
$MU May 10 P
$GILD Apr 80 P
$XLY Sep 65 P
$FCX Jan-18 5 P
$SWHC Apr 24 PS&amp;P500 #Stocks Performance $MAR $TWX $RRC $DLTR $NFLX $MOS $PVH $DG $M $KSS $DO $HOT $IPG $NWSA $GILD $GNW more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Performance $MAR $DLTR $NFLX $GILD $TSLA $VIAB $AAL $MNST $SPLS $SIRI $TSCO $STX $SBUX  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Performance $TWX $GILD $MET $TGT $GE $MO $GD $SBUX $MMM $ALL $COST $FOXA $SPG $AIG $DIS  more@ https://t.co/cKkr8cKsju#GileadSciences Merck's $200M damages in Gilead hep C case falls far short of expectations. Read more: https://t.co/WHhMQfM14D $GILD$GILD COO John F. Milligan FY 2015 total compensation $8.3 million  versus $8.3 million last year$GILD CEO John C. Martin 2015 total compensation $18.8  million versus $19 million in 2014$GILD CFO Robin L. Washington FY 2015 total compensation $5.6 million  versus $6.2 million in FY 2014RT @tgtxdough: MS $GILD On capital deployment, (1) mgt. is focused on liver diseases outside HCV, especially NASH, inflammation and oncologyRT @tgtxdough: MS $GILD ~4% royalties on past sales could be an indication of the go-forward royalty which is expected to be decided starti‚Ä¶MS $GILD On capital deployment, (1) mgt. is focused on liver diseases outside HCV, especially NASH, inflammation and oncologyMS $GILD ~4% royalties on past sales could be an indication of the go-forward royalty which is expected to be decided starting 3/28.$GILD:

New SEC Filing for GILD: Form DEF 14A (No. 0001193125-16-519487):

https://t.co/OJmUs9M283RT @JSTBiotech: $GBIM $GILD 24 week primary endpoint P2 HBV data in naive patients likely anytime in April based on March completion https:‚Ä¶$GILD - Additional Proxy Soliciting Materials (definitive) (defa14a) https://t.co/l6reJKJ0OnGilead Sciences releases salary data. CEO sees compensation fall -1%25 https://t.co/3OzGGqsOS6 $GILD$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts App$GILD - Proxy Statement (definitive) (def 14a) https://t.co/P7uXMHGyOPRT @jonathanrockoff: Think the increasing competition may be getting to $GILD 's hepatitis C franchise? Think again, Leerink says. https://‚Ä¶RT @Tootix: #GENFIT The definition of Biotech Stock Picking #NASH #Elafibranor $GNFT $ICPT $GILD $SAN  https://t.co/3pXWZr01Kf https://t.co‚Ä¶Apex Retest...textbook! $GILD https://t.co/X42jafnfVU. Took it off at the retest, no faith. Fear of losing profits, #winsomelearnsome$GILD sentiment rise to: 0.86, change: +0.6, sdr: 1.17, 1H, 2:00 PM, #nasdaq $NDX $SPYRT SeekingAlpha: Could Gilead Go For Celgene? https://t.co/1tz4TgShPp $CELG $GILD#Stocks moving higher with some nice moves in $gild $nflx and $tsla all up over 2%. Still holding the line, we need to get above 2070.All these Seeking Alpha authors writing about a $Gild $Celg merger. Dog I was on that shit 9 months ago, look up, im way too far aheadRT @FiercePharma: Merck's $200M damages in Gilead hep C case falls far short of expectations https://t.co/cZFoF4tjQi $MRK $GILD #pharma by ‚Ä¶Could Gilead Go For Celgene? https://t.co/ywfaxYgTFT $CELG $GILDCould Gilead Go For Celgene? https://t.co/8e7SE35Dxt $CELG $GILD$GILD ‚ÄúSeven weeks after launch of Zepatier ($MRK), Sovaldi and Harvoni retain a relatively favorable position..."" https://t.co/KYa6cAwmij$GILD:

One Reason Why Gilead (GILD) Stock Is Advancing Today:

https://t.co/KbWtAcnoiIOne Reason Why Gilead $GILD Stock Is Advancing Today https://t.co/00koJlyLWJOne Reason Why Gilead $GILD Stock Is Advancing Today https://t.co/cQMmsc3698 #StockActionRT @FiercePharma: Merck's $200M damages in Gilead hep C case falls far short of expectations https://t.co/cZFoF4tjQi $MRK $GILD #pharma by ‚Ä¶RT SeekingAlpha: Biogen's Newer Problems; Their Relevance To The Biotech Sector https://t.co/Z6FIufwP58 $ABBV $AMGN $GILD $IBB $IONS $MRK ‚Ä¶#GileadSciences Stock Rises As Analysts Still Like HCV Franchise. Read more: https://t.co/vocCq6buPM $GILDRT @FiercePharma: Merck's $200M damages in Gilead hep C case falls far short of expectations https://t.co/cZFoF4tjQi $MRK $GILD #pharma by ‚Ä¶Merck's $200M damages in Gilead hep C case falls far short of expectations https://t.co/cZFoF4tjQi $MRK $GILD #pharma by @TracyStaton$MRK $IONS $GILD:

Biogen‚Äôs Newer Problems; Their Relevance To The Biotech Sector:

https://t.co/eDl7iezySGBiogen's Newer Problems; Their Relevance To The Biotech Sector https://t.co/8FX0qpX1zJ $ABBV $AMGN $GILD $IBB $IONS $MRK $REGN $RHHBY $SNYBiogen's Newer Problems; Their Relevance To The Biotech Sector https://t.co/wE7qXBQpSH $ABBV $AMGN $GILD $IBB $IONS $MRK $REGN $RHHBY $SNYBiogen's Newer Problems; Their Relevance To The Biotech Sector https://t.co/ZjHUYBTlxq $ABBV $AMGN $GILD $IBB $IONS $MRK $REGN $RHHBY $SNYRT @ChinaInvest: RT SeekingAlpha: Biotechnology Poised To Move Higher https://t.co/IwULX56BKJ $ALXN $AMGN $BIIB $BMRN $CELG $CLDX $DVAX $EG‚Ä¶$GILD Closed good portion today for 7%, took 18 days. Can this go higher? Why not.$GILD 3/9-3/10 $88s is now proving to have been a NICE move. Not going to be GREEDY. $94s was a target. Scale Out in order.RT SeekingAlpha: Biotechnology Poised To Move Higher https://t.co/IwULX56BKJ $ALXN $AMGN $BIIB $BMRN $CELG $CLDX $DVAX $EGRX $GILD $IBB $I‚Ä¶#GileadSciences Gilead says it had no duty to develop less harmful AIDS drug in motion to d... Read more: https://t.co/F2OrN6CRx0 $GILDadded ICPT weekly calls , likely to run up towards FDA april 7th adcom panel , cheap on weekly chart here $GILD $SPy $SPX #biotech#GileadSciences Gilead to Pay $200 Million to Merck for HCV Patent Dispute. Read more: https://t.co/ihZWisnkXb $GILDRT @Benzinga: Data Shows Gilead's HCV Franchise Is Surviving New Competition $ABBV $GILD $MRK https://t.co/jO4ZPYCSJcBiotechnology Poised To Move Higher https://t.co/oFuep5f2Zi $ALXN $AMGN $BIIB $BMRN $CELG $CLDX $DVAX $EGRX $GILD $IBB $ILMN $INCY $IONSData Shows Gilead's HCV Franchise Is Surviving New Competition $ABBV $GILD $MRK https://t.co/jO4ZPYCSJc#GileadSciences' ""Buy"" Rating Reiterated at Citigroup Inc. Read more: https://t.co/rLYtbiZn4m $GILD$GILD Harvoni is covered by 100 percent of the top 20 Medicare plans while none cover Zepatier and 85 percent do not cover Viekira Pak $MRK$GILD Harvoni is covered by 100 percent of the top 20 Medicare plans while none cover Zepatier and 85 percent do not cover Viekira Pak  $MRKGilead is getting some Street love as its HCV franchise keeps powering along despite rivals: https://t.co/sTr4VSpuPT $GILD $ABBV $MRK $IONSRT @Tootix: #GENFIT The definition of Biotech Stock Picking #NASH #Elafibranor $GNFT $ICPT $GILD $SAN  https://t.co/3pXWZr01Kf https://t.co‚Ä¶Weekly Analysts‚Äô Ratings Changes for Gilead Sciences $GILD https://t.co/Mt7mQjvF6cIonis still gets a cash flow stream (even though less) than wasn't modeled in prior. And it's below where it was before verdict. $IONS $GILDWhy A Long/Short Portfolio Makes Sense Today - Part IV https://t.co/tNhfDK1vae $AAL $AAPL $ABX $AER $AVAL $BID $DE $DIS $GILD $HBAYF $IBMWhy A Long/Short Portfolio Makes Sense Today - Part IV https://t.co/0ZYw73NkJF $AAL $AAPL $ABX $AER $AVAL $BID $DE $DIS $GILD $HBAYF $IBMIf you traded alongside the jury decisions, most probably you made a loss. Good lesson for you traders. $GILD $MRK $IONSanyone care to pontificate what $IONS would be trading at today, had the jury found $GILD did not infringe on $MRK patents?6 Most Analyst Rated Stocks in Last 7 days: $NKE $RHT $AAPL $GILD $GIII $AKRX View all ratings here: https://t.co/1yGqm13bhmLarge Put Selling in $AGU $AMZN $DVN $GE $GILD $JPM $LCI $MRO $MS $NKE $OIH $PSTG $SDRL $SLW $TWX $VRX https://t.co/Cg7Yk4msrIRT @AndyBiotech: $GILD vs $MRK #HCV patent case: Jury ordered Gilead to pay Merck $200M in damages(&lt;$40M for $IONS), far less than the $2B ‚Ä¶$GILD doing exactly what it should. Excited for the long term hold. $CMG &amp; $TSLA killing it today. $AAPL trying to hold on to small gains.$GILD For the people. For the Constitution. For the truth. For integrity. For conservative values. FOR AMERICA!!! CRUZ 2016!!!!!!!S&amp;P500 #Stocks Performance $MAR $TWX $DLTR $GILD $NFLX $NWSA $HOT $DG $FMC $M $MNST $AAL $PVH $IPG $VIAB  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Performance $MAR $DLTR $GILD $NFLX $MNST $AAL $VIAB $SBUX $COST $NVDA $VIP $DISCA $MAT  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Performance $TWX $GILD $SBUX $COST $MON $MO $DIS $ALL $FB $FOXA $MET $TGT $GD $HD $DD $SPG  more@ https://t.co/cKkr8cKsju$GILD #Options volume chart in animation. More with #OptionsPro FREE app at https://t.co/K8PrRVM20E https://t.co/oIu9KC8pBpRT @MsPutOptions: $GILD surpassed resistance pt, currently the cloud is giving this 1 some upward issues, volume will have 2 improve https:‚Ä¶Commented on What's Up With Gilead https://t.co/kMeI2pFruS $ABBV $BIIB $IONS $MRK $PTLA $XBI $GILD$GILD surpassed resistance pt, currently the cloud is giving this 1 some upward issues, volume will have 2 improve https://t.co/GwDf12TTaRRT @OpenOutcrier: $GILD Apr 80 Put buyer 4600 for .09Gilead Sciences‚Äô $GILD ‚ÄúBuy‚Äù Rating Reiterated at Citigroup Inc. https://t.co/iAwSpD8MmHGilead Sciences's buy rating reiterated at Citigroup Inc.. $110.00 PT. https://t.co/cELNM64tUx $GILD #GILDRT @Tootix: #GENFIT The definition of Biotech Stock Picking #NASH #Elafibranor $GNFT $ICPT $GILD $SAN  https://t.co/3pXWZr01Kf https://t.co‚Ä¶#Tybost #ParagraphIV suit filed 3/25/16
#Gilead v. #Mylan
DE 1:16-cv-00192
$GILD $MYLGilead Sciences Reiterated Rating by Citigroup (Ranked 28th) to Buy with 110 PT $GILD #GILD https://t.co/nyq7xJnbR7Equities recently tagged #undervalued by the ClosingBell community: $GBSN $FHCO $GILD $P $AAP https://t.co/KW5Vl5Pl0jVolume Alert - GILD 93.97 Gilead Sciences Inc $GILD Hit a high today of 94.31 Closing the day 10:30 at 93.97 + https://t.co/r0r2363UjV$GILD Options #maxpain chart. #option #invest More with #OptionsPro FREE app at https://t.co/vmQaxw1x1K https://t.co/mGOZuyZZ7c$GILD $MRK:

Data Shows Gilead‚Äôs HCV Franchise Is Surviving New Competition:

https://t.co/9uKE3zv4I0RT @OpenOutcrier: $GILD (+1.0% pre) Gilead to Pay Merck $200M in Damages Over Hepatitis C Drug Patents (Far short of $MRK claims) 

https:/‚Ä¶Commented on Gilead Verdict: Who Won, Who Lost https://t.co/weNfqCBJ6U $IONS $MRK $GILDGilead Sciences's buy rating reiterated at Citigroup Inc.. $110.00 PT. https://t.co/cUk3sac1nH $GILD #GILDRT @OpenOutcrier: $GILD Apr 80 Put buyer 4600 for .09March 28 Biotech Update $ACAD $AGN $aldr $AMGN $GILD https://t.co/eDBD0zsJDJRT @adamfeuerstein: Leerink‚Äôs G. Porges says $MRK Zepatier launch worse than $ABBV Viekira Pak at same time point. $GILD maintains HepC dom‚Ä¶RT @JSTBiotech: $GBIM $GILD 24 week primary endpoint P2 HBV data in naive patients likely anytime in April based on March completion https:‚Ä¶RT @OpenOutcrier: $GILD Apr 80 Put buyer 4600 for .09$GILD Apr 80 Put buyer 4600 for .09$MRK $GILD:

Avoid Gilead:

https://t.co/cnhqvzRwxI$GILD #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/bij4t7Kj83RT @matthewherper: Is that surprising given that $MRK has to go after payers? No q re $GILD dominance. Q is can $MRK get a few billion. htt‚Ä¶RT @Tootix: #GENFIT The definition of Biotech Stock Picking #NASH #Elafibranor $GNFT $ICPT $GILD $SAN  https://t.co/3pXWZr01Kf https://t.co‚Ä¶Short Swing $GILD @ 94.27 kissed the 20ma on the weekly. If this one closes and confirms above the 20ma weekly I'll stop out!!RT @SA_BioTech: Avoid Gilead https://t.co/9ILw3hSjfr $MRK $GILDRT SeekingAlpha: Avoid Gilead https://t.co/4PZUQqdRUP $MRK $GILDAvoid Gilead https://t.co/9ILw3hSjfr $MRK $GILDAvoid Gilead https://t.co/S6UrjDbs9A $MRK $GILDMerrill Lynch Reiterates a Neutral Rating on Gilead Sciences $GILD https://t.co/KipiqlF0EC$GILD nonstop today - looking goodRT @Taarriqq: Nice bounce off ystrdays post  &gt; Macd curling up $GILD + 2.5$ $REGN $WMT https://t.co/3pLhLRzDwDRT @GantosJ: $GILD bouncing back from the 20MA &amp; 50MA area. breaking out the $93.19 for the 2nd time, Volatility Squeeze action ‚Üë https://t‚Ä¶RT @sanglucci: $NFLX $GILD only solid trades I'm seeing thus far on the longo... Tape is shit for me so I'm on hands$GILD:

Gilead Sciences Inc. (NASDAQ:GILD) Revamps Position In Street ‚Ä¶:

https://t.co/mO3up6n5w1$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/sUTPu7mnUP https://t.co/WcmTtofSxrRT @jonathanrockoff: Think the increasing competition may be getting to $GILD 's hepatitis C franchise? Think again, Leerink says. https://‚Ä¶RT @outsizedreturn: Last Weeks Change Key Financial Benchmarks $opk $mar $hot $fdc $incy $ppc $twx $gild $spls $f $aapl $ge #hedgefunds htt‚Ä¶RT @outsizedreturn: Last Weeks Change Key Financial Benchmarks $opk $mar $hot $fdc $incy $ppc $twx $gild $spls $f $aapl $ge #hedgefunds htt‚Ä¶$NFLX $GILD only solid trades I'm seeing thus far on the longo... Tape is shit for me so I'm on handsNice bounce off ystrdays post  &gt; Macd curling up $GILD + 2.5$ $REGN $WMT https://t.co/3pLhLRzDwD$SUNE $CALM $GILD $AMBA $UA $NFLX $STX $SBUX greeneryRT @Dougallan1: $gild: ‚ÄòAnother Pretender to Hepatitis C Throne Seems to Be Suffering the $abbv Fate‚Äô
https://t.co/ELqGsj9gBc$gild looking long$GILD trying to break that break out high of the other day$GILD bouncing back from the 20MA &amp; 50MA area. breaking out the $93.19 for the 2nd time, Volatility Squeeze action ‚Üë https://t.co/710gFgGK3DHigh Level Sector Look $RRC $WMB $ADP $CCE $DPS $HAS $SJM $WU $GILD $ESRX  $MMM $MAR $HOT $DG $SPLS $TWX $NFLX $GLW https://t.co/Ilo2Q8yU6j$gild: ‚ÄòAnother Pretender to Hepatitis C Throne Seems to Be Suffering the $abbv Fate‚Äô
https://t.co/ELqGsj9gBcStarting to love the longer term weekly pattern on $GILD into summer as well ... looking for $95 area #biotech$GILD for real this time ?Last Weeks Change Key Financial Benchmarks $opk $mar $hot $fdc $incy $ppc $twx $gild $spls $f $aapl $ge #hedgefunds https://t.co/kWzq8J14ep$GILD hodRT @OpenOutcrier: $GILD (+1.0% pre) IMS Script Data Shows Gilead Sciences Maintaining HCV Lead - Leerink 

https://t.co/JlyDLCNinzRT @jonathanrockoff: Think the increasing competition may be getting to $GILD 's hepatitis C franchise? Think again, Leerink says. https://‚Ä¶RT @jonathanrockoff: Think the increasing competition may be getting to $GILD 's hepatitis C franchise? Think again, Leerink says. https://‚Ä¶Think the increasing competition may be getting to $GILD 's hepatitis C franchise? Think again, Leerink says. https://t.co/GJUTD54zLalong $GILD 93Leerink Swann Reiterates an Outperform Rating on Gilead Sciences $GILD https://t.co/ipRAqfiKSTBetter than expected from $GILD perspective. https://t.co/E7oGzZBfiDRT @OpenOutcrier: $GILD (+1.0% pre) IMS Script Data Shows Gilead Sciences Maintaining HCV Lead - Leerink 

https://t.co/JlyDLCNinzLeerink Swann Reiterates an Outperform Rating on Gilead Sciences $GILD https://t.co/loLFxDFYME$GILD:

Gilead to Pay $200 Million to Merck for HCV Patent Dispute:

https://t.co/CMcmzNpfou$gild - inside candle forming on the 5 min - watch for long side break$GBIM $GILD 24 week primary endpoint P2 HBV data in naive patients likely anytime in April based on March completion https://t.co/8V26xJdOBI$GILD:

Biotech Stocks in Concerns- Gilead Sciences (NASDAQ:GILD ‚Ä¶:

https://t.co/fCaIL2MzlW$GILD Gilead Sciences has dodged one of the threats to its hepatitis C juggernaut. https://t.co/2iJIwE9Ex9Share an idea on $GILD Hope for a bounce at the open to drive the day.Fast forward to 4:24 interesting biotech. https://t.co/1EoN5xucZU $ACAD $ALDR $GILD $VCEL $QLIK $MDVN $MNOV $HOLX $ARLZ $CALMGILD Top news - Mar 28th, 2016 $GILD https://t.co/ZeKbasEkKc#Anyone can #copy but not #everyone can #copyright. $ALDR $ACAD $QLIK $CALM $FB $QQQ $YHOO $GILD $TGEN $UWTIGilead Sciences‚Äô $GILD Neutral Rating Reiterated at Bank of America https://t.co/x9xWGMPF9DLargest open interest increases among single stock options for 3/28 include $GE, $AAPL, $VRX, $BAC, and $GILD.RT @OpenOutcrier: $GILD (+1.0% pre) Gilead to Pay Merck $200M in Damages Over Hepatitis C Drug Patents (Far short of $MRK claims) 

https:/‚Ä¶Watch Idea - Gappers: $ALDR $GILD $CALM $AMZN  -rPremarket most active stocks: $ACAD, $TVIX, $SPIL, $XIV, $FB, $YHOO, $ALDR, $SQQQ, $AAPL, $GILDRT @OpenOutcrier: $GILD (+1.0% pre) IMS Script Data Shows Gilead Sciences Maintaining HCV Lead - Leerink 

https://t.co/JlyDLCNinzGilead Sciences, Inc. $GILD Earns Buy Rating from RBC Capital https://t.co/8uMX7bn8IV$GILD over Wed highs gets us $98-$100 https://t.co/lHdhfvPRZzGilead Sciences‚Äô $GILD Neutral Rating Reiterated at Bank of America https://t.co/3o5bHGfypbAIZ Ideas
See Here ---&gt; https://t.co/CF6ZHeThTw

$AIZ $GILD $ANF #tradeideasRT @matthewherper: Is that surprising given that $MRK has to go after payers? No q re $GILD dominance. Q is can $MRK get a few billion. htt‚Ä¶Gilead Sciences, Inc. $GILD Earns ‚ÄúOutperform‚Äù Rating from Credit Suisse https://t.co/h5i0fYLDHGIs that surprising given that $MRK has to go after payers? No q re $GILD dominance. Q is can $MRK get a few billion. https://t.co/l3NMZdDke1RT @OpenOutcrier: $GILD (+1.0% pre) Gilead to Pay Merck $200M in Damages Over Hepatitis C Drug Patents (Far short of $MRK claims) 

https:/‚Ä¶$GILD $MRK $IONS:

Gilead Verdict: Who Won, Who Lost:

https://t.co/w0FIyvq9nH$GILD undervalued or value trap? Regardless, looks ready to potentially break out hereGilead Sciences, Inc. $GILD Cut to Buy at Vetr Inc. https://t.co/5YOissGfOhRT @OpenOutcrier: $GILD (+1.0% pre) IMS Script Data Shows Gilead Sciences Maintaining HCV Lead - Leerink 

https://t.co/JlyDLCNinzRT @OpenOutcrier: $GILD (+1.0% pre) Gilead to Pay Merck $200M in Damages Over Hepatitis C Drug Patents (Far short of $MRK claims) 

https:/‚Ä¶RT @OpenOutcrier: $GILD (+1.0% pre) IMS Script Data Shows Gilead Sciences Maintaining HCV Lead - Leerink 

https://t.co/JlyDLCNinz$GILD (+1.0% pre) IMS Script Data Shows Gilead Sciences Maintaining HCV Lead - Leerink 

https://t.co/JlyDLCNinz$GILD (+1.0% pre) Gilead to Pay Merck $200M in Damages Over Hepatitis C Drug Patents (Far short of $MRK claims) 

https://t.co/HiVo3eg1JM40% Of Amgen Sales Are Due To Fall Off The Patent Cliff https://t.co/0GGlgMYMlG $AAPL $CSCO $GILD $AMGNRT @scalpthatstock: Box Breakout Trade Setup 
  https://t.co/gFdQIybxg7
  $GOOGL $GPRO $SPY $GILD $TWTRGilead Weakened After Loss To Merck In HCV Dispute https://t.co/hd16UL7ee7 $MRK $GILDBox Breakout Trade Setup 
  https://t.co/gFdQIybxg7
  $GOOGL $GPRO $SPY $GILD $TWTRMerck +0.9%, Gilead -2.1% as jury rules Merck&amp;#39;s patents valid https://t.co/fVA1I3oujw $MRK $GILD$GILD $ZAYO:

Blazing Stocks Calls Bulls- Gilead Sciences (NASDAQ:GILD), Zayo ‚Ä¶:

https://t.co/8gVAoWV5Na#GileadSciences, Inc. Stock Rating Upgraded by Vetr Inc. Read more: https://t.co/3ifQcGPbj5 $GILDhttps://t.co/65FXYqFxMZ $GILD the best.Large Put Selling https://t.co/cUKe6DHpM6 ‚Ä¶      $AGU $AMZN $DVN $GE $GILD $JPM $LCI $MRO $MS $NKE $OIH $PSTG $SDRL $SLW $TWX $VRX$GILD Asked to Pay Just $200 Million to¬†$MRK https://t.co/az5icKugqe$GILD is the leader in HCV.  Leerink calls Merck's Zepatier 'another pretender' in HCV space $MRK $ABBV: Full Story https://t.co/XpgDRiaNmIRT @adamfeuerstein: Leerink‚Äôs G. Porges says $MRK Zepatier launch worse than $ABBV Viekira Pak at same time point. $GILD maintains HepC dom‚Ä¶Leerink calls Merck's Zepatier 'another pretender' in HCV space $GILD $MRK $ABBV: Full Story https://t.co/qJOZJWSouhIMS Script Data Shows Gilead Sciences $GILD Maintaining HCV Lead - Leerink https://t.co/F9ojmnNu21 via ‚Üí @AlertTradeRT @AndyBiotech: $GILD -- Aussie #HCV patient shares his experience of getting Sovaldi from India for ~A$3000
http://t.co/UAhVnocY09 http:/‚Ä¶IMS Script Data Shows Gilead Sciences $GILD Maintaining HCV Lead - Leerink https://t.co/3Dj5kkZX3THURN P/E Ratio
See Here ---&gt; https://t.co/pGpXJikt1e

$HURN $GILD $RIO #shareMissed the weekend's news? Here's what to know #pharma $GILD $MRK #FDA #opioids #healthcare https://t.co/oF2WvvwF56 https://t.co/W8bhWRRJ7i$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/sUTPu7mnUP https://t.co/OaEUfA8ZWu$GILD:

Recent Analysts Ratings Fluctuations: Gilead Sciences, Inc ‚Ä¶:

https://t.co/83wBxL0a9BPremarket Biotech Digest 2016-03-28: $PTLA Betrixaban Setback, $ACAD Nuplazid NDA, $GILD to Pay Just $200¬†Million https://t.co/hnisyomOy7RT @techwhitepapers: $GILD set to pay to $MRK only 200mill jury decided.. much less than anticipated. so $GILD should get a sign of reliefRT @adamfeuerstein: Leerink‚Äôs G. Porges says $MRK Zepatier launch worse than $ABBV Viekira Pak at same time point. $GILD maintains HepC dom‚Ä¶RT @adamfeuerstein: Leerink‚Äôs G. Porges says $MRK Zepatier launch worse than $ABBV Viekira Pak at same time point. $GILD maintains HepC dom‚Ä¶RT @SFBusinessTimes: Gilead halts blood #cancer drug tests as trial patients die https://t.co/EaNwNTU3Gi $GILD https://t.co/xwtufElvrQ$GILD $SHPG:

How Much Revenue Analyst Expect? Gilead Sciences, Inc ‚Ä¶:

https://t.co/nY3RKDliO4RT @adamfeuerstein: Leerink‚Äôs G. Porges says $MRK Zepatier launch worse than $ABBV Viekira Pak at same time point. $GILD maintains HepC dom‚Ä¶RT @adamfeuerstein: Leerink‚Äôs G. Porges says $MRK Zepatier launch worse than $ABBV Viekira Pak at same time point. $GILD maintains HepC dom‚Ä¶Leerink‚Äôs G. Porges says $MRK Zepatier launch worse than $ABBV Viekira Pak at same time point. $GILD maintains HepC dominance.Weekly S&amp;P100 #Stocks Performance $ACN $AMZN $CELG $AMGN $BIIB $UNH $MRK $HPQ $LLY $PFE $AGN $BAC $GILD  more@ https://t.co/cKkr8cKsjuRT @tgtxdough: Large cap biotech PE. $IBB $CELG $GILD https://t.co/T3g9rQFZqXRT @pharm_specialty: #GileadSciences Jury: Gilead owes Merck $200M in damages over drug patents. Read more: https://t.co/OjLgND5q2E $GILD#GileadSciences Jury: Gilead owes Merck $200M in damages over drug patents. Read more: https://t.co/OjLgND5q2E $GILDCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Gilead Sciences, Inc. $GILD Stock Rating Upgraded by Vetr Inc. https://t.co/aAEL8v50UA$GILD set to pay to $MRK only 200mill jury decided.. much less than anticipated. so $GILD should get a sign of reliefGilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Leerink Swann https://t.co/UHbiqCAnz8RT SeekingAlpha: 1000: The True Value Of Seeking Alpha Revealed https://t.co/71LUL0hMea $MNST $ABX $AGNC $ARR $C $EGO $FB $FTR $GG $GILD $‚Ä¶$GILD:

Gilead Sciences (GILD) Short Interest Disclosure:

https://t.co/CW953qUzjHGILD 13,760,635 Stock Charts $GILD Gilead Sciences Inc. (NASDAQ) Last Updated: 03/27/2016 22:17:11 GILD Stock  https://t.co/Xhnt30cJpfGILD Current Price
See Here ---&gt; https://t.co/xC9gNDhSxt

$GILD $DE $DW #finance",2016-03-28,GILD,0
1,"RT @FinSentS_NASDAQ: $GILD:US Merck Seeks To Boost $200M Award In Gilead Drug Patent Case #GILEAD SCIENCES INC  https://t.co/lRvEWO6ew9 #NA‚Ä¶RT @FinSentS_SP500: $GILD:US Merck Seeks To Boost $200M Award In Gilead Drug Patent Case #GILEAD SCIENCES INC  https://t.co/JxXPVWIcwq #SP5‚Ä¶RT @StocksThatDoubl: If you don't consistently find trades like $VLTC +73%, then https://t.co/uAcamNRUPt https://t.co/GTBX9iaGPR $PM $GILD‚Ä¶If you don't consistently find trades like $VLTC +73%, then https://t.co/uAcamNRUPt https://t.co/GTBX9iaGPR $PM $GILD $CMCSA $C $IBM $STRT @raymond10mm: $WY $FE $STZ $BK $AON $L $LB $CMG $DD $VLO $ADP $HCA $ZTS $RAI $MS $LLTC $CCI $TXN $GILD $DOW $CF Beautiful #RALLY! https:‚Ä¶Added small $GILD, frustrating but I think we are almost ready, big position for me, would like to see some distance between 90 closes &lt;92.5RT @StocksThatDoubl: Want alerts for momentum stocks? SUBSCRIBE: https://t.co/uAcamNRUPt  https://t.co/GTBX9iaGPR $PM $GILD $CMCSA $C $IBM ‚Ä¶$GILD:US Merck Seeks To Boost $200M Award In Gilead Drug Patent Case #GILEAD SCIENCES INC  https://t.co/lRvEWO6ew9 #NASDAQWant alerts for momentum stocks? SUBSCRIBE: https://t.co/uAcamNRUPt  https://t.co/GTBX9iaGPR $PM $GILD $CMCSA $C $IBM $STRT @StocksThatDoubl: https://t.co/uAcamNRUPt subscribers alerted to 10-1800% gain stocks. JOIN NOW Promo https://t.co/OQCNEb9p9K $PM $GILD ‚Ä¶Slingshot Bullish https://t.co/a6o7VzExfD $PACW $MMM $INO $GILD $EXPD $SCHN $HSEA $SAP $NEWT $TAXI $LE $CSHCommented on Therapy Focus - TG Could Benefit From Zydelig Setback https://t.co/1oQCXbPhuj $GILD $TGTX$GILD:US Merck Seeks To Boost $200M Award In Gilead Drug Patent Case #GILEAD SCIENCES INC  https://t.co/JxXPVWIcwq #SP500https://t.co/uAcamNRUPt subscribers alerted to 10-1800% gain stocks. JOIN NOW Promo https://t.co/OQCNEb9p9K $PM $GILD $CMCSA $C $IBM $ST$GILD VA Tx costs segment airing on local news here.  Citing high prices for Harvoni and Sovaldi.Meritage Portfolio Management Boosts Position in Gilead Sciences, Inc. $GILD https://t.co/enW2WMtHXzSmith Asset Management Group LP Has $98,371,000 Position in Gilead Sciences, Inc. $GILD https://t.co/4OzG7z2tQjMeritage Portfolio Management Boosts Position in Gilead Sciences, Inc. $GILD https://t.co/IBpKiePL73Swiss National Bank Acquires 24,400 Shares of Gilead Sciences, Inc. $GILD https://t.co/i82f7V6qukSmith Asset Management Group LP Has $98,371,000 Position in Gilead Sciences, Inc. $GILD https://t.co/Q0buv9sIaJCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Banque Pictet &amp; Cie SA Increases Stake in Gilead Sciences, Inc. $GILD https://t.co/VM5qcSLYdyMeritage Portfolio Management Boosts Position in Gilead Sciences, Inc. $GILD https://t.co/54ZZDOHMrZSmith Asset Management Group LP Has $98,371,000 Position in Gilead Sciences, Inc. $GILD https://t.co/pfMXGKK4snConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNR$CTRV its CMX157 drug outperformed a rival treatment developed by $GILD for the hepatitis B virus during head-to-head in-vitro  testing.Still watching a break of ""95"" t\u2026 $GILD https://t.co/BQ8iGdqb6q$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/sUTPu7mnUP https://t.co/xjm8Fc8daeRT SeekingAlpha: Therapy Focus - TG Could Benefit From Zydelig Setback https://t.co/hdP9TBMZzF $GILD $TGTXTherapy Focus - TG Could Benefit From Zydelig Setback https://t.co/N7ST6Z0R8d $GILD $TGTXTherapy Focus - TG Could Benefit From Zydelig Setback https://t.co/rUfWsHcIEE $GILD $TGTXHere goes that #EOD run I was talking about $CTRV don't miss out!! #Squeeze #Bulls $NFLX $AAPL $GILD $TIVO $OHRP $KERX $COST $BWLD $FB $TSLA$WY $FE $STZ $BK $AON $L $LB $CMG $DD $VLO $ADP $HCA $ZTS $RAI $MS $LLTC $CCI $TXN $GILD $DOW $CF Beautiful #RALLY! https://t.co/YkLXnYdQcf#Biotech: Valuations Have Changed, Fundamentals Have Not $IBB $GILD $BIIB $CELG $REGN #mybluechips #stocks
https://t.co/eLCQhpU46G@aedmans Great article!1strategy I use if I'm bullish on MGMT e.g. $SBUX $KO $CSCO $PFE $GILD $WFC I'll invest100%! https://t.co/kJd6WezrO2$TSLA and $GILD erasing early losses, as well as the rest of the market. $CMG still red from downgrade.Gilead Sciences Has Highest Drug Efficacy in Market $GILD https://t.co/m0G5ifsY55 via @wstranscript$CRTV making a move? Or just trying to ride the $GILD wave while it's still hot?@MotherCabriniNY @runtodaylight there r restrictions on assets sales, asset sales would be minor, I think sale for all of $vrx to $gildRT @PortfolioArmor: Adding Downside Protection To Gilead Sciences $ABBV $MRK $GILD https://t.co/JHzHcXgKpzAdding Downside Protection To Gilead Sciences $ABBV $MRK $GILD https://t.co/JHzHcXgKpzRT @actaestfabulaXX: ContraVir claims CMX157 better than Gilead's TAF in hepatitis B; shares up 20% $CTRV $GILD https://t.co/MpUXvfmqAWHealth Care Sector Update for 03/29/2016: $PBYI $CTRV $GILD $BPMX https://t.co/b4uyWmNtAL via @midnighttrader @NasdaqContraVir claims CMX157 better than Gilead's TAF in hepatitis B; shares up 20% $CTRV $GILD https://t.co/1BImmhWCg7CIDM EOD Data
See Here ---&gt; https://t.co/JLSwTNgiEs

$CIDM $GILD $SAN #investing$CTRV claims CMX157 better than $GILD's TAF in hepatitis B, but studies are in vitro  https://t.co/KbP3nrsYKL by @SeekingAlphaLeerink Swann analyst Geoff Porges weighed in today with mixed views on healthcare giants $GILD and $BIIB: https://t.co/4pLbDNxRNL@UBS holds a healthcare conf in May.. many companies there . $AFMD $GNCA $VBLT $QURE .. yes $ADAP , $GILD  AND many more.Could Gilead Go For Celgene? https://t.co/a5h6fUuT09 $CELG $GILD - free #investing book &amp; newsltr = big profits - jeffee13@hotmail.comRT @actaestfabulaXX: ContraVir claims CMX157 better than Gilead's TAF in hepatitis B; shares up 20% $CTRV $GILD https://t.co/MpUXvfmqAWContraVir claims CMX157 better than Gilead's TAF in hepatitis B; shares up 20% $CTRV $GILD https://t.co/MpUXvfmqAWRT @TipRanks: Leerink Weighs In On Two Healthcare Giants: $GILD and $BIIB https://t.co/NfYfATNUagContraVir claims CMX157 better than Gilead's TAF in hepatitis B; shares up 20% https://t.co/FMLA4UFe5l $CTRV $GILDContraVir claims CMX157 better than Gilead's TAF in hepatitis B; shares up 20% https://t.co/FMLA4UWOWT $CTRV $GILDContraVir claims CMX157 better than Gilead's TAF in hepatitis B; shares up 20% https://t.co/tXFiAH2ABa $CTRV $GILDContraVir claims CMX157 better than Gilead's TAF in hepatitis B; shares up 20% https://t.co/t6omhN5KZb $CTRV $GILDContraVir claims CMX157 better than Gilead's TAF in hepatitis B; shares up 20% https://t.co/PGdEMxRIRn $CTRV $GILD$TGTX could benefit from $GILD Zydelig setback. A look at PI3K inhibitors in hematological conditions. https://t.co/KylLNUq11l#GileadSciences Merrill Lynch Bearish on Gilead Despite Trivial Merck Damages. Read more: https://t.co/papEpYK9wX $GILD$CTRV #EOD run up play in action bottom validated, re-climb in the works. #Bulls $NFLX $AAPL $GILD $TIVO $OHRP $KERX $COST $BWLD $FB $TSLA$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/sUTPu7mnUP https://t.co/KOVGUMCcAAFresh of $200M win, Merck is aiming at a larger slice of @GileadSciences HPV revenue https://t.co/pjv4niZuJK $MRK $GILDGILD Dividend
See Here ---&gt; https://t.co/EsFVSpjyeA

$GILD $HGG $CYNO #investingMorning Session Update: 2 Wins/3 Losses: $AAPL $CVS $BA $GILD $NFLX .. Waiting for the market to wake up a bit... https://t.co/rQFRz7DOLsRT @mcorcelli: Corcelli's 30 Second Morning Mkt Update $affx $rig $cnl $bac $fcx $gild $mu $crm $fb $aapl $ge $ibm $hp #hedgefunds https://‚Ä¶added ICPT  $SPy $SPX $GILD  april 7th playHold $CMG for now, still buying $GILD, very hopeful for $TSLA release on Thursday.RT SeekingAlpha: Adding Downside Protection To Gilead Sciences https://t.co/HTv6fpQEGH $ABBV $MRK $GILDGilead Sciences, Inc. $GILD Given Buy Rating at Citigroup Inc. https://t.co/VbPc6WBVgtGilead Sciences, Inc. $GILD Given Buy Rating at Citigroup Inc. https://t.co/yfkfbj58p7$CMG slashed by Wedbush with $400 target, concerns over $GILD sustainability with royalties, UBS bearish on $TSLA with $140 target.$GILD $MRK:

Adding Downside Protection To Gilead Sciences:

https://t.co/bORDVCaPuhVolume Alert - GILD 91.31 Gilead Sciences Inc $GILD Hit a high today of 92.24 Closing the day 10:30 at 91.31 - https://t.co/17Bh8eN6mSOur Picks Are Seeing Incredible Gains! Get Exclusive Early Access To Our New Alerts: https://t.co/dWbN7JMySK $GILD $NWSA $EBAYAdding Downside Protection To Gilead Sciences https://t.co/K1GfIjD7NO $ABBV $MRK $GILDAdding Downside Protection To Gilead Sciences https://t.co/jr571AHg2H $ABBV $MRK $GILDAdding Downside Protection To Gilead Sciences https://t.co/YM4J48CRGZ $ABBV $MRK $GILDAdding Downside Protection To Gilead Sciences https://t.co/KSfOOn4XoL $ABBV $MRK $GILDThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $GILD $NWSA $EBAYEmbrace Gilead $GILD https://t.co/fHcphmCO6DRT @TheIpHawk: $GILD filed suit v Mylan over Tybost in Delaware.Over 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $GILD $NWSA $EBAY$GILD was a really nice support becoming resistance for a nice quick trade long@bradloncar If one were to ask Maura Healey why investors attribute value to $GILD of only 7.4 times forward earnings, would she get it?RT @FinSentS_NASDAQ: $GILD:US Merck Seeks To Boost $200M Award In Gilead Drug Patent Case #GILEAD SCIENCES INC  https://t.co/S5hdNtJi1H #NA‚Ä¶If $IBB can get it's shit together, $IONS will have a nice day. A lot depends on $REGN and $GILD.$GILD:US Merck Seeks To Boost $200M Award In Gilead Drug Patent Case #GILEAD SCIENCES INC  https://t.co/S5hdNtJi1H #NASDAQ.
94.57% Average Gain
UNBIASED!
 .
https://t.co/mNVCwocg7V 
 .
$CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO https://t.co/ma8wyImDIm$GILD filed suit v Mylan over Tybost in Delaware.GILD Top news - Mar 29th, 2016 $GILD https://t.co/wE34SjiAdWRT @HumbleBioTrader: The biggest obstacle in biotech now is the politics of pricing. Great companies like $GILD being questioned by politic‚Ä¶barronsonline: Q&amp;A: Why Matthew Page of $IWIRX likes $WETF $GILD $CSCO $PAY and more https://t.co/0keZZ3KUl0 DeFo‚Ä¶ https://t.co/kF65Ueq35xNew trend started on $GILD when price was 90.68 https://t.co/yAYciSlhOq #TradingSystem #StockRT @barronsonline: Q&amp;A: Why Matthew Page of $IWIRX likes $WETF $GILD $CSCO $PAY and more https://t.co/oJUpDlqYY8 @DeFotis https://t.co/E1Co‚Ä¶Merrill Lynch Bearish on Gilead Despite Trivial Merck Damages $GILD , $MRK  
https://t.co/oPEbCKziAq https://t.co/5zZquCZcXpQ&amp;A: Why Matthew Page of $IWIRX likes $WETF $GILD $CSCO $PAY and more https://t.co/oJUpDlqYY8 @DeFotis https://t.co/E1CorzNRhj10 Companies With The Biggest Share Buybacks - https://t.co/0l5YWFCQ4Q - $MSFT $GE $GILD $MON $MSFT $UTX $V $DIS $GE $AAPL$GILD:

Stocks to Watch: North Atlantic Drilling Limited (NYSE:NADL ‚Ä¶:

https://t.co/HhgU8c1PmfLeerink Weighs In On Two Healthcare Giants: $GILD, $BIIB
https://t.co/tecz08UIWFRT @mcorcelli: Corcelli's 30 Second Morning Mkt Update $affx $rig $cnl $bac $fcx $gild $mu $crm $fb $aapl $ge $ibm $hp #hedgefunds https://‚Ä¶#GileadSciences Gilead ordered to pay $200 million in Sovaldi patent case. Read more: https://t.co/yyWat07zOi $GILDCorcelli's 30 Second Morning Mkt Update $affx $rig $cnl $bac $fcx $gild $mu $crm $fb $aapl $ge $ibm $hp #hedgefunds https://t.co/tcCmXAzYbi$GILD $ABT:

Analyst Recent Rating Update: Gilead Sciences, Inc. (NASDAQ ‚Ä¶:

https://t.co/U4lQJ9CZbNMTW News
See Here ---&gt; https://t.co/sZWpNcGldr

$MTW $MTP $GILD #shareGilead Sciences, Inc. $GILD Raised to ‚ÄúStrong-Buy‚Äù at Vetr Inc. https://t.co/gD38rNGBzHMasterclass Watchlist 3/29:

Gold: $FB $BABA $SWHC $TWTR

Silver:  $GILD $DVN $AAPL $MCD $WMT $FIT
$GPRO

Bronze: $NKE$GILD $RAD:

A Buy Signal For These Stocks: Gilead Sciences, Inc. (NASDAQ ‚Ä¶:

https://t.co/Cd8Z8U9pVF$CSAX #1 MMJ Security. 35 cent. OTCQB. $1m monthly revs. 7m float https://t.co/7D29lJtlEy

#stocks $LYB $YRD $GILD
https://t.co/f3yYLvCpjKLeerink Weighs In On Two Healthcare Giants: $GILD and $BIIB https://t.co/NfYfATNUagLYB 52Wk High
See Here ---&gt; https://t.co/CWbzBXbZ4Z

$LYB $YRD $GILD #pennystocksHCA Ask
See Here ---&gt; https://t.co/iOfo5olGjj

$HCA $GILD $CMCSA #invest$esrx down 21 percent since the nonsense with $abbv against $gild. They thought they had control of the pricing nonsense. Nope.RT SeekingAlpha: Embrace Gilead https://t.co/54zUXiMWMM $MRK $GILDEmbrace Gilead https://t.co/6NMOPuxq4Z $MRK $GILDEmbrace Gilead https://t.co/XLNDLySO4m $MRK $GILD$GILD $ZTS:

Take a look at Analysts Tips: Gilead Sciences, Inc. (NASDAQ:GILD ‚Ä¶:

https://t.co/teGDt0kZZtBest-Performing Value Strategies - Part 4: Backtesting The Magic Formula https://t.co/3wDBHZrKsC $AAPL #APPLE $AET $CSCO $DISCA $GILD $HPQBest-Performing Value Strategies - Part 4: Backtesting The Magic Formula https://t.co/x1tcbINFYs $AAPL #APPLE $AET $CSCO $DISCA $GILD $HPQ#GileadSciences Gilead must pay just $200m for hep C patents, says jury. Read more: https://t.co/wbvlR5JS2N $GILDGilead Sciences‚Äô $GILD ‚ÄúBuy‚Äù Rating Reiterated at RBC Capital https://t.co/onwIEml99WGilead Sciences‚Äô $GILD ‚ÄúOutperform‚Äù Rating Reiterated at Robert W. Baird https://t.co/YTM81Jo94MGilead Sciences‚Äô $GILD ‚ÄúOutperform‚Äù Rating Reiterated at Robert W. Baird https://t.co/5fGEakQaln10 Companies With The Biggest Share Buybacks - https://t.co/0l5YWFlfdi - $AAPL $AIG $DIS $GILD $GE $MON $MSFT $ORCL $UTX $VWondering about risks of $GILD? The 63-day volatility is 15.87% https://t.co/YrfwPBvvTu$GILD https://t.co/dZWRGe19sM Pot. intermed bot in Downtrend LONGERTERM Wly-Dly-Hly combo chart #trading #stocks https://t.co/SPhqzhHDvIRT @YahooFinance: Bottom 5 Stocks in 2016: $BAC, $AMZN, $NFLX, $GILD, $DIS - @serwer breaks it down, Watch: https://t.co/YsZ0m4rils https:/‚Ä¶RT @FinSentS_NASDAQ: $GILD:US Merck Seeks To Boost $200M Award In Gilead Drug Patent Case #GILEAD SCIENCES INC  https://t.co/9o9muUSj7Y #NA‚Ä¶RT @FinSentS_SP500: $GILD:US Merck Seeks To Boost $200M Award In Gilead Drug Patent Case #GILEAD SCIENCES INC  https://t.co/AnxKIxF4IS #SP5‚Ä¶$GILD:US Merck Seeks To Boost $200M Award In Gilead Drug Patent Case #GILEAD SCIENCES INC  https://t.co/9o9muUSj7Y #NASDAQhttps://t.co/uAcamNRUPt members alerted to 10-1800% potential. Subscribe https://t.co/UPw2skaweX $QQQ $INTC $HSBC $PEP $PM $GILD $CMCSABreaking through $GILD https://t.co/lP7vEsaMQ9Need help finding momentum trades? https://t.co/uAcamNRUPt https://t.co/qTR8WWxoW5 $WTW $HSBC $PEP $PM $GILD $CMCSA $BAC $ORCL $MRK$GILD:US Merck Seeks To Boost $200M Award In Gilead Drug Patent Case #GILEAD SCIENCES INC  https://t.co/AnxKIxF4IS #SP500RT @FiercePharma: Merck's $200M damages in Gilead hep C case falls far short of expectations https://t.co/cZFoF4tjQi $MRK $GILD #pharma by ‚Ä¶RT @adamfeuerstein: Leerink‚Äôs G. Porges says $MRK Zepatier launch worse than $ABBV Viekira Pak at same time point. $GILD maintains HepC dom‚Ä¶OTIC Ask
See Here ---&gt; https://t.co/syt1KuS7nw

$OTIC $FLKS $GILD #invest$GILD Gilead Sciences is a 5 star üí∞ dividend üí∞ stock with a 1.9% yield: https://t.co/9SYzIaSSwG https://t.co/I0LdfAAiRRCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Sell-signal detected for 7 stocks: $GILD $TWX $EQR $PEP $BXP $LLTC $PXAvoid Gilead https://t.co/qpw3VItYDR $MRK $GILDhttps://t.co/W3gditBjAt members alerted to $EPRS +23%  See track record and join today  https://t.co/gOZezqGZW2 $PM $GILD $CMCSA $C $IBMS:""Catalysts Calendar: $GBT 2H focused with EHA. $AMGN PCSK9. MPS7, new KRN23 &amp; UX007 = $RARE, HBV and NASH data= $GILD ...""RT @sanglucci: $NFLX $GILD only solid trades I'm seeing thus far on the longo... Tape is shit for me so I'm on handsRT @StocksThatDoubl: $AQXP +1819%. SEE TRACK RECORD &amp; SUBSCRIBE  https://t.co/W3gditBjAt https://t.co/zHAvlEkA1M $PM $GILD $CMCSA $C $IBM $‚Ä¶Avoid Gilead https://t.co/UZBzUCOdwY ‚Ä¶  @cafepharma @BiotechNews @pharmagossip @GenericPharma24 @pharmaguy $MRK $GILDRT @SA_BioTech: Avoid Gilead https://t.co/9ILw3hSjfr $MRK $GILD$AQXP +1819%. SEE TRACK RECORD &amp; SUBSCRIBE  https://t.co/W3gditBjAt https://t.co/zHAvlEkA1M $PM $GILD $CMCSA $C $IBM $STMAR 28 Monday, $GILD closed $92.46. My BULLISH target is $95.40RT @StocksThatDoubl: If you don't consistently find trades like $VLTC +73%, then https://t.co/uAcamNRUPt https://t.co/GTBX9iaGPR $PM $GILD ‚Ä¶If you don't consistently find trades like $VLTC +73%, then https://t.co/uAcamNRUPt https://t.co/GTBX9iaGPR $PM $GILD $CMCSA $C $IBM $STGILD still strong in spite the Merck patent loss Screw all the haters that say dump GILD! $GILD #pharmanews #biotech https://t.co/8ULspbKjthAvoid Gilead https://t.co/VbISJJkMzU $MRK $GILD$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Closes +1.25% For the Session:

https://t.co/z3i9ez4F9W",2016-03-29,GILD,0
2,"Jury Verdict Favors Sofosbuvir Royalty Claim by  Against Gilead https://t.co/oTiFQxi8iH $GILD $MRK #HCV #hepatitisOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $GILD $NWSA $EBAYFor a Possible Gilead $GILD-Celgene CELG Deal, Let Us Count the Ways https://t.co/jC6BjT3LNo https://t.co/OPglnRsKaIRT @tgtxdough: $GILD HepC US tracking slightly ahead
IMS reported February Harvoni sales of $853mn and Sovaldi sales of $232mn, for a total‚Ä¶RT @tgtxdough: $GILD HepC US tracking slightly ahead
IMS reported February Harvoni sales of $853mn and Sovaldi sales of $232mn, for a total‚Ä¶RT @FiercePharma: Gilead meds face little threat from hep C rivals Merck, BMS and AbbVie: analyst https://t.co/4I8yVQTa3j $GILD #pharma by‚Ä¶$GILD HepC US tracking slightly ahead
IMS reported February Harvoni sales of $853mn and Sovaldi sales of $232mn, for a total of $1.08bn$OXY $MU $GILD $IBM $AAPL:

Your first trade for Thursday, March 31:

https://t.co/8snNXon6Po@DrPaulyDeSantis Recall $GILD entered a BET inh into Prostate Cancer: https://t.co/w73bNQQeQkDo you think $GILD would buy $MDVN? $IBB $XBI $AMGN $JNJ $BIIB $INCY{FREE} WHAT'S MY FAVORITE SETUP? $SPY $TWTR $GPRO $GOOGL $GILD $STUDY - CLICK THE LINK &gt; https://t.co/wQ6aGmMyu7 https://t.co/gx05ljHAzQ#GileadSciences, Inc. Shares Bought by First National Trust Co. Read more: https://t.co/OG0IMbp1R3 $GILD#FastMoneyEspresso
FINAL TRADES:
Tim Seymour ‚Äî&gt; buy $OXY
David Seaburg ‚Äî&gt; buy $MU
Karen Finerman ‚Äî&gt; buy $GILD
Brian Kelly ‚Äî&gt; sell $IBMRT @AndyBiotech: #EASL2016 abstract book out
https://t.co/mLSUzVZWGl

#ILC2016 $GILD $ABBV $ENTA $MRK@petenajarian @CardyTruster @kevinolearytv @HalftimeReport $GILD $AMGN low PE n dividend $BIIB $CELG growth #biotech #investing #TomsTruthsGilead Sciences, Inc. $GILD Shares Bought by First National Trust Co. https://t.co/dgh8CrNen6Gilead Sciences, Inc. $GILD is Hudson Canyon Investment Counselors LLC‚Äôs 6th Largest Position https://t.co/PZmdxT8gLYGilead Sciences, Inc. $GILD Stake Decreased by Cadence Capital Management LLC https://t.co/OT8WAv8QUkGilead Sciences, Inc. $GILD Shares Sold by Denver Investment Advisors LLC https://t.co/6xleFVsktRGilead Sciences, Inc. $GILD Shares Bought by First National Trust Co. https://t.co/YOyaopij96Gilead Sciences, Inc. $GILD Shares Sold by Denver Investment Advisors LLC https://t.co/2L7thk2KMA$GILD ticks the boxes as a dream üí∞ dividend üí∞ stock with 1.9% yield https://t.co/E6pRYleaQI https://t.co/v5QXwaTCEf3 #Biotech Stocks That Make the Grade for Investors $AMAG $GILD $HZNP  https://t.co/qOZVOc7tZ8TZA Ex-Div Date
See Here ---&gt; https://t.co/7BKWpZSRg9

$TZA $FDC $GILD #stockRT @R4inb0w_: @ZatarraSucks @Logribel GENFIT NASDAQ... Answer : Tomorrow in NY... or not ;-) $GNFT $ICPT $GILD https://t.co/E9IHsye99kRT @pozmagazine: Gilead‚Äôs TLR7 Agonist Shows Promise in #HIV Cure Research Among Monkeys https://t.co/i9nHriHAjI @GileadSciences $GILDRT @hepatitismag: #Harvoni is Safe and Effective in Seniors With #Hepatitis C https://t.co/85mWwqjb66 @GileadSciences $GILD #HCV #hepC'Economist' In Me Says This Is A Threat To Gilead https://t.co/koMEfNGXSh ‚Ä¶ $ABBV $GILD  @MassAGO @AGSchneiderman https://t.co/R8NYffj1TnThe only thing that is really going to fuel biotech again is some buyouts.  $GILD pretty much set the tone last quarter saying NOPE!RT @R4inb0w_: @ZatarraSucks @Logribel GENFIT NASDAQ... Answer : Tomorrow in NY... or not ;-) $GNFT $ICPT $GILD https://t.co/E9IHsye99kRT @hepatitismag: #Harvoni is Safe and Effective in Seniors With #Hepatitis C https://t.co/85mWwqjb66 @GileadSciences $GILD #HCV #hepCRT SeekingAlpha: 'Economist' In Me Says This Is A Threat To Gilead https://t.co/8Ea5dqAHiP $ABBV $AET $ANTM $GILD'Economist' In Me Says This Is A Threat To Gilead https://t.co/DcsDv59Z1l $ABBV $AET $ANTM $GILD'Economist' In Me Says This Is A Threat To Gilead https://t.co/u4lwQxvGkY $ABBV $AET $ANTM $GILDRT SeekingAlpha: Gilead, Gilead Where Art Thou Gilead? https://t.co/Ts8DMmp8XS $MRK $CELG $GILDJBEM is bak 2 sendng out comprehensive DD.Goin bak 2 his roots:  https://t.co/hBrHFNeVvm $GIL $GILD $GILT $GIM $GIMO $GIS $GIVE $GJOGilead, Gilead Where Art Thou Gilead? https://t.co/jOEQhXZXWp $MRK $CELG $GILDGilead, Gilead Where Art Thou Gilead? https://t.co/vCYKZrD8EL $MRK $CELG $GILDCommented on Gilead Sciences Vs. Its Peers https://t.co/j80HUQtQpC $ABBV $AMGN $CELG $IBB $XBI $GILDRT @FiercePharma: Gilead meds face little threat from hep C rivals Merck, BMS and AbbVie: analyst https://t.co/4I8yVQTa3j $GILD #pharma by‚Ä¶RT @FiercePharma: Gilead meds face little threat from hep C rivals Merck, BMS and AbbVie: analyst https://t.co/4I8yVQTa3j $GILD #pharma by‚Ä¶Should #GileadSciences Feel Threatened By ContraVir's Hepatitis B Drug?. Read more: https://t.co/BwYiS32J24 $GILDRT SeekingAlpha: Watchlist Wednesday: Magic Formula https://t.co/a9Qaqmd8U7 $GILD $AAPL $VIA $VIAB $DGX $CA#Harvoni is Safe and Effective in Seniors With #Hepatitis C https://t.co/85mWwqjb66 @GileadSciences $GILD #HCV #hepCAvoid Gilead https://t.co/ivNGBqE2DI  $GILD https://t.co/fnTzNU8W2ZGILD Current Price
See Here ---&gt; https://t.co/NyKE2eAFNW

$GILD $GRPN $HFWA #stockmarketDAL Shares
See Here ---&gt; https://t.co/a5GYlZrPTV

$DAL $GILD $SHAK #stock$abus https://t.co/gwRgUsBLYJ very nice. $arwr $gild @RNAiAnalyst @smallcapbiotech @stb8444 @Shonaldo1In the high volatility world of Biotechs, $AMGN $GILD $CELG stand out as value companies with $$Billions in revenue! https://t.co/7fnYFzOR05#GileadSciences, Inc. Stock Rating Reaffirmed by Citigroup Inc. Read more: https://t.co/Es8j8tjsqd $GILDRT @AndyBiotech: $JNJ nuc AL-335 from Alios acquisition achieved 4.0~4.7log VL reduction at 800mg in #HCV GT 1-3

#ILC2016 $GILD $MRK https‚Ä¶@petenajarian @Sharpinsky Many,many is true- not majority I believe-we cant kill ourselves fast enough for a cure yet.  very soon tho $GILD@AACR16 Abstracts + partnerships w #EISAI Halaven &amp;$MRK Keytruda - plus PegpH20 targets -put $HALO in the lead on Solid Ca $GILD $NVS $PBYIThat would be a $100B purchase RT @pharm_specialty: #GileadSciences Could Gilead Buy Celgene to Become a Major Oncology Player?  $GILD$GILD Took off 1/3 #trading S at $91.66 avg from $93 ... rest can ride  https://t.co/HOYEAdVG7WRT @AndyBiotech: #EASL2016 abstract book out
https://t.co/sLo9M0QWzs

#ILC2016 $GILD $ABBV $ENTA $MRKAdding Downside Protection To Gilead Sciences https://t.co/KLU0pE4p9S $ABBV $MRK $GILD - free #investing book - jeffee13@hotmail.comRT @FiercePharma: Gilead meds face little threat from hep C rivals Merck, BMS and AbbVie: analyst https://t.co/4I8yVQTa3j $GILD #pharma by‚Ä¶Gilead meds face little threat from hep C rivals Merck, BMS and AbbVie: analyst https://t.co/4I8yVQTa3j $GILD #pharma by @TracyStaton@HalftimeReport $GTN $TWTR $GILD $BIIB $ILMN $BABA $WFC $AAPL $KMI $AXAS $WBA $GOOGL my halftime portfolio is -6% YTD but coming backGilead Sciences Vs. Its Peers https://t.co/tvujpr39Cq $GILD, $ABBV, $AMGN, $CELG, $IBB, $XBI

#BIOTECH#GileadSciences Could Gilead Buy Celgene to Become a Major Oncology Player?  . Read more: https://t.co/9H9ON7A2M7 $GILDCould Gilead Go For Celgene? https://t.co/znBiWRMsaj $GILD $CELG https://t.co/17hVkfpgFOTrading Rules - Discipline and staying strong: https://t.co/vVZZyIZdvD $GILD $TTWO $GM $SCO $REXX $YUM $ABBV $UCO $NXPI $USO $WPRT#biotech bottoming process taking longer than expected. We are still in 2 steps forward 1 1/2 steps back mode. $IBB $GILD $CLVS $HALO $VRTXRT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR $ALNY $BIIBVolume Alert - GILD 93.00 Gilead Sciences Inc $GILD Hit a high today of 93.57 Closing the day 10:30 at 93.00 + https://t.co/TSvgXSUx2SGilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Citigroup Inc. https://t.co/XkxfQbDY0YCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @GerberKawasaki: #stocks are testing crucial levels. 2070 is big on the S&amp;P500 If we can break though to 2100. The BULL is back! $aapl $‚Ä¶#stocks are testing crucial levels. 2070 is big on the S&amp;P500 If we can break though to 2100. The BULL is back! $aapl $dis $gild$JNJ nuc AL-335 from Alios acquisition achieved 4.0~4.7log VL reduction at 800mg in #HCV GT 1-3

#ILC2016 $GILD $MRK https://t.co/jUMkAg8mSIGILD Top news - Mar 30th, 2016 $GILD https://t.co/o5tt7Oa9MY$GILD +0,8% auf 92,90$ weniger Schadensersatz - geht es bei der #BBBiotech Beteiligung jetzt wieder aufw√§rts? /MS https://t.co/F9jUF6setLRough news for $GILD and $PTLA lately -- are our healthcare analysts sweating? Find out in this afternoon's episode.$GILD has more then enough cash to buy growth without making debt. If that is the problem...Biotech Investors: Here's How To Respond To The Bursting Bubble https://t.co/wZUaqFl2HG $AMGN $BIIB $CELG $GILD $SHPG $IBB@ZatarraSucks @Logribel GENFIT NASDAQ... Answer : Tomorrow in NY... or not ;-) $GNFT $ICPT $GILD https://t.co/E9IHsye99k$GILD $NVS:

Market Analyst Checklist Stocks: Gilead Sciences, Inc. (NASDAQ ‚Ä¶:

https://t.co/6UnpiYwbHGStarted $GILD short at $93Let's see what $LABU does at the (ma)50.  $LABD $ZIOP $JUNO $IBB $BIS $CELG $GILD $HZNP $KBIOQRT @StocksThatDoubl: $AQXP +1819%. SEE TRACK RECORD &amp; SUBSCRIBE  https://t.co/W3gditBjAt https://t.co/zHAvlEkA1M $PM $GILD $CMCSA $C $IBM $‚Ä¶$AQXP +1819%. SEE TRACK RECORD &amp; SUBSCRIBE  https://t.co/W3gditBjAt https://t.co/zHAvlEkA1M $PM $GILD $CMCSA $C $IBM $STRT @AndyBiotech: #EASL2016 abstract book out
https://t.co/sLo9M0QWzs

#ILC2016 $GILD $ABBV $ENTA $MRKRT @StocksThatDoubl: If you don't consistently find trades like $VLTC +73%, then https://t.co/uAcamNRUPt https://t.co/GTBX9iaGPR $PM $GILD‚Ä¶RT @bio_clouseau: $MRK will be presenting ""high efficacy"" data with 8 wk 3DAA regimen at ILC $GILD $ABBV$GILD $HAL:

Analyst Overview: Gilead Sciences, Inc. (NASDAQ:GILD ‚Ä¶:

https://t.co/DitqcIkjxjRT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶RT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶RT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶RT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK https://t.co/VUA3sMo2spIf you don't consistently find trades like $VLTC +73%, then https://t.co/uAcamNRUPt https://t.co/GTBX9iaGPR $PM $GILD $CMCSA $C $IBM $STGilead Sciences‚Äô $GILD Outperform Rating Reaffirmed at Leerink Swann https://t.co/Y0s4vUI9PbRT @StocksThatDoubl: Want alerts for momentum stocks? SUBSCRIBE: https://t.co/uAcamNRUPt  https://t.co/GTBX9iaGPR $PM $GILD $CMCSA $C $IBM‚Ä¶RT SeekingAlpha: Gilead Sciences Vs. Its Peers https://t.co/mJuZxej6FN $ABBV $AMGN $CELG $IBB $XBI $GILDRT @AndyBiotech: #EASL2016 abstract book out
https://t.co/sLo9M0QWzs

#ILC2016 $GILD $ABBV $ENTA $MRKRT @AndyBiotech: #EASL2016 abstract book out
https://t.co/sLo9M0QWzs

#ILC2016 $GILD $ABBV $ENTA $MRKGilead Sciences Vs. Its Peers https://t.co/7aY4ER5B8S $ABBV $AMGN $CELG $IBB $XBI $GILDGilead Sciences Vs. Its Peers https://t.co/x8jnIFLiu7 $ABBV $AMGN $CELG $IBB $XBI $GILDRT @AndyBiotech: #EASL2016 abstract book out
https://t.co/sLo9M0QWzs

#ILC2016 $GILD $ABBV $ENTA $MRKRT @AndyBiotech: #EASL2016 abstract book out
https://t.co/sLo9M0QWzs

#ILC2016 $GILD $ABBV $ENTA $MRKRT @AndyBiotech: #EASL2016 abstract book out
https://t.co/sLo9M0QWzs

#ILC2016 $GILD $ABBV $ENTA $MRKRT @AndyBiotech: #EASL2016 abstract book out
https://t.co/sLo9M0QWzs

#ILC2016 $GILD $ABBV $ENTA $MRKRT @AndyBiotech: #EASL2016 abstract book out
https://t.co/sLo9M0QWzs

#ILC2016 $GILD $ABBV $ENTA $MRK#EASL2016 abstract book out
https://t.co/sLo9M0QWzs

#ILC2016 $GILD $ABBV $ENTA $MRK$MRK will be presenting ""high efficacy"" data with 8 wk 3DAA regimen at ILC $GILD $ABBVWant alerts for momentum stocks? SUBSCRIBE: https://t.co/uAcamNRUPt  https://t.co/GTBX9iaGPR $PM $GILD $CMCSA $C $IBM $ST$GILD:

Analyst Rating Fluctuations to Observe: Gilead Sciences, Inc ‚Ä¶:

https://t.co/IlCn6pjgmzHCV tourism from China https://t.co/cN7eZkTbyu $GILD $ABBV $MRKRT @Tootix: #Genfit #EASL  
EFFICIENT IDENTIFICATION OF #NASH PATIENTS AT RISK WHO SHOULD BE TREAT $GNFT $ICPT $GILD $SAN https://t.co/8lA2‚Ä¶More dramatic than EPS, FX effects on drug availability $gild HepC $ibb https://t.co/NbazMrYcxL#Genfit #EASL  
EFFICIENT IDENTIFICATION OF #NASH PATIENTS AT RISK WHO SHOULD BE TREAT $GNFT $ICPT $GILD $SAN https://t.co/8lA2eAyBe6#Genfit #EASL  
IDENTIFICATION OF NOVEL MOLECULE COMPOUNDS WITH POTENT ANTIFIBROTIC PROPERTIES $GNFT $ICPT $GILD https://t.co/wSy0JssuOJ#Genfit #EASL  
RORŒ≥T INHIBITION IN THE LIVER PREVENTS HEPATIC FIBROSIS PROGRESSION $GNFT $ICPT $GILD $SAN https://t.co/4gZBZkxveh#Genfit #EASL RELATIONSHIP BETWEEN HEPATIC DISEASE SEVERITY &amp; CARDIOMETABOLIC AND ANTIINFLAMMATORY $GNFT $ICPT $GILD https://t.co/xrvux3QIrlRT @Tootix: #Genfit #EASL PNPLA3 STATUS IN #NASH IS ASSOCIATED WITH INCREASED HISTOLOGICAL SEVERITY.... $GNFT $ICPT $GILD $SAN https://t.co‚Ä¶RT @Tootix: #Genfit #EASL 
A POST-HOC ANALYSIS DEMONSTRATES HISTOLOGICAL AND CARDIOMETABOLIC EFFICACY $GNFT $ICPT $GILD $SAN https://t.co/m‚Ä¶$IBB
If $ACAD is bought out, which of these will it be?
@GileadSciences 
@Celgene 
@pfizer 
$PFE
$GILD
$CELG
$LLY#Genfit #EASL 
A POST-HOC ANALYSIS DEMONSTRATES HISTOLOGICAL AND CARDIOMETABOLIC EFFICACY $GNFT $ICPT $GILD $SAN https://t.co/mUBOmd4JM4#Genfit #EASL PNPLA3 STATUS IN #NASH IS ASSOCIATED WITH INCREASED HISTOLOGICAL SEVERITY.... $GNFT $ICPT $GILD $SAN https://t.co/mfHdZvGG9kRT @Tootix: #Genfit Research &amp; Development Event / March 31st 2016 Live Webcast from NYC 8AM (2PM French Time) $GNFT $ICPT $GILD
https://t.‚Ä¶#Genfit Research &amp; Development Event / March 31st 2016 Live Webcast from NYC 8AM (2PM French Time) $GNFT $ICPT $GILD
https://t.co/7geM4OZ4P6RT @GeryDIVRY: $GNFT $ICPT $GILD $CNAT $GLMD $TBRA #liverdiseases 

#NASH info newsletter

https://t.co/A37Qi3wMce$GNFT $ICPT $GILD $CNAT $GLMD $TBRA #liverdiseases 

#NASH info newsletter

https://t.co/A37Qi3wMcePLCE News
See Here ---&gt; https://t.co/nf0G2StRAH

$PLCE $CHTR $GILD #pennystocksGilead Sciences, Inc. $GILD Receives ‚ÄúA+‚Äù Credit Rating from Morningstar https://t.co/kQAdeG2WP8Gilead Sciences, Inc. $GILD Receives ‚ÄúA+‚Äù Credit Rating from Morningstar https://t.co/FVxR8dgyOT#GileadSciences Gilead Investors Shouldn't Worry About Merck Patent Dispute. Read more: https://t.co/n0wDZ8E2qV $GILDDUK Prev Close
See Here ---&gt; https://t.co/BiworCL2Zd

$DUK $LEI $GILD #invest1000: The True Value Of Seeking Alpha Revealed https://t.co/AOTjmtXkxD $MNST $ABX $AGNC $ARR $C $EGO $FB $FTR $GG $GILD $GLD $GWPH $JNJ$SMN News Updated Tuesday, March 29, 2016 12:59:25 PM $SDS $RIG $SDS $GILD https://t.co/xc2GURH8Pw$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/sUTPu7mnUP https://t.co/3LySyaPis8Three Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $GILD $NWSA $EBAYhttps://t.co/uAcamNRUPt members alerted to 10-1800% potential. Subscribe https://t.co/UPw2skaweX $QQQ $INTC $HSBC $PEP $PM $GILD $CMCSART @ontargt: What is rationale behind $15B devel costs? Average is &lt;$3B https://t.co/cne8eaWQZU $MRK $GILDOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $GILD $NWSA $EBAYNeed help finding momentum trades? https://t.co/uAcamNRUPt https://t.co/qTR8WWxoW5 $WTW $HSBC $PEP $PM $GILD $CMCSA $BAC $ORCL $MRKRT @techwhitepapers: @UBS holds a healthcare conf in May.. many companies there . $AFMD $GNCA $VBLT $QURE .. yes $ADAP , $GILD  AND many mo‚Ä¶RT @raymond10mm: #markets #trading $AAPL $GILD $JPM $MSFT $FB $GOOGL $WMT $HD$GRPN $BABA $IBM $CSCO $AMZN A Top Swing Trading Pattern https‚Ä¶RT @raymond10mm: #markets #trading $AAPL $GILD $JPM $MSFT $FB $GOOGL $WMT $HD$GRPN $BABA $IBM $CSCO $AMZN A Top Swing Trading Pattern https‚Ä¶#markets #trading $AAPL $GILD $JPM $MSFT $FB $GOOGL $WMT $HD$GRPN $BABA $IBM $CSCO $AMZN A Top Swing Trading Pattern https://t.co/XVD4u2A7pwRT @danwardbio: @JNapodano $GBIM potential milestones w $CELG and $GILD total something ridiculous like ~40x current market cap. Potential‚Ä¶MAR 29 Tuesday, $GILD closed $92.20$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Closes -0.28% For the Session:

https://t.co/8fXeag4wYM",2016-03-30,GILD,0
3,"Over 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $GILD $NWSA $EBAY$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Closes -0.12% For the Session:

https://t.co/jHbqD5NZBKRT @StocksThatDoubl: Want alerts for momentum stocks? SUBSCRIBE: https://t.co/uAcamNRUPt  https://t.co/GTBX9iaGPR $PM $GILD $CMCSA $C $IBM‚Ä¶Want alerts for momentum stocks? SUBSCRIBE: https://t.co/uAcamNRUPt  https://t.co/GTBX9iaGPR $PM $GILD $CMCSA $C $IBM $ST$GILD still looks very good loose flag here and above the 8D. https://t.co/XdG5s9i6OcRT @StocksThatDoubl: https://t.co/uAcamNRUPt subscribers alerted to 10-1800% gain stocks. JOIN NOW Promo https://t.co/OQCNEb9p9K $PM $GILD‚Ä¶https://t.co/uAcamNRUPt subscribers alerted to 10-1800% gain stocks. JOIN NOW Promo https://t.co/OQCNEb9p9K $PM $GILD $CMCSA $C $IBM $STPBCT Summary
See Here ---&gt; https://t.co/okpVy7my0A

$PBCT $SF $GILD #pennystocksRT @CatalystWatcher: Put the pieces of this together in regards to upcoming GS-4774 data. $GBIM $GILD https://t.co/wQxBBCvlOCBritish Airways Pensions Investment Management Ltd Maintains Position in #GileadSciences, I... Read more: https://t.co/xvNbsTAde8 $GILD@KOLBE_33 $IBM $GILD $QCOM are a few to see 5 years from now. Spent billions on BB. I think $AAPL wins since the stock isn't overvalued#GileadSciences, Inc. Position Held by Nippon Life Global Investors Americas Inc. Read more: https://t.co/xCpkDN7tgm $GILD8 Weeks of Harvoni + Vedroprevir Cures 96% of Hard-to-Treat #Hepatitis C https://t.co/OwCAu5rfSt #LiverMeeting $GILD #Liver15RT @psuvafan007: 011216 $RHHBY #Roche HBV Capsid inhibitors $GILD $ARWR $ABUS etc https://t.co/mAAFBXTS80British Airways Pensions Investment Management Ltd Maintains Position in Gilead Sciences, Inc. $GILD https://t.co/SUPwCxBlpWNortheast Investment Management Has $24,881,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/GS4ajHx8oH#GileadSciences Gilead Submits New Drug Application To Japan???s For Tenofovir Alafenamide ... Read more: https://t.co/6i2SIQa4WW $GILDBeanScreen for April 2016 https://t.co/3xD0sPzOm5 $GILD $AMBA $TSM $LCI$MSFT $GILD $QQQ: Most Active in After Hours as seen on SpeculatingStocks After-Hours, https://t.co/0sHRjqRl7f #specstocksGilead Sciences, Inc. $GILD Position Held by Nippon Life Global Investors Americas Inc. https://t.co/EZ6dZ4rbpkRT @R4inb0w_: Beyond NASH: Genfit jumps into another Critical Liver Condition (Labiotech.eu) $GNFT #NASH #PBC $ICPT $GILD https://t.co/r6GD‚Ä¶The #stocks *seeing the most volume in after hours*: $MSFT $GILD $QQQ $AAPL and $CSCO.Month over Month Sales: $M, $LB, $BA, $LULU, $IBM, $WFM, $DPZ, $UA, $GILD https://t.co/JwXkqjuCM2Top holdings ending March 2016: $AAPL, $GILD, $IBM, $FDX, $MA, $GOOGL, $DIS, $FB, $UA, $BX, $PEP, $BA, $WFM, $ISRG https://t.co/vqqJrUBK6iRT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @Tootix: #GENFIT RESOLVE IT Phase 3 for #Elafibranor : First to market, Partnership discussions, Biomarkers $GNFT $ICPT $GILD https://t.‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶PDT Stock Message Board
See Here ---&gt; https://t.co/fcFfKjDnoN

$PDT $MWW $GILD #finance011216 $RHHBY #Roche HBV Capsid inhibitors $GILD $ARWR $ABUS etc https://t.co/mAAFBXTS80Indian Generic Manufacturer Cipla Targeting US #HIV Market - Plans to launch generic version of $GILD Atripla #India https://t.co/dUq3gozYqJRT SeekingAlpha: Doubling Down In March https://t.co/axtcdWfOJd $CMI $DIS $GILD $HCP $MIC $STAG $STWD $TROW $UNPDoubling Down In March https://t.co/E07w2GHU2I $CMI $DIS $GILD $HCP $MIC $STAG $STWD $TROW $UNPDoubling Down In March https://t.co/fepHlLZPXh $CMI $DIS $GILD $HCP $MIC $STAG $STWD $TROW $UNPDoubling Down In March https://t.co/hrlsJzkf31 $CMI $DIS $GILD $HCP $MIC $STAG $STWD $TROW $UNPConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/DgrNThhkJM  $DIS $ALXN $NOAH $GILD $QUNR$IBB $CELG $XBI $BBC $GILD $NBIX $AMGN https://t.co/k6ZkTYHMFoGilead Sciences $GILD Stock Lifted by Leerink's Confidence https://t.co/VgLg8sIT9gGilead Sciences $GILD Stock Lifted by Leerink's Confidence https://t.co/RwPu2bM0ZV #StockActionRT @CatalystWatcher: Put the pieces of this together in regards to upcoming GS-4774 data. $GBIM $GILD https://t.co/wQxBBCvlOC$GILD:

Gilead Sciences (GILD) Stock Lifted by Leerink‚Äôs Confidence:

https://t.co/4VQJwvtlcwPut the pieces of this together in regards to upcoming GS-4774 data. $GBIM $GILD https://t.co/wQxBBCvlOC""The main conclusions we draw from abstracts is that $GILD‚Äôs dominance of HCV seems secure for the immediate future"" https://t.co/7wJFGU7GJtgood exit yesterday on $V and add entry on $VXX 2day..watching $V $NKE $GILD 4 adds to the long side. Patience. https://t.co/NTi77xruQY@GangLeader $GILD also needs to do good to push $IBB up ?$IBB $.SPX $VRTX $REGN $ALXN $BIIB $CELG $GILD $AMGN:

Can biotech recover from big slide?:

https://t.co/uP5kvz4wVFFive Large Cap Stocks with P/Es Below 15. A Must Buy? Zacks suggests: https://t.co/kR489RJOMb $GILDRT SeekingAlpha: Finding The Best Stocks To Invest In https://t.co/jTDciAvG8J $GILD $HA $WHGRT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶GILD Chart
See Here ---&gt; https://t.co/DTOEJIgbep

$GILD $AGM $EXPE #pennystocksGilead Sciences's neutral rating reiterated at Bank of America. $104.00 PT. https://t.co/1ZHwf8GxEo $GILD #GILDGilead Sciences Reiterated Rating by Bank of America (Ranked 44th) to Neutral with 104 PT $GILD #GILD https://t.co/nyq7xJnbR7Gilead Sciences's neutral rating reiterated at Bank of America. $104.00 PT. https://t.co/4CywFlXesO $GILD #GILD$GILD Gilead Submits New Drug Application to Japan‚Äôs Pharmaceu‚Ä¶ https://t.co/fhyElSYJvqBiotech Investors: Here's How To Respond To The Bursting Bubble https://t.co/xsTZC7fTDA $AMGN $BIIB $CELG $GILD $SHPG $IBBGilead Sciences: Leerink Sees Little That Would End Hepatitis-C Dominance https://t.co/CdVwY41npg via @barronsonline $GILD $ABBV $MRK $JNJRT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶GILD Ask Size
See Here ---&gt; https://t.co/N5a3X4OwHt

$GILD $KELYA $JAZZ #pennystocksMedivation: Let the M&amp;A Speculation Begin https://t.co/fK0LrhiK0H via @barronsonline $GILD $MDVN $AMGN $AZN $SNYRT @R4inb0w_: Beyond NASH: Genfit jumps into another Critical Liver Condition (Labiotech.eu) $GNFT #NASH #PBC $ICPT $GILD https://t.co/r6GD‚Ä¶RT @Tootix: "" #Genfit has a solid and clear vision for its huge market #blockbuster #Elafibranor - Discussions in progress w Pharmas"" $GNFT‚Ä¶$IBB wrv 263.18 last week $GILD (held wrv9013)  wrv 9087 $AMGN wrv 14844$GILD ""We are pleased w/results of P-3 studies...suggest TAF has potential to improve care of chronic hepB patients"" https://t.co/WJxDbUblgAMerrill Lynch Maintains a Neutral Rating on Gilead Sciences $GILD https://t.co/hab66UhwdmRT @R4inb0w_: Beyond NASH: Genfit jumps into another Critical Liver Condition (Labiotech.eu) $GNFT #NASH #PBC $ICPT $GILD https://t.co/r6GD‚Ä¶@lane_bryanalane @dongfidence @RNAiAnalyst $GILD Jury was out to lunch subtracting 15 billion in cost to make drugs. 1.5 billion maybe $IONS@HalftimeReport here are some stocks $WBA $GTN $AAPL $TWTR $ILMA $GOOGL $BABA $GILD $WFC $AXAS $PANW $STZ $KMI$GILD and $PFE, I feel some M&amp;A about to happen! @CNBC @markets @WSJmarkets @themotleyfool @FierceBiotech @FiercePharma@lane_bryanalane @ArtSlott @RNAiAnalyst $GILD was able to convince Jury higher payout would negatively impact R&amp;D budget. sounds bad right?RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @Tootix: #GENFIT RESOLVE IT Phase 3 for #Elafibranor : First to market, Partnership discussions, Biomarkers $GNFT $ICPT $GILD https://t.‚Ä¶RT @R4inb0w_: Beyond NASH: Genfit jumps into another Critical Liver Condition (Labiotech.eu) $GNFT #NASH #PBC $ICPT $GILD https://t.co/r6GD‚Ä¶RT @R4inb0w_: Beyond NASH: Genfit jumps into another Critical Liver Condition (Labiotech.eu) $GNFT #NASH #PBC $ICPT $GILD https://t.co/r6GD‚Ä¶Purchased shares of Gilead Science, $GILDRT @Tootix: "" #Elafibranor can be the solution for #PBC unlike #OCA which increase prurit. #Genfit has certitude &amp; confidence"" JFM $GNFT $I‚Ä¶RT @Tootix: "" #Genfit has a solid and clear vision for its huge market #blockbuster #Elafibranor - Discussions in progress w Pharmas"" $GNFT‚Ä¶Beyond NASH: Genfit jumps into another Critical Liver Condition (Labiotech.eu) $GNFT #NASH #PBC $ICPT $GILD https://t.co/r6GDVMtO3Y$GILD submits NDA to PMDA¬†Japan https://t.co/K9MFeCxW8YRT @Tootix: #GENFIT RESOLVE IT Phase 3 for #Elafibranor : First to market, Partnership discussions, Biomarkers $GNFT $ICPT $GILD https://t.‚Ä¶RT @Tootix: "" #Genfit has a solid and clear vision for its huge market #blockbuster #Elafibranor - Discussions in progress w Pharmas"" $GNFT‚Ä¶Binary event coming, &gt; 22% shorts ICPT  #biotech $GILD $TSLA  $SPy $SPX https://t.co/O1ato3aips"" #Genfit has a solid and clear vision for its huge market #blockbuster #Elafibranor - Discussions in progress w Pharmas"" $GNFT $ICPT $GILDRT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶Volume Alert - GILD 92.13 Gilead Sciences Inc $GILD Hit a high today of 92.75 Closing the day 10:30 at 92.13 + https://t.co/8hBVTZ3UqS"" #Elafibranor can be the solution for #PBC unlike #OCA which increase prurit. #Genfit has certitude &amp; confidence"" JFM $GNFT $ICPT $GILDYesterday We Made $94,000 In Just One Trade More Info Here https://t.co/ZMvOsK1CVa .. $GILD $NWSA $EBAYCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKjqBmD$IBB having a good day 
along with $JAZZ and other Biotech stocks
$GNCA $MDVN $EPZM $ONTY $XNCR $ALNY $INCY $JUNO etc.  
not $GILD or $VRXRT @R4inb0w_: GENFIT also intends to launch new trials in NASH for pediatric as well as cirrhosis subpopulations $GNFT $ICPT $GILD #Liverdi‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶5 Large Cap Stocks with P/Es Below 15: A Must Buy? $GILD is one of them
https://t.co/H3Vs8LOxm5#GileadSciences' ""Buy"" Rating Reiterated at Citigroup Inc. Read more: https://t.co/egPshlNhM2 $GILDRT @Tootix: ""Waiting good conditions to go to #Nasdaq. CoDevelopments are discussed with several pharmas for #Elafibranor in #NASH "" $GNFT‚Ä¶RT @R4inb0w_: GENFIT : to begin a Phase 2 clinical trial of Elafibranor in the treatment of PBC this year $GNFT $ICPT $GILD https://t.co/Om‚Ä¶@Sport234a @SRayleigh what I like about $MDVN b/o chatter is that c/b trigger 4 $GILD types who have benefited to date from waiting.RT @GraycellAdvisor: Biotechs Poised to Move Higher. https://t.co/o4GPqRRwcp $espr $mdvn $trvn $juno $kite $nbix $blue $itek $gild $incy $r‚Ä¶Biotechs Poised to Move Higher. https://t.co/o4GPqRRwcp $espr $mdvn $trvn $juno $kite $nbix $blue $itek $gild $incy $regn $vrtx $celg $regnRT @Tootix: ""Waiting good conditions to go to #Nasdaq. CoDevelopments are discussed with several pharmas for #Elafibranor in #NASH "" $GNFT‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶CNBC talking about big money finally leaving biotech... Let my thesis begin!!! $IBB $VRTX $GILD""Waiting good conditions to go to #Nasdaq. CoDevelopments are discussed with several pharmas for #Elafibranor in #NASH "" $GNFT $ICPT $GILD@RNAiAnalyst @lane_bryanalane $IONS almost 1% of $GILD hep-c sales = close to150M. Up to judge now I believe more likely to increase.GILD Top news - Mar 31st, 2016 $GILD https://t.co/cAfUkiaVUNRT @Tootix: #GENFIT RESOLVE IT Phase 3 for #Elafibranor : First to market, Partnership discussions, Biomarkers $GNFT $ICPT $GILD https://t.‚Ä¶$gild   starting strong this morning$GILD https://t.co/vPGdI0jDkl@lane_bryanalane you should have explained it to the thick jury. can you believe it they bought $gild's argument? $ionsRT @GantosJ: $GILD Submits New Drug Application to Japan‚Äôs Pharmaceutical Agency for Tenofovir for #HBV ... https://t.co/ewEbc06w42RT @Tootix: #GENFIT Upcoming newsflow 2016 2017 in #NASH and liver disease #Blockbuster #Elafibranor $GNFT $ICPT $GILD $SAN https://t.co/p9‚Ä¶@GantosJ: $GILD Submits New Drug Application to Japan's Pharmaceutical Agency for Tenofovir for #HBV ... https://t.co/txvf6lHe2q/s...@jimcramer $GILD, $HON, $LMTRT @Tootix: #GENFIT Upcoming newsflow 2016 2017 in #NASH and liver disease #Blockbuster #Elafibranor $GNFT $ICPT $GILD $SAN https://t.co/p9‚Ä¶Gilead $GILD To Be The Focus of Upcoming EASL - Leerink https://t.co/pBJSbKdLFvRT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @Tootix: #GENFIT Upcoming newsflow 2016 2017 in #NASH and liver disease #Blockbuster #Elafibranor $GNFT $ICPT $GILD $SAN https://t.co/p9‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @Tootix: #GENFIT Upcoming newsflow 2016 2017 in #NASH and liver disease #Blockbuster #Elafibranor $GNFT $ICPT $GILD $SAN https://t.co/p9‚Ä¶RT @Tootix: #GENFIT Upcoming newsflow 2016 2017 in #NASH and liver disease #Blockbuster #Elafibranor $GNFT $ICPT $GILD $SAN https://t.co/p9‚Ä¶RT @GantosJ: $GILD Submits New Drug Application to Japan‚Äôs Pharmaceutical Agency for Tenofovir for #HBV ... https://t.co/ewEbc06w42#GENFIT Upcoming newsflow 2016 2017 in #NASH and liver disease #Blockbuster #Elafibranor $GNFT $ICPT $GILD $SAN https://t.co/p9T2wbEBjg$GILD Submits New Drug Application to Japan‚Äôs Pharmaceutical Agency for Tenofovir for #HBV ... https://t.co/ewEbc06w42RT @Tootix: #GENFIT #Biomarkers Development for #NASH Non invasive Diagnosis Solutions $GNFT $ICPT $GILD $SAN https://t.co/7agnTcqv3gRT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @Tootix: #GENFIT #Fibrosis #Cirrhosis Phase 2 planned in late 2016 $GNFT $ICPT $GILD $SAN https://t.co/2IXFOWmtsBRT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶#GENFIT #Fibrosis #Cirrhosis Phase 2 planned in late 2016 $GNFT $ICPT $GILD $SAN https://t.co/2IXFOWmtsBRT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GNFT $ICPT $GILDRT @Tootix: #GENFIT RESOLVE IT Phase 3 for #Elafibranor : First to market, Partnership discussions, Biomarkers $GNFT $ICPT $GILD https://t.‚Ä¶RT @Tootix: #GENFIT The definition of Biotech Stock Picking #NASH #Elafibranor $GNFT $ICPT $GILD $SAN  https://t.co/3pXWZr01Kf https://t.co‚Ä¶RT @Tootix: #GENFIT #Biomarkers Development for #NASH Non invasive Diagnosis Solutions $GNFT $ICPT $GILD $SAN https://t.co/7agnTcqv3gRT @Tootix: #GENFIT launches 2 new Ph2 for #ELAFIBRANOR in #PBC and Pediatric #NASH + another Ph2 with a new anti-fibrotic compound $GNFT $‚Ä¶RT @R4inb0w_: GENFIT : to begin a Phase 2 clinical trial of Elafibranor in the treatment of PBC this year $GNFT $ICPT $GILD https://t.co/Om‚Ä¶RT @R4inb0w_: GENFIT also intends to launch new trials in NASH for pediatric as well as cirrhosis subpopulations $GNFT $ICPT $GILD #Liverdi‚Ä¶RT @Tootix: #GENFIT RESOLVE IT Phase 3 for #Elafibranor : First to market, Partnership discussions, Biomarkers $GNFT $ICPT $GILD https://t.‚Ä¶$GILD:

Market Analyst Earnings Target Overview: Gilead Sciences, Inc ‚Ä¶:

https://t.co/FrnHQQnIpDRT @Tootix: #GENFIT #Biomarkers Development for #NASH Non invasive Diagnosis Solutions $GNFT $ICPT $GILD $SAN https://t.co/7agnTcqv3g$IONS $GILD $MRK $IBB #Biotech #biotechology #Pharma #HepC #hepatitis @megtirrell  https://t.co/SpY5vh5k0A#GENFIT #Biomarkers Development for #NASH Non invasive Diagnosis Solutions $GNFT $ICPT $GILD $SAN https://t.co/7agnTcqv3g$GILD Follow up from February 5th, big resistance at 97.33 https://t.co/40A8UX1N9eRT @Tootix: #GENFIT Diversified Pipeline NYC March 2016 #Elafibranor #NASH #PBC #Fibrosis $GNFT $GNFTF $ICPT $GILD $SAN https://t.co/Qu8dof‚Ä¶RT @Tootix: #GENFIT #Elafibranor is the solution for liver disease &amp; metabolic disorders #Blockbuster $GNFT $ICPT $GILD $SAN https://t.co/n‚Ä¶RT @Tootix: #GENFIT RESOLVE IT Phase 3 for #Elafibranor : First to market, Partnership discussions, Biomarkers $GNFT $ICPT $GILD https://t.‚Ä¶RT @Tootix: #GENFIT RESOLVE IT Phase 3 for #Elafibranor : First to market, Partnership discussions, Biomarkers $GNFT $ICPT $GILD https://t.‚Ä¶RT @Tootix: #GENFIT RESOLVE IT Phase 3 for #Elafibranor : First to market, Partnership discussions, Biomarkers $GNFT $ICPT $GILD https://t.‚Ä¶RT @Tootix: #GENFIT RESOLVE IT Phase 3 for #Elafibranor : First to market, Partnership discussions, Biomarkers $GNFT $ICPT $GILD https://t.‚Ä¶#GENFIT RESOLVE IT Phase 3 for #Elafibranor : First to market, Partnership discussions, Biomarkers $GNFT $ICPT $GILD https://t.co/jGrBBbXdV0#GENFIT #Elafibranor is the solution for liver disease &amp; metabolic disorders #Blockbuster $GNFT $ICPT $GILD $SAN https://t.co/nkEl3aBztqRT @Tootix: #GENFIT Diversified Pipeline NYC March 2016 #Elafibranor #NASH #PBC #Fibrosis $GNFT $GNFTF $ICPT $GILD $SAN https://t.co/Qu8dof‚Ä¶RT @R4inb0w_: GENFIT also intends to launch new trials in NASH for pediatric as well as cirrhosis subpopulations $GNFT $ICPT $GILD #Liverdi‚Ä¶RT @Tootix: #GENFIT launches 2 new Ph2 for #ELAFIBRANOR in #PBC and Pediatric #NASH + another Ph2 with a new anti-fibrotic compound $GNFT $‚Ä¶RT @Tootix: #GENFIT Diversified Pipeline NYC March 2016 #Elafibranor #NASH #PBC #Fibrosis $GNFT $GNFTF $ICPT $GILD $SAN https://t.co/Qu8dof‚Ä¶RT @R4inb0w_: GENFIT also intends to launch new trials in NASH for pediatric as well as cirrhosis subpopulations $GNFT $ICPT $GILD #Liverdi‚Ä¶RT @R4inb0w_: GENFIT also intends to launch new trials in NASH for pediatric as well as cirrhosis subpopulations $GNFT $ICPT $GILD #Liverdi‚Ä¶#GileadSciences Gilead Science ""Curing Hepatitis C"" Richard Dobetsberger wikifolioTrader. Read more: https://t.co/1cv3uO1glM $GILDRT @R4inb0w_: GENFIT : to begin a Phase 2 clinical trial of Elafibranor in the treatment of PBC this year $GNFT $ICPT $GILD https://t.co/Om‚Ä¶Biotech Investors: Here's How To Respond To The Bursting Bubble https://t.co/JrlIohhHZd $AMGN $BIIB $CELG $GILD $SHPG $IBBRT @Tootix: #GENFIT launches 2 new Ph2 for #ELAFIBRANOR in #PBC and Pediatric #NASH + another Ph2 with a new anti-fibrotic compound $GNFT $‚Ä¶RT @Tootix: #GENFIT Diversified Pipeline NYC March 2016 #Elafibranor #NASH #PBC #Fibrosis $GNFT $GNFTF $ICPT $GILD $SAN https://t.co/Qu8dof‚Ä¶RT @R4inb0w_: GENFIT also intends to launch new trials in NASH for pediatric as well as cirrhosis subpopulations $GNFT $ICPT $GILD #Liverdi‚Ä¶RT @R4inb0w_: GENFIT : to begin a Phase 2 clinical trial of Elafibranor in the treatment of PBC this year $GNFT $ICPT $GILD https://t.co/Om‚Ä¶GENFIT also intends to launch new trials in NASH for pediatric as well as cirrhosis subpopulations $GNFT $ICPT $GILD #LiverdiseaseRT @R4inb0w_: GENFIT : to begin a Phase 2 clinical trial of Elafibranor in the treatment of PBC this year $GNFT $ICPT $GILD https://t.co/Om‚Ä¶GENFIT : to begin a Phase 2 clinical trial of Elafibranor in the treatment of PBC this year $GNFT $ICPT $GILD https://t.co/OmgdoIn8KHBiopharmaceutical company $GILD said it has submitted an NDA to Japan's Pharmaceutical and https://t.co/pif965tt08RT @Tootix: #GENFIT Diversified Pipeline NYC March 2016 #Elafibranor #NASH #PBC #Fibrosis $GNFT $GNFTF $ICPT $GILD $SAN https://t.co/Qu8dof‚Ä¶RT @Tootix: #GENFIT Diversified Pipeline NYC March 2016 #Elafibranor #NASH #PBC #Fibrosis $GNFT $GNFTF $ICPT $GILD $SAN https://t.co/Qu8dof‚Ä¶RT @Tootix: #GENFIT Diversified Pipeline NYC March 2016 #Elafibranor #NASH #PBC #Fibrosis $GNFT $GNFTF $ICPT $GILD $SAN https://t.co/Qu8dof‚Ä¶#GENFIT Diversified Pipeline NYC March 2016 #Elafibranor #NASH #PBC #Fibrosis $GNFT $GNFTF $ICPT $GILD $SAN https://t.co/Qu8dofOZdCBiotech Investors: Here's How To Respond To The Bursting Bubble https://t.co/8wO3jWKpCK $AMGN $BIIB $CELG $GILD $SHPG $IBB#EASL2016 Late Breaker Titles

hmmm... Not sure how $GILD feels about that Aussie abstract?
https://t.co/FmGJyKJBf8 https://t.co/en96YZjz9rBiotech Investors: Here's How To Respond To The Bursting Bubble https://t.co/Ab1xlgGMHK $AMGN $BIIB $CELG $GILD $SHPG $IBBRT @Tootix: #GENFIT launches 2 new Ph2 for #ELAFIBRANOR in #PBC and Pediatric #NASH + another Ph2 with a new anti-fibrotic compound $GNFT $‚Ä¶Why A Long/Short Portfolio Makes Sense Today - Part IV https://t.co/VvQh4eNxj9 $AAL $AAPL $ABX $AER $AVAL $BID $DE $DIS $GILD $HBAYF $IBM#GENFIT launches 2 new Ph2 for #ELAFIBRANOR in #PBC and Pediatric #NASH + another Ph2 with a new anti-fibrotic compound $GNFT $ICPT $GILDIBM, Micron, Gilead: Fast Money Picks For March 31 $GILD $IBM $MU via @benzinga https://t.co/Z4Yt77S4OpRT @revenuesprofits: How 60 Drug Companies Became 10 In Just 2 Decades? https://t.co/PegrCWQocK. #pharma $PFE $GILD $MRK $NOVN $SAN $RO $JN‚Ä¶Gilead submits TAF marketing application in Japan for HBV https://t.co/c1isODnh9P #premarket $GILD $GSKGilead submits TAF marketing application in Japan for HBV https://t.co/LxfpHPVLFQ #premarket $GILD $GSKGilead submits TAF marketing application in Japan for HBV https://t.co/a20R683vWu #premarket $GILD $GSKRT @Benzinga: IBM, Micron, Gilead: @CNBCFastMoney Picks For March 31 $MU $IBM $OXY $GILD https://t.co/tHZZYWDM0XIBM, Micron, Gilead: @CNBCFastMoney Picks For March 31 $MU $IBM $OXY $GILD https://t.co/tHZZYWDM0XThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sgRRp $GILD $NWSA $EBAYCheap call option upside: $DAL calls cheaper than 100% of history, $HD 99%, $CSCO 99%, $DIS 99%, $GILD 99%, $CRM 98%, $V 97%Over 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8QMnm $GILD $NWSA $EBAY@RNAiAnalyst Not sure whether we can trust $gild's accounting practices seeing how liberal it is w/ numbers. $mrk $ions$gild says to Senate $880M spent on sofos from 2012-14. Now at $MRK- $IONS trial says spent $4B to develop Harvoni+Sovaldi. Reconcile diff$GILD:

Last Analysts Rating Review: Gilead Sciences, Inc. (NASDAQ:GILD ‚Ä¶:

https://t.co/JgSMlJIDbX3 #Biotech Stocks That Make the Grade for Investors $AMAG $GILD $HZNP  https://t.co/qOZVObPSAyPremium Alerts Ranked #1 For Gains 2834% Last Week At https://t.co/ewcYkKTvDH .. $GILD $PTNT $CHDNhttps://t.co/uAcamO9vH1 members alerted to 10-1800% potential. Subscribe https://t.co/UPw2skaweX $QQQ $INTC $HSBC $PEP $PM $GILD $CMCSA#GileadSciences Gilead Submits New Drug Application to Japan's Pharmaceutical and Medical D... Read more: https://t.co/FwtkrL5OWd $GILD#GileadSciences Gilead Submits New Drug Application to Japans Pharmaceutical and Medical De... Read more: https://t.co/o5KlbaYmxg $GILD#GileadSciences Gilead Submits NDA In Japan For Tenofovir Alafenamide For Chronic HBV Patie... Read more: https://t.co/UnYwgVT4z5 $GILDGilead Sciences‚Äô $GILD ‚ÄúBuy‚Äù Rating Reiterated at Citigroup Inc. https://t.co/k6NZtCdxlHNeed help finding momentum trades? https://t.co/uAcamO9vH1 https://t.co/qTR8WWxoW5 $WTW $HSBC $PEP $PM $GILD $CMCSA $BAC $ORCL $MRK$GILD: Gilead Sciences submits NDA to Japan‚Äôs Pharmaceutical and Medical Devices Agency for Tenofovir Alafenamide https://t.co/8Jv1NUOH6l$GILD https://t.co/dZWRGe19sM Pot. cont. Uptrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/PH24DZPuOLCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5IBP News
See Here ---&gt; https://t.co/4OvKw9Tdvw

$IBP $HSKA $GILD #pennystocksRevisiting NASH: Therapeutic Targets And The Competitive Landscape https://t.co/6K9MQdcmgC $CNAT $ENTA $GALT $GILD $GLMD $GNFTF $ICPT $NVOIn summary $gild argues that what it paid for stolen goods (--&gt;pharmasset $11B) should be subtracted from damages caused by same. $IONS $MRKRayno Biopharmaceuticals Update 3/30 - Stuck In A Trading Range With Upside Opportunities $BMY $ACAD $IBB $GILD ... https://t.co/tq3hEeBYnlRT @Tootix: #Genfit #EASL 
A POST-HOC ANALYSIS DEMONSTRATES HISTOLOGICAL AND CARDIOMETABOLIC EFFICACY $GNFT $ICPT $GILD $SAN https://t.co/m‚Ä¶RT @AndyBiotech: $JNJ nuc AL-335 from Alios acquisition achieved 4.0~4.7log VL reduction at 800mg in #HCV GT 1-3

#ILC2016 $GILD $MRK https‚Ä¶$GILD Gilead Submits New Drug Application to Japan's Pharmaceutical and Medical Devices Agency for Tenofovir 
From our Stock News Alerts App$GILD - Gilead Submits New Drug Application to Japan‚Äôs Pharmaceutical &amp; Medical Devices Agency for Tenofovir https://t.co/SRCNHwB45NRT @AndyBiotech: #EASL2016 abstract book out
https://t.co/sLo9M0QWzs

#ILC2016 $GILD $ABBV $ENTA $MRKCommented on Gilead, Gilead Where Art Thou Gilead? https://t.co/BSdIORVakq $MRK $CELG $GILD#markets #trading $AAPL $GILD $JPM $MSFT $FB $GOOGL $GRPN $BABA $CSCO $AMZN How To Identify Quick Momentum Moves https://t.co/JSN6nQnA4gRT @tgtxdough: $GILD HepC US tracking slightly ahead
IMS reported February Harvoni sales of $853mn and Sovaldi sales of $232mn, for a total‚Ä¶3 #Biotech Stocks That Make the Grade for Investors $AMAG $GILD $HZNP  https://t.co/SIHFFGM92DRayno Biopharmaceuticals Update 3/30 - Stuck In A Trading Range With Upside Opportunities $BMY $ACAD $IBB $GILD ... https://t.co/yv2r50A3aeAny #BioTech investors out there?

Check out this fund:  https://t.co/8v5qUgfoS5

$GILD $BIIB $JAZZ $INSY $ALXN $AMRI $ANIK $BMRN #StocksRT @DrPaulyDeSantis: @DrPaulyDeSantis Recall $GILD entered a BET inh into Prostate Cancer: https://t.co/w73bNQQeQkMAR 30 Wednesday, $GILD closed $91.97. My BEARISH target is $90.00Buying Biotech stocks for Long term here will be rewarding. Many stocks are off by 50%. I like $regn and $gildhttps://t.co/KkHg4O78J2 &lt;&lt; 5 lessons for FREE from Tim https://t.co/KkHg4O78J2 TimSykes millionaire trader on $SPY $INO $SLV $GILD $CRUSIs The Biotech ETF IBB Forming A Double Bottom Pattern? https://t.co/aLuvEmhNLw $AMGN $BIIB $CELG $GILD $REGN $IBBhttps://t.co/W3gditBjAt members alerted to $EPRS +23%  See track record and join today  https://t.co/gOZezqGZW2 $PM $GILD $CMCSA $C $IBThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $GILD $NWSA $EBAY",2016-03-31,GILD,1
4,"#GileadSciences Gilead paying up to $1.2 B for Nimbus unit, drug, technology. Read more: https://t.co/PxYwfMC33u $GILD#GileadSciences Gilead paying up to $1.2B for Nimbus unit, drug candidate. Read more: https://t.co/4C0sSk7tzn $GILD#GileadSciences : FDA OKs Descovy, Gilead Science's latest combo HIV pill. Read more: https://t.co/cU2rDcW4aV $GILDRT @zbiotech: $GILD buying nimbus apollo unit, 400M upfront$GILD Strengthens #NASH Pipeline  https://t.co/x5b3dFVhc9RT @BosBizDon: Here's why Nimbus CEO @DonWNicholson didn‚Äôt just sell the whole company, rather than just its lead drug $GILD https://t.co/i‚Ä¶@fatdaddybulldog Luckily it's only money...just wish $AAPL, $GILD, and $CELG hadn't hurt me in the same place at the same time. #TrainADX Uptrend https://t.co/fkLC7L58p4 $GILD $JKHY $MTUM $GPN $YY $HRC $ATVI $ARMK $WNS $BRX $CEVA $ENSG $CABGY $FRAN $SPOK $CRF $KTWO $SQINasdaq100 #Stocks Trend $TSLA $ALXN $ISRG $AAPL $ILMN $AMGN $INTU $LBTYA $GILD $BMRN $CTXS $YHOO $FOXA $CHTR  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $ABBV $PFE $AAPL $TWX $AMGN $GILD $PEP $CVS $PM $BMY $MRK $FOXA $MCD $ABT $V $CMCSA $MDT  @ https://t.co/cKkr8cKsjuRT @ScripDonnaDC: #FDA OK's $GILD's #Descovy (emtricitabine/tenofovir alafenamide); 3rd TAF-based #HIV therapy
https://t.co/Z4GEzPN2RA 
#ph‚Ä¶$GILD ticks the boxes as a dream üí∞ dividend üí∞ stock with 1.9% yield https://t.co/E6pRYleaQI https://t.co/n3GN0SZBiB$agn to check my #s, $GILD down 13% would put $AGN at $225 SO&gt;&gt;&gt;.
buying $AGN here gets you stock W/O ANY DEAL premium adjusted for biotech$AGN a little help for the terrified-$AGN is trading where it was pre deal adjusted for pharma/bio perf using $GILD(has earnings) = $225It's True. Quality Leads Market Returns In Narrow Breadth Markets $HA $GILD $WHG https://t.co/d18oKbvP0GRT @Briefingcom: $GILD: Gilead Sciences announces FDA approval of Descovy, a fixed-dose combination for the treatment of HIV https://t.co/L‚Ä¶GILD Bid
See Here ---&gt; https://t.co/exENeSQXbD

$GILD $VER $EGO #invest#GileadSciences, Inc. Stake Lowered by Conning Inc. Read more: https://t.co/aHBgGTc8q5 $GILD@danielpronych I know $GILD better - I find it a bit safer than others. And it trades at a very low/better multiple than $AGN@AaronKrolik Meaning I like $GILD and its relatively safe for a quick scalp. That's the only biotech I've touched this year so far.$GILD NASH represents a significant commercial opportunity with estimated &gt;15M patients in the US, EU and Japan.$IBB has 190 holdings; top 10 = 57.83% weight; basically you are saying $AMGN $GILD $REGN $BIIB $CELG $ILMN $MYL $ALXN $VRTX $INCYRT @JuliaSkripkaSer: $GILD obviously looked at $ICPT for #NASH and decided against it.. mhmm$GILD --Looks like good risk/reward on the long side. https://t.co/fhq4ofdCFR#GileadSciences  Gilead's $1.2B deal just the latest between tiny Nimbus and a biotech giant. Read more: https://t.co/Kun68NxnSX $GILD#GileadSciences  Gilead's $1.2B deal just the latest between tiny Nimbus and a biotech giant. Read more: https://t.co/JIjJHmWM2F $GILD#GileadSciences  Gilead's $1.2B deal is just the latest between tiny Nimbus and a biotech g... Read more: https://t.co/ZOZt5GyKg3 $GILD$GILD FDA has approved Descovy as a treatment for HIV. Descovy, a combination of  emtricitabine and tenofovir alafenamide$GILD acquire a liver-drug program from Nimbus Therapeutics LLC for an  upfront payment of $400M and up to $800M (milestone reaches)@Nicole1515 What if a Would You Rather: $GILD or $AGN? (or other Biotechs) https://t.co/qiP6oZ6tjWWould be really funny if $PFE dropped $AGN bid then bought $GILD or $AMGN (top 2 holdings of $IBB) sending biotech thru the roof. HahaRT @IBD_Areeves: Gilead buys another NASH company -- an no, it's still not Intercept: https://t.co/0alA64oxrI $GILD $ICPTGilead Sciences, Inc. $GILD Stake Lowered by Conning Inc. https://t.co/lP1WmwiMw7Gilead Sciences, Inc. $GILD Shares Bought by Busey Trust CO https://t.co/5LyIImTyFVGilead Sciences, Inc. $GILD Shares Bought by Wesbanco Bank Inc. https://t.co/TwxrmPeULF$O $JPM $GILD:

Dividend Growth Portfolio: March Update:

https://t.co/YLWieQABoXGilead Sciences, Inc. $GILD Stake Lowered by Conning Inc. https://t.co/VWk5j4bUEHRT @Logribel: $GILD acquires #NASH Phase 1 drug from Nimbus for up to $1.2b - meanwhile, Genfit's whole Phase 3 program is valued ~$850m. L‚Ä¶@fezziwig2008 just in: $GILD has changed it's name to $ISIS, in an effort to get #Congress off it's back
;-)Dividend Growth Portfolio: March Update https://t.co/u4de6WO8Zq $AAPL #APPLE $ABBV $AFL $BA $COP $CSCO $CVS $CVX $GE $GILD $GIS $JPM $KODividend Growth Portfolio: March Update https://t.co/lG04AGiyUE $AAPL #APPLE $ABBV $AFL $BA $COP $CSCO $CVS $CVX $GE $GILD $GIS $JPM $KO#GileadSciences Acquires Nimbus Apollo for $400M. Read more: https://t.co/VOzRCJCMng $GILD#Rayno Biopharmaceuticals: New Buy Idea - #Roche Plc. $RHHBY Also $BMY $GILD $ABBV https://t.co/a8QcBFbWZC$GILD:

Gilead Sciences Acquires Nimbus Apollo for $400M:

https://t.co/ay6dWQTrN2Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5$GILD: Gilead Sciences announces FDA approval of Descovy, a fixed-dose combination for the treatment of HIV https://t.co/L8ekrembAp$GILD - Gilead Sciences Buys Liver-Drug Program -- Update https://t.co/7vHvFpesmJRT @adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.$GILD's new HIV formulation continues success with FDA approval of Descovy https://t.co/hocI6WzxKy#GileadSciences to acquire Nimbus for $400M. Read more: https://t.co/UGielOgtut $GILD$MRK breaking out right here on relatively strong volume.

$VRX $GILD $IBB https://t.co/V6VSGrmP7E#Gilead Sciences : Buys Liver-Drug Program -- Update https://t.co/tVlICVLxNc $GILDGilead $GILD Finally Makes a Buy, Snaps Up Massachusetts' Nimbus Apollo in $1.2 Billion Deal https://t.co/Wq652HAX9a https://t.co/ex1PJbAI3b$GILD:

Gilead Sciences Buys Liver-Drug Program:

https://t.co/EgzTlPjzwW@adamfeuerstein Do you think this indicates $GILD is less confident in simtuzumab after poor results in other fibrotic indications?RT SeekingAlpha: How Losing Body Weight Assists Me With Gaining Portfolio Weight https://t.co/1EGfVqzjYL $AJX $ARCC $BX $COP $GILD $HLF $H‚Ä¶Nasdaq100 #Stocks Trend $TSLA $ALXN $ISRG $CHTR $ADSK $AAPL $BMRN $ILMN $AMGN $CELG $GILD $LBTYA $INTU $CTXS  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $ABBV $PFE $MDT $AAPL $TWX $AMGN $CELG $GILD $CVS $PM $BMY $MRK $FOXA $MCD $ABT $MO $V  @ https://t.co/cKkr8cKsju#Options #maxpain chart for $GILD. #option #invest More with #OptionsPro FREE app at https://t.co/vmQaxw1x1K https://t.co/R7XRVZ5hJdS&amp;P100 #Stocks Performance $AGN $ABBV $PFE $MDT $AAPL $TWX $AMGN $MCD $VZ $UTX $T $CELG $ABT $LMT $GILD  more@ https://t.co/cKkr8cKsjuWondering about risks of $GILD? The 21-day volatility is 6.87% https://t.co/YrfwPBdUuU$PCLN
$OXY
$ORCL
$NFLX
$TSLA
$AMZN
$NKE
$GILD
--------------------
POONTANGHow Losing Body Weight Assists Me With Gaining Portfolio Weight https://t.co/sS3AB0TexR $AJX $ARCC $BX $COP $GILD $HLF $HTGC $LADR $LXPHow Losing Body Weight Assists Me With Gaining Portfolio Weight https://t.co/vjTA36gJvg $AJX $ARCC $BX $COP $GILD $HLF $HTGC $LADR $LXPCheck. Regeneron Pharmaceuticals Is My Top Pick In The Biotech Space https://t.co/nAh91Ou1T4 $ABBV $AMGN $ESRX $GILD $MRK $SNY $REGNThe FDA approved Gilead's Descovy for the treatment of HIV-1 in patients at least 12 years old $GILD https://t.co/fnnLSfckKC$AAPL $SPY $FB $TSLA $TWTR $GILD $EVERYTHING https://t.co/YuSTc0jTQ1RT @Logribel: $GILD acquires #NASH Phase 1 drug from Nimbus for up to $1.2b - meanwhile, Genfit's whole Phase 3 program is valued ~$850m. L‚Ä¶$GILD @GileadSciences third TAF-based HIV therapy approved by FDA https://t.co/yR2SahWpNN via @proactive_NA #AIDS https://t.co/rHNDIbUKDF#FDA clears $GILD's drug for HIV-1...it is less toxic to bones &amp; kidneys! #therapeutics 
https://t.co/i5r63dSBEn by @SeekingAlphaFDA clears Gilead's Descovy for HIV-1 https://t.co/VTkejhTZ3Q $GILDFDA clears Gilead's Descovy for HIV-1 https://t.co/TYSTJvB19H $GILDFDA clears Gilead's Descovy for HIV-1 https://t.co/7KGPlsUZYG $GILD3 Biotech Stocks on the Verge of an Overdue Run $AMGN $GILD $REGN - https://t.co/rHvJgfFccmRT @biotechday: Gilead signals its direction with $1.2 billion deal https://t.co/zxZl1sq6A7 #NASH $GILD https://t.co/CmTa728oxORT @adamfeuerstein: Son of Truvada‚Ä¶. $GILD https://t.co/FMT1a2MQ36Now why is there no spike/pop? $GILD https://t.co/fk1vm2p0zsRT @rleuty_biotech: Gilead signals its direction with $1.2 billion deal https://t.co/H277QDrufD #NASH $GILD https://t.co/181Od6ijucRT @biotechday: Gilead signals its direction with $1.2 billion deal https://t.co/zxZl1sq6A7 #NASH $GILD https://t.co/CmTa728oxORT @SFBIZronleuty: Gilead signals its direction with $1.2 billion deal https://t.co/GvjGMbnmDC #NASH $GILD https://t.co/VdkoyKdASK#FDA OK's $GILD's #Descovy (emtricitabine/tenofovir alafenamide); 3rd TAF-based #HIV therapy
https://t.co/Z4GEzPN2RA 
#pharma #biotech #AIDSRT @adamfeuerstein: Son of Truvada‚Ä¶. $GILD https://t.co/FMT1a2MQ36Gilead signals its direction with $1.2 billion deal https://t.co/zxZl1sq6A7 #NASH $GILD https://t.co/CmTa728oxOGilead signals its direction with $1.2 billion deal https://t.co/GvjGMbnmDC #NASH $GILD https://t.co/VdkoyKdASKGilead signals its direction with $1.2 billion deal https://t.co/H277QDrufD #NASH $GILD https://t.co/181Od6ijucRT @adamfeuerstein: Son of Truvada‚Ä¶. $GILD https://t.co/FMT1a2MQ36RT @adamfeuerstein: Son of Truvada‚Ä¶. $GILD https://t.co/FMT1a2MQ36RT @adamfeuerstein: Son of Truvada‚Ä¶. $GILD https://t.co/FMT1a2MQ36RT @BioRunUp: $GILD - FDA  Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead‚Äôs Third TAF-Based HIV TherapyRT @OpenOutcrier: $GILD gets FDA approval for Descovy -BBGRT @adamfeuerstein: Son of Truvada‚Ä¶. $GILD https://t.co/FMT1a2MQ36RT @fezziwig2008: $GILD cracked open its huge pocket book today for P1 NASH -has missed x 3 on Pancreatic Ca -trying a Jakafi-like Rx now -‚Ä¶RT @GantosJ: $GILD FDA Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead‚Äôs Third TAF-Based HIV Therapy... https://t.co/HAF1h‚Ä¶$GILD FDA Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead‚Äôs Third TAF-Based HIV Therapy... https://t.co/HAF1hkXfGw$GILD nabs another #FDA approval! #Descovy (emtricitabine/tenofovir alafenamide) was approved for #HIV treatment! https://t.co/QrRSQ7K7kR$GILD:

Analyst Sales Target Update: Gilead Sciences, Inc. (NASDAQ:GILD):

https://t.co/fGGyyaLcfFRT @OpenOutcrier: $GILD gets FDA approval for Descovy -BBGRT @Logribel: $GILD acquires #NASH Phase 1 drug from Nimbus for up to $1.2b - meanwhile, Genfit's whole Phase 3 program is valued ~$850m. L‚Ä¶RT @BioRunUp: $GILD - FDA  Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead‚Äôs Third TAF-Based HIV Therapy$GILD cracked open its huge pocket book today for P1 NASH -has missed x 3 on Pancreatic Ca -trying a Jakafi-like Rx now - $HALO soon- Now&gt;Q4RT @BioWorld: ICYMI: $GILD pads its NASH stash with potential $1.2B Nimbus deal https://t.co/CIlL4cbCncRT @BioWorld: ICYMI: $GILD pads its NASH stash with potential $1.2B Nimbus deal https://t.co/CIlL4cbCncRT @adamfeuerstein: Son of Truvada‚Ä¶. $GILD https://t.co/FMT1a2MQ36RT @TheTradeXchange: $GILD - U.S. Food and Drug Administration Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead‚Äôs Third TAF‚Ä¶Son of Truvada‚Ä¶. $GILD https://t.co/FMT1a2MQ36$GILD U.S. Food and Drug Administration Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead's Th
From our Stock News Alerts AppRT @alexserri1: $GILD - U.S. Food &amp; Drug Administration Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead‚Äôs https://t.co/3Ru‚Ä¶RT @OpenOutcrier: $GILD gets FDA approval for Descovy -BBG$GILD - U.S. Food &amp; Drug Administration Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead‚Äôs https://t.co/3RuPD27pv3$GILD
Gilead Announces FDA Has Approved Descovy https://t.co/0nsT0MQgDl$GILD gets FDA approval for Descovy -BBGRT @TheTradeXchange: $GILD - U.S. Food and Drug Administration Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead‚Äôs Third TAF‚Ä¶$GILD 
https://t.co/SDsnAwgklBRT @BioRunUp: $GILD - FDA  Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead‚Äôs Third TAF-Based HIV TherapyRT @OpenOutcrier: $GILD gets FDA approval for Descovy -BBG$GILD - U.S. Food and Drug Administration Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead‚Äôs Third TAF-Based HIV Therapy$GILD - FDA  Approves Descovy¬Æ (Emtricitabine, Tenofovir Alafenamide), Gilead‚Äôs Third TAF-Based HIV Therapy$GILD gets FDA approval for Descovy -BBGRT @IBD_Areeves: Gilead buys another NASH company -- an no, it's still not Intercept: https://t.co/0alA64oxrI $GILD $ICPT#GileadSciences Gilead paying up to $1.2B for Nimbus unit, drug candidate. Read more: https://t.co/xYLoQVymqs $GILDICYMI: $GILD pads its NASH stash with potential $1.2B Nimbus deal https://t.co/CIlL4cbCnc#GileadSciences Gilead Paying up to $1.2B For Nimbus Unit, Drug, Technology . Read more: https://t.co/8V88IvsJDT $GILD#GileadSciences Gilead paying up to $1.2 billion for Nimbus unit, drug, technology. Read more: https://t.co/dhT6ac3B7Y $GILD#GileadSciences Broadens Liver Program With Nimbus Acquisition. Read more: https://t.co/sAQU075f3k $GILD#PatentPalooza: One #PatentBattle in #HepC &amp; Another Patent Brawl Brewing On #CapitolHill https://t.co/wqghZ5Az9d $GILD $MRK $IONS $MDVNRT @CatalystWatcher: EASL is April 13-17. With the $GBIM trial ending in March, it's in $GILD's best interest to release 24-week data at or‚Ä¶EASL is April 13-17. With the $GBIM trial ending in March, it's in $GILD's best interest to release 24-week data at or before conference.#Gilead may be seeking a combination of drugs to treat non-alcoholic steatohepatitis &amp; liver disease. $GILD  https://t.co/uA6fOTj1wORT @IBD_Areeves: Gilead buys another NASH company -- an no, it's still not Intercept: https://t.co/0alA64oxrI $GILD $ICPTRT @theflynews: Intercept advances ahead of FDA AdComm after Gilead inks liver deal $GILD $ICPT: Full Story https://t.co/YB2IfEaabD@RunnersDad Ball is in $GILD's court, but EASL is 2 weeks away and it would be perfect timing.#GileadSciences Gilead to acquire Nimbus Apollo. Read more: https://t.co/W6Mshig49r $GILDRT @Logribel: $GILD acquires #NASH Phase 1 drug from Nimbus for up to $1.2b - meanwhile, Genfit's whole Phase 3 program is valued ~$850m. L‚Ä¶I think $GILD can get back to $100 soon. Will see#GileadSciences Gilead Finally Makes a Buy, Snaps Up Massachusetts' Nimbus Apollo in $1.2 B... Read more: https://t.co/oNyhCFo1HA $GILD$GILD buys early stage test tube company. Knowing how long NASH studies take, 1.2 billion was better off with a Russian bank at 9% annual$GILD:

Gilead (GILD) Stock Edges Up on $400 Million Nimbus Apollo ‚Ä¶:

https://t.co/SJZWBJG0VEFinally $GILD, now onward to a shopping spree! https://t.co/HbLoe9eAXSGilead $GILD Stock Edges Up on $400 Million Nimbus Apollo Acquisition https://t.co/W4VW8zzgpaGilead $GILD Stock Edges Up on $400 Million Nimbus Apollo Acquisition https://t.co/58HB0bJbJB #StockActionRT @theflynews: Intercept advances ahead of FDA AdComm after Gilead inks liver deal $GILD $ICPT: Full Story https://t.co/YB2IfEaabDIntercept advances ahead of FDA AdComm after Gilead inks liver deal $GILD $ICPT: Full Story https://t.co/YB2IfEaabD$IBB $ICPT $GILD $CLVS $PGNX $CHMA $SRPT $COLL $FLML like PDUFA &amp; adcom catalyst play? our free list here, $ICPT ... https://t.co/QnLAqwROrt#GileadSciences Gilead paying up to $1.2 B for Nimbus unit, drug, technology. Read more: https://t.co/PzyCMH16JM $GILD#GileadSciences Gilead paying up to $1.2 B for Nimbus unit, drug, technology. Read more: https://t.co/7fba1tq26D $GILD#GileadSciences Gilead paying up to $1.2 B for Nimbus unit, drug, technology. Read more: https://t.co/UpwlXGZvXR $GILD#GileadSciences Gilead paying up to $1.2 B for Nimbus unit, drug, technology. Read more: https://t.co/yxFU1Yl23E $GILDRT @IBD_Areeves: Gilead buys another NASH company -- an no, it's still not Intercept: https://t.co/0alA64oxrI $GILD $ICPT#GileadSciences Gilead paying up to $1.2 B for Nimbus unit, drug, technology. Read more: https://t.co/OujXmUx0WX $GILD#GileadSciences Gilead paying up to $1.2 B for Nimbus unit, drug, technology. Read more: https://t.co/1fC6jeBy3Y $GILD#GileadSciences Gilead Paying up to $1.2 B for Nimbus Unit, Drug, Technology. Read more: https://t.co/xXt512zV96 $GILDGilead building NASH bridges. $GILD $ICPT https://t.co/BKkitQzTbQGilead buys another NASH company -- an no, it's still not Intercept: https://t.co/0alA64oxrI $GILD $ICPT#GileadSciences : Buys Liver-Drug Program. Read more: https://t.co/NTjPLWUCxb $GILD#GileadSciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxlyase (ACC) ... Read more: https://t.co/9QT5BoX7HA $GILD#Biotechs showing life today after a period of stabilization, early signs of a trend reversal. $GERN $OCUL $NAVB $IBB $GILD#GileadSciences Gilead paying up to $1.2 B for Nimbus unit, drug, technology . Read more: https://t.co/EX3xQwFqJn $GILDRT @AndyBiotech: $GILD bets on another NASH program. Congrats @LifeSciVC @bmgallagherjr et al!
https://t.co/WKIL4w83Zd

EASL abstract https‚Ä¶#GileadSciences Gilead acquires Nimbus Apollo and its ACC program. Read more: https://t.co/2HOHCOHjZo $GILDRT @JuliaSkripkaSer: $GILD obviously looked at $ICPT for #NASH and decided against it.. mhmmRT SeekingAlpha: IBB Is About To Break Out With Significant Upside Potential https://t.co/DIlbGmu60G $AMGN $BIIB $CELG $GILD $MDVN $MRK $R‚Ä¶RT @FierceBiotech: Gilead bags early-stage NASH drug in $1.2B Nimbus deal: https://t.co/ife34ADmCd via @JohnCFierce $GILDGILD 94.75 Gilead Sciences Inc $GILD added to my watch list. Right now with GILD I am watching the last price  https://t.co/P4XPkBHQlERT @JMac_SI: Sent this out last night, but more interesting w/ $GILD deal today: let's be ready for $ICPT's panel. Join us: https://t.co/0c‚Ä¶RT @OpenOutcrier: Why $GILD and $AMGN Can Eye $MDVN As Acquisition Target 

https://t.co/cOR1KIF8g0Why $GILD and $AMGN Can Eye $MDVN As Acquisition Target 

https://t.co/cOR1KIF8g0RT @JMac_SI: Sent this out last night, but more interesting w/ $GILD deal today: let's be ready for $ICPT's panel. Join us: https://t.co/0c‚Ä¶RT @Logribel: $GILD acquires #NASH Phase 1 drug from Nimbus for up to $1.2b - meanwhile, Genfit's whole Phase 3 program is valued ~$850m. L‚Ä¶Our $GILD feeling love.IBB Is About To Break Out With Significant Upside Potential https://t.co/qj59jVdFzI $AMGN $BIIB $CELG $GILD $MDVN $MRK $REGN $SNY $RHHBYIBB Is About To Break Out With Significant Upside Potential https://t.co/q1uyzabZUK $AMGN $BIIB $CELG $GILD $MDVN $MRK $REGN $SNY $RHHBYIBB Is About To Break Out With Significant Upside Potential https://t.co/fWieiAKyIr $AMGN $BIIB $CELG $GILD $MDVN $MRK $REGN $SNY $RHHBYRT SeekingAlpha: Bull Case On Gilead Sciences https://t.co/BGDo3SsCA2 $GILDSent this out last night, but more interesting w/ $GILD deal today: let's be ready for $ICPT's panel. Join us: https://t.co/0cOoqPDx7W$GILD Strengthens #NASH Pipeline  https://t.co/RWZiwXbLrw$GILD acquires #NASH Phase 1 drug from Nimbus for up to $1.2b - meanwhile, Genfit's whole Phase 3 program is valued ~$850m. Logic? $GNFTFRT @psuvafan007: 011216 $RHHBY #Roche HBV Capsid inhibitors $GILD $ARWR $ABUS etc https://t.co/mAAFBXTS80It's True. Quality Leads Market Returns In Narrow Breadth Markets $HA $GILD $WHG https://t.co/u41fbsP4Dd$GILD expands into #NASH! Acquired #Nimbus drug for Non-Alcoholic SteatoHepatitis! Major cause of #liver cirrhosis! https://t.co/kqw4PFwMPGBull Case On Gilead Sciences https://t.co/lITGBvnA1g $GILDBull Case On Gilead Sciences https://t.co/T0qBUk8RUU $GILD#GileadSciences Gilead to pay up to $1.2B for Cambridge-born drug program. Read more: https://t.co/mRUpvXbJWl $GILD#GileadSciences Gilead to Acquire Nimbus Subsidiary and its ACC Inhibitor Program for Up to... Read more: https://t.co/PzJrKDtUxx $GILDJPM:"" $MRK $GILD IP Lawyers: impact relatively minimal to GILD valuation, $BIIB IPR proceeding could have fairly meaningful impact,...""Better Buy: #GileadSciences Inc. vs. Biogen Inc. Read more: https://t.co/tu3ua75Ggk $GILD#GileadSciences Nimbus's LLC Origins Pay off As Gilead Shells Out $400M For Liver Drug. Read more: https://t.co/SD1VnU79Bl $GILDRT @CarolineYLChen: CS note on $GILD's NASH deal says Nimbus approach ""interesting but early"", Gild building ""a combination approach in NAS‚Ä¶10 Best S&amp;P 500 Companies By Net Shareholder Distribution Yield - https://t.co/aD8DWLrGip - $AAPL $GILD $JNJ $MON $MSFT $ORCL $PG $UTX $WMT#GileadSciences Gilead paying up to $1.2 B for Nimbus unit, drug, technology. Read more: https://t.co/CP6IEx4mAF $GILDRT @BosBizDon: Here's why Nimbus CEO @DonWNicholson didn‚Äôt just sell the whole company, rather than just its lead drug $GILD https://t.co/i‚Ä¶#GileadSciences Gilead bags early-stage NASH drug in $1.2B Nimbus deal. Read more: https://t.co/OqHAOEQDDk $GILD#GileadSciences Gilead Finally Makes a Buy, Snaps Up Massachusetts' in $1.2 Billion Deal  . Read more: https://t.co/spa826XzBv $GILD#GileadSciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxlyase (ACC) ... Read more: https://t.co/Gx5bc52aIV $GILD#GileadSciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxlyase (ACC) ... Read more: https://t.co/cGdS9BRlDG $GILDCS note on $GILD's NASH deal says Nimbus approach ""interesting but early"", Gild building ""a combination approach in NASH""$GILD - Gilead Buys Liver-Drug Program https://t.co/dKGNDjeBeK$GILD - Gilead Buys Liver-Drug Program https://t.co/PuDClV0oPZ$GILD deal shows quality of mgmt team. NASH is a $10 B plus /yr opptnty (&gt;10 mil US pop &amp; 2-3 mil diagnosed annualy) cost $400mm upfront!""Today‚Äôs deal with $GILD is for a potential drug now in early-stage trials for nonalcoholic steatohepatitis..."" https://t.co/RFZGY2iJnX3 Biotech Stocks on the Verge of an Overdue Run $AMGN $GILD $REGN - https://t.co/Io60dl1i8h#Gilead Sciences : Buys Liver-Drug Program https://t.co/pKWbU4QRfr $GILDTextmunication Holdings, Inc. $TXHD Issues Shareholder Letter https://t.co/rFjb5jl3Sp $NE $SDRL $LEAS  $AAL $GILD https://t.co/jCwI0J4gDdNasdaq100 #Stocks Trend $TSLA $BMRN $ISRG $AAPL $ADSK $CELG $AMGN $ILMN $GILD $INTU $LBTYA $CTXS $LMCA $YHOO  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $ABBV $PFE $MDT $AAPL $CELG $AMGN $TWX $GILD $PEP $BMY $MRK $FOXA $ABT $V $MCD $CVS $PM  @ https://t.co/cKkr8cKsju#Gilead Sciences : Buys Liver-Drug Program https://t.co/ZTLaqaYSUd $GILD@Sport234a LOL i think $GILD not buying $GENFATTIE much more telling then $ICPTRT @JohnCFierce: Biotech valuations don't look to be declining much -- 
Gilead bags early-stage NASH drug in $1.2B Nimbus deal
$GILD
https:‚Ä¶RT @JebKeiper: Great article covering #NimbusTx deal with $GILD @BosBizDon https://t.co/xCMrJwNXFsRT @adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.RT @AndyBiotech: $GILD bets on another NASH program. Congrats @LifeSciVC @bmgallagherjr et al!
https://t.co/WKIL4w83Zd

EASL abstract https‚Ä¶RT @AndyBiotech: $GILD bets on another NASH program. Congrats @LifeSciVC @bmgallagherjr et al!
https://t.co/WKIL4w83Zd

EASL abstract https‚Ä¶@Sport234a WITH $gild already doing 2 mini deals for their nash prog seems they think it will be a big big seller like HCV...33 users on Vetr are bullish on Gilead Sciences, Inc., indicating a BUY Rating (4 stars) for $GILD https://t.co/jxBKjjj0RY@AnalystWire Hi - $GLMD - $GILD has an agreement with them already - right???Great article covering #NimbusTx deal with $GILD @BosBizDon https://t.co/xCMrJwNXFsRT @jonathanrockoff: $GILD to buy Nimbus Therapeutics' NASH unit for $400mn upfront in bid to bolster its drug research in the liver diseaseRT @jonathanrockoff: $GILD to buy Nimbus Therapeutics' NASH unit for $400mn upfront in bid to bolster its drug research in the liver disease@m_denniswinters @adamfeuerstein $GILD acquisition of Nimbus was cheaper than $ICPT, but we predict $GILD will clear the table and get $ICPTHere's why Nimbus CEO @DonWNicholson didn‚Äôt just sell the whole company, rather than just its lead drug $GILD https://t.co/iycaTL9wZN$GILD strengthens NASH¬†pipeline https://t.co/twne9Z49MH@adamfeuerstein $GILD buys $ICPT by end of the year. Its a San Diego theory.RT @OpenOutcrier: $GILD (+0.4% pre) Gilead to Acquire Nimbus' Acetyl-CoA Carboxlyase Program for NASH for $400M + Milestones 

https://t.co‚Ä¶RT @big3bio: Big3Deal Coverage: Nimbus and Gilead - https://t.co/hgQWSsdsxz #big3bio $GILD@adamfeuerstein @JacobPlieth surprised not down passed over 2x by $GILD on #NASH reminds me of $ACHN in #HCVVolume Alert - GILD 94.74 Gilead Sciences Inc $GILD Hit a high today of 94.85 Closing the day 10:30 at 94.74 + https://t.co/5HtcFougAyTop 5 HC -13% YTD vs -20.65% $IBB.  Last 21 days +4.65 outperf.  Watching $GILD $CELG $MDVN $BIIB $REGN on HC recov https://t.co/XTg1WMNtAlRT @zbiotech: nibus lead drug NDI-010976 with pI data at EASL $GILDRT @Tootix: #NASH $GILD $GNFT $ICPT NASH Weddings in progress. Who needs a safe &amp; efficient PPAR Alpha/Delta agonist ? https://t.co/jPfocDs‚Ä¶RT @BioWorld: $GILD-ed Apollo: Gilead takes Nimbus program for potential $1.2B https://t.co/CIlL4bU1vEAnd of course $ICPT is up today. Renewed interest in NASH, right? $GILDAnalyst Actions and Breaking News $EDAP $ESLT $GIG $GRPN $GILD $MRCY #stocks #stockmarket https://t.co/bN0pYLT1Kj$IBB very important test for #biotech right now!

$AMGN $GILD $CELG
$BIIB $REGN https://t.co/x8SZ3DWqIgRT @buysellshort: 3d stocks big moves today $ONVO only startingt plus ONVO has 3d liver and liver sector huge move off $GILD $CNATRT @Tootix: #NASH $GILD $GNFT $ICPT NASH Weddings in progress. Who needs a safe &amp; efficient PPAR Alpha/Delta agonist ? https://t.co/jPfocDs‚Ä¶RT @BadBoyzAuction: $GILD: Gilead Sciences announces acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase program$GILD strategic focus in inflammatory diseases. $crbp good target cb2 Endocannibanoid  ph2 data by ye CF&amp;scleroderma https://t.co/sRXJ86UZdQRT @Tootix: #NASH $GILD $GNFT $ICPT NASH Weddings in progress. Who needs a safe &amp; efficient PPAR Alpha/Delta agonist ? https://t.co/jPfocDs‚Ä¶Equities recently tagged #undervalued by the ClosingBell community: $GBSN $AAPL $AMD $GILD $GPRO https://t.co/KW5Vl5Pl0jRT @Tootix: #NASH $GILD $GNFT $ICPT NASH Weddings in progress. Who needs a safe &amp; efficient PPAR Alpha/Delta agonist ? https://t.co/jPfocDs‚Ä¶@1000Shares nice. $IBB helping all these biotechs stocks. $GILD $AMRN $GERN $ARIA$AAPL upgrades piling up as stock is above $110, same will happen when $DIS 105 $GILD 100 #investing #TomsTruths  https://t.co/kpezYWr0YTRT @adamfeuerstein: $GILD buying privately held Nimbus Therapeutics for NASH drug. $400M upfront.#NASH $GILD $GNFT $ICPT NASH Weddings in progress. Who needs a safe &amp; efficient PPAR Alpha/Delta agonist ? https://t.co/jPfocDsgPpRT @JuliaSkripkaSer: $GILD obviously looked at $ICPT for #NASH and decided against it.. mhmmRT @BioWorld: $GILD-ed Apollo: Gilead takes Nimbus program for potential $1.2B https://t.co/CIlL4bU1vERT @adamfeuerstein: $GILD buying privately held Nimbus Therapeutics for NASH drug. $400M upfront.$GILD tarvitsee uutta verta. Hirmukatetta jauhavat HepC-l√§√§kkeet jarruttavat kohta. https://t.co/UZab00pux9RT @RNAiAnalyst: $GILD-Nimbus shows that NASH is hot.  Chances are that this area eventually dominated by RNA Therapeutics.$CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO
 .
Last Day!
94.57% Average Gain
UNBIASED!
 .
https://t.co/mNVCwotQZt 
 .
 . https://t.co/9tJhTcUlCqRT @JuliaSkripkaSer: $GILD obviously looked at $ICPT for #NASH and decided against it.. mhmmRT @BioWorld: $GILD-ed Apollo: Gilead takes Nimbus program for potential $1.2B https://t.co/CIlL4bU1vE$GILD-ed Apollo: Gilead takes Nimbus program for potential $1.2B https://t.co/CIlL4bU1vE3d stocks big moves today $ONVO only startingt plus ONVO has 3d liver and liver sector huge move off $GILD $CNATRT @adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.$GILD: Gilead Sciences announces acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase programRT @bradloncar: $GILD has been consistent saying NASH is a priority.RT @JuliaSkripkaSer: $GILD obviously looked at $ICPT for #NASH and decided against it.. mhmmRT @IndvTrader: Commented on Biotech Will Blast Past Its 2015 Highs https://t.co/qTbt7iDOrv $GILD $LABU $REGN $IBB#NASH $NIMBUS $GNFT $ICPT What‚Äôs the real price of these BIOTECHS? $GILD  https://t.co/aHEW4FmZQ9$GILD: Gilead Sciences announces acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase program; Nimbus... https://t.co/ASIQub8KMqGILD Top news - Apr 4th, 2016 $GILD https://t.co/VdVbgdK8YmCommented on Biotech Will Blast Past Its 2015 Highs https://t.co/qTbt7iDOrv $GILD $LABU $REGN $IBBRT @TraderBiotech: $GILD Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA https://t.co/n5EFXyJu5qWith biotech still percolating, and crap basing, it's spring rotation watch which could provide for nice gains. $IBB $GILD $CELG $FIT $TWTR$GILD buying Phenex FXR program from Nimbus for $400M https://t.co/j1JAImFTBR#Rayno Biopharmaceuticals: New Buy Idea - #Roche Plc. $RHHBY Also $BMY $GILD $ABBV https://t.co/DSsiomWHzt10 Best S&amp;P 500 Companies By Net Shareholder Distribution Yield - https://t.co/aD8DWLJh9X - $AAPL $GILD $JNJ $MON $MSFT $ORCL $PG $UTX $WMT$GILD $BSX:

Biotech Stocks in Concerns- Gilead Sciences (NASDAQ:GILD ‚Ä¶:

https://t.co/2Tbwn8wP17$GILD Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA https://t.co/n5EFXyJu5q$GILD to buy Nimbus Therapeutics' NASH unit for $400mn upfront in bid to bolster its drug research in the liver diseaseRT @adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.April 4 Biotech Update $AGN $AMGN $ESPR $GILD $PFE https://t.co/JwVxqjkSGaBig3Deal Coverage: Nimbus and Gilead - https://t.co/hgQWSsdsxz #big3bio $GILDTo be fair to $GILD $400M upfront for a NASH, HCC candidate with not-yet-presented phase 1 data and and FDA Fast-Track seems a smart deal$GILD https://t.co/cKnatZ4prART @WrigleyTom: $GILD
Gilead Sciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxlyase Program for NASH and Other Liver‚Ä¶Of course. Just after I praised $GILD for investing in its own shares rather than acquisitions: https://t.co/sx3xiF5dl0 it acquires Nimbus$AMGN $AAPL $V $GILD $LULU Couple stocks at the overbought Hourly. All above the 70 Hourly RSI. If you are swinging these, trade cautiously.$GILD ""is paying $400M upfront to acquire early-stage pipeline of liver disease drugs from privately held Nimbus..."" https://t.co/UYTZ8ypXnjRT @AndyBiotech: $GILD bets on another NASH program. Congrats @LifeSciVC @bmgallagherjr et al!
https://t.co/WKIL4w83Zd

EASL abstract https‚Ä¶$GILD weeklies, watching closely thoughRT @BentheFidler: Nimbus‚Äôs LLC Origins Pay off As Gilead Shells Out $400M For Liver Drug https://t.co/VtT3BZkQa3 $GILD $ICPT @atlasventureRT @JohnCFierce: Biotech valuations don't look to be declining much -- 
Gilead bags early-stage NASH drug in $1.2B Nimbus deal
$GILD
https:‚Ä¶RT @JohnCFierce: Biotech valuations don't look to be declining much -- 
Gilead bags early-stage NASH drug in $1.2B Nimbus deal
$GILD
https:‚Ä¶Biotech Will Blast Past Its 2015 Highs https://t.co/Fc5J0ZYueJ $GILD $LABU $REGN $IBB$GILD NASH compound is nice - but investors be like: https://t.co/LVRMC91AvwShire And Baxalta - A Match Made In Heaven? (Part 1) https://t.co/fptCNGln5D $AMGN $BXLT $GILD $SHPGRT @BentheFidler: Nimbus‚Äôs LLC Origins Pay off As Gilead Shells Out $400M For Liver Drug https://t.co/VtT3BZkQa3 $GILD $ICPT @atlasventure$GILD weak$HALO 20% #Short interest, fireworks soon ?
$JAZZ $KITE $BLUE $BMRN $ESPR $GILD $BMY $PFECongrats! Rocketing ACC science progress in the brave new world of discovery at Nimbus Apollo launches in $GILD deal https://t.co/VzRccZN5pV$GILD Considered a cheap stock by valuation, around PE of 8 and still grow at good rate.. https://t.co/ZQ5SCT5QzVRT @adamfeuerstein: $GILD buying privately held Nimbus Therapeutics for NASH drug. $400M upfront.$GILD $GS $JPM $C $MS Silver Lake parked @ $8.5B in Cayman Islands when selling its Skype https://t.co/LzobP1B0Ea
 https://t.co/JZ9gcfxFRm$GILD has spent 400+M u/f and has to pay 1.27B in milestones for 2/4 of its NASH drugs. Both in its early stagesRT @adamfeuerstein: $GILD Bolsters Liver Disease Pipeline with Nimbus Drug Purchase https://t.co/ScYZRI3OYd via @TheStreetRT @WrigleyTom: $GILD
Gilead Sciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxlyase Program for NASH and Other Liver‚Ä¶RT SeekingAlpha: Shire And Baxalta - A Match Made In Heaven? (Part 1) https://t.co/Ddw6Mrempw $AMGN $BXLT $GILD $SHPGShire And Baxalta - A Match Made In Heaven? (Part 1) https://t.co/d2KWvVkHjL $AMGN $BXLT $GILD $SHPG$GILD paying $400m upfront for #NimbusTherapeutics #NASH drug AcetylcoA carboxylase inhibitor in phase I https://t.co/Za91uZrjjtRT @FierceBiotech: Gilead bags early-stage NASH drug in $1.2B Nimbus deal: https://t.co/ife34ADmCd via @JohnCFierce $GILD$GILD: https://t.co/SGBcglWJx8RT @adamfeuerstein: $GILD Bolsters Liver Disease Pipeline with Nimbus Drug Purchase https://t.co/ScYZRI3OYd via @TheStreetGilead to pay up to $1.2B for NASH drug program developed at Cambridge's Nimbus (an @atlasventure sturtup) $GILD https://t.co/P1aEI4aezD$GILD acquires Acetyl-CoA-Carboxylase (ACC) program from Nimbus for $400M. #NASH https://t.co/MWEzlrgajo$icpt how much did $gild offer to say no?  Don't think they approached $gnft.$GILD Announces Acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA https://t.co/Kv0npDWK2M #biotechstocks #biotech #stocksRT @svKatface: $GILD buying privately held Biomeds to pursue liver disease treatments; trials not as advanced as are $ICPT &amp; $GNFTNimbus‚Äôs LLC Origins Pay off As Gilead Shells Out $400M For Liver Drug https://t.co/VtT3BZkQa3 $GILD $ICPT @atlasventure$GILD buying privately held Biomeds to pursue liver disease treatments; trials not as advanced as are $ICPT &amp; $GNFThttps://t.co/ePmWPwtAaB $GILD making aggressive moves in NASH space w/ACC inhib.purchase(anything in my port. would have been better üòú).RT @megtirrell: $GILD paying $400m upfront, $800m potential milestones for Nimbus https://t.co/IimNESzFYm‚Äô-Acetyl-CoA

 https://t.co/wMi5Xc‚Ä¶RT @bmgallagherjr: $GILD acquires Nimbus Therapeutics Ph1 ACC inhibitor program in NASH for $1.2B - $400M upfront. Congrats to the team htt‚Ä¶RT @GerberKawasaki: Great start to the week. Apple upgraded. $aapl Tesla will be up sharply on record orders on #Model3 $tsla Gilead gets i‚Ä¶RT @adamfeuerstein: $GILD buying privately held Nimbus Therapeutics for NASH drug. $400M upfront.RT @m_denniswinters: ‚Äú@adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.‚Äù $gnft $icptRT @JacobPlieth: And not for the first time $GILD $ICPT https://t.co/wsAPQt0MQlGreat start to the week. Apple upgraded. $aapl Tesla will be up sharply on record orders on #Model3 $tsla Gilead gets into NASH. $gild$GILD To acquire Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase (ACC) Program for NASH and Other Liver Diseases for $400M hence $MNOVRT @fwpharma: Gilead to buy Nimbus Therapeutics‚Äô NASH programme for up to $1.2 billion https://t.co/pXmfhQ8tin $GILD #pharmaRT @AndyBiotech: $GILD bets on another NASH program. Congrats @LifeSciVC @bmgallagherjr et al!
https://t.co/WKIL4w83Zd

EASL abstract https‚Ä¶RT SeekingAlpha: Biotech Will Blast Past Its 2015 Highs https://t.co/DuqrMD9waQ $GILD $LABU $REGN $IBBRT @adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.RT @megtirrell: $GILD paying $400m upfront, $800m potential milestones for Nimbus https://t.co/IimNESzFYm‚Äô-Acetyl-CoA

 https://t.co/wMi5Xc‚Ä¶Biotech Will Blast Past Its 2015 Highs https://t.co/ZsXgWxc7sq $GILD, $LABU, $REGN, $IBBRT @OpenOutcrier: $GILD (+0.4% pre) Gilead to Acquire Nimbus' Acetyl-CoA Carboxlyase Program for NASH for $400M + Milestones 

https://t.co‚Ä¶RT @megtirrell: $GILD paying $400m upfront, $800m potential milestones for Nimbus https://t.co/IimNESzFYm‚Äô-Acetyl-CoA

 https://t.co/wMi5Xc‚Ä¶Biotech Will Blast Past Its 2015 Highs https://t.co/MMLIklpO5V $GILD $LABU $REGN $IBBBiotech Will Blast Past Its 2015 Highs https://t.co/i6mKyHRMIm $GILD $LABU $REGN $IBBBiotech Will Blast Past Its 2015 Highs https://t.co/069kUvbBNB $GILD $LABU $REGN $IBBRT @megtirrell: $GILD paying $400m upfront, $800m potential milestones for Nimbus https://t.co/IimNESzFYm‚Äô-Acetyl-CoA

 https://t.co/wMi5Xc‚Ä¶Gilead buys NASH program for up to $1.2B https://t.co/vcjHVQhC5R $GILD #GILDRT MarketCurrents: Gilead buys NASH program for up to $1.2B https://t.co/0QWuhCdTJF #premarket $GILD,https://t.co/Q0pEHTMLieIt's True. Quality Leads Market Returns in Narrow Breadth Markets. $WHG $HA $GILD https://t.co/LTdzmu26DO https://t.co/oZ2954OxxpRT @megtirrell: $GILD paying $400m upfront, $800m potential milestones for Nimbus https://t.co/IimNESzFYm‚Äô-Acetyl-CoA

 https://t.co/wMi5Xc‚Ä¶RT @adamfeuerstein: $GILD Bolsters Liver Disease Pipeline with Nimbus Drug Purchase https://t.co/ScYZRI3OYd via @TheStreetRT @adamfeuerstein: Right. My mistake. $GILD has four NASH drugs in the pipeline, including Nimbus compound.  https://t.co/hBAsUokbaPRT @GantosJ: $GILD Gilead Sciences Announces Acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase (ACC) Progra... https://t.co/5ynm4l‚Ä¶Long Watches: $TSLA, $RKUS, $EW, $HD, $ZFGN, $AAPL, $ACAD, $GILD! Short Watches: $ALK, $FB, $SWHC, $BHI, $BRCD!RT @adamfeuerstein: $GILD Bolsters Liver Disease Pipeline with Nimbus Drug Purchase https://t.co/ScYZRI3OYd via @TheStreetRT @adamfeuerstein: Right. My mistake. $GILD has four NASH drugs in the pipeline, including Nimbus compound.  https://t.co/hBAsUokbaPRT @adamfeuerstein: $GILD Bolsters Liver Disease Pipeline with Nimbus Drug Purchase https://t.co/ScYZRI3OYd via @TheStreetBackgrounder to @atlasventure 's Nimbus / $GILD deal today, via @LifeSciVC
https://t.co/RpEuH79uy8 https://t.co/M54ufd8m1TNASH is a worthy target for $GILD - big enough and growing prevalence suggest it could move the needle for GILD. https://t.co/e3DgEOLanh$GILD paying $400m upfront, $800m potential milestones for Nimbus https://t.co/IimNESzFYm‚Äô-Acetyl-CoA

 https://t.co/wMi5XcDopxRT @adamfeuerstein: Right. My mistake. $GILD has four NASH drugs in the pipeline, including Nimbus compound.  https://t.co/hBAsUokbaP$GILD bought company for NASH??  Dont take ur eye off the HBV ball $GILD :))RT @biotechbaumer: HUGE congrats to the Nimbus team @KapellerRosana @JebKeiper and investors @LifeSciVC @bmgallagherjr on their ACCi deal w‚Ä¶Gilead buys NASH program for up to $1.2B $GILD https://t.co/byszHUEVWoRight. My mistake. $GILD has four NASH drugs in the pipeline, including Nimbus compound.  https://t.co/hBAsUokbaPRT @JohnCFierce: Biotech valuations don't look to be declining much -- 
Gilead bags early-stage NASH drug in $1.2B Nimbus deal
$GILD
https:‚Ä¶$GILD-Nimbus shows that NASH is hot.  Chances are that this area eventually dominated by RNA Therapeutics.RT @MarketCurrents: Gilead buys NASH program for up to $1.2B https://t.co/hVVkn2cPte #premarket $GILDRT @GantosJ: $GILD Gilead Sciences Announces Acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase (ACC) Progra... https://t.co/5ynm4l‚Ä¶Gilead buys NASH program for up to $1.2B https://t.co/NbBVYxg0H1 #premarket $GILDGilead buys NASH program for up to $1.2B https://t.co/aYpJmBJaBH #premarket $GILDGilead buys NASH program for up to $1.2B https://t.co/CYtTaeoMPI #premarket $GILDGilead buys NASH program for up to $1.2B https://t.co/hVVkn2cPte #premarket $GILD$GILD:

Gilead Bolsters Liver Disease Pipeline with Nimbus Drug Purchase:

https://t.co/2w38XFjW9VRT @adamfeuerstein: $GILD Bolsters Liver Disease Pipeline with Nimbus Drug Purchase https://t.co/ScYZRI3OYd via @TheStreetRT @JohnCFierce: Biotech valuations don't look to be declining much -- 
Gilead bags early-stage NASH drug in $1.2B Nimbus deal
$GILD
https:‚Ä¶RT @adamfeuerstein: $GILD Bolsters Liver Disease Pipeline with Nimbus Drug Purchase https://t.co/ScYZRI3OYd via @TheStreetRT @JohnCFierce: Biotech valuations don't look to be declining much -- 
Gilead bags early-stage NASH drug in $1.2B Nimbus deal
$GILD
https:‚Ä¶@bmgallagherjr #NASH chess game is going on with $GILD transaction on Nimbus. I hope $GNFT @genfit_pharma will sign the right partner in USRT @FierceBiotech: Gilead bags early-stage NASH drug in $1.2B Nimbus deal: https://t.co/ife34ADmCd via @JohnCFierce $GILDGilead bags early-stage NASH drug in $1.2B Nimbus deal: https://t.co/g4v7VHPjkV via JohnCFierce $GILD story from FierceBiotech #biotech #p‚Ä¶$GILD Bolsters Liver Disease Pipeline with Nimbus Drug Purchase https://t.co/ScYZRI3OYd via @TheStreetRT @adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.RT @FierceBiotech: Gilead bags early-stage NASH drug in $1.2B Nimbus deal: https://t.co/ife34ADmCd via @JohnCFierce $GILDRT @WrigleyTom: $GILD
Gilead Sciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxlyase Program for NASH and Other Liver‚Ä¶Many kudos in order for today's Nimbus / $GILD deal. Best to start with @LifeSciVC's chest-thumper --&gt; https://t.co/lZIGb2GRGmGilead bags early-stage NASH drug in $1.2B Nimbus deal: https://t.co/ife34ADmCd via @JohnCFierce $GILDRT @fwpharma: Gilead to buy Nimbus Therapeutics' NASH programme for up to $1.2 billion https://t.co/1UHzyeDYtO $GILD #pharmaRT @JohnCFierce: Biotech valuations don't look to be declining much -- 
Gilead bags early-stage NASH drug in $1.2B Nimbus deal
$GILD
https:‚Ä¶RT @JohnCFierce: Biotech valuations don't look to be declining much -- 
Gilead bags early-stage NASH drug in $1.2B Nimbus deal
$GILD
https:‚Ä¶RT @JohnCFierce: Biotech valuations don't look to be declining much -- 
Gilead bags early-stage NASH drug in $1.2B Nimbus deal
$GILD
https:‚Ä¶RT @JacobPlieth: And not for the first time $GILD $ICPT https://t.co/wsAPQt0MQlBiotech valuations don't look to be declining much -- 
Gilead bags early-stage NASH drug in $1.2B Nimbus deal
$GILD
https://t.co/4Y61yf0PR8RT @adamfeuerstein: $GILD buying privately held Nimbus Therapeutics for NASH drug. $400M upfront.RT @WrigleyTom: $GILD
Gilead Sciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxlyase Program for NASH and Other Liver‚Ä¶RT @zbiotech: $GILD buying nimbus apollo unit, 400M upfrontHUGE congrats to the Nimbus team @KapellerRosana @JebKeiper and investors @LifeSciVC @bmgallagherjr on their ACCi deal with $GILD today!Interesting that $GILD has chosen to pass on $ICPT and $GNFT twice now, might be telling.Gilead to buy Nimbus Therapeutics' NASH programme for up to $1.2 billion https://t.co/1UHzyeDYtO $GILD #pharmaRT @adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.RT @AndyBiotech: $GILD bets on another NASH program. Congrats @LifeSciVC @bmgallagherjr et al!
https://t.co/WKIL4w83Zd

EASL abstract https‚Ä¶RT @JacobPlieth: And not for the first time $GILD $ICPT https://t.co/wsAPQt0MQlRT @AndyBiotech: $GILD bets on another NASH program. Congrats @LifeSciVC @bmgallagherjr et al!
https://t.co/WKIL4w83Zd

EASL abstract https‚Ä¶RT @AndyBiotech: $GILD bets on another NASH program. Congrats @LifeSciVC @bmgallagherjr et al!
https://t.co/WKIL4w83Zd

EASL abstract https‚Ä¶RT @OpenOutcrier: $GILD (+0.4% pre) Gilead to Acquire Nimbus' Acetyl-CoA Carboxlyase Program for NASH for $400M + Milestones 

https://t.co‚Ä¶RT @GantosJ: $GILD Gilead Sciences Announces Acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase (ACC) Progra... https://t.co/5ynm4l‚Ä¶RT @JacobPlieth: And not for the first time $GILD $ICPT https://t.co/wsAPQt0MQlRT @JacobPlieth: And not for the first time $GILD $ICPT https://t.co/wsAPQt0MQlRT @JacobPlieth: And not for the first time $GILD $ICPT https://t.co/wsAPQt0MQl$GILD #NimbusTx Press Release https://t.co/L19G8mstqMAnd not for the first time $GILD $ICPT https://t.co/wsAPQt0MQl$GILD bets on another NASH program. Congrats @LifeSciVC @bmgallagherjr et al!
https://t.co/WKIL4w83Zd

EASL abstract https://t.co/i32meeUoihRT @OpenOutcrier: $GILD (+0.4% pre) Gilead to Acquire Nimbus' Acetyl-CoA Carboxlyase Program for NASH for $400M + Milestones 

https://t.co‚Ä¶RT @adamfeuerstein: $GILD buying privately held Nimbus Therapeutics for NASH drug. $400M upfront.RT @adamfeuerstein: Clarification. $GILD is buying the liver disease drug pipeline from Nimbus, not the entire company.RT @adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.‚Äú@adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.‚Äù $gnft $icpt$GILD (+0.4% pre) Gilead to Acquire Nimbus' Acetyl-CoA Carboxlyase Program for NASH for $400M + Milestones 

https://t.co/TdGJYkjGh7‚Äú@adamfeuerstein: Clarification. $GILD is buying the liver disease drug pipeline from Nimbus, not the entire company.‚Äù $gnft $icpt$GILD obviously looked at $ICPT for #NASH and decided against it.. mhmmRT @bmgallagherjr: $GILD acquires Nimbus Therapeutics Ph1 ACC inhibitor program in NASH for $1.2B - $400M upfront. Congrats to the team htt‚Ä¶RT @JebKeiper: So pleased to be partnering with $GILD @GileadSciences!, phenomenal drug developers; committed to liver disease https://t.co‚Ä¶So pleased to be partnering with $GILD @GileadSciences!, phenomenal drug developers; committed to liver disease https://t.co/vkU8Murqpk@adamfeuerstein #NASH &amp; #HBV future revenues by $GILD might be &gt; than present #HCV sales. 
Then #cure for #HIV as part of life cycle mangtGilead $GILD to Acquire Nimbus Therapeutics' Acetyl-CoA Carboxlyase Program for NASH for $400M‚Ä¶ https://t.co/bj0yGzZ5zN via ‚Üí @AlertTradeRT @GantosJ: $GILD Gilead Sciences Announces Acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase (ACC) Progra... https://t.co/5ynm4l‚Ä¶RT @LifeSciVC: @adamfeuerstein $GILD only buying one program, housed in Nimbus Apollo. The rest of the company marches onward with other pr‚Ä¶$GILD ""includes the lead candidate NDI-010976, an ACC inhibitor, and other preclinical ACC inhibitors for the treatment of NASH.""RT @adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.RT @adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.RT @bmgallagherjr: $GILD acquires Nimbus Therapeutics Ph1 ACC inhibitor program in NASH for $1.2B - $400M upfront. Congrats to the team htt‚Ä¶RT @w_biltmore85: Investors: Gilead News Release $GILD NASH &amp; Liver programs aquired  https://t.co/BCTgwVlnNf@bradloncar #NASH &amp; #HBV future revenues by $GILD will probably be &gt;than present #HCV sales. Then #cure for #HIV as part of life cycle mangt$GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.$GILD acquires Nimbus NASH for $400 mill upfront$GILD Acquires Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase Program for NASH &amp; Other Liver Diseases 
400mln upfront, 800mln pot milestones$GILD Nimbus Therapeutics will receive an upfront payment of $400M with the potential $800M in development-related milestones over time.Gilead $GILD to Acquire Nimbus Therapeutics' Acetyl-CoA Carboxlyase Program for NASH for $400M Plus Milestones https://t.co/Od3WxCTsLI$GILD acquires Nimbus Therapeutics Ph1 ACC inhibitor program in NASH for $1.2B - $400M upfront. Congrats to the team https://t.co/sRUyIFWWHSGreat article of stocks to buy when the bottom is in. $GILD https://t.co/32VDcNVX1JRT @adamfeuerstein: $GILD buying privately held Nimbus Therapeutics for NASH drug. $400M upfront.Investors: Gilead News Release $GILD NASH &amp; Liver programs aquired  https://t.co/BCTgwVlnNf4/4 Daily Scan - $REGN $GILD $INO $CRMD $TERP $TSLA $SKYS $GNCA - https://t.co/KbRFEaBW7d$GILD we had that nice bet on the NOV 95 calls hit the tape on Friday.  https://t.co/0D1zlc8Xmh@adamfeuerstein $GILD only buying one program, housed in Nimbus Apollo. The rest of the company marches onward with other programsClarification. $GILD is buying the liver disease drug pipeline from Nimbus, not the entire company.$GILD not bad for small caps...https://t.co/OH3rHyu7p8RT @WallStChatter: $GILD Announces Acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase https://t.co/U7wqLJn2de$GILD Gilead Sciences Announces Acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase (ACC) Progra... https://t.co/5ynm4lmzkmnibus lead drug NDI-010976 with pI data at EASL $GILDRT @bradloncar: $GILD has been consistent saying NASH is a priority.RT @zbiotech: $GILD buying nimbus apollo unit, 400M upfront$GILD has been consistent saying NASH is a priority.RT @adamfeuerstein: $GILD buying privately held Nimbus Therapeutics for NASH drug. $400M upfront.RT @adamfeuerstein: $GILD buying privately held Nimbus Therapeutics for NASH drug. $400M upfront.$GILD Announces Acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase https://t.co/U7wqLJn2de$GILD Gilead Sciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxlyase (ACC) Program for 
From our Stock News Alerts App#Gilead Sciences : Announces Acquisition of Nimbus Therapeutics&amp;rsquo; Acetyl-... https://t.co/McGxgPMMoS $GILDRT @WrigleyTom: $GILD
Gilead Sciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxlyase Program for NASH and Other Liver‚Ä¶$GILD
Gilead Reports Purchase of Nimbus Therapeutics' ACC Program for NAS, Other Liver Diseases; Made $400M Up... https://t.co/uJu5ze7eSb$GILD buying privately held Nimbus Therapeutics for NASH drug. $400M upfront.RT @WrigleyTom: $GILD
Gilead Sciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxlyase Program for NASH and Other Liver‚Ä¶$GILD
Gilead Sciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxlyase Program for NASH and Other Liver Diseases -DJRT @zbiotech: $GILD buying nimbus apollo unit, 400M upfrontRT @zbiotech: $GILD buying nimbus apollo unit, 400M upfront$GILD buying nimbus apollo unit, 400M upfront$GILD - Gilead Sciences Announces Acquisition of Nimbus Therapeutics‚Äô Acetyl-CoA Carboxlyase (ACC) Program https://t.co/vL2FySxmv7#FusionIQ NEW Positive Timing Signal on $GILD Today https://t.co/9ImlXz4YNa Please Retweet #SignalsWe calculated 21-day Expected Return of $GILD for you: 6.28% https://t.co/mTgAzTSiLDTop Buy Stocks: $GILD, $GLPI, $MA, $MDLZ, $NVDA, $SC  https://t.co/ej8vdqUY7n@RNA_Biotech $ALNY is already minority owned by $SNY  No doubt they wished they owned $IONS instead. $Gild needs help in pipe,#biotech #RNA@m_denniswinters @tgtxdough True many FXR are in early stages. $GILD bought 1 with Phenex. I dont thk they go for another one with CV issuesRT @paulwoll: https://t.co/oslN3rVnpu  $GILD may be one to watch on move &gt; 94.30 for a trade to 98ishRT @tgtxdough: Few NASH related therapeutics $GILD $MRK $ICPT https://t.co/11GYXP184aCheap call option upside: $CRM calls cheaper than 100% of history, $GILD 99%, $BBRY 98%, $DIS 97%, $XLI 97%, $WBA 97%, $BABA 95%Weekly S&amp;P100 #Stocks Trend $V $MA $AAPL $SPG $ABT $AMGN $IBM $CMCSA $GILD $PEP $CSCO $CL $HD $MCD $LOW $SO  @ https://t.co/cKkr8cKsjuIt's True. Quality Leads Market Returns In Narrow Breadth Markets $HA $GILD $WHG https://t.co/d18oKbvP0GConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNR@jimcramer #cramerq jim, holding $NFLX, now at a s-t high &amp; near my cost! Do i sell, hold or schnitzel? same 4 $GILD? Trump recession?https://t.co/oslN3rVnpu  $GILD may be one to watch on move &gt; 94.30 for a trade to 98ishRT @Tootix: @m_denniswinters @tgtxdough I agree with you. I bet on #Genfit $GNFT because of: 1/Safety (CV) 2/Efficiency 3/Complementarity w‚Ä¶RT @lancejepsen: Gilead Sciences Gets FDA Approval For Genvoya $GILD https://t.co/9F9Nm67PRE https://t.co/nIvlJM9dmg@m_denniswinters @tgtxdough I agree with you. I bet on #Genfit $GNFT because of: 1/Safety (CV) 2/Efficiency 3/Complementarity with $GILDRT @tgtxdough: Few NASH related therapeutics $GILD $MRK $ICPT https://t.co/11GYXP184aRT @MargaretDudley1: ‚Äú@TIICANN: Subpoenas Served https://t.co/wWQJV0MZpc https://t.co/5IJyAkZwmn‚Äù #hepC $Gild #greed#GileadSciences, Inc. Downgraded by Vetr Inc. to ""Buy"". Read more: https://t.co/h0k9hcFmiT $GILD$GILD 94,12$ +2,5% #BBBiotech Beteiligung mit FDA-Entscheid am Donnerstag /MS https://t.co/urXvn8X2ncRT @tgtxdough: Few NASH related therapeutics $GILD $MRK $ICPT https://t.co/11GYXP184aRT @tgtxdough: Few NASH related therapeutics $GILD $MRK $ICPT https://t.co/11GYXP184aRT @BioBreakout: $GILD $ICPT $CLVS $CHMA $HRTX $PGNX $SRPT $COLL $FLML $SUPN Biotech Stocks Facing FDA Decision In April https://t.co/DibXF‚Ä¶Gilead Sciences, Inc. $GILD Downgraded by Vetr Inc. to ‚ÄúBuy‚Äù https://t.co/ak33Oih01uGilead Sciences, Inc. $GILD Downgraded by Vetr Inc. to ‚ÄúBuy‚Äù https://t.co/lAV8HwWra4@tgtxdough this table tells me that $gild would love to have an effective Nash asset.  They will acquire one of the leaders soon.  $icpt.Watching $CHMA $BIND $GILD big catalysts this month. #biotechhttps://t.co/uAcamNRUPt alerted $PTX +45% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/OQCNEb9p9K $HOT $AMAT $ITUB $MT $GILD $HST $AAConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/DgrNThhkJM  $DIS $ALXN $NOAH $GILD $QUNRGilead Price Reductions No Big Deal https://t.co/UKZEazWzns $GILD Shares of the day: APA group stapled and Ramsay Health Care Ltd$GOOGL $LULU $GILD $NUGT $GLD.  Protect your investments and follow me.  $NKE $UA $AAPL $FB $NFLX https://t.co/lGYHgNskp6Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @tgtxdough: Actual IMS Sales jan 16 and US. Adjusted Sales for 1Q $GILD $CELG https://t.co/oUHntcP4E5Actual IMS Sales jan 16 and US. Adjusted Sales for 1Q $GILD $CELG https://t.co/oUHntcP4E5RT @tgtxdough: Few NASH related therapeutics $GILD $MRK $ICPT https://t.co/11GYXP184aRT @tgtxdough: Few NASH related therapeutics $GILD $MRK $ICPT https://t.co/11GYXP184aRT @tgtxdough: Few NASH related therapeutics $GILD $MRK $ICPT https://t.co/11GYXP184a100-102 tractor beam $GILD https://t.co/nx7XIS8Umi$GILD chart: 100-102 tractor beam. https://t.co/kUgUtfRNtQFew NASH related therapeutics $GILD $MRK $ICPT https://t.co/11GYXP184aThese are the date for PDFUA &amp; Adcom for April. $IBB $ICPT $GILD $CLVS $PGNX $CHMA $SRPT $COLL $FLML https://t.co/zTilFv3Qwr@OphirGottlieb @CMLviz does $GILD really have 60 phase trials?  I thought there were around 12.@kristopher_ho @JoeFCaputo $GILD calls or $GLD calls fgt?Four Best #Biotech #Stocks of the First Quarter of 2016 $KIN $CRMD $ALIOF $MESO Also $AMGN $GILD $SHPG $BXLT https://t.co/xu3NT8MYjFRT @BioBreakout: $GILD $ICPT $CLVS $CHMA $HRTX $PGNX $SRPT $COLL $FLML $SUPN Biotech Stocks Facing FDA Decision In April https://t.co/DibXF‚Ä¶",2016-04-04,GILD,1
5,"JOHN MARTIN C Executive Chairman Sells $7,684,007 Worth of $GILD Gilead Sciences, Inc. - #Form4 #InsiderTrading - https://t.co/hLfBa8t5AY$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Closes +1.41% For the Session:

https://t.co/Lj0K8XZZfg$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/ZQWSl0IyFFEVP of Gilead Sciences just disposed of 5,000 shares  https://t.co/UmWPDJzGc5 $GILD$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/U61QPsRvtDJOHN MILLIGAN F Pres and CEO Sells $8,757,664 Worth of $GILD Gilead Sciences, Inc. - #Form4 #InsiderTrading - https://t.co/Ywd9oksWjD$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/b7QGl4vKcH.@JimCramer's 'Off the Charts': Biotech gets a short-term bottom $GILD $IBB https://t.co/IXNoPdrQxrS&amp;P500 #Stocks Trend $PFE $GILD $CELG $LMT $ALXN $NOC $PM $CCE $MRK $BMY $ABBV $EW $ZTS $EBAY $NFLX $ISRG $BSX @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $NEM $ESV $PFE $PHM $PXD $VRTX $EBAY $RTN $GILD $HES $DVN $HAL $O $APA $CHK  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $TSLA $GILD $CELG $ALXN $EBAY $NFLX $ISRG $FOXA $BMRN $INCY $AMGN $ILMN $GRMN $ADP $TXN @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $TSLA $VRTX $EBAY $GILD $CELG $BIIB $ALXN $NFLX $GRMN $LLTC $CHRW $ADP $NTAP  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $PFE $GILD $CELG $LMT $PM $MRK $BMY $ABBV $FOXA $AMGN $JNJ $PEP $MCD $TXN $CL $LOW $ABT  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $PFE $RTN $GILD $DVN $HAL $CELG $LMT $BIIB $BA $UNP $JNJ $SLB $TXN $CL $PG $PM  more@ https://t.co/cKkr8cKsjuGilead Sciences's EVP  Commercial Ops just cashed-in 2,000 options  https://t.co/3Wzxyx159V $GILD$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts App$GILD:

New Insider Transaction on GILD by EVP  Commercial Ops:

https://t.co/v15rQs6cfZ https://t.co/CswOOEroSI$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/bUzWOR8yO8$GILD relative strength vs industry, sector &amp; market moving up to next level overhead on positive accumulaiton https://t.co/bNmVY02MIzGilead's Acquisition Strategy Becomes Clearer $GILD $GLPG #Galapagos  https://t.co/D9wOp4AxJCGilead Sciences initiated by BMO Capital Markets at market perform. https://t.co/rJ4eClsxtx $GILD #GILDGilead Sciences Initiated Coverage by BMO Capital Markets (Ranked 12th) to Market Perform $GILD #GILD https://t.co/nyq7xJnbR7RT SeekingAlpha: Multiple Model Portfolio Vs The S&amp;P 500: Q1 Performance Review https://t.co/4AJudSlpT4 $CLDT $CRWS $DLTH $FL $GILD $HLT $‚Ä¶Multiple Model Portfolio Vs The S&amp;P 500: Q1 Performance Review https://t.co/0FmZu73J9p $CLDT $CRWS $DLTH $FL $GILD $HLT $HOT $RGC $SJBMultiple Model Portfolio Vs The S&amp;P 500: Q1 Performance Review https://t.co/mrTRGr0xt2 $CLDT $CRWS $DLTH $FL $GILD $HLT $HOT $RGC $SJBGilead Sciences initiated by BMO Capital Markets at market perform. https://t.co/kwsjKQc1oR $GILD #GILDRT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶Tuesday's Trading Journal &amp; Stats -&gt; https://t.co/iGVWerXECM
$ESRX $FB $GILD $VRX $WNR $SPY #trading #stocks #daytrade #stockmarketTuesday's Trading Journal &amp; Stats -&gt; https://t.co/6YA061fbpL
$ESRX $FB $GILD $VRX $WNR $SPY #trading #stocks... https://t.co/5grd2d3LvIGilead Sciences, Inc. $GILD Shares Bought by California Public Employees Retirement System https://t.co/Mj9zshODOaChartwell Investment Partners LLC Reduces Stake in Gilead Sciences, Inc. $GILD https://t.co/FAXK5CFSFcRT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶Princeton Alpha Management LP Has $4,043,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/LEHA22U2WuGeneva Advisors LLC Has $57,674,000 Position in Gilead Sciences, Inc. $GILD https://t.co/qtvPiXgWpZGilead Sciences, Inc. $GILD Shares Bought by California Public Employees Retirement System https://t.co/iPronQiiR1Jackson Wealth Management LLC Sells 3,127 Shares of Gilead Sciences, Inc. $GILD https://t.co/gkgqvpPSoIGeneva Advisors LLC Has $57,674,000 Position in Gilead Sciences, Inc. $GILD https://t.co/VD5SzfIynnChartwell Investment Partners LLC Reduces Stake in Gilead Sciences, Inc. $GILD https://t.co/FXbQYyLcj0Chartwell Investment Partners LLC Reduces Stake in Gilead Sciences, Inc. $GILD https://t.co/HboKYILJxz@BattagliaCE @avidresearch Why $GILD targeting TLR7, not TLR9???$GILD Verticals doing well today :) Flat on $ValeGilead's Acquisition Strategy Becomes Clearer https://t.co/pLjgWEmHft $GILD, $GLPGTrading Rules - Discipline and staying strong: https://t.co/vVZZyIZdvD $GILD $TTWO $GM $SCO $REXX $YUM $ABBV $UCO $NXPI $USO $WPRT@tgtxdough $GILD MP; $102 PT)
HCV Franchise Declines Increase Focus on M&amp;A to Fill Pipeline Gap and Allow HBV and NASH Pipeline to MatureBMO April 05, 2016
Research Report
 M. Ian Somaiya
BMO Capital Markets Corp.Initiating Coverage of $CELG $AMGN $GILD and $BIIBGILD $GILD https://t.co/ESe64t9r79New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https://t.co/aEVMYkWYpj@avidresearch Waiting $GILD GS-9620 P2 data release soon.  Might see combo study w $GILD TAF Nuc w ARC520, too. $ARWR ""milestone rich.""@avidresearch $JNJ-Novira 3-778 ready for P2-combo studies, waiting to partner. $ARWR ARC-520 'hook-up' seems logical.  GS-9620 $GILD, too.RT @FierceBiotech: ICYMI: Gilead gains next-gen HIV approval from FDA as it looks to beat back competition: https://t.co/bGQLxjDUDI by @Pha‚Ä¶S&amp;P500 #Stocks Trend $PFE $GILD $CELG $ALXN $LMT $NOC $MRK $BMY $CCE $PM $EW $ABBV $ADP $BSX $ISRG $ZTS $LLL  @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $NEM $DVN $PFE $PXD $APA $PHM $VRTX $GILD $EBAY $MRO $HES $NBL $RTN $HAL $CELG  more@ https://t.co/RPeaHBHYi0Gilead's Acquisition Strategy Becomes Clearer https://t.co/ur0Jfjd2w3 $GLPG $GILDNasdaq100 #Stocks Trend $TSLA $GILD $CELG $ALXN $ADP $ISRG $BMRN $EBAY $NFLX $TXN $FOXA $INCY $CHTR $AAPL $AMGN @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $TSLA $VRTX $GILD $EBAY $CELG $ALXN $NFLX $BIIB $NTAP $LLTC $FAST $REGN $ADP  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $PFE $GILD $CELG $LMT $MRK $BMY $PM $ABBV $JNJ $TXN $PEP $HD $FOXA $CL $AAPL $AMGN $MCD  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $DVN $PFE $GILD $RTN $HAL $CELG $BIIB $BA $LMT $UNP $JNJ $TXN $COP $MRK $PCLN  more@ https://t.co/cKkr8cKsjuNotable Tuesday Option Activity: $MTCH  $SNA  $GILD #stockoptions https://t.co/6Gx11ZGbixRT @pozmagazine: FDA OKs Gilead‚Äôs Descovy, a Safer Version of #Truvada, for #HIV Treatment Only (Not for #PrEP) https://t.co/eeTHAwFmiF $GI‚Ä¶#stocks still lower today. Nice moves higher in $gild $noc $lmt and $tsla Bonds in rally mode. Weaker $dis and $aaplFDA OKs Gilead‚Äôs Descovy, a Safer Version of #Truvada, for #HIV Treatment Only (Not for #PrEP) https://t.co/eeTHAwFmiF $GILD @GileadSciencesCommented on StockTwits: $GILD ""Analysts expect drug to become blockbu... https://t.co/8mmjQSZ1bT@matthewherper @RxRegA Any guesses on $GILD 2016 two HBV ""additional programs""? https://t.co/4RknlUgqm6APR 05 Tuesday, $GILD HIGH was $96.69 and hit my BULLISH target $95.40 from MAR 28 Monday‚òïüí∞üôåGilead contractor PharmaChem starts $120M Bahamas expansion https://t.co/CIV9SHmwqO $GILDI don't see any resistance for $TWTR on it's way up to $22.00 in a short time. $SPY $AAPL $GOLD $GILD $TSLA $AGN $PFE #FB #NFLX $AMZNlong $GILD at 96.02RT @FiercePharma: Gilead contractor PharmaChem starts $120M Bahamas expansion https://t.co/K8upNhKPdA $GILD #pharma #manufacturing by @Eric‚Ä¶#GileadSciences $GILD Pledges $1.2B to Acquire #NimbusTherapeutics Subsidiary https://t.co/pgCOjyPfAd #mergersandacquisitionsRT @VailshireCap: Sectors: Long biotech. Long gold/silver. Short refiners. -- https://t.co/iClE4419yP 
$IBB $GILD $REGN $CELG $BMY $RGLD $G‚Ä¶4 Great Stocks To Ride The $IBB Rebound $AMAG $GILD $HZNP $PRAH https://t.co/Km9opn8rN1Mittelfristiges Signal! $GILD: Ein steigender Keil wurde bei 95.139 USD nach oben durchbrochen:  https://t.co/2P4JcHP9cGHow Hedge Funds‚Äô Top Healthcare Bets Performed in Q1
$AGN, $PFE, $GILD, $TEVA, $VRX
https://t.co/L8cwPolWcVHow Hedge Funds‚Äô Top Healthcare Bets Performed in Q1
$AGN, $PFE, $GILD, $TEVA, $VRX
https://t.co/hJf6UoyECNFDA approves $GILD's Descovy, its third drug using new form of tenofovir to win approval https://t.co/hocI6WzxKyRT @adamfeuerstein: $GILD buying privately held Nimbus Therapeutics for NASH drug. $400M upfront.Sectors: Long biotech. Long gold/silver. Short refiners. -- https://t.co/iClE4419yP 
$IBB $GILD $REGN $CELG $BMY $RGLD $GSV $MUX $TSOICYMI: Gilead gains next-gen HIV approval from FDA as it looks to beat back competition: https://t.co/NybIOToXOm by PharmaceuticBen $GILD ‚Ä¶ICYMI: Gilead gains next-gen HIV approval from FDA as it looks to beat back competition: https://t.co/bGQLxjDUDI by @PharmaceuticBen $GILDGilead contractor PharmaChem starts $120M Bahamas expansion https://t.co/K8upNhKPdA $GILD #pharma #manufacturing by @EricSFierceRT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶$GILD is improving. High volume node, gap fill &amp; downtrend are all in alignment at $101s. https://t.co/cD9xTD9MDp https://t.co/yMhoiy2BJ9RT @FierceBiotech: Gilead gains next-gen HIV approval from FDA as it looks to beat back competition: https://t.co/bGQLxjDUDI by @Pharmaceut‚Ä¶@JustinPulitzer what about $gild now? R we seeing a trend reversal to the upside?Commented on Gilead's Acquisition Strategy Becomes Clearer https://t.co/oPxmMMXyX6 $GLPG $GILD$GILD Gilead Sciences Stock Update - https://t.co/DM96jlrGrd$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Update:

https://t.co/HX0KvrEb65Gilead's #Acquisition Strategy Becomes Clearer https://t.co/TU40WfCaQW $GLPG $GILD#GileadSciences Gilead  Announces  Acquisition  Of  Nimbus Therapeutics' Acetyl-CoA  Carbox... Read more: https://t.co/WKLvmb9Bg2 $GILD$GILD:

Why Is Gilead Sciences (GILD) A Zacks Rank #1 Stock Right Now?:

https://t.co/cGlozjBHHX$WY $FE $STZ $BK $AON $L $LB $CMG $DD $VLO $ADP $HCA $ZTS $RAI $MS $LLTC $CCI $TXN $GILD $DOW $CF #markets red today https://t.co/ByYhQgLQor#GileadSciences, Inc Teases Investors With Tiny But Smart Deal. Read more: https://t.co/HzyboQQATp $GILDRT @BioPharmaDive: $GILD's new HIV formulation continues success with FDA approval of Descovy https://t.co/hocI6WzxKyDown 3 For 3 Today For The Morning Session. Very choppy market with very little follow through. $ESRX $FB $GILD... https://t.co/wY09PykY3g$GILD up 1.5% on a red day$GILD $GILD follow through from entry yday +2.00 https://t.co/lhdpZFuW09#GileadSciences Gilead Paying Up to $1.2B for Nimbus Unit, Drug Candidate . Read more: https://t.co/E8yfi1uWd6 $GILD#GileadSciences Gilead Paying Up to $1.2B for Nimbus Unit, Drug Candidate. Read more: https://t.co/y8Xhdb6FPC $GILDICYMI: Nimbus liver drug bought by $GILD for $400M cash plus incentives https://t.co/X00b3xfdDPRT @FierceBiotech: Gilead gains next-gen HIV approval from FDA as it looks to beat back competition: https://t.co/bGQLxjDUDI by @Pharmaceut‚Ä¶Exiting $GILD scalp plus .50/shareOh $GILD, so happy I bought you at 89 #Gilead #GILD https://t.co/RZmwB2VPr8$GILD cruising https://t.co/hrAWgAMA1WBank of America Reaffirms ‚ÄúNeutral‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/5K2KCqnCfnMittelfristiges Signal! $GILD: Ein Trendkanal wurde bei 96.601 USD nach oben durchbrochen:  https://t.co/BnrGuTQxYeS&amp;P500 #Stocks Trend $GILD $PFE $NOC $LMT $ALXN $CCE $MRK $BSX $BMY $PM $BDX $MNK $EW $ABBV $JNJ $KMB $EL $PEP @ https://t.co/RPeaHBHYi0$IBB Bio's still working on the 270 B/O. If close thru here, I'm seeing Double Bottom &amp; 290T. $LABU $VRX $CXR $GILD https://t.co/b1VgKOY3f6S&amp;P500 #Stocks Performance $VRTX $NEM $GILD $OKE $DO $CNX $MCHP $APA $RTN $MRO $ESV $XYL $PFE $BA $REGN  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $GILD $ALXN $ISRG $TSLA $BMRN $FOXA $INCY $EBAY $NFLX $SPLS $AMGN $ILMN $ADP $TXN $SBAC @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $VRTX $GILD $INCY $REGN $BIIB $TXN $LLTC $ALXN $EBAY $CELG $MNST $NFLX $FB  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $GILD $PFE $LMT $MRK $BMY $PM $ABBV $JNJ $PEP $FOXA $HD $AMGN $CL $TXN $ABT $MCD $AAPL  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $GILD $RTN $PFE $BA $BIIB $TXN $DVN $LMT $JNJ $CELG $HD $FB $APC $MRK $CL $DOW  more@ https://t.co/cKkr8cKsjuRT @fwpharma: Gilead to buy Nimbus Therapeutics' NASH programme for up to $1.2 billion https://t.co/1UHzyeDYtO $GILD #pharma@MarketCurrents Make that 4 $IONS owned/licensed drugs with Phase 3 top line data in 1H17 #biotech $AKAO $IBB $GILD $MRK $BIIB @RNAiAnalystDo you know that #WallStreet price for $GILD is $114.6 https://t.co/mpDel0oxXdPretty sure this won't be the last we see of @GileadSciences Corp Dev team in 2016. #nimbus #apollo $GILDRT @iviewmarkets: $SPY Winners/Losers at the Open $AN $GILD $MCHP $BA $EBAY $RTN $CLX $JNJ $SPLS $AGN $DRI $ENDP $BXLT $CI $AKAM $ADM https‚Ä¶The still undervalued $GILD continues to help pull #biotech out of its doldrums. A lot of my SMID bios starting to join. $RPTP $OMED $HALO$GILD follow through from entry yday +2.00 https://t.co/NlzWcHOqnA$gild should  be hitting resistance here#Gilead Sciences Inc Teases #Investors with Tiny but Smart #Deal - $GILD
https://t.co/YiYb5Ir2RP https://t.co/8C7qiRF1x4Gilead's Acquisition Strategy Becomes Clearer https://t.co/Di6yr1iRBL $GLPG $GILD$RAX $GILD $SCTY $BA $LMT $MRO $PFE Some green on my radar showing relative strength.$GILD Just a Beast! after we had those NOV 97.50 Call Buyers on the 1stGILD Top news - Apr 5th, 2016 $GILD https://t.co/hVwSj1mtjrCommented on Gilead's Acquisition Strategy Becomes Clearer https://t.co/AsH93hggnm $GLPG $GILDNotable gainers among liquid option names this morning include $VRTX (+3.5%), $NEM (+2.7%), $QEP (+2.2%), $GILD (+2.2%), and $X (+1.4%),Wondering about risks of $GILD? The 63-day volatility is 15.08% https://t.co/YrfwPBdUuU$GILD:

Gilead‚Äôs Acquisition Strategy Becomes Clearer:

https://t.co/7oyPXqJI6A$GILD There is ALWAYS one troll/moron on every board. I'd suggest do do the same thing!Volume Alert - GILD 96.24 Gilead Sciences Inc $GILD Hit a high today of 96.30 Closing the day 10:29 at 96.24 + https://t.co/2tBxvH4a45Gilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Leerink Swann https://t.co/HhOir5wpymPopular: $TWTR, $AVXL, $BA, $GILD, $SUNE, $PANW, $SA, $VCRA, $NOC, $CI, $BXLT, $RTN, $DANCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5#Options #maxpain chart for $GILD. #option #invest More with #OptionsPro FREE app at https://t.co/vmQaxw1x1K https://t.co/ECeslAbKw5CYDY running, FLKS is just starting: https://t.co/lwSyWTxOEB $GEVA $GFOO $GFOOE $GILD $GILD.MX $GIS.DE $GLMD $GLPG.BRRT @BosBizDon: Boston Business Journal Report: Gilead's $1.2B Deal With Nimbus https://t.co/OkojJ4K59G via @NECN $GILDBtw, Estimated #Earnings Per Share for $GILD is $3.05 it's 3.24% of the current price https://t.co/ITADQ4KDmZ$GILD I must say, nice bounce off the lows. #stocks$BMY $GILD $PFE $MRK #Stocks at or near the Overbought Hourly. All over 70 Hourly RSI as $SPY has an Hourly RSI of 37.26.Great move from $GILD today trying to keep my portfolio upOn t√§t√§ odotettukin, mutta nyt $GILD marssii SP500-k√§rjess√§ +2.5%. Kannatti panna kassaa liikkeelle investoimalla maksal√§√§kkeeseen!$GILD #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/aPKXlTaeeeHigh level Sector Names working: $NEM $MUR $APA $MRO $DVN $CLX $DPS $VRTX $GILD $BIIB $BMY $RTN $BA $EBAY $AN $SPLS https://t.co/DKGleCA1mC$GILD $LLY:

Gilead Sciences, Inc. (NASDAQ:GILD) To Pay $1.2 Billion For A Unit ‚Ä¶:

https://t.co/6nylMpiGZ7Short $GILD for a scalpTwo Healthcare Analysts Share Mixed Views on $VRX and $GILD https://t.co/RRikn5kYho#GileadSciences 
          Gilead's Descovy receives FDA approval to treat HIV
          . Read more: https://t.co/poxunWxY3a $GILD#GileadSciences Gilead gains next-gen HIV approval from FDA as it looks to beat back compet... Read more: https://t.co/iwL1ujEaOx $GILD$GILD  gave it to you when it was red this morning, and boom babyRT @TaxHavens: $GILD Went through $96 like butter.Gilead Sciences, Inc. $GILD Rating Reiterated by Morgan Stanley https://t.co/SJP5URSWaDCommented on StockTwits: $GILD could be a 3point jump in price today is N... https://t.co/nwES25N44wRT @TaxHavens: $GILD Went through $96 like butter.$GILD Went through $96 like butter.RT @marketgauge: $IBB and $GILD out performing early again. More here: https://t.co/9ztdh788WDCommented on StockTwits: $GILD ""The combination is the backbone of Gilead's newest HIV medicines..."" https://t.co/PlpOQwIJId$GILD $OAK:

Watch List: NVIDIA Corporation (NASDAQ:NVDA), Gilead Sciences ‚Ä¶:

https://t.co/ojyl6w7fZs""FDA OK's Descovy, $GILD's latest combo HIV pill"" https://t.co/Oe6FIQezhm via @YahooFinance$SPY Winners/Losers at the Open $AN $GILD $MCHP $BA $EBAY $RTN $CLX $JNJ $SPLS $AGN $DRI $ENDP $BXLT $CI $AKAM $ADM https://t.co/EO8KuJgPbB$GILD $BAM:

Fast Moving Stocks: Achillion Pharmaceuticals, Inc. (NASDAQ ‚Ä¶:

https://t.co/QBfr8xK4UYCommented on StockTwits: $GILD ""has two other treatments in developmen... https://t.co/RiHgJizv3R$GILD Something is up. going higher on good volume. Maybe on news?""The deal reinforces $GILD's preference for early-stage drugs, on which the company can make its mark"" https://t.co/zjZiIpoKBC$GILD https://t.co/6nKFvE1kUr#GileadSciences Gilead paying up to $1.2B for Nimbus unit, drug candidate. Read more: https://t.co/gb5wKZWTT5 $GILDYou have to #learn to save your #breath and just let #experience #teach certain #people. $MRVL $ICPT $VRX $GILD $NFLX $INVT $JNJ $SWHC $RH$GILD ‚¨ÜÔ∏è$IBB and $GILD out performing early again. More here: https://t.co/9ztdh788WDRT @BioStockAddict: $GILD trading over $95. First time in months.$GILD :)$GILD trading over $95. First time in months.RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. headlines &amp; coffee are served.. https://t.co/MQEtu1I2LX #pharma #opioids #drugpric‚Ä¶$GILD strongNext stop? $GILDRT @MargaretDudley1: @LisaVikingstad @jamezdhawaii Salk also did not patent the vaccine. He was about patients not profits, unlike $Gild wi‚Ä¶The Next Big Step For Gilead? $GILD https://t.co/YGOcsNO7VpRetweeted China Invest (@ChinaInvest):

RT SeekingAlpha: The Next Big Step For Gilead? https://t.co/xKBn7QnYPE $GILD https://t.co/woMQu1tBsDRT @ChinaInvest: RT SeekingAlpha: The Next Big Step For Gilead? https://t.co/dlcJFT2xu8 $GILDOff the bat, $NFLX $FB $LABU $GILD are some i see in green. Also $LNKD for a brief moment. Banks hammered I guess.$GILD outperforming the sector again. Slightly higher with $XLV down 1.2%.$GILD Big buyers holding the stock up early - against the general market down. $MRK $JNJ $ABBVRT SeekingAlpha: The Next Big Step For Gilead? https://t.co/dlcJFT2xu8 $GILD$GILD doesn‚Äôt look so bad!@techwhitepapers ANYONE?  what is A common demominator between Nimbus that got purchased by $GILD https://t.co/NAnl2PbAHc and $LIFE ?RT @FierceBiotech: Gilead gains next-gen HIV approval from FDA as it looks to beat back competition: https://t.co/bGQLxjDUDI by @Pharmaceut‚Ä¶The Next Big Step For Gilead? https://t.co/6tC7DIOsvi $GILDThe Next Big Step For Gilead? https://t.co/0h73Qvh5Lr $GILDHas $ICPT intercepted the ball from $GILD? Are they about to run it in at Thurs adcom? Off-label potential for NASH? https://t.co/ytydIj0CdHBoston Business Journal Report: Gilead's $1.2B Deal With Nimbus https://t.co/OkojJ4K59G via @NECN $GILD@MaxNisen what does it say abt Simtuzumab that $GILD already made 2 nash purchases Phenoix &amp; now niimbus...$GILD:

Gilead Bets on Livers and Patience:

https://t.co/pp0IpGVXci$GILD:

Analyst Price Target Estimates: Gilead Sciences, Inc. (NASDAQ ‚Ä¶:

https://t.co/Pfsii2jJaD$icpt after bds, we can start to assess that $gild wouldn't pay what icpt was asking.  Position of strength.RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. headlines &amp; coffee are served.. https://t.co/MQEtu1I2LX #pharma #opioids #drugpric‚Ä¶RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. headlines &amp; coffee are served.. https://t.co/MQEtu1I2LX #pharma #opioids #drugpric‚Ä¶RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. headlines &amp; coffee are served.. https://t.co/MQEtu1I2LX #pharma #opioids #drugpric‚Ä¶Pharmalot.. Pharmalittle.. Good Morning.. headlines &amp; coffee are served.. https://t.co/MQEtu1I2LX #pharma #opioids #drugprices $GILD $SNYGilead gains next-gen HIV approval from FDA as it looks to beat back competition: https://t.co/NybIOToXOm by PharmaceuticBen $GILD story f‚Ä¶RT @FierceBiotech: Gilead gains next-gen HIV approval from FDA as it looks to beat back competition: https://t.co/bGQLxjDUDI by @Pharmaceut‚Ä¶RT @FierceBiotech: Gilead gains next-gen HIV approval from FDA as it looks to beat back competition: https://t.co/bGQLxjDUDI by @Pharmaceut‚Ä¶Gilead gains next-gen HIV approval from FDA as it looks to beat back competition: https://t.co/bGQLxjDUDI by @PharmaceuticBen $GILDCyclical Strategy Says Buy FMC https://t.co/Riz1VgH3YI $BWA $CLDT $CRWS $DLTH $FL $GILD $HLT $RGC $TGT $FMCDividend Growth Portfolio: March Update https://t.co/cpMDq0bVyK $AAPL $ABBV $AFL $BA $COP $CSCO $CVS $CVX $GE $GILD $GIS $JPM $KO $LUV $MART @fwpharma: Gilead to buy Nimbus Therapeutics' NASH programme for up to $1.2 billion https://t.co/1UHzyeDYtO $GILD #pharma$GILD:

Gilead Sciences (NASDAQ:GILD) Declare Takeover of Nimbus ‚Ä¶:

https://t.co/xpFK0GI4v8$GILD acquires NASH¬†program https://t.co/J2pLLIyTDGPremarket Biotech Digest: $GILD Finally Makes An Acquisition, $AGN Tumbles, $ZFGN Surges https://t.co/nHBk05P9Mv$GILD $WWE:

Gilead Sciences (NASDAQ:GILD) Releases FDA Authorization of ‚Ä¶:

https://t.co/aHp3mktpRR$GILD:

Traders Watch List: Gilead Sciences, (NASDAQ:GILD), Hemispherx ‚Ä¶:

https://t.co/m3NYCNZX0P$GILD:

Analysts Observing Stocks: Gilead Sciences, Inc. (NASDAQ:GILD ‚Ä¶:

https://t.co/ouv9bPaBOp#GileadSciences to acquire Nimbus Apollo in $1.2bn deal. Read more: https://t.co/rRCBO92BIk $GILDTraders Watch List: $GILD $HEB https://t.co/sGMO7HajNqWhy is $GILD down?: Their PDUFA date is 4/7. Is it because I bought it?    submitted by    /u/wattagonado  [li... https://t.co/TVk79xZXzcHealthcare Stock That Must Be in Shareholder‚Äôs Watch List: $GILD $BXLT https://t.co/EYsuQ3Hgg9$GILD $BXLT:

Healthcare Stock That Must Be in Investor‚Äôs Watch List: Gilead ‚Ä¶:

https://t.co/luTf6Xt4LiCheap call option upside: $MDT calls cheaper than 100% of history, $DAL 100%, $T 100%, $BBRY 99%, $GILD 98%, $ORCL 98%, $HD 97%Weekly Nasdaq100 #Stocks Trend $ALXN $ILMN $TSLA $BMRN $ISRG $LBTYA $AAPL $YHOO $AMGN $CTXS $INTU $FOXA $GILD  @ https://t.co/YdSIjFJqHfWeekly S&amp;P100 #Stocks Trend $AAPL $ABBV $BMY $AMGN $PFE $MRK $PEP $CVS $PM $FOXA $GILD $TWX $V $MCD $ABT  @ https://t.co/cKkr8cKsju#GileadSciences Gilead to pay $400 million for drug candidate. Read more: https://t.co/qM3IHWfR7A $GILDRT @lancejepsen: Gilead Sciences FDA Approves Descovy For Treatment of HIV $GILD https://t.co/9F9Nm67PRE https://t.co/IscJKnSwk1RT @MargaretDudley1: @LisaVikingstad @jamezdhawaii Salk also did not patent the vaccine. He was about patients not profits, unlike $Gild wi‚Ä¶@LisaVikingstad @jamezdhawaii Salk also did not patent the vaccine. He was about patients not profits, unlike $Gild with #hepC$GILD Gilead Buys Liver-Drug Program‚Ä¶ https://t.co/XmkvOJCYpR$GILD Gilead Sciences Announces Acquisition of Nimbus Therapeu‚Ä¶ https://t.co/wCzkrM0Zi7Gilead Sciences: Tiny M&amp;A $GILD $LIFE https://t.co/S6DviHMrfm https://t.co/AR8DhFB16w https://t.co/a7GmKm0WF1@techwhitepapers these are the news about $GILD and Nimbus https://t.co/NAnl2PbAHc .. what ingredient is common to $LIFE ?OK so $GILD paid over 1bill $ for Nimbus.. what is a common denominator between Nimbus target and $LIFE target/technology?#GileadSciences FDA OKs Descovy, Gilead Science's latest combo HIV pill. Read more: https://t.co/SC1FoTCJaQ $GILD#GileadSciences FDA OKs Descovy, Gilead Science's latest combo HIV pill. Read more: https://t.co/YNx7AYXn1B $GILD#GileadSciences FDA OKs Descovy, Gilead Science's latest combo HIV pill. Read more: https://t.co/A6gpSXDwpr $GILD#GileadSciences FDA OKs Descovy, Gilead Science's latest combo HIV pill. Read more: https://t.co/l8ku1G9O22 $GILD#GileadSciences FDA OKs Descovy, Gilead Science's latest combo HIV pill. Read more: https://t.co/mFFsYY1lAd $GILDHealthcare Stocks Lead On A Lackluster Day $BMY $EW $RHHBY $ACAD $ALNY $ALXN $ANAC $IBB $GILD $NBIX $VRTX $ZIOP ... https://t.co/RfC2zV4csiRT @adamfeuerstein: $GILD Bolsters Liver Disease Pipeline with Nimbus Drug Purchase https://t.co/ScYZRI3OYd via @TheStreetRT @jonathanrockoff: $GILD to buy Nimbus Therapeutics' NASH unit for $400mn upfront in bid to bolster its drug research in the liver diseaseRT @adamfeuerstein: Son of Truvada‚Ä¶. $GILD https://t.co/FMT1a2MQ36Commented on Embrace Gilead https://t.co/b7kx7M1uad $MRK $GILDCommented on Gilead Sciences Vs. Its Peers https://t.co/nFKc2XmY45 $ABBV $AMGN $CELG $IBB $XBI $GILDCommented on Gilead, Gilead Where Art Thou Gilead? https://t.co/lhN6b4QeBV $MRK $CELG $GILDCommented on Bull Case On Gilead Sciences https://t.co/5yEmijCJ7y $GILDGilead Sciences, Inc. $GILD Lowered to ‚ÄúBuy‚Äù at Vetr Inc. https://t.co/p58YYGxDGlGilead Sciences, Inc. $GILD Lowered to ‚ÄúBuy‚Äù at Vetr Inc. https://t.co/3EXY3irNMT$GILD Strengthens #NASH Pipeline  https://t.co/RWZiwXbLrwMore +ve $GILD news (with warnings) FDA OKs Descovy, Latest Combo HIV Pill https://t.co/snvPNE25tv via @ABCSBR Bid Size
See Here ---&gt; https://t.co/gBbx7EUx3x

$SBR $GILD $LQMT #pennystocksLT fave of mine (not held in this a/c) $GILD acquisition. Stock largely unmoved after recent run. https://t.co/SE4O7NDp63 via @BostonGlobe@SkeleCap @DorsiaCapital @LongShortTrader @Sparticuszorro @AcaciaCap there will be a time to go hard in the paint on $GILD again#GileadSciences Gilead paying up to $1.2B for Nimbus unit, drug candidate. Read more: https://t.co/YQLYsxz3Wa $GILDhttps://t.co/uAcamNRUPt alerted $PTX +45% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/OQCNEb9p9K $HOT $AMAT $ITUB $MT $GILD $HST $AA@DorsiaCapital @LongShortTrader @Sparticuszorro @AcaciaCap $GILD &gt; haters, but need new IP@LongShortTrader @Sparticuszorro @AcaciaCap @mugatushair haha, $GILD has made me feel like worst seeking alpha mark, but all that CASH!RT @Taarriqq: $XBI 10000+ CALLS  $ICPT $IBB $GILD $TWTR+8% $SPY $IWM $QQQ   SECTOR ANALYSIS- LEVELS/PATTERN/OPTIONS FLOW https://t.co/Mkg9M‚Ä¶@LongShortTrader @Sparticuszorro @AcaciaCap @mugatushair true, although same argument can be made for $GILD, with &gt;&gt;&gt;CFO.RT @rleuty_biotech: Gilead signals its direction with $1.2 billion deal https://t.co/H277QDrufD #NASH $GILD https://t.co/181Od6ijucHealthcare Stocks Lead On A Lackluster Day $BMY $EW $RHHBY $ACAD $ALNY $ALXN $ANAC $IBB $GILD $NBIX $VRTX $ZIOP ... https://t.co/TeucuTOu6hRT @FierceBiotech: Gilead bags early-stage NASH drug in $1.2B Nimbus deal: https://t.co/ife34ADmCd via @JohnCFierce $GILD#GileadSciences FDA OKs Descovy, Gilead Science's latest combo HIV pill. Read more: https://t.co/ym529pfiez $GILDCYDY running, FLKS is just starting: https://t.co/lwSyWTxOEB $GIL $GILD $GILT $GIM $GIMO $GIS $GIVE $GJO#GileadSciences Gilead acquiring Nimbus' NASH subsidiary. Read more: https://t.co/RrPa0M0nEV $GILD#Rayno Biopharmaceuticals: New Buy Idea - #Roche Plc. $RHHBY Also $BMY $GILD $ABBV https://t.co/DSsiomWHzt#GileadSciences FDA approves Gilead's Descovy. Read more: https://t.co/ia80K0F7g9 $GILDBearish Doji https://t.co/tbvtbJoC41 $RRC $COMM $TRMB $CMS $CHTR $SWFT $GILD $DLR $KMB $TRV $FOXA $UTX $NXPI $MSFT $CMRX $CUBE $DUK $GPK$GILD back over $100 this yearCheap put options and hedges: $SLV puts cheaper than 93% of history, $DAL 92%, $BBRY 89%, $MAS 88%, $GILD 86%, $CSCO 84%, $AAPL 84%RT @Taarriqq: $XBI 10000+ CALLS  $ICPT $IBB $GILD $TWTR+8% $SPY $IWM $QQQ   SECTOR ANALYSIS- LEVELS/PATTERN/OPTIONS FLOW https://t.co/Mkg9M‚Ä¶$XBI 10000+ CALLS  $ICPT $IBB $GILD $TWTR+8% $SPY $IWM $QQQ   SECTOR ANALYSIS- LEVELS/PATTERN/OPTIONS FLOW https://t.co/Mkg9M2ToRTGilead Sciences FDA Approves Descovy For Treatment of HIV $GILD https://t.co/9F9Nm67PRE https://t.co/IscJKnSwk1RT @CatalystWatcher: EASL is April 13-17. With the $GBIM trial ending in March, it's in $GILD's best interest to release 24-week data at or‚Ä¶FRO Last Trade
See Here ---&gt; https://t.co/pHNVjQqulN

$FRO $GILD $BBRY #stockmarketRT @adamfeuerstein: $GILD now has 3 NASH drugs in its pipeline, all with different mechanisms of action.The Nimbus / $GILD news was this morning, right?#GileadSciences Gilead's third TAF-Based HIV therapy approved by FDA. Read more: https://t.co/VQVLwkvlTC $GILD#GileadSciences FDA Approves Gilead's Third TAF-Based HIV Treatment. Read more: https://t.co/fJmdaImDkd $GILD",2016-04-05,GILD,1
6,"@psuvafan007 @avidresearch Now we back to calling it 'TLR7/8?  $GILD  $ARWR.RT @pharm_specialty: CFO4Life L.P. Raises Position in #GileadSciences, Inc. (). Read more: https://t.co/kWWGNP4miw $GILDRT @TickerReport: DE Burlo Group Inc. Purchases Shares of 169,968 Gilead Sciences, Inc. $GILD https://t.co/QurDIdAjxHRT @Max_Grigoryev: $GILD is it going to break $100? https://t.co/CgoQjeCoC0RT @Fibonacciqueen: $GILD I was late to the party on this one https://t.co/VOpQHM93BZRT @SleekMoneycom: State of Alaska Department of Revenue Buys Shares of 14,680 Gilead Sciences, Inc. $GILD https://t.co/ZHNoJpgJlwRT @pharm_specialty: #GileadSciences, Inc. Shares Bought by Stonebridge Capital Advisors LLC. Read more: https://t.co/lENocI2kJm $GILDRT @pharm_specialty: CFO4Life L.P. Raises Position in #GileadSciences, Inc. (). Read more: https://t.co/kWWGNP4miw $GILD$AAPL $SPY $SPX $GILD $TSLA $GILD $DIS LMAOOOO @NASDboy  https://t.co/jkbsCJ3Jt6$GILD:

Gilead Sciences (NASDAQ:GILD) Receives ‚ÄòMarket Perform‚Äô Rating ‚Ä¶:

https://t.co/Sa0TX8xqjfRT @WallStJesus: MORNING $IBB SWEEPERS LEAD BIOS | ANOTHER BAZOOKA FIRED IN $FB | WISEGUY ACTION IN REVIEW https://t.co/BIZb8uu3ZF
$SPY $VR‚Ä¶Nasdaq100 #Stocks Trend $INCY $BMRN $ILMN $ALXN $CELG $REGN $BIIB $AMGN $EBAY $TSLA $ISRG $GILD $FOXA $ADP  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $CELG $BIIB $PFE $AMGN $MRK $MDT $ABT $ABBV $GILD $FOXA $TWX $BMY $PM $LMT $V $MO $PG  @ https://t.co/cKkr8cKsjuRT @psuvafan007: @psuvafan007 $ARWR $GILD #HBV challenge https://t.co/GSKGqtaUz2RT @JeaYu21: $NVDA $GILD $CREE Wednesday Trades Blog + $708 Profits https://t.co/ydgXmPWMPnOn the other side, $GILD up 6.7% since purchase. I really like this one long-term.Did yest mark the bottom in biotech? $gild $celg $gsk $ibb $vrx. Looking like it.@psuvafan007 $ARWR $GILD #HBV challenge https://t.co/GSKGqtaUz2Over Keltner https://t.co/itxqNh3cuO $AAPL $GILD $RAX $XHB $EXAS $TXMD $MIK $AGEN $RLGY $SEAS $NVO $IMGN $ALNY $ARCC $SPPI $EBS $JAZZ $DGX#GileadSciences Biotech Stock Roundup: Gilead's HIV Drug Approved, Regeneron Up on Positive... Read more: https://t.co/oJ6LiBp2FJ $GILD23:35-&gt;https://t.co/vqaokSKgmf

Also,see:https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/GOUhn7Y5HICFO4Life L.P. Raises Position in #GileadSciences, Inc. (). Read more: https://t.co/kWWGNP4miw $GILD#GileadSciences, Inc. Shares Bought by Stonebridge Capital Advisors LLC. Read more: https://t.co/lENocI2kJm $GILD#Options #maxpain chart for $GILD. #option #invest More with #OptionsPro FREE app at https://t.co/vmQaxw1x1K https://t.co/7oK5xKaksf$GILD round 2 tomorrow for biotechState of Alaska Department of Revenue Buys Shares of 14,680 Gilead Sciences, Inc. $GILD https://t.co/ZHNoJpgJlw$GILD #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/TvoxO1GfwQRT @WallStJesus: MORNING $IBB SWEEPERS LEAD BIOS | ANOTHER BAZOOKA FIRED IN $FB | WISEGUY ACTION IN REVIEW https://t.co/BIZb8uu3ZF
$SPY $VR‚Ä¶RT @WallStJesus: MORNING $IBB SWEEPERS LEAD BIOS | ANOTHER BAZOOKA FIRED IN $FB | WISEGUY ACTION IN REVIEW https://t.co/BIZb8uu3ZF
$SPY $VR‚Ä¶$GILD #Options volume chart in animation. More with #OptionsPro FREE app at https://t.co/K8PrRVM20E https://t.co/9uDSMzgytL$GILD I was late to the party on this one https://t.co/VOpQHM93BZMORNING $IBB SWEEPERS LEAD BIOS | ANOTHER BAZOOKA FIRED IN $FB | WISEGUY ACTION IN REVIEW https://t.co/BIZb8uu3ZF
$SPY $VRX $ENDP $GILD$GILD is it going to break $100? https://t.co/CgoQjeCoC0RT @GerberKawasaki: Seeing continued strength in gilead after getting into NASH. Looks like liver issues and obesity it is. Great business.‚Ä¶State of Alaska Department of Revenue Buys Shares of 14,680 Gilead Sciences, Inc. $GILD https://t.co/G3D0YpLxtSCFO4Life L.P. Raises Position in Gilead Sciences, Inc. $GILD https://t.co/3brBF2xwJ2DE Burlo Group Inc. Purchases Shares of 169,968 Gilead Sciences, Inc. $GILD https://t.co/QurDIdAjxHDE Burlo Group Inc. Purchases Shares of 169,968 Gilead Sciences, Inc. $GILD https://t.co/qWnlZQjScXCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @Logribel: New #SeekingAlpha article ""#NASH Drugs: A Comprehensive Review Of Current Clinical Trials"" https://t.co/xXcivpLFBF $ICPT $GNF‚Ä¶$GILD if this nudges 97.50 99.45 is nextToday was the 5th consecutive winning day for $GILD. Can it end up again? https://t.co/ok0SPgwsQT #stocks https://t.co/WLRC6xJLppNot sure what to do with $GILD? Explore our #fundamental pros and cons.  https://t.co/NgREtgOwQu$GILD:

Here‚Äôs a Reason Gilead (GILD) Stock is Gaining Today:

https://t.co/sacVs75YfUNasdaq100 #Stocks Trend $INCY $VRTX $BMRN $CELG $ILMN $REGN $BIIB $ALXN $EBAY $AMGN $TSLA $ISRG $FOXA $GILD  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $CELG $BIIB $PFE $AMGN $MRK $ABT $ABBV $MDT $FOXA $GILD $TWX $BMY $PM $LMT $HAL $CMCSA  @ https://t.co/cKkr8csQUUHere's a Reason Gilead $GILD Stock is Gaining Today https://t.co/eCz0FcICNOHere's a Reason Gilead $GILD Stock is Gaining Today https://t.co/ahblHCbkz0 #StockActionGilead stock advancing along with biotech sector today: https://t.co/rdqtkBtPaO via @TheStreet $GILD$AAPL $SPY $SPX $GILD $TSLA $GILD $DIS üòÇüòÇüòÇ let's hope rally continues https://t.co/4QT3PCQKspRT @Brian_Rye: With Cruz's WI win, maybe a good time to review his #FDA vision: $GILD $PFE Via @TheTerminal https://t.co/IrrN5hvYWE https:/‚Ä¶NEW POST: Painting the Picture  https://t.co/YWk5BYwEqv $AMGN $BIS $GILD $IBB $XBI$GILD damn can't catch a breakWith Cruz's WI win, maybe a good time to review his #FDA vision: $GILD $PFE Via @TheTerminal https://t.co/IrrN5hvYWE https://t.co/EDL1KAmrMlLVS Chart
See Here ---&gt; https://t.co/gfrOGnnFKN

$LVS $GILD $TGT #pennystockssold $UVXY on open 17% gain , bought some more $GILD yesterday , and entered $BIIB after open , biotech might recover soonUpdate on the week so far:  out $GILD trade $87-&gt;$95+, out $LABU $24-&gt;$32+, out $HRTX $16.40-&gt;$21+, out extra... https://t.co/Zd8RUhlx6YGilead's Acquisition Strategy Becomes Clearer https://t.co/mlyDQ8y0Gg $GLPG $GILD - free #investing book = profits - jeffee13@hotmail.comAsc. triangle break out, 98.25 R (150 SMA) $GILD https://t.co/gEiHYKaKK4$GILD shoot no catalyst left but 97.50 needs to break if you want 100 or more$GILD should be at 97.50 real quick$IBB Looking at the strength in leading bio names $CELG $AMGN $GILD $REGN, it doesn't look like this rally is going to run out steam here#GileadSciences Gilead is a Cheap Growth Stock Worth Buying Now. Read more: https://t.co/4p2p8wKKpn $GILDAlso early in taking the $7+ gain in $GILD yesterday....though ok for a couple weeks. If you don't own any, $NK should start the next leg.RT: Great watchlist this week for potential longs
$P $KEY $NLY $ESV $NPBC $ITUB $OAS $IAU $RAD $GILD https://t.co/v5CPe47kYDRT @TraceyRyniec: Gilead's Stock is on Sale: Should You Buy? Shares are up 10% since @bartosiastics and I discussed $GILD. Video: https://t‚Ä¶Gilead's Stock is on Sale: Should You Buy? Shares are up 10% since @bartosiastics and I discussed $GILD. Video: https://t.co/hsCBNni0MnGILD $GILD https://t.co/nYM2LRJ6O7RT @Logribel: New #SeekingAlpha article ""#NASH Drugs: A Comprehensive Review Of Current Clinical Trials"" https://t.co/xXcivpLFBF $ICPT $GNF‚Ä¶RT @TheStockKid: $SRPT with a huge $60PT set by analyst.  Stock also has a gap to fill around $28.  

$IBB $VRX $GILD $MRK https://t.co/3VR‚Ä¶Ok, so this is a new 30 day high on $GILD. What next? More strength to come? https://t.co/gbVCOlZVaU #stocks https://t.co/BABfQmOPyVGilead takeout of Nimbus stokes buying in other NASH players https://t.co/KWA33wr67S $GILD $GLMD $MNOV $RGLS$GILD #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/6a3FJkZ2KJ10 Best S&amp;P 500 Companies By Net Shareholder Distribution Yield - https://t.co/aD8DWLrGip - $AAPL $GILD $JNJ $MON $MSFT $ORCL $PG $UTX $WMT$GILD and here Coke the profit takers$GILD here we are. https://t.co/hFKTBjC9ah$GILD #Options volume chart in animation. More with #OptionsPro FREE app at https://t.co/K8PrRVM20E https://t.co/cEmNHKBSDgCommented on: ""Gilead takeout of Nimbus stokes buying in other NASH players"" https://t.co/jfhnPRAcU0 $GILD $GLMD $MNOV $RGLS@ifbarna Sector chart saved $IBB. $VRX (mkt cap $11B) is small in comparison to $GILD (mkt cap $133B), which saw losses. #stocks #investingRT @whotrades: $GILD is a Cheap Growth Stock Worth Buying Now
https://t.co/rWqM1J62bVRotation into biotech is happening, especially the long over suppressed names $IBB $SNY $GILD $AMGN $REGN $NK $OPHT#GileadSciences, Inc. Price Target Increased to $101.00 by Analysts at Jefferies Group. Read more: https://t.co/yAnaviIHvb $GILDMonthly Review Of DivGro: March 2016 https://t.co/6tPzzBf9tt $ABBV $GILD $MIC $STWD $TROW $UNP $GD $O.PD $QCOM $WBA $BBL $COP$SRPT with a huge $60PT set by analyst.  Stock also has a gap to fill around $28.  

$IBB $VRX $GILD $MRK https://t.co/3VRJE7gZUiRT SeekingAlpha: Monthly Review Of DivGro: March 2016 https://t.co/9JYKOorAZm $ABBV $GILD $MIC $STWD $TROW $UNP $GD $O.PD $QCOM $WBA $BBL ‚Ä¶@Sport234a if IAN has only one more shot  IMHO needs it to be a game changer.   $CELG $BIIB $GILD 3 that IMHO are immediate game changers üí∞#GileadSciences Why Gilead is paying $1.2B for a drug by Nimbus (BBJ Live) (Video). Read more: https://t.co/t91HG6tq3A $GILDMonthly Review Of DivGro: March 2016 https://t.co/NVmiXtPv5t $ABBV $GILD $MIC $STWD $TROW $UNP $GD $O.PD $QCOM $WBA $BBL $COPMonthly Review Of DivGro: March 2016 https://t.co/FQUDMMBnqt $ABBV $GILD $MIC $STWD $TROW $UNP $GD $O.PD $QCOM $WBA $BBL $COP$GILD another signal to buy https://t.co/ATE52V1k7B$GILD is a Cheap Growth Stock Worth Buying Now
https://t.co/rWqM1J62bV$IONS $GILD $MRK $MDCO MTSL Issue 824 ""Patents Re-Visited"" available now at https://t.co/vZMPDclqgA subscribe today!$GILD is going up. I remember a recommendation on whotrades to buy it at $85. Nice! https://t.co/ppFEYbJ01cEyes wide open now for most peeps. Will be more telling if this move continues next week $IBB $GILD $CELG $AMGN $REGN $BIIB $JAZZ $ILKM $VRX$GILD cmon you mofo break that 97.50StockTwits Trending via @Stocks_Live $IBB $TRXC $SHPG $TSLA $MOMO $LABD $CELG $WYNN $SCTY $CREE $GILD $AVXL $AGIO https://t.co/D20ABE9b8gWith a yield of 1.9% Gilead Sciences is a üí∞ dividend üí∞ stock worth a look $GILD https://t.co/SR6WQgdSS7 https://t.co/A9knxagkXm$GILD wow big sells here$GILD looks like big wall at 97.50, rest time$GILD: Analyst action by BMO Capital on Gilead Sciences: https://t.co/011aJRX4QO https://t.co/6DTcrPRWdlIs now a good time to invest into Gilead? $GILD https://t.co/OGQnZdZvceKudos to $GILD for reigniting the M&amp;A in bioland. Almost look like a wasteland for a whole quarter.RT @R4inb0w_: NASH Drugs: A Comprehensive Review Of Current Clinical Trials By @Logribel $GNFT $ICPT $TBRA $GLMD $GILD $GALT $CNAT https://‚Ä¶RT @Logribel: New #SeekingAlpha article ""#NASH Drugs: A Comprehensive Review Of Current Clinical Trials"" https://t.co/xXcivpLFBF $ICPT $GNF‚Ä¶Gilead takeout of Nimbus stokes buying in other NASH players https://t.co/63YrTtBjjb $GILD $GLMD $MNOV $RGLSBiotech Sector Outlook (video + static charts) - https://t.co/8GlXA7UHZ2 $XBI $IBB $PBE $GILD $AMGN $ABBV $CELG $BIIB $REGNRT @stockguy22: we noticed March31st when $IBB $JAZZ started to move..others playing catch up like $GILD $INCY $JUNO etc @vladmazek  https:‚Ä¶Gilead takeout of Nimbus stokes buying in other NASH players https://t.co/ULW6fP1NiH $GILD $GLMD $MNOV $RGLSGilead takeout of Nimbus stokes buying in other NASH players https://t.co/mrJISbY1ed $GILD $GLMD $MNOV $RGLSGilead takeout of Nimbus stokes buying in other NASH players https://t.co/bFk8zZMt0y $GILD $GLMD $MNOV $RGLSGilead takeout of Nimbus stokes buying in other NASH players https://t.co/MREGiO2DWF $GILD $GLMD $MNOV $RGLSI'd have to go back at least a year to find a day where $REGN, $BIIB, $GILD and $CELG have had this kind of sustained strength! $IBB $XBIRT @ stockguy22 ""we noticed March31st when $IBB $JAZZ started to move..others playing catch up like $GILD $INCY $J‚Ä¶ https://t.co/w5vy9uzZsN""clayton: GILD 96.30 Gilead Sciences Inc $GILD added to my https://t.co/AmhMvIxn44clayton: GILD 96.30 Gilead Sciences Inc $GILD added to my https://t.co/t5Pjr1PiXA$AGN $GILD
#Cramer&gt;Allergan may be #Acquisition #Target for Gilead.
FAST Growth&gt;#Allergan+#CashHeavy #Gilead #Drug 
 https://t.co/tzmCQcqjAgCommented on Gilead Has Bottomed - The Question Is How Much Upside Ahead? https://t.co/HACO5ijY9a $GILD$GILD right at resistance.  sold some, see what happens here#GileadSciences PharmaChem Breaks Ground on $130M Expansion Project. Read more: https://t.co/sUHRCXBooM $GILDGILD 96.30 Gilead Sciences Inc $GILD added to my watch list. Right now with GILD I am watching the last price  https://t.co/xKF01OobRywe noticed March31st when $IBB $JAZZ started to move..others playing catch up like $GILD $INCY $JUNO etc @vladmazek  https://t.co/RsLw0b99yL$GILD:

Biotech Stock Roundup: Gilead‚Äôs HIV Drug Approved, Regeneron ‚Ä¶:

https://t.co/OaOmP6Wxeu$GILD going higher! 101, then maybe 108 chart https://t.co/Awg6HWUNDbVetr Inc. Downgrades Gilead Sciences, Inc. $GILD to Buy https://t.co/8qLboNoDX8Gilead buys NASH program for up to $1.2B https://t.co/0Mfpotu0jI $GILDYes, Biotechs have some political pressure...but $GILD &amp; $AGN have cash on hand ready to buy... $IBB baby!!Gilead Sciences‚Äô $GILD ‚ÄúHold‚Äù Rating Reiterated at Morgan Stanley https://t.co/wDxrxmgZIw$gild lag is killing me. just killing me...f**k beta.Gilead Sciences Boost Price Target by Jefferies &amp; Co (Ranked 20th) to Hold with 101 PT $GILD #GILD https://t.co/nyq7xJnbR7$NVDA $GILD $CREE Wednesday Trades Blog + $708 Profits https://t.co/ydgXmPWMPnGilead Sciences's PT raised by Jefferies Group to $101.00. hold rating. https://t.co/6S0sPNPYvs $GILD #GILDHealthcare names hot again for us today $ENDP $ANIP $KITE $JUNO $UTHR $BIIB $MYL $MCK $CELG $TEVA $GILD and $UHS https://t.co/3OrWvW2GD5Bullish on $GILD Long $GILD  https://t.co/vrhDzq91YQRT @SA_BioTech: 'Economist' In Me Says This Is A Threat To Gilead https://t.co/DcsDv59Z1l $ABBV $AET $ANTM $GILDRT @Logribel: New #SeekingAlpha article ""#NASH Drugs: A Comprehensive Review Of Current Clinical Trials"" https://t.co/xXcivpLFBF $ICPT $GNF‚Ä¶$GILD:

Gilead (GILD) is a Cheap Growth Stock Worth Buying Now:

https://t.co/rOJbc7EfVX$GILD real nice. $100 soon ??RT @GerberKawasaki: #stocks starting to lift off. #oil higher. Nice move in Tesla $tsla. Seeing some love in biotech. $gild $ilmn. This mar‚Ä¶#stocks starting to lift off. #oil higher. Nice move in Tesla $tsla. Seeing some love in biotech. $gild $ilmn. This market is feeling good!S&amp;P500 #Stocks Trend $CELG $STZ $KMX $ALXN $PFE $EBAY $EW $AMGN $ISRG $MDT $BMY $ABBV $MRK $GILD $FOXA $CCE  @ https://t.co/RPeaHBHYi0The time to sell the portfolio $AAPL $DSW $GBX $GILD is at least 2 weeks away.Nasdaq100 #Stocks Trend $CELG $ILMN $ALXN $EBAY $AMGN $ISRG $TSLA $GILD $FOXA $BMRN $INCY $NFLX $LMCA $AAPL  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $CELG $PFE $AMGN $MDT $BMY $ABBV $MRK $GILD $FOXA $PM $LMT $ABT $PG $HAL $MO $AAPL $BIIB  @ https://t.co/cKkr8cKsju$TSLA $GILD what a ride, whoa baby$GILD 100 by end of week!$GILD: Analyst action by BMO Capital on Gilead Sciences: https://t.co/011aJRX4QO https://t.co/ksD8ryJjouRT @R4inb0w_: NASH Drugs: A Comprehensive Review Of Current Clinical Trials By @Logribel $GNFT $ICPT $TBRA $GLMD $GILD $GALT $CNAT https://‚Ä¶RT @Logribel: New #SeekingAlpha article ""#NASH Drugs: A Comprehensive Review Of Current Clinical Trials"" https://t.co/xXcivpLFBF $ICPT $GNF‚Ä¶$IBB $CELG $GILD $BIIB $AMGN $REGN MY TOP 10 POSITIONS BIOTECHNOLOGY, $VRTX $ALXN 
(Giant company) , https://t.co/borQWNNOrxEverything $GILD is looking to buy is ~2% more expensive as of today... $XLVRT @Taarriqq: $xbi + 3.7%  may 55 5000 calls block bot , few of us were in #hotsector kept repeating $ibb $icpt $gild https://t.co/Mkg9M2To‚Ä¶RT @macroQmicro: Century mark? $GILD on weekly chart next resistance looks like 100 where price converges with 200-day MA https://t.co/NIoW‚Ä¶The #biotech bounce is done for today. Needs to rest a bit &amp; digest the move of the last 2 weeks. But it ain't over. $IBB $GILD $VRTX $HALOTraders Sell #GileadSciences, Inc. on Strength After Insider Selling. Read more: https://t.co/IxrELGHAVC $GILD@aawayne @ZTracer $GILD makes up for all the other cos that didn't make blockbuster drugs :P but I get your point.You now have 3 companies set free looking to buy others, $PFE, $AGN, and $GILD, should lead to more consolidation$BIIB still holding from $260 .. $LABU $IBB $HZNP $CELG $GILD https://t.co/M7XX4DdiS8NASH Drugs-A Comprehensive Review Of Current Clinical Trials- $AZN, $BMS, $CANF,  $CNAT,  $EMIS, $ENTA, $GALT, $GILD https://t.co/wmb0TeeNDzRT @RNAiAnalyst: $ions a hot takeover property: first $biib then $gild now $pfe possible suitorGreat job of calling $IBB trade in the $240's, @AriWald when you were on @CNBCFastMoney Wasn't easy... $GILD was the strongest one then.RT @Taarriqq: $xbi + 3.7%  may 55 5000 calls block bot , few of us were in #hotsector kept repeating $ibb $icpt $gild https://t.co/Mkg9M2To‚Ä¶Volume Alert - GILD 96.65 Gilead Sciences Inc $GILD Hit a high today of 97.17 Closing the day 10:29 at 96.65 + https://t.co/PR6kClS2Zd$xbi + 3.7%  may 55 5000 calls block bot , few of us were in #hotsector kept repeating $ibb $icpt $gild https://t.co/Mkg9M2ToRTCentury mark? $GILD on weekly chart next resistance looks like 100 where price converges with 200-day MA https://t.co/NIoWW2BbvuRT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶$GILD is just on a tear. I got in at around $83... I expected short term weakness but looks like I lucked out at bought the bottom!$SRPT load the boat under $21.....they're giving everyone a free pass here!  $ACAD $EXEL $HRTX $GALE $GILD$ions a hot takeover property: first $biib then $gild now $pfe possible suitor$GILD losing steam 96.50 is key break downRT @Logribel: New #SeekingAlpha article ""#NASH Drugs: A Comprehensive Review Of Current Clinical Trials"" https://t.co/xXcivpLFBF $ICPT $GNF‚Ä¶$GILD: Analyst action by BMO Capital on Gilead Sciences: https://t.co/011aJRX4QO https://t.co/MnhBv9wlHjGILD Top news - Apr 6th, 2016 $GILD https://t.co/5DvlTJUORiGILD % Change
See Here ---&gt; https://t.co/uRXZkUuuad

$GILD $RVLT $DEWM #stocksRT @CatalystWatcher: $GILD has seen the $GBIM 24 week data since late February. 1st trial for GS-4774 they didn't release. Now they are. ht‚Ä¶With death of inversions like $AGN $PFE other stocks like $CELG $GILD $ABBV $AMGN benefit from less political focus on Biotech/Pharma sector$GILD  https://t.co/a6csA9fnq9BMO analyst Ian Somaiya initiated coverage: Gilead $GILD with a ‚Äúmarket perform‚Äù rating and $102 price target.Price Target Alert: Trading the Zacks price target change for GILEAD SCIENCES¬†$GILD https://t.co/usfVNfkD3k https://t.co/DXEfVHLPi8$GILD keep trending higher #stockmarkets,#daytrading,#swingtrading,#investing,#stocktrading https://t.co/IBQxgGH6CCRT @Taarriqq: $BIOTECH BOOM AGAIN $XOP + 2.5%  may 55 5000 calls block bot , all up $icpt $ibb $gild , from our video https://t.co/Mkg9M2To‚Ä¶RT @Taarriqq: $BIOTECH BOOM AGAIN $XOP + 2.5%  may 55 5000 calls block bot , all up $icpt $ibb $gild , from our video https://t.co/Mkg9M2To‚Ä¶$BIOTECH BOOM AGAIN $XOP + 2.5%  may 55 5000 calls block bot , all up $icpt $ibb $gild , from our video https://t.co/Mkg9M2ToRTRT @CatalystWatcher: $GILD has seen the $GBIM 24 week data since late February. 1st trial for GS-4774 they didn't release. Now they are. ht‚Ä¶$GILD has seen the $GBIM 24 week data since late February. 1st trial for GS-4774 they didn't release. Now they are. https://t.co/xhOaGd0hjwRT @R4inb0w_: NASH Drugs: A Comprehensive Review Of Current Clinical Trials By @Logribel $GNFT $ICPT $TBRA $GLMD $GILD $GALT $CNAT https://‚Ä¶@WallStreetBean finally getting that breakout from $gild@smartertrader $GILD on fire$GILD added SHORT 97.10$GILD your biggest consideration https://t.co/hz3xPKx2T6 https://t.co/hPiWuJedF0$GILD breakout of the downtrend channel. https://t.co/kGEbib1ENkRT @R4inb0w_: NASH Drugs: A Comprehensive Review Of Current Clinical Trials By @Logribel $GNFT $ICPT $TBRA $GLMD $GILD $GALT $CNAT https://‚Ä¶Upcoming biotech corporate events shown in Enchilada include 4/7/16 $GILD #PDUFA date and $MRK #dividend pay date https://t.co/sEdyQqo6DiNASH Drugs: A Comprehensive Review Of Current Clinical Trials By @Logribel $GNFT $ICPT $TBRA $GLMD $GILD $GALT $CNAT https://t.co/NK7BoulhYk$GBIM phase 2 trial completed with $GILD according to updated post here....https://t.co/srAow2YBpkNew #SeekingAlpha article ""#NASH Drugs: A Comprehensive Review Of Current Clinical Trials"" https://t.co/xXcivpLFBF $ICPT $GNFTF $GILD $NVO$GILD is the one large Pharma that could credibly make a run at buying $AGNRT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶RT @GerberKawasaki: Seeing continued strength in gilead after getting into NASH. Looks like liver issues and obesity it is. Great business.‚Ä¶$GILD added short 96.70Drug price cuts in Japan sink in though details sparse https://t.co/3TeWG45vV0 $GILD $PFE $LLYRT @CatalystWatcher: Critical phase 2 $GBIM $GILD data likely before end of next week...Massive upside should it be + at 24 weeks.$GILD going for highs@BeckyQuick @andrewrsorkin @JoeSquawk @davidfaber @carlquintanilla  Cramer thinks $GILD to buy $AGN. New co. called GilliganRT @aschwartzphd: $GBIM $GILD GS-4774 - Primary completion date per https://t.co/IMXpwhsER3 https://t.co/jqL0S6AQYTRT @aschwartzphd: $GBIM $GILD GS-4774 - Primary completion date per https://t.co/IMXpwhsER3 https://t.co/jqL0S6AQYTCritical phase 2 $GBIM $GILD data likely before end of next week...Massive upside should it be + at 24 weeks.Traders Sell Gilead Sciences, Inc. $GILD on Strength Following Insider Selling https://t.co/ZehcW1EbecRT @GerberKawasaki: Seeing continued strength in gilead after getting into NASH. Looks like liver issues and obesity it is. Great business.‚Ä¶RT @aschwartzphd: $GBIM $GILD GS-4774 - Primary completion date per https://t.co/IMXpwhsER3 https://t.co/jqL0S6AQYT@jimcramer calling for $GILD and $AGN merger I like that$GBIM $GILD GS-4774 - Primary completion date per https://t.co/IMXpwhsER3 https://t.co/jqL0S6AQYTRT @GerberKawasaki: Seeing continued strength in gilead after getting into NASH. Looks like liver issues and obesity it is. Great business.‚Ä¶$GILD SHORT 96.15RT @GerberKawasaki: Seeing continued strength in gilead after getting into NASH. Looks like liver issues and obesity it is. Great business.‚Ä¶RT @GerberKawasaki: Seeing continued strength in gilead after getting into NASH. Looks like liver issues and obesity it is. Great business.‚Ä¶Seeing continued strength in gilead after getting into NASH. Looks like liver issues and obesity it is. Great business. $gildRT @JeaYu21: $MON $CREE $SRPT $GILD chart https://t.co/lb1QBeOOIcGilead's Acquisition Strategy Becomes Clearer https://t.co/2AyxmLBczL $GLPG $GILD$GILD still hasn't identified target 2 replace inevitable HepC rev fall. With $PFE $AGN merger off, whatever it will b may be more expensive$GILD $BSX:

Healthcare Movers: Baxalta Incorporated (NYSE:BXLT), Gilead ‚Ä¶:

https://t.co/xFVwSmJ793In Play Longs: $AAPL $AYI $CELG $GILD $NFLX $SRPT $STZ $TEVA $TRXC $SWHC $ENDPWonder if $AGN and $PFE being back in the M&amp;A game forces $GILD's hand to make a purchase#SPX $GILD early morning bid +.7% channel resistance at 96.34$MON $CREE $SRPT $GILD chart https://t.co/lb1QBeOOIcGilead Sciences EVP Paul Rutherford Carter Sells $182,680.00 in $GILD https://t.co/rGBwCogLSWGilead Sciences EVP Paul Rutherford Carter Sells $182,680.00 in $GILD https://t.co/3AkpX79uFC$GILD $BHI Stocks News Buzz https://t.co/pzcizWoYeM@jimcramer $GILD #CramerQRT @agrudadvisors: Gilead Sciences gains 1.41% to $95.57 on Tuesday : Among top 10 gainers on S&amp;P500. $GILD #biopharma #stockmarketBMO busy in biotech initiating coverage $GILD $BIIB both 'market perform' PT $102 &amp; $283Gilead Sciences gains 1.41% to $95.57 on Tuesday : Among top 10 gainers on S&amp;P500. $GILD #biopharma #stockmarketGilead Sciences, Inc. $GILD EVP Paul Rutherford Carter Sells 2,000 Shares https://t.co/nYi1wUez4mGilead Sciences, Inc. $GILD EVP Paul Rutherford Carter Sells 2,000 Shares https://t.co/BdFQgH4lirRT @BentheFidler: As Rivals Make News, Intercept Heads To Daylong Hearing For Liver Drug https://t.co/WkbpRVxL76 by @alexlash $GILD $ICPT$GILD $CVS:

Analysts Spotlight: Gilead Sciences, Inc. (NASDAQ:GILD) , CVS ‚Ä¶:

https://t.co/rUIcTrnyVrGilead Sciences, Inc. $GILD EVP Paul Rutherford Carter Sells 2,000 Shares https://t.co/USMO9t1coE$GILD: Analyst action by BMO Capital on Gilead Sciences: https://t.co/011aJRX4QO https://t.co/xT8us2eoVlRT @bret_jensen: Commented on Gilead's Acquisition Strategy Becomes Clearer https://t.co/oPxmMMXyX6 $GLPG $GILDCommented on Gilead's Acquisition Strategy Becomes Clearer https://t.co/oPxmMMXyX6 $GLPG $GILD$GILD Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/dzMbNAHGhG$GILD Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/zaVmQ3f5UV$GILD Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/kFbR58vcxGRT @BioStockAddict: Gilead's Acquisition Strategy Becomes Clearer $GILD $GLPG #Galapagos  https://t.co/D9wOp4AxJCAs Rivals Make News, Intercept Heads To Daylong Hearing For Liver Drug https://t.co/WkbpRVxL76 by @alexlash $GILD $ICPTGilead Sciences, Inc. $GILD CEO John F. Milligan Sells 112,000 Shares https://t.co/Um5183dnkbDaily picks here. $USO and $UWTI here. I also like $GILD on FDA approval.Weekly S&amp;P500 #Stocks Trend $EW $ALXN $PFE $GILD $CCE $NOC $ABBV $BMY $LMT $CELG $MRK $PM $ZTS $BSX $ISRG  @ https://t.co/RPeaHBHYi0Weekly S&amp;P500 #Stocks Performance $SHW $PX $EW $ALXN $REGN $ZTS $VRTX $RCL $PFE $BIIB $CCL $GILD $CCE $BSX more@ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $TSLA $ALXN $GILD $CELG $ISRG $EBAY $NFLX $BMRN $FOXA $INCY $ILMN $AMGN $GRMN  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $TSLA $ALXN $REGN $VRTX $INCY $BMRN $BIIB $ILMN $GILD $CERN $MDLZ  more@ https://t.co/YdSIjFJqHfWeekly S&amp;P100 #Stocks Trend $PFE $GILD $ABBV $BMY $LMT $CELG $MRK $PM $FOXA $AMGN $PEP $JNJ $MCD $CL $TXN  @ https://t.co/cKkr8cKsjuWeekly S&amp;P100 #Stocks Performance $PFE $BIIB $GILD $RTN $MCD $ABBV $BMY $MDLZ $AMGN $LMT $V $CELG $AAPL  more@ https://t.co/cKkr8cKsju@yusschr @NotaBubble @Nicole1515 Heard Cramer put the Kibash on $GILD yesterday. Recommended $CELG, $REGN $BIIB etc &amp; thinks $IBB bottomed.$GILD:

Latest Analyst‚Äôs EPS Target Review: Gilead Sciences, Inc. (NASDAQ ‚Ä¶:

https://t.co/fTPzzxvr5D$GILD $BHI:

Gilead Sciences, (NASDAQ:GILD) &amp; Baker Hughes Incorporated ‚Ä¶:

https://t.co/VvW8JyQKpU$GILD:

Why Paul Carter Unloaded 2000 Shares of Gilead Sciences, Inc ‚Ä¶:

https://t.co/XnpkHPwvHKCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKjqBmD$GILD:

The Insider John Martin Sold 100000 shares of Gilead Sciences, Inc ‚Ä¶:

https://t.co/ZKgKpXfKBH4 Great Stocks To Ride The $IBB Rebound $AMAG $GILD $HZNP $PRAH https://t.co/Km9opn8rN1#GileadSciences Gilead acquires Nimbus Apollo &amp; its ACC programme for NASH &amp; other liver di... Read more: https://t.co/y9FyZgjf99 $GILD#GileadSciences, Inc. EVP Paul Rutherford Carter Sells 2,000 Shares. Read more: https://t.co/npnAjHZq9p $GILD#GileadSciences Gilead contractor PharmaChem starts $120M Bahamas expansion. Read more: https://t.co/MRhkfPvDgs $GILDChartwell Investment Partners LLC Reduces Stake in #GileadSciences, Inc. (). Read more: https://t.co/aQYzGQGJ96 $GILDWhy Is #GileadSciences A Zacks Rank #1 Stock Right Now?. Read more: https://t.co/wcS9wd8kNk $GILD#GileadSciences, Inc. Shares Bought by California Public Employees Retirement System. Read more: https://t.co/EFLmY19bcB $GILD#GileadSciences Gilead Buy Could Bolster Galmed Valuation. Read more: https://t.co/h3qf7BAcn3 $GILD#GileadSciences Expands Reach in HIV Drugs Market. Read more: https://t.co/PulTzoHKa0 $GILD#GileadSciences FDA Approves Descovy (Emtricitabine, Tenofovir Alafenamide), Gilead???s Thi... Read more: https://t.co/eoaY84Ax4i $GILD#GileadSciences Gilead Descovy Wins FDA Nod, To Buy Nimbus Liver Program. Read more: https://t.co/OPl9YZAryn $GILDRT @InsiderWire: JOHN MILLIGAN F Pres and CEO Sells $8,757,664 Worth of $GILD Gilead Sciences, Inc. - #Form4 #InsiderTrading - https://t.co‚Ä¶RT @InsiderWire: JOHN MARTIN C Executive Chairman Sells $7,684,007 Worth of $GILD Gilead Sciences, Inc. - #Form4 #InsiderTrading - https://‚Ä¶Gilead Sciences Chairman John Martin Sells $9,324,000.00 in $GILD https://t.co/bF6oVT3VTwGilead Sciences Chairman John Martin Sells $9,324,000.00 in $GILD https://t.co/8xREcwSk2a$CELG $GILD $AMGN nice price targets set @BMORT @FierceBiotech: ICYMI: Gilead gains next-gen HIV approval from FDA as it looks to beat back competition: https://t.co/bGQLxjDUDI by @Pha‚Ä¶$GILD:

Analyst Rating Update on Gilead Sciences (GILD):

https://t.co/nL7N4I7MfiRT @macroQmicro: $GILD relative strength vs industry, sector &amp; market moving up to next level overhead on positive accumulaiton https://t.c‚Ä¶@mugatushair @LongShortTrader @RChang6 would simply state, youre right no one cares how ""good"" $GILD is at Capital Deployment...@avidresearch @BattagliaCE I'd be surprised $GILD RT inhibitors do much for HBV. Just another disease maintenance drug. Cant hurt 2 try tho.@LongShortTrader @RChang6 I can also refer to you @DrPaulyDeSantis who is #1 $gild dude on Twitter IMO@LongShortTrader @RChang6 FYI I've covered $GILD and $AGN for years. Im playing devils advocate.@LongShortTrader @RChang6 I don't agree with that view, or view of $GILD. But market can meme it's way to stupidity.@avidresearch @BattagliaCE Is $GILD hoping TLR7 agonist activation of IFN-Œ±/Œ≤ bleeds over to HBV? But since HBV can evade IFN, I'm lost.@LongShortTrader @RChang6 IMO $GILD has best in class cap allocation record and is constantly doubted, and always has been. Doubt $AGN too?US Gov't Reduces ACA Costs -Approves Biosimilars-Stops Tax Aversion Motivated M&amp;A's-Next?-Medicare Negotiate Drug Price $IBB $PFE $AGN $GILD@avidresearch @BattagliaCE $GILD GS-9620 (TLR7) makes sense for ssRNA HCV &amp; HIV, but not so much for (mostly) dsDNA HBV which is TLR9 ligandMoney Flows: Selling on Strength: Among stocks that were up today, these had the largest outflow of money: $PFE $BIL $GILD $TSLA $CELG top 5@RChang6 There is an argument to be made for $AGN to trade at a $GILD multiple. Could get ugly.Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5@avidresearch @BattagliaCE $GILD more comfy w HCV (ssRNA:TLR7) than HBV (CpG DNA:TLR9)? IP issues? Weird, b/c $DVAX HBV vax uses TLR9.$GILD has had a great earnings performance in the last few years https://t.co/q9OpNAPB0u https://t.co/7JYH1U9egq$GILD:

112000 Shares of Gilead Sciences, Inc. (GILD) Stock are sold by ‚Ä¶:

https://t.co/wv7QbnHcW3$GILD:

John F. Milligan Sells 112000 Shares of Gilead Sciences, Inc. (GILD ‚Ä¶:

https://t.co/nqKj1feeSrFDA clears Gilead's Descovy for HIV-1 $GILD https://t.co/kQcgBu6rx4Cheap put options and hedges: $BBRY puts cheaper than 92% of history, $SLV 91%, $DAL 89%, $GILD 82%, $AAPL 82%, $GE 81%, $MAS 81%@WhiteCoatMafia one possible way is follow the $GILD path and look for smaller deals$GILD:

Gilead Sciences (NASDAQ: GILD) Executives are Making Moves ‚Ä¶:

https://t.co/H4mXycAYu1@AndyBiotech And yet, they attack the likes of $GILD, $MDVN, pcsk9 etc. Insulin is certainly not innovation in 2016.RT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶Thanks Jim &amp; Carolyn for gr8 fib charts&amp;analysis of $IBB, $BIIB, $REGN, $CELG &amp; $GILD on @MadMoneyOnCNBC tonight. @Fibonacciqueen @jimcramer@GangLeader $GILD hit the trend line before puling back https://t.co/3wYpQYcplt$GILD with the FDA approval for its HIV drug. Obvious BUY tomorrow.RT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶4 Great Stocks To Ride The $IBB Rebound $AMAG $GILD $HZNP $PRAH https://t.co/Ur2IDTx0X2Gilead Sciences (NASDAQ: GILD) Executives are Making Moves with Their Shares $GILD https://t.co/lefj5Pjynk",2016-04-06,GILD,0
7,"Will market make a U-turn tomorrow? $RLYP $LEI $OCUL $CPXX $PACB (#notTrading $GOOG $DIS $YAHOO $GILD $SBUX) https://t.co/sKOiqYxRPBhttps://t.co/uAcamNRUPt alerted $PTX +45% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/OQCNEb9p9K $HOT $AMAT $ITUB $MT $GILD $HST $AAThis @BMO manager says there are opportunities in #healthcare and #tech, like $GILD: https://t.co/QmpA5p4oZf #investing #stocks #mutualfunds{NEW POST} FEATURING: $SPY $BABA $NKE $GS $GPRO $X $CMG $COST $XOM $UA $GILD $TWTR $TSLA - https://t.co/BZJ48XD5Ml https://t.co/KyRu2PQ09SRT @Benzinga: How One Analyst Is Playing The #Biotech Rebound This Week $BIIB $BLUE $CELG $GILD $MRK $PFE $IBB https://t.co/RLGhZfS4c9Nasdaq100 #Stocks Trend $CELG $BMRN $INCY $WYNN $AMGN $SBUX $TSLA $GILD $CHKP $ILMN $REGN $BIIB $ADP $CMCSA  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $MRK $PFE $CELG $LMT $AMGN $HAL $SBUX $UTX $MMM $ABBV $BMY $GILD $MCD $JNJ $MO $PEP $V  @ https://t.co/cKkr8cKsjuHow One Analyst Is Playing The #Biotech Rebound This Week $BIIB $BLUE $CELG $GILD $MRK $PFE $IBB https://t.co/RLGhZfS4c9Traders Buy #GileadSciences, Inc. on Weakness on Insider Selling. Read more: https://t.co/Lx7odkHyiS $GILDInvestors Buy Gilead Sciences, Inc. $GILD on Weakness on Insider Selling https://t.co/oPYuqF9uo0RT @JeaYu21: $GILD melting$GILD - FDA Panel Backs Approval of Liver-Disease Drug https://t.co/sVCYNW2p4WTraders Buy Gilead Sciences, Inc. $GILD on Weakness on Insider Selling https://t.co/Kp9uOn905u$ICPT OCA approval along with $GILD's acquisition agreement of Nimbus Therapeutics show promising future for effective treatment of NASH.RT @tgtxdough: Few NASH related therapeutics $GILD $MRK $ICPT https://t.co/11GYXP184aStochastic Sell https://t.co/gVcxSjhPf1 $IBB $XLV $BDSI $BIIB $GILD $ABBV $NMBL $MRK $EXEL $ILMN $PDLI $AMGN $GRMN $TWX $INCY $COMM $BIB#GileadSciences : Studies from Gilead Sciences Inc. Yield New Data on Antivirals [Implicati... Read more: https://t.co/4J4CHS7FWP $GILDPeloton Wealth Strategists Acquires 3,200 Shares of #GileadSciences, Inc. (). Read more: https://t.co/TeWFTkDGbo $GILD$ICPT Adcom results 17-0. Will lift all NASH biotech sector tommorrow $GILD $NVO $TBRA $GLMD, $GALT $CNAT , $MNOV #BullishCrossvault Capital Management LLC Boosts Stake in #GileadSciences, Inc. (). Read more: https://t.co/rPYvOZFcw8 $GILD#GileadSciences, Inc. Shares Sold by Tealwood Asset Management Inc. Read more: https://t.co/rQsfJmiaJ1 $GILD30pts lower at lows--&gt; Not exactly fans of rally to $SPX 2066 
$SPY $GILD $CELG $ALXN $BIIB 
https://t.co/xZhjbNutNg https://t.co/0PNeSQWJHv$GILD:

Gilead Sciences Incorporated (NASDAQ:GILD) Short Interest ‚Ä¶:

https://t.co/nlc1VPFDCYPeloton Wealth Strategists Acquires 3,200 Shares of Gilead Sciences, Inc. $GILD https://t.co/qnYhk5bIInGilead: My Impatience Grows https://t.co/06YTTn1Hmf $GILDGilead Sciences, Inc. $GILD Shares Sold by Tealwood Asset Management Inc. https://t.co/EfqRywBU9ORT SeekingAlpha: Gilead: My Impatience Grows https://t.co/acFhtLI21z $GILD$GILD:

Gilead: My Impatience Grows:

https://t.co/gVzhqVAsBYGilead: My Impatience Grows https://t.co/tpVjCb8tGx $GILDGilead: My Impatience Grows https://t.co/e55QS8asGH $GILDLam Research Corporation Leads Our Nasdaq Top-Ten List $AMGN $ATVI $AVGO $CSCO $GILD $INTC $LRCX $MSFT $NTES https://t.co/9gxNgdMVYzCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5#GileadSciences Gilead antiviral API supplier expanding plant after US FDA OKs Descovy. Read more: https://t.co/k3B5mXeqsL $GILDRT @WallStJesus: BUYERS STILL VERY SELECTIVE HERE, SOME BUYING IN BIOS $JAZZ $GILD $ENDP -- $NKE &amp; MORE $SBUX@RTNRTN you are short $gild as well?CHMT Yield
See Here ---&gt; https://t.co/ZIvcWLO9YO

$CHMT $GILD $GBT #finance#GileadSciences Gilead keeps Martin's pay going strong at $18.8M in his last year as CEO. Read more: https://t.co/44R53JOPsd $GILDRT @DozenStocks: Nasdaq100 #Stocks Trend $BMRN $CELG $WYNN $AMGN $INCY $TSLA $GILD $ILMN $REGN $BIIB $CHKP $ADP $CMCSA $AVGO  @ https://t.c‚Ä¶Worst #sentiment for #SP1500 #stocks at market close: $ADSK $GILD $BSX $STT $MA (2016/04/07) #stocktrading #predictiveanalytics #bigdataWorst sentiment for SP1500 stocks at market close: $ADSK $GILD $BSX $STT $MA (2016/04/07) #sentiment #stock #alexandriaNasdaq100 #Stocks Trend $BMRN $CELG $WYNN $AMGN $INCY $TSLA $GILD $ILMN $REGN $BIIB $CHKP $ADP $CMCSA $AVGO  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $MRK $PFE $CELG $LMT $AMGN $UTX $GILD $MO $PEP $ABBV $ABT $BIIB $BMY $HAL $COP $MCD  @ https://t.co/cKkr8cKsjuRT @TalkMarkets: Healthcare Stocks Lead On A Lackluster Day $BMY $EW $RHHBY $ACAD $ALNY $ALXN $ANAC $IBB $GILD $NBIX $VRTX $ZIOP ... https:‚Ä¶$GILD $BIIB $CELG $MRK:

How One Analyst Is Playing The Biotech Rebound This Week:

https://t.co/tjOh4CNIe0$GILD pathetic move today means I'll buy more here.  I'm still bullish, forget JapanRT @MorningstarCDN: This @BMO manager is rebuilding his positions in #healthcare and #tech: https://t.co/QmpA5p4oZf #investing #stocks #mut‚Ä¶Hope everyone had a great day. $YHOO, $JAZZ and $GILD nice intraday plays. Still holding $NKE Calls $CNP Puts Gravy Baby. Nip on $SPY &amp; $FBRT @NovateurBio: Jim Cramer's 'Off the Charts': #Biotech gets a short-term bottom $GILD $IBB https://t.co/RKUiLPiSRj via @TheStreetThis @BMO manager is rebuilding his positions in #healthcare and #tech: https://t.co/QmpA5p4oZf #investing #stocks #mutualfunds $GILDRT @NovateurBio: Jim Cramer's 'Off the Charts': #Biotech gets a short-term bottom $GILD $IBB https://t.co/RKUiLPiSRj via @TheStreetBullish on $GILD Long $GILD - Adding to position https://t.co/YHscLwJRctRT @JeaYu21: $YHOO $GILD $SPY $NKE https://t.co/oYJp29q1BNRT @JeaYu21: $YHOO $GILD $SPY $NKE https://t.co/oYJp29q1BNRT @JeaYu21: $GILD meltingRT @FiercePharma: Gilead keeps Martin's pay going strong at $18.8M in his last year as CEO https://t.co/YTN1iIzXlj $GILD #pharma by @EmilyW‚Ä¶$GILD I hope we have some support hereJim Cramer's 'Off the Charts': #Biotech gets a short-term bottom $GILD $IBB https://t.co/RKUiLPiSRj via @TheStreetRT @CarpeNoctom: $GILD also making gains on FDA approval of new HIV drug. Also discussed on #SetupSunday @btcWhaleclub https://t.co/5igWZWk‚Ä¶Gilead Sciences $GILD announces entry into agreement under which Gilead will acquire Nimbus Apollo https://t.co/jgpLdfOlhE#GileadSciences, Inc. Coverage Initiated at BMO Capital Markets. Read more: https://t.co/yW1O2YiRgs $GILDbarronsonline: RT barronsstckblog: Is Biotech Back? https://t.co/e75eDmb81W via barronsonline $REGN $VRTX $GILD $ALXN $CELGRT @barronsstckblog: Is Biotech Back? https://t.co/r5L11Nchog via @barronsonline $REGN $VRTX $GILD $ALXN $CELGRT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶Gilead Sciences, Inc. $GILD Coverage Initiated at BMO Capital Markets https://t.co/NqTZIr6FXQ$GILD also making gains on FDA approval of new HIV drug. Also discussed on #SetupSunday @btcWhaleclub https://t.co/5igWZWkWVnGilead Sciences, Inc. $GILD Coverage Initiated at BMO Capital Markets https://t.co/yGNA9SlBm3$GILD this stock just can't move todayIs Biotech Back? https://t.co/r5L11Nchog via @barronsonline $REGN $VRTX $GILD $ALXN $CELGRT @WallStJesus: BUYERS STILL VERY SELECTIVE HERE, SOME BUYING IN BIOS $JAZZ $GILD $ENDP -- $NKE &amp; MORE $SBUXBUYERS STILL VERY SELECTIVE HERE, SOME BUYING IN BIOS $JAZZ $GILD $ENDP -- $NKE &amp; MORE $SBUX@msttrader $GILD suffered same fate yesterday.RT @FiercePharma: Gilead keeps Martin's pay going strong at $18.8M in his last year as CEO https://t.co/YTN1iIzXlj $GILD #pharma by @EmilyW‚Ä¶Gilead keeps Martin's pay going strong at $18.8M in his last year as CEO https://t.co/YTN1iIzXlj $GILD #pharma by @EmilyWFierceWorst #sentiment for #SP1500 #stocks at midday: $ADSK $GILD $BSX $STT $MA (2016/04/07) #stocktrading #predictiveanalytics #bigdataWorst sentiment for SP1500 stocks at midday: $ADSK $GILD $BSX $STT $MA (2016/04/07) #sentiment #stock #alexandriaRT @RTNRTN: $ICPT chart .. will trade tomorrow  loaded with shorts  $SPX $SPY $GILD #biotech #stocks Weekly chart is key https://t.co/ulnrJ‚Ä¶$ICPT chart .. will trade tomorrow  loaded with shorts  $SPX $SPY $GILD #biotech #stocks Weekly chart is key https://t.co/ulnrJ3aVpPRT @JSTBiotech: Makes sense for $GBIM 24 week ph2 HBV data to be released next week, concurrently with EASL, as $GILD will have a heavy pre‚Ä¶$GILD gawd!!!!@Ken_Kulig Would be treatment naive population, but still over $1 billion mark. $GILD will likely move into phase 2b or start combo trial.RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @R4inb0w_: GENFIT : ""We think we can take 50 percent of the (NASH) market,"" Genfit Chief Executive Jean-Francois Mouney told Reuters $GN‚Ä¶RT @Tootix: ""#Genfit #Elafibranor [Efficacy + Tolerability + Security] profile is better than #OCA "" JF Mouney https://t.co/1QJdHtKvSZ $GNF‚Ä¶@msttrader I Should have taken some profits on $GILD yesterday.RT SeekingAlpha: Why Are Quality Biotech's Soaring? https://t.co/rXauMlrt4n $AGN $ALXN $BIIB $BMY $CELG $GILD $IBB $MDVN $PFE $REGNWhy Are Quality Biotech's Soaring? https://t.co/rUgLvq0W80 $AGN $ALXN $BIIB $BMY $CELG $GILD $IBB $MDVN $PFE $REGNRT @aschwartzphd: $GBIM $GILD GS-4774 - Primary completion date per https://t.co/IMXpwhsER3 https://t.co/jqL0S6AQYTRT @CatalystWatcher: Critical phase 2 $GBIM $GILD data likely before end of next week...Massive upside should it be + at 24 weeks.RT @JSTBiotech: Makes sense for $GBIM 24 week ph2 HBV data to be released next week, concurrently with EASL, as $GILD will have a heavy pre‚Ä¶Nasdaq100 #Stocks Trend $BBBY $CHKP $CELG $REGN $BMRN $TSLA $INCY $WYNN $AMGN $ALXN $SBUX $SPLS $GILD $ILMN  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $PFE $MRK $CELG $LMT $AMGN $HAL $SBUX $GILD $UTX $MO $BIIB $PEP $PM $V $TWX $CMCSA $ABT  @ https://t.co/cKkr8cKsju$GILD need more $$ to buy more callsThis @BMO manager says $GILD is among his top picks in #healthcare: https://t.co/QmpA5p4oZf #investing #stocks #tech #consumer #mutualfunds$GILD If you want to add, wait until at least 94.  Going there for sure, likely tomorrow.$GILD what a joke$GILD From hero to zero.  Too soon and too violent for mere profit-taking.  Wonder who got a hold on what news.$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD): Rundown on Share ‚Ä¶:

https://t.co/yyBCYnUUDe$GILD:

Biotech Bullish Run After Analysts Estimates: Gilead Sciences ‚Ä¶:

https://t.co/Qk2E5DMLQWAs healthcare stocks rally. We buy The 4 Horsemen of #Biotech https://t.co/zqRpeLXzF1 #aviateUS $AMGN $GILD $BIIB $CELG Capital At Risk[VIDEO ] $STUDY $IBB $BTK $BIS $ZBIO $VRX $ENDP $GILD $ALDR $AGN $BSX ""Uniformity"" @ MULTIPLE RSI Resistance Lines https://t.co/qxZcdtdPwkVolume Alert - GILD 96.27 Gilead Sciences Inc $GILD Hit a high today of 97.63 Closing the day 10:30 at 96.27 - https://t.co/y3yvsaViKXGilead keeps Martin's pay going strong at $18.8M in his last year as CEO: https://t.co/5hCYmAQMrN $GILD #pharmaFDA approves $GILD Descovy for HIV-1. Bullish. Valuation price at $115. OTM call volumes continue to increase.$GILD @SeekingAlpha is clearly undervalued and apparently investors are really taking their time reacting to it. https://t.co/eUOHCmETPHWest Coast Bio Roundup: Pfizer‚Äôs BBC Ghosts, Gilead‚Äôs NASH, HLI‚Äôs Cash | https://t.co/FpPUWLqtBp $GILD #EXOME#Took #Profit Apr 95 Calls $GILD.... +130%As per prior post (sarcasm) (no #trading positions), cue #biotech reversals ... $IBB $CELG $GILD $VRX https://t.co/ZtJzFidbQy #stocks ...$GILD meltingRT @JSTBiotech: Makes sense for $GBIM 24 week ph2 HBV data to be released next week, concurrently with EASL, as $GILD will have a heavy pre‚Ä¶$GILD profit takers can't see 98RT @JSTBiotech: Makes sense for $GBIM 24 week ph2 HBV data to be released next week, concurrently with EASL, as $GILD will have a heavy pre‚Ä¶Makes sense for $GBIM 24 week ph2 HBV data to be released next week, concurrently with EASL, as $GILD will have a heavy presence there$ILMN $GILD $IBB whats wrong with biotech today?RT @JeaYu21: $YHOO $GILD $SPY $NKE https://t.co/oYJp29q1BN$GILD can't believe I chasedRT @bret_jensen: Commented on Gilead Has Bottomed - The Question Is How Much Upside Ahead? https://t.co/HACO5ijY9a $GILDBiotech breakout? Not so fast says @mnkahn. $IBB $XBI $GILD $REGN $BMRN $REGN $NKTR $MYGN https://t.co/vuMwBL2UNx https://t.co/WhuClb9BV3VNDA Summary
See Here ---&gt; https://t.co/ygMu2wVC0P

$VNDA $GILD $RDS.A #investingBiotech breakout? Not so fast video 4:00 https://t.co/Ng262It8nK $IBB $XBI $GILD $REGN $BMRN $REGN $NKTR $MYGN @TechnicianApp$GILD great$AMRN $GERN $GILD $ZYNE $ARIA biotechs I likeNice continuation in $CELG #biotech rotation still in play w/ $GILD running too. $IBB ... shorts gut punched https://t.co/ZtJzFidbQy $LABUGilead Sciences, Inc. $GILD Price Target Increased to $101.00 by Analysts at Jefferies Group https://t.co/VH800XmltO$GILD holding up wellWorst #sentiment for #SP1500 #stocks at market open: $ADSK $GILD $BSX $STT $MA (2016/04/07) #stocktrading #predictiveanalytics #bigdataWorst sentiment for SP1500 stocks at market open: $ADSK $GILD $BSX $STT $MA (2016/04/07) #sentiment #stock #alexandriaJury Verdict Favors Sofosbuvir Royalty Claim by  Against Gilead https://t.co/oTiFQxi8iH $GILD $MRK #HCV #hepatitis$YHOO $GILD $SPY $NKE https://t.co/oYJp29q1BNPoliticians celebrate Pfizer-Allergan breakup.  I see new round of domestic mergers to benefit US valuations in sector $AGN $PFE $GILD $JUNOGILD Top news - Apr 7th, 2016 $GILD https://t.co/ab0IgZzMzaCommented on Gilead Has Bottomed - The Question Is How Much Upside Ahead? https://t.co/HACO5ijY9a $GILDGilead Sciences, Inc. $GILD Chairman John C. Martin Sells 100,000 Shares https://t.co/2lYIsbUpM6$IBB Biotech Will Blast Past Its 2015 Highs https://t.co/ol1NrLaPqz $GILD $LABU $REGN $IBBWest Coast Bio Roundup: Pfizer‚Äôs BBC Ghosts, Gilead‚Äôs NASH, HLI‚Äôs Cash https://t.co/Ze12MGrxpj via @alexlash $GILD $AGN $ICPT$GILD:

Gilead Sciences, (NASDAQ:GILD) Holds Zacks Rank #1; Intercept ‚Ä¶:

https://t.co/ifOzm8A9gh$GILD Holds Zacks Rank #1; $ICPT Receives Upgrade at Wells Fargo https://t.co/J8N9agUhjHCheap call option upside: $BBRY calls cheaper than 100% of history, $GILD 99%, $DAL 99%, $ORCL 96%, $MDT 95%, $STZ 94%, $DIS 94%@PFOLIOALERT RESULTS APR 6 $PFE (+3.8%) $MRK (+2%) $GILD (+1.2%) $IMMU (+3.4%) $ADXS (+10.8%) $AMGN (+3.2%)
https://t.co/mUqg3vekddPaul Rutherford Carter Sells 2,000 Shares of Gilead Sciences, Inc. $GILD Stock https://t.co/4ZLdBWJFYH@PFOLIOALERT PREDICTS WINNERS APRIL 7 $GILD $REGN $ADXS $PTLA
$AMGN $IMMU $MRK $MDVN $CELG $CELG
USING CHAOS THEORY
https://t.co/mUqg3vekdd10 Best S&amp;P 500 Companies By Net Shareholder Distribution Yield - See more at: https://t.co/xk9yY5G7NH - $MSFT $GILD $AAPL $JNJ $MON $PGWeekly S&amp;P500 #Stocks Trend $EW $REGN $ALXN $BIIB $CELG $PFE $MNK $ZTS $AMGN $GILD $MLM $EBAY $STZ $ABBV $BMY  @ https://t.co/RPeaHBHYi0Weekly S&amp;P500 #Stocks Performance $EW $REGN $ALXN $VRTX $BIIB $CELG $PFE $MNK $ZTS $AMGN $GILD $HES $MLM  more@ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $INCY $REGN $TSLA $ALXN $BMRN $ILMN $BIIB $CELG $AMGN $GILD $EBAY $ISRG $FOXA  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $INCY $REGN $TSLA $ALXN $VRTX $BMRN $ILMN $BIIB $CELG $AMGN $GILD  more@ https://t.co/YdSIjFJqHfWeekly S&amp;P100 #Stocks Trend $BIIB $CELG $PFE $AMGN $GILD $ABBV $BMY $MRK $FOXA $ABT $MDT $TWX $PM $LMT $V $MO  @ https://t.co/cKkr8cKsjuWeekly S&amp;P100 #Stocks Performance $BIIB $CELG $PFE $AMGN $GILD $DVN $ABBV $BMY $MRK $LLY $MDLZ $FOXA $ABT  more@ https://t.co/cKkr8cKsjuModel of HCC incidence US &amp; impact of HCV treatment $GILD $ABBV $ENTA $BMY $MRK https://t.co/DFkvSZOahj (no paywall) https://t.co/VYY1UeGB3pJohn F. Milligan Sells 112,000 Shares of #GileadSciences, Inc. Stock. Read more: https://t.co/2C8zUzc1VS $GILDCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @JeaYu21: $GILD SHORT 96.15RT @JeaYu21: $GILD added short 96.70RT @JeaYu21: $GILD added SHORT 97.10$GILD $SRPT are Stocks to Buy https://t.co/Hwfcvg0MLZ$GILD:

Gilead Sciences, (NASDAQ:GILD) &amp; Sarepta Therapeutics ‚Ä¶:

https://t.co/EdjY3FvDsVRT @JeaYu21: $GILD losing steam 96.50 is key break downRT @JeaYu21: $NVDA $GILD $CREE Wednesday Trades Blog + $708 Profits https://t.co/ydgXmPWMPnGILD Ideas
See Here ---&gt; https://t.co/QWnc7B7MgX

$GILD $ACN $EXC #investingDo you know that #Book Value for $GILD is $13.03 https://t.co/dYpmlEXDNpWeekly Investment Analysts‚Äô Ratings Changes for Gilead Sciences $GILD https://t.co/l9mB4vlN6cDo you know that #WallStreet price for $GILD is $114.6 https://t.co/mpDel0oxXdRT @BioBounce: $IBB has 190 holdings; top 10 = 57.83% weight; basically you are saying $AMGN $GILD $REGN $BIIB $CELG $ILMN $MYL $ALXN $VRTX‚Ä¶We calculated 63-day Expected Return of $GILD for you: -0.9% https://t.co/mTgAzTSiLDRT @techwhitepapers: so $GILD thought it will buy assets cheaper by waiting and waiting. now $PFE $AGN dinosaurs joined in hunting and it c‚Ä¶$GILD 96.17 small place off open long, but close to top of channel so tight stop. Bigger play on bottom break later https://t.co/fLKhVGENmHhttps://t.co/uAcamNRUPt alerted $PTX +45% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/OQCNEb9p9K $HOT $AMAT $ITUB $MT $GILD $HST $AAUnicorn Bay rating for $GILD is 3.5 out of 5. https://t.co/jD70zGcNYERT @GerberKawasaki: Seeing continued strength in gilead after getting into NASH. Looks like liver issues and obesity it is. Great business.‚Ä¶so $GILD thought it will buy assets cheaper by waiting and waiting. now $PFE $AGN dinosaurs joined in hunting and it cant wait too longRT @JSTBiotech: As standalone company, $GBIM would be worth $20-40 next summer if 2nd $GILD trial hits, this upside potential must be recog‚Ä¶@MsTriciaD cool, luv puppies. $GILD bot end of march. only trading couple tickers at a time till I get more time.  NC, nice. where r u nowPDM Day High
See Here ---&gt; https://t.co/a0GcByZ3VA

$PDM $GILD $BAK #stockmarketRT @HedgeBz: Action in Review ‚Äì Bios Doing Biosector Things via @wallstjesus @sanglucci $GILD $IBB¬†$PFE https://t.co/76YWNypreP https://t.c‚Ä¶RT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶Sick action in bios today, trimmed far too early on $celg, still holding $gild. Added $nke to $ua holding today, both had call sweeps alldayRT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶$GILD: Analyst action by BMO Capital on Gilead Sciences: https://t.co/011aJRX4QO https://t.co/1CidcKbXuhRT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶RT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶RT @Fibonacciqueen: $GILD I was late to the party on this one https://t.co/VOpQHM93BZRT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶RT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶RT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA $SPY $AMGN $GILDCheap put options and hedges: $T puts cheaper than 93% of history, $BBRY 91%, $DAL 91%, $SLV 90%, $GILD 86%, $SDS 84%, $VZ 84%A, B and D. Throw in $GILD too. EVERYBODY, GO LONG $XBI  https://t.co/OJQXjyvUk4RT @JeaYu21: $NVDA $GILD $CREE Wednesday Trades Blog + $708 Profits https://t.co/ydgXmPWMPnRT @BiotechMoney18: These are the date for PDFUA &amp; Adcom for April. $IBB $ICPT $GILD $CLVS $PGNX $CHMA $SRPT $COLL $FLML https://t.co/zTilF‚Ä¶With $pfe $agn not buying each other, $gild better make some deals too...this market looking very cheap with m&amp;a sure to pick up imoRT @scalpthatstock: T3 Live Daily Recap: Switching Gears
https://t.co/KwT5RZUh7x
$SPX $SPY $AMZN $GOOGL $FB $FEYE $CYBR $SHAK $IBB $GILD $C‚Ä¶RT @sellputs: Action in Review ‚Äì Bios Doing Biosector Things via @wallstjesus @sanglucci $GILD $IBB $PFE  https://t.co/4PcJZPNzfET3 Live Daily Recap: Switching Gears
https://t.co/KwT5RZUh7x
$SPX $SPY $AMZN $GOOGL $FB $FEYE $CYBR $SHAK $IBB $GILD $CELG $VRX $USOAction in Review ‚Äì Bios Doing Biosector Things via @wallstjesus @sanglucci $GILD $IBB $PFE  https://t.co/4PcJZPNzfERT @HedgeBz: Action in Review ‚Äì Bios Doing Biosector Things via @wallstjesus @sanglucci $GILD $IBB¬†$PFE https://t.co/76YWNypreP https://t.c‚Ä¶Action in Review ‚Äì Bios Doing Biosector Things via @wallstjesus @sanglucci $GILD $IBB¬†$PFE https://t.co/76YWNypreP https://t.co/umGZqKoAMsBAP EOD Data
See Here ---&gt; https://t.co/qyFsMFRa7Y

$BAP $SALT $GILD #investingThese #options buyers generated profits: $GILD $IBB $MAR $MDVN $PFE $SHPG via https://t.co/6CpFVbEZW3 https://t.co/ltCBRqfAKo$GILD 99 by end of week!!  Let's go!!",2016-04-07,GILD,1
8,"Money Bulls Are Coming @apricityforum
Michael James Enterprises, Inc
Do not worry about $GILD $UNPRT @jescobar1976: @TeamBlackWaterJ Must Buy Now
Co. Tickr    Michael James Ent (MJTV)
Old picks $TSLA $OCLR $GILD@Larry25Smith Must Buy Now
Ticker: #OTCBB #MJTV
Bye $BHI $GILD $PFEWeekly Pick @grungefreako
$MJTV (Michael James Ent Inc)
No more buys $GILD $GENC@TeamBlackWaterJ Must Buy Now
Co. Tickr    Michael James Ent (MJTV)
Old picks $TSLA $OCLR $GILD** High Float Buy ** @SecurityKit
Michael James Enterprises, Inc
No on $GILD $TNAB U L L I S H --- B U Y A L E R T @asterisco67
Michael James Enterprises (MJTV)
No on $OHRP $GILD@D_Dextra Success this week, Buy
Co. Tickr= *MJTV*
Others $NVO $CBYL $GILDOrder On Pink Sheets @leaveittoethan
#OTCBB $MJTV
No on $GILD $ABX@DianaHershi28 A #WallStreet Pick
Company - Michael James Enterprises, Inc
My old picks $ADHD $SLDR $GILDSuccess this week, Buy @Destri_Empowers
*MJTV*
No more buying $GERN $GILD#Wallstreet Buy Now @RandyCarranco
$MJTV
No more buys $GILD $AAB U L L I S H ! B U Y A L E R T @emmmapearsonn
$MJTV (Michael James Ent Inc)
Now sold: $GILD $CSXGILD 52Wk Low
See Here ---&gt; https://t.co/2Z1QEafU9d

$GILD $LNKD $AGIO #stockmarketHigh float Order Now! @kerryc88
Michael James Enterprises (MJTV)
Now sold: $GILD $PBR@TownofSnowmass OTC Selection 
Y! Symbol   OTCBB: $MJTV
No on $EXEL $TGT $GILD@stephenteacher Buy ASAP
Stock Symbol! $MJTV
Bye $SBUX $CSCO $GILD$GILD:US Gilead Sciences, Inc. (GILD) Price Target Raised to $101.00 #GILEAD SCIENCES INC  https://t.co/DK5kxJmSsM #NASDAQ1234 Bullish https://t.co/vPDfXgV4AS $JNPR $SIG $XLY $CVS $QQQ $PAH $FOLD $PAYX $VIG $KIM $GILD $PACB $MDT $HD $RCL $SYF $XLV $LYBBUY! SURGE INCOMING @theovertime1410
""MJTV""
Other picks $JPM $GILDBuy ASAP on @RobertRufa
MJTV
Other buys: $GILD $AMZN@shulamithbond Bullish Analysts
Yahoo Finance MJTV (Michael James Ent Inc)
Others $MRK $GILD $CF@brreeeeee_ SURGE INCOMING BUY
Co Symbol: !MJTV!
Sell: $NVS $ASMB $GILDMonday Bulls Are Out! @yosshii16
Michael James Ent.
Old choices $GILD $SBUXOTC Selection  @IgnacioJulianGo
MJTV, OTCBB
Sell: $CBYL $GILD@DrSalGainsbury Analyst's Alert Buy
The Symbol OTC: MJTV
No on $XLRN $ACAD $GILDGilead $GILD Seeks to Build 6-Story Lab in HQ Expansion, May House Up to 5,000 New Employees https://t.co/htE7AZJxU7 https://t.co/W6t4rhPaWd@LifeExtension Place a order for
Company   Michael James Ent (MJTV)
Now sold: $GILD $BTX $ENDPMassive Monday Pump Incoming @maliaanela23
$MJTV
Sell: $GILD $DIART @raymond10mm: $AAPL $FB $AMZN $PG $MCD $GS $C $GE $UTX $SLB $XOM $GOOGL $AGN $WMT $QQQ $IWM $GILD $HON $JPM $DIS Day ended mixed. https:‚Ä¶Low Float This Week! @CruzCrew_GA
MJTV, OTCBB
Others $GILD $TRXC$GILD - bull flag. Looking for a b/o above 97.50 https://t.co/coLqR9WJVsA #WallStreet Pick @DadSelfie
!MJTV!
Other favorites $GILD $WKHS@Sabiyara Opening Bell Buys
Tickr   OTCBB, $MJTV
Other favorites $DRD $ICPT $GILD$GILD ticks the boxes as a dream üí∞ dividend üí∞ stock with 1.8% yield https://t.co/wPh0AYspC6 https://t.co/GQzXsV1gXLMonday Orders @KyleTaylorLucas
OTCBB, MJTV
Sell: $GILD $SILDrugs and Biotech Getting Perky https://t.co/mODxkK063u via @barronsonline $IBB $MRK $GILD $AMGN $GSKMonday Money News @_JDulaney_
OTC: $MJTV
Others $GILD $QQQEMoney Monday Alert @lemonverbena_
OTC @ $MJTV
No more buys $CBYL $GILD$AAPL $FB $AMZN $PG $MCD $GS $C $GE $UTX $SLB $XOM $GOOGL $AGN $WMT $QQQ $IWM $GILD $HON $JPM $DIS Day ended mixed. https://t.co/thTBGsdjDXBuy This On OTC Markets @tenjunkmiles
Michael James Enterprises, Inc
Sold: $GILD $XIncoming OTC Buy @PressJacked
#OTCBB #MJTV
The old picks $GILD $ASTIBiotechs fell out of favor today with only $AFMD and $GWPH showing positive.  $GILD $ATRA $CARA near flat today.A Hot #Wallstreet Buy @kslayyyy
MJTV
My old picks $GILD $PSUNPump Incoming On @PinkRoses21
#OTCBB $MJTV
No more buying $GILD $MUX$GILD: Analyst action by BMO Capital on Gilead Sciences: https://t.co/011aJRX4QO https://t.co/e1bbmAMeFf#GileadSciences, Inc. Shares Bought by Essex Financial Services Inc. Read more: https://t.co/RQxt9nrVct $GILDRT @jowens510: Gilead hepatitis C drug is the most expensive. No. 2 is ... Gilead's other hep C drug.
$GILD
https://t.co/EFwGUZmiCg https:/‚Ä¶Money Bulls Are Coming @nailiah
OTC: MJTV
My old picks $GILD $NUGTSuccess this week, Buy @TheShitastrophy
Michael James Ent (MJTV)
Monday sold $NATR $GILDAnalyst's Alert Buy @duniabizonline
~MJTV~
Old picks $GILD $HRC@ToyubommNews Order Up The Pink Sheets
Stock Ticker! #OTCBB #MJTV
Hold: $ACRS $EDUC $GILDBuy! To The Moon! @bqkhyun10
MJTV, OTCBB
Sold all: $GILD $BDMSICYMI: Gilead plots broader expansion at Foster City hometown: https://t.co/15gEdbPwmR $GILD story from FierceBiotech #biotech #pharma#Monday #Money #Buy @LucidBrake
Michael James Enterprises ($MJTV)
Old picks $GILD $GALE@petedoom Yep, that's true.  With $GBIM seeking strategic alternatives, I wonder if data is strong enough for $GILD to acquire GBIM's prtfloHuge buys incoming on @fourwebs
OTC: $MJTV
No more buying $GILD $COTRT SeekingAlpha: M&amp;A - Without Shaxalta A Meagre Quarter https://t.co/bGqbev0K7D $PFE $AGN $SHPG $MYL $GILD $ABBVICYMI: Gilead plots broader expansion at Foster City hometown: https://t.co/1Yor6aIO0N $GILDM&amp;A - Without Shaxalta A Meagre Quarter https://t.co/5QMz5pE9jM $PFE $AGN $SHPG $MYL $GILD $ABBVGilead hepatitis C drug is the most expensive. No. 2 is ... Gilead's other hep C drug.
$GILD
https://t.co/EFwGUZmiCg https://t.co/mbp2ay7vrs@Adecco_Kendal Hot Pick #wolfofwallstreet
Symbol   $MJTV
Sold all: $VXX $GILD $ACRSSuccess this week, Buy @heraldly
~MJTV~
No on $GILD $EMC#GileadSciences IQWiG says Gileads antiHIV drug genvoya offers slightly lower benefits than... Read more: https://t.co/hAFp7n2jkg $GILD#GileadSciences Mixed IQWiG views on Gileads Genvoya. Read more: https://t.co/IIEs8dQ8Z0 $GILD@ChaseLester_CL purchasing shares is up to you, however, keep in mind co. has 6M O/S, 2 collaborations with $GILD and $CELG with Ph2 trialsOTC Markets Buy Alert @Infospresses
#MJTV
Don't worry about $GILD $MNOV#GileadSciences Gilead Seeks to Build Six-Story Lab in HQ Expansion, May House Up to 5,000 ... Read more: https://t.co/waun0zt5VG $GILDRT @NASDboy: $AAPL $SPY $SPX $GILD $TSLA $GILD $DIS üòÇüòÇüòÇ let's hope rally continues https://t.co/4QT3PCQKspRT @NASDboy: $AAPL $SPY $SPX $GILD $TSLA $GILD $DIS üòÇüòÇüòÇ let's hope rally continues https://t.co/4QT3PCQKspB U L L I S H !! B U Y @reading_im
$MJTV
Others $GILD $BDMSHot Pick #wolfofwallstreet @Beatriz_hygor
MJTV (Michael James Ent Inc)
Other buys: $GILD $GSK@espressojobs Giant Monday Purchase
The Symbol  MJTV (Michael James Ent Inc)
And hold $BAC $GILD $BEAT** High Float Buy ** @philcalandra
OTC @ MJTV
Bye $GILD $SBUX@HasinoSiya0731 #WolfOfWallStreet Buy News
Stock Ticker  $MJTV (Michael James Enterprises, Inc)
Hold: $LIFE $MNKD $GILDRT @JSTBiotech: Makes sense for $GBIM 24 week ph2 HBV data to be released next week, concurrently with EASL, as $GILD will have a heavy pre‚Ä¶$GBIM per 10K is having phase II readouts on GS-4774 at 24wks instead of 48wks, $GILD has results.  When is conference that GILD will be at?#WolfOfWallStreet Buy News @SeanSilcoff
Michael James Enterprises ($MJTV)
And hold $GILD $ACHNGiant Monday Purchase @DeptHealthPress
$MJTV (Michael James Enterprises, Inc)
Old favorites $GERN $GILD@sophiesrun Weekly Pick
Y! Ticker   #OTCBB #MJTV
Forget $AIG $GILD $STZ@ArthurMurrayUSA OTC Markets Buy Alert
Ticker: MJTV (Michael James Enterprises, Inc)
No more buys $WBA $GILD $PFEPink Sheet Stock Pick @bftghana
#MJTV
Other success $GILD $CBYL5 Takeaways from What‚Äôs Hot in Boston #Biotech @BentheFidler ‚Ä¶ #xconbio $BIIB $GILD $IRWD https://t.co/OdqZXT5ATDPrice Target Alert: Trading the Zacks price target change for GILEAD SCIENCES¬†$GILD https://t.co/pHsiiBFlXr https://t.co/Crtqg0Gdjs$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Reported Basic Consolidated ‚Ä¶:

https://t.co/di6qIN51B9RT @stockingup333: $GBIM quietly preparing for major move on Phase II data readout on HBV with collaboration partner $GILD. + results expec‚Ä¶RT @stockingup333: $GBIM 2.0 fastly approaching, this time once 200ma breaks can see potential run above $5+ on positive Phase II data with‚Ä¶RT @stockingup333: $GBIM quietly preparing for major move on Phase II data readout on HBV with collaboration partner $GILD. + results expec‚Ä¶RT @stockingup333: $GBIM 2.0 fastly approaching, this time once 200ma breaks can see potential run above $5+ on positive Phase II data with‚Ä¶Monday Success Buy @Vikend
MJTV, $OTCBB
Sold all: $GILD $VXXRT @FierceBiotech: Gilead plots broader expansion at Foster City hometown: https://t.co/M2qeq4yGdF $GILD via @PharmaceuticBenB U L L I S H B U Y  @craigchek
OTC: MJTV
No more buys $ARAY $GILD$GBIM 2.0 fastly approaching, this time once 200ma breaks can see potential run above $5+ on positive Phase II data with $GILDBuy Shares ASAP @alisamurray111
#OTC #MJTV
Forget $GILD $BHI$GBIM quietly preparing for major move on Phase II data readout on HBV with collaboration partner $GILD. + results expected &amp; milestones$GILD $AAPL $GS $JPM Did the $8.5B $MSFT paid for Skype end up being parked in the Cayman Islands? https://t.co/lTwIU5lHmZ $CELG $C $MS $GETWITTER ALERT Order @kingbush_FGFC
OTCBB, MJTV
Other buys: $CELG $GILDHuge buys incoming on @IletseOcioreh
#MJTV
Other success $GILD $NUGTETRADE BUY ALERT @Sh_Khalifa_FANS
""MJTV""
Bye $GILD $POTPPL can become successful order now @JacquelynAadams
OTCBB: $MJTV
Other favorites $GILD $CELG@_LaAlameda Do not wait on this
Ticker    OTCBB, MJTV
Other success $PXLG $GILD $MDTH#GileadSciences, Inc. Position Lowered by Greenleaf Trust. Read more: https://t.co/9XJD0UeDq1 $GILD$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Focusing on Company ‚Ä¶:

https://t.co/BH617xjVHoAnalyst's Alert Buy @LisaVikingstad
Michael James Enterprises (MJTV)
Old choices $GILD $LNCO@Denisegray1982 A Hot #Wallstreet Buy
The Symbol    OTCBB: $MJTV
Bye $KNSY $DDD $GILDWith $IBB back over support $GILD https://t.co/TmFGFxUFZm$GILD chart: With $IBB back over support. https://t.co/GpRZ2UJFC4RT @ReformedJoker: Monday Note: $ES $SPX $SMH $AVGO $INTC $NVDA $MXL $MSFT $NFLX $FB $UA $V $GILD $GWPH $TSLA and *Moore!

    IT's A BULL‚Ä¶RT @ReformedJoker: Monday Note: $ES $SPX $SMH $AVGO $INTC $NVDA $MXL $MSFT $NFLX $FB $UA $V $GILD $GWPH $TSLA and *Moore!

    IT's A BULL‚Ä¶@justmarkup MONDAY MONEY ALERT Order
Y! Symbol! MJTV (Michael James Enterprises, Inc)
Sold all: $GM $GILD $BABABuying on Market @jaiz30
$MJTV (Michael James Ent Inc)
No more buying $GILD $GSV$GILD ""In contrast to overall trends, U.S. deaths due to liver cancer have increased."" https://t.co/24thMOZNaMEarnings Season! Momentum Monday: $GILD, $BIIB, $PFE. LTC: $V-Ascending Triangle https://t.co/O2qO3UIS2B #investoolsFEYE Investor Opinions
See Here ---&gt; https://t.co/AJbQbnLekB

$FEYE $CUK $GILD #stocksPlace a order for @fatmaxkh
$MJTV (Michael James Enterprises, Inc)
Other buys: $GILD $SRPTLast month we added to our $GILD position and started a new one in $BWLD
We see slow, steady, unspectacular growth going forward near term@PaulFoster1303 #Wallstreet Buy Now
Yahoo Finance  $MJTV (Michael James Enterprises, Inc)
Don't worry about $AAPL $GILD $UNPBUY NOW. DO NOT WAIT @SABIASQUEIBP
OTC @ MJTV
Sell: $GILD $MOEEQ News
See Here ---&gt; https://t.co/QOrXJYTXc0

$EEQ $GILD $LXFT #tradeideasRT @BentheFidler: Five Takeaways from ‚ÄúWhat‚Äôs Hot in Boston Biotech‚Äù https://t.co/9ukaJ7tIYc #xconbio $BIIB $GILD $IRWDVolume Alert - GILD 96.82 Gilead Sciences Inc $GILD Hit a high today of 97.05 Closing the day 10:30 at 96.82 + https://t.co/aMPHEpAEiB@omega_today Analyst's Alert Buy
Co. Tickr= #MJTV
Old choices $MBLY $ADUS $GILDMust Buy Now @jonathansryan
OTC @ MJTV
No more buys $GILD $BWLDOrder up on the bell! @MPTrending
MJTV, $OTCBB
Old picks $GILD $ACET@alwayswithyoumw #Penny #Stock #Alert
Stock Symbol  MJTV, OTCBB
Other buys: $QQQE $GSV $GILD@Littleelo3 Buy! To The Moon!
Company   $MJTV (Michael James Ent Inc)
Others $AKTX $GILD $AAL#WolfOfWallStreet Buy News @uchino0123
Michael James Enterprises (MJTV)
Other buys: $GILD $ASMBRT SeekingAlpha: Pfizer: Master Of Diversity https://t.co/bOi5IfpOhA $AGN $GILD $AAPL $AMGN $AXP $CSCO $ETN $MSFT $SHPG $PFEMoney Bulls Are Coming @LATechDigest
OTC: $MJTV
Don't worry about $GILD $GOOGPfizer: Master Of Diversity https://t.co/bQEmprsDfG $AGN $GILD $AAPL $AMGN $AXP $CSCO $ETN $MSFT $SHPG $PFE$AAPL $FB $AMZN $PG $MCD $GS $C $GE $UTX $SLB $XOM $GOOGL $AGN $WMT $QQQ $IWM $GILD $HON $JPM $DIS Nice day rally! https://t.co/Usct2NeWZhOrder Up The Pink Sheets @JMJLyons
OTCBB: $MJTV
Sell: $GILD $AMZNLOW E.P.S.
See Here ---&gt; https://t.co/TTlgj259o7

$LOW $GILD $CMI #pennystocks$GILD  is expanding its research facilities...keeping up with the pace of innovation 
https://t.co/uOE7FJ4LOPRT @ReformedJoker: Monday Note: $ES $SPX $SMH $AVGO $INTC $NVDA $MXL $MSFT $NFLX $FB $UA $V $GILD $GWPH $TSLA and *Moore!

    IT's A BULL‚Ä¶Monday Note: $ES $SPX $SMH $AVGO $INTC $NVDA $MXL $MSFT $NFLX $FB $UA $V $GILD $GWPH $TSLA and *Moore!

    IT's A BULL MKT!

     ‚ù£, MOM@WilliamGoldsmi7 Early News Alert
Yahoo Finance! $MJTV
My old picks $CMG $GILD $OXIGBuy ASAP on @ValeraAndreev1
#OTC #MJTV
No more buys $GILD $BAXGILD Top news - Apr 11th, 2016 $GILD https://t.co/takBcyRcpSPlace a order ASAP on @lauriesandra
~MJTV~
Other picks $GILD $SPMO$CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO
 .
94.57% Average Gain
100% UNBIASED!
 .
https://t.co/2qE8x3QQQ8 https://t.co/Wqm9DcBpKzOpening Bell Buys @makelovenotporn
*MJTV*
No more buying $GVP $GILD$ABBV $GILD:

Portfolio of Most Active Stocks: AbbVie Inc. (NYSE:ABBV) , Gilead ‚Ä¶:

https://t.co/u79SqmbFU0RT @SA_Portfolio: Valuation Dashboard: Healthcare - Update https://t.co/ciyYRcXcHt $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $‚Ä¶@M0eBin Huge Monday News
Symbol   Michael James Enterprises, Inc
No more buys $MBLY $RELV $GILDGilead Sciences, Inc. $GILD Shares Bought by Essex Financial Services Inc. https://t.co/xqLrJlzomLRT SeekingAlpha: Valuation Dashboard: Healthcare - Update https://t.co/MA5jJjNNUA $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $‚Ä¶Buy Alert On The Bell @IrinaSherezade
MJTV, OTCBB
Others $GILD $NFLX@dayejavoo Order Up The Pink Sheets
Stock Symbol    #OTC #MJTV
Do not worry about $NFLX $GILD $NAVBSolaris Asset Management LLC Increases Stake in Gilead Sciences, Inc. $GILD https://t.co/eXrp5iugs6Cim Investment Mangement Inc. Holds Position in Gilead Sciences, Inc. $GILD https://t.co/A2PC0sCSUmCim Investment Mangement Inc. Holds Position in Gilead Sciences, Inc. $GILD https://t.co/H8HsAmWzd4Valuation Dashboard: Healthcare - Update https://t.co/TXxdomJsbF $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $LCI $MASI $MCKValuation Dashboard: Healthcare - Update https://t.co/ciyYRcXcHt $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $LCI $MASI $MCKValuation Dashboard: Healthcare - Update https://t.co/VhN5NgbuxC $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $LCI $MASI $MCKGilead plots broader expansion at Foster City hometown: https://t.co/m9XnDVBun6 $GILD via PharmaceuticBen story from FierceBiotech #biotec‚Ä¶People can get rich. Buy Now @sexwithmyloveh
#MJTV #OTC
Monday sold $GILD $SUNERT @WallStreetTrend: How Fun Workplace Design Can Increase Productivity  https://t.co/ck1fDJEljp $xlv $xlp $gild $qcom $f $btu https://t.co‚Ä¶Happier Employees Make Companies Great  https://t.co/JeNPYDxdQa $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx https://t.co/T5T9G3YLCcHow Fun Workplace Design Can Increase Productivity  https://t.co/ck1fDJEljp $xlv $xlp $gild $qcom $f $btu https://t.co/aUtCbnXtrMRT SeekingAlpha: Gilead: Is NASH The Third Leg Of Blockbuster Triumvirate? https://t.co/1FjqqdLrdy $GILDRT @fezziwig2008: This is a $PFE - Wash U study- Showing PFE is targeting PDA- a threat to $GILD &amp; another reason to consider $HALO https:/‚Ä¶Gilead Sciences, Inc. $GILD Coverage Initiated at BMO Capital Markets https://t.co/5HWKWuW6gtGilead plots broader expansion at Foster City hometown: https://t.co/M2qeq4yGdF $GILD via @PharmaceuticBen@viswam_rao Pink Sheet Stock Order
Symbol    OTC @ MJTV
Other picks $BBRY $GILD $TNSUThis is a $PFE - Wash U study- Showing PFE is targeting PDA- a threat to $GILD &amp; another reason to consider $HALO https://t.co/b0MtvBSVMtRT @SA_BioTech: Gilead: Is NASH The Third Leg Of Blockbuster Triumvirate? https://t.co/FAYHmvK9KF $GILD$GILD can't get past 97Gilead: Is NASH The Third Leg Of Blockbuster Triumvirate? https://t.co/FAYHmvK9KF $GILDGilead: Is NASH The Third Leg Of Blockbuster Triumvirate? https://t.co/RL7HlwbNBS $GILD$GILD people way too bullish on this stock.  It's stuck for nowGiant Monday Buy Order @GlesbyMarks
OTCBB: MJTV
Sell: $GILD $AAL@lindajacobspr Early Buy 
Stock Ticker Michael James Enterprises (MJTV)
No more buying $NFLX $PEP $GILDRT @BentheFidler: Five Takeaways from ‚ÄúWhat‚Äôs Hot in Boston Biotech‚Äù https://t.co/9ukaJ7tIYc #xconbio $BIIB $GILD $IRWD$GILD keeps going up! More to come! https://t.co/wxq5aYJApkCommented on Gilead: Is NASH The Third Leg Of Blockbuster Triumvirate? https://t.co/zjnq5my6l8 $GILD$GILD Sciences Rebounds
https://t.co/RqEzalpVeS@writetargetJen A Hot #Wallstreet Buy
Co Symbol! #OTCBB #MJTV
Monday sold $HIHO $GILD $ASMBNot sure what to do with $GILD? Explore our #fundamental pros and cons.  https://t.co/NgREtgOwQu@Monica_Soul_Air SURGE INCOMING BUY
Y! Ticker   $MJTV
Do not worry about $GILD $NATR $SBUXThanks @BentheFidler for a great event, and for the details on the $GILD - #NimbusTx deal! https://t.co/I6Qta3AvoERT @AndysCycles: $IBB components sorted by RS (23d 130d 260d weighted): 
$AMGN $CELG $ILMN $GILD $BIIB $MYL $ALXN $BMRN $REGN $VRTX https:/‚Ä¶Weekly Alert @aDAMFAUTEUX
#OTCBB $MJTV
Forget $GILD $GE@Lonewolfrider67 Analyst's Alert Buy
Y! Symbol   Michael James Enterprises, Inc
Old picks $ADHD $GILD $ACRSRT @JustinPulitzer: My #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA https:‚Ä¶RT @JustinPulitzer: My #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA https:‚Ä¶RT @JustinPulitzer: My #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA https:‚Ä¶My #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA https://t.co/lk4DBQOui3Weekly Alert @QueenCityWork
$MJTV (Michael James Enterprises, Inc)
Other buys: $SUNE $GILDMonday OTC Pick @youngmelissaa
*MJTV*
The old picks $GILD $TSovaldi remains most expensive drug $GILD https://t.co/5ggHCB1EF7B U L L I S H --- B U Y @Virgo_ARATarot
MJTV, OTCBB
The old choices $HRC $GILDFive Takeaways from ‚ÄúWhat‚Äôs Hot in Boston Biotech‚Äù https://t.co/9ukaJ7tIYc #xconbio $BIIB $GILD $IRWDGilead Is Too Busy With Its Pipeline For A Big Acqusition https://t.co/oC0s1JBG4q $GILDCommented on What If Gilead Goes Shopping? https://t.co/3Y8NMSTjQ2 $GILDU.K. Portfolio Update: Q1 2016 And Lessons Learned https://t.co/XWoyIHCM7N $AAPL #APPLE $AGN $AMGN $AZN $BA $BBL $BHP $CVS $DIS $GILD $GSKU.K. Portfolio Update: Q1 2016 And Lessons Learned https://t.co/DYx7SLu7bO $AAPL #APPLE $AGN $AMGN $AZN $BA $BBL $BHP $CVS $DIS $GILD $GSKPatrick Byrne has Hepatitis C? Aren't there like cures for hep C (pardon my ignorance if not)? Multiple cures in fact? $OSTK $GILD $ABBV ETC@stfuantweet Market Riches BuyNow
Y! Symbol- *MJTV*
My old picks $ACRS $TECH $GILD@mamrecruiting Order up on the bell!
Y! Symbol   $MJTV (Michael James Enterprises, Inc)
Sold all: $WYNN $NATR $GILDRT @AnneMarieTrades: Join me on Benzinga's PreMarket Prep w/ Joel and Dennis this morning - https://t.co/TCtZ1PmQfF #study $SPX $GILD $STZ‚Ä¶@0R0DRUIN Market Riches BuyNow
Company= Michael James Enterprises ($MJTV)
Old favorites $SPY $GILD $FREEWeekly Pick @RepentIess
OTC: $MJTV
Sold: $GILD $EW@AndreasMaslo Buy ASAP on
Stock Symbol  !MJTV!
Don't worry about $VIX $GILD $OHRPSTOCK MARKET STOCK CHART TECHNICAL ANALYSIS VIDEO 
  https://t.co/QsNc2GfcAd
  $QQQ $PANW $V $X $GPRO $AMZN $GILD $CMG $NKEWhere were you (invested) when the biotech sector woke up?
$IBB $CELG $REGN $GILD $BMY $AMGN

Invest wisely with https://t.co/iClE4419yP$GILD good steady vol and increase stochastic for long termMonday Pick Insider Alert @Comcast_FL_XSP
OTCBB, MJTV
Old favorites $GILD $CRYOTC Alert Buy @BronzeLily
OTC @ $MJTV
Monday sells $WKHS $GILD@podnbvrt Become a wolf this week Buy
The Symbol! OTC: MJTV
Hold: $STZ $GILD $IWY$GILD $FPO:

Top Stories: Encana Corporation (NYSE:ECA), Gilead Sciences Inc ‚Ä¶:

https://t.co/RO9hnBw8iBHuge buys incoming on @EmilyHitchcock1
#MJTV
Bye $GILD $NKE#Wallstreet Buy Now @varmoney
MJTV, $OTCBB
Don't worry about $GILD $ARAYMonday Orders @MausMichel
OTC: $MJTV
And hold $VTL $GILDRT SeekingAlpha: What If Gilead Goes Shopping? https://t.co/getoqoxoZP $GILD@VeeDub78 yep, at least a defined higher low before getting bullish (well, as bullish as this mkt will allow. Ha) $GILDTWITTER ALERT Order @shutersAteam
MJTV, OTCBB
Sold: $GILD $BHI@VeeDub78 I know the feel. Haha. Look at price action in the last two Aprils noted on the chart. $GILDWhat If Gilead Goes Shopping? https://t.co/g8KsqGn243 $GILDWhat If Gilead Goes Shopping? https://t.co/qQTmbTSJS7 $GILD@AnthonyMaceroni I'd like to see it push through the resistance line or - even a riskier try - if taps back to 81.5 before going long. $GILDPurchased OTC Now @SeoeunSuho
MJTV, OTCBB
The old picks $GILD $NFLX@sachismile2525 B U L L I S H -- B U Y
Ticker    MJTV, $OTCBB
And hold $ADHD $BIIB $GILDPeople can get rich. Buy Now @Mic_Amott
OTC @ $MJTV
Sold all: $ARAY $GILDGilead Sciences, Inc. $GILD Given A+ Credit Rating by Morningstar https://t.co/qYoPIQ4kmxEye-Catching Healthcare Stocks: $GILD $MNKD https://t.co/KdWYNbcuCcRT @AnneMarieTrades: Join me on Benzinga's PreMarket Prep w/ Joel and Dennis this morning - https://t.co/TCtZ1PmQfF #study $SPX $GILD $STZ‚Ä¶RT @marketexclusive: Market Exclusive Weekly #biotech update https://t.co/EbEfw9aBfH $opk $ctlt $teva $icpt $gild $gsk $pfe $clvs $chma #st‚Ä¶RT @marketexclusive: Market Exclusive Weekly #biotech update https://t.co/EbEfw9aBfH $opk $ctlt $teva $icpt $gild $gsk $pfe $clvs $chma #st‚Ä¶RT @marketexclusive: Market Exclusive Weekly #biotech update https://t.co/EbEfw9aBfH $opk $ctlt $teva $icpt $gild $gsk $pfe $clvs $chma #st‚Ä¶RT @marketexclusive: Market Exclusive Weekly #biotech update https://t.co/EbEfw9aBfH $opk $ctlt $teva $icpt $gild $gsk $pfe $clvs $chma #st‚Ä¶RT @marketexclusive: Market Exclusive Weekly #biotech update https://t.co/EbEfw9aBfH $opk $ctlt $teva $icpt $gild $gsk $pfe $clvs $chma #st‚Ä¶Market Exclusive Weekly #biotech update https://t.co/EbEfw9aBfH $opk $ctlt $teva $icpt $gild $gsk $pfe $clvs $chma #stocks #researchJoin me on Benzinga's PreMarket Prep w/ Joel and Dennis this morning - https://t.co/TCtZ1PmQfF #study $SPX $GILD $STZ $NKE $WYNN $CL_F $GC_F@angelrebellion BUY NOW. DO NOT WAIT
Co. Tickr - #OTCBB $MJTV
Old picks $PMD $GILD $QQQBuy Shares ASAP @Laura_EW
OTCBB: $MJTV
Old favorites $GILD $AMRI@claairecarlson Monday OTC Pick
Ticker: $MJTV
Other buys: $HOG $BITI $GILDA #wallstreet Buy Today! @ArapornW
#OTCBB $MJTV
The old picks $GILD $PXLG#Monday #Money #Buy @SendMeAnOffer
Michael James Ent.
The old picks $SUNE $GILDCheap call option upside: $DAL calls cheaper than 99% of history, $PG 99%, $GILD 98%, $GE 97%, $CSCO 95%, $BABA 93%, $ORCL 93%Become a wolf this week Buy @julesvdme
OTCBB: $MJTV
Now sold: $GILD $ACRX@Cilvrnum People can get rich. Buy Now
Co Symbol! MJTV (Michael James Enterprises, Inc)
And hold $NVS $GILD $VIX@judenebo B U L L I S H - B U Y A L E R T
The Symbol #OTCBB #MJTV
Bye $RELV $GILD $MUOrder Up The Pink Sheets @JosephBenggio
*MJTV*
No more buying $GILD $LITEPink Sheet Stock Pick @JochVerWalensis
Michael James Ent ($MJTV)
Old favorites $GILD $AGNHuge Monday News @BillIrvine17
#MJTV
Sell: $ARAY $GILDSuccess this week, Buy @BankettoUK
#OTCBB #MJTV
Monday sells $EXAS $GILDCommented on Gilead Has Bottomed - The Question Is How Much Upside Ahead? https://t.co/HACO5ijY9a $GILDMonday OTC Choice @HkotRasAY09bBIh
#OTCBB #MJTV
Old favorites $GILD $LNCO#GileadSciences, Inc. Assigned ""A+"" Credit Rating. Read more: https://t.co/skpnhmsy6W $GILD#GileadSciences, Inc. Assigned ""A+"" Credit Rating. Read more: https://t.co/g37x7xc1DS $GILDCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Doc Day Boston - Key Summaries from 20 physicians
$VRTX, $CELG, $GILD, $BIIB, $AMGN, $ICPT, $KITE, $ACOR, $PRTA https://t.co/YvRxtefIv3Insider Selling: Gilead Sciences, Inc. $GILD Chairman Sells $9,324,000.00 in Stock https://t.co/KLDxLyLHKEGilead Is Too Busy With Its Pipeline For A Big Acqusition https://t.co/mhrYALP6RT $GILDDNAI Open
See Here ---&gt; https://t.co/52GtgobN4w

$DNAI $SMH $GILD #pennystocksRT @fgusequity: $GILD https://t.co/dZWRGe19sM Pot. pullback in Downtrend LONGERTERM Wly-Dly-Hly combo chart #trading #stocks https://t.co/P‚Ä¶$GILD https://t.co/dZWRGe19sM Pot. pullback in Downtrend LONGERTERM Wly-Dly-Hly combo chart #trading #stocks https://t.co/PY86hZYsPuGilead Sciences, Inc. $GILD Forecasted to Post Q1 2016 Earnings of $3.29 Per Share https://t.co/yhu0leoTfMRT @biotech_forum: Biotech Forum Daily Digest: Relypsa Buyout? Valeant Surges, Spotlight On Inovio https://t.co/HNwEuemujA $AGN $AZN $BMRN‚Ä¶RT @MikeF_trading: $IBB pullback friday after big day wednesday, still on my watch list

$SPY $GILD $REGN
#daytrading https://t.co/VGV82Vd5‚Ä¶RT @MikeF_trading: $IBB pullback friday after big day wednesday, still on my watch list

$SPY $GILD $REGN
#daytrading https://t.co/VGV82Vd5‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO (4/10): $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA ht‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO (4/10): $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA ht‚Ä¶@m_denniswinters Anything is possible,  $GILD latest HiV drug was approved several days early.RT @JustinPulitzer: #StockMarket Weekend Review VIDEO (4/10): $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA ht‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO (4/10): $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA ht‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO (4/10): $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA ht‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO (4/10): $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA ht‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO (4/10): $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA ht‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO (4/10): $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA ht‚Ä¶#StockMarket Weekend Review VIDEO (4/10): $VIX $TLT $IBB $GILD $DB $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA https://t.co/lk4DBQOui3$gild $glpg was a great example of what I hope happens to many other companiesGilead says innovation justifies price. - This is the most expensive drug in America https://t.co/NIAuhMCqcq $GILDRT @RatingsNetwork: Gilead Sciences's buy rating reiterated at Mizuho. $130.00 PT. https://t.co/xEdJfWEPHd $GILD #GILD$GILD:

After Today‚Äôs Bearish Options Activity, Is Gilead Sciences, Inc.‚Äôs Near ‚Ä¶:

https://t.co/96b6qV0OwL23:15-&gt;https://t.co/vqaokSKgmf

Also,see:https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/yMnOK5Po1w$IBB #biotech #chart and #TechnicalAnalysis https://t.co/4VmjNefONP $REGN $CELG $GILD #etf #wallstreet #cnbc #bloomberg #fox #stocks #option@troysuite I actually take that back‚Ä¶ I was confusing it w/ another chart in $GILD. Really is a progression line. Will clarify in my video.GILD Stock Forum
See Here ---&gt; https://t.co/Oz89NdYGWo

$GILD $XYL $VLO #nasdaq$GILD $BSX:

Weekly CEO Sells Highlight: Gilead Sciences, Boston Scientific ‚Ä¶:

https://t.co/n8FQYmMZxx",2016-04-11,GILD,1
9,"The old picks $GILD @Gidgetrocks TUESDAY MONEY ALERT Order Ecosciences, Inc@JocelynPierce ETRADE BUY ALERT
Co Symbol    Ecosciences Inc ""ECEZ""
Other success $DLA $GILD $PFE@SiegelNY Buying on Market
Symbol  Ecosciences, Inc
Other picks $FIA $GILD $QQQBye $GILD @JohnSaunders68 Tuesday Bulls Are Out! ""ECEZ""RT @biotechtoreador: @JohnCFierce I assume $GILD is busy making drugs that confer tremendous benefit, reducing healthcare spending  and pat‚Ä¶My old picks $GILD @YouTubeXRev Early Buy  Ecosciences Inc $ECEZBuy any of this yet? @mrscoop70
$ECEZ (Ecosciences, Inc)
Do not worry about $OHRP $GILDForget $GILD @ceslestequeen Tuesday Pick Insider Alert Ecosciences Inc $ECEZRT @OphirGottlieb: $GILD has been a beauty since the panic selling.@_bea_ruiz_ Other picks $GILD Tuesday News ""$ECEZ"" Eco-Logical Tablets, Shares gonna rise$GILD - Robert W. Baird Reaffirms Outperform Rating for Gilead Sciences, Inc. #GILD https://t.co/gh5qCyaemBGilead Sciences, Inc. $GILD Receives Outperform Rating from Robert W. Baird https://t.co/joIZqtZIFMHuge Tuesday News @RogerPTY25
#ECEZ
Bye $IWY $GILDGilead Sciences Reiterated Rating by Robert W. Baird (Ranked 17th) to Outperform with 135 PT $GILD #GILD https://t.co/nyq7xJnbR7No more buys $GILD @svtcorrientes #Breaking #News Buy ""$ECEZ""RT @OphirGottlieb: $GILD has been a beauty since the panic selling.$GILD has been a beauty since the panic selling.Sold all: $GILD @OnlyHypercar Huge Tuesday Buy OTC MKTS: ECEZGilead Sciences's outperform rating reiterated at Robert W. Baird. $135.00 PT. https://t.co/tZgtfFsZ7n $GILD #GILDGilead Sciences's outperform rating reiterated at Robert W. Baird. $135.00 PT. https://t.co/c124WWxKLA $GILD #GILD@16Damero OTC Selection 
Symbol OTC MKTS: ECEZ
Sell: $SIRI $PFE $GILDRT @Benzinga: Cancer Drug Stocks Are The Picture Of Health $AMGN $AZN $GILD $SNY https://t.co/gXaoMEa8PF via @MotifInvestingNow sold: $GILD @HStylesAddixt Buy Now By The Opening Bell! $ECEZ (Ecosciences, Inc)@PremierCovina ETRADE BUY ALERT
Stock Tickr! Ecosciences
Bye $NFLX $NKE $GILDNo on $GILD @NoTranceNoLife Super high float order now Ecosciences Inc ""ECEZ""Medivation: Biotech‚Äôs Most Wanted?  https://t.co/7tD8Hx5sUX via @barronsonline $MDVN $SNY $GILD $AMGN $AZNOther picks $GILD @d9_ku Purchased OTC Now OTC MKTS: ECEZNo more buys $GILD @Aykutivgin Do not wait around!  E C E ZCancer Drug Stocks Are The Picture Of Health $AMGN $AZN $GILD $SNY https://t.co/gXaoMEa8PF via @MotifInvestingOther buys: $GILD @alexchapman01 #Tuesday #money #success Ecosciences, Inc#Tuesday #Morning #Bell @suejones2063672
""ECEZ""
Now sold: $BEAT $GILD1234 Bullish https://t.co/OFwk5YvHzD $CHRW $PFE $NRZ $TJX $PYPL $RGC $RAD $GNW $ODP $TQQQ $ABT $HLF $DSW $TTWO $SRPT $GILD $MDVN $SYFDon't worry about $GILD @Polar_Bear_West Buy Before The Bell Ecosciences Inc $ECEZDo not worry about $GILD @pinofseven Buy Shares ASAP Ecosciences (ECEZ)Forget $GILD @The_Anti_Fox Incoming OTC Buy Ecosciences (ECEZ)@AXMEA2013 TWITTER ALERT Order
Stock Symbol! OTC MKTS: ECEZ
No more buys $TRXC $JCP $GILDBye $GILD @_Phan5sos1D_ Weekly Alert EcosciencesOTC Markets Buy Alert @tornadolarry
 E C E Z  
Others $HRC $GILDRT @GeryDIVRY: @carine1111111 @markpun @genfit  yes for people who want to discover NASH before investing in the future drugs . $ICPT $GNFT‚Ä¶Old favorites $GILD @eriaWieman Giant Tuesday Buy Order Ecosciences Inc23:15-&gt;https://t.co/vqaokSKgmf

Also,see:https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/cElatJ5arLRT @ScripMandy: The always insightful @BMTEdny provides good insight into competitive #HCV market. $GILD $MRK $ABBV #ILC2016  https://t.co/‚Ä¶And hold $GILD @StoryofaKilla_ Analysts Are Bullish OTC Markets $ECEZOther picks $GILD @trumpthreats Pump Incoming On $ECEZRT @biospace: Fresh Off Its $1.2 Billion Deal, Gilead $GILD Has Cash to Go Shopping Again https://t.co/hg90rU9AV8 https://t.co/l3MXLKclGi@daniel_bird12 Stock Trade Buy
Tickr- Ecosciences
Other picks $ODP $PHOT $GILDA #WallStreet Pick @Dolfo62
""ECEZ""
Others $ACHN $GILD@JohnCFierce I assume $GILD is busy making drugs that confer tremendous benefit, reducing healthcare spending  and patient suffering?Other favorites $GILD @affinity_tv Giant Tuesday Purchase $ECEZ (Ecosciences, Inc)@realtimesydney Early Buy 
Y! Symbol    OTC MKTS $ECEZ
My old picks $PBR $AAAP $GILDToday sold $GILD @_princess_petty Must Buy Now $ECEZHow Etsy Uses Big Data For Ecommerce To Put Buyers And Sellers In The Best Light¬† $GILD https://t.co/ZKGOGN3JXiOther picks $GILD @_Palak09_ Place a order ASAP on OTCMKTS: ECEZRT @AnthonyMaceroni: @AnthonyMaceroni I guess it's fair to say the month of April loves $GILD. Note: low P/E comp to ind avg &amp; historical h‚Ä¶Hold: $GILD @ZachLonsinger Stock Trade Buy OTC Markets $ECEZ#Tuesday #money #success @vestasilva
Ecosciences Inc
Other favorites $REXX $GILDCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5@cardiobrief I doubt that $GILD gives a damn -- or they're really good about hiding it.Hold: $GILD @crossFitexit23 A #WallStreet Pick $ECEZ (Ecosciences, Inc)Buying on Market @paulladentro
""ECEZ""
Other buys: $HRC $GILDOther picks $GILD @moxiza Place a order for ""$ECEZ""@SJShorks Order These Shares ASAP
Stock Ticker  #ECEZ
No more buys $NUGT $ATNM $GILD@EmilyMaeBest Trade Alert
Y! Symbol=  E C E Z  
Today sells $SPMO $GILD $SLDRI'm getting my drug pricing panel together for BIO. Would have loved to have $GILD, but they always seem to be busy elsewhere. #AlackandalasMy old picks $GILD @TheValueNaire Buy Alert On The Bell $ECEZ (Ecosciences, Inc)Tuesday Orders @lconnectnet
Ecosciences Inc
Do not worry about $AXU $GILDSold all: $GILD @InnovatInvestor Massive Pump Coming On !$ECEZ!Crash in $VRX makes other biotech such as $ABBV , $AMGN , &amp; $GILD much more interesting &amp; safe...@AnthonyMaceroni right there, but needs a weekly close above that trend line to get bullish IMO. Chart not updated yet. $GILD. No pos.Old choices $GILD @datmano Order These Shares ASAP OTC MKTS: ECEZSold all: $GILD @Rubencamachoe Success this week, Buy  E C E Z@drdivinity Order Up The Pink Sheets
Co Symbol !$ECEZ!
Other picks $POZN $GILD $GGBye $GILD @AbdiTV Purchased OTC Now OTC Markets $ECEZ@Terra4Trump Buy This On OTC Markets
Y! Ticker= ""$ECEZ""
Other success $QQQ $AXU $GILDOther picks $GILD @Future__Prez Hope you are buying this Ecosciences Inc $ECEZ@samplegirl91 Huge Tuesday News
Stock Ticker: Ecosciences Inc
Today sold $DVN $GM $GILDNo more buys $GILD @wobby_tubby BIG BUY ALERT! $ECEZ (Ecosciences, Inc)RT @biospace: Fresh Off Its $1.2 Billion Deal, Gilead $GILD Has Cash to Go Shopping Again https://t.co/hg90rU9AV8 https://t.co/l3MXLKclGiLongs: $JBLU, $BOX, $DWTI, $MPEL, $DUST Shorts: $GILD, $CSell: $GILD @publicodom Huge Tuesday Buy EcosciencesRT @biospace: Fresh Off Its $1.2 Billion Deal, Gilead $GILD Has Cash to Go Shopping Again https://t.co/hg90rU9AV8 https://t.co/l3MXLKclGiSell: $GILD @VasaVorlicek Huge Tuesday Buy ECEZ (Ecosciences Inc)Today sold $GILD @asherahresearch Trade Alert $ECEZ (Ecosciences, Inc)No more buys $GILD @Gemstoneclean Order Up The Pink Sheets Ecosciences, IncShort $GILDThe old picks $GILD @Dante_Valleta B U L L I S H ! B U Y Ecosciences Inc $ECEZ@raulcomercioext Did you get your shares yet?
Y! Symbol! #ECEZ
Sold all: $JPM $IBB $GILDOld favorites $GILD @KayinMui Giant Tuesday Buy Order Ecosciences Inc ""ECEZ""$GILD chart https://t.co/oTGSiDnUSe via https://t.co/SVA6QdDLfi -- bout to bust thru#GileadSciences, Inc. Position Reduced by Trilogy Global Advisors LP. Read more: https://t.co/3Y5FSij4lA $GILDTuesday Success Buy @jemmy_madison
Ecosciences
Sold all: $EW $GILDNow sold: $GILD @holidaystz Weekly Pick Ecosciences IncIncoming OTC Buy @kevin_vorr
Ecosciences, Inc
Sold: $EBAY $GILDOther success $GILD @muhimywilufi True OTCMarkets Selection #ECEZFresh Off Its $1.2 Billion Deal, Gilead $GILD Has Cash to Go Shopping Again https://t.co/hg90rU9AV8 https://t.co/l3MXLKclGiNo more buying $GILD @GEMsocialhub Buying on Market Ecosciences, Inc$GILD $GILD Heres the move to $100+. Triangle break https://t.co/giMhFNz5eIOld favorites $GILD @_nixter A True Wall Street Wolf Pick Ecosciences Inc $ECEZ@Juba_man Do not wait on this
Stock Ticker  E C E Z  
No more buying $TNSU $GILD $ADUSin $GILD and $BIIBNo more buys $GILD @CesarCastroMx Do not wait around! $ECEZNo on $GILD @a_avila29 Super high float order now Ecosciences, Inc$GILD Daily - looks to be flagging https://t.co/bwKm2CV0t7 via https://t.co/xwjHFVSbOfTrue OTCMarkets Selection @YoubidderGrace
!$ECEZ!
Bye $TVIX $GILDHeres the move to $100+ $GILD https://t.co/QIkWzoTjXQ ~ via https://t.co/Kd2qwcsyitSell: $GILD @BrandonHeat69 Buy #OTCBB #STOCKS $ECEZ (Ecosciences, Inc)Heres the move to $100+ $GILD https://t.co/sHsIzA9SDP$GILD chart: Heres the move to $100+. https://t.co/JjpPVVq56FRT @OpenOutcrier: $GILD Sciences: Expect a Miss? 

https://t.co/6inW1fER5q via @barronsonline@Haidarbarbouti Money Bulls Are Coming
Stock Tickr  Ecosciences
Other picks $NUGT $CRM $GILD$GILD ""We are modeling total Hep C sales in Europe of $1.0B versus $846M last quarter"" - Baird https://t.co/y0sFjjvmCBDo not worry about $GILD @DanielEllison Pink Sheet Stock Order ""ECEZ""Gilead Sciences: Expect a Miss? $GILD $IBB $MRK https://t.co/S6DviHMrfm https://t.co/XQdBqmflvz https://t.co/5oABZMbYajMy old picks $GILD @ImChrisAllin Buy Now By The Opening Bell! Ecosciences, IncGilead Sciences: Baird contends that Q1 earnings ‚Äúmay be light‚Äù but still sees good things ahead for its stock
https://t.co/x6h6TgPYMN $GILDGilead Sciences: Expect an Earnings  Miss? https://t.co/rRO0wed8P9 via @barronsonline $GILD $IBB $MRKRT @OpenOutcrier: $GILD Sciences: Expect a Miss? 

https://t.co/6inW1fER5q via @barronsonline$GILD Sciences: Expect a Miss? 

https://t.co/6inW1fER5q via @barronsonlineDai Ichi Life Insurance CO. LTD. Sells 7,268 Shares of Gilead Sciences, Inc. $GILD https://t.co/oZTwMjL9wcCypress Asset Management Inc. TX Has $4,129,000 Position in Gilead Sciences, Inc. $GILD https://t.co/qc3gAJQXRt#GileadSciences Fresh Off Its $1.2 Billion Deal, Gilead Has Cash to Go Shopping Again. Read more: https://t.co/6hy3B6pY00 $GILD#GileadSciences Fresh Off It's $1.2 Billion Deal, Gilead Has Cash to Go Shopping Again  . Read more: https://t.co/GAORoDZz9w $GILDRT @BioStockAddict: $GILD i said $100 this week, sissie. You still have 3 more days. Trade like a man.Today sold $GILD @PatPSGdepuis82 Buy Shares ASAP Ecosciences Inc@MusicMafia77 Giant Tuesday Purchase
Ticker Ecosciences (ECEZ)
No more buys $GILD $DLA $AAPLPeople can get rich. Buy Now @TheColdCivilWar
OTC MKTS $ECEZ
Others $GILD $SVXYTuesday Bulls Are Out! @ThoughtsOfTony
OTC MKTS $ECEZ
No more buying $KND $GILDMassive Tuesday Pump Incoming @Malikai93
Ecosciences Inc
Old picks $GILD $HEMPRT @GeryDIVRY: @carine1111111 @markpun @genfit  yes for people who want to discover NASH before investing in the future drugs . $ICPT $GNFT‚Ä¶$GILD i said $100 this week, sissie. You still have 3 more days. Trade like a man.@MaldronWexford Huge Monday Buy
Y! Ticker Ecosciences (ECEZ)
The old picks $POZN $GILD $CFGEPlace a order ASAP on @freddoso
EECZ (Ecosciences Inc)
No on $GILD $CAH@joefromatlanta Monday OTC Pick
Co Symbol    Ecosciences Inc $ECEZ
Do not worry about $ADHD $BHI $GILDRT @SheffStation: $IBB $XBI..interesting to be reminded of top 3 $XBI holdings $ACAD $MDVN $NBIX. $IBB top 3 has $AMGN $GILD $BIIB https://‚Ä¶B U L L I S H - B U Y @tarot_cards
#ECEZ
Other picks $GILD $AKRX#GileadSciences Baird: Gilead Set For Q1 EPS Miss, But Hep C Trends Still Good Long Term. Read more: https://t.co/XhsJevoAgW $GILDThe always insightful @BMTEdny provides good insight into competitive #HCV market. $GILD $MRK $ABBV #ILC2016  https://t.co/G3sca3QMQCWLL Day High
See Here ---&gt; https://t.co/QT2exRM9Dh

$WLL $BX $GILD #investMy #ILC2016 comments in @ScripMandy article (subs only) https://t.co/tQlGWbq5MM $RGLS $ABBV $MRK $GILD https://t.co/k1KQzIeIqW~ PLACE BUY IN NOW ~ @Iglesias_9Silvi
OTC MKTS: ECEZ
Monday sells $GILD $XLIPink Sheet Stock Buy @INSEADKnowledge
OTC MKTS: ECEZ
No more buys $GALE $GILD@PoliticalCaptn #Breaking #News Buy
Tickr   $ECEZ
Other favorites $WBA $GILD $SLDRB U L L I S H !!! B U Y @mike96bennett
""ECEZ""
Sold: $COST $GILDPurchased OTC Now @pepavm21
OTCMKTS: ECEZ
Other buys: $GILD $ACADBuy Says The Analyst @juninhoalmeidaj
$ECEZ (Ecosciences, Inc)
Now sold: $GRPN $GILDWith $14B in cash, #Gilead $GILD shopping spree may continue! Hep C drugs #Harvoni &amp; #Sovaldi made $20B in 2015! https://t.co/MVDE8tyRWEBuying on Market @martncs
EECZ (Ecosciences Inc)
Bye $GILD $AKRXEveryone is buying this week! @withmuchregrets
""ECEZ""
Others $GILD $LACDFJefferies Group Boosts Gilead Sciences, Inc. $GILD Price Target to $101.00 https://t.co/x4ISEZHzBoJefferies Group Boosts Gilead Sciences, Inc. $GILD Price Target to $101.00 https://t.co/Fz0Uv5xYZ5@SchusterInst !! TWITTER BUY ALERT !!
Stock Symbol - Ecosciences Inc $ECEZ
And hold $WYNN $GILD $NUGTA True Wall Street Wolf Pick @lindieface
#ECEZ
Now sold: $GILD $AKTXRT @Benzinga: Baird: Gilead Set For Q1 EPS Miss, But Hep C Trends Still Good Long Term $GILD $MRK https://t.co/1enR5pkDMCSuper high float order now @iammarlymar
OTCMKTS: ECEZ
And hold $GILD $NKE$AAPL $FB $AMZN $PG $MCD $GS $C $GE $UTX $SLB $XOM $GOOGL $AGN $WMT $QQQ $IWM $GILD $HON $JPM $DIS Nice day rally! https://t.co/Dfave5tc7BBaird: Gilead Set For Q1 EPS Miss, But Hep C Trends Still Good Long Term $GILD $MRK https://t.co/1enR5pkDMCGILD Stock Message Board
See Here ---&gt; https://t.co/BxiakUtbS4

$GILD $CTRL $MO #pennystocksVolume Alert - GILD 95.70 Gilead Sciences Inc $GILD Hit a high today of 96.43 Closing the day 10:30 at 95.70 - https://t.co/0m8SZFW1QpGILD Top news - Apr 12th, 2016 $GILD https://t.co/3HQpbYVEO3With little federal action, drug-pricing battle may shift to states. $GILD Via @TheTerminal: https://t.co/dsiTD7sdDw https://t.co/4YzYKIgaJZCall/Put Highest % volume changes:  Calls: $XLE, $HSBC, $JCP, $VLO, $FXE.  Puts: $IBM, $BMY, $SLB, $COP, $GILD.RT @GeryDIVRY: @carine1111111 @markpun @genfit  yes for people who want to discover NASH before investing in the future drugs . $ICPT $GNFT‚Ä¶RT @GeryDIVRY: @carine1111111 @markpun @genfit  yes for people who want to discover NASH before investing in the future drugs . $ICPT $GNFT‚Ä¶Happier Employees Make Companies Great  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx https://t.co/ICM3uXMkdoRT @GeryDIVRY: @carine1111111 @markpun @genfit  yes for people who want to discover NASH before investing in the future drugs . $ICPT $GNFT‚Ä¶@carine1111111 @markpun @genfit  yes for people who want to discover NASH before investing in the future drugs . $ICPT $GNFT $GILD $TBRASFTW Investor long-term stock recommendation: $GILD Gilead Sciences, Inc. (SS: 86) https://t.co/ajLDr7suct$GILD And we are just beginning to identify them https://t.co/BL0O7cx2bS@tgtxdough lots of news flow $TRIL $GILD $ICPT https://t.co/VFNAQ32edERT @SheffStation: $IBB $XBI..interesting to be reminded of top 3 $XBI holdings $ACAD $MDVN $NBIX. $IBB top 3 has $AMGN $GILD $BIIB https://‚Ä¶$IBB $XBI..interesting to be reminded of top 3 $XBI holdings $ACAD $MDVN $NBIX. $IBB top 3 has $AMGN $GILD $BIIB https://t.co/QGwmYudqFA@jimcramer $GILDValuation Dashboard: Healthcare - Update https://t.co/6xptvA2ptr $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $LCI $MASI $MCKRT @fgusequity: $GILD https://t.co/dZWRGe19sM Pot. pullback in Downtrend LONGERTERM Wly-Dly-Hly combo chart #trading #stocks https://t.co/8‚Ä¶$GILD https://t.co/dZWRGe19sM Pot. pullback in Downtrend LONGERTERM Wly-Dly-Hly combo chart #trading #stocks https://t.co/8NeuLrxaVlCheap call option upside: $DAL calls cheaper than 100% of history, $GILD 99%, $PG 99%, $CRM 97%, $CSCO 95%, $HD 94%, $BABA 93%Weekly Nasdaq100 #Stocks Performance $ULTA $STX $INCY $CTRP $CELG $MDLZ $ESRX $VRTX $NXPI $GILD $VOD $ILMN  more@ https://t.co/YdSIjFJqHfWeekly S&amp;P100 #Stocks Performance $HAL $COP $PFE $OXY $KMI $CELG $MDLZ $CVX $UTX $SLB $GILD $BA $MRK $AMGN more@ https://t.co/cKkr8cKsjuRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @marketexclusive: Gilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNGilead Sciences, Inc. (NASDAQ:GILD) Commits To Expand To Foster City https://t.co/tgzWzt2oBk $GILD $ILMNRT @ChinaInvest: RT SeekingAlpha: Low Volatility Stocks - Cheaper Than Some Suggest? https://t.co/OL9Henz1xo $CLX $ESS $FB $GILD $PGRT @ChinaInvest: RT SeekingAlpha: Low Volatility Stocks - Cheaper Than Some Suggest? https://t.co/OL9Henz1xo $CLX $ESS $FB $GILD $PGRT SeekingAlpha: Low Volatility Stocks - Cheaper Than Some Suggest? https://t.co/OL9Henz1xo $CLX $ESS $FB $GILD $PGLow Volatility Stocks - Cheaper Than Some Suggest? https://t.co/EfGVQPDLsI $CLX $ESS $FB $GILD $PGLow Volatility Stocks - Cheaper Than Some Suggest? https://t.co/adqJGYhsel $CLX $ESS $FB $GILD $PG#GileadSciences, Inc. Stake Reduced by Canyon Capital Advisors LLC. Read more: https://t.co/zJGCQ0czOt $GILDAberdeen Asset Management PLC UK Sells 58,723 Shares of #GileadSciences, Inc. (). Read more: https://t.co/mpSqARcKoU $GILDRanks #1 with over 80% in alert gains today. Click here https://t.co/ewcYkLb72h .. $GILD $PTNT $CHDN$GILD:US Gilead Sciences, Inc. (GILD) Shares Bought by Guinness Asset Management Ltd #GILEAD SCIENCES INC  https://t.co/54r6Csk004 #NASDAQRT @Vince_Stanzione: $GILD Gilead makes 2 of the most expensive prescription drugs in US - pricing worries? but overall has plenty margin h‚Ä¶$1,000-a-pill is death sentence for HCV patients https://t.co/BFYgVZnzez RT #HCV #HepC $GILD #PatientsOverProfit$Green Valley Investors LLC Maintains Position in #GileadSciences, Inc. (). Read more: https://t.co/Bl50uoioUY $GILDMoney Monday Alert @voxsanto
MJTV, OTCBB
Sold: $GILD $LNCO@L_Walt05 Buy Shares ASAP
Tickr OTCBB: MJTV
Forget $PXLG $GILD $CRYBuy This On OTC Markets @kingdomOnfire
!MJTV!
Sold all: $LITE $GILDMassive Monday Pump Incoming @HSolok
Michael James Enterprises (MJTV)
No more buys $SVXY $GILD** High Float Buy ** @timinhoustontex
#MJTV
Monday sold $GILD $ACHNPlace a order ASAP on @motohouse21st
#OTC #MJTV
Sold all: $GILD $EWJWeekly Alert @PieLordLBP
#OTC #MJTV
Old choices $AXN $GILDGiant Monday Purchase @aagiigaa
OTCBB: MJTV
Sold all: $CCM $GILD@janinehutton #Monday #Morning #Bell
Co Symbol- OTCBB: MJTV
No more buying $GM $GILD $HOG@keithkahn People can get rich. Buy Now
Symbol   OTCBB: $MJTV
Monday sold $AEGR $GILD $VZCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5OTC Alert Buy @club_jahdai
""MJTV""
Sold: $GILD $DRDGiant Monday Buy Order @its_shene_duh
MJTV, $OTCBB
Do not worry about $GE $GILDWeekly Pick @OhWowHaha
Michael James Enterprises (MJTV)
Others $GILD $WKHSPurchased OTC Now @Carl_Burnside
Michael James Enterprises, Inc
My old picks $AMZN $GILD@mycanadiancute Pink Sheet Stock Order
Ticker OTCBB, $MJTV
The old picks $IWY $GILD $GLDPink Sheet Stock Buy @teamtrolls
$MJTV (Michael James Ent Inc)
Other favorites $GILD $PSET@NowByu Everyone is buying this week!
Co Symbol- MJTV, $OTCBB
Forget $BBRY $GILD $SEACEveryone is buying this week! @anneliseblue
OTC @ $MJTV
Old choices $GILD $APCMonday Success Buy @DanDePetris
Michael James Enterprises ($MJTV)
No more buys $NATR $GILDRT @AmericanBanking: Gilead Sciences, Inc. $GILD Shares Bought by Guinness Asset Management Ltd https://t.co/0SoCCzNISVCheap put options and hedges: $DAL puts cheaper than 92% of history, $T 90%, $GILD 88%, $SLV 86%, $GE 84%, $CRM 82%, $AAPL 78%MONDAY MONEY ALERT Order @samanthaaaaaaan
#OTCBB $MJTV
The old choices $GILD $AXN@MaidFabulousInc Order On Pink Sheets
Stock Symbol: Michael James Enterprises, Inc
Bye $WYNN $GILD $UA@King_Dreams94 Hot Pick #wolfofwallstreet
Co. Tickr- Michael James Enterprises ($MJTV)
No more buys $ACET $GILD $LIFE$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Closes -0.27% For the Session:

https://t.co/MHOVWy3yDZMassive Monday Pump Incoming @_Bry_an
Michael James Ent.
Do not worry about $GILD $WFC#Breaking #News Buy @godfatherrules
$MJTV (Michael James Enterprises, Inc)
Sold all: $FIA $GILDIncoming OTC Buy @HCOnlineCourses
OTCBB, MJTV
Hold: $GILD $REXXBuy Before The Bell @2manparlay
MJTV, OTCBB
No more buying $GILD $BAXJBF Capital Inc. Continues to Hold Stake in Gilead Sciences, Inc. $GILD https://t.co/MvMarM71SvGilead Sciences, Inc. $GILD Position Lowered by Alpine Woods Capital Investors LLC https://t.co/OouF2j77v3Gilead Sciences, Inc. $GILD Shares Bought by Guinness Asset Management Ltd https://t.co/TBV7tpE9M3Gilead Sciences, Inc. $GILD Shares Bought by Guinness Asset Management Ltd https://t.co/0SoCCzNISVStock Trade Buy @wendythesizzler
MJTV (Michael James Enterprises, Inc)
My old picks $GILD $PCLNMonday OTC Choice @CrimeHoy
Michael James Enterprises, Inc
Bye $TECH $GILDOrder These Shares ASAP @pokerbandit22
OTCBB, MJTV
Do not worry about $GILD $TEVA@HaramHafiy Order up on the bell!
Tickr   OTCBB: MJTV
No more buying $BBRY $EWZ $GILDB U L L I S H !! B U Y @Will_Pringle26
OTCBB: MJTV
Other success $GILD $MUXBUY NOW. DO NOT WAIT @JBo308
*MJTV*
Bye $GILD $PXLGOrder On Pink Sheets @BiggCrossFit
MJTV (Michael James Ent Inc)
Hold: $GILD $AUY@bintfilm Huge buys incoming on
The Symbol- MJTV (Michael James Enterprises, Inc)
Other picks $GRPN $AMRI $GILD@Appy_GeekFR Must Buy Now
Ticker: MJTV, OTCBB
And hold $POT $GILD $VIVOSuccess this week, Buy @expoaparis
OTC @ $MJTV
Others $GILD $NVO@sizey5 #Wallstreet Buy Now
Y! Ticker OTCBB: MJTV
Other buys: $PEP $ESRX $GILDOrder On Pink Sheets @DavidLiles3
OTCBB, $MJTV
Now sold: $GILD $CSX@PhilStockMarket Buy! To The Moon!
Stock Symbol! Michael James Enterprises (MJTV)
No more buys $KNSY $GILD $GSHigh float Get Now @ashleygoldd
MJTV (Michael James Enterprises, Inc)
The old picks $GILD $HOGRT @biospace: Gilead $GILD Seeks to Build 6-Story Lab in HQ Expansion, May House Up to 5,000 New Employees https://t.co/htE7AZJxU7 https://‚Ä¶@candidpaul Massive Pump Coming On
Stock Ticker    MJTV (Michael James Ent Inc)
No more buying $MRK $GILD $VIX",2016-04-12,GILD,0
10,"RT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶Long $GILD today at 97RT @Taq888: None of $GILD HepB drugs a) reduce HBsAg significantly  b) generate anti-HBs. None. $ARWR looking like a very attractive partne‚Ä¶Elder Blue https://t.co/bFuCK2uPJg $KGC $GILD $GLD $IYR $ABBV $HOG $TEVA $CAR $VER $IAU $FAST $CAG $DYN $URBN $DDD $NGD $VNQ $FTNT$GILD:US Gilead Sciences, Inc. (GILD) Position Decreased by Bank of Hawaii #GILEAD SCIENCES INC  https://t.co/IafHABKoIu #NASDAQRT @Vince_Stanzione: $GILD Gilead makes 2 of the most expensive prescription drugs in US - pricing worries? but overall has plenty margin h‚Ä¶RT @OpenOutcrier: Hepatitis C treatment for under $300 coming soon [18-24 months] 
(from the Guardian-UK)

https://t.co/IrNrxPKman $GILD$GILD:US Gilead Sciences, Inc. (GILD) Position Decreased by Bank of Hawaii #GILEAD SCIENCES INC  https://t.co/L5TpM3EuNN #SP500RT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶RT @tgtxdough: February IMS Sales Analysis For Large-Cap Biotech $AMGN $GILD $CELG https://t.co/Jjddo5gS0FFebruary IMS Sales Analysis For Large-Cap Biotech $AMGN $GILD $CELG https://t.co/Jjddo5gS0FRT @SAlphaTrending: Did Warren Buffett Just Pick Ajit? https://t.co/Jod9LDPSXU $ALK $AZN $BHI $BRK.A $BUD $CHTR $DEO $FB $GILD $GOOG $GOOGL‚Ä¶Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Gilead and Fossil are 2 stocks undervalued according to #PeterLynch's valuation method https://t.co/BGlueUxBsn $GILD $FOSLI'm long $GILD

https://t.co/8CW0o5VFca$AGN arb position liquidation has driven px to stupid lows now.'17/16 eps growth+21%,P/E next 12m=15.4,P/E17=12.7x $GILD on '17at 8x w/1%groSince this tweet (ex-div):
$GILD +17%
$CMI +26%
$TRN -7%
$F +9%
https://t.co/xK669oHitkRT @AndyBiotech: $GILD It's rather vague how @DNDi licensed Sofosbuvir in its report:
https://t.co/2Ud2dpMW5s
@dsobek @ColeTFRoberts https:‚Ä¶@psuvafan007 Value still there in Nuc therapy w ARC520.  $GILD TAF (1/10th the dosing of VIREAD) may bode well in combo T w ARC520.@BattagliaCE It seems like nice start (esp DNA ‚¨áÔ∏è), but let's not get carried away (not that u are). HBV challenges remain üòâ $GILD $ARWRMandatum Life Insurance Co Ltd Invests $2,845,000 in Gilead Sciences, Inc. $GILD https://t.co/DnVtt9S7lDRT @OpenOutcrier: Hepatitis C treatment for under $300 coming soon [18-24 months] 
(from the Guardian-UK)

https://t.co/IrNrxPKman $GILD@AndyBiotech @DNDi @dsobek seems like $GILD is leaving money on the table if they licensed it at these prices...RT @OpenOutcrier: Hepatitis C treatment for under $300 coming soon [18-24 months] 
(from the Guardian-UK)

https://t.co/IrNrxPKman $GILDRT @OpenOutcrier: Hepatitis C treatment for under $300 coming soon [18-24 months] 
(from the Guardian-UK)

https://t.co/IrNrxPKman $GILDHepatitis C treatment for under $300 coming soon [18-24 months] 
(from the Guardian-UK)

https://t.co/IrNrxPKman $GILD@POTUSFerocUS $GILD told me this morning they don't ahve GS-4774 data there. Abstract deadline was mid Feb. But they will share with GBIMRT @AndyBiotech: $GILD It's rather vague how @DNDi licensed Sofosbuvir in its report:
https://t.co/2Ud2dpMW5s
@dsobek @ColeTFRoberts https:‚Ä¶RT @SAlphaTrending: Did Warren Buffett Just Pick Ajit? https://t.co/Jod9LDPSXU $ALK $AZN $BHI $BRK.A $BUD $CHTR $DEO $FB $GILD $GOOG $GOOGL‚Ä¶@AndyBiotech @DNDi @ColeTFRoberts I suspect $GILD is letting them have additional geographies but you are right it is not clear.$GILD It's rather vague how @DNDi licensed Sofosbuvir in its report:
https://t.co/2Ud2dpMW5s
@dsobek @ColeTFRoberts https://t.co/2YtKGV0QbSRT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶@POTUSFerocUS @stockingup333 It's actually not a material event to them. Market cap too high. $GILD will share with $GBIM so they can PR.This is Why Everyone Wants to Buy Medivation https://t.co/767642JvYI via @barronsonline $MDVN $SNY $GILD $AZN $AMGN@AndyBiotech do you how the patent conflict would work? I imagine $GILD might not have patent protection in these middle-income countriesRT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶RT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶@stockingup333 It would make sense for $GILD to. $ANDS was bought out shortly after their phase 2 hep c data.@AndyBiotech umm, the treatment contains sovaldi.  Not sure how that is going to work given that is till owned by $GILDRT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶RT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶RT @biospace: Fresh Off Its $1.2 Billion Deal, Gilead $GILD Has Cash to Go Shopping Again https://t.co/hg90rU9AV8 https://t.co/l3MXLKclGi@CatalystWatcher you suppose $GILD might be the one to acquire it or someone else?Mitsubishi UFJ Kokusai Asset Management CO. LTD. Has $40,937,000 Position in Gilead Sciences, Inc. $GILD https://t.co/8oAOd2aOqJ$GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co/3YKRuiNVoURT @SAlphaTrending: Did Warren Buffett Just Pick Ajit? https://t.co/Jod9LDPSXU $ALK $AZN $BHI $BRK.A $BUD $CHTR $DEO $FB $GILD $GOOG $GOOGL‚Ä¶Did Warren Buffett Just Pick Ajit? https://t.co/Jod9LDPSXU $ALK $AZN $BHI $BRK.A $BUD $CHTR $DEO $FB $GILD $GOOG $GOOGL $GPN $HAL $HPYMost HBV therapies have benefit of HBV being DNA virus, it mutates less than RNA virus (HCV, HIV, Flu) $ARWR $GILD https://t.co/xNXvwPN7VtRT SeekingAlpha: My Dividend Portfolio : Q1 2016 https://t.co/krW6rGXksA $MA $V $BP $VZ $CME $CLB $MELI $RMD $WAB $PII $VWO $GILDRT SeekingAlpha: Did Warren Buffett Just Pick Ajit? https://t.co/aIaZVSsggp $ALK $AZN $BHI $BRK.A $BUD $CHTR $DEO $FB $GILD $GOOG $GOOGL $‚Ä¶Gilead's Earnings Are Not What You Think They Are https://t.co/1zL4tS1N60 $GILD""valuations in the sector are particularly attractive and for large caps at a decade low"" #biotech $IBB $AMGN $BIIB $CELG $GILD $REGN ...My Dividend Portfolio : Q1 2016 https://t.co/tRUU2SH0db $MA $V $BP $VZ $CME $CLB $MELI $RMD $WAB $PII $VWO $GILDMy Dividend Portfolio : Q1 2016 https://t.co/B5mZ3WB2qd $MA $V $BP $VZ $CME $CLB $MELI $RMD $WAB $PII $VWO $GILDDid Warren Buffett Just Pick Ajit? https://t.co/7qegddrA2L $ALK $AZN $BHI $BRK.A $BUD $CHTR $DEO $FB $GILD $GOOG $GOOGL $GPN $HAL $HPYDid Warren Buffett Just Pick Ajit? https://t.co/cjMcP8DRp1 $ALK $AZN $BHI $BRK.A $BUD $CHTR $DEO $FB $GILD $GOOG $GOOGL $GPN $HAL $HPYGilead's Earnings Are Not What You Think They Are https://t.co/kMamsA53pj $GILDNone of $GILD HepB drugs a) reduce HBsAg significantly  b) generate anti-HBs. None. $ARWR looking like a very attractive partner/buyout.JBEM pick FLKS data release on 4/19. Read here: https://t.co/RJhHbIwnlX $GIL $GILD $GILT $GIM $GIMO $GIS $GIVE $GJOWill #GileadSciences, Inc Shock Everyone With Earnings This Quarter. Read more: https://t.co/fSatwRkoQj $GILDRT SeekingAlpha: Gilead's Earnings Are Not What You Think They Are https://t.co/9sdSQajcrU $GILDGilead's Earnings Are Not What You Think They Are https://t.co/3VGflrnz5Y $GILD$GILD where are we $GILD https://t.co/2zLNVujEYB$GILD chart: $GILD where are we. https://t.co/9s9McwBaomGilead's Earnings Are Not What You Think They Are https://t.co/pi9f2gb4WB $GILDGilead's Earnings Are Not What You Think They Are https://t.co/IvxH9SGXsc $GILD$GILD:

Checking EPS Growth for Gilead Sciences Inc. (NASDAQ:GILD):

https://t.co/aQVZd45P6CRT @DozenStocks: Weekly Nasdaq100 #Stocks Trend $ALXN $ISRG $MAT $LBTYA $STX $ILMN $GILD $TXN $CTXS $AAPL $ULTA $QCOM $TSLA  @ https://t.co‚Ä¶Weekly Nasdaq100 #Stocks Trend $ALXN $ISRG $MAT $LBTYA $STX $ILMN $GILD $TXN $CTXS $AAPL $ULTA $QCOM $TSLA  @ https://t.co/YdSIjG11yNSunTrust: 9 Biotech Companies are Profitable. Medivation is the only midcap. https://t.co/20dMzgKTn5 @barronsonline $MDVN $SNY $GILD $AMGN@stockingup333 Received email from $GILD this morning. GS-4774 won't be at EASL b/c abstract submission deadline missed Still believe soon.Just want to summarize the info I have right now about active stocks. Interesting summary about $GILD and $TEVA
https://t.co/Cw7oXhsC3p$VRX , $GILD and $AMGN have done more to improve the lives of AIDS patients than any other companies. We respect that.Rayno Biopharmaceuticals 2016 Update: 4/14 All In The Green! $BMY $IBB $GILD $XBI $ABBV $BLUE https://t.co/cHODqi6iR2RT @pozmagazine: FDA OKs Gilead‚Äôs Descovy, a Safer Version of #Truvada, for #HIV Treatment Only (Not for #PrEP) https://t.co/eeTHAwFmiF $GI‚Ä¶Nasdaq100 #Stocks Trend $ALXN $MAT $ISRG $LBTYA $ILMN $GILD $STX $TXN $CTXS $AAPL $ULTA $QCOM $TSLA $AMGN $AMZN @ https://t.co/YdSIjFJqHf$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Reported Comprehensive ‚Ä¶:

https://t.co/HPjTVP21tKVolume Alert - GILD 96.94 Gilead Sciences Inc $GILD Hit a high today of 97.97 Closing the day 10:59 at 96.94 - https://t.co/Jxm2864pbMRT @TipRanks: Analysts Adjust Estimates on $GILD and $TEVA https://t.co/wfgjQoXiRF(-$70 Million)(losses) over last 2yrs w $250 million mkt cap. $TITN Stock up 50% in 2 mos. is it a biotech $LXRX $MDVN $SNY $GILD $BIIB $IBBRT @reshmagar: .#BPCLive No sir-@RonWyden @ChuckGrassley found that $GILD INAPPROPRIATELY priced #HCV drug, period, putting profit above pt‚Ä¶.#BPCLive No sir-@RonWyden @ChuckGrassley found that $GILD INAPPROPRIATELY priced #HCV drug, period, putting profit above pts. @NPAliveGilead: Is NASH The Third Leg Of Blockbuster Triumvirate? https://t.co/Yon5Nc0Zcl $GILDMarshall Wace LLP Decreases Stake in Gilead Sciences, Inc. $GILD https://t.co/LfgBPIAJTNGILD Top news - Apr 13th, 2016 $GILD https://t.co/YFEVXg8Sgx$GILD $TEVA interesting, pharma is on fire https://t.co/oScxXPvqBjAnalysts Adjust Estimates on $GILD and $TEVA
https://t.co/xThXUYR5Jc$arwr best believe the $BMY $ABBV &amp; $MRK's of the world won't lose the HBV battle to $GILD without a good fight.Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKjqBmDClosed $GILD short small green from yesterday$ARWR hot acquisition, will $GILD pay $10B again. The value is worth much higher, as the patient population is much higher$GILD:US Gilead Sciences, Inc. (GILD) Position Decreased by Bank of Hawaii #GILEAD SCIENCES INC  https://t.co/aTaiWc1EYU #NASDAQAnalysts Adjust Estimates on $GILD and $TEVA https://t.co/wfgjQoXiRFRT @aschwartzphd: $ARWR &amp; $GBIM both failed in virally-suppressed HBV. $ARWR just succeeded in Rx naive. Will $GILD $GBIM GS-4774 succeed a‚Ä¶bio going now $IBB $XBI $NBIX $GILDGileadSciences hits a 1 quarter high https://t.co/aE2bhADJXH $GILD #GileadSciences https://t.co/BRWwnRY8cw$NE $GILD:

Trader‚Äôs Watch List: Noble Corp plc (NYSE:NE), Gilead Sciences Inc ‚Ä¶:

https://t.co/jWvJw5og4LRT @tgtxdough: CS top pics in biotech $CELG $GILD $BMRN https://t.co/iAk7Wsy7tuWill Gilead #Sciences, Inc $GILD Shock Everyone With #Earnings This Quarter --&gt;&gt; https://t.co/hf6Pyf4FQh https://t.co/1HUHCA3Htr$98.66 today? $GILD https://t.co/2w79YbmcH7$GILD chart: $98.66 today?. https://t.co/qaOd2GczQGRT @pozmagazine: FDA OKs Gilead‚Äôs Descovy, a Safer Version of #Truvada, for #HIV Treatment Only (Not for #PrEP) https://t.co/eeTHAwFmiF $GI‚Ä¶@adamfeuerstein  $GILD 9620 results out this q.  should make it more promising..no hbsAg knockdown= virus makes a comeback $ARWRFDA OKs Gilead‚Äôs Descovy, a Safer Version of #Truvada, for #HIV Treatment Only (Not for #PrEP) https://t.co/eeTHAwFmiF $GILD @GileadSciencesRT @aschwartzphd: $ARWR &amp; $GBIM both failed in virally-suppressed HBV. $ARWR just succeeded in Rx naive. Will $GILD $GBIM GS-4774 succeed a‚Ä¶RT @TradingWTTrend: Long Stock Picks April 13 2016

https://t.co/9Qbsc1AcQR

$CHK $CLF $FTI $GILD $JD $KMI $LYB $NFLX $RDC $RIG$ARWR &amp; $GBIM both failed in virally-suppressed HBV. $ARWR just succeeded in Rx naive. Will $GILD $GBIM GS-4774 succeed as well? #EASL2016Q1 2016 EPS Estimates for #GileadSciences, Inc. Lifted by Leerink Partner. Read more: https://t.co/wNpbFUZPR8 $GILD#GileadSciences, Inc. Given Outperform Rating at Robert W. Baird. Read more: https://t.co/7LK5LNhPML $GILD$GILD $UNH:

Analysts Actions to Focus: Gilead Sciences, Inc. (NASDAQ:GILD ‚Ä¶:

https://t.co/myeYK5gJzsRT @AllAboutTheDivi: Dividend Growth Portfolio: March Update https://t.co/aXfDc4BsTr $AAPL $ABBV $AFL $BA $COP $CSCO $CVS $CVX $GE $GILD $G‚Ä¶Rayno Biopharmaceuticals 2016 Update: 4/14 All In The Green! $BMY $IBB $GILD $XBI $ABBV $BLUE https://t.co/tcxBKvtAmFMultiple Model Portfolio Vs The S&amp;P 500: Q1 Performance Review https://t.co/7RTTFp2PzC $CLDT $CRWS $DLTH $FL $GILD $HLT $HOT $RGC $SJB#Futures up
#DAX &gt; 10,000
#Euro #Stoxx 50 up 2.65%
#euro down
Hope $GILD $CELG #hedged #eurUsd 2017 https://t.co/QCJkYxNhp7Dividend Growth Portfolio: March Update https://t.co/aXfDc4BsTr $AAPL $ABBV $AFL $BA $COP $CSCO $CVS $CVX $GE $GILD $GIS $JPM $KO $LUV $MACheap call option upside: $GILD calls cheaper than 100% of history, $DAL 99%, $PG 98%, $BABA 96%, $CSCO 95%, $GE 94%, $HD 93%Healthcare Stocks in the Spotlight: $GILD $ABBV https://t.co/IKptLPfIqUQ1 2016 EPS Estimates for Gilead Sciences, Inc. $GILD Lifted by Leerink Partner https://t.co/ACgIAlTswC$GILD $ABBV:

Healthcare Stocks in the Spotlight: Gilead Sciences, (NASDAQ:GILD ‚Ä¶:

https://t.co/Bn09k7bLU3The old picks $GILD @las_vegas_world Pink Sheet Stock Buy $ECEZ (Ecosciences, Inc)Other favorites $GILD @DreamdoSchools People can get rich. Buy Now ""ECEZ""#Biotech Will Blast Past Its 2015 Highs https://t.co/eBzBBywaQA $GILD $LABU $REGN $IBB$GILD:US Gilead Sciences, Inc. (GILD) Position Decreased by Bank of Hawaii #GILEAD SCIENCES INC  https://t.co/DQEFSrucwM #NASDAQRT @biospace: Fresh Off Its $1.2 Billion Deal, Gilead $GILD Has Cash to Go Shopping Again https://t.co/hg90rU9AV8 https://t.co/l3MXLKclGiDon't worry about $GILD @DrHerukhuti Stock pick is going to be great! #ECEZ$GILD:US Gilead Sciences, Inc. (GILD) Position Decreased by Bank of Hawaii #GILEAD SCIENCES INC  https://t.co/OFt1O8hdVC #SP500@Binsalis021 Do not wait on this
Stock Ticker! OTCMKTS: ECEZ
Now sold: $VTL $GILD $EBAYForget $GILD @adheeth #Tuesday #Money #Buy OTC MKTS $ECEZMy old picks $GILD @viennabeo Buying on Market Ecosciences IncLong Stock Picks April 13 2016

https://t.co/9Qbsc1AcQR

$CHK $CLF $FTI $GILD $JD $KMI $LYB $NFLX $RDC $RIGOther buys: $GILD @koenfucius TWITTER ALERT Order OTC Markets $ECEZ@xkk365xs Hope you are buying this
Yahoo Finance  Ecosciences Inc
Other success $SIRI $GILD $VIX@tatiux Buy Before The Bell
Co Symbol    OTC MKTS: ECEZ
No more buys $DVN $GILD $CBYLForget $GILD @Lamaskeproduce Buy! To The Moon! !$ECEZ!Sold: $GILD @Lupeapreza News Out! Order Now OTC Markets $ECEZPlace a order for @emhess31
#ECEZ
Do not worry about $ALC $GILDDon't worry about $GILD @OldSchool92_ Analysts Are Bullish ECEZ (Ecosciences Inc)Others $GILD @kavgoov1960 This stock pick is gonna be good OTC Markets $ECEZOther picks $GILD @OrryPounders Purchased OTC Now $ECEZ (Ecosciences, Inc)Now sold: $GILD @Fashion_Scrubs Buy This Tuesday Insider News Pick OTC MKTS $ECEZThe old picks $GILD @kaba79 Analysts Are Bullish ""ECEZ""Others $GILD @FollowHKNews Buy ASAP OTC Markets $ECEZ@DrakeNotingale Order up on the bell!
Stock Symbol Ecosciences Inc $ECEZ
The old picks $DE $BAK $GILD$GILD: Expect a Miss? - Barron's https://t.co/BL85YXDkClLow Float This Week! @XANAXDREAMS
Ecosciences Inc
Do not worry about $CCC $GILDNo on $GILD @peacenfreedom News Out! Order Now Ecosciences Inc@mattbeall B U L L I S H !! B U Y
Co. Tickr $ECEZ (Ecosciences, Inc)
Other success $VIVO $GILD $DVNNo on $GILD @D0it_forDemetri Analysts Are Bullish OTC MKTS: ECEZOld picks $GILD @GTArtist Stock Is Gonna Rock!  E C E ZRayno Biopharmaceuticals 2016 Update: 4/14 All In The Green! $BMY $IBB $GILD $XBI $ABBV $BLUE https://t.co/cHODqi6iR2Other success $GILD @JarrellRooksglg BUY! SURGE INCOMING EcosciencesSold all: $GILD @russelllopez73 Pink Sheet Stock Buy  E C E Z@thelounge24_7 Everyone is buying this week!
Y! Symbol Ecosciences, Inc
Other favorites $GRPN $ZNGA $GILDOld picks $GILD @RickiVann #Tuesday #money #success $ECEZ (Ecosciences, Inc)And hold $GILD @brunoanhaia #Penny #Stock #Alert Ecosciences Inc $ECEZBye $GILD @Luiselduro2497 Incoming OTC Buy #ECEZSell: $GILD @biyou7city Order Up The Pink Sheets ""ECEZ""Today sold $GILD @alanBStardmp Order On Pink Sheets !$ECEZ!$GILD channel break. 97.74 resistance, higher to test 100.5 https://t.co/PJk4uJZNtd https://t.co/fQ8YeCvNqJ@SolarMelt @SeattleTechie40 $GILD in charge of that, but seems to care more about good immune responses vs. reduction, if you listen to CCOther favorites $GILD @JacobLizj I am counting on this stock pick Ecosciences Inc ""ECEZ""Callahan Advisors LLC Has $8,651,000 Position in #GileadSciences, Inc. (). Read more: https://t.co/djV07uyGmu $GILDCallahan Advisors LLC Has $8,651,000 Position in #GileadSciences, Inc. (). Read more: https://t.co/zBXJSewoQ2 $GILD#GileadSciences, Inc. Position Decreased by Bank of Hawaii. Read more: https://t.co/feFk92BZMJ $GILDCG Asset Management LLC Reduces Stake in #GileadSciences, Inc. (). Read more: https://t.co/x6WkQkdyux $GILDThe old choices $GILD @walkerareanews I'm counting on this pick! $ECEZ@SolarMelt @SeattleTechie40 Plus, $GILD still seems very much vested in GS-4774. Last year CC they inferred the 2nd trial would succeedSell: $GILD @Jackiee_O18 Tuesday Pick Insider Alert  E C E ZDo not worry about $GILD @JordanZiegler Huge Tuesday Buy Ecosciences, IncOld picks $GILD @fossilfriendly Must Buy Now Ecosciences Inc $ECEZRT @tgtxdough: @tgtxdough lots of news flow $TRIL $GILD $ICPT https://t.co/VFNAQ32edENo more buys $GILD @7_irii PPL can become successful order now #ECEZBye $GILD @TLencoe B U L L I S H B U Y  !$ECEZ!Other picks $GILD @TwoChicksIndy Incoming OTC Buy Ecosciences@yashnaruka3213 OTC Selection Tuesday
Symbol- !$ECEZ!
And hold $PBR $GILD $AIGNo more buying $GILD @OSOvision1 News Out! Order Now OTCMKTS: ECEZCheap put options and hedges: $DAL puts cheaper than 92% of history, $T 90%, $GE 87%, $GILD 86%, $SLV 81%, $VZ 81%, $AAPL 80%RT @patoda: @MochaSkinDee Order Up The Pink Sheets
Stock Ticker= Ecosciences Inc $ECEZ
Old picks $TSLA $GILD $ATRI@MochaSkinDee Order Up The Pink Sheets
Stock Ticker= Ecosciences Inc $ECEZ
Old picks $TSLA $GILD $ATRI#Tuesday #Morning #Bell @Cande_Silvero
#ECEZ
Do not worry about $ATRI $GILDForget $GILD @_bg37 Analysts Are Bullish Ecosciences, Inc@tashajacqueline Massive Pump Coming On
Stock Ticker ""ECEZ""
Other buys: $DLA $T $GILDDo not worry about $GILD @ThisjustN_ People can get rich. Buy Now #ECEZ$GILD:

A Few Key Points I Am Focusing On From Gilead Sciences ‚Ä¶:

https://t.co/lw17BjlpFF@PaulYouSoCrazy Tuesday Orders
Stock Tickr  !$ECEZ!
Old choices $FIA $GILD $JPMSold all: $GILD @CalgaryCruz Super high float order now OTC Markets $ECEZA Few Key Points I Am Focusing On From Gilead Sciences' Upcoming Earnings Release https://t.co/oNGYvZaP4h $ABBV $AMGN $IBB $MRK $PFE $GILDA Few Key Points I Am Focusing On From Gilead Sciences' Upcoming Earnings Release https://t.co/iSxBZmIrGS $ABBV $AMGN $IBB $MRK $PFE $GILDThe old choices $GILD @MNelson_ISU Huge buys incoming on !$ECEZ!Don't worry about $GILD @LindaBelan Buy shares yet? Ecosciences (ECEZ)No on $GILD @emma_fox_ Buying on Market Ecosciences IncThe old picks $GILD @PaulCalvaruso TWITTER ALERT Order Ecosciences Inc $ECEZ@kaebmoo #Pinksheet #Pick
Tickr    Ecosciences Inc ""ECEZ""
Do not worry about $SIRI $GILD $NKEDo not worry about $GILD @sangnu Buy any of this yet? OTCMKTS: ECEZNo more buying $GILD @saladjames Buy Says The Analyst Ecosciences IncA True Wall Street Wolf Pick @Dewasa_AJA
OTC MKTS $ECEZ
Other favorites $BHI $GILDAnd hold $GILD @altoryproperty B U L L I S H ! B U Y A L E R T $ECEZ@DEwxyauIn5jfx3r Incoming OTC Buy
Tickr! OTCMKTS: ECEZ
Other picks $SPMO $SLDR $GILD#Tuesday #Money #Buy @tbagtag
Ecosciences Inc ""ECEZ""
Other picks $PMD $GILDToday sells $GILD @elzabmoncao #WolfOfWallStreet Buy News OTC MKTS $ECEZ@webs1934 #Breaking #News Buy
Co. Tickr    Ecosciences Inc
No more buys $ASTI $BEAT $GILDSold all: $GILD @AshleyLynn1014 ~ PLACE BUY IN NOW ~ $ECEZOther picks $GILD @nerdattorney OTC Alert Buy $ECEZ (Ecosciences, Inc)Other picks $GILD @swingtradeinfo Buy #OTCBB #STOCKS EcosciencesShell Asset Management Co. Has $14,552,000 Position in Gilead Sciences, Inc. $GILD https://t.co/zaKVm4mFhXShell Asset Management Co. Has $14,552,000 Position in Gilead Sciences, Inc. $GILD https://t.co/fIlTKDMVd3@redditanarchism Did you get your shares yet?
Stock Symbol ECEZ (Ecosciences Inc)
Don't worry about $MET $GILD $CRYNo more buying $GILD @SeattleSportsCo Money Bulls Are Coming #ECEZToday sells $GILD @WallAlleb Buy ASAP on $ECEZ@match6969 Buy Says The Analyst
Symbol  OTC MKTS $ECEZ
Old picks $PHOT $SLDR $GILDOther picks $GILD @davidkbaugh Pink Sheet Stock Order $ECEZNo more buying $GILD @jjvalser Buy Now By The Opening Bell!  E C E ZTeacher Retirement System of Texas Cuts Stake in Gilead Sciences, Inc. $GILD https://t.co/R8zSgVz8fcTeacher Retirement System of Texas Cuts Stake in Gilead Sciences, Inc. $GILD https://t.co/rgmBXHnzJoBye $GILD @BreitfartNews A Hot #Wallstreet Buy ECEZ (Ecosciences Inc)@JohnCFierce $GILD on the couch for drug $ discuss.?  Isn't that like a Q&amp;A with Satan on the best air conditioning techniques?$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Closes +1.47% For the Session:

https://t.co/2ZV89mqbx9Old favorites $GILD @S99Th Tuesday Alert OTCMKTS: ECEZ",2016-04-13,GILD,1
11,"$GILD 3-month high close attempting to escape 9-month downtrend; could confirm above 102 where S/R meets 200dma https://t.co/pk3hc7LViTRT @amandamicklus: Lots #NASH deals, $GILD/Nimbus, $TBRA/Dong-A &amp; $SNTA reverse merger w/ Madrigal; Madrigal formed out of VIA Pharma, form‚Ä¶@MaisaCorp or $GILD eyes to buy $GNFT ?@Ryan_J_Ferguson $GILD still has plenty of room to run..I will BTFD.Trading Stats &amp; Journal For Thursday 4/14: https://t.co/EDvQIdxpYj
$AAPL $WMB $GILD $V $NUGT $HD $NFLX
#trading... https://t.co/pJPdwKseWeTrading Stats &amp; Journal For Thursday 4/14: https://t.co/1Deg8sQPxO
$AAPL $WMB $GILD $V $NUGT $HD $NFLXAdded to $GILD today on takeout of yesterday's highGood day today. Verticals on $GILD paying well.  New Straddles on $AMZN r already ITM #OptionsNasdaq100 #Stocks Performance $AAL $VRTX $EXPE $TSCO $PCLN $CTXS $WFM $ALXN $GILD $AMZN $CERN $BIDU $AMAT  more@ https://t.co/YdSIjFJqHfRT @pharmalot: Pharmalot.. Pharmallittle.. Good Morning.. a $300 #hepatitis C pill is being developed. https://t.co/4KsjKk0dhN #pharma $GIL‚Ä¶S&amp;P100 #Stocks Performance $OXY $BAC $BLK $C $COP $PCLN $JPM $MS $MET $GILD $AMZN $COF $MRK $V $BK $UNP  more@ https://t.co/cKkr8cKsjuRT @BlinkX90: @SheffStation $GBIM 2nd HBV trial for treatment naive patients (easier population) funded by $GILD, believe $170m milestones‚Ä¶RT @CatalystWatcher: The GS-4774 primary endpoint was reached in February. $GILD has been looking at data for a while now. Only a matter of‚Ä¶$GILD:US Gilead Sciences, Inc. (GILD) Shares Bought by Calamos Wealth Management LLC #GILEAD SCIENCES INC  https://t.co/LyzAFqO7ft #NASDAQ$ICPT ... $GILD eyes to buy $ICPT?New $GILD chart posted: https://t.co/6UXThp9PFFRotating Into Health Care $BSX $VRX $IBB $REGN $AMGN $BIIB $CELG $GILD $ABBV https://t.co/RSXWjVeRxWRT @aschwartzphd: $ARWR Mkt cap 400MM + data HBV in RX naive. $GBIM Mkt cap 10MM, low float with likely + HBV data &amp; trial run by $GILD-cra‚Ä¶RT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶RT @JohnTuckerPhD: Unclear how this fits with $GILD sofosbuvir license to Patent Pool, which does not cover middle income countries.‚Äú@BMTEdny: Impressive sofos/velpat + GS-9857 TE (incl DAA) GT1-6 study 1168/1169 $GILD #ILC2016 https://t.co/MIdrVzJJYk‚ÄùRT @BMTEdny: Impressive sofos/velpat + GS-9857 TE (incl DAA) GT1-6 study 1168/1169 $GILD #ILC2016 https://t.co/MtL3duKQT2RT @aschwartzphd: $ARWR Mkt cap 400MM + data HBV in RX naive. $GBIM Mkt cap 10MM, low float with likely + HBV data &amp; trial run by $GILD-cra‚Ä¶RT @aschwartzphd: $ARWR Mkt cap 400MM + data HBV in RX naive. $GBIM Mkt cap 10MM, low float with likely + HBV data &amp; trial run by $GILD-cra‚Ä¶RT @amandamicklus: Lots #NASH deals, $GILD/Nimbus, $TBRA/Dong-A &amp; $SNTA reverse merger w/ Madrigal; Madrigal formed out of VIA Pharma, form‚Ä¶RT @amandamicklus: Lots #NASH deals, $GILD/Nimbus, $TBRA/Dong-A &amp; $SNTA reverse merger w/ Madrigal; Madrigal formed out of VIA Pharma, form‚Ä¶Lots #NASH deals, $GILD/Nimbus, $TBRA/Dong-A &amp; $SNTA reverse merger w/ Madrigal; Madrigal formed out of VIA Pharma, former Roche compoundsL &amp; S Advisors Inc Sells 1,256 Shares of Gilead Sciences, Inc. $GILD https://t.co/d2TNwh64zeAn Application for the Trademark ""A CURE FOR EVERY TYPE"" Has Been Filed by #GileadSciences. Read more: https://t.co/gZP0JVp7FL $GILDL &amp; S Advisors Inc Sells 1,256 Shares of Gilead Sciences, Inc. $GILD https://t.co/LJ8lXTQxEXGilead's Earnings Are Not What You Think They Are https://t.co/PEkNlStyN7 $GILDGilead $GILD Stock Gained Today, Barclays Anticipates Q1 Earnings Beat https://t.co/ihd05dPtcwGilead $GILD Stock Gained Today, Barclays Anticipates Q1 Earnings Beat https://t.co/fLAyya6hlP #StockActionArrowhead Pharmaceuticals Inc Attractive for Gilead https://t.co/PrpwxnEm8p $GILD https://t.co/Dtcc1UxnviNasdaq100 #Stocks Performance $AAL $VRTX $TSCO $EXPE $CTXS $WFM $PCLN $NFLX $AMZN $ALXN $GILD $CERN $MYL  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Performance $BAC $OXY $C $BLK $JPM $MET $PCLN $AMZN $GILD $COF $MRK $COP $UNP $GS $BK $MS  more@ https://t.co/cKkr8cKsju$IONS owns $RGLS shares gets royalties. Own both.  #biotech #RNA $IBB $MRK $GILD $IBB $ALNY https://t.co/W6nMvqhwSBRT @ben_levisohn: Gilead Sciences: Maybe It‚Äôll Beat After All? https://t.co/1ve2r7WgM7 via @barronsonline $GILD $AMGN $CELG $BIIB $IBBTrading Rules - Discipline and staying strong: https://t.co/vVZZyIZdvD $GILD $TTWO $GM $SCO $REXX $YUM $ABBV $UCO $NXPI $USO $WPRTDave-Trading ‚Äì April Edition $ABBV $AGN $BIIB $CELG $GILD https://t.co/ePbpZeVU36RT @CatalystWatcher: The GS-4774 primary endpoint was reached in February. $GILD has been looking at data for a while now. Only a matter of‚Ä¶The GS-4774 primary endpoint was reached in February. $GILD has been looking at data for a while now. Only a matter of time for $GBIM.RT @JSTBiotech: @BlinkX90 @SheffStation yup, easier population, plus they will get a large milestone if $GILD proceeds into ph2b or ph3 aft‚Ä¶RT @BlinkX90: @SheffStation $GBIM 2nd HBV trial for treatment naive patients (easier population) funded by $GILD, believe $170m milestones‚Ä¶RT @BMTEdny: Impressive sofos/velpat + GS-9857 TE (incl DAA) GT1-6 study 1168/1169 $GILD #ILC2016 https://t.co/MtL3duKQT2$GILD coming back is good for my portfolio, I think it will be over 130 in long term.Healthy consolidatio\u2026 $GILD https://t.co/SAq0ujZogGRT @CatalystWatcher: Not to mention this was an open label trial and $GILD CHOSE to share 24-week data with $GBIM unlike with the 1st one h‚Ä¶RT @aschwartzphd: $ARWR Mkt cap 400MM + data HBV in RX naive. $GBIM Mkt cap 10MM, low float with likely + HBV data &amp; trial run by $GILD-cra‚Ä¶$GILD:

Analysts give average Rating of ‚ÄúBuy‚Äù to Gilead Sciences, Inc ‚Ä¶:

https://t.co/6d72sf7Xr5Gilead Sciences, Inc. $GILD Rating Reiterated by Robert W. Baird https://t.co/EpqkWV74xBGilead Sciences: Maybe It‚Äôll Beat After All? https://t.co/vU2x49wQGE via @barronsonline $GILD $CELG $AMGN $BIIB $IBBGilead Sciences, Inc. $GILD Rating Reiterated by Robert W. Baird https://t.co/brCVMNs9ZSTop picks from @modelpriceguy: Gilead Sciences, General Electric &amp; Apple $GILD $GE $AAPLGilead Sciences: Maybe It‚Äôll Beat After All? https://t.co/1ve2r7WgM7 via @barronsonline $GILD $AMGN $CELG $BIIB $IBBRT @SAlphaTrending: Allergan: Life After Pfizer https://t.co/f1nO44beQj $AAPL #APPLE $AMGN $AXP $BA $CMI $CSCO $ETN $EV $FCF $GILD $IBM $IN‚Ä¶Past picks from @modelpriceguy returned -4.52 Intel $INTC (-1.89%) Cisco $CSCO (-1.96%) &amp; Gilead Sciences $GILD (-9.71%)#Bot May 97.5 Calls $GILDAllergan: Life After Pfizer https://t.co/f1nO44beQj $AAPL #APPLE $AMGN $AXP $BA $CMI $CSCO $ETN $EV $FCF $GILD $IBM $INTC $MSFT $ORCL $PFERT @R4inb0w_: $GNFT $GILD 
Interventions de GENFIT et GILEAD au programme aujourd'hui de l' #ILC2016 √† Barcelone https://t.co/xZp1YN1WBU@BioStockAddict you gave them a week, they take you seriously I guess :-) $gildTraders Buy Shares of Gilead Sciences, Inc. $GILD on Weakness https://t.co/E6ZIegBQcmRT @WallStJesus: $GILD APRIL BULL FLOW THIS MORNING  ..Traders Buy Shares of Gilead Sciences, Inc. $GILD on Weakness https://t.co/I6u325YKyN$GILD HOD. Go baby go !after a crazy choppy morning, a lot of great setups playing out and forming bull flags at HODs
$NXPI $LULU $OXY $CRM $GILD $AMZN $FB $C $AALRT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶Commented on Yes, Allergan Is Pretty Cheap https://t.co/5OG6cctYHd $ABBV $GILD $MYL $ABT $GSK $AZN $BMY $LLY $MRK $AGNNot to mention this was an open label trial and $GILD CHOSE to share 24-week data with $GBIM unlike with the 1st one https://t.co/30gFo6w9DXRT @aschwartzphd: $ARWR Mkt cap 400MM + data HBV in RX naive. $GBIM Mkt cap 10MM, low float with likely + HBV data &amp; trial run by $GILD-cra‚Ä¶$ARWR Mkt cap 400MM + data HBV in RX naive. $GBIM Mkt cap 10MM, low float with likely + HBV data &amp; trial run by $GILD-crazy move potential.@BlinkX90 @SheffStation yup, easier population, plus they will get a large milestone if $GILD proceeds into ph2b or ph3 after this trialRT @BlinkX90: @SheffStation $GBIM 2nd HBV trial for treatment naive patients (easier population) funded by $GILD, believe $170m milestones‚Ä¶$GILD SVR12 pangenotype very impressive  https://t.co/vrsEmBGKGv@SheffStation $GBIM 2nd HBV trial for treatment naive patients (easier population) funded by $GILD, believe $170m milestones still due.Impressive sofos/velpat + GS-9857 TE (incl DAA) GT1-6 study 1168/1169 $GILD #ILC2016 https://t.co/MtL3duKQT2RT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶RT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶You people may find this article of interest on $GILD, $UTHR and the Pulmonary Arterial Hypertension https://t.co/CXRdH58YeqNasdaq100 #Stocks Trend $PCLN $BIDU $GILD $CHKP $CTRP $EBAY $NFLX $CTXS $NVDA $AAPL $FOXA $LMCA $NXPI $ULTA  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $AAL $PCLN $BIDU $TSCO $GILD $EXPE $AMZN $CHKP $GOOGL $ORLY $WFM $CERN $FB  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $C $OXY $JPM $PCLN $COF $BK $GILD $BLK $DD $USB $DOW $MA $BMY $UTX $AXP $ABT $MDT $AAPL  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $BAC $C $OXY $JPM $PCLN $GS $COF $BK $GILD $NKE $BLK $DD $USB $DOW $MET $V  more@ https://t.co/cKkr8cKsjuRT SeekingAlpha: Yes, Allergan Is Pretty Cheap https://t.co/QAN2dtplq7 $ABBV $GILD $MYL $ABT $GSK $AZN $BMY $LLY $MRK $AGNEgerton Capital UK LLP Sells 1,299,329 Shares of Gilead Sciences, Inc. $GILD https://t.co/j0hEAvTWI5Egerton Capital UK LLP Sells 1,299,329 Shares of Gilead Sciences, Inc. $GILD https://t.co/ctR1GnLc2iYes, Allergan Is Pretty Cheap https://t.co/rf4CiCbUEq $ABBV $GILD $MYL $ABT $GSK $AZN $BMY $LLY $MRK $AGNRT @JohnTuckerPhD: Unclear how this fits with $GILD sofosbuvir license to Patent Pool, which does not cover middle income countries.APD Market Cap
See Here ---&gt; https://t.co/ULftpNazT2

$APD $GILD $OMI #investYes, Allergan Is Pretty Cheap https://t.co/PRdrvAVYPM $ABBV $GILD $MYL $ABT $GSK $AZN $BMY $LLY $MRK $AGNRT @BPGAG: $IBB $CELG $GILD short-term bearish - too many eyeballs with big sentiment shift recently - it's a rotational market here #biote‚Ä¶RT @R4inb0w_: $GNFT $GILD 
Interventions de GENFIT et GILEAD au programme aujourd'hui de l' #ILC2016 √† Barcelone https://t.co/xZp1YN1WBUGreat article about $GILD and $TEVA - summary with target price and interesting explanation
https://t.co/Cw7oXhsC3pMorning Session Update 2 Wins/2 Loss $AAPL $WMB $GILD $V #stocktrading #stockmarket #stocktrader #equity #futures #forex #consistencyMorning Session Update 2 Wins/2 Loss $AAPL $WMB $GILD $V #trading #stocks #equities #training #stockmarket #daytrade https://t.co/ZFQ7eSdfXAVolume Alert - GILD 98.36 Gilead Sciences Inc $GILD Hit a high today of 98.69 Closing the day 10:30 at 98.36 + https://t.co/mwcjiQOMPiYes, Allergan Is Pretty Cheap https://t.co/P17JuZRet3 $ABBV $GILD $MYL $ABT $GSK $AZN $BMY $LLY $MRK $AGNGood question. $GILD https://t.co/VryZqgweTK$IBB $CELG $GILD short-term bearish - too many eyeballs with big sentiment shift recently - it's a rotational market here #biotech #stocks$HALO - making preparations to Test/Treat Solid Tumors for HA/KRAS/BRAF-will @RHHBY $MRK/ $BMY/ $GILD/ $AMGN follow? https://t.co/zxhCAAe701Rotating Into Health Care $BSX $VRX $IBB $REGN $AMGN $BIIB $CELG $GILD $ABBV https://t.co/ryU7n7HbtZGILD Top news - Apr 14th, 2016 $GILD https://t.co/ZhThnw4BHw$GILD strong againRT @WallStJesus: LIGHT ACTION EARLY: BULL FLOW LED BY $UVXY PUT BUYING, $XLE CALL SWEEPER -- $NFLX CALL SPD, $GILD BULL FLOW@portefeuillefun how about $gild maybe breaking 100 soon?  Could that break your boredness?RT @WallStJesus: LIGHT ACTION EARLY: BULL FLOW LED BY $UVXY PUT BUYING, $XLE CALL SWEEPER -- $NFLX CALL SPD, $GILD BULL FLOW$GILD:US Gilead Sciences, Inc. (GILD) Shares Bought by Calamos Wealth Management LLC #GILEAD SCIENCES INC  https://t.co/WxLAwM581k #NASDAQRT @WallStJesus: $GILD APRIL BULL FLOW THIS MORNING  ..RT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyRT @WallStJesus: LIGHT ACTION EARLY: BULL FLOW LED BY $UVXY PUT BUYING, $XLE CALL SWEEPER -- $NFLX CALL SPD, $GILD BULL FLOWLIGHT ACTION EARLY: BULL FLOW LED BY $UVXY PUT BUYING, $XLE CALL SWEEPER -- $NFLX CALL SPD, $GILD BULL FLOWRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyICYMI: 4/13/16 VIDEO ANALYSIS: $AAPL $GPRO $TWTR $FB $BIDU $CMG $COST $DIS $GILD https://t.co/r1VWdPqsPpRT @DeviantCharts: $GILD UP IN EARLY TRADE$GILD UP IN EARLY TRADE$GILD Squeeze coming https://t.co/rHP7INisUP$GILD wheeeeRT @R4inb0w_: $GNFT $GILD 
Interventions de GENFIT et GILEAD au programme aujourd'hui de l' #ILC2016 √† Barcelone https://t.co/xZp1YN1WBU$GILD breaking out of the pennant noted the other dayRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyRT @R4inb0w_: $GNFT $GILD 
Interventions de GENFIT et GILEAD au programme aujourd'hui de l' #ILC2016 √† Barcelone https://t.co/xZp1YN1WBUAdded to $GILD $98.46 avgRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyRT @R4inb0w_: $GNFT $GILD 
Interventions de GENFIT et GILEAD au programme aujourd'hui de l' #ILC2016 √† Barcelone https://t.co/xZp1YN1WBURT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyRT @BioStockAddict: @BioStockAddict $98.07. Come on baby. 2 more days. Show me $100. $GILDRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyStarted a #trading S $GILD $98.20 avg $VXX trade solely to generally protect against big run-up into earnings$GNFT $GILD 
Interventions de GENFIT et GILEAD au programme aujourd'hui de l' #ILC2016 √† Barcelone https://t.co/xZp1YN1WBU$GILD looking to 101$GILD calls working$GILD APRIL BULL FLOW THIS MORNING  ..RT @BioStockAddict: @BioStockAddict $98.07. Come on baby. 2 more days. Show me $100. $GILD@BioStockAddict $98.07. Come on baby. 2 more days. Show me $100. $GILD$GILD after coiling forever yesterday is moving.Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOey$AAPL $FB $AMZN $PG $MCD $GS $C $GE $UTX $SLB $XOM $GOOGL $AGN $WMT $QQQ $IWM $GILD $HON $JPM $DIS #market mixed. https://t.co/4DMUJP9xNSRT @OpenOutcrier: $GILD Apr 96 Call Buyer +1k for $1.69RT @OpenOutcrier: $GILD Apr 96 Call Buyer +1k for $1.69RT @BMTEdny: TAF shows sim efficacy in #HBV pts w/improved results in bone density &amp; renal safety in PIII at wk48 #ILC2016 $GILD https://t.‚Ä¶RT @OpenOutcrier: $GILD Apr 96 Call Buyer +1k for $1.69$GILD Apr 96 Call Buyer +1k for $1.69RT @pharmalot: Pharmalot.. Pharmallittle.. Good Morning.. a $300 #hepatitis C pill is being developed. https://t.co/4KsjKk0dhN #pharma $GIL‚Ä¶TAF shows sim efficacy in #HBV pts w/improved results in bone density &amp; renal safety in PIII at wk48 #ILC2016 $GILD https://t.co/i6q1AdFo7GRT @pharmalot: Pharmalot.. Pharmallittle.. Good Morning.. a $300 #hepatitis C pill is being developed. https://t.co/4KsjKk0dhN #pharma $GIL‚Ä¶RT @pharmalot: Pharmalot.. Pharmallittle.. Good Morning.. a $300 #hepatitis C pill is being developed. https://t.co/4KsjKk0dhN #pharma $GIL‚Ä¶Pharmalot.. Pharmallittle.. Good Morning.. a $300 #hepatitis C pill is being developed. https://t.co/4KsjKk0dhN #pharma $GILD $AMPH #opioidsJBEM pick CYDY runng hard, FLKS is nxt: https://t.co/RJhHbIwnlX $GEVA $GFOO $GFOOE $GILD $GILD.MX $GIS.DE $GLMD $GLPG.BRPer @DNDi, 42 million HCV infected people live in middle income countries not impacted by $GILD's patent pool licensesUnclear how this fits with $GILD sofosbuvir license to Patent Pool, which does not cover middle income countries.Merck's Zepatier beats Sovaldi + pegIFN/RBV in late-stage HCV study $MRK $GILD $ABBV $BMY https://t.co/gswTntVYrcStock Chart Technical Analysis Video 4/13/16 
  https://t.co/MbYVn7T0Bb
  $AAPL $AMGN $IDU $CMG $COST $DIS $GILD $GPRO $FB $TWTRRT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶Oh, this is bad! Merck's Zepatier beats Sovaldi + pegIFN/RBV in late-stage HCV study $MRK $GILD $ABBV $BMY $RGLS https://t.co/39ijbcxDFdRT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶$GILD:

Stocks within Analysts Screening: Gilead Sciences, Inc. (NASDAQ ‚Ä¶:

https://t.co/UUMYUyQx25RT @AndyBiotech: $GILD It's rather vague how @DNDi licensed Sofosbuvir in its report:
https://t.co/2Ud2dpMW5s
@dsobek @ColeTFRoberts https:‚Ä¶Merck&amp;#39;s Zepatier beats Sovaldi + pegIFN/RBV in late-stage HCV study https://t.co/2Bv5GnCuA6 $MRK $GILD $ABBV $BMYRT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶Merck's Zepatier beats Sovaldi + pegIFN/RBV in late-stage HCV study https://t.co/E31pV1tIH7 #premarket $MRK $GILD $ABBV $BMYMerck's Zepatier beats Sovaldi + pegIFN/RBV in late-stage HCV study https://t.co/0YKDcjmmz8 #premarket $MRK $GILD $ABBV $BMYMerck's Zepatier beats Sovaldi + pegIFN/RBV in late-stage HCV study https://t.co/gG3f4jH9vm #premarket $MRK $GILD $ABBV $BMYTLP Quotes
See Here ---&gt; https://t.co/lKRznSnxy0

$TLP $ROVI $GILD #shareCheap call option upside: $GILD calls cheaper than 100% of history, $DAL 100%, $LOW 99%, $DIS 97%, $HD 96%, $BABA 96%, $XLI 95%Healthcare &amp; Basic Materials Stock Buzz: $GILD $REXX https://t.co/fvzWYDZn43Short Interest in #GileadSciences, Inc. Declines By 8.3%. Read more: https://t.co/nQScHeB1YX $GILDRT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶RT @lancejepsen: Gilead Sciences Gets FDA Approval For Genvoya $GILD https://t.co/9F9Nm67PRE https://t.co/nIvlJM9dmgCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5@DR_tweetUK Do you have the data for #HBV &amp; #NASH prevelance worldwide and in geographic regions? Trying to understand $GILD's pipeline
$IBB$GILD is so grossly undervalued
#HCV prevelance huge
Any feedback on #HIV #cure potential?
https://t.co/HwDjHXOHTl https://t.co/LkoiiF1Rtx$GILD:

Short Interest in Gilead Sciences, Inc. (GILD) Declines By 8.3%:

https://t.co/7jJqY4VX9WConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5t0Bl  $DIS $ALXN $NOAH $GILD $QUNR$GILD:US Gilead Sciences, Inc. (GILD) Shares Bought by Calamos Wealth Management LLC #GILEAD SCIENCES INC  https://t.co/j5AEttPjAW #NASDAQ@iangtobin Even $GILD's pricing ex-US/EU strategy, laudable though it appears, is a fairly crude approach to large and varied geographies.$GILD:US Gilead Sciences, Inc. (GILD) Shares Bought by Calamos Wealth Management LLC #GILEAD SCIENCES INC  https://t.co/CszQj62kTf #SP500$ABBV $GILD $RX:

Prescription Drug Spending Hits Record $425 Billion in U.S.:

https://t.co/dfnn9sMA0gGILD Ideas
See Here ---&gt; https://t.co/P37nLXhD36

$GILD $PGX $ABC #stocksRT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶Comerica Bank Cuts Stake in #GileadSciences, Inc. (). Read more: https://t.co/IryiyzbYGi $GILDRT @reshmagar: .#BPCLive No sir-@RonWyden @ChuckGrassley found that $GILD INAPPROPRIATELY priced #HCV drug, period, putting profit above pt‚Ä¶RT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶RT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶RT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶RT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶Cheap put options and hedges: $DAL puts cheaper than 98% of history, $T 94%, $LOW 92%, $GILD 91%, $GE 87%, $AAPL 86%, $XLI 86%RT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶{NEW VIDEO} 4/13 CHARTS: $AAPL $GPRO $TWTR $FB $BIDU $CMG $COST $DIS $GILD -CLICK THE LINK&gt; https://t.co/S6EwRw6qQG https://t.co/53dp9JMsZDRT @AndyBiotech: $GILD $ABBV $MRK --&gt; #HCV treatment for under $300 coming soon 
https://t.co/E00dS4taAN

DNDi PR at #ILC2016 
https://t.co‚Ä¶Comerica Bank Cuts Stake in Gilead Sciences, Inc. $GILD https://t.co/XHuKrZYzrART @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶Gilead Sciences, Inc. $GILD Position Increased by Mitchell Capital Management Co. https://t.co/tKMccyHNRgRT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶Stevens Capital Management LP Has $20,066,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/QVr9BJP1vdRT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶RT @JohnCFierce: $GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://‚Ä¶$GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop #dumbbiotechreporting using U.S. pricing --
https://t.co/Cx40quSErw@CatalystWatcher @POTUSFerocUS @Smallinvestor81 I see, so if that is the case, does that mean they move to Ph3 or a Ph2b or depend on $GILD?@CatalystWatcher @POTUSFerocUS @Smallinvestor81 Pardon my ignorance, but with that P value &lt; 0.05 what does that mean for $GIBM and $GILD?$GILD expecting this to stall around 100-101, big position for me, huge win since the 90 breakout@SharKKuss I am long $gild ., sovaldi already sells for 500 in poor countries üòÄ$GILD up about 17% from our initial look Feb 7th. Keeping it real with a look back at our tweets https://t.co/zsGSBcx3T0",2016-04-14,GILD,1
12,".@autumnalcity87 will sell half of $GILD from this basket here soon.Commented on Yes, Allergan Is Pretty Cheap https://t.co/RiprwF7L50 $ABBV $GILD $MYL $ABT $GSK $AZN $BMY $LLY $MRK $AGN@jimcramer biopharma on the cheap from election fears? $GILD $LCIRT @R4inb0w_: #NASH Mkt : $GILD Gilead's New Nimbus NASH Asset May Require More-Frequent Dosing (Bloomberg BI) $ICPT $GNFT GENFIT https://t‚Ä¶$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $NASDAQ Have a good niight https://t.co/BHqyK18tOj$GILD:US Illumina (ILMN): Stock Poised to Beat Q1 Earnings #GILEAD SCIENCES INC  https://t.co/aKRkf3I0oF #NASDAQ$ABBV AbbVie looks to battle $GILD Gilead with new hep C data https://t.co/YxdBmjwSqp via @FierceBiotech$GILD:US Illumina (ILMN): Stock Poised to Beat Q1 Earnings #GILEAD SCIENCES INC  https://t.co/n5NZSU7ceZ #SP500Schroder Investment Management Group Has $258,604,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/DpAeqcUosCRT @RobertLKruse: @DoylestownKhan Well, many people speculate that $GILD will just buy whoever emerges as a successful drug, so you could j‚Ä¶RT @R4inb0w_: $GILD : Nimbus‚Äôs NDI-010976 may need more frequent
dosing vs Intercept‚Äôs OCA, Genfit‚Äôs elafibranor $GNFT #NASH https://t.co/R‚Ä¶RT @BMTEdny: Metabolic wrapup highlights target-based drugs in development for NAFLD/NASH #ILC2016 $ICPT $GILD $TBRA https://t.co/Au5vvKYfm5#GileadSciences Gilead Announces Multiple Scientific Presentations Demonstrating Broad Util... Read more: https://t.co/kvWgs5NatV $GILDCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5@DoylestownKhan Well, many people speculate that $GILD will just buy whoever emerges as a successful drug, so you could just look there.@RobertLKruse U are a smart chap. What company has the best chance in your opinion to HepB $arwr $alny $isis $gild or $abus or other?$GILD Gilead hep C cocktail cures a pocket of drug-resistant cases https://t.co/KAbGmhLaOw via @FierceBiotechRT @pharmalot: NY AG sues health insurer for restricting hepatitis C drug coverage.. who's next? https://t.co/qGcESh9IGm #pharma $GILD $ABB‚Ä¶American Capital Management Inc. Takes Position in Gilead Sciences, Inc. $GILD https://t.co/epBZngvegnLipe &amp; Dalton Invests $2,230,000 in Gilead Sciences, Inc. $GILD https://t.co/UEbPtLksmhAmerican Capital Management Inc. Takes Position in Gilead Sciences, Inc. $GILD https://t.co/LaAbWP6Zr4$WAT #biotech stock breaking long term resistance

$IBB $REGN $AMGN $GILD https://t.co/WVoeoeixZxEMA broadens scope of safety review for Hep C antivirals https://t.co/GQvbpsIlQE $GILD $BMY $ABBVRT @Pzaa_Guy: $GILD - There's a 0.0000000000028% Chance This Drug Doesn't Work https://t.co/TVB2nv2L8bGilead Sciences $GILD ‚Äì Research Analysts‚Äô Weekly Ratings Changes https://t.co/oBcF29MbxrRT @ReformedJoker: LUNCH NOTE https://t.co/Q8xVF7IQzA $SPX $EEM $SMH BULL MKT $AVGO $NVDA $INTC $MXL $MSFT $FB $NFLX $TSLA $UA $V $TGT $GIL‚Ä¶RT @ReformedJoker: LUNCH NOTE https://t.co/Q8xVF7IQzA $SPX $EEM $SMH BULL MKT $AVGO $NVDA $INTC $MXL $MSFT $FB $NFLX $TSLA $UA $V $TGT $GIL‚Ä¶Biotech stocks again: $GILD $CELG $ACAD $ARIA
https://t.co/5vg8vaVmQt#GileadSciences Gilead Presents New Data Highlighting Progress In Liver Fibrosis  . Read more: https://t.co/zvequmKpiP $GILDRT @ReformedJoker: $ES BULL NEVER LEFT $SMH $AVGO $INTC $NVDA $MXL $FB $NFLX $MSFT $TSLA $UA $V $TGT $GILD $GWPH 'RISK ON/OFF' OVER [L]earn‚Ä¶RT @Smallinvestor81: $GBIM imagine a co. trading at 12 million mkt cap, potentially worth 500 million just from $CELG .  Every program paid‚Ä¶I want to buy $GILD right now at 8.8 p/e but I know that Hillary Clinton's mission is to tank healthcare stocks...RT @R4inb0w_: $GILD : Nimbus‚Äôs NDI-010976 may need more frequent
dosing vs Intercept‚Äôs OCA, Genfit‚Äôs elafibranor $GNFT #NASH https://t.co/R‚Ä¶RT @R4inb0w_: $GILD : Nimbus‚Äôs NDI-010976 may need more frequent
dosing vs Intercept‚Äôs OCA, Genfit‚Äôs elafibranor $GNFT #NASH https://t.co/R‚Ä¶Price Target Alert: Trading the Zacks price target change for GILEAD SCIENCES¬†$GILD https://t.co/2z69EYHVn0 https://t.co/GykrcAUsQIICYMI: AbbVie looks to battle Gilead with new once-daily hep C data: https://t.co/CxdKZLY86s $GILD $ABBV via PharmaceuticBen story from Fi‚Ä¶ICYMI: AbbVie looks to battle Gilead with new once-daily hep C data: https://t.co/MFERH23gLE $GILD $ABBV via @PharmaceuticBen@RiskReversal @twitter I like the chart on $GILD here, earnings coming up and they are a cash cow. Need some M&amp;A though.What do $GILD, $AMGN, $CELG, $BIIB and $REGN have in common?  https://t.co/1HCajBGEJFthe other side of debate on drug pricing despite the drug effectiveness and patients being cured $GILD &amp; $ABBV  https://t.co/MPsq3LGSSmWhat do $GILD, $AMGN, $CELG, $BIIB and $REGN have in common?  https://t.co/iStSv03lAv$gild.. Type 1 and 2 Met... Free money at this point :)Another Study Finds Six Weeks of Harvoni Can Cure Acute #Hepatitis C https://t.co/NO2ToDJt3N #EASL #EASL2016 #ILC2016 $GILD$GILD:

Gilead Presents Multiple HCV and HBV Data at Liver Congress:

https://t.co/ynaafUdPbs$GBIM imagine a co. trading at 12 million mkt cap, potentially worth 500 million just from $CELG .  Every program paid for by $Celg or $GildCan New HCV Data Help AbbVie Inc Against #GileadSciences, Inc?. Read more: https://t.co/tmM7607idi $GILDRT @pharmalot: NY AG sues health insurer for restricting hepatitis C drug coverage.. who's next? https://t.co/qGcESh9IGm #pharma $GILD $ABB‚Ä¶$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Checking on Earnings:

https://t.co/wvpfP48hjO#Took #Profit May 97.5 Calls $GILD....+120%NY AG sues health insurer for restricting hepatitis C drug coverage.. who's next? https://t.co/qGcESh9IGm #pharma $GILD $ABBV $MRK#GileadSciences Gilead, AbbVie Tout Impressive Data for Hepatitis C Drugs . Read more: https://t.co/f6VqboU8WB $GILD#GileadSciences Gilead AbbVie Tout Impressive Data for Hepatitis C Drugs. Read more: https://t.co/IuCpXkxsT3 $GILDPepsi's Q1 - Flat At Best: No 'Alpha' Here, And What Looks Better https://t.co/BuwfwQekjv $ABBV $AMGN $BIIB $CELG $GILD $KO $NVO $PG $SPYRT SeekingAlpha: Pepsi's Q1 - Flat At Best: No 'Alpha' Here, And What Looks Better https://t.co/Wh9SvxqOE9 $ABBV $AMGN $BIIB $CELG $GILD $‚Ä¶Commented on Cheap Heroin: Gilead's X Factor https://t.co/nlHKgIzJyV $GILDPepsi's Q1 - Flat At Best: No 'Alpha' Here, And What Looks Better https://t.co/OfLkjcJ8Gj $ABBV $AMGN $BIIB $CELG $GILD $KO $NVO $PG $SPYGreat summary ahead of earnings in pharma sector: $ACAD $GILD $CELG $ARIA
https://t.co/5vg8vaVmQt$CELG &amp; $JUNO
https://t.co/hb0Pn87CWU
Another reason why $GILD should either
a. buy $CELG or
b. buy $ZIOP or
c. Buy them all!Volume Alert - GILD 99.41 Gilead Sciences Inc $GILD Hit a high today of 99.64 Closing the day 10:30 at 99.41 + https://t.co/CEwdyiZXzLRT @pharm_specialty: #GileadSciences Gilead unveils results From two phase 3 studies evaluating tenofovir alafen... Read more: https://t.co‚Ä¶#GileadSciences Gilead unveils results From two phase 3 studies evaluating tenofovir alafen... Read more: https://t.co/Ypw9yjghGi $GILD#GileadSciences Gilead unveils results From two phase 3 studies evaluating tenofovir alafen... Read more: https://t.co/l4XWkwMU4l $GILDRT SeekingAlpha: Continuing To Add To Allergan In A Portfolio Beating The Market https://t.co/5TLQP5hkva $BIIB $EV $GILD $GOOG $MHFI $ORLY‚Ä¶RT @BMTEdny: Metabolic wrapup highlights target-based drugs in development for NAFLD/NASH #ILC2016 $ICPT $GILD $TBRA https://t.co/Au5vvKYfm5Continuing To Add To Allergan In A Portfolio Beating The Market https://t.co/1rJ5o5LuBB $BIIB $EV $GILD $GOOG $MHFI $ORLY $PCLN $RHI $SWKSContinuing To Add To Allergan In A Portfolio Beating The Market https://t.co/ZRRWKcDS0v $BIIB $EV $GILD $GOOG $MHFI $ORLY $PCLN $RHI $SWKSContinuing To Add To Allergan In A Portfolio Beating The Market https://t.co/6MHMVqBJsl $BIIB $EV $GILD $GOOG $MHFI $ORLY $PCLN $RHI $SWKSGILD Top news - Apr 18th, 2016 $GILD https://t.co/AyxhI79XIkRT @R4inb0w_: $GILD : Nimbus‚Äôs NDI-010976 may need more frequent
dosing vs Intercept‚Äôs OCA, Genfit‚Äôs elafibranor $GNFT #NASH https://t.co/R‚Ä¶$GILD and $DIS pop$GILD:US Illumina (ILMN): Stock Poised to Beat Q1 Earnings #GILEAD SCIENCES INC  https://t.co/BTfah5V60F #NASDAQ$gild target  $99 #1  target #2  98.92...$gild short.. 99.30$gild looks ready to break through $100 PPS with new price targets.   $gbim should move on this too$GILD power house. :) Great bio tech and when it roars it's usually a good sign $LABU will follow$IBB $CELG $GILD $REGN $BIIB $XBI

super strong$GILD I love you$DIS $GILD
$FB üëÄRT @BPGAG: Odds of a ""blow-off top"" increasing by the day. #Doha - shrug; a correction is coming - eventually, but ... $IBB $YELP $GILD $X‚Ä¶$GILD $CELG $ACAD $ARIA https://t.co/0vTYqyicSvOdds of a ""blow-off top"" increasing by the day. #Doha - shrug; a correction is coming - eventually, but ... $IBB $YELP $GILD $X $STLD $TSLACowen Biotech Q1 Preview: $GILD $CELG $ACAD $ARIA 
https://t.co/bWKpDLdPuMAbbVie looks to battle Gilead with new once-daily hep C data: https://t.co/NpU9HKLHSo  $GILD $ABBVRT @R4inb0w_: $GILD : Nimbus‚Äôs NDI-010976 may need more frequent
dosing vs Intercept‚Äôs OCA, Genfit‚Äôs elafibranor $GNFT #NASH https://t.co/R‚Ä¶Happier Employees Make Companies Great  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx https://t.co/qJC2NqQFvXRT @R4inb0w_: $GILD : Nimbus‚Äôs NDI-010976 may need more frequent
dosing vs Intercept‚Äôs OCA, Genfit‚Äôs elafibranor $GNFT #NASH https://t.co/R‚Ä¶RT @FierceBiotech: AbbVie looks to battle Gilead with new once-daily hep C data: https://t.co/MFERH23gLE $GILD $ABBV via @PharmaceuticBenAbbVie looks to battle Gilead with new once-daily hep C data: https://t.co/CxdKZLY86s $GILD $ABBV via PharmaceuticBen story from FierceBio‚Ä¶AbbVie looks to battle Gilead with new once-daily hep C data: https://t.co/MFERH23gLE $GILD $ABBV via @PharmaceuticBenRT @TipRanks: Cowen Biotech Q1 Preview: $GILD $CELG $ACAD $ARIA https://t.co/3CoWF8SVhlCheap Heroin: Gilead's X Factor $GILD https://t.co/t8aR7osZfc$GILD : Nimbus‚Äôs NDI-010976 may need more frequent
dosing vs Intercept‚Äôs OCA, Genfit‚Äôs elafibranor $GNFT #NASH https://t.co/RvbMyzumvv$GILD New PDUFA Date 2016-11-11 GILEAD SCIENCES, INC. Link:https://t.co/7HwDEJW3gh Calendar:https://t.co/sCt1qKoMdr$PFE $GILD:

Friday Hot stocks: Pfizer, Inc. (NYSE:PFE) , Gilead Sciences, Inc ‚Ä¶:

https://t.co/r5KrFdYk3iRT SeekingAlpha: Why Express Scripts Is A Tremendous Opportunity For Long-Term Investors https://t.co/5WHnJvTiQy $ABBV $IMMY $GILD $WBA $C‚Ä¶Why Express Scripts Is A Tremendous Opportunity For Long-Term Investors https://t.co/Ewx04XmMkP $ABBV $IMMY $GILD $WBA $CVS $UNH $ESRXRT @R4inb0w_: #NASH Mkt : $GILD Gilead's New Nimbus NASH Asset May Require More-Frequent Dosing (Bloomberg BI) $ICPT $GNFT GENFIT https://t‚Ä¶RT SeekingAlpha: Cheap Heroin: Gilead's X Factor https://t.co/J8JBmtdbK1 $GILDWhat kind of asshole writes a piece like this? 

Cheap Heroin: Gilead's X Factor $GILD https://t.co/VEI9N6JflCCheap Heroin: Gilead's X Factor https://t.co/0CqN3TXfUn $GILDCheap Heroin: Gilead's X Factor https://t.co/mfBce0rlPU $GILDJBEM releases new pick 'MBVX'.Full DD here:  https://t.co/BXfT4dyvo5 $GIL $GILD $GILT $GIM $GIMO $GIS $GIVE $GJO$GILD $OUT:

Mix Wondering Stocks- Gilead Sciences (NASDAQ:GILD), Outfront ‚Ä¶:

https://t.co/BJRW8oHyuGRT @R4inb0w_: #NASH Mkt : $GILD Gilead's New Nimbus NASH Asset May Require More-Frequent Dosing (Bloomberg BI) $ICPT $GNFT GENFIT https://t‚Ä¶RT @fgusequity: $GILD https://t.co/dZWRGe19sM Pot. cont. Uptrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/TfGloAJ6PyRT @fgusequity: $GILD https://t.co/dZWRGe19sM Pot. cont. Uptrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/TfGloAJ6PyRT @fgusequity: $GILD https://t.co/dZWRGe19sM Pot. cont. Uptrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/TfGloAJ6Py$GILD https://t.co/dZWRGe19sM Pot. cont. Uptrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/TfGloAJ6PyBiotech Trade Alerts Archive -2016-04-15- $MRNS, $OREX, $ARIA, $RGLS, $ABBV, $GILD https://t.co/lrejaeXK2n$CYDY Reports Complete Viral Load Suppression with PRO140
 in HIV-Infected Patients for Up to 20 Months $GILD https://t.co/PnV0242VKxRT @R4inb0w_: #NASH Mkt : $GILD Gilead's New Nimbus NASH Asset May Require More-Frequent Dosing (Bloomberg BI) $ICPT $GNFT GENFIT https://t‚Ä¶Cheap call option upside: $DAL calls cheaper than 100% of history, $CRM 100%, $GILD 100%, $BBRY 100%, $LEN 100%, $LOW 99%, $SNDK 99%RT @R4inb0w_: #NASH Mkt : $GILD Gilead's New Nimbus NASH Asset May Require More-Frequent Dosing (Bloomberg BI) $ICPT $GNFT GENFIT https://t‚Ä¶RT @datamonitor_MH: SOF/VEL/GS-9857 effective as 12w salvage, but likely v. expensive as $GILD primary positioning it as 8w pan-GT standard‚Ä¶RT @R4inb0w_: #NASH Mkt : $GILD Gilead's New Nimbus NASH Asset May Require More-Frequent Dosing (Bloomberg BI) $ICPT $GNFT GENFIT https://t‚Ä¶RT @R4inb0w_: #NASH Mkt : $GILD Gilead's New Nimbus NASH Asset May Require More-Frequent Dosing (Bloomberg BI) $ICPT $GNFT GENFIT https://t‚Ä¶RT @R4inb0w_: #NASH Mkt : $GILD Gilead's New Nimbus NASH Asset May Require More-Frequent Dosing (Bloomberg BI) $ICPT $GNFT GENFIT https://t‚Ä¶RT @philstockworld: Philstockworld Top Trade Review: $AAPL $ABX $BA $CAKE $CMG $DIS $IBM $GILD $LL $UNG $SPY -- https://t.co/EX5SYjdwBC htt‚Ä¶RT @R4inb0w_: #NASH Mkt : $GILD Gilead's New Nimbus NASH Asset May Require More-Frequent Dosing (Bloomberg BI) $ICPT $GNFT GENFIT https://t‚Ä¶#NASH Mkt : $GILD Gilead's New Nimbus NASH Asset May Require More-Frequent Dosing (Bloomberg BI) $ICPT $GNFT GENFIT https://t.co/GJ4P0ECkN6Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5SOF/VEL/GS-9857 effective as 12w salvage, but likely v. expensive as $GILD primary positioning it as 8w pan-GT standard for tx-naive #HCV$GILD 99% SVR12 after 12 weeks of SOF/VEL/GS-9857 in tx-experienced GT-1-6 patients. 50% had comp. cirrhosis and 60% had baseline RAVs #HCV$GILD: Gilead Sciences present studies highlighting progress with approved therapies and investigational... https://t.co/3nX3shfL0m23:15--&gt; https://t.co/vqaokSKgmf

Also, see: https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/pE353zRirt$GILD:

HC Stocks Acts: Gilead Sciences, Inc. (GILD), Jazz Pharmaceuticals ‚Ä¶:

https://t.co/QyS8ebrxXKRT @DrSManian: $gbim data $gild https://t.co/KaB4GPQ7PVProblem for $RGLS and other HCV also-rans is that $GILD triple combo looks excellent.RT @bio_clouseau: $GILD 3DAA data for prior failed from yesterday.12 wk w/o RBV 99% across GT1-6 $ABBV $MRK $ENTA  https://t.co/c0DiZoBAbtRT @FierceBiotech: ICYMI: Gilead hep C cocktail cures a pocket of drug-resistant cases: https://t.co/inxhkcMfKe $GILD via @JohnCFierce http‚Ä¶$JNJ $GILD:

By How Much Will Johnson &amp; Johnson Raise Its Dividend This Week?:

https://t.co/ye1k26ONQeRT @theflynews: On The Fly: Top five weekend stock stories $AZN $MDVN $VZ $YHOO $TIME $GOOG $GOOGL $MRK $ABV $GILD $SGEN $BMY ... https://t‚Ä¶RT @theflynews: On The Fly: Top five weekend stock stories $AZN $MDVN $VZ $YHOO $TIME $GOOG $GOOGL $MRK $ABV $GILD $SGEN $BMY ... https://t‚Ä¶RT @theflynews: On The Fly: Top five weekend stock stories $AZN $MDVN $VZ $YHOO $TIME $GOOG $GOOGL $MRK $ABV $GILD $SGEN $BMY ... https://t‚Ä¶Stock trade alerts https://t.co/uAcamNRUPt JOIN NOW Promo https://t.co/e2zXG3II89 $MCUR $AMAT $ITUB $MT $GILD $HST $AA $GMRT @theflynews: On The Fly: Top five weekend stock stories $AZN $MDVN $VZ $YHOO $TIME $GOOG $GOOGL $MRK $ABV $GILD $SGEN $BMY ... https://t‚Ä¶On The Fly: Top five weekend stock stories $AZN $MDVN $VZ $YHOO $TIME $GOOG $GOOGL $MRK $ABV $GILD $SGEN $BMY ... https://t.co/UHaWn25DLYTrading Rules - Discipline and staying strong: https://t.co/vVZZyIZdvD $GILD $TTWO $GM $SCO $REXX $YUM $ABBV $UCO $NXPI $USO $WPRT@Nateballamolly $gild funded $gbim for these hepatitis results.@biotechnova $GILD (like) $AAPL; both r like blue whales; rel poor valuations 7-8x PEs, mkt thinks wat next (HepC, iPhone)@biotechnova @redacre $GILD went from $20B to $150B as well, more than comp for what they got. 1% exp success has led to 99% BLOAT.RT @Taq888: None of $GILD HepB drugs a) reduce HBsAg significantly  b) generate anti-HBs. None. $ARWR looking like a very attractive partne‚Ä¶@pbmech $GILD way more innovative than $AAPL",2016-04-18,GILD,1
13,"FULL GAME PLAN UP: https://t.co/5BNVcvV5YD ""ALL charts annotated"" $CPHD $NBIX $HIMX $ORCL $VWR $UNFI $GILD $V $GS https://t.co/abKG3autAIRT @bret_jensen: Commented on Biotech: The Rally Could Just Be Beginning https://t.co/kLEee0nLui $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $P‚Ä¶RT @raymond10mm: $GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $NASDAQ Have a good night. https‚Ä¶$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $NASDAQ Have a good night. https://t.co/yUUSxJ2bDXstuck to the plan and sold calls against my long today $GILD$GILD:US Insurers balk at paying for hepatitis C drugs #GILEAD SCIENCES INC  https://t.co/5U9IS4L1Nv #NASDAQ$GILD still increasing in strength from our Feb 7th call, but not extremely strong trend yet. https://t.co/46TFrfoZ5FRT @GeryDIVRY: $ICPT $GNFT $GLMD $GILD  a realistic market analysis on NASH 
https://t.co/CkQGQjGtKAAnother Study Finds Six Weeks of Harvoni Can Cure Acute #Hepatitis C https://t.co/NO2ToDJt3N #EASL #EASL2016 #ILC2016 $GILDFULL GAME PLAN UP: https://t.co/5BNVcvV5YD ""come see what we bring on a daily basis"" $CPHD $NBIX $HIMX $ORCL $VWR $UNFI $GILD $V $GS $APA@tijd de nieuwe aandelen voor $GILD zijn nog niet meegerekend bij uitgeven effecten en beurskapitalisatie. $GLPG

https://t.co/r0gGLDLxpk$GILD:

Top Stocks of the day: Gilead Sciences Inc. (NASDAQ:GILD):

https://t.co/WbqABPjSlwGilead Sciences, Inc. $GILD Position Increased by Palladium Partners LLC https://t.co/01vTKQrVCZ$GILD $GILD https://t.co/HGJXlY4MkbRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyGilead Sciences, Inc. $GILD Stake Increased by Cambridge Investment Research Advisors Inc. https://t.co/2fiIvgQZA5RT @tgtxdough: MTSL Comments on last week takeover chatter $RLYP $MDVN $GILD https://t.co/JfiTF3dsLmRT @SA_HealthInvest: Biotech: The Rally Could Just Be Beginning https://t.co/uFITPjZgzg $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $‚Ä¶Nelson Van Denburg &amp; Campbell Wealth Management Group LLC Has $1,223,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/LfFXDB9qXUNelson Van Denburg &amp; Campbell Wealth Management Group LLC Has $1,223,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/YyYn1909uSWhy I think this could be the beginning of a significant move in the sector... https://t.co/SZngMNkE1w $ABBV $AGN $AZN $GILD $PFE $SNY $VRXSuntrust Banks Inc. Has $42,354,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/672wc0r54YSuntrust Banks Inc. Has $42,354,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/mWK3knG4r7RT @TopGunFP: $GILD really shouldn't be this cheap: 7x $12 analysts '16 estimate.$GILD still undervalued.  Ready to move above $100 again soon.Commented on Biotech: The Rally Could Just Be Beginning https://t.co/kLEee0nLui $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRXRT @getvolatility: Cheap call option upside: $GILD calls cheaper than 100% of history, $CVS 100%, $DAL 100%, $ORCL 100%, $DOW 100%, $DHR 10‚Ä¶RT @getvolatility: Cheap put options and hedges: $DAL puts cheaper than 100% of history, $BBRY 99%, $GILD 97%, $T 97%, $DOW 90%, $CMCSA 90%‚Ä¶$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Check on Analyst Ratings:

https://t.co/sPcTOEiIigRT @tgtxdough: MTSL Comments on last week takeover chatter $RLYP $MDVN $GILD https://t.co/JfiTF3dsLmStock trade alerts https://t.co/uAcamNRUPt JOIN NOW Promo https://t.co/e2zXG3II89 $MCUR $AMAT $ITUB $MT $GILD $HST $AA $GMRT @R4inb0w_: ÈòÖËØªÂÖ≥‰∫éÈùûÈÖíÁ≤æÊÄßËÑÇËÇ™ËÇù : ÈùûÈÖíÁ≤æÊÄßËÑÇËÇ™ÊÄßËÇùÁÇé #NASH : GENFIT #Elafibranor $GNFT $ICPT $DSP $GILD https://t.co/NpjbES1bU3RT @R4inb0w_: #NASH Mkt : $GILD Gilead's New Nimbus NASH Asset May Require More-Frequent Dosing (Bloomberg BI) $ICPT $GNFT GENFIT https://t‚Ä¶3 Biotech Stocks That Could Endure Hillary Clinton $GILD $REGN $EBS https://t.co/AjpHQNQ3oW https://t.co/b0LhcBzHJ3RT @HCVNEWDRUGS: Gilead - Some Takeaways From The Recent Liver Meeting https://t.co/t0nZdlXxfo $ABBV $IBB $MRK $RGLS $GILDMy child just keeps on growing. Long on $GILD https://t.co/wZbbCgW1hjRT @tgtxdough: MTSL Comments on last week takeover chatter $RLYP $MDVN $GILD https://t.co/JfiTF3dsLmWhy Johnson &amp; Johnson‚Äôs Earnings are Good News for Big Biotech https://t.co/r02N0gTs19 via @barronsonline $JNJ $BIIB $AMGN $GILD $IBBMTSL Comments on last week takeover chatter $RLYP $MDVN $GILD https://t.co/JfiTF3dsLmRT @bs2537: Commented on Biotech: The Rally Could Just Be Beginning https://t.co/Rnw8VHXVKw $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $S‚Ä¶Commented on Biotech: The Rally Could Just Be Beginning https://t.co/Rnw8VHXVKw $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRX@jimcramer am i diversified $GILD $DUK $GLW $CSCO $NLY #madtweets #amidiversifiedBiotech: The Rally Could Just Be Beginning https://t.co/gKroXrjQdh $ABBV, $AGN, $AMGN, $AZN, $CELG, $GILD, $MDVN, $PFE, $SNY, $SGYP, $VRXBiotech: The Rally Could Just Be Beginning https://t.co/SZngMNCfq6 $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRXRT SeekingAlpha: Biotech: The Rally Could Just Be Beginning https://t.co/XL6qNoRfSX $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGY‚Ä¶Biotech: The Rally Could Just Be Beginning https://t.co/uFITPjZgzg $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRXJohnson &amp; Johnson‚Äôs earnings are good news for big biotechs Gilead Sciences, Biogen, Amgen
https://t.co/LZVFybMLA4 $JNJ $GILD $BIIB $AMGNÿßŸÑŸäŸàŸÖ Ÿäÿ¥ÿØŸàŸÜ ŸÅŸä ÿßŸÑÿ≥ŸàŸÇ ŸàŸäÿ¨ŸÑÿØŸàŸÜ ŸÅŸä ÿßŸÑÿ¥ÿ±ŸÉÿßÿ™ #ÿßŸÑÿØÿßŸà 
ŸÖŸÜ Ÿäÿ™ÿßÿ®ÿπ ÿßŸÑŸÖÿ§ÿ¥ÿ± ŸäŸÅŸàÿ™ ŸÉÿ´Ÿäÿ± ŸÖŸÜ ÿßŸÑŸÅÿ±ÿµ.. 
ÿπŸÜÿØŸä ÿµŸÅŸÇÿßÿ™ ŸÉŸàŸÑ ŸÅŸä $CHK $CVX $COP $GILD ŸàŸÇŸÜŸàÿπ ÿ®ÿßŸä ÿ±ÿ®ÿ≠ üòâ@stockingup333 but you're right it's not causing any uplift, just more of a single edged sword I guess.  Just glad $Gild is doing well$GILD touched $100 again earlier. That was pleasant.@petedoom I don't think $GILD breaking $100 affects $GBIM in any way.  What will affect $gbim is the ph2 results that $gild completed Feb.@shamokindam Yep, I'm long, and anticipating the ph2 results release soon, waiting on $GILD to provide details so $GBIM can PR results.RT @davidmilstead: These two stocks offer lessons in how not to go ‚Äòthe Valeant way‚Äô $DHR $GILD $VRX $VRX.CA https://t.co/MrJWy7J9ojOut of $GILD +3% since entry, looking a little overextended here, needs a breather5 Nasdaq 100 Stocks For Momentum Investors $CMCSA $CTXS $GILD $LLTC $NVDA https://t.co/Bd3W12cwg5These two stocks offer lessons in how not to go ‚Äòthe Valeant way‚Äô $DHR $GILD $VRX $VRX.CA https://t.co/MrJWy7J9ojhttps://t.co/KkHg4O78J2 &lt;&lt; 5 lessons for FREE from Tim https://t.co/KkHg4O78J2 TimSykes millionaire trader on $SPY $INO $SLV $GILD $CRUSLangfristiges Signal! $GILD: Ein Trendkanal wurde bei 100.343 USD nach oben durchbrochen:  https://t.co/DXb8Xt8ik2Gilead - Some Takeaways From The Recent Liver Meeting https://t.co/t0nZdlXxfo $ABBV $IBB $MRK $RGLS $GILDGilead - Some Takeaways From The Recent Liver Meeting https://t.co/FI3Qgd1M2A $ABBV $IBB $MRK $RGLS $GILDVolume Alert - GILD 100.69 Gilead Sciences Inc $GILD Hit a high today of 100.73 Closing the day 10:30 at 100.6 https://t.co/bJnJj2aa9LRT @R4inb0w_: ÈòÖËØªÂÖ≥‰∫éÈùûÈÖíÁ≤æÊÄßËÑÇËÇ™ËÇù : ÈùûÈÖíÁ≤æÊÄßËÑÇËÇ™ÊÄßËÇùÁÇé #NASH : GENFIT #Elafibranor $GNFT $ICPT $DSP $GILD https://t.co/NpjbES1bU3Biophrama, Tech, Small Caps, and Financials still nowhere near ATHs.  This rally has just begun - wake me up when $GILD and $AAPL top $150.Gilead - Some Takeaways From The Recent Liver Meeting https://t.co/RaJsGFeOon $GILD https://t.co/wIJ06ZjoitCommented on Cheap Heroin: Gilead's X Factor https://t.co/nlHKgIzJyV $GILD$JNJ $GILD:

Johnson &amp; Johnson Reports Q1 ‚Äì Review And Analysis:

https://t.co/dPv0lwtqXn$GILD:US Insurers balk at paying for hepatitis C drugs #GILEAD SCIENCES INC  https://t.co/OE1NLlFZDM #NASDAQGILD Top news - Apr 19th, 2016 $GILD https://t.co/IfTEo5lgnJ$GILD Gilead Retains Hep-C Market Dominance ‚Äì EASL Data - https://t.co/HijuzZD6Ah$GILD through $100. Love it. Going to hold through earnings.$GILD set-up noted last week - nearing first tgt area hereRT @BK_Stocks: Txt BKSTOCKS to 84483 for next $TPAC FREE Alert $SPY $CMG $YHOO $GILD $CMCSA $AMZN $GM $TSLA $MRK $USO $EURUSD $AAPL https:/‚Ä¶$gild $100 break.   Let's see if $gbim gets a sympathy move@CNBC $GILD poised for breakout to the upside!$GILD $100RT @GerberKawasaki: Gilead hit $100 yeah! We have our three horses over $100 again. $aapl $dis $gildRT @OptionSweeps: 1010 $GILD Fri 4/22 99.0 Calls (Wkly) $1.50Gilead hit $100 yeah! We have our three horses over $100 again. $aapl $dis $gildPlanning to sell some covered calls $GILDHow Fun Workplace Design Can Increase Productivity  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f $btu1010 $GILD Fri 4/22 99.0 Calls (Wkly) $1.50@BioStockAddict $GILD 100 dolla holla. 2 days late but still 100 dolla holla.Building a Powerful Brand by Creating More Value  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f https://t.co/OSMTBQtJaSRT @OG1949: $CELG, $GILD, $UTHR and other biotech's all slowly rising. This is my favorite sector based on growth prospects and reasonable‚Ä¶RT @GeryDIVRY: $ICPT $GNFT $GLMD $GILD  a realistic market analysis on NASH 
https://t.co/CkQGQjGtKAAnother Study Finds Six Weeks of #Harvoni Can Cure Acute #HepC https://t.co/j43HrJUfRN $GILD @GileadSciences #EASL #EASL2016 #ILC2016Favor Healthcare stocks like the traditionally strong $UNH, $JNJ, $BCR, $BDX, $SYK, while better risk rewards in $MDT, $GILD, $ALXN,  $XRAYCommented on Gilead - Some Takeaways From The Recent Liver Meeting https://t.co/17agYOfOSJ $ABBV $IBB $MRK $RGLS $GILD$CELG, $GILD, $UTHR and other biotech's all slowly rising. This is my favorite sector based on growth prospects and reasonable valuationsRT @R4inb0w_: $GILD : Nimbus‚Äôs NDI-010976 may need more frequent
dosing vs Intercept‚Äôs OCA, Genfit‚Äôs elafibranor $GNFT #NASH https://t.co/R‚Ä¶RT @SA_BioTech: The Hunt For Niches In Gilead's World https://t.co/ukYB4Jm9Qc $RGLS $ABBV $GILDRT @SA_BioTech: Gilead - Some Takeaways From The Recent Liver Meeting https://t.co/qZFA0pzpKK $ABBV $IBB $MRK $RGLS $GILDRT @TraderBiotech: Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @R4inb0w_: ÈòÖËØªÂÖ≥‰∫éÈùûÈÖíÁ≤æÊÄßËÑÇËÇ™ËÇù : ÈùûÈÖíÁ≤æÊÄßËÑÇËÇ™ÊÄßËÇùÁÇé #NASH : GENFIT #Elafibranor $GNFT $ICPT $DSP $GILD https://t.co/NpjbES1bU3$GILD $ABBV:

Gilead ‚Äì Some Takeaways From The Recent Liver Meeting:

https://t.co/h7CpUuEgInOver Keltner https://t.co/yQVnYY5ix9 ‚Ä¶ $IWM $GILD $AZN $FOX $BAX $VER $TNA $HCP $HON $CBG $ACN $PLD $AMGN $CRM $GOOG $ILMN $MDY $IWN$ABBV $GILD:

The Hunt For Niches In Gilead‚Äôs World:

https://t.co/vfm0zSCOexRT SeekingAlpha: Gilead - Some Takeaways From The Recent Liver Meeting https://t.co/EDRhuOgdI6 $ABBV $IBB $MRK $RGLS $GILDRT SeekingAlpha: The Hunt For Niches In Gilead's World https://t.co/25zQ5Kr65p $RGLS $ABBV $GILDGilead - Some Takeaways From The Recent Liver Meeting https://t.co/qZFA0pzpKK $ABBV $IBB $MRK $RGLS $GILDGilead - Some Takeaways From The Recent Liver Meeting https://t.co/9XEiVb5rzB $ABBV $IBB $MRK $RGLS $GILDThe Hunt For Niches In Gilead's World https://t.co/ukYB4Jm9Qc $RGLS $ABBV $GILDThe Hunt For Niches In Gilead's World https://t.co/qIWEaaUVxL $RGLS $ABBV $GILDRT @R4inb0w_: ÈòÖËØªÂÖ≥‰∫éÈùûÈÖíÁ≤æÊÄßËÑÇËÇ™ËÇù : ÈùûÈÖíÁ≤æÊÄßËÑÇËÇ™ÊÄßËÇùÁÇé #NASH : GENFIT #Elafibranor $GNFT $ICPT $DSP $GILD https://t.co/NpjbES1bU3ÈòÖËØªÂÖ≥‰∫éÈùûÈÖíÁ≤æÊÄßËÑÇËÇ™ËÇù : ÈùûÈÖíÁ≤æÊÄßËÑÇËÇ™ÊÄßËÇùÁÇé #NASH : GENFIT #Elafibranor $GNFT $ICPT $DSP $GILD https://t.co/NpjbES1bU3Will I finally get the $100 PT ive been waiting for on $GILD today!? IBB call sweepers active yesterday, let's see $300 by FridayRT @VERBEECK_A: $GNFT $GALE $ICPT $GILD $IMR St√©atoh√©patite non alcoolique Vue d'ensemble de pipeline de d√©veloppement de m√©dicament https:‚Ä¶Gilead Sciences, Inc. $GILD Receives A+ Credit Rating https://t.co/9XCsyBSdvrCheap call option upside: $GILD calls cheaper than 100% of history, $CVS 100%, $DAL 100%, $ORCL 100%, $DOW 100%, $DHR 100%, $DIS 100%5 Nasdaq 100 Stocks For Momentum Investors $CMCSA $CTXS $GILD $LLTC $NVDA https://t.co/TXikhyaoeE$GNFT $GALE $ICPT $GILD $IMR St√©atoh√©patite non alcoolique Vue d'ensemble de pipeline de d√©veloppement de m√©dicament https://t.co/cHEdEZxt1FCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5#GileadSciences Gilead Presents Multiple HCV and HBV Data at Liver Congress. Read more: https://t.co/ZLMuGoiOUp $GILDGilead Sciences, Inc. $GILD Receives Consensus Rating of ‚ÄúBuy‚Äù from Brokerages https://t.co/5nUTU1CpQ0$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating ‚Ä¶:

https://t.co/xdpApdXJzH$GILD:US Insurers balk at paying for hepatitis C drugs #GILEAD SCIENCES INC  https://t.co/tN6uCgZK0u #NASDAQ$GILD:US Gilead Sciences, Inc. (GILD) Shares Sold by Bradley Foster &amp; Sargent Inc. CT #GILEAD SCIENCES INC  https://t.co/ikrFqPrBo6 #SP500RT @FierceBiotech: ICYMI: AbbVie looks to battle Gilead with new once-daily hep C data: https://t.co/MFERH23gLE $GILD $ABBV via @Pharmaceut‚Ä¶$IBB base still looks good,needs 2move up soon 2keep symmetry. $BIIB eps 4/21, $GILD $CELG $AMGN eps 4/28. $LABU https://t.co/Rf3KvBgWHh5 Nasdaq 100 Stocks For Momentum Investors $CMCSA $CTXS $GILD $LLTC $NVDA https://t.co/Bd3W12cwg5RT @BK_Stocks: Txt BKSTOCKS to 84483 for next $TPAC FREE Alert $SPY $CMG $YHOO $GILD $CMCSA $AMZN $GM $TSLA $MRK $USO $EURUSD $AAPL https:/‚Ä¶RT @BK_Stocks: Txt BKSTOCKS to 84483 for next $TPAC FREE Alert $SPY $CMG $YHOO $GILD $CMCSA $AMZN $GM $TSLA $MRK $USO $EURUSD $AAPL https:/‚Ä¶RT @BK_Stocks: Txt BKSTOCKS to 84483 for next $TPAC FREE Alert $SPY $CMG $YHOO $GILD $CMCSA $AMZN $GM $TSLA $MRK $USO $EURUSD $AAPL https:/‚Ä¶Calamos Advisors LLC Has $53,815,000 Position in #GileadSciences, Inc. (). Read more: https://t.co/iov1BS91Zu $GILD#GileadSciences Her Majesty the Queen in Right of the Province of Alberta as represented by... Read more: https://t.co/Gh6kiinJiS $GILDCheap put options and hedges: $DAL puts cheaper than 100% of history, $BBRY 99%, $GILD 97%, $T 97%, $DOW 90%, $CMCSA 90%, $SDS 88%Not Viekira-Pak, but this once daily dosing can bite $GILD quite a bit.
https://t.co/3LfwrymbugNJ State Employees Deferred Compensation Plan Has $4,048,000 Position in Gilead Sciences, Inc. $GILD https://t.co/fTtKfuRDSNCalamos Advisors LLC Has $53,815,000 Position in Gilead Sciences, Inc. $GILD https://t.co/egA13UaGv4$GILD - NJ State Employees Deferred Compensation Plan Has $4,048,000 Position in Gilead‚Ä¶ https://t.co/6r18nh2A04$GILD - Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta‚Ä¶ https://t.co/JfUK0u91um$GILD - Calamos Advisors LLC Has $53,815,000 Position in Gilead Sciences, Inc. #GILD https://t.co/bRnfnqJCcr$GILD - NJ State Employees Deferred Compensation Plan Has $4,048,000 Position in Gilead‚Ä¶ https://t.co/6KS8k0WDGx$GILD - Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta‚Ä¶ https://t.co/HIKQKQjDDo$GILD - Calamos Advisors LLC Has $53,815,000 Position in Gilead Sciences, Inc. #GILD https://t.co/xlOrGi9qqCRT @BioWorld: Aiming to one-up $GILD in blood cancer, Chi-Med kicks off phase I trials for PI3Kd blocker$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Closes +0.93% For the Session:

https://t.co/pW4NA4cC0jRT @ReformedJoker: FYI MY ONLY $IBB NAMES $GWPH $GILD #BULLISH I GOTTA UNDERSTAND THE BUSINESS AND 99.9% IN THAT SECTOR UM NO!FYI MY ONLY $IBB NAMES $GWPH $GILD #BULLISH I GOTTA UNDERSTAND THE BUSINESS AND 99.9% IN THAT SECTOR UM NO!Aiming to one-up $GILD in blood cancer, Chi-Med kicks off phase I trials for PI3Kd blockerOver Keltner https://t.co/yQVnYYmTVJ $IWM $GILD $AZN $FOX $BAX $VER $TNA $HCP $HON $CBG $ACN $PLD $AMGN $CRM $GOOG $ILMN $MDY $IWN",2016-04-19,GILD,1
14,"RT @OphirGottlieb: (1/10)

Here comes a Biotech Chart Storm

$GILD Revenue

Story --&gt; https://t.co/LwvR17k08k https://t.co/TSaEhDFV1b$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Closes +0.67% For the Session:

https://t.co/eIOUnbRrm3RT @OphirGottlieb: (1/10)

Here comes a Biotech Chart Storm

$GILD Revenue

Story --&gt; https://t.co/LwvR17k08k https://t.co/TSaEhDFV1b(1/10)

Here comes a Biotech Chart Storm

$GILD Revenue

Story --&gt; https://t.co/LwvR17k08k https://t.co/TSaEhDFV1bRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶$GILD:US Baxter Bros Inc. Has $1,194,000 Position in Gilead Sciences, Inc. (GILD) #GILEAD SCIENCES INC  https://t.co/a8DuKHmyth #NASDAQ$GILD:US Baxter Bros Inc. Has $1,194,000 Position in Gilead Sciences, Inc. (GILD) #GILEAD SCIENCES INC  https://t.co/ImCFpHuDg6 #SP500Commented on Gilead - Some Takeaways From The Recent Liver Meeting https://t.co/17agYOfOSJ $ABBV $IBB $MRK $RGLS $GILD$GILD back above $100 as hoped.Gilead Sciences, Inc. $GILD Shares Sold by Condor Capital Management https://t.co/u6OU1EukwnRT @raymond10mm: $GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE nice rally &amp; profit taking https‚Ä¶RT @TraderBiotech: Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKjqBmDRT @Tootix: #NAFLD and Cardiovascular Risk: Pathophysiological Mechanisms and Implications #NASH $GNFT $ICPT $GILD https://t.co/qzDnF8JXilCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKjqBmD$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE nice rally &amp; profit taking https://t.co/rji9nMcgHlRT @Tootix: #NAFLD and Cardiovascular Risk: Pathophysiological Mechanisms and Implications #NASH $GNFT $ICPT $GILD https://t.co/qzDnF8JXil#NAFLD and Cardiovascular Risk: Pathophysiological Mechanisms and Implications #NASH $GNFT $ICPT $GILD https://t.co/qzDnF8JXilRT @fobmanny: @JimCramer: @GileadSciences #GileadSciences needs to do a deal $GILD https://t.co/3Ou6rfmeFb @sandeepmatai@JimCramer: @GileadSciences #GileadSciences needs to do a deal $GILD https://t.co/3Ou6rfmeFb @sandeepmataiRT SeekingAlpha: Gilead, The Investable Two Product Company https://t.co/aRrovwkGBa $GILDWhy It May Be Time to Get #BullishOnBiotech - #biotech our purpose is to provide institutional research to... https://t.co/Z6YEMsD0yV $GILDRT @ReformedJoker: WHAT A DIFFERENCE A TRADE MAKES! $ES $SMH $AVGO $INTC $NVDA $MXL $FB $MSFT $V $TGT $UA $TSLA $GILD $GWPH $TBT AND $VIX $‚Ä¶WHAT A DIFFERENCE A TRADE MAKES! $ES $SMH $AVGO $INTC $NVDA $MXL $FB $MSFT $V $TGT $UA $TSLA $GILD $GWPH $TBT AND $VIX $12-13 $UVXY WHY NOT!$GILD long continuing to work. If you GAF about valuation metrics: EV/EBITDA 6.4RT @pharm_specialty: Jim Cramer -- #GileadSciences Needs to Do a Deal. Read more: https://t.co/z5hqsmj9yd $GILDJim Cramer -- #GileadSciences Needs to Do a Deal. Read more: https://t.co/z5hqsmj9yd $GILDGilead, The Investable Two Product Company https://t.co/nCBr7zrrdo $GILDGilead, The Investable Two Product Company https://t.co/DjkjBmGNWO $GILDStock trade alerts https://t.co/uAcamNRUPt JOIN NOW Promo https://t.co/e2zXG3II89 $MCUR $AMAT $ITUB $MT $GILD $HST $AA $GMEaton Vance Management Cuts Stake in Gilead Sciences, Inc. $GILD https://t.co/7d0QObzIERCommented on What Caused Gilead Sciences' Recent Rally https://t.co/3rPnD8HRpa $MRK $GILD$JNJ $GILD $AMGN ""we have been impressed by magnitude of price increases taken by large brand biopharmaceutical..."" https://t.co/M9eHomLxTjRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @pharm_specialty: Jim Cramer -- #GileadSciences Needs to Do a Deal. Read more: https://t.co/XpR6Ptgwa0 $GILDJim Cramer -- #GileadSciences Needs to Do a Deal. Read more: https://t.co/XpR6Ptgwa0 $GILDRT @CatalystWatcher: To add - last year $GILD sent GS-4774 data from 1st trial to $GBIM late Tuesday. $GBIM reported Wednesday morning. Sam‚Ä¶What Caused Gilead Sciences' Recent Rally $GILD https://t.co/rBHhwG3dUMTo add - last year $GILD sent GS-4774 data from 1st trial to $GBIM late Tuesday. $GBIM reported Wednesday morning. Same thing will happen.RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶$GILD needs earning to get it through 200 day SMA.$GILD trading at ridiculously low multiples.$CELG trading at more normal levels. https://t.co/fJp9MEjCJmRT @StockNewsWires: $GILD:

Jim Cramer ‚Äî Gilead Sciences Needs to Do a Deal:

https://t.co/BBOdwL7NL6What Caused Gilead Sciences' Recent Rally $GILD https://t.co/sg4j762jZfRT @CatalystWatcher: It's been approx 51 days since end of Feb ~ 7.5 weeks. Based on historical average, $GILD should be close to sharing G‚Ä¶$GILD:

Jim Cramer ‚Äî Gilead Sciences Needs to Do a Deal:

https://t.co/BBOdwL7NL6Impressive how $GILD (in green) has clawed back, while $CELG hasn't done much last 6 months $XBI $IBB #drugs #pharma https://t.co/J2peM3brPBIt's been approx 51 days since end of Feb ~ 7.5 weeks. Based on historical average, $GILD should be close to sharing GS-4774 data with $GBIMSad if true....Drug prices to continue upward march according to bullish analyst https://t.co/T7wB093A1p $JNJ $AMGN $GILD $BIIB$GILD great technical action in this name...use these levels to trade against https://t.co/y4R10mx5knRT @bret_jensen: Commented on: ""Drug prices to continue upward march according to bullish analyst"" https://t.co/DN6lEzcBYp $JNJ $AMGN $GILD‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT SeekingAlpha: What Caused Gilead Sciences' Recent Rally https://t.co/AqZuFkeG6J $MRK $GILDDrug prices to continue upward march according t... $JNJ $AMGN $GILD $BIIB $LLY $BXLT $ABBV $CELG $BMY $SHPG https://t.co/2BAA3pyxhNRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Commented on: ""Drug prices to continue upward march according to bullish analyst"" https://t.co/DN6lEzcBYp $JNJ $AMGN $GILD $BIIBRT @Henry_Fund: HF Research analyst Charles Schaller (@BizCharlie) issues BUY rating on $GILD. Target price: $115-120. Report: https://t.co‚Ä¶What Caused Gilead Sciences' Recent Rally https://t.co/OLjwUiWlqC $MRK $GILDWhat Caused Gilead Sciences' Recent Rally https://t.co/nToqjvTZl6 $MRK $GILDRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶$GILD purchased compound in preclincal for #NASH for 1bill+ . $VBLT has 2 for #NASH https://t.co/GjjlMX3FD3 .. looking for partners.RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Drug prices are going higher, no matter what politicians say. Long $GILD $CELG $BIIB #biotech #investing #TomsTruths https://t.co/JK4HZtBvSsRT @Henry_Fund: HF Research analyst Charles Schaller (@BizCharlie) issues BUY rating on $GILD. Target price: $115-120. Report: https://t.co‚Ä¶On which planet is making money a bad thing? Bernie-land? Bizarro-topia? $JNJ $AMGN $CELG $GILD $BIIBDrug prices to continue upward march according to bullish analyst https://t.co/387j3fne6x $JNJ, $AMGN, $GILD, $BIIB, $LLY, $BXLT, $ABBVRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Volume Alert - GILD 100.54 Gilead Sciences Inc $GILD Hit a high today of 100.96 Closing the day 10:30 at 100.5 https://t.co/dBaJEpmi8dRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Drug prices to continue upward march according to bullish analyst https://t.co/NFrExlJjHu $JNJ $AMGN $GILD $BIIBDrug prices to continue upward march according to bullish analyst https://t.co/ho36OtNYMF $JNJ $AMGN $GILD $BIIBDrug prices to continue upward march according to bullish analyst https://t.co/UcFpuFuK7p $JNJ $AMGN $GILD $BIIBRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶HF Research analyst Charles Schaller (@BizCharlie) issues BUY rating on $GILD. Target price: $115-120. Report: https://t.co/G8CZhGeqR0RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Which stock will be the first to return to $120?
$CELG, $DIS or $GILD?

https://t.co/iClE4419yP
https://t.co/lMxakEziQuRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @OpenOutcrier: $GILD May 97.5 Call Buyers +1k for $5.00RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GILD $BIIB$gild been strong$GILD price target of $190 in 18 months.
Take advantage of the mispriced opportunity.

https://t.co/iClE4419yP
https://t.co/lMxakEziQuBiotech: The Rally Could Just Be Beginning https://t.co/7pMn9274WM $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRXRT @OpenOutcrier: $GILD May 97.5 Call Buyers +1k for $5.00$GILD moving up steadilyRT @OpenOutcrier: $GILD May 97.5 Call Buyers +1k for $5.00$GILD May 97.5 Call Buyers +1k for $5.00RT @OpenOutcrier: $GILD May 97.5 Call Buyers +1k for $5.00$GILD May 97.5 Call Buyers +1k for $5.00$GILD May 97.5 Call Buyers +1k for $5.00""We see upside to $GILD from outside-the-US Hep C sales...greater access in US from relaxed fibrosis restrictions.."" https://t.co/E1MDiwpWXdRT @GerberKawasaki: Our four horses all over $100 again. üê¥ $aapl $dis $gild $fb How do you like our ponies?Our four horses all over $100 again. üê¥ $aapl $dis $gild $fb How do you like our ponies?Happier Employees Make Companies Great  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx https://t.co/GKGFLw36mtHow Fun Workplace Design Can Increase Productivity  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f $btu https://t.co/xYspWtRsrQBuilding a Powerful Brand by Creating More Value  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f https://t.co/fgcZJk2OTTGILD Top news - Apr 20th, 2016 $GILD https://t.co/rHRBTNyiWd$GILD: ApproachingKeyLevel+ (100.00), 4:2Accel+Dy, tf:1101011, ch:+0.5%, 3MoHi+, bigFlt:1.4B, 30DyChgLo:+15%; TLM:1.2; ILM:1.5@jimcramer #CramerQ  $GILD  nice move lately lets get back over 100Commented on Biotech: The Rally Could Just Be Beginning https://t.co/kLEee0nLui $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRX@Varneyco @JeffDeWitAZ @realDonaldTrump Amen Brother!!! #MakeAmericaGreatAgain $twtr $opht $feye $regn $celg $gild$KRO $GILD:

Active Stocks to Watch: Kronos Worldwide, Inc. (NYSE:KRO), Gilead ‚Ä¶:

https://t.co/JW4bmKZRJK$GILD $BXLT:

Biotech Stocks: Repros Therapeutics Inc. (NASDAQ:RPRX), Illumina ‚Ä¶:

https://t.co/45m86lTP6Z$GILD:

Recent Analysts Rating Overview: Gilead Sciences, Inc. (NASDAQ ‚Ä¶:

https://t.co/nltRiGhLn64/20 watchlist:  long: $VMW, $FIT, $GPRO,  $WYNN  SHORT: $INTC, $NFLX, $VIAB, $AAPL, $APC, $GILD, $KO4/20 watchlist:  long: $VMW, $FIT, $GPRO,  $WYNN  SHORT: $INTC, $NFLX, $VIAB, $AAPL, $APC, $GILD, $KO$REGN under pressure after $WFC downgrade. $IBB $BIIB $CELG $GILDRT @AlphaAddict: $GILD $GBIM ""An estimated 240 million people worldwide are chronically infected w HBV"" https://t.co/V2QA4lISn2@JNapodano so what is your 12 month price target on $ATNM and do you think it's a #buyout target of $GILD $CELG $ABBV or a big #pharma?RT @fgusequity: $GILD https://t.co/dZWRGdJy4c Pot. pullback in Downtrend LONGERTERM Wly-Dly-Hly combo chart #trading #stocks https://t.co/n‚Ä¶$GILD https://t.co/dZWRGdJy4c Pot. pullback in Downtrend LONGERTERM Wly-Dly-Hly combo chart #trading #stocks https://t.co/nkHbHH820c$BSX $GILD:

Investor‚Äôs Watch List ‚Äì Boston Scientific Corporation, (NYSE:BSX ‚Ä¶:

https://t.co/Z0T611dlNgFULL GAME PLAN UP: https://t.co/5BNVcvDuA3 ""ALL charts annotated"" $CPHD $NBIX $HIMX $ORCL $VWR $UNFI $GILD $V $GS https://t.co/zgcBwHvuprXNET 52Wk High
See Here ---&gt; https://t.co/eFx80PvVdv

$XNET $GILD $FITX #nasdaqSold $GILD at $99.95 for a 19% gain not including profits from reinvested dividends. Congrats to those who bought with me on January 29th!$GILD Gilead Sciences is a 5 star üí∞ dividend üí∞ stock with a 1.8% yield: https://t.co/f4OVenc0Xj https://t.co/9FgTIL9y5uCheap call option upside: $DAL calls cheaper than 100% of history, $GILD 100%, $XLI 99%, $CMCSA 99%, $VZ 99%, $ORCL 99%, $LOW 99%CRD.B Company Info
See Here ---&gt; https://t.co/uAzxQaKmjU

$CRD.B $DIA $GILD #pennystocks$GILD:US Baxter Bros Inc. Has $1,194,000 Position in Gilead Sciences, Inc. (GILD) #GILEAD SCIENCES INC  https://t.co/3ptXLW18uf #NASDAQRT @MargaretDudley1: I worked 4 over 2 years trying to get cure for #hepC released by greedy pharma giant $Gild. Bernie was first 2call the‚Ä¶I worked 4 over 2 years trying to get cure for #hepC released by greedy pharma giant $Gild. Bernie was first 2call them out! #heppers4BernieRT @chartsmarter: FULL GAME PLAN UP: https://t.co/5BNVcvV5YD ""ALL charts annotated"" $CPHD $NBIX $HIMX $ORCL $VWR $UNFI $GILD $V $GS https:/‚Ä¶RT @Terri1618: $IBB base still looks good,needs 2move up soon 2keep symmetry. $BIIB eps 4/21, $GILD $CELG $AMGN eps 4/28. $LABU https://t.c‚Ä¶Potential Reversal / $GILD https://t.co/JtyNmfcFSn$GILD $GBIM ""An estimated 240 million people worldwide are chronically infected w HBV"" https://t.co/V2QA4lISn2Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5@stockingup333 @danwardbio roughly end of Feb.  $GILD is definitely making this HCV market get ramped up for something. Combo/cure perhaps.@danwardbio @Smallinvestor81 I'm just wondering what's taking so long to release data? $gild has data since end of Feb. right? $gbim PR cmon@danwardbio 2 are licensed to $Gild,  2 are $Celg 1 w/ option by $Celg the rest are theirs. those big companies are funding this Co.23:15--&gt; https://t.co/vqaokSKgmf

Also, see: https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/crmPzU2HGUCheap put options and hedges: $DAL puts cheaper than 100% of history, $GILD 95%, $LOW 93%, $T 93%, $DOW 91%, $TNA 91%, $UNH 90%Gilead Sciences, Inc. $GILD Stake Raised by Winton Capital Group Ltd https://t.co/8zNNTpKSOA$GILD vs OH 200sma https://t.co/vZh6LNhIpxElder Blue https://t.co/XTWMVZnAoQ $HMY $GILD $FOXA $XLK $XRX $MDLZ $CPXX $TWX $CNP $LABU $LOW $SLM $EXAS $XHB $AMZN $UTX $CMC $MNST",2016-04-20,GILD,1
15,"$GILD:

Stock Update (NASDAQ:GILD): Gilead Sciences to Release First ‚Ä¶:

https://t.co/Kla0ITO0ZZ#GileadSciences ""Rare innovation to cure a deadly disease"" - Gilead gives reasons why Harvo... Read more: https://t.co/IdQKTi7vzl $GILDThis is one bio that I really do like. $GILD https://t.co/6RZ3gOLmSE$GILD found that 101 PT today; took half profits for a double and letting the rest ride for ERRT @marketcall: .@ArrowCapital's Alex Ruus' top picks: Alaris Royalty, Gilead Sciences &amp; Magna International $AR $GILD $MGRT @Taarriqq: Sector analysis-Biotech $labu $xbi $gild $ibb support/res/trend/options flow analysis $spy +37k puts in OI $iwm $FB  https://‚Ä¶$GILD long.Expansion Breakout https://t.co/XTOCUCpUvr $CTXS $USG $JCI $BDN $TYC $IBN $AXP $FITB $DHR $DHI $PKG $SPLK $GILD $EXEL $UNXL $PTC $PLXS.@ArrowCapital's Alex Ruus' top picks: Alaris Royalty, Gilead Sciences &amp; Magna International $AR $GILD $MGInsider Selling: #GileadSciences, Inc. EVP Sells 40,000 Shares of Stock. Read more: https://t.co/BVrHaA6Fg4 $GILD$GILD. What &gt; 100, goes to 110? https://t.co/2NWCdf0ENoRT @biotechnova: $GLPG $GILD Galapagos reports additional data with
filgotinib from the Phase 2 FITZROY study https://t.co/u3sphaN9Lv$GILD Gilead Sciences to Release First Quarter 2016 Financial Results on Thursday, April 28, 2016 https://t.co/tc5Dpt3LwT#Biotech Recovery Rally: Steady As She Goes-#Biogen Rallies On Earnings $IBB $INCY $BIIB $GILD $XBI $XLV $AGIO $QQQ https://t.co/7mrFPj6HfURT @pharmamaven: ISI survey who $GILD should buy- agree w/ comment - GILD should buy $ZIOP before $MRK KGaA does. $XON $IBB $XBI $BTK https‚Ä¶$GILD Gilead Sciences to Release First Quarter 2016 Financial Results on Thursday, April 28, 2016
From our Stock News Alerts App$GILD - Gilead Sciences to Release First Quarter 2016 Financial Results on Thursday, April 28, 2016 https://t.co/A1951D6CfeCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5@Canuck_Technical_Trades both my $GILD holdings are finally green after many months. Not that I ever worry about the future of this company.RT @Taarriqq: Sector analysis-Biotech $labu $xbi $gild $ibb support/res/trend/options flow analysis $spy +37k puts in OI $iwm $FB  https://‚Ä¶RT @Taarriqq: Sector analysis-Biotech $labu $xbi $gild $ibb support/res/trend/options flow analysis $spy +37k puts in OI $iwm $FB  https://‚Ä¶Sector analysis-Biotech $labu $xbi $gild $ibb support/res/trend/options flow analysis $spy +37k puts in OI $iwm $FB  https://t.co/rRwtaRuVATRT @billgunderson: $GILD making a very nice move. Good chart. Quality biotechs on the move. No position in this one yet.5 days winning on $GILD. Surely it can't do a 6th? https://t.co/50CN8zmQds #stocks https://t.co/fGO8twqz1L@BioStocks @jq1234t Thought we'd get more data. Is it because $GILD partnership or less robust results?$GLPG $GILD Galapagos reports additional data with
filgotinib from the Phase 2 FITZROY study https://t.co/u3sphaN9LvI find it odd when folks don't appreciate SIMPLE GIANT DOMINANT BUSINESS $GILD  https://t.co/WoyCjzfaW5$GILD will not be announcing it's next gen business acquisitions today out of respect for Prince.@JustinPulitzer Is the $gild break through $101 sustainable?RT @OpenOutcrier: Biotechs closing on highs $GILD $AMGN $FOLD $BIIB $CELG#GileadSciences, Inc Q1 Earnings: Bull Run to End Soon. Read more: https://t.co/2EGANzMWjG $GILD$GILD Taking out the 200 day MA on close.CLOSING #BULLISH $ES NOTE: $UA 10YR HOLD BET THE #CEO #KevinPlank ON DECK #EARNINGS $MSFT $V $GOOGL | NOTABLES $GILD $NVDA $AVGO *MOORE  ...The strong stay strong. $GILDBiotechs closing on highs $GILD $AMGN $FOLD $BIIB $CELG@JustinPulitzer What are your thoughts on $gild now?$GILD:

Gilead Sciences Incorporated (NASDAQ:GILD) Sellers Covered ‚Ä¶:

https://t.co/ud01pguo0cInteresting but somehow odd gradual rise in $GILD stock price, but I still consider it significantly undervalued &amp; management underrated.@MadMoneyOnCNBC Which biotech has the most drugs in their pipeline? $BIIB $GILD $CELGHopefully can also get a sweet beat out of $GILD which reports earnings next week$GILD Quietly up nearly 25% from early Feb. bottom.#GileadSciences Descovy will help Gilead maintain HIV market dominance in short term: Report. Read more: https://t.co/sxZtky81B2 $GILD$GILD making a very nice move. Good chart. Quality biotechs on the move. No position in this one yet.Quite a run---maybe a little profit taking is due though before next week's earnings? $GILD https://t.co/3rt0S3HXk1RT @ChinaInvest: RT SeekingAlpha: Rotating Into Health Care https://t.co/9Mj0xg935p $ABBV $AMGN $BIIB $BSX $CELG $GILD $GLD $IBB $REGN $TMO‚Ä¶$GILD encountering overhead from 2015 as hits 2016 high &amp; touches 200dma first time since November https://t.co/dRwMF1ggO7@TweetLeni $GILD too , come on now.. 200 sma$HZNP great day here. Don't care how or why, just smiles also $GILD$GILD:

New Insider Transaction on GILD by EVP, Corp &amp; Med  Affairs:

https://t.co/wJXOuwKDOQ https://t.co/WmCHgtJYVYGilead Sciences, Inc. $GILD is Foresters Investment Management Company Inc.‚Äôs 5th Largest Position https://t.co/fLIwX1oG57$GILD:

Gregg Alton Unloaded $4000574 Worth of Gilead Sciences, Inc ‚Ä¶:

https://t.co/u2j0x36meT$GILD:

Analyst 52-Week Target Update : Gilead Sciences, Inc. (NASDAQ ‚Ä¶:

https://t.co/gO5uyN4KIBRT SeekingAlpha: Rotating Into Health Care https://t.co/9Mj0xg935p $ABBV $AMGN $BIIB $BSX $CELG $GILD $GLD $IBB $REGN $TMO $VRXGilead Sciences Q1 #Earnings: Bull Run to End Soon $GILD  --.&gt; https://t.co/8YO3YwsCRN https://t.co/duyVCdAYpc$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts App$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/AV4r9aUhVQ$GILD at 200 sma, fabulous, GILD aunty will now buy calls..NUGT Day High
See Here ---&gt; https://t.co/Kry7IuUAbf

$NUGT $GILD $MDR #investingBeat the index stocks, $SBAC, $ACN, $UNH,$LRCX,$SEE,$HCA ,$TSN, $GILD, $LUV,  $QVCA,$AMG,$STZ, https://t.co/KsMO2p5JO2$GILD at downtrend line from highs. #Resistance https://t.co/xCE9xYiDiUGILD Financials
See Here ---&gt; https://t.co/CyRSEYS8bE

$GILD $MU $SKY #invest$GILD filled the gap and kissed the declining 200dma - I'd take and trim from the flag b/o noted last week#Took #Profit May 97.5 Calls $GILD (#Remaining 1/2 #Position)....+240%RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶$GILD Continues to lead!RT SeekingAlpha: Can Humira Still Dominate In 2022? https://t.co/Ev9YbEQdy8 $GILD $AMGN $PFE $JNJ $CHRS $NVS $RHHBY $SNY $ICPT $BMY $ABBVRT @TheStreet: Is $GILD headed even higher? https://t.co/fzyLOaFmNi https://t.co/zrdEZYPYpSRT @EconomistSaif: $GILD #stocks #options $SPY $IBB  #health #oil

You got it buddy üëèüèΩüëèüèΩ https://t.co/HezvVteaAi$GILD #stocks #options $SPY $IBB  #health #oil

You got it buddy üëèüèΩüëèüèΩ https://t.co/HezvVteaAiVolume Alert - GILD 100.87 Gilead Sciences Inc $GILD Hit a high today of 101.00 Closing the day 10:30 at 100.8 https://t.co/jjHMJW2xNm$GILD $PFE:

Can Humira Still Dominate In 2022?:

https://t.co/ZDObVSOsSHCan Humira Still Dominate In 2022? https://t.co/u9h83U0FYu $GILD $AMGN $PFE $JNJ $CHRS $NVS $RHHBY $SNY $ICPT $BMY $ABBVAnother Study Finds Six Weeks of Harvoni Can Cure Acute #Hepatitis C https://t.co/NO2ToDJt3N #EASL #EASL2016 #ILC2016 $GILD@jimcramer $sbux $gild $ua $nke $intc $csco $dpsRT @newsomenuggets: ""Just closed the final 1/3 of my $GILD swing trade at 101.51.  2.23 R totalon the wholw trade."" - Stan J #reallifetrade‚Ä¶$GILD still moving been in since $89.50.""Just closed the final 1/3 of my $GILD swing trade at 101.51.  2.23 R totalon the wholw trade."" - Stan J #reallifetrader #testimoney@ifahaa2 $GILD üòòüöÄCommented on Gilead - Some Takeaways From The Recent Liver Meeting https://t.co/17agYOfOSJ $ABBV $IBB $MRK $RGLS $GILD$gild may 102c trade$IBB catching a bid -- may finally benefit from rotating bull market. Big biotech ER a catalyst...

$AMGN $REGN $GILD $CELG$XBI $AMGN $REGN $GILD WOW$GILD #uptrend continuation detected around 10:30 AM, Apr 21 EDT; use 100.76, 99.97 as stop #bullishRT @Vince_Stanzione: $GILD earnings next week 28th April continues move higher $110 next? https://t.co/fpgHl98e0oNice run...happens when most don't trust it. $GILD$xbi 31k calls vs 900 put , call  ratio 32*  ,,caught at day low support, rolling $ibb +4$ $regn $gild took off too ¬¢bio boom$GILD earnings next week 28th April continues move higher $110 next? https://t.co/fpgHl98e0o$GILD:US Is Gilead Headed Even Higher? #GILEAD SCIENCES INC  https://t.co/Hvbw3MxN6H #NASDAQ$GILD:US Is Gilead Headed Even Higher? #GILEAD SCIENCES INC  https://t.co/gyw8oTn2Xr #SP500$GILD +0,6% 100,75$ #Gilead kurz vor Ausbruch √ºber #GD200 Tradingchance auf schnelle 10% Kursziel 111$ #Buy /SO https://t.co/txs9Vro6pEHappier Employees Make Companies Great  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx https://t.co/S0VkobxzO9GILD Top news - Apr 21st, 2016 $GILD https://t.co/uxXxZsR08I$IBB trading tight

$GILD $AMGN
$REGN https://t.co/AlQYclu5TWRT @bret_jensen: Commented on Biotech: The Rally Could Just Be Beginning https://t.co/kLEee0nLui $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $P‚Ä¶RT @megtirrell: A potential drug for #Zika? We visited $GILD's labs to see what it holds in its antiviral library: https://t.co/2Xjd45PIcdRT @megtirrell: A potential drug for #Zika? We visited $GILD's labs to see what it holds in its antiviral library: https://t.co/2Xjd45PIcd$GILD:

Top stocks to Review: Gilead Sciences, Inc. (NASDAQ:GILD) , Prima ‚Ä¶:

https://t.co/YIWaBdrdyJRT @megtirrell: A potential drug for #Zika? We visited $GILD's labs to see what it holds in its antiviral library: https://t.co/2Xjd45PIcd#ELAFIBRANOR #NASH $ICPT $GILD $GNFT  https://t.co/DZ3zSYE8r1RT @megtirrell: A potential drug for #Zika? We visited $GILD's labs to see what it holds in its antiviral library: https://t.co/2Xjd45PIcdA potential drug for #Zika? We visited $GILD's labs to see what it holds in its antiviral library: https://t.co/2Xjd45PIcdRT @TheStreet: Is $GILD headed even higher? https://t.co/fzyLOaFmNi https://t.co/zrdEZYPYpS$gild reclaims $100 mark. I remain long5 Stocks That Could Hike Their Dividends 20%
$DIVIDENDSTOCKS $AAPL $FDX $GILD $MAR $MA https://t.co/Yuqu4A9zXu https://t.co/8kj0d51rNcRT @Tootix: #NAFLD and Cardiovascular Risk: Pathophysiological Mechanisms and Implications #NASH $GNFT $ICPT $GILD https://t.co/qzDnF8JXil@techwhitepapers and of course $GILDRT @TheStreet: Is $GILD headed even higher? https://t.co/fzyLOaFmNi https://t.co/zrdEZYPYpSIs Gilead headed even higher? https://t.co/7dPtJkaXxF via @TheStreet $GILDIs $GILD headed even higher? https://t.co/fzyLOaFmNi https://t.co/zrdEZYPYpS$GILD:

Analyst‚Äôs Valuable Buzzers: Gilead Sciences, Inc. (NASDAQ:GILD ‚Ä¶:

https://t.co/UyTR5UK9TKIs $GILD headed even higher? https://t.co/E4grYD9ss2 https://t.co/XHYRhXhOTVRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Commented on Biotech: The Rally Could Just Be Beginning https://t.co/kLEee0nLui $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRXCheap call option upside: $DIS calls cheaper than 100% of history, $BABA 100%, $DAL 100%, $DHR 100%, $GILD 100%, $EMC 100%, $VZ 99%RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Gilead, The Investable Two Product Company https://t.co/txLzOwIMc6 $GILDRT @Henry_Fund: HF Research analyst Charles Schaller (@BizCharlie) issues BUY rating on $GILD. Target price: $115-120. Report: https://t.co‚Ä¶Another Study Finds Six Weeks of #Harvoni Can Cure Acute #HepC https://t.co/j43HrJUfRN $GILD @GileadSciences #EASL #EASL2016 #ILC2016Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5#GileadSciences, Inc. Position Maintained by National Mutual Insurance Federation of Agricu... Read more: https://t.co/iPTnsGmbMH $GILDBig Pharma earnings:

Earnings/sales estimates according to Yahoo:

C  $AMGN $BMY $BIIB $MRK $ABBV $PFE $GILD $CELG https://t.co/TM6BY3HlRRCheap put options and hedges: $DAL puts cheaper than 100% of history, $GILD 98%, $DHR 94%, $XHB 92%, $T 91%, $DOW 89%, $SDS 88%RT @investimonials: Why we're increasingly bullish on #biotech $XBI $BIB #XBI $JNJ $GILD -- https://t.co/n8CqkHwwdOWhy we're increasingly bullish on #biotech $XBI $BIB #XBI $JNJ $GILD -- https://t.co/n8CqkHwwdO@OphirGottlieb Is it advisable to invest in more individual co.s or invest in $IBB Owns $ILMN $GILD $RLYPHemenway Trust Co LLC Buys 17,018 Shares of Gilead Sciences, Inc. $GILD https://t.co/AzVJBbM6HJGAM Holding AG Has $59,607,000 Position in Gilead Sciences, Inc. $GILD https://t.co/ZIbXkUA3y2$GILD:

Gilead Sciences, Inc. (GILD) Position Maintained by National Mutual ‚Ä¶:

https://t.co/y8zLBwbzqoCommented on Gilead, The Investable Two Product Company https://t.co/VTFfd7kKMz $GILDSouth Dakota Investment Council Sells 46,600 Shares of Gilead Sciences, Inc. $GILD https://t.co/E2s7bnVyPy",2016-04-21,GILD,1
16,"RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Nasdaq100 #Stocks Trend $TMUS $TSCO $MXIM $BIIB $CHTR $ULTA $FOXA $GILD $CELG $SIRI $QCOM $CSX $ESRX $AMGN  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $BIIB $DIS $MDT $FOXA $GILD $CELG $DHR $TWX $USB $BK $UNP $MON $QCOM $BMY $AXP $ABBV $CVS @ https://t.co/cKkr8cKsjuThe M&amp;A Rumor Mill Points to Gilead $GILD Acquiring Intercept Pharma $ICPT https://t.co/Qe97P9s6DV https://t.co/ifmZMMttT9NR7 Stocks https://t.co/RMc25iLopk $VIAV $RIO $NRG $XLV $NWL $TAHO $YELP $XLU $NKTR $GILD $MCO $UA.C $AXP $HUN $OGE $SRE $YINNRT @1BestTrader: $AAPL SELL

$CMG $TWTR $EBAY $BWLD $CRUS $FB $FSLR $UPS $CELG $AMZN $LNKD $BIDU $SWKS $FCX $V $GILD $HELE $NXPI $CVX https‚Ä¶$AAPL SELL

$CMG $TWTR $EBAY $BWLD $CRUS $FB $FSLR $UPS $CELG $AMZN $LNKD $BIDU $SWKS $FCX $V $GILD $HELE $NXPI $CVX https://t.co/uVvQhodppXRT @pharmalot: More drug makers are taking hefty price hikes on more drugs.. read how much.. https://t.co/ruynQhbjxo #pharma $JNJ $GILD $CE‚Ä¶5 Stocks to Watch this Week  - $AAPL $CMG $FB $AMZN $GILD @chipotletweets @amazon @facebook https://t.co/UTuAh5z8wm https://t.co/fZMOrW1EzxRT @KeeblerElf3: $GILD so stretched but stil owrht a half size trade r/g 102.40 break https://t.co/8A2GTVmzvfRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbP$GILD Bullish DailyPlay for Tuesday April 26th, 2016 - Gilead Sciences 
https://t.co/6LSTNpnccE https://t.co/lfIqRj7QgyRT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ Mix Day. https://t.co/n1aTnIlRVeRT @BioStocks: $GILD European Commission Grants Marketing Authorization for Descovy for Treatment of HIV https://t.co/YkghFxJlPO$GILD so stretched but stil owrht a half size trade r/g 102.40 break https://t.co/8A2GTVmzvf@rpmreportmike @pinksheetsutter Looks like $GILD‚Äôs Truvada had oneRT @R4inb0w_: #NASH $GILD $GNFT $ICPT #Elafibranor #Liverdisease @EASLnews  https://t.co/Ilo36IciE1RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @R4inb0w_: #NASH $GILD $GNFT $ICPT #Elafibranor #Liverdisease @EASLnews  https://t.co/Ilo36IciE1RT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5#NASH $GILD $GNFT $ICPT #Elafibranor #Liverdisease @EASLnews  https://t.co/Ilo36IciE1$GILD candle above 200ma. Earnings Thursday. ECM authorization for two doses of HIV treatment.RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @StockTwits: Earnings Reports:
Mon $HAL
Tue $AAPL $TWTR $CMG $MMM $T
Wed $FB $BA $PYPL
Thu $AMZN $GILD $AMGN
Fri $XOM $CVXRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbP$agn just to update the market, biotech &amp; $GILD (as proxy for large biotech with actual earnings) have moved to where $AGN value now ~$244+RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶$GILD current positions
#stocks https://t.co/RufIT1H7EmI wrote already some times ago, that I prefer $GILD, $GERN and $LLY 
#stocks despite currently $GILD is #bearish, I do not change positionRT @FiercePharma: Gilead HIV biz draws farther ahead of ViiV with Descovy's FDA nod: analyst https://t.co/0Mf0Sy3h89 $GILD $GSK #pharma #ma‚Ä¶RT @biotech_forum: Biotech: The Train Has Left The Station https://t.co/ct5PlUEJCY $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $‚Ä¶RT @pharmalot: More drug makers are taking hefty price hikes on more drugs.. read how much.. https://t.co/ruynQhbjxo #pharma $JNJ $GILD $CE‚Ä¶$GILD - looks like it‚Äôs setting up for a breakout over 102.40

15min/5days https://t.co/Ka7Inb34cKNasdaq100 #Stocks Trend $TMUS $TSCO $MXIM $BIIB $FOXA $ULTA $GILD $CELG $CHTR $SIRI $NVDA $ESRX $CERN $AMGN  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $BIIB $FOXA $MDT $DIS $GILD $DHR $CELG $TWX $BK $UNP $MON $USB $BMY $AXP $HD $AMGN $ABT  @ https://t.co/cKkr8cKsjuCommented on Biotech: The Train Has Left The Station https://t.co/v0gzOfpMw0 $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @ReformedJoker: $FB $UA $AVGO $NVDA $SMH $TSLA $GILD $GWPH $TGT $TBT $ES_F 2075 -  2068 STOP $GC_F 1236  $BTCUSD https://t.co/dTB9yaExAt‚Ä¶RT @ReformedJoker: $FB $UA $AVGO $NVDA $SMH $TSLA $GILD $GWPH $TGT $TBT $ES_F 2075 -  2068 STOP $GC_F 1236  $BTCUSD https://t.co/dTB9yaExAt‚Ä¶Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶$FB $UA $AVGO $NVDA $SMH $TSLA $GILD $GWPH $TGT $TBT $ES_F 2075 -  2068 STOP $GC_F 1236  $BTCUSD https://t.co/dTB9yaExAt Re-ENTER The BLOG$GILD:

Gilead Sciences, Inc. (NASDAQ:GILD) Company Earnings in Focus:

https://t.co/BrMqMP0VIaRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶$GILD European Commission Grants Marketing Authorization for G‚Ä¶ https://t.co/X5kajDMEQ7RT @mcorreia: @pick1998_2 Nice calls on $CBYL and $ROKA. Holding. Thoughts on $GBIM HBV candidate? Tiny float + $GILD/$CELG partnerships. H‚Ä¶RT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6The Sleep Well Portfolio Outperforms Both The S&amp;P 500 And The FANG https://t.co/Wry05PuNqM $GILD $MRK $JNJ $MMM $ETN $WMT $XOMRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶Five Stocks To Watch This Week - April 25, 2016 $CMG $AAPL $AMZN $GILD $FB https://t.co/UHfDFpJd2ZRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶@Chet_Kincaid $GILDRT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @StockTwits: GET READY. Here are the companies reporting earnings next week: https://t.co/NXptPkQX70

$AAPL $FB $TWTR $CMG $GILD https:/‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @MarketSavage: $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/oYbYGVzNLJ$FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/oYbYGVzNLJRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶$GILD In 101.90 out 102.14 , done for the dayRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @TipRanks: Biotech Week Ahead: $GILD, $CELG, and $KERX https://t.co/pZn8E2DHEW$GILD:

Share Performance Check on : Gilead Sciences, Inc. (NASDAQ:GILD):

https://t.co/KdxD3KxQS6RT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6$IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @FiercePharma: Gilead HIV biz draws farther ahead of ViiV with Descovy's FDA nod: analyst https://t.co/0Mf0Sy3h89 $GILD $GSK #pharma #ma‚Ä¶Gilead HIV biz draws farther ahead of ViiV with Descovy's FDA nod: analyst https://t.co/0Mf0Sy3h89 $GILD $GSK #pharma #marketingThe 69 Most Overbought Stocks This Week https://t.co/zfynMTgJWR $XOM $GILD $COP #InvestingRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶$AMZN beast! 

$FB $GILD looking good@pick1998_2 Nice calls on $CBYL and $ROKA. Holding. Thoughts on $GBIM HBV candidate? Tiny float + $GILD/$CELG partnerships. Huge upside.RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Upcoming Earnings $AAPL $XOM $FB $AMZN $T $PG $BUD $PFE $BABA $CVX $FMX $MRK $CMCSA $NVO $GILD $PTR $HSBC $AMGN $TOT https://t.co/Cg7Yk4msrIRT @bleeckersarl: $ICPT's best #JOKE: #OCA patent 4""prevention of...CV disease...&amp; 4 reducing HDL cholesterol"" $GILD @adamfeuerstein  https‚Ä¶Strong Product Portfolio Drove Biogen‚Äôs 1Q16 Profit Margins $AMGN $BIIB $CELG $GILD https://t.co/vI6KpsUpBVGilead Sciences, Inc. $GILD Stock Rating Lowered by Vetr Inc. https://t.co/qTlchkyCCLRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Gilead Sciences, Inc. $GILD Stock Rating Lowered by Vetr Inc. https://t.co/wTqBcgPHWyThe MA Rumor Mill Points to Gilead Acquiring Intercept #Pharma https://t.co/OmBzFrKij3 #biotech $GILDRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @DozenStocks: Nasdaq100 #Stocks Trend $TMUS $MXIM $BIIB $CELG $TSCO $FOXA $GILD $ALXN $CSX $TSLA $CTXS $AMGN $QCOM $LLTC  @ https://t.co‚Ä¶Nasdaq100 #Stocks Trend $TMUS $MXIM $BIIB $CELG $TSCO $FOXA $GILD $ALXN $CSX $TSLA $CTXS $AMGN $QCOM $LLTC  @ https://t.co/YdSIjFJqHf@TheHoInPsycho and let me explain also why .. for many many reasons but $GILD drug is also BETTER than anything else .@TheHoInPsycho first will be $ALNY from what I humbly understand. $ARWR wants to compare itself to $GILD but it aint $gildChinese FDA to expedite review of new hepatitis C meds https://t.co/GvPjTdCle6 $ABBV $GILD $BMYThese Stocks Will Hike Their Dividends 20%: Buy Now https://t.co/OYgpvwZCUa $AAPL $FDX $GILD $MAR $MACommented on Biotech: The Train Has Left The Station https://t.co/ZkGDll5v4K $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @pharmalot: More drug makers are taking hefty price hikes on more drugs.. read how much.. https://t.co/ruynQhbjxo #pharma $JNJ $GILD $CE‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: EMA CHMP April meeting agenda out
https://t.co/d6xe9QBT2D

On deck for opinions:
$ABBV $BIIB Daclizumab 
$AGN Avycaz 
$GIL‚Ä¶Biotech: The Train Has Left The Station https://t.co/ct5PlUEJCY $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBB$ICPT's best #JOKE: #OCA patent 4""prevention of...CV disease...&amp; 4 reducing HDL cholesterol"" $GILD @adamfeuerstein  https://t.co/EfZE5z9eveRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @pharmalot: More drug makers are taking hefty price hikes on more drugs.. read how much.. https://t.co/ruynQhbjxo #pharma $JNJ $GILD $CE‚Ä¶RT @BPGAG: Have great day. Tons of #earnings coming. Don't get bombed in those #stocks. $AAPL $FB $TWTR $GILD $CELG $AMGN $BIIB https://t.c‚Ä¶Volume Alert - GILD 101.80 Gilead Sciences Inc $GILD Hit a high today of 102.33 Closing the day 10:30 at 101.8 https://t.co/m04tgoiABaRT @StockTwits: GET READY. Here are the companies reporting earnings next week: https://t.co/NXptPkQX70

$AAPL $FB $TWTR $CMG $GILD https:/‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶MON $SRPT adcom #SCOTUS IPR WED $VRX senate hearing $VRTX earnings THU $ABBV $ALXN $BMY $CELG $AMGN $BMRN $GILD FRI CHMPRT @BPGAG: Have great day. Tons of #earnings coming. Don't get bombed in those #stocks. $AAPL $FB $TWTR $GILD $CELG $AMGN $BIIB https://t.c‚Ä¶RT @BPGAG: $GILD Only holding 20% after taking small profits twice this AM ... #biotech #stocks $IBB  https://t.co/O0mbIViZO9Have great day. Tons of #earnings coming. Don't get bombed in those #stocks. $AAPL $FB $TWTR $GILD $CELG $AMGN $BIIB https://t.co/l5a9NSFtWhRT @BPGAG: $GILD Only holding 20% after taking small profits twice this AM ... #biotech #stocks $IBB  https://t.co/O0mbIViZO9@TheHoInPsycho NOT TRUE. not true. they have a Toll receptor program .. similar to $GILD and tech is proven by $ALNY partnership$GILD Only holding 20% after taking small profits twice this AM ... #biotech #stocks $IBB  https://t.co/O0mbIViZO9RT @StocksThatDoubl: Stock trade alerts https://t.co/uAcamNRUPt JOIN NOW Promo https://t.co/e2zXG3II89 $MCUR $AMAT $ITUB $MT $GILD $HST $AA‚Ä¶#GileadSciences European Commission Grants Marketing Authorization for Gilead's Fixed-Dose ... Read more: https://t.co/5laig3gTq3 $GILDGilead HIV biz draws farther ahead of ViiV with Descovy's FDA nod: analyst: https://t.co/EzFYUe3cxb $GILD #pharma #marketing#GileadSciences BRIEF-Gilead's treatment for HIV receives marketing authorization from euro... Read more: https://t.co/ZFfoXwz5Gh $GILD$AZN $GSK $GILD $CELG Bio/Pharma cohort holding serve..RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶DGI For The DYI: Q1 2016 [] https://t.co/H7YQkZgf2v [] $BDX $CLDT $DLR $OXY $XEL $CVX $XOM $KO $MMM $MSFT $GILD $O https://t.co/A9ihfGwbeIRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶EMA CHMP April meeting agenda out
https://t.co/d6xe9QBT2D

On deck for opinions:
$ABBV $BIIB Daclizumab 
$AGN Avycaz 
$GILD Odefsey.
94.57% Avg Gain
100% Unbiased
 .
https://t.co/2qE8x3QQQ8 
 .
 .
$CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO https://t.co/C48Jrk3udE$AGN $PFE $CELG $GILD:

Biotech: The Train Has Left The Station:

https://t.co/0Plev0fPumRT @ChinaInvest: RT SeekingAlpha: Biotech: The Train Has Left The Station https://t.co/igt6tYyXAp $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $‚Ä¶RT SeekingAlpha: Biotech: The Train Has Left The Station https://t.co/igt6tYyXAp $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $I‚Ä¶Biotech: The Train Has Left The Station https://t.co/zyGDgavWAM $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶Biotech: The Train Has Left The Station https://t.co/gYfP0vJM7w $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBB$GILD 110 Calls BUYING Activity expiring on 15th Jul, Vol 1300RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Commented on Biotech: The Train Has Left The Station https://t.co/v0gzOfpMw0 $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶GILD Top news - Apr 25th, 2016 $GILD https://t.co/xg7FRfLqDDRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @stocktrader300: Earnings this week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU $DPZ $UPS ht‚Ä¶The Sleep Well Portfolio Outperforms Both The S&amp;P 500 And The FANG https://t.co/DSUVC50vck $GILD $MRK $JNJ $MMM $ETN $WMT $XOM$GILD gets EC approval for¬†F/TAF https://t.co/zqw6lN6Px4Gilead Sciences, Inc. $GILD Shares Bought by Calvert Investment Management Inc. https://t.co/FbxLlZhRmDRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶wow $GILD exploding

$ $ $ $ $ $ $$GILD Descovy is the First New HIV Treatment Backbone Approved in the EU in Over a Decade https://t.co/CgSfJ0lKW3Took more off #trading S $GILD $101.90 for small profits above $102 from last week$BCRX Trading alert went out last night to members.
https://t.co/F0CpFtylQ4
Other #Biotech stocks $GILD $FPRX $INO $MDVNGilead Sciences, Inc. $GILD Shares Bought by Calvert Investment Management Inc. https://t.co/yEUmmlTQLyRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶biotech not as weak as other sectors right now 
$XBI $GILD $BIIBBiotech: The Train Is Leaving The Station https://t.co/5wPGVlk3YM $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBApril 25 Biotech Update $BIIB $BMRN $GILD $LLY $prgo https://t.co/pRReQNMzwyTook some small profits in #trading S $GILD $102Biotech Week Ahead: $GILD $CELG $KERX
https://t.co/UetxLK1mKPEuropean Commission approves Gilead&amp;#39;s F/TAF for HIV-1 https://t.co/jDnn7a6zcQ $GILDRT @BioStocks: $GILD European Commission Grants Marketing Authorization for Descovy for Treatment of HIV https://t.co/YkghFxJlPORT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @StocksThatDoubl: Stock trade alerts https://t.co/uAcamNRUPt JOIN NOW Promo https://t.co/e2zXG3II89 $MCUR $AMAT $ITUB $MT $GILD $HST $AA‚Ä¶Stock trade alerts https://t.co/uAcamNRUPt JOIN NOW Promo https://t.co/e2zXG3II89 $MCUR $AMAT $ITUB $MT $GILD $HST $AA $GMKing Luther Capital Management Corp Purchases 405 Shares of Gilead Sciences, Inc. $GILD https://t.co/zqEnfeqa0X$GILD: Gilead Sciences granted marketing authorization by the European Commission for fixed-dose combination... https://t.co/SUCXP5xaL9$GILD European Commission Grants Marketing Authorization https://t.co/akPFMujjIHRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶#Biotech #stocks ... everybody on the tee-vee ""wanted"" it on Fri ...are they still right up against resistance? $IBB $CELG $GILD $AMGN $BIIBRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Connor Clark &amp; Lunn Investment Management Ltd. Reduces Stake in Gilead Sciences, Inc. $GILD https://t.co/NVfB0nrJAV#StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA https://t.co/cR5Rb9Itg0RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶$GILD European Commission Grants Marketing Authorization https://t.co/oyu3dgSWM1 #biotechstocks #biotech #stocksRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶$GILD $HON:

These 2 Stocks May Proved To Be Valuable Today: Gilead Sciences ‚Ä¶:

https://t.co/DrorOiOYcDRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶$IBB under the ""keep it simple"" banner, this ETF is only selling at 18X.  Heavy exposure to $AMGN, $BIIB, $CELG $GILD $REGN. Down from $400.RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Gilead Gets European Commission Marketing Authorization For HIV-1 Infection Drug $GILD https://t.co/PP9ClRpP5z via @benzinga$GILD
Gilead Gets European Commission Marketing Authorization For HIV-1 Infection DrugRT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶$GILD $NVS:

Most Traded stocks: Gilead Sciences, Inc. (NASDAQ:GILD ‚Ä¶:

https://t.co/cSP1tdJesoRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶These 2 Stocks May Proved To Be Valuable Today: $GILD $HON https://t.co/jyvMYJHxwzRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - ‚Ä¶ https://t.co/BrkIxn94JiRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.co/46TicoBGufRT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @TipRanks: Biotech Week Ahead: $GILD, $CELG, and $KERX https://t.co/pZn8E2DHEWRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶EC Grants Marketing Authorization for $GILD's Combination Descovy (Emtricitabine,Tenofovir Alafenamide) for Txof HIV https://t.co/HgTlz3pZOgŸáÿßŸÑÿßÿ≥ÿ®Ÿàÿπ #ÿßŸÑÿ≥ŸàŸÇ_ÿßŸÑÿßŸÖÿ±ŸäŸÉŸä $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELERT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @BioStocks: $GILD European Commission Grants Marketing Authorization for Descovy for Treatment of HIV https://t.co/YkghFxJlPORT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @BioStocks: $GILD European Commission Grants Marketing Authorization for Descovy for Treatment of HIV https://t.co/YkghFxJlPORT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶$NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://t.co/rQUmhHgYn0RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶Biotech Week Ahead: $GILD, $CELG, and $KERX https://t.co/pZn8E2DHEWRT @BioStocks: $GILD European Commission Grants Marketing Authorization for Descovy for Treatment of HIV https://t.co/YkghFxJlPORT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @BioStocks: $GILD European Commission Grants Marketing Authorization for Descovy for Treatment of HIV https://t.co/YkghFxJlPORT @BioStocks: $GILD European Commission Grants Marketing Authorization for Descovy for Treatment of HIV https://t.co/YkghFxJlPORT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BMRN $GILD

FRI
CHMPRT @stocktrader300: Lots of earnings next week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU http‚Ä¶$GILD EU approves Descovy ( F/TAF) for HIV-1RT @BioStocks: $GILD European Commission Grants Marketing Authorization for Descovy for Treatment of HIV https://t.co/YkghFxJlPOPDCO Last Trade
See Here ---&gt; https://t.co/m10m2Vw7cJ

$PDCO $GILD $GVA #stockmarketUnited Capital Financial Advisers LLC Has $21,249,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/Zhda0z4Iz8$GILD European Commission Grants Marketing Authorization for Descovy for Treatment of HIV https://t.co/YkghFxJlPORoundview Capital LLC Continues to Hold Stake in Gilead Sciences, Inc. $GILD https://t.co/Cg0PoVLT3bEuropean Commission approves Gilead's F/TAF for HIV-1 https://t.co/WMyTdY078y #premarket $GILDEuropean Commission approves Gilead's F/TAF for HIV-1 https://t.co/2448PfWDka #premarket $GILDEuropean Commission approves Gilead's F/TAF for HIV-1 https://t.co/iyxM8zIzux #premarket $GILD$GILD European Commission Grants Marketing Authorization for Gilead‚Äôs Fixed-Dose Combination Descovy¬Æ (Emtrici... https://t.co/tc5Dpt3LwT$GILD European Commission Grants Marketing Authorization for Gilead's Fixed-Dose Combination Descovy¬Æ (Emtric
From our Stock News Alerts App$GILD - European Commission Grants Marketing Authorization for Gilead‚Äôs Fixed-Dose Combination Descovy¬Æ https://t.co/aUVbYgV3ecRT @BiotechMoney18: $PXD $AAPL $TWTR $FB $CMG $PNRA $BWLD $YELP $GILD $EXPE $LNKD $BIDU $BMRN $PSX earnings reports &amp; economic calendar htt‚Ä¶RT @BiotechMoney18: $PXD $AAPL $TWTR $FB $CMG $PNRA $BWLD $YELP $GILD $EXPE $LNKD $BIDU $BMRN $PSX earnings reports &amp; economic calendar htt‚Ä¶RT @GeryDIVRY: $GILD $ICPT $GLMD $GNFT

an error was corrected on one of the Gilead program drug number .. sorryRT @StockTwits: GET READY. Here are the companies reporting earnings next week: https://t.co/NXptPkQX70

$AAPL $FB $TWTR $CMG $GILD https:/‚Ä¶Cheap call option upside: $GILD calls cheaper than 100% of history, $DIS 100%, $DAL 99%, $CMCSA 99%, $CBS 99%, $BABA 98%, $GM 98%Weekly Nasdaq100 #Stocks Trend $BMRN $ESRX $FOXA $NXPI $TSCO $LLTC $CTXS $SBAC $ADSK $VOD $BIIB $ALXN $GILD  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $ENDP $VIAB $DISH $BMRN $WDC $VRTX $CSX $TSCO $BIIB $ALXN $GILD $ESRX  more@ https://t.co/YdSIjFJqHfRT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶STAR Open
See Here ---&gt; https://t.co/JICpeTezhn

$STAR $OLLI $GILD #stocksRT @StockTwits: GET READY. Here are the companies reporting earnings next week: https://t.co/NXptPkQX70

$AAPL $FB $TWTR $CMG $GILD https:/‚Ä¶RT @AzizAlshenaifi: Ÿáÿ∞ÿß ÿßŸÑÿ£ÿ≥ÿ®Ÿàÿπ .. ÿßÿπŸÑÿßŸÜ ÿ£ÿ±ÿ®ÿßÿ≠ Ÿà ŸÜÿ™ÿßÿ¶ÿ¨ ÿ£ŸáŸÖ ÿßŸÑÿ¥ÿ±ŸÉÿßÿ™ 

$FB $AAPL $AMZN $TWTR $GILD $LNKD $CELG $SWKS $JBLU $NXPI $BA https://‚Ä¶Ÿáÿ∞ÿß ÿßŸÑÿ£ÿ≥ÿ®Ÿàÿπ .. ÿßÿπŸÑÿßŸÜ ÿ£ÿ±ÿ®ÿßÿ≠ Ÿà ŸÜÿ™ÿßÿ¶ÿ¨ ÿ£ŸáŸÖ ÿßŸÑÿ¥ÿ±ŸÉÿßÿ™ 

$FB $AAPL $AMZN $TWTR $GILD $LNKD $CELG $SWKS $JBLU $NXPI $BA https://t.co/OMq7fEzlocRT @True_North1914: Ÿáÿ∞ÿß ÿßŸÑÿ£ÿ≥ÿ®Ÿàÿπ ÿ¨ÿØÿß ÿ≠ÿßŸÅŸÑ ÿ•ÿπŸÑÿßŸÜ ÿ£ÿ±ÿ®ÿßÿ≠ ÿ£ŸáŸÖ ÿßŸÑÿ¥ÿ±ŸÉÿßÿ™ üòà

$FB $AAPL $AMZN $TWTR $GILD $LNKD $CELG $SWKS $JBLU $NXPI $BA https://t‚Ä¶RT @True_North1914: Ÿáÿ∞ÿß ÿßŸÑÿ£ÿ≥ÿ®Ÿàÿπ ÿ¨ÿØÿß ÿ≠ÿßŸÅŸÑ ÿ•ÿπŸÑÿßŸÜ ÿ£ÿ±ÿ®ÿßÿ≠ ÿ£ŸáŸÖ ÿßŸÑÿ¥ÿ±ŸÉÿßÿ™ üòà

$FB $AAPL $AMZN $TWTR $GILD $LNKD $CELG $SWKS $JBLU $NXPI $BA https://t‚Ä¶Ÿáÿ∞ÿß ÿßŸÑÿ£ÿ≥ÿ®Ÿàÿπ ÿ¨ÿØÿß ÿ≠ÿßŸÅŸÑ ÿ•ÿπŸÑÿßŸÜ ÿ£ÿ±ÿ®ÿßÿ≠ ÿ£ŸáŸÖ ÿßŸÑÿ¥ÿ±ŸÉÿßÿ™ üòà

$FB $AAPL $AMZN $TWTR $GILD $LNKD $CELG $SWKS $JBLU $NXPI $BA https://t.co/tPY8O7t120Not sure what to do with $GILD? Explore our #fundamental pros and cons.  https://t.co/NgREtgOwQuRT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶Gilead Sciences, Inc. $GILD Given ‚ÄúA+‚Äù Credit Rating by Morningstar https://t.co/bNSI8Ya2aT@avidresearch @WhiteCoatMafia $ARWR &amp; $JNJ looking for an 'immune enhancer' to replace peg-IFNa. 'Hook-up"" w $GILD. Just my speculation.RT @AliAlhouli: ÿ¥ÿ±ŸÉÿßÿ™ ÿ≥ÿ™ÿπŸÑŸÜ ÿßŸÑÿßÿ≥ÿ®Ÿàÿπ ÿßŸÑŸÇÿßÿØŸÖ ÿåÿåÿå ŸàÿßŸáŸÖŸáÿß #ÿßŸÑÿ≥ŸàŸÇ_ÿßŸÑÿßŸÖÿ±ŸäŸÉŸä
$AAPL $FB $TWTR $CMG $GILD https://t.co/8OutrD4FgCRT @stocktrader300: Lots of earnings next week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU http‚Ä¶$GILD $ICPT $GLMD $GNFT

an error was corrected on one of the Gilead program drug number .. sorryRT @TomSilver39: Very interesting week, my watch list: $SRPT $MSTX $CYTR $FB $AAPL $TSLA $CELG $ABBV $AMZN $AMGN $BMRN $GILD ..... Good luckRT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶RT @TomSilver39: Very interesting week, my watch list: $SRPT $MSTX $CYTR $FB $AAPL $TSLA $CELG $ABBV $AMZN $AMGN $BMRN $GILD ..... Good luckRT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶Very interesting week, my watch list: $SRPT $MSTX $CYTR $FB $AAPL $TSLA $CELG $ABBV $AMZN $AMGN $BMRN $GILD ..... Good luckRT @StockTwits: GET READY. Here are the companies reporting earnings next week: https://t.co/NXptPkQX70

$AAPL $FB $TWTR $CMG $GILD https:/‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶RT @davidmoadel: Earnings reports &amp; economic calendar $PXD $AAPL $TWTR $FB $CMG $PNRA $BWLD $YELP $GILD $EXPE $LNKD $BIDU $BMRN $PSX https:‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @AliAlhouli: ÿ¥ÿ±ŸÉÿßÿ™ ÿ≥ÿ™ÿπŸÑŸÜ ÿßŸÑÿßÿ≥ÿ®Ÿàÿπ ÿßŸÑŸÇÿßÿØŸÖ ÿåÿåÿå ŸàÿßŸáŸÖŸáÿß #ÿßŸÑÿ≥ŸàŸÇ_ÿßŸÑÿßŸÖÿ±ŸäŸÉŸä
$AAPL $FB $TWTR $CMG $GILD https://t.co/8OutrD4FgCEarnings reports &amp; economic calendar $PXD $AAPL $TWTR $FB $CMG $PNRA $BWLD $YELP $GILD $EXPE $LNKD $BIDU $BMRN $PSX https://t.co/6xJWFeGUXaRT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶GILD Quotes
See Here ---&gt; https://t.co/zF8dw8jYj2

$GILD $RY $AMAG #investRT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V https://t.co/cR5Rb9Itg0$GILD $CELG both trading above resistance. https://t.co/6eCkaaB23K. https://t.co/PSiq2pBql9. $IBB(Apr 25-29) Weekly Market Strategies $QQQ, $BP, $SCO, $FB, $BRSS, $ALSN, $GILD, $CHRW, $CL, $AET, $CHD, $YNDX, $SMRT https://t.co/OKRkH5ylkE$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/1skbYLsG8yCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @StockTwits: GET READY. Here are the companies reporting earnings next week: https://t.co/NXptPkQX70

$AAPL $FB $TWTR $CMG $GILD https:/‚Ä¶RT @BiotechMoney18: $PXD $AAPL $TWTR $FB $CMG $PNRA $BWLD $YELP $GILD $EXPE $LNKD $BIDU $BMRN $PSX earnings reports &amp; economic calendar htt‚Ä¶RT @GotSanctuary: notable earnings this week
LargeCaps: $CVX $CMCSA $GILD $TOT $AMGN $MO $BMY $NVO $SNY $MA $GSK $MMM $BP $ABBV $DCM https:‚Ä¶RT @GeryDIVRY: GILEAD‚Äôs POSSIBLES STRATEGIES IN NASH $GILD $ICPT $GLMD $GNFT https://t.co/zEej2DOjhQRT @Terri1618: $LABU $IBB tight,abstracts on 5/19 for 6/9 biotech conf. $CELG $GILD $AMGN eps 4/28. $TSLA $YRD tight,sto oversold https://t‚Ä¶Big #earnings this week from $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA https://t.co/gV7ilGFI4B$LABU $IBB tight,abstracts on 5/19 for 6/9 biotech conf. $CELG $GILD $AMGN eps 4/28. $TSLA $YRD tight,sto oversold https://t.co/DA5FcKS96WRT @stocktrader300: Earnings this week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU $DPZ $UPS ht‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶Earnings this week $HAL $MMM $JBLU $PG $EBAY $SNDK $BP $AAPL $TWTR $GILD $AMZN $LNKD $BA $PYPL $UPS $AMGN $DOW $RCL https://t.co/DEeU6n5QAwRT @StockTwits: GET READY. Here are the companies reporting earnings next week: https://t.co/NXptPkQX70

$AAPL $FB $TWTR $CMG $GILD https:/‚Ä¶Earnings this week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU $DPZ $UPS https://t.co/Wb8Y0nGCniRT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @stocktrader300: Lots of earnings next week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU http‚Ä¶RT @iknowtybo: 5 Stocks to Watch this Week 4/25 - $AAPL, $CMG, $FB, $AMZN, $GILD5 Stocks to Watch this Week 4/25 - $AAPL, $CMG, $FB, $AMZN, $GILD$GILD $ETN $WMT $XOM:

The Sleep Well Portfolio Outperforms Both The S&amp;P 500 And The ‚Ä¶:

https://t.co/ZNLaAKJ2NtRT @StockTwits: GET READY. Here are the companies reporting earnings next week: https://t.co/NXptPkQX70

$AAPL $FB $TWTR $CMG $GILD https:/‚Ä¶RT SeekingAlpha: The Sleep Well Portfolio Outperforms Both The S&amp;P 500 And The FANG https://t.co/9rELRKqbQF $GILD $MRK $JNJ $MMM $ETN $WMT‚Ä¶$GILD $JNJ $MMM $ETN:

The Sleep Well Portfolio Outperforms Both The S&amp;P 500 And The ‚Ä¶:

https://t.co/nR8C0EZKsm",2016-04-25,GILD,0
17,"GILD Volume
See Here ---&gt; https://t.co/JZ64GDgm0A

$GILD $AWGI $JBLU #stockRT @CatalystWatcher: $GILD and $GBIM confidentiality agreement. Section 8.3 which discusses M&amp;A is relevant. https://t.co/rjX23NAkplRT @BioStocks: $GILD European Commission Grants Marketing Authorization for Descovy for Treatment of HIV https://t.co/YkghFxJlPORT @biospace: Gilead $GILD Seeks to Build 6-Story Lab in HQ Expansion, May House Up to 5,000 New Employees https://t.co/htE7AZJxU7 https://‚Ä¶$GILD:US First Houston Capital Inc. Sells 150 Shares of Gilead Sciences, Inc. (GILD) #GILEAD SCIENCES INC  https://t.co/MAv0tPxdA8 #NASDAQRT @BiotechRadar: 1st International Workshop on NASH Biomarkers 29-30/04 $GNFT $GILD $LLY $MRK...- https://t.co/wBM5zi4pP5@CatalystWatcher i believe at such a low PPS and Shares, $Gild could buy this in a flash for Tarmogen alone. Especially if its the backboneChina poised to approve HCV drugs, major players hope to capitalize $GILD $ABBV $MRK $BMY $JNJ https://t.co/Dc1FakA4KJ@aschwartzphd @CatalystWatcher so in other words $GBIM can release results before $Gild would? Or only gild can? Sorry just glancedRT @CatalystWatcher: $GILD and $GBIM confidentiality agreement. Section 8.3 which discusses M&amp;A is relevant. https://t.co/rjX23NAkpl$GILD and $GBIM confidentiality agreement. Section 8.3 which discusses M&amp;A is relevant. https://t.co/rjX23NAkplRT @biospace: The M&amp;A Rumor Mill Points to Gilead $GILD Acquiring Intercept Pharma $ICPT https://t.co/Qe97P9s6DV https://t.co/ifmZMMttT9GILD pre earnings analysis $GILD https://t.co/Z5QwWm96ux$GILD chart: GILD pre earnings analysis. https://t.co/OPqcopz5lTRT @pharmalot: Health plans reach deal w/NY State to remove restrictions on hepatitis C meds.. https://t.co/NwBusz0LaT #pharma $GILD $ABBV‚Ä¶RT @CarolineYLChen: Andy Slavitt @CMSGov bringing up $GILD hep C cures, says local govts don't have ""magic pots of money,"" need new pay mod‚Ä¶RT @BiotechRadar: 1st International Workshop on NASH Biomarkers 29-30/04 $GNFT $GILD $LLY $MRK...- https://t.co/wBM5zi4pP5Gilead Sciences, Inc Wins EU Approval for a Potential Blockbuster HIV Drug https://t.co/uNTFrNOVI2 $GILD https://t.co/XjG9PjPonPRT @BiotechRadar: 1st International Workshop on NASH Biomarkers 29-30/04 $GNFT $GILD $LLY $MRK...- https://t.co/wBM5zi4pP5$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/C6i5caNlE3Funny comparison I know,but I think $AAPL should roughly trade at $GILD fP/E.Risks &amp;lack of diversification &amp; cash hoard similar.Low 80s ok.People finally realizing insurers/PBMs are withholding this wonderful treatment from their patients #Long $GILD $IBB https://t.co/fZ6GUyx3hy$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ Mix Day. https://t.co/KToEV2hd2hConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5t0Bl  $DIS $ALXN $NOAH $GILD $QUNR@jimcramer in your opinion what is the better play for biotech, $GILD or $ABBV?Gilead Sciences, Inc. $GILD Cut to Hold at Vetr Inc. https://t.co/gFgygzJNRAGilead Sciences, Inc. $GILD Cut to Hold at Vetr Inc. https://t.co/MPCchmWxj8RT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @biospace: The M&amp;A Rumor Mill Points to Gilead $GILD Acquiring Intercept Pharma $ICPT https://t.co/Qe97P9s6DV https://t.co/ifmZMMttT9RT @CatalystWatcher: To add - last year $GILD sent GS-4774 data from 1st trial to $GBIM late Tuesday. $GBIM reported Wednesday morning. Sam‚Ä¶sold $GILD $95c@RunnersDad I don't think $GILD ever had any intention of releasing 24-week data. Only 48. It's material to GBIM tho.@CatalystWatcher Was that the one that was filed on 2-5-16? Would that gag order apply to $GILD as well?@CatalystWatcher Are you now expecting $GILD to release updates on their collaboration? Can a NDA be submitted based on results of phase 2?RT @stockingup333: for anyone that doesn't know $gbim and $gild who has WorldWide commercial rights here: https://t.co/ws1MjUSCYVGilead Sciences Shows Further Upside Potential $GILD https://t.co/HkQytekZVjRT @CatalystWatcher: $GILD ER 4/28. $GBIM ER approx May 12/13. Expect important updates on GS-4774 and the strategic alternatives resolutio‚Ä¶Commented on Gilead - Some Takeaways From The Recent Liver Meeting https://t.co/17agYOfOSJ $ABBV $IBB $MRK $RGLS $GILDRT @stockingup333: $GBIM just over $2/sh, expecting Ph2 readouts for GI-4774 with $GILD, and oh wait, they have Ph2 MTC expected out 2nd ha‚Ä¶RT @stockingup333: @stockingup333 5M Float stock, trading at these low levels, positive Ph2 data with $GILD sends this running hard imo.for anyone that doesn't know $gbim and $gild who has WorldWide commercial rights here: https://t.co/ws1MjUSCYVAEP Financials
See Here ---&gt; https://t.co/tALIBKV9Gi

$AEP $AXL $GILD #stocksMrPrud's [#Watchlist] Que's | $GILD https://t.co/A1GXHdPZIg https://t.co/K7QaMm3zPeRT @stockingup333: $GBIM just over $2/sh, expecting Ph2 readouts for GI-4774 with $GILD, and oh wait, they have Ph2 MTC expected out 2nd ha‚Ä¶@stockingup333 $GILD will be giving out the results not $GBIM?@stockingup333 5M Float stock, trading at these low levels, positive Ph2 data with $GILD sends this running hard imo.RT @CatalystWatcher: $GILD ER 4/28. $GBIM ER approx May 12/13. Expect important updates on GS-4774 and the strategic alternatives resolutio‚Ä¶$GBIM just over $2/sh, expecting Ph2 readouts for GI-4774 with $GILD, and oh wait, they have Ph2 MTC expected out 2nd half '16 with $CELGRT @CatalystWatcher: $GILD ER 4/28. $GBIM ER approx May 12/13. Expect important updates on GS-4774 and the strategic alternatives resolutio‚Ä¶$GILD ER 4/28. $GBIM ER approx May 12/13. Expect important updates on GS-4774 and the strategic alternatives resolution.$GILD $IBB $XBI getting a decent bounce. 

$BMRN hit a buy point.

$BIIB not really bouncing yet.Out of $GILD Puts .90 to 1.26$GILD ER on 4/28 After Close. SP were UP 17 times out of last 25 qtrs (68%) in ER. https://t.co/GqG6jkKtPHHepatitis C drug restrictions target of @AGSchneiderman agreement with 7 insurers $GILD $ABBV https://t.co/urAKS9wXMo5 NASDAQ 100 Stocks for Momentum Investors $FOX $GILD $QVCA $AMGN $ULTA https://t.co/tdyP2tD0xd https://t.co/cWNiF5gAX8@swat_premium any thoughts on $gild for ER today?RT @BiotechRadar: 1st International Workshop on NASH Biomarkers 29-30/04 $GNFT $GILD $LLY $MRK...- https://t.co/wBM5zi4pP5RT @CarolineYLChen: Andy Slavitt @CMSGov bringing up $GILD hep C cures, says local govts don't have ""magic pots of money,"" need new pay mod‚Ä¶Andy Slavitt @CMSGov bringing up $GILD hep C cures, says local govts don't have ""magic pots of money,"" need new pay models  #WMIF16RT @ebcapital: Can Arrowhead Do For Hep B What Gilead Sciences Did For Hep C? $ARWR $GILD --  The Motley Fool https://t.co/AlCU8XXaPNRT @biospace: The M&amp;A Rumor Mill Points to Gilead $GILD Acquiring Intercept Pharma $ICPT https://t.co/Qe97P9s6DV https://t.co/ifmZMMttT9RT @biospace: The M&amp;A Rumor Mill Points to Gilead $GILD Acquiring Intercept Pharma $ICPT https://t.co/Qe97P9s6DV https://t.co/ifmZMMttT9@McDermf17 @IncredibleTrade Slowly creeping up.  Would like to see $GBIM pull off $Kbio type move. 5M Float, $GILD/$CELG clinicals.RT @biospace: The M&amp;A Rumor Mill Points to Gilead $GILD Acquiring Intercept Pharma $ICPT https://t.co/Qe97P9s6DV https://t.co/ifmZMMttT9RT @bleeckersarl: $ICPT's best #JOKE: #OCA patent 4""prevention of...CV disease...&amp; 4 reducing HDL cholesterol"" $GILD @adamfeuerstein  https‚Ä¶RT @biospace: The M&amp;A Rumor Mill Points to Gilead $GILD Acquiring Intercept Pharma $ICPT https://t.co/Qe97P9s6DV https://t.co/ifmZMMttT9$GILD ticks the boxes as a dream üí∞ dividend üí∞ stock with 1.7% yield https://t.co/MVKWRAQqUO https://t.co/ghqYp5dnIK1st International Workshop on NASH Biomarkers 29-30/04 $GNFT $GILD $LLY $MRK...- https://t.co/wBM5zi4pP5RT @NassarInvesting: Snagged $GILD  100P at .90 today. Currently 1.34. $IBBRT @GeryDIVRY: @biospace $GILD $ICPT
https://t.co/zEej2DOjhQ https://t.co/oRIP0GJRPDRT @pharmalot: Health plans reach deal w/NY State to remove restrictions on hepatitis C meds.. https://t.co/NwBusz0LaT #pharma $GILD $ABBV‚Ä¶RT @pharmalot: Health plans reach deal w/NY State to remove restrictions on hepatitis C meds.. https://t.co/NwBusz0LaT #pharma $GILD $ABBV‚Ä¶$GILD $IBB Took #trading S Gilead down to 10% at $101.40 from 102.14 avg  https://t.co/gjbhAoPrd3China poised to approve HCV drugs, major players hope to capitalize https://t.co/GN6nBF4YWB $GILD $ABBV $MRK $BMYChina poised to approve HCV drugs, major players hope to capitalize https://t.co/OJgXfMW6vE $GILD $ABBV $MRK $BMYChina poised to approve HCV drugs, major players hope to capitalize https://t.co/DRKO4U0Jwn $GILD $ABBV $MRK $BMYNasdaq100 #Stocks Trend $MU $NXPI $PCAR $CHTR $MXIM $BIIB $DISH $INTU $HSIC $QCOM $TXN $SIRI $GILD $ADSK $EBAY  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $DOW $LMT $BA $BIIB $DD $BK $QCOM $TXN $USB $WFC $XOM $TWX $DIS $MDT $GILD $OXY $EMR  @ https://t.co/cKkr8cKsjuRT @pharmalot: Health plans reach deal w/NY State to remove restrictions on hepatitis C meds.. https://t.co/NwBusz0LaT #pharma $GILD $ABBV‚Ä¶Snagged $GILD  100P at .90 today. Currently 1.34. $IBBHealth plans reach deal w/NY State to remove restrictions on hepatitis C meds.. https://t.co/NwBusz0LaT #pharma $GILD $ABBV $MRKRT @GeryDIVRY: LES STRATEGIES POSSIBLES DE GILEAD ( $GILD ) DANS LA #NASH https://t.co/nuRJWiQewsbe cautious w/ $GILD here. it‚Äôs come far and fast. broke s/t trend. may want to correct a bit b4 ER https://t.co/MhDy6Tzj7kCommented on Biotech: The Train Has Left The Station https://t.co/v0gzOfpMw0 $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @WallStHorizon: Follow us for #earnings, #dividend, #investor conference updates like these: $CMCA $F $BA $FB $AMZN $GILD $XOM $HAL http‚Ä¶Follow us for #earnings, #dividend, #investor conference updates like these: $CMCA $F $BA $FB $AMZN $GILD $XOM $HAL https://t.co/fuikVI7Vtr$GILD breaking down? https://t.co/hk8ZUJ5FmxRT @GeryDIVRY: @biospace $GILD $ICPT
https://t.co/zEej2DOjhQ https://t.co/oRIP0GJRPDVolume Alert - GILD 102.76 Gilead Sciences Inc $GILD Hit a high today of 103.10 Closing the day 10:31 at 102.7 https://t.co/DF357sLFDT@techwhitepapers $GILD is too big. ..  $PRQR and $LIFE could be players.. but their programs are also early ( $LIFE has liiver n preclincal)Stock trade alerts https://t.co/uAcamNRUPt JOIN NOW Promo https://t.co/e2zXG3II89 $MCUR $AMAT $ITUB $MT $GILD $HST $AA $GMBios weak.  $GILD $CELG $IBB lowsGilead Sciences, Inc Wins EU Approval for a Potential Blockbuster HIV Drug - https://t.co/Vt3nGjyhSg - $GILD https://t.co/peeVBsUoM8Gilead Sciences Wins EU Approval for a Potential Blockbuster HIV #Drug $GILD --&gt;&gt; https://t.co/WCDRG7Ig2X https://t.co/XUoLEIKJS5RT @datamonitor_MH: Descovy (F/TAF) gains EU approval for tx of #HIV patients aged &gt;12 years. $GILD hoping to swap pts from Truvada before‚Ä¶$GILD:US First Houston Capital Inc. Sells 150 Shares of Gilead Sciences, Inc. (GILD) #GILEAD SCIENCES INC  https://t.co/tUDzAjcOJX #NASDAQ$GILD Gilead May seasonality and important chart development right here right now &gt;&gt;&gt;&gt; https://t.co/xU9tmG75IHRT @biospace: Gilead $GILD Seeks to Build 6-Story Lab in HQ Expansion, May House Up to 5,000 New Employees https://t.co/htE7AZJxU7 https://‚Ä¶GILD Top news - Apr 26th, 2016 $GILD https://t.co/XCkPkVhKZK@Chub519 Yeah, definitely improving here.  BUT, if broader markets tank, may head back down. Watch $CELG, $GILD, $BIIB and $REGN.$GILD:US First Houston Capital Inc. Sells 150 Shares of Gilead Sciences, Inc. (GILD) #GILEAD SCIENCES INC  https://t.co/AF0aMDsjYv #SP500sold 3/4 $GILD at 103Gilead Sciences hits a 1 quarter high https://t.co/aE2bhADJXH $GILD #GileadSciences https://t.co/ySp7YqOk9U$GILD 2016 high moving above resistance at 102 out of a Jan-Apr rounding bottom https://t.co/IK4vwDg82IRT @ebcapital: Can Arrowhead Do For Hep B What Gilead Sciences Did For Hep C? $ARWR $GILD --  The Motley Fool https://t.co/AlCU8XXaPNCan Arrowhead Do For Hep B What Gilead Sciences Did For Hep C? $ARWR $GILD --  The Motley Fool https://t.co/AlCU8XXaPNRT @ZacharyBrennan: $GILD spent $980k on lobbying in Q1, or a little less than what they make every hour from Sovaldi and Harvoni sales htt‚Ä¶RT @ZacharyBrennan: $GILD spent $980k on lobbying in Q1, or a little less than what they make every hour from Sovaldi and Harvoni sales htt‚Ä¶$GILD spent $980k on lobbying in Q1, or a little less than what they make every hour from Sovaldi and Harvoni sales https://t.co/AXDQ1bOb6sRT @MikeF_trading: $BIIB breaking out

#biotech $GILD
$IBB $REGN https://t.co/zaYZaT1HXSGilead Sciences, Inc. $GILD Shares Sold by American Money Management LLC https://t.co/EThGm65Q8B via @RatingsNetwork$BIIB breaking out

#biotech $GILD
$IBB $REGN https://t.co/zaYZaT1HXSGilead Sciences, Inc. $GILD Shares Sold by American Money Management LLC https://t.co/A2H57NcwOFRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @blaine_delancey: Stocks I watch with earnings this week: 4/26: $AAPL $EBAY $SAVE $WHR $TWTR 4/27: $FB $HLT $ORLY $AOS $PYPL 4/28: $AMZN‚Ä¶Hoy Corto $AAPL, Largo $GILD. #TRMXStocks I watch with earnings this week: 4/26: $AAPL $EBAY $SAVE $WHR $TWTR 4/27: $FB $HLT $ORLY $AOS $PYPL 4/28: $AMZN $GILD $LNKDRT @BiotechMoney18: $PXD $AAPL $TWTR $FB $CMG $PNRA $BWLD $YELP $GILD $EXPE $LNKD $BIDU $BMRN $PSX earnings reports &amp; economic calendar htt‚Ä¶CLB Yield
See Here ---&gt; https://t.co/or0skgqYSN

$CLB $GILD $UA #nasdaqRT @Benzinga: Big #Biotech In The Earnings Spotlight $AMGN $CELG $GILD https://t.co/5ccwKEVKLrBig #Biotech In The Earnings Spotlight $AMGN $CELG $GILD https://t.co/5ccwKEVKLr#GileadSciences secures EU approval for new HIV treatment. Read more: https://t.co/7psOKAvsUT $GILDRT SeekingAlpha: Gilead Sciences: Bad News Priced In https://t.co/obTsxCNv8i $GILDGilead Sciences: Bad News Priced In https://t.co/lJUQUn1Cc4 $GILDGilead Sciences: Bad News Priced In https://t.co/TkIbqzBpuh $GILDRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶Gilead Sciences: Bad News Priced In - Gilead Sciences, Inc. (NASDAQ:GILD) | Seeking Alpha

#Gilead $GILD https://t.co/G7A65tSI5SDoes recent uptrend in $GILD price indicate a better #earnings. Trade #BioTech #stocks #options b4 #earnings and profit from timely #tradeRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶AIMT Investor Opinions
See Here ---&gt; https://t.co/lwabZPRQud

$AIMT $DHR $GILD #stocksRT @GeryDIVRY: LES STRATEGIES POSSIBLES DE GILEAD ( $GILD ) DANS LA #NASH https://t.co/nuRJWiQews@biospace $GILD $ICPT
https://t.co/zEej2DOjhQ https://t.co/oRIP0GJRPDLES STRATEGIES POSSIBLES DE GILEAD ( $GILD ) DANS LA #NASH https://t.co/nuRJWiQewsRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶Cheap call option upside: $DIS calls cheaper than 100% of history, $BABA 99%, $GILD 99%, $CMCSA 98%, $DAL 98%, $MSFT 97%, $XHB 96%RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶Biotech Trade Alerts Archive -2016-04-25- $EVOK, $ABBV, $FCSC, $ARLZ, $PRGO, $BMY, $GILD, $SRPT, $DEPO https://t.co/XIAIlgsPSDRT @bret_jensen: Commented on Biotech: The Train Has Left The Station https://t.co/v0gzOfHnUA $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP‚Ä¶Weekly Nasdaq100 #Stocks Trend $TSCO $TMUS $BIIB $MXIM $GILD $CHTR $CELG $FOXA $ULTA $SIRI $QCOM $CSX $ESRX  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $VIAB $WDC $TSCO $ENDP $TMUS $BIIB $CSX $BMRN $SIRI $GILD $VRTX $CHTR  more@ https://t.co/YdSIjFJqHfWeekly S&amp;P100 #Stocks Trend $BIIB $BK $USB $GILD $DIS $CELG $MDT $DHR $FOXA $TWX $UNP $MON $QCOM $AXP $BMY  @ https://t.co/cKkr8cKsjuWeekly S&amp;P100 #Stocks Performance $UNP $MS $BK $BAC $MON $AXP $UNH $COF $USB $BIIB $GS $EMC $C $WFC $GILD  more@ https://t.co/cKkr8cKsjuCommented on Gilead's Acquisition Strategy Becomes Clearer https://t.co/oPxmMNfalG $GLPG $GILDCommented on Biotech: The Train Has Left The Station https://t.co/v0gzOfHnUA $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶Major Healthcare Stocks In The Process Of Breaking Out: Gilead And Bristol Myers $BMY $GILD https://t.co/yoIEU5gCdtDescovy (F/TAF) gains EU approval for tx of #HIV patients aged &gt;12 years. $GILD hoping to swap pts from Truvada before July 2018 patent exp.The Sleep Well Portfolio Outperforms Both The S&amp;P 500 And The FANG https://t.co/e9zbgrHa37 $GILD $MRK $JNJ $MMM $ETN $WMT $XOMRT @R4inb0w_: #NASH $GILD $GNFT $ICPT #Elafibranor #Liverdisease @EASLnews  https://t.co/Ilo36IciE1Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Gilead Sciences, Inc. $GILD EVP Sells $4,000,400.00 in Stock https://t.co/vXSbMedXeyGilead Sciences, Inc. $GILD EVP Sells $4,000,400.00 in Stock https://t.co/1ceTllg3nTRT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶NE Prev Close
See Here ---&gt; https://t.co/mohRwgErnC

$NE $GILD $CCXI #shareFive Stocks To Watch This Week - April 25, 2016 $CMG $AAPL $AMZN $GILD $FB https://t.co/UHfDFpJd2ZRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @gxd123: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD... https://t.co/msZoGkDMUq via @Stock‚Ä¶EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD... https://t.co/msZoGkDMUq via @StockTwitsRT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶#Biotech #options trend 4 companies Rptg #earnings this Wk. Trade timely #options Hi VOL in $GILD;Hi OI in $ALXN https://t.co/0kgRXUIcju$GILD short ratio @ 2.47. Track short ratio w/ #options trends to make better trades $GILD Out-of-the-money #options https://t.co/pcC0c3X4YSV. High VOL (1000+ contracts) in $GILD $102 calls trading @ $2.05? Good Buy? Follow #options trends 4 HI Alpha trade https://t.co/njHWGkanjMRT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶@POTUSFerocUS New to the ticker, not sure what standard procedure is for $GILD relaying info.$CELG, $AMGN, $ALXN, $GILD reporting #earnings this week. Trade #Biotech #options to realize high profits. #stocks https://t.co/oQEwZcVBc8RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶We calculated 21-day Expected Return of $GILD for you: 13.16% https://t.co/mTgAzTSiLDGILD Ask
See Here ---&gt; https://t.co/SmE4UsDpiQ

$GILD $ESPR $LOXO #investing$GILD #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/gAO7gGyfEBMajor Healthcare Stocks In The Process Of Breaking Out: Gilead And Bristol Myers $BMY $GILD https://t.co/N6BCiWlGQyRT @StockTwits: GET READY. Here are the companies reporting earnings next week: https://t.co/NXptPkQX70

$AAPL $FB $TWTR $CMG $GILD https:/‚Ä¶Wondering about #sentiment indicator for $GILD? The Short Ratio is 2.47% https://t.co/aGOMONHc1Uany undergrad life science majors that arnt graduating this spring, check this summer internship at the great $GILD https://t.co/1zvtN2xA9kRT @Duckingmoney: Tomorrow the fun starts: $aapl $fb $cmg $ebay $mnst $bidu $amzn $bwld $ups $gild $lnkd https://t.co/GAUGE5IbAERT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @raymond10mm: $GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ Mix Day. https‚Ä¶RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶$GILD chart: Clear trend break. https://t.co/w9qD9WA9SOClear trend break $GILD https://t.co/aJP5GFST7yRT @AmericanBanking: Gilead Sciences, Inc. $GILD Shares Sold by FTB Advisors Inc. https://t.co/xbxDX7e5EjRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPGilead Sciences, Inc. $GILD Stake Boosted by Synovus Financial Corp https://t.co/y1w5fTGkcOConfluence Wealth Management LLC Cuts Stake in Gilead Sciences, Inc. $GILD https://t.co/lxOBP2AnjTGilead Sciences, Inc. $GILD Shares Sold by FTB Advisors Inc. https://t.co/X0rQSC3ZQdFirst Houston Capital Inc. Sells 150 Shares of Gilead Sciences, Inc. $GILD https://t.co/WwWHYYPAgHGilead Sciences, Inc. $GILD Shares Sold by FTB Advisors Inc. https://t.co/xbxDX7e5EjFirst Houston Capital Inc. Sells 150 Shares of Gilead Sciences, Inc. $GILD https://t.co/88DhkvKqlKCheap put options and hedges: $DAL puts cheaper than 94% of history, $VZ 91%, $T 90%, $MSFT 89%, $GILD 89%, $XHB 89%, $FSLR 88%$GILD $AET:

New York Insurers to Change Coverage of Hepatitis C Drugs:

https://t.co/nyy3pZXMTG$GILD this puppy needs to announce something no one expects..RT @WrigleyTom: $NXPI $JBLU $FCX $AAPL $CMG
$TWTR $EBAY $BWLD $PNRA $CRUS
$FB $FSLR $UPS $CELG $AMZN
$LNKD $BIDU $SWKS $GILD $HELE https://‚Ä¶RT @Duckingmoney: Tomorrow the fun starts: $aapl $fb $cmg $ebay $mnst $bidu $amzn $bwld $ups $gild $lnkd https://t.co/GAUGE5IbAERT @Duckingmoney: Tomorrow the fun starts: $aapl $fb $cmg $ebay $mnst $bidu $amzn $bwld $ups $gild $lnkd https://t.co/GAUGE5IbAERT @Duckingmoney: Tomorrow the fun starts: $aapl $fb $cmg $ebay $mnst $bidu $amzn $bwld $ups $gild $lnkd https://t.co/GAUGE5IbAEFive Stocks To Watch This Week - April 25, 2016 $CMG $AAPL $AMZN $GILD $FB https://t.co/u90xH7faUjRT @Duckingmoney: Tomorrow the fun starts: $aapl $fb $cmg $ebay $mnst $bidu $amzn $bwld $ups $gild $lnkd https://t.co/GAUGE5IbAETomorrow the fun starts: $aapl $fb $cmg $ebay $mnst $bidu $amzn $bwld $ups $gild $lnkd https://t.co/GAUGE5IbAERT @biospace: The M&amp;A Rumor Mill Points to Gilead $GILD Acquiring Intercept Pharma $ICPT https://t.co/Qe97P9s6DV https://t.co/ifmZMMttT9RT @StockTwits: GET READY. Here are the companies reporting earnings next week: https://t.co/NXptPkQX70

$AAPL $FB $TWTR $CMG $GILD https:/‚Ä¶",2016-04-26,GILD,0
18,"Earnings-Reaction to Watch Thursday $MO, $GILD, $HELE, $JNPR, $ELLI, $GRPN, $CIT, $DFT, $BIDU, $ITC, $FLEX, $P, $I https://t.co/roaB562ZmV@SkeleCap @AdamGaglio I own $gild too and in other news contain multitudesParabolic SAR Sell https://t.co/TA8enrHTdd $VUG $HUBB $CELG $VONG $IXJ $GILD $IWF $OEF $MGK $UFPI $IUSG $AOS $GRA $CRM $ROLL $CHRW $XLVhttps://t.co/43UVEMo8n1  Earning Watchlist for tomorrow mega cap: $AMZN, $GILD, $MO, $BMY, $MA, $ABBV, $UPS, $CELG, $BIDU@DorsiaCapital @AdamGaglio yeah. ""Make $GILD P/E Great Again. Oh. Also America.""Busy again tomorrow #earnings $GILD, $MO, $AMZN, $EXPE, $F, $LNKD, $MA, $PENN, $SIRI, $TMO, $TWC, $VC, $WDC https://t.co/QegwvOjEVuSuper Thursday: Q1 2016 Earnings In Full Swing. Here is what I am trading: $GILD $LNKD https://t.co/FC9L24tN5yTrading Rules - Discipline and staying strong: https://t.co/vVZZyIZdvD $GILD $TTWO $GM $SCO $REXX $YUM $ABBV $UCO $NXPI $USO $WPRT$GILD $ABBV $ENTA ‚ÄîV-Pak vs Harvoni (global GT1 mkt) calendar 4Q15:

https://t.co/ExVZzah9yd

We‚Äôll know 1Q16 numbers by this time tomorrow.Bearish crossover looming $GILD https://t.co/E9cZRKqm1u$GILD chart: Bearish crossover looming. https://t.co/vEDF1rnAJYEarnings I'm watching tomorrow: $AMZN (expecting a miss) and $AMGN &amp; $GILDTomorrow is a big day for biotech as a slew of them report earnings. Good luck to all who hold $UTHR, $CELG, $GILD and others#Earnings expected Thurs: $AMZN $GILD $AMGN $MO $BMY- 5 largest U.S. companies by market cap. 5 things to consider: https://t.co/YpCN9gqRyXEric, Mora Congrats On Standing Up For Constituents &gt; https://t.co/0CcyJHrwMw ‚Ä¶ ‚Ä¶ $GILD @MassAGO @AGSchneiderman https://t.co/37hc9Fdz0i$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ #FOMC up https://t.co/ZmnRAKFnl6#Earnings Tomorrow-P5
$FET $FII $FLEX $FLS $FPO $GABC $GB $GERN $GFF $GIFI $GILD $GIMO $GNBC $GNW $GRPN 
https://t.co/wkf0X8Rups@AdamGaglio @DorsiaCapital yes that little detail. If $GILD can barely toe the line, $VRX clearly over it.RT @RunnersDad: @CatalystWatcher @Ken_Kulig Would it be out of the question for $GILD to announce they are acquiring $GBIM and release data‚Ä¶Last 10 minutes of $GILD $CELG $BIIB $IBB trading is absolutely criminal, predatory #HFT at absolute worst #investing #biotech #TomsTruthsEarnings After Close 4-28-2016 https://t.co/cfPzyqf5TS  $DGII $DLR $BOOM $EHTH $EPR $ELLI $EDE $ESS $EXPE $FII $FPO $FLEX $GNW $GIMO $GILD$GILD #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/DgIpvit3xk$GILD ticks the boxes as a dream üí∞ dividend üí∞ stock with 1.7% yield https://t.co/MVKWRAQqUO https://t.co/q9FXuXkqK0@Ken_Kulig data before any M&amp;A would be idea. Let's see what $GILD says tomorrow before I speculate further.$IBB components were easy to setup 4 max profit by MMs to hedge 2morrow big ER day. $CELG $AMGN $GILD $ALXN. Going up@Ken_Kulig Proxy will be after ER. I will have a pretty good idea what's happening after $GILD ER tomorrow.ARWR valuation at ~$350M on + HBV combination data. $GBIM at $12M with a shot at becoming a piece in the $GILD HBV cocktail.Should have listened to @JuliaSkripkaSer and grabbed some of those $GILD $100 calls in the 80s. Always a good buy.@GerberKawasaki I could do with it, but dinner is already cooking here. In other news $GILD is on deck tomorrow üçÄ@RunnersDad @Ken_Kulig The data would likely be used to negotiate value of company. Prob not released as $GILD cares more about 48-weekRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶StockTwits Trending: 
$NUGT $SPY $TWTR $GLD $TLT $FCX $XON $QQQ $UUP $DWTI $CMG $UWTI $AMZN $BA $GILD $DUST $AAPL https://t.co/oN8KsRHztF$GILD like some warnings that are being issued by other companies.@CatalystWatcher @Ken_Kulig Would it be out of the question for $GILD to announce they are acquiring $GBIM and release data as well?#Options #maxpain chart for $GILD. #option #invest More with #OptionsPro FREE app at https://t.co/vmQaxw1x1K https://t.co/Gl8GMR24vNlooking at some $GILD call options10 Growth Stocks to Grow Old With $UA $FB $AMZN $GILD $ULTA https://t.co/raKU6jh59L https://t.co/34llXp3AZyRT @OptionsHawk: $GILD 4,285 of May 6th (W) $95 puts active all morning, $0.55 to $0.70.  Similar to AAPL, large, cheap, lots of cash, no g‚Ä¶Market Outlook: Landmines to Avoid https://t.co/bcpWY91Gi2 $ABBV $AMGN $CELG $GILD $LGIH $TMHCRT @BioPharmaDive: 7 New York insurers end restrictions on coverage for hepatitis C drugs https://t.co/DAVAm8pF0K $MRK $ABBV $GILDRT @tgtxdough: @tgtxdough $TGTX science behind the  TGR-1202 superiority $GILD https://t.co/k64t27dD0a@MattBroadwell I'm liking $CELG into earnings; using an option. Pull back ahead could be a cheap entry. Also own $GILD; should be good.$GILD earnings tomorrow. maybe new news from M&amp;A front? def $GILD will talk about #liver #nash and related.7 New York insurers end restrictions on coverage for hepatitis C drugs https://t.co/DAVAm8pF0K $MRK $ABBV $GILD@tgtxdough $TGTX science behind the  TGR-1202 superiority $GILD https://t.co/k64t27dD0aAvoid Gilead $GILD https://t.co/4YnCXHuAojRT @OptionsHawk: $GILD 4,285 of May 6th (W) $95 puts active all morning, $0.55 to $0.70.  Similar to AAPL, large, cheap, lots of cash, no g‚Ä¶$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/iX5cnKUVa1 https://t.co/XX3HDBEQBwRT @CatalystWatcher: $GILD Q1 ER tomorrow. They decide how and when GS-4774 data is released. $GBIM holders should pay close attention.#GileadSciences Big Biotech In The Earnings Spotlight. Read more: https://t.co/1aYdhJK3gG $GILD$GILD Q1 ER tomorrow. They decide how and when GS-4774 data is released. $GBIM holders should pay close attention.RT @biospace: The M&amp;A Rumor Mill Points to Gilead $GILD Acquiring Intercept Pharma $ICPT https://t.co/Qe97P9s6DV https://t.co/ifmZMMttT9RT @biospace: The M&amp;A Rumor Mill Points to Gilead $GILD Acquiring Intercept Pharma $ICPT https://t.co/Qe97P9s6DV https://t.co/ifmZMMttT9similar put speculation in $GILD today, seeing the same thing in $AAPL yesterday ahead of earnings. Gilead reports after the bell tonightAdded $gild $95 puts .. At $0.69RT @OptionsHawk: $GILD 4,285 of May 6th (W) $95 puts active all morning, $0.55 to $0.70.  Similar to AAPL, large, cheap, lots of cash, no g‚Ä¶$GILD #biotech #investing #TomsTruths NY insurers end restrictions on coverage for hepatitis C  https://t.co/Et0hUdsIET via @biopharmadiveSeekingAlpha: Avoid Gilead https://t.co/0CcyJHrwMw ‚Ä¶ $GILD @cafepharma @GenericPharma24 @pharmagossip @DTNPharmaNewsRT @ChinaInvest: RT SeekingAlpha: Avoid Gilead https://t.co/hFgiMXSMMg $GILDRT @OptionsHawk: $GILD 4,285 of May 6th (W) $95 puts active all morning, $0.55 to $0.70.  Similar to AAPL, large, cheap, lots of cash, no g‚Ä¶RT @OptionsHawk: $GILD 4,285 of May 6th (W) $95 puts active all morning, $0.55 to $0.70.  Similar to AAPL, large, cheap, lots of cash, no g‚Ä¶RT @OptionsHawk: $GILD 4,285 of May 6th (W) $95 puts active all morning, $0.55 to $0.70.  Similar to AAPL, large, cheap, lots of cash, no g‚Ä¶RT @OptionsHawk: $GILD 4,285 of May 6th (W) $95 puts active all morning, $0.55 to $0.70.  Similar to AAPL, large, cheap, lots of cash, no g‚Ä¶RT @OptionsHawk: $GILD 4,285 of May 6th (W) $95 puts active all morning, $0.55 to $0.70.  Similar to AAPL, large, cheap, lots of cash, no g‚Ä¶RT @OptionsHawk: $GILD 4,285 of May 6th (W) $95 puts active all morning, $0.55 to $0.70.  Similar to AAPL, large, cheap, lots of cash, no g‚Ä¶short $GILD https://t.co/oK5AfG432B$GILD 4,285 of May 6th (W) $95 puts active all morning, $0.55 to $0.70.  Similar to AAPL, large, cheap, lots of cash, no growthVolume Alert - GILD 100.69 Gilead Sciences Inc $GILD Hit a high today of 101.78 Closing the day 10:30 at 100.6 https://t.co/DcduErmx90@TheHoInPsycho major game changer for $GILD is that its oral :) .. that will be huge in HBV esp the delivery mechanism@stb8444 @techwhitepapers look at $ABBV vs. $GILD... Granted abbv drug inferior but still was never competition for gild.Get daily event reports like these for your watchlist w/ Enchilada https://t.co/6N2XyRnNXx, $GILD $CELG $ABBV $AMGN https://t.co/FVYOHQ9igYSeven New York insurers end restrictions on coverage for hep C drugs https://t.co/DAVAm8pF0K $GILD $ABBV $MRK$ABBV steps up battle in #HepC with new cure rates for combo drug https://t.co/BB4IkkJytD $GILD #pharma https://t.co/QfLvwzttqvCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Another Study Finds Six Weeks of Harvoni Can Cure Acute #Hepatitis C https://t.co/3CuQnueIYG #EASL #EASL2016 #ILC2016 $GILD@Smallinvestor81 I agree, I think $gbim with $celg and $gild as collaborators has plenty of milestones and royalties tied in. Time will tellQuote of the year ""How biotech specialist missed the biggest sector rotation in years?"" lost in the trees - $SRPT $VRX $GILD $BIIBGilead $GILD is likely to exceed expectations with its first quarter #earnings on April 28 https://t.co/RGdEPTTpVh https://t.co/uYbPOnvKqBApril 27 Biotech Update $ABBV $CELG $GILD $LLY $SRPT https://t.co/vEQ1OgRPxe$GILD $IBB Took off last of #trading S Gilead at $100.65 from 102.14 avg  https://t.co/mPnihMncFV@jimcramer biotech is not out of bear market. $REGN $IMGN $GILD ERs coming.$ANTM comments on HepC this morning

$GILD https://t.co/2dCmovp6t4As predicted, lawsuits matter - 7 New York insurers cave on hep C restrictions amid pushback from NY AG  $GILD  https://t.co/zaafKA8tE9GILD Top news - Apr 27th, 2016 $GILD https://t.co/ZIRiQsTMdNRT SeekingAlpha: Avoid Gilead https://t.co/hFgiMXSMMg $GILDRT @tgtxdough: CS $GILD $CELG preview notes https://t.co/XmC0ToHgImCS $GILD $CELG preview notes https://t.co/XmC0ToHgImAvoid Gilead https://t.co/DcNWNep8Na $GILDAvoid Gilead https://t.co/wPdTvtkBYe $GILDRT @SashaDamouni: Drug Prices Keep Rising Despite Intense Criticism https://t.co/sen5K1EeqZ $JNJ $GILD $AMGN $CELGRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶Drug Prices Keep Rising Despite Intense Criticism https://t.co/sen5K1EeqZ $JNJ $GILD $AMGN $CELG$AGG $BND $BOND $PTY $SPY $TLT $IMGN $SAN $FXA $AAPL $VTI $VIX $GOOGL $IDRA $CTIX $SDS $EFA $ITB $HGU $AXN $ACAD $GILD $IWM $BND $JBLU $VNQ‚Ä¶5 Nasdaq 100 Stocks For Momentum Investors - April 26, 2016 $AMGN $GILD $ULTA $FOX $QVCA https://t.co/iCY2MSU0i5RT @delawemon: „ÇÆ„É™„Ç¢„Éâ„Å´„Å®„Å£„Å¶Â§ß„Åç„Å™„Éû„Éº„Ç±„ÉÉ„Éà„ÅåÈñã„Åë„Çã„Å™„ÄÇhttps://t.co/PY4M2J1gWg
$GILDRT @BiotechRadar: 1st International Workshop on NASH Biomarkers 29-30/04 $GNFT $GILD $LLY $MRK...- https://t.co/wBM5zi4pP57 Undervalued Stocks To Buy And 3 To Sell $AMGN $CELG $GILD $MSFT $NFLX $XHB $ABBV $GOOGL $TPH $LGIH $TMHC $SCWX https://t.co/4Hd61D9b8P„ÇÆ„É™„Ç¢„Éâ„Å´„Å®„Å£„Å¶Â§ß„Åç„Å™„Éû„Éº„Ç±„ÉÉ„Éà„ÅåÈñã„Åë„Çã„Å™„ÄÇhttps://t.co/PY4M2J1gWg
$GILD@psuvafan007 @Slingshot_Invst TDF soon 2b replaced by TAF $GILD.  Didn't know pot existed comboT w Heplisav $DVAX $ARWR $JNJ, others.10 Best S&amp;P 500 Companies By Net Shareholder Distribution Yield - See more at: https://t.co/0SpurrxGsJ - $MSFT $WMT $XOM $GILD $JNJ $MONRT @VetrRatings: 27 users on Vetr are bullish on Gilead Sciences, Inc., indicating a BUY Rating (3.5 stars) for $GILD https://t.co/jxBKjjj0‚Ä¶27 users on Vetr are bullish on Gilead Sciences, Inc., indicating a BUY Rating (3.5 stars) for $GILD https://t.co/jxBKjjj0RYAMG National Trust Bank Sells 9,667 Shares of #GileadSciences, Inc. (). Read more: https://t.co/lk3IldlAvO $GILD$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/iX5cnKUVa1 https://t.co/4tHt3nvDlzEDGW Investor Opinions
See Here ---&gt; https://t.co/2EaRMVbG93

$EDGW $GILD $TNP #shareGilead Sciences, Inc. $GILD Upgraded to ‚ÄúBuy‚Äù at Vetr Inc. https://t.co/Dc7IhsWYgK$GILD received a new alert. Find out why at https://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt  #NYSE #NASDAQ #markets 894Gilead Sciences, Inc. $GILD Upgraded to ‚ÄúBuy‚Äù at Vetr Inc. https://t.co/wsl91FEX4FBig Biotech In The Earnings Spotlight $AMGN $CELG $GILD https://t.co/aliuhFtcDX$GILD received a new alert. Find out why at https://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt  #NYSE #NASDAQ #markets 882Gilead Sciences upgraded by Vetr Inc. to buy. $107.61 PT. https://t.co/7HErxCxdUb $GILD #GILDIntrust Bank NA Sells 288 Shares of Gilead Sciences, Inc. $GILD https://t.co/AwASCksXlBAMG National Trust Bank Sells 9,667 Shares of Gilead Sciences, Inc. $GILD https://t.co/5lWMN91BAwGilead Sciences, Inc. $GILD Position Boosted by Krasney Financial LLC https://t.co/uGolx0BsQ85 Nasdaq 100 Stocks For Momentum Investors - April 26, 2016 $AMGN $GILD $ULTA $FOX $QVCA https://t.co/3F4Z5x6UooArtemis Investment Management LLP Purchases 7,017 Shares of Gilead Sciences, Inc. $GILD https://t.co/Ecnj0BdSWR7 Undervalued Stocks To Buy And 3 To Sell $AMGN $CELG $GILD $MSFT $NFLX $XHB $ABBV $GOOGL $TPH $LGIH $TMHC $SCWX https://t.co/TwXw8o5mzZ$CELG $GILD $AMGN https://t.co/nR9eSFTrJwRT @RinoNewsdotcom: Why would $AAPL want to buy any of these dogs? $TSLA valuation is an absolute JOKE! Should buy $GILD &amp; $QCOM! https://t‚Ä¶Why would $AAPL want to buy any of these dogs? $TSLA valuation is an absolute JOKE! Should buy $GILD &amp; $QCOM! https://t.co/Osj6RL2r3vCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @pharmalot: Health plans reach deal w/NY State to remove restrictions on hepatitis C meds.. https://t.co/NwBusz0LaT #pharma $GILD $ABBV‚Ä¶Cheap put options and hedges: $DAL puts cheaper than 94% of history, $VZ 94%, $ZNGA 93%, $GILD 89%, $MSFT 86%, $TNA 85%, $FB 84%RT @stockingup333: for anyone that doesn't know $gbim and $gild who has WorldWide commercial rights here: https://t.co/ws1MjUSCYVRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbP@BattagliaCE @Slingshot_Invst I guess $ARWR ARC520/21 + $DVAX TLR9 agonist + entecavir or TDF would make compelling biological sense. $GILDRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbP@AmYisraelChai16 I've heard too many retards say they want to ""hide money in biotech"" for stability &amp; safety. My eyes are on $GILDRT @pharmalot: Health plans reach deal w/NY State to remove restrictions on hepatitis C meds.. https://t.co/NwBusz0LaT #pharma $GILD $ABBV‚Ä¶RT @mr_showkz99: China poised to approve HCV drugs, major players hope to capitalize $GILD $ABBV $MRK $BMY $JNJ https://t.co/Dc1FakA4KJ",2016-04-27,GILD,0
19,"RT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶@LTbioinvestor $GILD not even a top 10 holding in $XBIRT @RebeccaDRobbins: Forced to discount hep C drugs, Gilead misses on revenue. My quick breakdown of $GILD's Q1 earnings: https://t.co/FelF‚Ä¶@actaestfabulaXX my concern is perhaps $GILD does not see a compelling opportunity in the space which would be a big negative for the sector$GILD-Gilead is down nearly 12% from the recent high. Here‚Äôs how you trade it. https://t.co/aUssCf2dewRT @SwatOptions: $GILD lower after earnings and very nice stats @OptionsFlux with MAY.06 PUT 105 add 4.7k contracts plus PUT vol rise https‚Ä¶Don't Sell Gilead - Sell Options And Buy The Stock Instead: https://t.co/rzvKYBgaww $GILD https://t.co/JMCFA3a598RT @RebeccaDRobbins: Forced to discount hep C drugs, Gilead misses on revenue. My quick breakdown of $GILD's Q1 earnings: https://t.co/FelF‚Ä¶If $GILD had underpromised last qtr., the stock would be up 10%.
Ignore the negative morons on this great company. https://t.co/muavylueJtGilead $GILD down -5% after hours. Follow it all here - https://t.co/RuTh0429pGRT @LTbioinvestor: totally agree ... they are too busy to mirror themselves, but success is not forever.
$AAPL $GILD https://t.co/ji9GBt8E92RT @inner_scorecard: This is not the year for Optically Cheap Capital LLC. $AAPL $AMZN $FB $GILD$IBB headwinds a) $GILD dithering b) $SRPT ignoring FDA c) $VRX sorry but raising prices d) Silly $SNY $MDVN e) Pharma‚Äôs PAPs . f) E. WarrenRT @LTbioinvestor: only way to save $XBI tomorrow is some $GILD clear words about n imminent shopping season, but few chances IMHOExplore #fundamental numbers and pros and cons for $GILD https://t.co/IFnkAQiwhE@bret_jensen is $gild stuck at &lt;$100 if they don't please investors with M&amp;A activities? stock is been at such low valuation for so longRT @LTbioinvestor: $GILD buyback strategy is a loosing one, and that was clear to all except $GILD management.
Buybacks are for loosersUnicorn Bay rating for $GILD is 3.54 out of 5. https://t.co/jD70zGcNYEBought $abt today..  $gild selling 8x bust that rascal in the 80's tomorrow &amp; this old dog is going hunting.Decent Earnings, But Going NOWHERE $GILD - https://t.co/X4zSDJl4LJRT @SwatOptions: $GILD lower after earnings and very nice stats @OptionsFlux with MAY.06 PUT 105 add 4.7k contracts plus PUT vol rise https‚Ä¶$GILD says 3 mil untreated HEP C patients in USA. W drug epidemic, there will be a NEVER ENDING supply of customers. Do the math! @jimcramerRT @srqstockpicker: Small cap bio peeps look at $gild down 6% and say pshhh thats what we call Tuesday$GILD $FLEX: significant After Hours Decliners as seen on SpeculatingStocks After-Hours, https://t.co/0sHRjqRl7f #stocksRT @statnews: Forced to discount expensive hepatitis C drugs, Gilead misses sales target https://t.co/FUfF4wEUMk  $GILDRT @inner_scorecard: This is not the year for Optically Cheap Capital LLC. $AAPL $AMZN $FB $GILDGo for singles, not home runs when it comes to #daytrading #trading.  $DRYS $PRGN $OSX $UCO $TWTR $AAPL $AMZN $GILD https://t.co/taklJhKPu1RT @CarolineYLChen: $GILD has now treated close to 1 million patients with its HCV drugs, Milligan saysRT @megtirrell: Several of the large commercial payers opened up access to pts regardless of fibrosis scores in Q1, triggering discounts, $‚Ä¶$GILD  I won't be surprised to see many other stocks (this pretty up that so many are bullish on) turn sour.

$SPY https://t.co/4cB3JvLsxmOptions scanner sellers coming out AH with  winning ER posts, they kept them for AH cuz they were not sure abt them lol  $spy $gild $expeRT @Chemistfrog: Grabbed some $GILD at 91.75 AH..@smallcapbiotech No bidding war neccessary! $GILD should finally buy one of them, over and out! The rest goes to other large caps ;)RT @inner_scorecard: This is not the year for Optically Cheap Capital LLC. $AAPL $AMZN $FB $GILDRT @DailyStockPlays: Why These Stocks Are Trading Down After Hours https://t.co/gI2UVloaXI $AKS $FLEX $GILD $MOH $NPTN $NSR $SWKS $SYNA $WDCRT @statnews: Forced to discount expensive hepatitis C drugs, Gilead misses sales target https://t.co/FUfF4wEUMk  $GILDRT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶This is not the year for Optically Cheap Capital LLC. $AAPL $AMZN $FB $GILDRT @Dougallan1: Long $gild since 1994/5 at 38c Quarterly dividend larger than initial investment. Mgt brilliant -will buy what they want wh‚Ä¶$GILD Welp those $102 weekly lotto calls I bought near the close probably are worth less the belly button lint now.RT @IBD_ECarson: After Hours: Amazon, LinkedIn, Baidu, Expedia Soar, Gilead Flops https://t.co/LJ7yFdWKFz $AMZN $LNKD $BIDU $EXPE $GILD $AM‚Ä¶Why These Stocks Are Trading Down After Hours https://t.co/gI2UVloaXI $AKS $FLEX $GILD $MOH $NPTN $NSR $SWKS $SYNA $WDCRT @srqstockpicker: Small cap bio peeps look at $gild down 6% and say pshhh thats what we call Tuesday$GILD u stupid or what ? Learn from $CELG &amp; buy $OPHT $ITCI $NVAX etc. Throw darts in bioland if u wan higher PE. Ppl need #hopium üòÇRT @LTbioinvestor: $GILD buyout rumors not starting yet ?!?
#sarcasmSmall cap bio peeps look at $gild down 6% and say pshhh thats what we call TuesdayRT @RNAiAnalyst: $GILD in light of HCV sales dynamics, better hurry up w/ testing HBV combo Rx, including RNAi ones: https://t.co/wAfeN0UEDHCommented on Well, That Was Unexpected https://t.co/0lZZXA1QnN $GILDRT @SwatOptions: $GILD lower after earnings and very nice stats @OptionsFlux with MAY.06 PUT 105 add 4.7k contracts plus PUT vol rise https‚Ä¶$GILD lower after earnings and very nice stats @OptionsFlux with MAY.06 PUT 105 add 4.7k contracts plus PUT vol rise https://t.co/4LGxpLXM8C$GILD. Board needs 2 take serious actions before co goes off the cliff.Div&amp;buyback r good but not @ detriment of multi year stock declinesGilead Sciences announces quarterly dividend of $0.47.  Payable on 6/29/2016. 1.94% Yield.  https://t.co/6Y5JUcxxL4 $GILD #GILD@jbaksht @Estimize As we talk yesterday, $GILD PUT rise this week made us stay cautious into EPS. Some options stats https://t.co/ewpYDi955n$GILD is very cheap but the stock has lost its mojo. https://t.co/NH42kpIXeE@actaestfabulaXX @megtirrell whomever buys HBV look for a bidding war if anyone else aside from $gild gets involved...RT @tradingplays: $GILD - puke waterfall pattern... https://t.co/80fLFieBA6RT @DewDiligence: $GILD CC‚ÄîChina HCV pop=10-20mln,genotyping uncommon so need4 pan-genotypic regimen. Companion read:
   
https://t.co/yAMw‚Ä¶RT @statnews: Forced to discount expensive hepatitis C drugs, Gilead misses sales target https://t.co/FUfF4wEUMk  $GILDRT @AndyBiotech: $GILD #HCV QoQ decline driven by higher US rebates, wholesaler price cuts in Japan,etc

Pricing, pricing, pricing... https‚Ä¶1234 Bullish https://t.co/pS6dQofeYd $BLL $KERX $OC $AMZN $DNKN $XLV $CELG $GPK $BEN $GILD $LUV $SGYP $LABU $MAS $PBCT $XBI $GRFSRT @statnews: Forced to discount expensive hepatitis C drugs, Gilead misses sales target https://t.co/FUfF4wEUMk  $GILDRT @statnews: Forced to discount expensive hepatitis C drugs, Gilead misses sales target https://t.co/FUfF4wEUMk  $GILDRT @RebeccaDRobbins: Forced to discount hep C drugs, Gilead misses on revenue. My quick breakdown of $GILD's Q1 earnings: https://t.co/FelF‚Ä¶RT @RebeccaDRobbins: Forced to discount hep C drugs, Gilead misses on revenue. My quick breakdown of $GILD's Q1 earnings: https://t.co/FelF‚Ä¶Well, That Was Unexpected https://t.co/MmkRzCgYCq $GILDRT @RebeccaDRobbins: Forced to discount hep C drugs, Gilead misses on revenue. My quick breakdown of $GILD's Q1 earnings: https://t.co/FelF‚Ä¶RT @statnews: Forced to discount expensive hepatitis C drugs, Gilead misses sales target https://t.co/FUfF4wEUMk  $GILDRT @statnews: Forced to discount expensive hepatitis C drugs, Gilead misses sales target https://t.co/FUfF4wEUMk  $GILDRT @RebeccaDRobbins: Forced to discount hep C drugs, Gilead misses on revenue. My quick breakdown of $GILD's Q1 earnings: https://t.co/FelF‚Ä¶RT @adamfeuerstein: $GILD Q1 earnings slides:

Key Accomplishments and 2016 Overview

Corporate: Actively assessing business development op‚Ä¶RT @LTbioinvestor: $GILD should be happy so they can buy their own stock cheaper ....
and probably even cheaper next Q$GILD ...  That is THE Question ...... Maybe waiting for Martin to leave??? https://t.co/Cvrub5lJdUForced to discount expensive hepatitis C drugs, Gilead misses sales target https://t.co/FUfF4wEUMk  $GILD@DividendMaster u didn't, the author of the article link I sent u did. His whole argument was predicated on $GILD being cheap b/c of low PERT @RebeccaDRobbins: Forced to discount hep C drugs, Gilead misses on revenue. My quick breakdown of $GILD's Q1 earnings: https://t.co/FelF‚Ä¶RT @RebeccaDRobbins: Forced to discount hep C drugs, Gilead misses on revenue. My quick breakdown of $GILD's Q1 earnings: https://t.co/FelF‚Ä¶$GILD $AAPL Confused? Here: The Tragedy of Value Investing: https://t.co/DA3DWR25Bl@idaustin uh, where did I mention a PE for $GILD ?RT @RebeccaDRobbins: Forced to discount hep C drugs, Gilead misses on revenue. My quick breakdown of $GILD's Q1 earnings: https://t.co/FelF‚Ä¶$GILD - puke waterfall pattern... https://t.co/80fLFieBA6RT @RebeccaDRobbins: Forced to discount hep C drugs, Gilead misses on revenue. My quick breakdown of $GILD's Q1 earnings: https://t.co/FelF‚Ä¶Pretty much me this earnings season... $AAPL $GOOGL $MSFT $FB $AMZN $LNKD $GILD https://t.co/0HgVQpNlAvForced to discount hep C drugs, Gilead misses on revenue. My quick breakdown of $GILD's Q1 earnings: https://t.co/FelFR1Dnu8 @statnews$GILD LOL!$GILD Eventually you get competition and run out of people to cure. https://t.co/Z61WmbU1qLGrabbed some $GILD at 91.75 AH..Why GILD Is DOWN In After Hours Trading Gilead Sciences Earnings Results https://t.co/KQ61n5Rk5u $GILD$GILD $ABBV $ENTA ‚Äî1Q16 V-Pak vs Harvoni (global GT1 mkt):

https://t.co/2qiK4IHOW4$Gild is still a great company; well managed, cheap value, and great long term holding. Buying at this level  is what your looking forRT SeekingAlpha: Well, That Was Unexpected https://t.co/8QBcQ5cSu5 $GILDRT @CNBCClosingBell: After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnzRT @IBD_ECarson: After Hours: Amazon, LinkedIn, Baidu, Expedia Soar, Gilead Flops https://t.co/LJ7yFdWKFz $AMZN $LNKD $BIDU $EXPE $GILD $AM‚Ä¶RT @chessNwine: NEW POST: Stock Market Recap 04/28/16 {Video} https://t.co/gAxSpc1zUz $AMZN $GILD $LNKD $QQQ $SPY$GILD active, relative volume: 7.6, 1H, 6:00 PM, #nasdaq $SPY $NDXLooks like my $GILD 95 #coveredcalls will be worthless tomorrow@RNAiAnalyst  and then you'll wait for oral version. $ARWR must be bot now. If $GILD doesn't see it they won't own hbv$GILD - Gilead Reports Drop in Hepatitis C Drug Revenue -- Update https://t.co/6PcuENXAdoWell, That Was Unexpected https://t.co/9Rrywp9YtL $GILDWell, That Was Unexpected https://t.co/aG86onuQIQ $GILDWell, That Was Unexpected https://t.co/E6OPeJcC9w $GILDScan results - 1,2,3 Pullback Bullish today: $OUTR $CVT $GILD $LGND $KFY $PTC $ALKS $SCLN $AMGN $AOS ... https://t.co/o96iIkvaq0@DividendMaster https://t.co/b5p71mOGUV probably the dumbest analysis of $GILD I've ever read. Low P/E &lt;&gt;= cheap, low P/E means (tweet 1of2)$GILD #filgotinib still on track. Initiate Phase3 in RA &amp; Crohn &amp; Phase2 in UC all in Q3 16 $GLPG https://t.co/koD0dE1FyD@pawcio2009 @Dougallan1 $gild needs acquisitions. Round up the usual suspects: $arwr $icpt $incy $vrtx $bmy
https://t.co/VJ5QO5D5tR@megtirrell $GILD team up with $XON &amp; $ZIOP?RT @actaestfabulaXX: That's interesting! $DVAX $ARWR ? just to name a few. Speed on $GILD!! Prefer MACH 3 now üöÄ https://t.co/5kYNchrd8v#GileadSciences Gilead Earnings Trip Over Both the Top and Bottom Lines. Read more: https://t.co/WSXCG6PwZs $GILDRT @DewDiligence: $GILD CC slides:

https://t.co/mQytxHdFsM$GILD is the opposite of $ABBV.  One is super conservative now about BO while other is over aggressive. Which one will end up well?RT @LeanneBMiller: $GILD &amp; $AMGN report in less than 1 hour!

Why biotech‚Äôs biggest names could rally the sector ¬ª 

https://t.co/FxtLdZTclvThat's interesting! $DVAX $ARWR ? just to name a few. Speed on $GILD!! Prefer MACH 3 now üöÄ https://t.co/5kYNchrd8vCommented on Celgene Reports Q1, Lowers EPS Guidance A Little: Analysis https://t.co/6lw6KDKRPs $AGN $GILD $MYL $CELGRT @megtirrell: On Hep B cure, Norbert says $GILD has ""a very open mind"" in terms of looking to add to portfolioRT @IBD_ECarson: After Hours: Amazon, LinkedIn, Baidu, Expedia Soar, Gilead Flops https://t.co/LJ7yFdWKFz $AMZN $LNKD $BIDU $EXPE $GILD $AM‚Ä¶Day + Post Market Trading $EXPE $GILD 19 Trades 13 Wins, 3 losses, 3 break even - Overall: $11,800 day + $6,560 post https://t.co/gWvLYCGl89$GILD $YHOO are the Most Active in After Hours as seen on SpeculatingStocks After-Hours, https://t.co/0sHRjqRl7f #stocks$SYNA $BCOV $GILD are significant After Hours Decliners as seen on SpeculatingStocks After-Hours, https://t.co/0sHRjqRl7f""Bo knows sports"".  
Is "" $GILD knows liver"" an investment thesis? #HCV #HBV #NASH #NASH #NASH &amp; more #NASH https://t.co/J64ktluE9K#DIVCON 4 #dividend increases: @AveryDennison, @principal, @EssexProperties,  @GileadSciences, and Occidental. $AVY $PFG $ESS $GILD $OXY$GILD lmao  https://t.co/LvW4bahU295 Best ROE Stocks to Beat Earnings Blues $BAK $K $MO $AVGO $GILD https://t.co/vrepZW4ubmCommented on StockTwits: $GILD ""results were also hurt by a $200 million charge for litigation with $MRK"" https://t.co/ZKurRJaGBJRT @Dougallan1: Long $gild since 1994/5 at 38c Quarterly dividend larger than initial investment. Mgt brilliant -will buy what they want wh‚Ä¶$GILD  the ultimate value trap now down 9RT @IBD_ECarson: After Hours: Amazon, LinkedIn, Baidu, Expedia Soar, Gilead Flops https://t.co/LJ7yFdWKFz $AMZN $LNKD $BIDU $EXPE $GILD $AM‚Ä¶$GILD ""U.S. Harvoni sales declined due to an increase in discounts required to open up access to patients w/ lower (liver) fibrosis scores""After Hours: Amazon, LinkedIn, Baidu, Expedia Soar, Gilead Flops https://t.co/LJ7yFdWKFz $AMZN $LNKD $BIDU $EXPE $GILD $AMGNLong $gild since 1994/5 at 38c Quarterly dividend larger than initial investment. Mgt brilliant -will buy what they want when they want.RT @CatalystWatcher: $GILD just mentioned GS-4774, but was very mum about plans. Overall, they seem very secretive on Hep B. $GBIM$GILD ""The hep C numbers are a little light in the USA and that could be due to higher rebating and more competition"" - RBCNoteworthy Thursday Option Activity: $GILD  $JIVE  $CWST #stockoptions https://t.co/L8g8yLo3LURT @chartsmarter: ChartSmarter Friday Game Plan: https://t.co/DNJkZSmngN ""tech earnings overload"" $AMZN $LNKD $EXPE $GILD $SYMC $AMGN https‚Ä¶@adamfeuerstein  the best bio co in the world only buying best co shares.it won't work untill they buy others' as with sovaldi $GILDRT @megtirrell: On Hep B cure, Norbert says $GILD has ""a very open mind"" in terms of looking to add to portfolioI think it will probably get back over $96 quite fast though. $GILDSetting incremental buy limits all the way down to $87 tomrow &amp; nxt week - if I get lucky, woot! If not -will be happy w/ what I get! $GILDUniversal market rule. Drugs aren't spared. $GILD  https://t.co/l91SW9XtPg$GILD in light of HCV sales dynamics, better hurry up w/ testing HBV combo Rx, including RNAi ones: https://t.co/wAfeN0UEDHChartSmarter Friday Game Plan: https://t.co/DNJkZSmngN ""tech earnings overload"" $AMZN $LNKD $EXPE $GILD $SYMC $AMGN https://t.co/Sl00vVABCdRT @InvestorPlace: $GILD Is Going NOWHERE - https://t.co/9ieyX0Qn2t$GILD has manifold NASH programs b/c NASH is complex, multifaceted disease (according2 CC).$GILD Q&amp;A: do u have the assets u need in HepB? Norbert: 2 add'l internal programs haven't disclosed yet, INDs coming; open 2 outside assetsRT @megtirrell: $GILD down 5.5% on Q1 miss
eps $3.03 vs $3.15 est
rev $7.79B vs $8.12B est
hep C rev $4.29B vs $4.6B est
dividend raised 9%‚Ä¶RT @ifbarna: In fact $GILD had higher profits in the last year than $AMZN did in... well, everGilead 1Q profit tumbles on slower hepatitis C drug sales $GILD https://t.co/d69Z0Y4ecA via @YahooFinanceRT @DewDiligence: $GILD CC slides:

https://t.co/mQytxHdFsMRT @megtirrell: ""Nobody really wants a dividend increase, they want to know how they're going to expand their pipeline"" -- Stephanie Link o‚Ä¶RT @megtirrell: On Hep B cure, Norbert says $GILD has ""a very open mind"" in terms of looking to add to portfolioThe *largest decliners in after hours* for you to watch tomorrow: $SYNA $GILD $WDC $SWKS and $FLEX.Buybacks are a nice instrument 2 support a stock price for a while but how about the growth story?Works only with expansion/innovation $GILDRT @megtirrell: On Hep B cure, Norbert says $GILD has ""a very open mind"" in terms of looking to add to portfolioRT @HumbleBioTrader: $GILD &amp; $AAPL Both Need to Buy some Growth Drivers in their respective markets!On Hep B cure, Norbert says $GILD has ""a very open mind"" in terms of looking to add to portfolio$GILD just mentioned GS-4774, but was very mum about plans. Overall, they seem very secretive on Hep B. $GBIM$GILD P/E is like 7 - HAVE to buy. lol$GILD CC slides:

https://t.co/mQytxHdFsMRT @actaestfabulaXX: Not impossible to see $GILD @ $80 in the nearest time. It's crazy! Management wake up!! @GileadSciences  https://t.co/‚Ä¶@WilliamGerber1 jaja we should thank abbv for that then. $ABBV and their deal w/express scripts made $GILD reevaluate their pricing@biotechnova Yes, the big Drop before the close is very suspicious. $GILDRT @biotechnova: $GILD If you don't think leaks are true... https://t.co/yyADCf62aoRT @bradloncar: $GILD is the largest component of the $IBB. 8.47% weighting.Took my ball and went home. Will revisit $gild at 83Wondering about risks of $GILD? The 63-day volatility is 12.7% https://t.co/YrfwPBdUuURT @bradloncar: $GILD is the largest component of the $IBB. 8.47% weighting.$GILD says competition brings lower prices and will defend market share vigorously.  Will continue to lower prices as necessary.RT @WilliamGerber1: $GILD 10 to 20 million in China thought to have HCV.RT @LTbioinvestor: $GILD will probably drag $IBB down below 270$ tomorrow, and $XBI will follow ....
Next week make or break for #biotechs,‚Ä¶Another earningspalooza after the bell today $AMZN $LNKD $GILD $P $WDC $EXPE https://t.co/3EKaQ8cvK5$GILD Q1 ""Harvoni missed badly in the U.S. but outperformed abroad, while Sovaldi did the opposite.""RT @RNAiAnalyst: $GILD, the $AAPL of biotech. Tough to find second act, hoarding cash.$GILD, the $AAPL of biotech. Tough to find second act, hoarding cash.RT @LTbioinvestor: totally agree ... they are too busy to mirror themselves, but success is not forever.
$AAPL $GILD https://t.co/ji9GBt8E92@StockTwits Trending via @Stocks_Live $AMZN $GILD $LNKD $GRPN $AAPL $WLL $BIDU $QQQ $CLF $EXPE $AMGN $SWKS $UVXY https://t.co/nQhPVL0Ze1RT @LTbioinvestor: only way to save $XBI tomorrow is some $GILD clear words about n imminent shopping season, but few chances IMHORT @megtirrell: Q for the epidemiologists out there: how does $GILD know there are 1.5m undiagnosed HCV pts in the U.S. if they're undiagno‚Ä¶RT @LTbioinvestor: $GILD buyback strategy is a loosing one, and that was clear to all except $GILD management.
Buybacks are for loosers@RyanEGerry B/c under the terms of the $GILD collab they cannot release sensitive data when M&amp;A is involved. I posted the screenshot.$GILD Japan gt2 (Sovaldi), initial pat bolus, came down, now stable flow. Not expecting further price decr this yr post 30% vol disc in Mar.RT @ifbarna: In fact $GILD had higher profits in the last year than $AMZN did in... well, everRT @adamfeuerstein: $GILD says insurers opened access to HCV pats w/ lower fibrosis scores but that, in turn, triggered larger discounts.RT @InvestorPlace: $GILD Is Going NOWHERE - https://t.co/9ieyX0Qn2t$GILD CC‚ÄîChina HCV pop=10-20mln,genotyping uncommon so need4 pan-genotypic regimen. Companion read:
   
https://t.co/yAMwdaGwNP
$ABBV $ENTART @WilliamGerber1: @WilliamGerber1 $GILD Follow up by Michael Yee.  Patients up 10% but revenue down 11% equates to price down 20%? A: yes‚Ä¶@cali_sunnyd sweet... $gild earnings put going to pay big time tomorrow.. $0.69 to 5$ easily at openRT @megtirrell: $GILD CEO: ""We do see some good opportunities out there as well as internally"" in cancer. Norbert: Zydelig increased appeti‚Ä¶RT @megtirrell: ""Nobody really wants a dividend increase, they want to know how they're going to expand their pipeline"" -- Stephanie Link o‚Ä¶#GileadSciences Announces First Quarter 2016 Financial Results. Read more: https://t.co/I6Z5e7tDaD $GILDRT @megtirrell: $GILD down 5.5% on Q1 miss
eps $3.03 vs $3.15 est
rev $7.79B vs $8.12B est
hep C rev $4.29B vs $4.6B est
dividend raised 9%‚Ä¶RT @bradloncar: $GILD is the largest component of the $IBB. 8.47% weighting.RT @bradloncar: $GILD is the largest component of the $IBB. 8.47% weighting.$GILD is the largest component of the $IBB. 8.47% weighting.Growth still the concern w/ $GILD. Will be until they buy something larger. $CELG warrants the higher multiple now! https://t.co/ohchKN98BMI may as well be another $ARWR long who asks why $GILD doesn't buy 'em... since HepC revs are dropping for Gilead. Co needs new IP$GILD Is Going NOWHERE - https://t.co/9ieyX0Qn2t$GILD 10 to 20 million in China thought to have HCV.$GILD active, relative volume: 11.66, 1H, 5:00 PM, #nasdaq $SPY $NDXRT @HumbleBioTrader: $GILD &amp; $AAPL Both Need to Buy some Growth Drivers in their respective markets!RT @adamfeuerstein: $GILD says insurers opened access to HCV pats w/ lower fibrosis scores but that, in turn, triggered larger discounts.RT @JustinPulitzer: $GILD $89.99 is 61.8% Fib of the recent range. VERY key level https://t.co/EoSbFgSA3wRT @WilliamGerber1: @WilliamGerber1 $GILD Follow up by Michael Yee.  Patients up 10% but revenue down 11% equates to price down 20%? A: yes‚Ä¶RT @megtirrell: $GILD CEO: ""We do see some good opportunities out there as well as internally"" in cancer. Norbert: Zydelig increased appeti‚Ä¶RT @chessNwine: NEW POST: Stock Market Recap 04/28/16 {Video} https://t.co/gAxSpc1zUz $AMZN $GILD $LNKD $QQQ $SPY$GILD fuck! https://t.co/ZWR8XMAFNBNot impossible to see $GILD @ $80 in the nearest time. It's crazy! Management wake up!! @GileadSciences  https://t.co/c4p14f2cRhRT @megtirrell: $GILD CEO: ""We do see some good opportunities out there as well as internally"" in cancer. Norbert: Zydelig increased appeti‚Ä¶$GILD CEO: ""We do see some good opportunities out there as well as internally"" in cancer. Norbert: Zydelig increased appetite to do moreNEW POST: Stock Market Recap 04/28/16 {Video} https://t.co/gAxSpc1zUz $AMZN $GILD $LNKD $QQQ $SPY@WilliamGerber1 $GILD Follow up by Michael Yee.  Patients up 10% but revenue down 11% equates to price down 20%? A: yes, but s/b stable nowRT @megtirrell: $GILD's willingness to go hostile in M&amp;A would be dependent on situation, CEO says in response to @MarkSchoenebaum Q@bradloncar @DewDiligence It's not today! #competition #pricing $GILD $ABBV $MRKRT @biotechnova: $GILD Another quarter, another dividend hike... MehRT @megtirrell: Several of the large commercial payers opened up access to pts regardless of fibrosis scores in Q1, triggering discounts, $‚Ä¶RT @megtirrell: $GILD's willingness to go hostile in M&amp;A would be dependent on situation, CEO says in response to @MarkSchoenebaum QRT @megtirrell: $GILD's willingness to go hostile in M&amp;A would be dependent on situation, CEO says in response to @MarkSchoenebaum QRT @sultanofstocks: @megtirrell Every drug co. should have $GILD 's problems. Its qtrly EPS exceeds most drug co's YRLY EPS. Best DRUG co.‚Ä¶RT @megtirrell: $GILD's willingness to go hostile in M&amp;A would be dependent on situation, CEO says in response to @MarkSchoenebaum QRT @LTbioinvestor: $GILD should be happy so they can buy their own stock cheaper ....
and probably even cheaper next QRT @megtirrell: $GILD's willingness to go hostile in M&amp;A would be dependent on situation, CEO says in response to @MarkSchoenebaum QHolding May 6th, 98 $GILDRT @megtirrell: $GILD's willingness to go hostile in M&amp;A would be dependent on situation, CEO says in response to @MarkSchoenebaum QRT @megtirrell: Several of the large commercial payers opened up access to pts regardless of fibrosis scores in Q1, triggering discounts, $‚Ä¶$GILD's willingness to go hostile in M&amp;A would be dependent on situation, CEO says in response to @MarkSchoenebaum Qwell this is why $GILD held up so well last few months https://t.co/W1UwSO4SfQRT @adamfeuerstein: $GILD says insurers opened access to HCV pats w/ lower fibrosis scores but that, in turn, triggered larger discounts.$GILD Gilead Sciences declares 0.47 cents dividend. Gilead Sciences declares $0.47 dividend
https://t.co/qGWBmJhOz2I wouldn't touch $GILD with a ten foot pole. But that's just me...$GILD - Gilead Reports Drop in Hepatitis C Drug Revenue https://t.co/ZoogsTqInIIn fact $GILD had higher profits in the last year than $AMZN did in... well, ever$AMZN &amp; $LNKD up on earnings. Biotech $GILD hammered. $QQQ will get a boost tomorrow initially, but will it hold... https://t.co/D9GreWOu6fRT @KrustyTown: Three things that died this week. $GILD $AAPL $PRINCECheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @adamfeuerstein: When growth-craving biotech investors read about a dividend increase in $GILD https://t.co/F19tGMFs10Popular: $GILD, $AMGN, $SWKS, $P, $OUTR, $WDC, $BABA, $TLGT, $LOGM, $SGEN, $PRLB, $BZH, $ATHN, $NUSRT @adamfeuerstein: $GILD says insurers opened access to HCV pats w/ lower fibrosis scores but that, in turn, triggered larger discounts.$GILD Several payors opened up to patients with lower fibrosis scores, and this triggered prior negotiated discounts.RT @CNBC: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/z3NqKgWamY https://t.co/D‚Ä¶$GILD says insurers opened access to HCV pats w/ lower fibrosis scores but that, in turn, triggered larger discounts.RT @megtirrell: Several of the large commercial payers opened up access to pts regardless of fibrosis scores in Q1, triggering discounts, $‚Ä¶$GILD makes 20√ó PS more than $AMZN. Gotta be confident selling the market that's held by easing-catered Frankenstocks like the trash AMZN isSeveral of the large commercial payers opened up access to pts regardless of fibrosis scores in Q1, triggering discounts, $GILD saysRT @megtirrell: Q for the epidemiologists out there: how does $GILD know there are 1.5m undiagnosed HCV pts in the U.S. if they're undiagno‚Ä¶$GILD HCV miss. Pricing pressures. Need to buy the growth.RT @megtirrell: Q for the epidemiologists out there: how does $GILD know there are 1.5m undiagnosed HCV pts in the U.S. if they're undiagno‚Ä¶RT @megtirrell: Still 3m pts in U.S. yet to be treated for HCV, half undiagnosed, $GILD saysOf course I have $GILD to buffer my $AMZN excitementThree things that died this week. $GILD $AAPL $PRINCE$GILD has big support at $90.25 - $92.68 Downside $90.25 tested 3 times but failed to pass it.RT @Biotech2050: $GILD #BUYBACKS $8B (6% of market cap)RT @OptionsHawk: $GILD down a cool 5.5%, can lock these in 400-500% gains https://t.co/42VhRYV4v6Gilead Sciences declares $0.47 dividend https://t.co/AZCWx2tI1Z $GILDGilead Sciences declares $0.47 dividend https://t.co/qh20rZxvqZ $GILD@Biotech2050 I'm not sure that buybacks are any longer a helpful instrument for $GILD Investors wants to see expansion in other sectors!@StockBookie Covered half AH on $GILD @ 90.45 holding last half.RT @megtirrell: Citi's Robyn K says $GILD Q1 HCV U.S. discounts appear to be 47%Q for the epidemiologists out there: how does $GILD know there are 1.5m undiagnosed HCV pts in the U.S. if they're undiagnosed?RT @megtirrell: Still 3m pts in U.S. yet to be treated for HCV, half undiagnosed, $GILD saysStill 3m pts in U.S. yet to be treated for HCV, half undiagnosed, $GILD saysRT @megtirrell: $GILD citing increase in gross to net adjustments, shortening in treatment duration in HCVRT @dsobek: While talking about $GILD we should note that $BMRN raised vimizim guidance and reiterate profit in 2017RT @Financial_Orbit: What every $GILD shareholder will hope kicks in... (note sub $90/share a price just below where is AH) https://t.co/Dc‚Ä¶RT @DividendMaster: with $AMZN up ,  nobody will even notice anihilation of $GILD and  S&amp;P can close above 2100 tomorrowRT @megtirrell: $GILD citing increase in gross to net adjustments, shortening in treatment duration in HCVRT @megtirrell: $GILD citing increase in gross to net adjustments, shortening in treatment duration in HCVWhat every $GILD shareholder will hope kicks in... (note sub $90/share a price just below where is AH) https://t.co/DcuQYYABxTRT @stockguy22: #afterhours 
.. Online Cos doing great 
UP $AMZN $EXPE $LNKD $P $AZPN $PCLN 

DOWN $SYNA $GILD $AKS $SWKS https://t.co/wr22‚Ä¶$GILD management appears clueless, absolutely clueless!$GILD citing increase in gross to net adjustments, shortening in treatment duration in HCVRT @stockguy22: #afterhours 
.. Online Cos doing great 
UP $AMZN $EXPE $LNKD $P $AZPN $PCLN 

DOWN $SYNA $GILD $AKS $SWKS https://t.co/wr22‚Ä¶Message to $gild management: 
- you got cash
- dividends are not cool
- just start buying shit
- preferably shit I own
- thank youRT @JustinPulitzer: I‚Äôll prob sell some $85 $GILD puts if there‚Äôs still some juice for same day exp. Let‚Äôs see.@dsobek @adamfeuerstein Getting very frustrating already.  Val's were the lowest they could've been a few months ago &amp; still nothing $GILD$AMZN $EXPE $BIDU $LNKD $GILD $SPY $IBB https://t.co/2WhpG0Xvc8$AMZN $EXPE $BIDU $LNKD $GILD $SPY $IBB Market &amp; earnings recap for 4/28 https://t.co/mz9ZORBDMuWe calculated 21-day Expected Return of $GILD for you: 9.4% https://t.co/mTgAzTSiLD@LTbioinvestor do not underestimate $GILD. #NASH market is coming...#ELAFIBRANOR!RT @megtirrell: ""Nobody really wants a dividend increase, they want to know how they're going to expand their pipeline"" -- Stephanie Link o‚Ä¶$GILD Will Remain Undervalued Until It Puts Its Money to Work the Right Way - https://t.co/9ieyX0Qn2t$GILD ""For full-year 2016...still expects total product sales of $30B to $31B, in line with average Wall Street estimate of $30.16B""RT @megtirrell: $GILD down 5.5% on Q1 miss
eps $3.03 vs $3.15 est
rev $7.79B vs $8.12B est
hep C rev $4.29B vs $4.6B est
dividend raised 9%‚Ä¶RT @TradingForGodoT: Gilead logs Q1 miss https://t.co/ImrYILiUG5 via @fastFT $GILD #SPXEARNINGS YET ANOTHER HIGH QUALITY GROWTH STOCK TAKES‚Ä¶with $AMZN up ,  nobody will even notice anihilation of $GILD and  S&amp;P can close above 2100 tomorrow$GILD ""Q1 revenue from its hepatitis C drugs fell 5.6%""Gilead logs Q1 miss https://t.co/ImrYILiUG5 via @fastFT $GILD #SPXEARNINGS YET ANOTHER HIGH QUALITY GROWTH STOCK TAKES A HIT üò≥RT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶$GILD oh shit. This one&amp;#39;s gonna hurt $IBB $XBI ||| first miss since the launch Sovaldi$GILD shareholders right now https://t.co/WZnuNVfusERT @StockTwits: Uh-oh. One of the biggest biotech stocks, Gilead, just missed earnings badly: https://t.co/pTx3STflMk

$GILD $IBB $XBIStill like $GILD long. Nice cash pile, good GAAP earnings and nice PE.my hospital &amp; practice started filling many HCV rxs through a 340B program this year - and we do &gt;1000 a year, wonder how much effect $gild$GILD $QQQ $IBB  https://t.co/FgVa9dcTo8RT @megtirrell: Citi's Robyn K says $GILD Q1 HCV U.S. discounts appear to be 47%RT @SPGLearnings: $GILD reports #EPS of $3.03 vs. $3.13 est., #revenue of $7.79B vs. $8.07B est. #SPXearningsRT @megtirrell: Citi's Robyn K says $GILD Q1 HCV U.S. discounts appear to be 47%Gilead $GILD Stock Down in After-Hours Trading on Q1 Earnings, Revenue Miss https://t.co/VARfwqCzMfwinners $AMZN $QLIK for tomorrow, $GILD : loser ..Gilead $GILD Stock Down in After-Hours Trading on Q1 Earnings, Revenue Miss https://t.co/sPBOUxNF6u #StockActionRT @Pivotal_Pivots: $GILD the Yearly Pivots showed you where to buy and sell. No Guessing! https://t.co/xJFNzFWOyP https://t.co/AIY2F2f7og$GILD should be happy so they can buy their own stock cheaper ....
and probably even cheaper next QCiti's Robyn K says $GILD Q1 HCV U.S. discounts appear to be 47%RT @dsobek: $GILD declining to flat sales.  No growth in near term from pipeline. Lots of cash. Sector a lot cheaper. What were they waitin‚Ä¶RT @adamfeuerstein: $GILD Q1 earnings slides:

Key Accomplishments and 2016 Overview

Corporate: Actively assessing business development op‚Ä¶RT @adamfeuerstein: $GILD mentions higher HepC drug rebates in Q1.RT @dsobek: While talking about $GILD we should note that $BMRN raised vimizim guidance and reiterate profit in 2017RT @adamfeuerstein: $GILD Q1 earnings slides:

Key Accomplishments and 2016 Overview

Corporate: Actively assessing business development op‚Ä¶RT @adamfeuerstein: When growth-craving biotech investors read about a dividend increase in $GILD https://t.co/F19tGMFs10$GILD mentions higher HepC drug rebates in Q1.Agreed! Now or never! #GameofThrones must end here üö´ $XBI $IBB $GILD https://t.co/2ZFO5qhbuX$GILD misses on earnings making me 0/1 on public stock plays. But hey, you've gotta #riskit to get the #biscuit. More plays coming soon...RT @BioStocks: $GILD $0.47 dividendRT @JustinPulitzer: $GILD $89.99 is 61.8% Fib of the recent range. VERY key level https://t.co/EoSbFgSA3wI‚Äôll prob sell some $85 $GILD puts if there‚Äôs still some juice for same day exp. Let‚Äôs see.$GILD approaching in red zone and probably next long opportunity is coming https://t.co/uNkE128zLmRT @CarolineYLChen: $GILD has now treated close to 1 million patients with its HCV drugs, Milligan saysWill #Gilead's Run Come To An End This Quarter? $GILD Also $MRK https://t.co/5uyDv6axia$AMZN huge pop after earnings beat. Will it get sold off via $FB today? $LNKD beat was sold off AH from 140 now around 130. $GILD down bigRT @AndyBiotech: Both $GILD and $ABBV #HCV franchise had big misses in Q1, the power of $MRK Zepatier competition?$GILD $89.99 is 61.8% Fib of the recent range. VERY key level https://t.co/EoSbFgSA3w@cvpayne Not sohappy with $GILDRT @AndyBiotech: $GILD #HCV franchise Q1 sales $4,294M misses consensus of $4,607M

Mainly driven by weak Harvoni US sales: $1,407M vs $1,8‚Ä¶RT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶RT @megtirrell: ""Nobody really wants a dividend increase, they want to know how they're going to expand their pipeline"" -- Stephanie Link o‚Ä¶@dsobek $CELG would cure a lot of $GILD issues???? Why not ?????$GILD has now treated close to 1 million patients with its HCV drugs, Milligan says$GILD El gigante biotecnol√≥gica Gilead cae %4 en el post market. Reporta u$s 0,11 menos por acci√≥n que lo estimado.$GILD ‚Üì 7% AH@cvpayne Earnings season is the best! Incredible how some companies get SMASHED. Check $GNC. OUCH! Will buy more $GILD if it gets hit!RT @CNBCClosingBell: After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnzRT @ stockguy22 ""#afterhours 
.. Online Cos doing great 
UP $AMZN $EXPE $LNKD $P $AZPN $PCLN 

DOWN $SYNA $GILD $A‚Ä¶ https://t.co/WcQB0gNtDP""@1simpletrader $GILD SmokedI can‚Äôt see $MRK Zapatier impacting sales of $GILD and $ABBV that much but I would suspect that payors maintain limited access@megtirrell Every drug co. should have $GILD 's problems. Its qtrly EPS exceeds most drug co's YRLY EPS. Best DRUG co. in world @jimcramerRT @CNBC: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/z3NqKgWamY https://t.co/D‚Ä¶$GILD Q1 earnings slides:

Key Accomplishments and 2016 Overview

Corporate: Actively assessing business development opportunities.RT @StockTwits: Uh-oh. One of the biggest biotech stocks, Gilead, just missed earnings badly: https://t.co/pTx3STflMk

$GILD $IBB $XBIRT @adamfeuerstein: When growth-craving biotech investors read about a dividend increase in $GILD https://t.co/F19tGMFs10$GILD after hours https://t.co/5oM3RBHCCZRT @CNBCClosingBell: After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnzRT @PipsToDollars: Room is on fire today.
@VictorTellegio holding $LNKD 
Others have $amzn c 
None of us holding $GILD hahahaRT @LTbioinvestor: $GILD buyback strategy is a loosing one, and that was clear to all except $GILD management.
Buybacks are for loosers@ReformedBroker thoughts on $GILD going forward?RT @Vegastrader66: $GILD
Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11BHow long until the sell side notes talking about who $GILD should buy? My prediction the top three will be $BMRN, $VRTX, and $INCY$GILD Out - light volume - .46 X 2K shares = $920$AMGN trading down off some good headline numbers. 
$GILD trading down on some bad ones. 

Such is the muddled world of biotech.RT @adamfeuerstein: When growth-craving biotech investors read about a dividend increase in $GILD https://t.co/F19tGMFs10$GILD HAS GOT TO ANNOUNCE AN ACQUISITION SOON. @VeeDub78$GILD earnings miss... https://t.co/wx7SiZQDsPRT @biotechnova: $GILD If you don't think leaks are true... https://t.co/yyADCf62aoRT @AndyBiotech: $GILD #HCV QoQ decline driven by higher US rebates, wholesaler price cuts in Japan,etc

Pricing, pricing, pricing... https‚Ä¶The question is do they swing big or go for singles &amp; doubles... $GILD https://t.co/f5ePlIDXODGilead Sciences Q1 top line up 3%; net income off 18%; Harvoni sales down 16%; shares down 6% after... $GILD https://t.co/anCpn9pPvBRT @megtirrell: $GILD down 5.5% on Q1 miss
eps $3.03 vs $3.15 est
rev $7.79B vs $8.12B est
hep C rev $4.29B vs $4.6B est
dividend raised 9%‚Ä¶$GILD buyback strategy is a loosing one, and that was clear to all except $GILD management.
Buybacks are for loosersRT @dsobek: While talking about $GILD we should note that $BMRN raised vimizim guidance and reiterate profit in 2017Catch our live updates from $GILD's Q1 2016 #earnings conference call @ 4:30 p.m. ET. Join here: https://t.co/DL8ZFqZJkSMeg Terrell @CNBC reports $GILD earnings as ""disappointing"". CEO's of ALL drug companies wish their co's were so disappointing. 8 PE 2% div.$GILD #HCV QoQ decline driven by higher US rebates, wholesaler price cuts in Japan,etc

Pricing, pricing, pricing... https://t.co/75cr0lh5o4While talking about $GILD we should note that $BMRN raised vimizim guidance and reiterate profit in 2017$GILD and $AMZN have enough cash to buy every man woman and child in America their own AK-47Conference call: (16:30): $AZPN, $BGS, $BRKS, $COWN, $CYTK, $ELLI, $GILD, $GWGH, $NPTN, $NSR, $SGEN, $SPNC, $VDSI, $VRSN, $WMARGiven how smart $GILD is, and how impatient people are with them, wouldn't be the worst company to have dual-class shares.@blarsonbrf Brett, now we know why $CELG is still the king of the big #biotechs and $GILD has that discount.  Down 10% in AH.#GileadSciences Announces Second Quarter 2016 Dividend. Read more: https://t.co/wqLmanhVYx $GILDRT @LTbioinvestor: $GILD will probably drag $IBB down below 270$ tomorrow, and $XBI will follow ....
Next week make or break for #biotechs,‚Ä¶$GILD hasn't been here since the flash crash of 2015. https://t.co/Za27sVX54aGilead‚Äôs Profit, Hepatitis C Drugs Sales Miss Estimates https://t.co/MyWzoDOGQi via @business $GILDhahaha 
I've been using $GILD to estimate $AGN fair value as a biotech w/earnings
tonight $GILD dropped to match $AGN
up my smart arse it isRT @BioStocks: $GILD cash, cash equivalents $21.3B.RT @BioStocks: $GILD cash, cash equivalents $21.3B.$GILD another $AAPL , buying at $88Gilead $GILD Down In Post-Market Activity $GILD https://t.co/kX7ycn9wye$GILD cash, cash equivalents $21.3B.RT @LTbioinvestor: totally agree ... they are too busy to mirror themselves, but success is not forever.
$AAPL $GILD https://t.co/ji9GBt8E92@bradloncar Ha and $GILD has turned into the $AAPL of biotech.@sssvenky $GILD plugged to hole for now. I don't know what your position is. https://t.co/Pu9P19PaIT$GILD Long - 2K@CatalystWatcher please let go of this.  $GILd &lt; $GBIM.  I'm long both and I don't believe itonly way to save $XBI tomorrow is some $GILD clear words about n imminent shopping season, but few chances IMHOI do need a lobotomy but not for shorting GILD :) Scaled into puts between 98-101 ‚Äú@jpankey100: $GILD anyone short GILD needs a lobotomy‚ÄùRT @megtirrell: ""Nobody really wants a dividend increase, they want to know how they're going to expand their pipeline"" -- Stephanie Link o‚Ä¶RT @pharmalot: Gilead deal to sell Sovaldi in poor countries meets criticism.. why? read here http://t.co/VIcZ6QtZmK #pharma $GILD #hepatit‚Ä¶RT @biotechnova: $GILD If you don't think leaks are true... https://t.co/yyADCf62aoI wish I could have received the $GILD information at 3:30 then I could have dumped too.SELL $FE 34.26, SHORT $GILD 96.98, SELL $KBH 13.64, SELL $LEN 45.74. More stock tips &amp; details at: https://t.co/QqCqiQyc0oRT @biotechnova: $GILD If you don't think leaks are true... https://t.co/yyADCf62ao@GileadSciences Q1 top line up 3%; net income off 18%; Harvoni sales down 16%; shares down 6% after hours $GILD https://t.co/J4bv9wp375$GILD  $IBB   hmmm.... hmm.....1 for 2 in earnings season . Won on $FB but lost on $Gild . Still likely to come out slightly ahead due to risk management. #TradingRT @megtirrell: $GILD down 5.5% on Q1 miss
eps $3.03 vs $3.15 est
rev $7.79B vs $8.12B est
hep C rev $4.29B vs $4.6B est
dividend raised 9%‚Ä¶#afterhours 
.. Online Cos doing great 
UP $AMZN $EXPE $LNKD $P $AZPN $PCLN 

DOWN $SYNA $GILD $AKS $SWKS https://t.co/wr22ipdpwRtotally agree ... they are too busy to mirror themselves, but success is not forever.
$AAPL $GILD https://t.co/ji9GBt8E92When growth-craving biotech investors read about a dividend increase in $GILD https://t.co/F19tGMFs10@dsobek Whatever it takes $GILDRT @megtirrell: ""Nobody really wants a dividend increase, they want to know how they're going to expand their pipeline"" -- Stephanie Link o‚Ä¶RT @megtirrell: ""Nobody really wants a dividend increase, they want to know how they're going to expand their pipeline"" -- Stephanie Link o‚Ä¶Retweeted Meg Tirrell (@megtirrell):

$GILD down 5.5% on Q1 miss
eps $3.03 vs $3.15 est
rev $7.79B vs $8.12B est... https://t.co/xE1Rch6OV7RT @megtirrell: $GILD down 5.5% on Q1 miss
eps $3.03 vs $3.15 est
rev $7.79B vs $8.12B est
hep C rev $4.29B vs $4.6B est
dividend raised 9%‚Ä¶@megtirrell Amazing how similar $gild is to $aapl. Victims of their own success. Both need to reset and start over. They'll be back.RT @CatalystWatcher: No mention of GS-4774 by $GILD on ER. Still waiting on CC. My guess $GILD has shared the data with $GBIM and $GBIM fin‚Ä¶RT @megtirrell: $GILD down 5.5% on Q1 miss
eps $3.03 vs $3.15 est
rev $7.79B vs $8.12B est
hep C rev $4.29B vs $4.6B est
dividend raised 9%‚Ä¶RT @adamfeuerstein: $GILD US product sales $4.4B in Q1, down from $5.2B in the year-ago quarter.RT @AndyBiotech: $GILD #HCV franchise Q1 sales $4,294M misses consensus of $4,607M

Mainly driven by weak Harvoni US sales: $1,407M vs $1,8‚Ä¶$GILD. Need a new game plan. Time for the board to dig deep and make the necessary changesGilead Sciences Q1 top line up 3%; net income off 18%; Harvoni sales down 16%; shares down 6% after hours https://t.co/INVmBdgTrm $GILDGilead Sciences Q1 top line up 3%; net income off 18%; Harvoni sales down 16%; shares down 6% after hours https://t.co/JZ6VOkRjfN $GILDGilead Sciences Q1 top line up 3%; net income off 18%; Harvoni sales down 16%; shares down 6% after hours https://t.co/JW8FS5w2k8 $GILDRT @megtirrell: $GILD down 5.5% on Q1 miss
eps $3.03 vs $3.15 est
rev $7.79B vs $8.12B est
hep C rev $4.29B vs $4.6B est
dividend raised 9%‚Ä¶$GILD down 5.5% on Q1 miss
eps $3.03 vs $3.15 est
rev $7.79B vs $8.12B est
hep C rev $4.29B vs $4.6B est
dividend raised 9% to 47cents/shrRT @PipsToDollars: Room is on fire today.
@VictorTellegio holding $LNKD 
Others have $amzn c 
None of us holding $GILD hahaha$GILD Out, break even - Price StallRoom is on fire today.
@VictorTellegio holding $LNKD 
Others have $amzn c 
None of us holding $GILD hahahaMaybe $GILD master plan is to report a bad quarter to hit the sector only to buy companies cheaper later in the year@AndyBiotech Could $MRK have cornered $GILD in HCV? Also remember they will collect royalties along with $IONS$GILD down $9 for the day""Nobody really wants a dividend increase, they want to know how they're going to expand their pipeline"" -- Stephanie Link on $GILDRT @AndyBiotech: Both $GILD and $ABBV #HCV franchise had big misses in Q1, the power of $MRK Zepatier competition?Looking forward to $GILD call in 10 mins. Even tho I'm OUT of biotech this year - I'm into $GILD. Ridiculously cheap.Is $GILD next $VRX ?$GILD Another quarter, another dividend hike... MehRT @Wolfmetric: $GILD Japan antiviral revenues were $1.1B, down from $1.4B last quarter, expected to pick up the slack from softer US market$GILD ouch.$GILD div increase$GILD Long - 2K sharesRT @dsobek: $GILD declining to flat sales.  No growth in near term from pipeline. Lots of cash. Sector a lot cheaper. What were they waitin‚Ä¶$GILD &amp; $AAPL Both Need to Buy some Growth Drivers in their respective markets!$GILD nice div increase - I got a nice surprise huge div from them out of the blue last month. Good timing. lol$GILD OUT not bouncing hard..$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts AppRT CNBC ""EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD ‚Ä¶ https://t.co/gXskkhRW76""Gilead Sciences misses by $0.11, misses on revenue $GILD https://t.co/NyXbaBIgfHVetr Inc. Upgrades Gilead Sciences, Inc. $GILD to ‚ÄúBuy‚Äù https://t.co/ZYTn3btzJzState of Tennessee Treasury Department Has $110,659,000 Position in Gilead Sciences, Inc. $GILD https://t.co/2ie9R9C0YeCrushed, I've been a seller here but this still hurts. $GILD https://t.co/VgGgIny1jqRT @CNBCClosingBell: After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnzRT @Wolfmetric: $GILD Japan antiviral revenues were $1.1B, down from $1.4B last quarter, expected to pick up the slack from softer US marketTime to buy / add $GILD and forget about it.I'd be surprised if $GILD didn't move towards $86 in the next couple of days: https://t.co/eAyj52PcAS#STOCKALERT ‚û° New intraday downward move on Gilead Sciences.. $GILD - down -7.04% in‚Ä¶ ‚Äï via https://t.co/RUCrszNkSI https://t.co/pttHOXl8tV$gild holy crapage batman$GILD&gt;92.27 smallRT @Wolfmetric: $GILD Japan antiviral revenues were $1.1B, down from $1.4B last quarter, expected to pick up the slack from softer US marketSo $GILD has a gripload of cash &amp; their stock just got 8% less expensive #buyback much?$GILD Japan antiviral revenues were $1.1B, down from $1.4B last quarter, expected to pick up the slack from softer US market$GILD the Yearly Pivots showed you where to buy and sell. No Guessing! https://t.co/xJFNzFWOyP https://t.co/AIY2F2f7ogOuch. $GILD not going to help $IBB tomorrow. 3.03 vs 3.14 eps, 7.8 vs 8.06 revGilead Sciences $GILD Misses Q1 EPS by 10c https://t.co/TFMfvkKHDT via ‚Üí @AlertTradeRT @CNBCClosingBell: After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnz$gild results confirm what everyone in big pharma has always known
for$
a half-assed treatment that sorta works but doesnt cure beats a cureNo mention of GS-4774 by $GILD on ER. Still waiting on CC. My guess $GILD has shared the data with $GBIM and $GBIM finalizing a transaction.Does $gild make up their SG&amp;A daily?  How possibly do 200m less in one qtr for that line item. https://t.co/vL3Lt6rw8L$GILD Now yields 2.05% at $91.50. Gonna be nice to get 2.35% at $80.After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnz$GILD reports Q1 EPS $3.03, consensus $3.14 
Reports Q1 revenue $7.8B, consensus $8.11B.I kind of feel bad for $GILD because I used to like it. Oh well.New intraday downward move on Gilead Sciences.. $GILD - down -7.04% in 19 minutes - https://t.co/AucREgyfh7 https://t.co/1TttvsVkWwRT @dsobek: $GILD declining to flat sales.  No growth in near term from pipeline. Lots of cash. Sector a lot cheaper. What were they waitin‚Ä¶$GILD will probably drag $IBB down below 270$ tomorrow, and $XBI will follow ....
Next week make or break for #biotechs, bounce or breakdown$GILD - Current Report Filing (8-k) https://t.co/EzcB9MloaxBoth $GILD and $ABBV #HCV franchise had big misses in Q1, the power of $MRK Zepatier competition?$GILD sitting in all that cash. C'mon acquire some bios!RT @adamfeuerstein: $GILD US product sales $4.4B in Q1, down from $5.2B in the year-ago quarter.RT @SPGLearnings: $GILD reports #EPS of $3.03 vs. $3.13 est., #revenue of $7.79B vs. $8.07B est. #SPXearningsRT @AndyBiotech: $GILD #HCV franchise Q1 sales $4,294M misses consensus of $4,607M

Mainly driven by weak Harvoni US sales: $1,407M vs $1,8‚Ä¶RT @dsobek: $GILD declining to flat sales.  No growth in near term from pipeline. Lots of cash. Sector a lot cheaper. What were they waitin‚Ä¶RT @dsobek: $GILD declining to flat sales.  No growth in near term from pipeline. Lots of cash. Sector a lot cheaper. What were they waitin‚Ä¶RT @dsobek: $GILD declining to flat sales.  No growth in near term from pipeline. Lots of cash. Sector a lot cheaper. What were they waitin‚Ä¶RT @SPGLearnings: $GILD reports #EPS of $3.03 vs. $3.13 est., #revenue of $7.79B vs. $8.07B est. #SPXearningsRT @StockTwits: Uh-oh. One of the biggest biotech stocks, Gilead, just missed earnings badly: https://t.co/pTx3STflMk

$GILD $IBB $XBIRT @dsobek: $GILD declining to flat sales.  No growth in near term from pipeline. Lots of cash. Sector a lot cheaper. What were they waitin‚Ä¶RT @adamfeuerstein: $GILD Harvoni Q1 sales $3.01B, short of consensus $3.2BRT @adamfeuerstein: $GILD Q1 total revenue $7.8B miss consensus $8.0B although total product sales $7.7B beats consensus $7.6BRT @AndyBiotech: $GILD #HCV franchise Q1 sales $4,294M misses consensus of $4,607M

Mainly driven by weak Harvoni US sales: $1,407M vs $1,8‚Ä¶RT @adamfeuerstein: $GILD US product sales $4.4B in Q1, down from $5.2B in the year-ago quarter.$GILD US product sales $4.4B in Q1, down from $5.2B in the year-ago quarter.RT @StockTwits: Uh-oh. One of the biggest biotech stocks, Gilead, just missed earnings badly: https://t.co/pTx3STflMk

$GILD $IBB $XBIRT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶RT @dsobek: $GILD declining to flat sales.  No growth in near term from pipeline. Lots of cash. Sector a lot cheaper. What were they waitin‚Ä¶RT @CNBC: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/z3NqKgWamY https://t.co/D‚Ä¶$fb $lnkd $amzn winners and $gild big loser like $aapl. holding on to cash, needs to do some acquisition. cash is not laying eggsso it turns out it could have been worse

could have been short $AMZN and long $GILD into after hours
too$GILD reports #EPS of $3.03 vs. $3.13 est., #revenue of $7.79B vs. $8.07B est. #SPXearnings$GILD Q1 cash flow from operating activities was $3.9B$GILD declining to flat sales.  No growth in near term from pipeline. Lots of cash. Sector a lot cheaper. What were they waiting for again?$GILD Ouch........ https://t.co/eJ9HGUo3v0RT @OptionsHawk: $GILD down a cool 5.5%, can lock these in 400-500% gains https://t.co/42VhRYV4v6RT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶RT @biotechnova: $GILD If you don't think leaks are true... https://t.co/yyADCf62aoIn contrast $GILD taking a big hit on revenue miss and shrinking profits.@modern_rock this ER season so far about $FB and $AMZN, $NFLX $AAPL $GILD all tanking.Retweeted Daniel Miller (@WallStreetBean):

$GILD finished Q1 with $21.3B in cash + equivs vs $26.2B last QRT @WallStreetBean: $GILD finished Q1 with $21.3B in cash + equivs vs $26.2B last Q$gild whoaaaaa$GILD down a cool 5.5%, can lock these in 400-500% gains https://t.co/42VhRYV4v6$GILD If you don't think leaks are true... https://t.co/yyADCf62aoRT @StockTwits: Uh-oh. One of the biggest biotech stocks, Gilead, just missed earnings badly: https://t.co/pTx3STflMk

$GILD $IBB $XBI$GILD buyout rumors not starting yet ?!?
#sarcasm@StockTwits @BobPisani How about how it tanked right before close and earnings release?  Someone knew something. $GILD$GILD finished Q1 with $21.3B in cash + equivs vs $26.2B last Q$GILD you still think buying your own stock is the best place for your money. Avoid acquiring a company and you will be able to buy cheaper.$GILD AH https://t.co/1fWPDr3unpRT @Benzinga: Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B
 $GILD https://t.co/oazu0hpNceRT @StockTwits: Uh-oh. One of the biggest biotech stocks, Gilead, just missed earnings badly: https://t.co/pTx3STflMk

$GILD $IBB $XBI$AMZN up huge AH +11%
$GILD down AH -4%

I'll take the offset. Huge bounce back qtr for $AMZN. Beat revenue by $1B!@afortunetraders CONGRATS on $GILD earnings Play!!‚òïüí∞üôå WOW!!!$GILD Gilead Sciences Announces Second Quarter 2016 Dividend
From our Stock News Alerts AppRT @Street_Insider: Gilead Sciences $GILD Misses Q1 EPS by 10c https://t.co/Ay25X4kDOpRT @CNBC: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/z3NqKgWamY https://t.co/D‚Ä¶RT @CNBC: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/z3NqKgWamY https://t.co/D‚Ä¶RT @AndyBiotech: $GILD #HCV franchise Q1 sales $4,294M misses consensus of $4,607M

Mainly driven by weak Harvoni US sales: $1,407M vs $1,8‚Ä¶BOOM 3 for 3 on earnings $amzn $lnkd and $gild Christmas comes early this week... $$$$@GerberKawasaki why is $GILD tanking AH? I didnt trade all day, so no monitoring it.RT @StockTwits: Uh-oh. One of the biggest biotech stocks, Gilead, just missed earnings badly: https://t.co/pTx3STflMk

$GILD $IBB $XBIRT @Street_Insider: Gilead Sciences $GILD Misses Q1 EPS by 10c https://t.co/Ay25X4kDOpUh-oh. One of the biggest biotech stocks, Gilead, just missed earnings badly: https://t.co/pTx3STflMk

$GILD $IBB $XBIRT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶Gilead Sciences $GILD Misses Q1 EPS by 10c https://t.co/Ay25X4kDOpGilead Sciences misses by $0.11, misses on revenue https://t.co/EqqYeye4IG $GILD$GILD Q1 revs +2.6%, net income -16%, non-GAAP net income -6.5% YoYRT @OptionsHawk: $GILD ugly miss and $AMGN crushed #'s..same story..different quarterRT @adamfeuerstein: $GILD Q1 total revenue $7.8B miss consensus $8.0B although total product sales $7.7B beats consensus $7.6B$GILD #BUYBACKS $8B (6% of market cap)RT @AndyBiotech: $GILD #HCV franchise Q1 sales $4,294M misses consensus of $4,607M

Mainly driven by weak Harvoni US sales: $1,407M vs $1,8‚Ä¶RT @adamfeuerstein: $GILD Q1 total revenue $7.8B miss consensus $8.0B although total product sales $7.7B beats consensus $7.6B$GILD #HCV franchise Q1 sales $4,294M misses consensus of $4,607M

Mainly driven by weak Harvoni US sales: $1,407M vs $1,884M consensus$GILD looks good to me.$GILD Q1 total revenue $7.8B miss consensus $8.0B although total product sales $7.7B beats consensus $7.6B$GILD
Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B$GILD Gilead Sciences Announces First Quarter 2016 Financial Results
From our Stock News Alerts AppRT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶ok $GILD calls will be some loss, but cant complain.Missed $AMZN's blowout earnings, but I'll suffer with the $GILD fall. Sigh. Long-term horizon needs to keep me going.@dsobek Orrrrr, $GILD misses badly.RT @jarredtrax: $GILD missed.RT @Benzinga: Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B
 $GILD https://t.co/oazu0hpNceRT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶RT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶RT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶Another stock in my portfolio disappoints and misses earnings $GILD slammed after hoursRT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶$AMZN crushed it. $GILD mssedRT @MarketCurrents: Gilead Sciences misses by $0.11, misses on revenue https://t.co/nVRjnUs2pp $GILDNot a great reaction from $GILD.RT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶RT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶$GILD on the other hand is getting beat up on earnings down to the 93 area.RT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶$amzn Higher - they actually turned a profit

$GILD lower...  because it's $GILDRT @CNBCnow: EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.c‚Ä¶RT @Benzinga: Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B
 $GILD https://t.co/oazu0hpNceTurn over the cards it's the flush $GILD  https://t.co/AasnFychDvRT @jarredtrax: $GILD missed.EARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/z3NqKgWamY https://t.co/DG9TShV0dZRT @Benzinga: Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B
 $GILD https://t.co/oazu0hpNceRT @adamfeuerstein: $GILD Harvoni Q1 sales $3.01B, short of consensus $3.2BRT @Benzinga: Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B
 $GILD https://t.co/oazu0hpNceEARNINGS: Gilead Q1 EPS $3.03 Adj. vs. $3.15 Est.; Q1 Revs. $7.79B vs. $8.12B Est. ‚Ä¢ $GILD https://t.co/b4j1ASBzXN https://t.co/OQpe7fDNpQ$GILD Harvoni Q1 sales $3.01B, short of consensus $3.2B$GILD miss. 
$AMGN beat &amp; raise$GILD - Gilead Sciences Announces Second Quarter 2016 Dividend https://t.co/3BqhTZZRS6$GILD miss$GILD whiffRT @SEEKINGALPHA_FS: Gilead Sciences misses by $0.11, misses on revenue https://t.co/k4gwk9qloh $GILD$GILD ugly miss and $AMGN crushed #'s..same story..different quarterRT @jarredtrax: $GILD missed.Retweeted Bio Stocks‚Ñ¢ (@BioStocks):

$GILD $0.47 dividendRT @BioStocks: $GILD $0.47 dividendRT @MarketCurrents: Gilead Sciences misses by $0.11, misses on revenue https://t.co/nVRjnUs2pp $GILDRT @Benzinga: Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B
 $GILD https://t.co/oazu0hpNce$GILD: Gilead Sciences prelim Q1 $3.03 vs $3.13 Capital IQ Consensus Estimate; revs $7.79 bln vs $8.07 bln Capital IQ Consensus EstimateRT @Benzinga: Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B
 $GILD https://t.co/oazu0hpNceRT @Benzinga: Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B
 $GILD https://t.co/oazu0hpNce$GILD put it into da cheap seats$GILD - Gilead Sciences Announces First Quarter 2016 Financial Results https://t.co/JmYYXHPdYnGilead Sciences misses by $0.11, misses on revenue https://t.co/k4gwk9qloh $GILDGilead Sciences misses by $0.11, misses on revenue https://t.co/oOQZov8yRA $GILDGilead Sciences misses by $0.11, misses on revenue https://t.co/nVRjnUs2pp $GILD$GILD missed.RT @Benzinga: Gilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B
 $GILD https://t.co/oazu0hpNceRT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.$GILD $0.47 dividendGilead Sciences Reports Q1 Adj EPS $3.03 Vs Est $3.14, Sales $7.79B Vs Est $8.11B
 $GILD https://t.co/oazu0hpNceRetweeted TopstepTrader (@TopstepTrader):

$GILD 1Q ADJ EPS $3.03, EST. $3.15RT @TopstepTrader: $GILD 1Q ADJ EPS $3.03, EST. $3.15@DeLoCRG everything turned but $GILD seemed fastest but odds are the market just derisked$GILD miss on both$GILD 1Q ADJ EPS $3.03, EST. $3.15RT @Smallinvestor81: @Globalmess65 @ChaseLester_CL $GBIM has deal w/ $Celg also w/ $400m+ possible. $GILD buys for $250m gets back what the‚Ä¶Even if $gild beats it will only go back to the open price of this morning of $100... Oh well and if they miss back to test 83 againGave you time to get out or sell calls over the 200d / $100 $GILD$GILD not looking healthy into ER.@sharkbiotech nice last minute puke in $gild into ERI know the market turned but $GILD falling faster on volume into earnings.RT @CarolineYLChen: *Deep breath* 
Next up, $AMGN and $GILD.$GILD 97.80 long here into earnings*Deep breath* 
Next up, $AMGN and $GILD.RT @madaznfootballr: Notable earnings AH $AMZN $GILD $LNKD $BIDURT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.Notable earnings AH $AMZN $GILD $LNKD $BIDU$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/ohahHU90zZ$GILD weak into the close.RT @jarredtrax: $GILD selling off like there‚Äôs no tomorrowRT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.RT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.RT @eWhispers: top #earnings $FB $AAPL $AMZN $TWTR $CMG $F $GILD $LNKD $FCX $CELG $SWKS $JBLU $T $NXPI $BA  https://t.co/lObOE0uRjZ https:/‚Ä¶Celgene Reports Q1, Lowers EPS Guidance A Little: Analysis https://t.co/MNStubEBtA $AGN $GILD $MYL $CELGGilead Sciences, Inc. $GILD Shares Bought by Airain ltd https://t.co/XltcAN54Cm$GILD selling off like there‚Äôs no tomorrowRT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.Gilead tonight. 11 beats in a row but worries about future growth. $GILD https://t.co/cbK0uYJbOPRT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.RT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.$AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.RT @GerberKawasaki: It's bio tech buyout day with a third merger being announced. Amazing. Wish Gilead would get in on this action. $GILD$AGO SELL

$CMG $TWTR $EBAY $BWLD $CRUS $FB $FSLR $UPS $CELG $AMZN $LNKD $BIDU $SWKS $FCX $V $GILD $HELE $NXPI $CVX https://t.co/mpyYaISgUFRT @GerberKawasaki: It's bio tech buyout day with a third merger being announced. Amazing. Wish Gilead would get in on this action. $GILDRT @LeanneBMiller: $GILD &amp; $AMGN report in less than 1 hour!

Why biotech‚Äôs biggest names could rally the sector ¬ª 

https://t.co/FxtLdZTclv@Carl_C_Icahn let's get rich together on the coming biotech rally. #Ridethewave #KyleandCarlEnterprises $GILDToday's Slots  https://t.co/YTMU7PBZx6 Daily #Earnings Trades $AMZN $BIDU $WDC $SWKS $JNPR $GILD $AMGN$gild down before earnings.. Hope that changes after the report$GILD and $AMZN will decide the fate of QQQ@Globalmess65 @ChaseLester_CL $GBIM has deal w/ $Celg also w/ $400m+ possible. $GILD buys for $250m gets back what they spent plus HBV drugRT @LeanneBMiller: $GILD &amp; $AMGN report in less than 1 hour!

Why biotech‚Äôs biggest names could rally the sector ¬ª 

https://t.co/FxtLdZTclvRT @LeanneBMiller: $GILD &amp; $AMGN report in less than 1 hour!

Why biotech‚Äôs biggest names could rally the sector ¬ª 

https://t.co/FxtLdZTclv$GILD &amp; $AMGN report in less than 1 hour!

Why biotech‚Äôs biggest names could rally the sector ¬ª 

https://t.co/FxtLdZTclvIt's bio tech buyout day with a third merger being announced. Amazing. Wish Gilead would get in on this action. $GILD$GILD nice bounce off the VWAP... 100 support.....@Globalmess65 @ChaseLester_CL $Gild has WW license w/ $GBIM for HBV drug@RedDogT3 $CELG had a big reversal today off ""light"" earnings.  $GILD and $AMGN earnings tonight so maybe the same or better for those two@Smallinvestor81 @Globalmess65 If $GILD buys $GBIM that will make me happyRT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT SeekingAlpha: Celgene Reports Q1, Lowers EPS Guidance A Little: Analysis https://t.co/Z7t67JglY6 $AGN $GILD $MYL $CELG@MattBroadwell Lol; I'm a sucker for earnings roulette! , I made $.50 on $CELG option. Giddy up $GILD  ;)Celgene Reports Q1, Lowers EPS Guidance A Little: Analysis https://t.co/BMi2XU8WoW $AGN $GILD $MYL $CELGCelgene Reports Q1, Lowers EPS Guidance A Little: Analysis https://t.co/Sq1mOUH4wI $AGN $GILD $MYL $CELGCelgene Reports Q1, Lowers EPS Guidance A Little: Analysis https://t.co/Kxo85LyjsZ $AGN $GILD $MYL $CELGRT @HCPG: 290 huge area -- 3/4 largest components of $IBB report today $AMGN $GILD $CELG https://t.co/B7y4silu15290 huge area -- 3/4 largest components of $IBB report today $AMGN $GILD $CELG https://t.co/B7y4silu15RT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶Broadcom LTD Moves Into First Place On Our Nasdaq Top-Ten List $AMAT $ATVI $NVDA $AVGO $CSCO $GILD $INTC $LRCX  https://t.co/Rs4AuJgCPRRT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶@CTLTrading1 $AMGN and $GILD ER tonight fyi.@VSimonAbraham @BattagliaCE @truthtracer Ha. So, $GILD TAF = TDF in all practical aspects (except IP). Product lifecycling at it's finest ;)@VailshireCap Is it a pipe dream then to hope for a miss, soft guide and no meaningful acquisition from $GILD so I get to buy it lower?RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶$GILD ticks the boxes as a dream üí∞ dividend üí∞ stock with 1.7% yield https://t.co/MVKWRAQqUO https://t.co/XOpsgsFH8yA little bit of a riskier play here but I went long $GILD this morning. Should report solid earnings and its p/e is below 9.@BattagliaCE @psuvafan007 @truthtracer   Video from EASL2016 HepB.  Exp treatments in the first 12min. $ARWR $GILD
https://t.co/k1F61yfcjp$GILD I can see them making an offer for $KITERT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶Do you know that #WallStreet price for $GILD is $114.05 https://t.co/mpDel0oxXdRT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶This would be a great day for $GILD to (again) blow out earnings, raise guidance and--finally--announce a transformative acquisition.RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶$gild cup n handle... $100.50 longRT @CBOE: Earnings Next Week https://t.co/gS9k8PmhMn reporting after the close $AMZN $AMGN $ATHN $BIDU $LNG $EXPE $GNW $GILD $HIG $JNPR $LN‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶$GILD earnings tonight  https://t.co/W4aFGvOEeH via https://t.co/11Wpw9y7t1RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @CBOE: Earnings Next Week https://t.co/gS9k8PmhMn reporting after the close $AMZN $AMGN $ATHN $BIDU $LNG $EXPE $GNW $GILD $HIG $JNPR $LN‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶7 Dividend Stocks With ""Hidden"" Yields You NEED to Own $SHW $DPZ $GILD $ALK ... 
https://t.co/41RqvIbyB3RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶$GILD like it's winning cousin $CELG however the $GILD reports today and is in the tight range of between 100.30 - 100.73, wait for the B/O.Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/35hh05LP1U@HalftimeReport guys any thoughts on $GILD before earnings? Thx!Gilead Sciences Reiterated Rating by Credit Suisse (Ranked 27th) to Outperform with 120 PT $GILD #GILD https://t.co/nyq7xJnbR7Gilead Sciences's outperform rating reiterated at Credit Suisse. $120.00 PT. https://t.co/jt1QyNP48K $GILD #GILDGilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Credit Suisse https://t.co/ZAm11RY6FWRT @ZenTrends: Hold onto your hats Biotech Longs, $GILD $CELG $AMGN report after the bell. $IBBHold onto your hats Biotech Longs, $GILD $CELG $AMGN report after the bell. $IBBGilead Sciences's outperform rating reiterated at Credit Suisse. $120.00 PT. https://t.co/x5k2CpW9nn $GILD #GILDEarnings Next Week https://t.co/gS9k8PmhMn reporting after the close $AMZN $AMGN $ATHN $BIDU $LNG $EXPE $GNW $GILD $HIG $JNPR $LNKD $MRVLshorting $GILD like trying to hold a rubber ball under water. It's about to blow up on you!$GILD needs to close above $100.73 on the 5-min chart to really run.The 10 Best Growth Stocks to Buy for Retirement $AMZN $GILD $ULTA $PCLN $JD ... 
https://t.co/mjsB86gEz4$ARWR The next $GILD in the making https://t.co/1K4hfaSreTRT @SashaDamouni: $ABBV says $MRK price strategy has hurt hep-C drug sales - $GILDRT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶$GILD back to green.. closed the gap... holding half long from 100...$GILD weak hands gone. All clear for afternoon rally in GILD and the rest of biotech. Senate hearings yesterday were a joke as expected.RT @SashaDamouni: $ABBV says $MRK price strategy has hurt hep-C drug sales - $GILDVolume Alert - GILD 99.68 Gilead Sciences Inc $GILD Hit a high today of 100.55 Closing the day 10:30 at 99.68  https://t.co/D6FdTosb0J$GILD about to close the gap...#Earnings Today-P5
$EYES $FET $FII $FLEX $FLS $FPO $GABC $GAS $GB $GFF $GIFI $GILD $GIMO $GNBC $GNW 
https://t.co/wkf0X8Rups$GILD about to breakout &gt; 100...Gilead Sciences $GILD Stock Retreats Ahead of Q1 Results Despite Credit Suisse's Optimism https://t.co/WBlHcOw1Fd #StockActionGilead Sciences $GILD Stock Retreats Ahead of Q1 Results Despite Credit Suisse's Optimism https://t.co/sEN5TZHgtZRT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶$GILD $AMGN Valeant and Sarepta up big, GILD down. I'm sure this makes sense to someone. Who?$GILD anyone short GILD needs a lobotomy$GILD here we go... looking weak... 99.50 crack cmon...If $GILD makes no mention of 24-week GS-4774 data later today, one can assume $GBIM is only allowed to use it as bargaining chip for M&amp;A.$gild c'mon &lt; 99.50 crackWhich Will Trump: Healthcare M&amp;A, or Earnings? https://t.co/JF2C82OShH
$GILD $AMGN $BMRN all report after the bell. Some quick #s to know.Q1 GDP was weak, but attention should be more focused on Q2 GDP. $AMZN earnings out today, $GILD as well.$GILD looking at 99.50 break down for short...RT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶RT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶RT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶$GILD $AMGN looking for solid beats this evening. Biotech will be back in favor starting tonight. Mark this post!RT @SashaDamouni: $ABBV says $MRK price strategy has hurt hep-C drug sales - $GILDAvoid Gilead https://t.co/k1PD8hOPsB $GILDRT @SashaDamouni: $ABBV says $MRK price strategy has hurt hep-C drug sales - $GILDRT @SashaDamouni: $ABBV says $MRK price strategy has hurt hep-C drug sales - $GILD$ABBV says $MRK price strategy has hurt hep-C drug sales - $GILDWe had a good trade on Gilead #trading S this week from above $102 but we were out yesterday before earnings... $GILD $IBB #riskSitten katsotaan, meneek√∂ $GILD yh√§ enemm√§n lokeroon: maailman halvin megayritys. https://t.co/xDh8LTQLej$GILD - shorted at 99.85#earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https://t.co/mOH8LeUftX$GILD amazing 60 min dip buy damn.Will #Gilead's Run Come To An End This Quarter? $GILD Also $MRK https://t.co/tdIMKgBQmC$GILD #GileadSciences -1,3% 99,29$ schwach vor Zahlen. Im Fokus #GD200. #Trading-#Buy Ziel: 120$ /SO https://t.co/TJPT4JCExy$GILD when the stock blows out earnings those who sold are going to attempt to physically kick themselves in the ^ss that should be fun$GILD below 200dma and $100Just picked up 30 $GILD May 20 110 calls @ avg of 0.26 #earningsseason #biotechrallystartsnow https://t.co/SjNIhNISwl$GILD Thanks for the nice little sell-off for no reason. Pros love you guys. You just hand them $$$$Gilead Earnings Outlook https://t.co/hTDNwesPbm $GILDGILD Top news - Apr 28th, 2016 $GILD https://t.co/jXXG5oLjYRTwo big deals in bio tech as well. One with Abbvie. $abbv. Getting into cancer treatments. A good move. GIlead reports today. $gildNotable companies reporting #earnings today - $AMZN $GILD $AMGN $BMY $MA $CELG $BIDU $TWC $F &amp; more https://t.co/j5WSqU0OT2 via Scutify7 Dividend Stocks With ""Hidden"" Yields You NEED to Own $SHW $DPZ $GILD $ALK  ... 
https://t.co/41RqvIbyB3$AMZN, $BIDU, $F, $GILD reporting today. See last 4 qrtrs of price movement history on the earnings announcement. https://t.co/dKmzrBz2LPGalapagos bolsters case for Gilead-partnered Crohn‚Äôs drug with 20-week data: https://t.co/DQPhd5hWHb $GILD story from FierceBiotech #biote‚Ä¶Top Earnings Thur 4/28 After: $AEM $AMGN $AMZN $ATHN $BIDU $BMRN $CENX $DLR $ELLI $EMN $EXPE $FLEX $GILD $GNW $GRPN $HIG $JNPR $LNKD (1/2)Big day for pharma. Trading into $gild https://t.co/pqDBsHE1Zw$GILD - AbbVie Agrees to Buy Stemcentrx, Reports Jump in Earnings https://t.co/FxhmpcV1yERT @daytradingninja: Notable #Earnings {3/3 AfterHours} 2016.04.28
$AMZN $AMGN $BIDU $CUBE $EXPE $GILD $GRPN $JNPR $LNKD $N $P $QLIK $SWKS‚Ä¶Galapagos bolsters case for Gilead-partnered Crohn‚Äôs drug with 20-week data: https://t.co/WxfR8sV7DT $GILDRT @MyStockLifeLive: #MSLMorningUpdate: #Earnings  $MA $AMZN $LNKD $GRPN $GILD $F $BIDU https://t.co/5lBR4SDnbj https://t.co/ZmSYQIkYORRT @MyStockLifeLive: #MSLMorningUpdate: #Earnings  $MA $AMZN $LNKD $GRPN $GILD $F $BIDU https://t.co/5lBR4SDnbj https://t.co/ZmSYQIkYOR#MSLMorningUpdate: #Earnings  $MA $AMZN $LNKD $GRPN $GILD $F $BIDU https://t.co/5lBR4SDnbj https://t.co/ZmSYQIkYORRT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $‚Ä¶RT @biotechnova: Key names reporting AH: $GILD $SWKS $LNKD $BIDUKey names reporting AH: $GILD $SWKS $LNKD $BIDURT @CarolineYLChen: and we haven't even gotten to $GILD earns yet.RT @CarolineYLChen: and we haven't even gotten to $GILD earns yet.Early news on $ABBV $ABT $BMY $CELG $SRPT $JUNO $MRK $GILDand we haven't even gotten to $GILD earns yet.Notable #Earnings {3/3 AfterHours} 2016.04.28
$AMZN $AMGN $BIDU $CUBE $EXPE $GILD $GRPN $JNPR $LNKD $N $P $QLIK $SWKS $STRZA $SNE $VRSN $WDC@megtirrell @MarkSchoenebaum probably as $gild basically has all the #HCV market - we will soon assessRT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $‚Ä¶RT SeekingAlpha: Gilead Earnings Outlook https://t.co/EzsT8ntUcC $GILDGilead Earnings Outlook https://t.co/umKlmwMLIc $GILDGilead Earnings Outlook https://t.co/wTEBhyDtM4 $GILD@RNAiAnalyst Don't expect too much. Not looking great so far $GILD $IONS $MRK Low settlement possibleRE the $IONS/MRK vs $GILD patent infringement issue. A wise man asked Q: in light of peanut penalties, y bother taking IP license at all?RT @tgtxdough: @tgtxdough $TGTX science behind the  TGR-1202 superiority $GILD https://t.co/k64t27dD0aRT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $‚Ä¶@biotechnova yupp, all that matters for $IBB :) &amp; then $GILD later.Notable companies reporting #earnings today - $AMZN $GILD $BMY $MA $CELG $BIDU $TWC &amp; more https://t.co/0y8B0170wd https://t.co/ImiDQrjgyYRT @fgusequity: $GILD https://t.co/dZWRGe19sM Pot. pullback in Downtrend LONGERTERM Wly-Dly-Hly combo chart #trading #stocks https://t.co/y‚Ä¶$GILD https://t.co/dZWRGe19sM Pot. pullback in Downtrend LONGERTERM Wly-Dly-Hly combo chart #trading #stocks https://t.co/y9HcU8dUzyRT @OphirGottlieb: (1/10)

Here comes a Biotech Chart Storm

$GILD Revenue

Story --&gt; https://t.co/LwvR17k08k https://t.co/TSaEhDFV1bRT @megtirrell: A potential drug for #Zika? We visited $GILD's labs to see what it holds in its antiviral library: https://t.co/2Xjd45PIcdRT @BioStocks: $GILD European Commission Grants Marketing Authorization for Descovy for Treatment of HIV https://t.co/YkghFxJlPORT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $‚Ä¶#Update US Earnings Release for today: $MO $BMY $MA $ABBV $DCM $UPS $CELG $CL $AMZN $GILD $AMGN $BIDU $AMX $FMX $HIG $EXPEWhy does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $BMRN $GILD $SGENCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5chartguy89: 2016 Trending Stocks: GILD 100.72 Stock Charts $GILD Gilead Sciences https://t.co/3G2cmyd0s1$GILD:US Aegerion (AEGR): Can the Stock Surprise in Q1 Earnings? #GILEAD SCIENCES INC  https://t.co/WT1zQqB02i #NASDAQSeasonal charts of companies reporting earnings today: https://t.co/hqYOaqLyHu $AET $AEM $MO $AMZN $AMGN $BMY $CL $EMN $F $GILD $UPS $VIABRT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶@_bhaveshpatel I see that. Tomorrow will likely determine where biotech goes in the interim. $AMGN, $CELG and $GILD all report.RT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 4/24 $VIX $TLT $IBB $ALKS $GILD $GLD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $V ht‚Ä¶@pbmech $GBIM on your radar at all? Partnership w/ both $GILD and $CELG.I am bullish on $GILD with a target price of $109.72 in 6 mos. on Vetr! https://t.co/mCcfzhVpjN#GileadSciences, Inc. (NASDAQ:), LinkedIn Corporation (NYSE:LNKD) - Amazon Earnings, GDP An... Read more: https://t.co/Fkmz5Kyx0t $GILDWe calculated 21-day Expected Return of $GILD for you: 9.72% https://t.co/mTgAzTSiLDAlta Capital Management LLC Boosts Stake in Gilead Sciences, Inc. $GILD https://t.co/GXa1CPh40lGilead Sciences, Inc. $GILD Position Boosted by Ray Gerald L &amp; Associates Ltd. https://t.co/oAerYseZfOGilead Sciences, Inc. $GILD Position Boosted by Ray Gerald L &amp; Associates Ltd. https://t.co/bv457GBaUJCheap put options and hedges: $GLW puts cheaper than 96% of history, $T 95%, $DHR 94%, $DAL 93%, $VZ 91%, $GILD 89%, $MA 88%$GILD info https://t.co/AUmf7Vg8StRT @StocksMD: $UPS $ABBV $DOW $AMZN $GILD $AMGN $XOM $CVX $SPY $QQQ $FB $AAPL  https://t.co/wPF4ybekUqRT @StocksMD: $UPS $ABBV $DOW $AMZN $GILD $AMGN $XOM $CVX $SPY $QQQ $FB $AAPL  https://t.co/wPF4ybekUqExplore #fundamental numbers and pros and cons for $GILD https://t.co/IFnkAQiwhEAccumulated $LABU (not D) today, few more in early am (on 'false' dip); Go $CELG $GILD $AMGN (the only decency left in $IBB) :B Nikkei GREEN@Pharmdca No one knows, but $GILD and $CELG report tomorrow. Perhaps the market reaction will offer some clues...$GILD #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/w62BKEKvFJ$UPS $ABBV $DOW $AMZN $GILD $AMGN $XOM $CVX $SPY $QQQ $FB $AAPL  https://t.co/wPF4ybekUqRT @Lin_ling_88: Major league earnings on tap: Thursday, April 28 $AMZN $GILD $BIDU  https://t.co/vueLHIyplnMajor league earnings on tap: Thursday, April 28 $AMZN $GILD $BIDU  https://t.co/vueLHIyplnStock trade alerts https://t.co/uAcamNRUPt JOIN NOW Promo https://t.co/e2zXG3II89 $MCUR $AMAT $ITUB $MT $GILD $HST $AA $GMAn article I wrote for Seeking Alpha on $GILD https://t.co/2kvgPqHWqART @OptionsHawk: $GILD 4,285 of May 6th (W) $95 puts active all morning, $0.55 to $0.70.  Similar to AAPL, large, cheap, lots of cash, no g‚Ä¶@Amazon Earnings Top 5 Things You Need To Know For Thursday $AMZN $LNKD $BIDU $GILD $FB https://t.co/LGvMXoWO1C https://t.co/QMHhn8ZNST",2016-04-28,GILD,0
20,"$GILD - Judge Allows More Evidence in Patent Dispute After Gilead Says Merck Attorney Lied -- Update https://t.co/ajft9XEUEGRT @TickerTV: Gilead Sciences | $GILD Stock | Down Hard In After Hours https://t.co/CoCvQKAdBT #gild #gileadTOP US: 1 $GILD 114% 2 $LAZ 106% 3 $CYH 105% 4 $BX 104% 5 $ESNT 103% https://t.co/UwzMWQCh0S@LiberalLaHippie @BarbarianCap Long $GILD ?Stochastic Oversold https://t.co/5LjveYxTr1 $CAH $AEL $SPWR $AMX $ALR $GILD $EWT $TER $BEN $SWKS $HOLX $FSLR $AMAT $LYB $OCN $GPS $DRH$GILD they know how to play small ball...$MRK playing hardball w/government payers.  Big miss@US sales..no track record outside of antiviralWhat Are Analysts Saying About Q1 At Big Biotech? Price increases are v impt. https://t.co/ta7qmN0RwY $AMGN $BIIB $GILD $CELG$GILD: Analyst action by Citigroup on Gilead Sciences: https://t.co/fW7rFvsD2F https://t.co/SWfHGuTyp1Merck's pockets to remain empty as judge reopens sofosbuvir patent case with Gilead; $200M awa... $MRK $GILD https://t.co/hmGE4730WeRT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning... welcome to the working week.. Valeant was  a 'sewer' https://t.co/FD8q3mWvOJ #pha‚Ä¶RT @ChinaInvest: RT SeekingAlpha: The Gilead Merck Patent Case Takes A Surprising Turn https://t.co/JSytfS13Vh $MRK $GILD#Dow Barely Posts Monthly Gain As Indices Pare Losses $DIA Also $QQQ $GILD $SPY $IBB https://t.co/r97JNufZKTBryan Garnier on $GLPG analyst pres late Friday: $GILD milestone payments way earlier then prev. expected. (&gt; $1.3B) https://t.co/z5mLE35X0sRT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶$GILD - Judge Allows More Evidence in Patent Dispute After Gilead Says Merck Attorney Lied -- Update https://t.co/5J050FGXU3RT SeekingAlpha: The Gilead Merck Patent Case Takes A Surprising Turn https://t.co/JSytfS13Vh $MRK $GILDWent long $GILD at the exact right time Haha  https://t.co/1oGFquhOdaFull Video Outlook for #Financial #Markets Inc $GILD in our #mtbanalysis Magazine &gt; https://t.co/zI5Xp6WLLK #Stocks https://t.co/WHDhuTwjIQJudge allows more evidence in patent dispute after Gilead says Merck attorney lied  https://t.co/yF95nHCgjC $GILD $MRKRT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶#GileadSciences Judge Allows More Evidence in Patent Dispute After Gilead Says Merck Attorn... Read more: https://t.co/kd7gcUqlI4 $GILDThe Gilead Merck Patent Case Takes A Surprising Turn https://t.co/YvVBmdMetB $MRK $GILDThe Gilead Merck Patent Case Takes A Surprising Turn https://t.co/j6S1yF3BM8 $MRK $GILDHigh Put Activity https://t.co/DuWgxTjccx  $ACAD $BY $BHI $BIDU $JNJ $WF $F $ABX $CLF $WT $DDD $FXI $GILD $IBB $NE $GDX $CRRT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶RT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶RT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶RT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶RT @BioStockAddict: Gilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move $GILD $GLPG https://t.co/nZGG95NZ0NGilead: The Buzz Is Gone, One Heck Of A Company Remains https://t.co/OYc35SGTtN $GILD$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ rally !! https://t.co/tuZFX3NkPWRT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶RT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $MRK $GILD$GILD - Judge Allows More Evidence in Gilead-Merck Patent Dispute https://t.co/9Lf5CqwoeCHow many people just retired buying dips in $gild over the years$gild should be between $100-$105 in short order#Hcv #hepC #hepatitis $GILD #vote4BernieSanders https://t.co/dE6GgnOnx8$GILD - Judge Allows More Evidence in Patent Dispute After Gilead Says Merck Attorney Lied https://t.co/BBDorgEYGV$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/iX5cnKUVa1 https://t.co/WIYkKpRfVKRT SeekingAlpha: 28 Dividend Increases: April 25-29, 2016 (Part 2: Non-Financials) https://t.co/XCuXX2KO2t $AAPL #APPLE $AVY $GILD $GWW $I‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT‚Ä¶ #invest28 Dividend Increases: April 25-29, 2016 (Part 2: Non-Financials) https://t.co/DSbbBaPNga $AAPL #APPLE $AVY $GILD $GWW $IBM $JNJ $JNS $LM28 Dividend Increases: April 25-29, 2016 (Part 2: Non-Financials) https://t.co/W54CBk16nf $AAPL #APPLE $AVY $GILD $GWW $IBM $JNJ $JNS $LM28 Dividend Increases: April 25-29, 2016 (Part 2: Non-Financials) https://t.co/cZ72CwNrJh $AAPL #APPLE $AVY $GILD $GWW $IBM $JNJ $JNS $LMICYMI: Can Arrowhead Do For #Hep B What Gilead Sciences Did For HepC? $ARWR |The Motley Fool $GILD  https://t.co/ngnQBP4PRv@canuck2usa and $GILD too$GILD $89...I am out of this if it hits $89.90...still have my stop in#GileadSciences, Inc. Stock Rating Reaffirmed by Credit Suisse. Read more: https://t.co/ILvE0yFyXl $GILDHammer time in $GILDüíØ $IBIO BULLISH $3PT üíØ $NUGT $EBIO $GILD $TLOG $JNUG $MU $MNST $GG $BIDU $IBB $IBKR $GASX $HYH $GASL $BRK.A $DUST $GRPN $TCK $ABIO#Gilead: What's Your Long-term Thesis? $GILD https://t.co/GNLWHVu1FPGilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Credit Suisse https://t.co/RgqFEKTcfm$GILD I do like the low today of 86.75 to trade against on Gilead.RT @jpsloan3: If The S&amp;P 500 Index Were A Stock, Would You Buy It Now? https://t.co/HxTESPDTRo $AAPL $AMZN $BRK.A $BRK.B $CB $DIS $FB $GE $‚Ä¶If The S&amp;P 500 Index Were A Stock, Would You Buy It Now? https://t.co/HxTESPDTRo $AAPL $AMZN $BRK.A $BRK.B $CB $DIS $FB $GE $GILD $GOOG$GILD pretty nice straight line rip off the lows. Waiting for it to hit major resistance.Don't Sell Gilead - Sell Options And Buy The Stock Instead: https://t.co/rzvKYBgaww $GILDThree Biotech Stocks With Ten-bagger Potential $HALO $DVA $GILD
https://t.co/BGCxVKr6bOPatent Case Against Gilead Reopened; Result Could Remove Share Overhang https://t.co/t0j9627n5w $ABBV $MRK $PFE $SNY $GILDGood News: #GileadSciences Discounted Its Drugs Again. Read more: https://t.co/UAIJRaf6i3 $GILDIf The S&amp;P 500 Index Were A Stock, Would You Buy It Now? https://t.co/HMDi56oELq $AAPL #APPLE $AMZN $BRK.A $BRK.B $CB $DIS $FB $GE $GILDIf The S&amp;P 500 Index Were A Stock, Would You Buy It Now? https://t.co/84Vc8zGkNX $AAPL #APPLE $AMZN $BRK.A $BRK.B $CB $DIS $FB $GE $GILD@techwhitepapers if $GILD passes y someone else may like y $OCRX–¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–∞—è —Ü–µ–ª—å - 180 $GILD https://t.co/LGZfajqg8LRT @CraigScott31: If you hopped in $GILD or $VRX when I did this am , https://t.co/RwTCW8TKfoIf you hopped in $GILD or $VRX when I did this am , https://t.co/RwTCW8TKfo$WDC $GILD $HAL üëÄAdded to $GILD position today via long common/short puts, position is underwater again$GILD greenbto $GILD Aug 100c, still waiting on fill for Aug 105cRT @CarlyHFierce: 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier: https://t.co/yAzEg7GsJa $MRK $ABBV $GILD #phar‚Ä¶Gilead Sciences to Merck: Not So Fast‚Ä¶ https://t.co/QNN48EN2gr via @barronsonline $GILD $MRKRT @bret_jensen: Commented on Gilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move https://t.co/8kAWUZbk0R $GLPG $M‚Ä¶@CraigScott31 you're a beast! That's a great trade and your already up on $GILD too?Gilead Sciences, Inc. $GILD Shares Bought by Swedbank https://t.co/dMuPvAEjaKFIL Ltd Cuts Position in Gilead Sciences, Inc. $GILD https://t.co/JB69YGup8f$MRK award vs $GILD will be most like thrown out IMO, resulting in new parent fight #investing #biotech #TomsTruths  https://t.co/PFerQqOfhaRT @afortunetraders: Sold another 65% of my $gild holdings... $0.69 earnings play to $7.10 (went to high of 8.20$ today) https://t.co/gTc6C‚Ä¶Gilead Sciences, Inc. $GILD Shares Bought by Swedbank https://t.co/KyBhOXeyy0Sold another 65% of my $gild holdings... $0.69 earnings play to $7.10 (went to high of 8.20$ today) https://t.co/gTc6Cl86Attaking a small position in $GILD @ $88Federal judge allows $GILD, $MRK to enter in new evidence in high-stakes patent case over hep C meds https://t.co/MLlveHtteS$gild almost green https://t.co/dLwJTCznkKwould agree with you on $GILD .......  certaily on swap vs $BMY .....same divvy yield  to  boot https://t.co/fTuoiPe5urMartingale Asset Management L P Boosts Stake in Gilead Sciences, Inc. $GILD https://t.co/kjpHZwNVhi$GILD back to $88@jimcramer likes $BMY more than $GILD.  Everyone DUMPING on $GILD - good BUY signal. PE puts all drug co's to shame! https://t.co/AtEKjUR2H3@WhiteCoatMafia Issue is ""reopening"" of $GILD $MRK patent case as reported by @business but judge did not use that word. Also #biotechs weakRT @tgtxdough: Big biotech $IBB  Longterm looks cheap???? $CELG $GILD $BIIB https://t.co/RAtEIvqFBvWould you rather own $GILD, $BMY, $CELG (equal dollar weight).
@jimcramer @GuyAdami @sultanofstocks @CNBCFastMoneyHappier Employees Make Companies Great  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 1How Fun Workplace Design Can Increase Productivity  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f $btu 1RT @biospace: Gilead $GILD Seeks to Build 6-Story Lab in HQ Expansion, May House Up to 5,000 New Employees https://t.co/htE7AZJxU7 https://‚Ä¶RT @tgtxdough: Big biotech $IBB  Longterm looks cheap???? $CELG $GILD $BIIB https://t.co/RAtEIvqFBv@mikegoodma Stocks Where Sentiment Has Worsened
$ACRX $ANAC $CHMA $GILD $PTCTMerck's pockets to remain empty as judge reopens sofosbuvir patent case with Gilead; $200M award most ... https://t.co/SGlmF7wVaS $MRK $GILDMerck's pockets to remain empty as judge reopens sofosbuvir patent case with Gilead; $200M award most ... https://t.co/aDVXgxARS9 $MRK $GILDMerck's pockets to remain empty as judge reopens sofosbuvir patent case with Gilead; $200M award most ... https://t.co/H10KrTdfwn $MRK $GILDStill holding 2500 shares of $GILD bought late morning at $87.06 https://t.co/s1rdom7gRYBuilding a Powerful Brand by Creating More Value  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f 1RT @BioStockAddict: Gilead Stock: Analyzing 5 Key Suppliers $GILD $GLPG https://t.co/vSWD1UziNlRT @tgtxdough: Big biotech $IBB  Longterm looks cheap???? $CELG $GILD $BIIB https://t.co/RAtEIvqFBvBig biotech $IBB  Longterm looks cheap???? $CELG $GILD $BIIB https://t.co/RAtEIvqFBvGilead Sciences to Merck: Not So Fast‚Ä¶ https://t.co/PC5rL1lsso $GILD $MRK https://t.co/J4C2Q4nWeART @BioStockAddict: Gilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move $GILD $GLPG https://t.co/nZGG95NZ0NCharts  I  see as  Bearish:  $NFLX, GOOGL, $GILD, $CELG,...Bullish  $EBIX  $ERI   $CVX, MDVN,  $BMYGilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move $GILD $GLPG https://t.co/nZGG95NZ0NRT @FiercePharma: New contention a Merck scientist lied sends Gilead hep C patent fight back to court https://t.co/GL9DmxnmcV $MRK $GILD #p‚Ä¶RT @FiercePharma: 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier https://t.co/CxejkhmAIN $MRK $ABBV $GILD #pharm‚Ä¶RT @FiercePharma: New contention a Merck scientist lied sends Gilead hep C patent fight back to court https://t.co/GL9DmxnmcV $MRK $GILD #p‚Ä¶RT @FiercePharma: New contention a Merck scientist lied sends Gilead hep C patent fight back to court https://t.co/GL9DmxnmcV $MRK $GILD #p‚Ä¶RT @FiercePharma: New contention a Merck scientist lied sends Gilead hep C patent fight back to court https://t.co/GL9DmxnmcV $MRK $GILD #p‚Ä¶@Biotech2050 @GileadSciences From $GILD conf call:MarkS says small bios not engaging due to low valuations.New contention a Merck scientist lied sends Gilead hep C patent fight back to court https://t.co/GL9DmxnmcV $MRK $GILD #pharma @EricPFierceHigh Put Activity https://t.co/DuWgxTjccx ‚Ä¶ $ACAD $BY $BHI $BIDU $JNJ $WF $F $ABX $CLF $WT $DDD $FXI $GILD $IBB $NE $GDX $CRCommented on Gilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move https://t.co/8kAWUZbk0R $GLPG $MDVN $GILD$GILD is within 60ish cents of my call last week$VRX New CEO, possible changing name of Co. Bill Ackman thinks the turn around will be QUICK!

$SPY $QQQ #ShortSqueeze $IBB $XBI $CELG $GILDRT @ChinaInvest: RT SeekingAlpha: Gilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move https://t.co/lXWuCweVmf $GLP‚Ä¶RT SeekingAlpha: Gilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move https://t.co/lXWuCweVmf $GLPG $MDVN $GILDGilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move https://t.co/nZe0U2ES4P $GLPG $MDVN $GILDGilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move https://t.co/oZq4FLZ1JG $GLPG $MDVN $GILDRT @MagnoliaG2012: IBB Expecting A Rebound Ahead Of ASCO https://t.co/PcX7DacccS $ABBV $GILD $REGN $SNY $VRX $IBBIBB Expecting A Rebound Ahead Of ASCO https://t.co/PcX7DacccS $ABBV $GILD $REGN $SNY $VRX $IBBRT @MauriceOnTW: @BioStockAddict @portefeuillefun $GLPG $GILD may go BID for initial period then QD maintenance. Probably have 2 ig not 3 d‚Ä¶@BioStockAddict @portefeuillefun $GLPG $GILD may go BID for initial period then QD maintenance. Probably have 2 ig not 3 dose regimens in P3May 2: Gilead's a Heck of a Company; Google Sheds Light on Lens; SFBay #2 on GEN List https://t.co/yy7STtlnn1 Stories on $GILD $CDXS $DRRXUnusual Put Activity https://t.co/DuWgxTANB7 $ACAD $BY $BHI $BIDU $JNJ $WF $F $ABX $CLF $WT $DDD $FXI $GILD $IBB $NE $GDX $CRRT @TipRanks: Credit Suisse Weighs In On $GILD and $CELG Following Earnings https://t.co/zKWnFnugPpüíØ $IBIO BULLISH $3PT üíØ $NUGT $EBIO $GILD $TLOG $JNUG $MU $MNST $GG $BIDU $IBB $IBKR $GASX $HYH $GASL $BRK.A $DUST $GRPN $TCK $ABIORT SeekingAlpha: IBB Expecting A Rebound Ahead Of ASCO https://t.co/iLN6G8BN8r $ABBV $GILD $REGN $SNY $VRX $IBBGilead Sciences is Oversold $GILD $BBH #dividends https://t.co/1c2GVxYnNKIBB Expecting A Rebound Ahead Of ASCO https://t.co/yZ0553hkPw $ABBV $GILD $REGN $SNY $VRX $IBBIBB Expecting A Rebound Ahead Of ASCO https://t.co/pWcxiNyk3H $ABBV $GILD $REGN $SNY $VRX $IBBIBB Expecting A Rebound Ahead Of ASCO https://t.co/uOemJJtgnm $ABBV $GILD $REGN $SNY $VRX $IBBWhat Drove AbbVie‚Äôs Solid Performance in 1Q16? $ABBV $AMGN $CELG $GILD https://t.co/UBDJr6cPmIGilead: The Buzz Is Gone, One Heck Of A Company Remains https://t.co/sEZ5Ik0GJk $GILD$GILD Judge Re-Opens Case Amid Claim $MRK Scientist Lied - @KartikayM | https://t.co/899xgqczfA https://t.co/gNIcXe56gsHow Fun Workplace Design Can Increase Productivity  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f $btu 1Happier Employees Make Companies Great  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 1@CraigScott31 I bought some $GILD this morning at $87.06My $GILD play: 

BTO short term Iron Condor(near term think it's pegged)

BTO naked LEAP Calls, not ITM

BTO sm deep OTM puts
Ttl $400-500kRT @CraigScott31: My $gild play coming...Building a Powerful Brand by Creating More Value  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f 5MAY 02 Monday, $GILD is $87.36 @ 11:38. My BEARISH target is $86.57Why Vertex's 1Q16 Earnings Were a Disappointment $AMGN $CELG $GILD $QQQ https://t.co/OK1vzp5xpc$GILD $STX $SPLS options have the largest change in price. Free options screener. https://t.co/YRdUp0plr2$GILD long if it goes above 87.40... might break at 87 again...RT @canuck2usa: $GILD pre #ER Weekly 50sma tag and retrace sure was a nice R/R set up for a short : https://t.co/5y4EUJUGHNMy $gild play coming...$GILD pre #ER Weekly 50sma tag and retrace sure was a nice R/R set up for a short : https://t.co/5y4EUJUGHN$GILD chart: Possible H+S Top. https://t.co/QCwBCjDdBrRT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶Credit Suisse Weighs In On $GILD and $CELG Following Earnings https://t.co/zKWnFnugPp$gild(con't) don't look at charts, that is garbage analysis. So, this week will implementing strategy based on near term dead weight...So on $gild....Around $26B in cash, lgst component of $IBB, HepC plateau, $19B FCF, $12B buyback, HIV &amp; Liver Disease pipeline...$GILD there is the breakdown...Sold $GILD TOO EARLY DAMMIT https://t.co/3XR1MqaKz3Federal judge reopens high-stakes patent case between $MRK and $GILD https://t.co/MLlveHtteS$GILD under 86.90 should send itIf I had to guess- $GILD swoops in and buys $MDVN$GILD short maybe under 87...watching#Dow Barely Posts Monthly Gain As Indices Pare Losses $DIA Also $QQQ $GILD $SPY $IBB https://t.co/tIHisjua8nGilead Sciences Received its Third Buy in a Row $GILD https://t.co/UwfdvAoF9sSo did some thinking on $GILD this weekend.....H &amp; S TOP projects to 40 bucks  $GILD chart https://t.co/hkuYTbElRB via https://t.co/5BlRc0tTEg$GILD chart https://t.co/76eN5MUf6r via https://t.co/5BlRc0tTEgVolume Alert - GILD 87.88 Gilead Sciences Inc $GILD Hit a high today of 89.45 Closing the day 10:30 at 87.88 - https://t.co/KPJXRUIVrM@jimcramer Negative about $GILD? It has a PE like its selling cars! Gets punished for an ""overpriced"" wonderdrug! #actionalerts s/b BUYING!Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5@StockBookie Covered last half $GILD @ 87.06 this position is closes! Another WINNER!!RT @ideagenerator01: $GILD Can $GILD get the $MRK verdict overturned?

https://t.co/KoR0vW00tISold $gild this morning +%70 sold too early. Grabbed $FB calls currently + a hairRT @FiercePharma: 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier https://t.co/CxejkhmAIN $MRK $ABBV $GILD #pharm‚Ä¶RT @FiercePharma: 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier https://t.co/CxejkhmAIN $MRK $ABBV $GILD #pharm‚Ä¶Credit Suisse Weighs In $GILD and $CELG Following Earnings
https://t.co/Qjko8j78tGRT MarketCurrents: Merck making inroads in HCV market with aggressive pricing of Zepatier https://t.co/Tc4XjqTgjh $ABBV $GILD $MRK,www.bla‚Ä¶Merck making inroads in HCV market with aggressive pricing of Zepatier https://t.co/QmicQGVU7C $ABBV $GILD $MRKMerck making inroads in HCV market with aggressive pricing of Zepatier https://t.co/WUyrDTtnoj $ABBV $GILD $MRKMerck making inroads in HCV market with aggressive pricing of Zepatier https://t.co/SfCJAJjq4T $ABBV $GILD $MRKRT @FiercePharma: 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier https://t.co/CxejkhmAIN $MRK $ABBV $GILD #pharm‚Ä¶2 Attractive Possible Takeovers In Biotech https://t.co/pVGvtVRAQS $GILD $RLYP $IONSRT @outsizedreturn: #Commodity Mkt Update $spy $vxx $yinn $nky $oil $uso $amzn $msft $v $gild $aapl #hedgefunds https://t.co/nraWgiv32g htt‚Ä¶'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier https://t.co/CxejkhmAIN $MRK $ABBV $GILD #pharma #marketingRT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶May 2 Biotech Update $AGN $BMRN $CELG $GILD $INCY https://t.co/arl573vpRpRT @CarlyHFierce: 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier: https://t.co/yAzEg7GsJa $MRK $ABBV $GILD #phar‚Ä¶Biotech Forum Daily Digest: Gilead Post Earnings, ACADIA FDA Nod, Dynavax's Setback $GILD #biotechnlogy #stocks  https://t.co/OcjyQKwEk3How Fun Workplace Design Can Increase Productivity  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f $btu 5Happier Employees Make Companies Great  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 1RT @outsizedreturn: #Commodity Mkt Update $spy $vxx $yinn $nky $oil $uso $amzn $msft $v $gild $aapl #hedgefunds https://t.co/nraWgiv32g htt‚Ä¶RT @CarlyHFierce: 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier: https://t.co/yAzEg7GsJa $MRK $ABBV $GILD #phar‚Ä¶may buy back $GILD on this post-earnings dive.RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning... welcome to the working week.. Valeant was  a 'sewer' https://t.co/FD8q3mWvOJ #pha‚Ä¶üíØ $IBIO BULLISH $3PT üíØ $NUGT $EBIO $GILD $TLOG $JNUG $MU $MNST $GG $BIDU $IBB $IBKR $GASX $HYH $GASL $BRK.A $DUST $GRPN $TCK $ABIOGilead Sciences hits a 1 month low https://t.co/SFMrq46T3v $GILD #GileadSciences https://t.co/1HzaV4FrpwBuilding a Powerful Brand by Creating More Value  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f 5RT @outsizedreturn: #Commodity Mkt Update $spy $vxx $yinn $nky $oil $uso $amzn $msft $v $gild $aapl #hedgefunds https://t.co/nraWgiv32g htt‚Ä¶Gilead Sciences, Inc. $GILD Downgraded to Hold at Maxim Group https://t.co/6Wn5PNqLPYRT @outsizedreturn: #Commodity Mkt Update $spy $vxx $yinn $nky $oil $uso $amzn $msft $v $gild $aapl #hedgefunds https://t.co/nraWgiv32g htt‚Ä¶RT @CarlyHFierce: 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier: https://t.co/yAzEg7GsJa $MRK $ABBV $GILD #phar‚Ä¶RT @CarlyHFierce: 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier: https://t.co/yAzEg7GsJa $MRK $ABBV $GILD #phar‚Ä¶I am 8 years old in this pic, #Apple II C behind me $spy $vxx $aapl $gild $t $f $baba $nxpi https://t.co/DlyX2Fg2zj https://t.co/MuXNijpM3ORT @CarlyHFierce: 'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier: https://t.co/yAzEg7GsJa $MRK $ABBV $GILD #phar‚Ä¶'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier: https://t.co/yAzEg7GsJa $MRK $ABBV $GILD #pharma #marketingGILD Exchange
See Here ---&gt; https://t.co/wE2cC3Xvka

$GILD $GOOG $DHR #stocksPatent Case Against Gilead Reopened; Result Could Remove Share Overhang https://t.co/7MpaW0LvBn $ABBV $MRK $PFE $SNY $GILD#Commodity Mkt Update $spy $vxx $yinn $nky $oil $uso $amzn $msft $v $gild $aapl #hedgefunds https://t.co/nraWgiv32g https://t.co/TSmsaL2V3V.
94.57% Avg Gain
100% Unbiased
 .
https://t.co/mNVCwotQZt 
 .
 .
$CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO https://t.co/jMnEJeh5pa$GILD on #HBV  . mentions $GBIM vaccine .. but also that it opens up to what  may need in this broad indication https://t.co/zbrgdCoOuIRT @ShayneHeffernan: $AMZN, $F, $GILD, $LVLT, $WDC, $WLL Wall Street‚Äôs Top Analysts‚Äô Upgrades, Downgrades and Initiations =&gt; https://t.co/s‚Ä¶$GILD takes #NASH very seriously  4 compounds including recent buyout. it will verify results and do more BD if need https://t.co/uOxZOxsJQSMasterclass Watchlist 5/2:

Gold: $LNKD $NFLX $CELG $VRX $GILD $AAPL*

Silver: $FB* $WMT$AMZN, $F, $GILD, $LVLT, $WDC, $WLL Wall Street‚Äôs Top Analysts‚Äô Upgrades, Downgrades and Initiations =&gt; https://t.co/sxO8XvlHBaNew Post: Rotation https://t.co/kVwxs6f7kC $IBB $GILD $BAC $C $GS $AAPL $GOOGL $MSFT $USO $SLV $GLD $UWTI $DWTI $MUX $STUDY$GILD on oncology.. will revisit a bit later after dissecting abit https://t.co/g18Yi1yhsJRT SeekingAlpha: Gilead: The Buzz Is Gone, One Heck Of A Company Remains https://t.co/qZsCwtmDDl $GILDwho $GILD may purchase? .. lets reverse engineer Nimbus decision... and think forwards? .. https://t.co/smpyKXto1EGilead: The Buzz Is Gone, One Heck Of A Company Remains https://t.co/c7hH4tGHdC $GILDGilead: The Buzz Is Gone, One Heck Of A Company Remains https://t.co/xoJ6Uq1rUk $GILDRT @bret_jensen: $ACAD $GILD $IBB Two Week Free Trials to The Biotech Forum Expire Midnight Monday EST https://t.co/UKTOLZBpJg https://t.co‚Ä¶$GILD may go hostile? .. well it prefers not but it depends looks like. https://t.co/mtYiYJRUdf$GILD on #NASH .. 15mill patients and leading indication causing liver transplantation by 2020. https://t.co/9WJaZeYwzhStocks I'm playing today: $VRX, $AAPL, $GILD, $IONS, $KITE and $MSFT.RT @1ResilientSoul: #bankholidaymonday #ChillinTime üå§üëåüèºüòéüëçüèºUntil tomorrow..  $PTX $KEM $CYH $EGLE $APOL $PWE $PBMD $IAG $NUGT $ACAD $GILD ht‚Ä¶GILD Top news - May 2nd, 2016 $GILD https://t.co/j822kxxl1LMy #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT https://t.co/JN79C3epFAhttps://t.co/uAcamNRUPt alerted $PTX +45% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/OQCNEb9p9K $HOT $AMAT $ITUB $MT $GILD $HST $AAGilead Stock: Analyzing 5 Key Suppliers $GILD $GLPG https://t.co/vSWD1UziNl5/2 watch list:LONG:$SBUX  $NOV, $SYNA, $APOL, $ACAD, $GNC SHORT: $SNDK, $GILD, $ABT, $ALK, $KORS, $WDC, $TSO, $TGT, $STJ5/2 watch list:LONG:$SBUX  $NOV, $SYNA, $APOL, $ACAD, $GNC SHORT: $SNDK, $GILD, $ABT, $ALK, $KORS, $WDC, $TSO, $TGT, $STJPharmalot.. Pharmalittle.. Good Morning... welcome to the working week.. Valeant was  a 'sewer' https://t.co/FD8q3mWvOJ #pharma $VRX $GILD#bankholidaymonday #ChillinTime üå§üëåüèºüòéüëçüèºUntil tomorrow..  $PTX $KEM $CYH $EGLE $APOL $PWE $PBMD $IAG $NUGT $ACAD $GILD https://t.co/HUEkU6lgdf#GileadSciences receives positive CHMP opinion for Odefsey to treat HIV. Read more: https://t.co/rbXNQUM5WG $GILDWatching $GDX, $AG, $ACAD, $FCX, $GLBS, $C, $GILD. $PRGNKCM Investment Advisors LLC Raises Stake in Gilead Sciences, Inc. $GILD https://t.co/zdKLo10VR6Full Video Analysis, Charts &amp; Outlook on $STJ $FCX $GG $WLL $TWTR $GILD $AAPL $FSLR &amp; $SPX  https://t.co/lOmNfT6Th6 https://t.co/qR2scZm62DRT @Lin_ling_88: HCV hijacks the host's fat metabolism for its own survival, growth, and transport in the human body. $GILD $BMY $MRK https‚Ä¶RT @TickerTV: Gilead Sciences | $GILD #Stock | Down Hard In After Hours https://t.co/CoCvQKAdBT | #StockMarket $SPY $DIA $QQQ https://t.co/‚Ä¶RT @TickerTV: Gilead Sciences | $GILD #Stock | Down Hard In After Hours https://t.co/CoCvQKAdBT | #StockMarket $SPY $DIA $QQQ https://t.co/‚Ä¶RT @Smallinvestor81: $GBIM nice mention on $Gild article https://t.co/ABLdTQBhAF@mhrob here y go $GILD looks for more M&amp;A even hostile takeovers https://t.co/YJdoDW78f6 .. go for it :)$GILD$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/iX5cnKUVa1 https://t.co/Az9rl90KdrRT @portefeuillefun: Bought back those 100 $GILD at $88.77. @zzlangerhans #zzporteRT SeekingAlpha: Gilead: Mistakes Made By Bulls And Bears https://t.co/WkM5ulH1uO $RHHBY $GILDGilead: Mistakes Made By Bulls And Bears https://t.co/eoQW1USkWI $RHHBY $GILDGilead: Mistakes Made By Bulls And Bears https://t.co/Fhi47S2DRW $RHHBY $GILD$STJ $FCX $GG $WLL $TWTR $GILD $AAPL $FSLR $SPX  - In-Depth Video Technical Analysis on #Charts for these #tockers https://t.co/mUkEDjh2UcRT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶Changes to Top #Biotech Ratings. $CELG $GILD $BMRN $ALXN $AMGN
https://t.co/iveyMQSfOJBarron's 500: America's Top Companies $AAL $ABC $BIIB $GILD $GM $FB https://t.co/6uJK68c2wfRT @MMMnews: Missed the weekend's news? Here's what to know #pharma $GILD #HepC #cancerdrugs $VRX $AZN https://t.co/pwnCixxvMp https://t.co‚Ä¶Gilead Sciences | $GILD Stock | Down Hard In After Hours https://t.co/CoCvQKAdBT #gild #gileadGilead Sciences | $GILD Stock | Down Hard In After Hours https://t.co/o0v19yZnM8 #gild #gileadMissed the weekend's news? Here's what to know #pharma $GILD #HepC #cancerdrugs $VRX $AZN https://t.co/pwnCixxvMp https://t.co/oZfoolC15a$GBIM nice mention on $Gild article https://t.co/ABLdTQBhAF$GILD Can $GILD get the $MRK verdict overturned?

https://t.co/KoR0vW00tIRT @TickerTV: Gilead Sciences | $GILD #Stock | Down Hard In After Hours https://t.co/CoCvQKAdBT | #StockMarket $SPY $DIA $QQQ https://t.co/‚Ä¶Gilead Sciences | $GILD #Stock | Down Hard In After Hours https://t.co/CoCvQKAdBT | #StockMarket $SPY $DIA $QQQ https://t.co/GSEWDqke52RT @GeryDIVRY: $GILD $GNFT $ICPT $GLMD 
STAY INFORMED ON #NASH 
register to the #NASHBIOTECH Newsletter
https://t.co/A37Qi3wMce https://t.c‚Ä¶RT @mytradingbuddy: Full Video Analysis, Charts &amp; Outlook $STJ $FCX $GG $WLL $TWTR $GILD $AAPL $FSLR &amp; $SPX  https://t.co/RFG8E8oU3d https:‚Ä¶Full Video Analysis, Charts &amp; Outlook $STJ $FCX $GG $WLL $TWTR $GILD $AAPL $FSLR &amp; $SPX  https://t.co/RFG8E8oU3d https://t.co/QSsc2FCVOYERIC Day High
See Here ---&gt; https://t.co/lUN0tvZoOk

$ERIC $URRE $GILD #tradeideasRT @tgtxdough: Large Cap Biotech MAJOR pipeline catalyst EVENTS $BIIB $IBB $GILD $CELG https://t.co/hQKxTNAmnJBought back those 100 $GILD at $88.77. @zzlangerhans #zzporteGilead Sciences, Inc. has  fallen -9.06% today, Vetr users are indicating a target price of $105.06 for $GILD https://t.co/tQKhqWD6ZBRT @GeryDIVRY: $GILD $GNFT $ICPT $GLMD 
STAY INFORMED ON #NASH 
register to the #NASHBIOTECH Newsletter
https://t.co/A37Qi3wMce https://t.c‚Ä¶RT @GeryDIVRY: $GILD $GNFT $ICPT $GLMD 
STAY INFORMED ON #NASH 
register to the #NASHBIOTECH Newsletter
https://t.co/A37Qi3wMce https://t.c‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶10 Big-Name Stocks Raising The Bar With Higher Dividends $BBT $EXC $IBM $JNJ $MET $UTX $WFC $XOM $AAPL $GILD https://t.co/zs0M4fAke0RT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶Gilead Sciences (GILD:NASDAQ) loses 09.06% to $88.21 on Friday : Among top 10 losers on S&amp;P500 $GILD #StockMarket #nasdaq #biotechnlogyGilead Sciences (GILD:NASDAQ) loses 09.06% to $88.21 on Friday : Among top 10 losers on S&amp;P500 $GILD #StockMarket #nasdaq #biotechnlogy$GILD $GNFT $ICPT $GLMD 
STAY INFORMED ON #NASH 
register to the #NASHBIOTECH Newsletter
https://t.co/A37Qi3wMce https://t.co/CiZgWGYjUY$GILD ""I am going to double my position in GILD√É¬¢√¢¬Ç¬¨√Ç¬¶ new developments"" on Yahoo! Finance message boards: https://t.co/1Bwyikcl1CTOP US: 1 $GILD 114% 2 $LAZ 106% 3 $CYH 105% 4 $BX 104% 5 $ESNT 103% https://t.co/H4aYGMshY3$GILD: Analyst action by Citigroup on Gilead Sciences: https://t.co/fW7rFvsD2F https://t.co/1y1BBwVl5lHCV hijacks the host's fat metabolism for its own survival, growth, and transport in the human body. $GILD $BMY $MRK https://t.co/DJdFKA5I8T$GILD 88,21$ -9,1% #BBBiotech stark trotz schwachem Q1 des Top-5-Werts #Buy #Biotech /SC https://t.co/qIOFawB5Oy https://t.co/lRQj3VpKm5SELL #Gilead Sciences, Inc., $GILD. Target: 84.18 (-4.57%).
 https://t.co/5e7Mz2Lxi6  #trading #stocks #investing$GILD:US Gilead Sciences, Inc. (GILD) Rating Reiterated by BMO Capital Markets #GILEAD SCIENCES INC  https://t.co/UWOPLiJd48 #SP500RT @FierceBiotech: Galapagos bolsters case for Gilead-partnered Crohn‚Äôs drug with 20-week data: https://t.co/WxfR8sV7DT $GILDRT @adamfeuerstein: $GILD Q1 total revenue $7.8B miss consensus $8.0B although total product sales $7.7B beats consensus $7.6BRT @AndyBiotech: $GILD #HCV franchise Q1 sales $4,294M misses consensus of $4,607M

Mainly driven by weak Harvoni US sales: $1,407M vs $1,8‚Ä¶RT @AndyBiotech: $GILD #HCV QoQ decline driven by higher US rebates, wholesaler price cuts in Japan,etc

Pricing, pricing, pricing... https‚Ä¶RT @AndyBiotech: $GILD vs $MRK patent case plot thickens‚Ä¶

Judge Re-Opens Case Amid Claim MRK Scientist Lied
https://t.co/kO0BQnrpFa
https:‚Ä¶RT @tgtxdough: Large Cap Biotech MAJOR pipeline catalyst EVENTS $BIIB $IBB $GILD $CELG https://t.co/hQKxTNAmnJRT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶$GILD - SELL Signal at 88.166 on Apr 29, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investingGilead Sciences, Inc. $GILD Issues Quarterly  Earnings Results, Misses Expectations By $0.10 EPS https://t.co/JdrsygzgMhGilead Sciences, Inc. $GILD Issues Quarterly  Earnings Results, Misses Expectations By $0.10 EPS https://t.co/m0BZD7q7B3@mhrob not sure if $ARWR fits into $GILD paradigm .. I think $ARWR also may look for a FAR EAST buyer/patner. best a Chinese pharmaGilead Sciences upgraded by Vetr Inc. to strong-buy. $105.06 PT. https://t.co/Aq9WzBHyJX $GILD #GILDRT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶Patent Case Against Gilead Reopened; Result Could Remove Share Overhang $GILD https://t.co/4489uuxD42$GILD: The Deals Elephant Is in the Room - Disappointing results put potential acquisitions back into focus https://t.co/mmlZgDZAouRT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶Infographic report on Gilead Sciences $GILD https://t.co/WXl0APjZFv https://t.co/Vwlu5pJiuhRT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶Gilead Sciences upgraded by Vetr Inc. to strong-buy. $105.06 PT. https://t.co/Dj4zXzbDAb $GILD #GILDGilead Sciences's buy rating reiterated at RBC Capital. https://t.co/LiWbT3TVdj $GILD #GILDNew Post: Rotation https://t.co/kVwxs6f7kC $IBB $GILD $AAPL $GOOGL $MSFT $BAC $C $GS $USO $SLV $GLD $UWTI $DWTI $MUX $STUDY@mhrob I think their lack of initiative makes investors not get into #biotech .. if $GILD doesnt buy what should we? not sure whats going n$GILD will support hold or will it drop to the bottom?https://t.co/SqAf1kri94 https://t.co/yxng3iPTdt@mhrob the buyer usually goes down .. so $GILD def will go up eventually . cheap and all but needs to consolidate and build pipeline via M&amp;A@mhrob look up on $GILD 30week SMA .. going down. it may require some time to accumulate here. also dont forget! its forced to buy pipeline!@techwhitepapers the names are $AMGN $BMY $OPK $EBS $NKTR $LGND $MRK $JAZZ ........ $celg and $gild are missing in action.RT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX https://t.co/JN79C3epFART @MarketsRecap: 10 Big-Name Stocks Raising The Bar With Higher Dividends $BBT $EXC $IBM $JNJ $MET $UTX $WFC $XOM $AAPL $GILD https://t.co‚Ä¶Gilead Sciences Reiterated Rating by RBC Capital Mkts (Ranked 57th) to Buy $GILD #GILD https://t.co/nyq7xJnbR7$GILD HCV pricing likely stabilized; VA funding resolved; pan-geno candidate 6/2016 PDUFA; China has proj 11m HCV, launch might be '17 v '19Gilead Sciences's buy rating reiterated at RBC Capital. https://t.co/nZuFWEpau0 $GILD #GILDCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @TwoFourInsight: Indian Generic Manufacturer Cipla Targeting US #HIV Market - Plans to launch generic version of $GILD Atripla #India ht‚Ä¶10 Big-Name Stocks Raising The Bar With Higher Dividends $BBT $EXC $IBM $JNJ $MET $UTX $WFC $XOM $AAPL $GILD https://t.co/1CBfHfOYpU$GILD bottoms can be $85 $87 Asia markets tumble, with Nikkei dropping nearly 4%, ASX off 1.2% https://t.co/NXUlvttFT4RT @bradloncar: $GILD is the largest component of the $IBB. 8.47% weighting.$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/iX5cnKUVa1 https://t.co/e2NG2sP9u1@OptionsAction @Michael_Khouw @Trading_Analyst $CELG has a false breakout also https://t.co/hQQq8rYXYz    $GILD@OptionsAction @Michael_Khouw due to a FALSE breakout like for $GILD and $CELG@Trading_Analyst $CELG has a false breakout also https://t.co/hQQq8rYXYz   $GILD@tgtxdough $GILD https://t.co/9iLbHnr8g4$CELG false breakout  https://t.co/hQQq8rYXYz  $GILDGilead Sciences, Inc. $GILD Given ‚ÄúMarket Perform‚Äù Rating at BMO Capital Markets https://t.co/GVvnnBLJ2PGilead Sciences, Inc. $GILD Receives ‚ÄúOutperform‚Äù Rating from Robert W. Baird https://t.co/RjGKkPLm49Gilead Sciences, Inc. $GILD Receives ‚ÄúOutperform‚Äù Rating from Robert W. Baird https://t.co/9hqp5LxZd9@megtirrell @MarkSchoenebaum Go hostile is not in $GILD cultureRT @Drchik23: $gild analyst ratings over the weekend: https://t.co/9Eq5eTTNZE$GILD $STX $SPLS options have the largest change in price. Free options screener. https://t.co/YRdUp0plr2$GILD - Leerink Swann Reiterates Outperform Rating for Gilead Sciences, Inc. #GILD https://t.co/qxQOqMzzLM$GILD - Gilead Sciences' #GILD ""Outperform"" Rating Reiterated at Robert W. Baird https://t.co/5SUp0PKHGr$GILD back to 85 - 87 supports https://t.co/VXxOJvFr5eRT @pbrat40plus: Full Video Outlook for #Financial #Markets Inc $GILD on the #mtbanalysis Magazine &gt; https://t.co/oajSmtH1Jb #Stocks https:‚Ä¶$GILD - Leerink Swann Reiterates Outperform Rating for Gilead Sciences, Inc. #GILD https://t.co/KNrnlq6NXw$GILD - Gilead Sciences' #GILD ""Outperform"" Rating Reiterated at Robert W. Baird https://t.co/2OKIK9uCBUGilead Sciences's market perform rating reiterated at BMO Capital Markets. $97.00 PT. https://t.co/fBx22sIJwY $GILD #GILDGilead Sciences's outperform rating reiterated at Robert W. Baird. $135.00 PT. https://t.co/xwoESsqih9 $GILD #GILDRobert W. Baird Reaffirms Outperform Rating for Gilead Sciences, Inc. $GILD https://t.co/T6aUuA4kv5@DayTraderBio $GILD $87 is a strong support,  so we ca see a bottom this week under $88 close to 87-85 https://t.co/FXfOHIYJbjBMO Capital Markets Reaffirms Market Perform Rating for Gilead Sciences, Inc. $GILD https://t.co/PsOTOpCfs6$GILD $87 is a strong support,  so we ca see a bottom this week under $88 close to 87-85 https://t.co/FXfOHIYJbjFull Video Outlook for #Financial #Markets Inc $GILD on the #mtbanalysis Magazine &gt; https://t.co/oajSmtH1Jb #Stocks https://t.co/VVeNL2h6XzFull Video Outlook for #Financial #Markets Inc $GILD on the #mtbanalysis Magazine &gt; https://t.co/HFZXNybpIF #Stocks https://t.co/OALMFwXJPAFull Video Outlook for #Financial #Markets Inc $GILD on the #mtbanalysis Magazine &gt; https://t.co/ORznQuRxFB #Stocks https://t.co/wMiFBGpTvsFull Video Outlook for #Financial #Markets Inc $GILD on the #mtbanalysis Magazine &gt; https://t.co/lHVUb3eBNv #Stocks https://t.co/iazZpFkUEWFull Video Outlook for #Financial #Markets Inc $GILD on the #mtbanalysis Magazine &gt; https://t.co/S75b6pK6oV #Stocks https://t.co/varZjGhr9WGilead Sciences, Inc. $GILD Rating Reiterated by BMO Capital Markets https://t.co/p6SMbhytffRobert W. Baird Reiterates ‚ÄúOutperform‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/aS9vnvmMNEGilead Sciences, Inc. $GILD Given ‚ÄúMarket Perform‚Äù Rating at BMO Capital Markets https://t.co/Gy2BWsBbIV$GILD $85 is the channel support, watch tomorrow  https://t.co/i8k9Ah54gGRT @surinotes: $GILD (Weekly) Head and Shoulders pattern https://t.co/jyCPOoJJCK$gild analyst ratings over the weekend: https://t.co/9Eq5eTTNZEGilead Sciences, Inc. $GILD Given ‚ÄúMarket Perform‚Äù Rating at BMO Capital Markets https://t.co/BfdzqMZrIeGilead Sciences, Inc. $GILD Receives ‚ÄúOutperform‚Äù Rating from Robert W. Baird https://t.co/cexLYGqEi6Gilead Sciences, Inc. $GILD Receives ‚ÄúOutperform‚Äù Rating from Robert W. Baird https://t.co/uUH78ufshL$GILD (Weekly) Head and Shoulders pattern https://t.co/jyCPOoJJCKGilead Sciences, Inc. $GILD Earns ‚ÄúOutperform‚Äù Rating from Leerink Swann https://t.co/7r6UgdwF4EGilead Sciences's market perform rating reiterated at BMO Capital Markets. $97.00 PT. https://t.co/y12FYZsbEO $GILD #GILDGilead Sciences's outperform rating reiterated at Robert W. Baird. $135.00 PT. https://t.co/zHxJEsu4of $GILD #GILDGilead Sciences Reiterated Rating by BMO Capital Markets (Ranked 12th) to Market Perform with 97 PT $GILD #GILD https://t.co/nyq7xJnbR7Gilead Sciences Reiterated Rating by Robert W. Baird (Ranked 17th) to Outperform with 135 PT $GILD #GILD https://t.co/nyq7xJnbR7Gilead Sciences‚Äô $GILD ‚ÄúOutperform‚Äù Rating Reiterated at Robert W. Baird https://t.co/rlpsm4hofKLeerink Swann Reiterates Outperform Rating for Gilead Sciences, Inc. $GILD https://t.co/v8OfLdOfNW$GILD - Gilead Sciences' #GILD ""Outperform"" Rating Reiterated at Leerink Swann https://t.co/uS8dIUBEKDLeerink Swann Reiterates Outperform Rating for Gilead Sciences, Inc. $GILD https://t.co/hKS7qeDLDtGilead Sciences, Inc. $GILD Given Outperform Rating at Leerink Swann https://t.co/4IfVOGHzc4Gilead Sciences, Inc. $GILD Given Outperform Rating at Leerink Swann https://t.co/xx33I7rZACGilead Sciences's outperform rating reiterated at Leerink Swann. $123.00 PT. https://t.co/810vVUtcAG $GILD #GILDRunaway Gap Down https://t.co/a6GjKOzrRW $ALR $CPHD $DGLD $DUST $ESI $GDXS $GILD $GRPN $IMGN $JDST $MERC $MOBL $MOH $NWHM $RM $SYNA $TBBKGilead Sciences's outperform rating reiterated at Leerink Swann. $123.00 PT. https://t.co/A9cBHB2ioP $GILD #GILDGilead Sciences Reiterated Rating by Leerink Swann (Ranked 66th) to Outperform with 123 PT $GILD #GILD https://t.co/nyq7xJnbR7The trade in $GILD on Friday returned a whopping 488%! Here is the trade outline and some ideas for Monday trades https://t.co/OuGdMyXWaTRT @tgtxdough: Large Cap Biotech MAJOR pipeline catalyst EVENTS $BIIB $IBB $GILD $CELG https://t.co/hQKxTNAmnJRT @tgtxdough: Large Cap Biotech MAJOR pipeline catalyst EVENTS $BIIB $IBB $GILD $CELG https://t.co/hQKxTNAmnJRT @fantasystocktra: Gilead Sciences | $GILD #Stock | Down Hard In After Hours https://t.co/YLDibnU3oD | #StockMarket $SPY $DIA $QQQ https:‚Ä¶RT @tgtxdough: Large Cap Biotech MAJOR pipeline catalyst EVENTS $BIIB $IBB $GILD $CELG https://t.co/hQKxTNAmnJGilead Sciences | $GILD #Stock | Down Hard In After Hours https://t.co/YLDibnU3oD | #StockMarket $SPY $DIA $QQQ https://t.co/mgvHnMiXpS",2016-05-02,GILD,0
21,"@MrktTourist @EddyElfenbein same question for $GILD or $ICE suspect you like all three?Heard on Motley Fool: Gilead ( $GILD ) is the Apple of ( $AAPL ) of biotech$GILD looking very vulnerable on a critical S https://t.co/rACdk6I7xe@Sharma1981N @exMBB 10-13% seems to be the norm. It's only much lower for co's like $gild $biib etc. That rate isn't high. It's on point.#GileadSciences Can Gilead Shares Still Really Rise to $150?. Read more: https://t.co/29cJV4AkTf $GILDRT @mytradingbuddy: Full Video Outlook for #Financial #Markets Inc $GILD on our #mtbanalysis Magazine &gt; https://t.co/KNUPP8dEHG #Stocks htt‚Ä¶180 Bearish https://t.co/SC9qfUHqQ1 $AKAM $TEX $ADI $GILD $MSFT $BBVA $ZIOP $CLDX $IBB $IRWD $JUNO $CAA $NFLX $TEF $ANF $INCY $BLUE7 Undervalued Stocks To Buy And 3 To Sell $MSFT $NFLX $ABBV $GILD $LGIH $ABBV $AMGN #options #trading            --&gt;https://t.co/qZl6CVQkWpCloud resistance for $GILD is extremely strong, you can still wait to buy this week...I do not expect it rising past $88 this weekUpdated $GILD chart-if this support holds at 87-86s, time to buy [I posted about this right after earnings came out] https://t.co/lCm32TX2x8RT @Benzinga: The Next Sector Rotation Will Be To Biotechs $BIIB $GILD $PFE  https://t.co/40jJM0mOZtRT @mytradingbuddy: Full Video Outlook for #Financial #Markets Inc $GILD on our #mtbanalysis Magazine &gt; https://t.co/KNUPP8dEHG #Stocks htt‚Ä¶RT @mytradingbuddy: Full Video Outlook for #Financial #Markets Inc $GILD on our #mtbanalysis Magazine &gt; https://t.co/KNUPP8dEHG #Stocks htt‚Ä¶RT @mytradingbuddy: Full Video Outlook for #Financial #Markets Inc $GILD on our #mtbanalysis Magazine &gt; https://t.co/KNUPP8dEHG #Stocks htt‚Ä¶RT @mytradingbuddy: Full Video Outlook for #Financial #Markets Inc $GILD on our #mtbanalysis Magazine &gt; https://t.co/KNUPP8dEHG #Stocks htt‚Ä¶RT @mytradingbuddy: Full Video Outlook for #Financial #Markets Inc $GILD on our #mtbanalysis Magazine &gt; https://t.co/KNUPP8dEHG #Stocks htt‚Ä¶RT @R4inb0w_: Therapy focus ‚Äì #NASH projects set for data in dog days of summer #GENFIT #Elafibranor $GNFT $ICPT $GLMD $TBRA $GILD https://‚Ä¶Full Video Outlook for #Financial #Markets Inc $GILD on our #mtbanalysis Magazine &gt; https://t.co/KNUPP8dEHG #Stocks https://t.co/6v7P0DCq3yGilead Sciences, Inc. $GILD Rating Lowered to Hold at Maxim Group https://t.co/WM30jgZM98Gilead Sciences, Inc. $GILD Rating Lowered to Hold at Maxim Group https://t.co/H3wToHcmkT$GILD - Gilead Sciences, Inc. #GILD Earns Outperform Rating from Credit Suisse https://t.co/PLreGPFDQ6Top ten pharma/drug companies by market cap are $JNJ $RHHBY $PFE $NVS $MRK $NVO $GILD $BMY $AMGN $SNYRT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9RT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9$GILD - Gilead Sciences, Inc. #GILD Earns Outperform Rating from Credit Suisse https://t.co/46oDH9kXw8RT @R4inb0w_: Therapy focus ‚Äì #NASH projects set for data in dog days of summer #GENFIT #Elafibranor $GNFT $ICPT $GLMD $TBRA $GILD https://‚Ä¶Gilead Sciences, Inc. $GILD Earns Outperform Rating from Credit Suisse https://t.co/fMheV4sRq4RT @R4inb0w_: Therapy focus ‚Äì #NASH projects set for data in dog days of summer #GENFIT #Elafibranor $GNFT $ICPT $GLMD $TBRA $GILD https://‚Ä¶Gilead Sciences, Inc. $GILD Earns Outperform Rating from Credit Suisse https://t.co/6mlvjAHNb6$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $NASDAQ Have a good night https://t.co/TepPehUJV2$GILD RISK OFF DAY..random... $GILD and $SBUX finishing right near the lows and $TWTR flirting with closing above $14RT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9Also go under $87 a sec $GILDYo $GILD - go chat with $CLX about how to do acquisitionsAdded more Gilead $GILD (12 shares, $20 dividend income) https://t.co/8tL3Da4ZJP   #dividend#GileadSciences Is Cannibalizing Its Own Sales, and Management Loves It. Read more: https://t.co/gED1dwuJku $GILDShort $ILMN and $GILDJust dipped my toe into $GILD .. Couldn't resist.Long $GILD $87.67!This Is Why Gilead Remains a Top Dividend Stock: https://t.co/mhVYVCHa4j $GILD #Dividend https://t.co/VHdDgMM4Pm@bradloncar &amp; $GILD $CELG The new 'big pharma'. Been given a rough ride in the 1Q call seasonRT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9RT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9RT @FiercePharma: New contention a Merck scientist lied sends Gilead hep C patent fight back to court https://t.co/GL9DmxnmcV $MRK $GILD #p‚Ä¶More information about $GILD on https://t.co/GWqTGGCmUlRT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9$GILD back over $88RT @AndyBiotech: $ICPT @adar170 @anachtomi Nope, $GILD has a safer and cleaner FXR agonist that could move into Ph3 soon in NASH
https://t.‚Ä¶Can $gild Really Rise to $150?
https://t.co/NjvQQ6wDPyRT @afortunetraders: All out of $gild $95 puts for $7.20 .. Amazing trade from $0.69 ..I think we can go higher from this point if doesn't‚Ä¶@AndyBiotech @anachtomi so far Simtuzumab ha sbeen disapointing in other indications why is $GILD so confident in 9674?Pretty similar to a trade we place a few months back on $GILD https://t.co/vpu3gEC813RT SeekingAlpha: Therapy Focus - NASH Projects Set For Data In Dog Days Of Summer https://t.co/ug1zx30uYw $GNFTF $TBRA $IMROY $GILDRT SeekingAlpha: A Prescription For High Risk Fever https://t.co/Or0kC3P7Qk $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX ‚Ä¶A Prescription For High Risk Fever https://t.co/gPQCtFDPvM $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCIall out og $gild puts from 0.69$ to $7.2 on $95 puts .. played for earnings... 10x returnAll out of $gild $95 puts for $7.20 .. Amazing trade from $0.69 ..I think we can go higher from this point if doesn't break low of yesterdayHappier Employees Make Companies Great  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 2How Fun Workplace Design Can Increase Productivity  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f $btu 2A Prescription For High Risk Fever https://t.co/kkuKlhUXHZ $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCIA Prescription For High Risk Fever https://t.co/BDMZC40kWf $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCIA Prescription For High Risk Fever https://t.co/2b97FFOfWx $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCIRT @AndyBiotech: $ICPT @adar170 @anachtomi Nope, $GILD has a safer and cleaner FXR agonist that could move into Ph3 soon in NASH
https://t.‚Ä¶Connor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/DgrNThhkJM  $DIS $ALXN $NOAH $GILD $QUNR$ICPT @adar170 @anachtomi Nope, $GILD has a safer and cleaner FXR agonist that could move into Ph3 soon in NASH
https://t.co/DAfFrrxDm8Building a Powerful Brand by Creating More Value  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f 2What really matters to me is $GERN. Hope to see aome good news by end of 2016.

I can hold $GERN-$JNJ &amp; $GILD for many years. 
I'm dreaming.2011-2012 $VRUS
2012-2015 $GILD
Till then, it was fantastic.

2016 $PTCT $SRPT
Brutal failure. Still long some to confirm my bet though.RT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9RT @R4inb0w_: Therapy focus ‚Äì #NASH projects set for data in dog days of summer #GENFIT #Elafibranor $GNFT $ICPT $GLMD $TBRA $GILD https://‚Ä¶@WSJ Gilead Sciences has a strong case here, I'm pretty confident this will go $GILD's way.$GILD: Analyst action by Citigroup on Gilead Sciences: https://t.co/fW7rFvsD2F https://t.co/N9cvloYpDORT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶@anachtomi @AndyBiotech maybe $GILD wanted all pending lawsuits settled before buying :) JKMorgan Stanley Reiterates Hold Rating for Gilead Sciences, Inc. $GILD https://t.co/SAnKNtrz68RT @CountryCaller: $GILD #GileadSciences defended at Argus following weak Q1 - https://t.co/ctx89cscKbRT @Benzinga: The Next Sector Rotation Will Be To Biotechs $BIIB $GILD $PFE  https://t.co/40jJM0mOZt$GILD bouncing nicely off the $87 low today which is a higher low than yesterday which was $86.75 ishbto $GILD Aug 105cRT @Benzinga: The Next Sector Rotation Will Be To Biotechs $BIIB $GILD $PFE  https://t.co/40jJM0mOZtThe Next Sector Rotation Will Be To #Biotechs $BIIB $GILD $PFE  https://t.co/SI1Q2vtvzw via @benzingaRT @Benzinga: The Next Sector Rotation Will Be To Biotechs $BIIB $GILD $PFE  https://t.co/40jJM0mOZtThe Next Sector Rotation Will Be To Biotechs $BIIB $GILD $PFE  https://t.co/40jJM0mOZtCredit Suisse: Sanofi‚Äôs Bid ‚ÄòSignificantly Undervaluing‚Äô Medivation Pipeline,  https://t.co/YXYBBqhauX @barronsonline $MDVN $SNY $AZN $GILD$GILD #GileadSciences defended at Argus following weak Q1 - https://t.co/ctx89cscKbDon't Sell Gilead - Sell Options And Buy The Stock Instead: https://t.co/rzvKYBgaww $GILD https://t.co/CWoZgUEyGqTherapy focus ‚Äì #NASH projects set for data in dog days of summer #GENFIT #Elafibranor $GNFT $ICPT $GLMD $TBRA $GILD https://t.co/rkuRlXO8tuLangfristiges Signal! $GILD: Ein Trendkanal wurde bei 95.381 USD nach unten durchbrochen:  https://t.co/OQGmhwWsfoRT @lifeinbach: BACK TO THE $GILD
One of my favorite companiesRT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9Wish I sold $GILD yesterday before it gapped down today. Oh wellNASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9How Fun Workplace Design Can Increase Productivity  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f $btu 2Happier Employees Make Companies Great  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 2RT @BioStockAddict: Gilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move $GILD $GLPG https://t.co/nZGG95NZ0NBuilding a Powerful Brand by Creating More Value  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f 1BACK TO THE $GILD
One of my favorite companies$GILD $STX $SPLS options have the largest change in price. Free options screener. https://t.co/YRdUp0plr2Top Decliners (&gt;$30)
$DCCPY $SRCL $MOH $SRCLP $MGA $USCXW $SYNA $WDC $USCRW $ALR $CSH $HRC $GILD $LPNT $MANTVolume Alert - GILD 87.55 Gilead Sciences Inc $GILD Hit a high today of 89.12 Closing the day 10:30 at 87.55 - https://t.co/hQFu8amE4ZHey at least I bought $GILD at the right spot this morning. lol$GILD Judge Allows More Evidence in Patent Dispute After Gilea‚Ä¶ https://t.co/poe0rN6knH$GILD Judge Allows More Evidence in Patent Dispute After Gilea‚Ä¶ https://t.co/24mou1AJFo$GILD Judge Allows More Evidence in Gilead-Merck Patent Disput‚Ä¶ https://t.co/R6VK3wYm9f$GILD Judge Allows More Evidence in Patent Dispute After Gilea‚Ä¶ https://t.co/bWMDlqCtupRT @Biotech2050: @mikegoodma @tgtxdough might not be a priority for $TGTX but in the hands of @GileadSciences $GILD this could be a corners‚Ä¶RT @Suttmeier: How To Trade Biotechs $BIIB $AMGN $CELG $GILD $REGN
https://t.co/Bzi86aKo1eHow To Trade Biotechs $BIIB $AMGN $CELG $GILD $REGN
https://t.co/Bzi86aKo1eRT @amandamicklus: $MRK/ $GILD Sovaldi patent infringement reopened; judge considering ""unclean hands"" argument, @scripnews https://t.co/Wz‚Ä¶How To Trade Biotechs $BIIB $AMGN $CELG $GILD $REGN https://t.co/NGcsEvsqTg$GILD if it  breaks  86.64 goes lower.......$GILD is looking great for long. Also $JD is a nightmare.$GILD Testing yesterday consolidation levels.@stocktrader300 think $GILD is a good buy here?What Are Analysts Saying About Q1 At Big Biotech? Price increases are v impt. https://t.co/mBoLPgxboU $AMGN $BIIB $GILD $CELG via @ldtimme‚Ä¶Adding back some long $GILDHow Fun Workplace Design Can Increase Productivity  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f $btu 1Happier Employees Make Companies Great  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 2Gilead Sciences, Inc. Remains Strong $GILD https://t.co/1jDb1pFCqcBuilding a Powerful Brand by Creating More Value  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f 1Out $gild calls at $1.45 from .92 entryMrPrud's [#Watchlist] Que's | $GILD https://t.co/A1GXHdPZIg https://t.co/2t8nLWW2SzRT @Nvestly: RT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT‚Ä¶ #investRT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶$GILD greenRT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶GILD Top news - May 3rd, 2016 $GILD https://t.co/bH6E91AOSmMasterclass Watchlist 5/3

Gold: $NFLX $VRX $CELG $FB $GILD*

Silver: $BABA*  $XOM

Bronze: $JPM*$MRK/ $GILD Sovaldi patent infringement reopened; judge considering ""unclean hands"" argument, @scripnews https://t.co/WzfbNrFKsBCapital World Investors Sells 110,000 Shares of Gilead Sciences, Inc. $GILD https://t.co/dlGPEEiZqcRT @JeaYu21: $CVS $UA $AIG $GILD chart https://t.co/21gPjUcIOYRT @JeaYu21: $CVS $UA $AIG $GILD chart https://t.co/21gPjUcIOY$CVS $UA $AIG $GILD chart https://t.co/21gPjUcIOY$GILD: Analyst action by Credit Suisse on Gilead Sciences: https://t.co/iX5cnKUVa1 https://t.co/VyoaK680fqIf The S&amp;P 500 Index Were A Stock, Would You Buy It Now? https://t.co/OeY9VSAdHC $AAPL $AMZN $BRK.A $BRK.B $CB $DIS $FB $GE $GILD $GOOG@mikegoodma @tgtxdough might not be a priority for $TGTX but in the hands of @GileadSciences $GILD this could be a cornerstone productNo one wanted $BIIB 's hem biz. Same token, no one wanted BIIB WITH its hem biz. Just underperforming $CELG and $GILD YTD, since earnings$STJ $FCX $GG $WLL $TWTR $GILD $AAPL $FSLR $SPX - Technical Analysis Video on all these - link below https://t.co/mG9ZWBIE5D$GILD is case study in classic reinvestment risk - HCV ultimately is a cliff in the US - cresting the cliff now https://t.co/gAuko3PSyBFull Video Analysis, Charts &amp; Outlook on $STJ $FCX $GG $WLL $TWTR $GILD $AAPL $FSLR &amp; $SPX  https://t.co/RFG8E87jbF https://t.co/69pprR8QmZRT SeekingAlpha: Gilead Sciences Q1 Key Insights https://t.co/DnMKjqtRq6 $GILDGilead Sciences Q1 Key Insights https://t.co/9TTvIHvHbk $GILDGilead Sciences Q1 Key Insights https://t.co/2Q3DeWGvFf $GILDHigh Put Activity https://t.co/DuWgxTjccx ‚Ä¶    $ACAD $BY $BHI $BIDU $JNJ $WF $F $ABX $CLF $WT $DDD $FXI $GILD $IBB $NE $GDX $CRHammer-Candlestick nach Abverkauf bei #GileadSciences $GILD(89,00$/+0,9%)Klares Kaufsignal! #GD200 #Buy /SL https://t.co/mrqyv5GTJ2ICYMI: Gilead Makes Headway With Merck 'Unclean Hands' Argument
https://t.co/F8ubUwVy5a
$GILD $MRK #pharma #biotech #HCVRT @PorschePicks: https://t.co/p7tVeIZFvX Millionaire Road Map Trading top students win a Porsche for a yr! $LNKD $CVX $GILD $STX $PDid you Check out the Video Analysis, Charts &amp; Outlook on $STJ $FCX $GG $WLL $TWTR $GILD $AAPL $FSLR &amp; $SPX https://t.co/PofmaXYYjZFed Judge Reopens Gilead $GILD Case Amid Allegations Former Merck &amp; Co. $MRK Scientist Lied https://t.co/cU5kBmteaB https://t.co/Ybb3rLNWdBCommented on Gilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move https://t.co/8kAWUZbk0R $GLPG $MDVN $GILDCommented on 2 Attractive Possible Takeovers In Biotech https://t.co/HaY3ySFLyi $GILD $RLYP $IONSGOOG Ask
See Here ---&gt; https://t.co/hyeeelorCn

$GOOG $ENTA $GILD #investingRT @ScripDonnaDC: Gilead Makes Headway With Merck 'Unclean Hands' Argument
https://t.co/F8ubUwVy5a 
$GILD $MRK #pharma #biotech #SovaldiCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @BioStockAddict: Bryan Garnier on $GLPG analyst pres late Friday: $GILD milestone payments way earlier then prev. expected. (&gt; $1.3B) ht‚Ä¶Gilead Sciences, Inc. $GILD Receives ‚ÄúA+‚Äù Credit Rating https://t.co/6RATbNuC2ghttps://t.co/p7tVeIZFvX Millionaire Road Map Trading top students win a Porsche for a yr! $LNKD $CVX $GILD $STX $P$GILD - Gilead Seeks to Tame Merck Case -- WSJ https://t.co/QJZnFX8vlwDividend Growers From The Past Week - https://t.co/QhE8xSCB6x - $AAPL $BBT $CMA $IBM $OAK $SUN $WFC $UTX $GILD $JLL $MET $PFG $CFR $EXCGILD Chart
See Here ---&gt; https://t.co/OsPdO50xsD

$GILD $LMT $ATHN #nasdaqSELL #Gilead Sciences, Inc., $GILD. Target: 82.85 (-6.91%).
 https://t.co/5e7Mz2Lxi6  #trading #stocks #investingOur DCF has $GILD available at a 11% discount - why the sale??: https://t.co/fC4BVy9eg9 https://t.co/gxWeVD7PgnFull Video Outlook for #Financial #Markets Inc $GILD on the #mtbanalysis Magazine &gt; https://t.co/3Q1JBCHFLM #Stocks https://t.co/E65y3qzDhMFull Video Outlook for #Financial #Markets Inc $GILD on the #mtbanalysis Magazine &gt; https://t.co/CS6qmInrny #Stocks https://t.co/prVGcYpAOHFull Video Outlook for #Financial #Markets Inc $GILD on the #mtbanalysis Magazine &gt; https://t.co/BfOFf6qmZS #Stocks https://t.co/rdjTpKd2DWFull Video Outlook for #Financial #Markets Inc $GILD on the #mtbanalysis Magazine &gt; https://t.co/mdHOtGvLso #Stocks https://t.co/0sgiaVkSNGFull Video Outlook for #Financial #Markets Inc $GILD on the #mtbanalysis Magazine &gt; https://t.co/HUmkMfBtVL #Stocks https://t.co/Xn4EzLQQKF@ScottTexJohnson let's not blame $VRX disaster on biotech sell-off; $GILD $CELG $AMGNs O/P $IBB handsomely; $VRX was a hedge fund 'mistake'$GILD $VRTX $CELG $BIIB $AMGN $BMRN
https://t.co/tyTvmEO4b2
RBC #biotech video
$IBB $XBI$GILD : osaripettymys on pureskeltu, nyt oikeudenk√§yntirintamalta hyvi√§ uutisia: https://t.co/0mrD0dK9ktRT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶TERP Ideas
See Here ---&gt; https://t.co/zmGlrDHwlS

$TERP $GILD $MAR #shareRT @ScripDonnaDC: Gilead Makes Headway With Merck 'Unclean Hands' Argument
https://t.co/F8ubUwVy5a 
$GILD $MRK #pharma #biotech #SovaldiRT @TalkMarkets: #Dow Barely Posts Monthly Gain As Indices Pare Losses $DIA Also $QQQ $GILD $SPY $IBB https://t.co/tIHisjua8n#Dow Barely Posts Monthly Gain As Indices Pare Losses $DIA Also $QQQ $GILD $SPY $IBB https://t.co/tIHisjua8nRT @ScripDonnaDC: Gilead Makes Headway With Merck 'Unclean Hands' Argument
https://t.co/F8ubUwVy5a 
$GILD $MRK #pharma #biotech #SovaldiRT @dsobek: $GILD declining to flat sales.  No growth in near term from pipeline. Lots of cash. Sector a lot cheaper. What were they waitin‚Ä¶RT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶$GILD is at $89.00, below its Chandelier Exit of $94.99 https://t.co/mzYDAAfZsT #GILDCommented on Gilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move https://t.co/JbluyN1Kpp $GLPG $MDVN $GILDGilead Makes Headway With Merck 'Unclean Hands' Argument
https://t.co/F8ubUwVy5a 
$GILD $MRK #pharma #biotech #SovaldiRT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶RT @GeryDIVRY: $GILD $GNFT $ICPT $GLMD 
STAY INFORMED ON #NASH 
register to the #NASHBIOTECH Newsletter
https://t.co/A37Qi3wMce https://t.c‚Ä¶RT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶$GILD $STX $SPLS options have the largest change in price. Free options screener. https://t.co/YRdUp0plr2High Put Activity https://t.co/DuWgxTjccx    $ACAD $BY $BHI $BIDU $JNJ $WF $F $ABX $CLF $WT $DDD $FXI $GILD $IBB $NE $GDX $CRGeneral American Investors Co. Inc. Continues to Hold Stake in Gilead Sciences, Inc. $GILD https://t.co/eobXDsMh7eEdge Asset Management Inc. Acquires 372 Shares of Gilead Sciences, Inc. $GILD https://t.co/VisD0clGN7Gilead Sciences, Inc. $GILD Shares Bought by Howland Capital Management LLC https://t.co/Ms6JTa9UxwRT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶Gilead Sciences, Inc. $GILD Shares Bought by Howland Capital Management LLC https://t.co/5WJcyepT1eRT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶RT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶RT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶RT @Loftus: Judge allows more evidence in HepC patent dispute after Gilead says ex-Merck attorney lied: https://t.co/ANVkgNS1PR via @WSJ $M‚Ä¶CE Stock Forum
See Here ---&gt; https://t.co/KtLjMSq71C

$CE $GILD $BRG #stocksGilead Sciences, Inc. $GILD Stake Maintained by Plancorp LLC https://t.co/oT0ed62pGoThe #biotech giant $GILD sunk 9% after shortcoming earnings estimate on 4/28/16, first in 8 quarters. 

https://t.co/mhxlkzo59o

Rebound?High Put Activity https://t.co/DuWgxTjccx   $ACAD $BY $BHI $BIDU $JNJ $WF $F $ABX $CLF $WT $DDD $FXI $GILD $IBB $NE $GDX $CR$GLPG +11% $50-holla $GILDRT @RKLouie1: Judge allows more evidence in a drug-patent dispute after Gilead says a former Merck patent attorney lied
https://t.co/GUesgi‚Ä¶Judge allows more evidence in a drug-patent dispute after Gilead says a former Merck patent attorney lied
https://t.co/GUesgiF5CH $GILD $MRKToday`s #unusualprofits #options: $ABX $DPM $ETE $FCX $GILD $SLV $SSRI $STX via https://t.co/MBahY6U0fH https://t.co/sBl4YE90R6High Put Activity https://t.co/DuWgxTjccx  $ACAD $BY $BHI $BIDU $JNJ $WF $F $ABX $CLF $WT $DDD $FXI $GILD $IBB $NE $GDX $CRMAY 02 Monday, $GILD closed $89.00",2016-05-03,GILD,0
22,"$GILD https://t.co/yNtI0xugjT$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ Mix Day. https://t.co/aGhwwteg41$AAPL $FB $AMZN $PG $MCD $GS $C $GE $UTX $SLB $XOM $GOOGL $AGN $WMT $QQQ $IWM $GILD $HON $JPM $DIS #markets lower. https://t.co/wLscD4grJxGilead Sciences, Inc. $GILD CEO John F. Milligan Sells 112,000 Shares https://t.co/dEUYxnDmgg5 #Stocks to Buy for Growth, Value, and #Yield $F $GM $PEB $AMGN $ABBV Also $AAPL $GILD $MSFT $FB https://t.co/kinlWsNcbiRT @Briefingcom: $GILD: Gilead Sciences Correction: Gildan (GIL) not Gilead will acquire Alstyle; prior comment has been removed https://t.‚Ä¶$GILD: Gilead Sciences Correction: Gildan (GIL) not Gilead will acquire Alstyle; prior comment has been removed https://t.co/lMTHVEJ3b8Ionis Pharma Reports Q1, Updates, And Falls: Why I Bought The Dip https://t.co/nTLJScigQ6 $BIIB $SNY $ALNY $GSK $MRK $BAYRY $XBI $GILD166 ticks today, plus some futures and equities trades in $TWTR $GILD long side...no ES still, but im lurking https://t.co/8esdYOfQZV.@CarpeNoctom 1D $GILD 
patent dispute &amp; neg earnings (fundamentals) + technical resistance = massive pullback https://t.co/uZln1A0ziLhttps://t.co/G9pMgSr1JY &lt; Review of this fantastic traders teaching service! Try it for FREE! $GILD $CMG $XON $FBetter Buy: #GileadSciences vs. Biogen. Read more: https://t.co/sYeKevJqgL $GILDBREAKING: Fitbit, GoPro, Chipotle, Gilead, Priceline, and United Airlines all planning Online TV services.  $FIT $GPRO $CMG $PCLN $GILD $UALGood read: China medical tourism firms taking HCV patients to India for Sovaldi ... $GILD  https://t.co/NWwNxm8vcq‚Ä¶  RT @BioPharmaJosh.@MFIndustryFocus Thanks so much for addressing my question, Kristine! Great conversations in today's episode. $GILD $SRPT #InvestTogether.@ebcapital Great article, thanks! Which do you like better as a long-term buy, $GILD or $CELG?Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/zLKGdqw0ucHere is a list of value stocks on sale this week: https://t.co/OdSEvGpgXt $NNA $NMM $ABT $GILD $NTDOYGilead Sciences, Inc. $GILD Stock Rating Upgraded by Vetr Inc. https://t.co/LwNNq29tLzGilead Sciences, Inc. $GILD Stock Rating Upgraded by Vetr Inc. https://t.co/AucNBIQMKFSince $86s did not hold for $GILD look out for $84s [I would personally not buy before $84s]... https://t.co/87fY8hY80VGilead Sciences‚Äô $GILD ‚ÄúHold‚Äù Rating Reiterated at Morgan Stanley https://t.co/YZ8ps3wAmePriced at ~7x forward earnings, $GILD is valued as though nobody is ever going to contract Hep C again.$GILD .....üíÉüòçüòçüéàüòäüíÉ https://t.co/UwHSCgvilgRT @avidresearch: perfectly captures the complexity of Hep B and HIV $ARWR $GILD $BMY $MRK https://t.co/2C4QyMGsnkAdded to $GILDperfectly captures the complexity of Hep B and HIV $ARWR $GILD $BMY $MRK https://t.co/2C4QyMGsnkStockTwits trending: 
$SCTY $PCLN $AAL $BBRY $NUGT $AMAG $PETX $DAL $MU $GILD $MGM $MTCH $ETSY $UAL $ASPS $TWTR $SWN https://t.co/czw2IJsw7mVoya Financial Advisors Inc. Raises Stake in Gilead Sciences, Inc. $GILD https://t.co/QyWv5MJ2Bd$GILD President &amp; CEO sold USD 18,5 M in shares https://t.co/QiyNFN5cbUWOW! $GILD stopped playing around with sucking in Calls and now is going DOWN.$GILD:

New Insider Transaction on GILD by President and CEO:

https://t.co/mK7801cdo4 https://t.co/jYf0lNMA46$GILD Get alerts on momentum stocks before the run happens! Here‚Äôs How‚Ä¶Google ‚ÄúLionStockAlerts‚Äù and thank me later.Popular: $AAL, $MU, $GILD, $AMAG, $GOGO, $PETX, $SWN, $DAL, $LUV, $BDX, $MUR$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts App$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/bafDOAQVUdRT @BioPharmaJosh: Good read: China medical tourism firms taking HCV patients to India for Sovaldi ... $GILD  https://t.co/LD0AltrOCaChinese Look to #India for Health and Hope | Sixth Tone #HCV $GILD https://t.co/4ZEat65D0L$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/NsVm2Z7cnxVan ECK Associates Corp Has $91,833,000 Position in Gilead Sciences, Inc. $GILD https://t.co/iNvOt0HQBgRT @SFinanciers: Don't Sell Gilead - Sell Options And Buy The Stock Instead: https://t.co/rzvKYBgaww $GILD https://t.co/9ZqPPHg5J5RT @stockmonitorapp: RSI heading into oversold on $GILD, crossed below 30. Showing weakness? https://t.co/VG0IZogks6 #stocks https://t.co/S‚Ä¶RT @BioPharmaJosh: Good read: China medical tourism firms taking HCV patients to India for Sovaldi ... $GILD  https://t.co/LD0AltrOCaGood read: China medical tourism firms taking HCV patients to India for Sovaldi ... $GILD  https://t.co/LD0AltrOCa@darealmanmib closed 3/4 of $GILD Put Spreads Credit 7.5
Sold all 92.5 Puts 7.9 per
Shorted 1/2 $GILD 85.6 v 84.5 weekly puts.
So oversold$GILD good buy @ 82-83 range$GILD #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/WStuuXUEJt.@DaveCBenoit Very important to view #ROIC on a relative basis within industries. Companies like $GILD have 50+% b/c of intangible assets.Citigroup Inc. Cuts Gilead Sciences, Inc. $GILD Price Target to $105.00 https://t.co/SEf2pAFFlgHappier Employees Make Companies Great  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 3How Fun Workplace Design Can Increase Productivity  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f $btu 3RT SeekingAlpha: Economic Earnings: The Antidote To Accounting Profits https://t.co/XFCKpaaNlO $AAPL #APPLE $C $CHL $CVX $DB $GILD $GOOGL ‚Ä¶Building a Powerful Brand by Creating More Value  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f 3Economic Earnings: The Antidote To Accounting Profits https://t.co/vPhei2tr2d $AAPL #APPLE $C $CHL $CVX $DB $GILD $GOOGL $LYG $MSFT $ETREconomic Earnings: The Antidote To Accounting Profits https://t.co/xSrd3VOR1m $AAPL #APPLE $C $CHL $CVX $DB $GILD $GOOGL $LYG $MSFT $ETRRSI heading into oversold on $GILD, crossed below 30. Showing weakness? https://t.co/VG0IZogks6 #stocks https://t.co/STxCaBeHsiMAY 04 Wednesday, $GILD is $85.70 now @ 1:12. My BEARISH target is $84.605 #Stocks to Buy for Growth, Value, and #Yield $F $GM $PEB $AMGN $ABBV Also $AAPL $GILD $MSFT $FB https://t.co/Yqf4ZX8e7v#Options #maxpain chart for $GILD. #option #invest More with #OptionsPro FREE app at https://t.co/vmQaxw1x1K https://t.co/mnnK6qiIu4@ChaseLester_CL @wellbri4. Between $Celg data in 2Q and the $Gild data/anything this should move.  volume could simply be people covering$gild any takers down here? https://t.co/VhPdPEcsooGilead Sciences, Inc. $GILD Lowered to Hold at Zacks Investment Research https://t.co/ktWzwdEB0q$GILD under the 86.13 support3 Biotechs $UTHR $GILD $ENDP may be ready to bounce back from big slides! 
https://t.co/ErKTbUM35eFor $GILD, on the BEARISH side $82.05 and on the BULLISH side $90.70 keep showing up. $GILD is $86.04 now @ 12:39. Which side will win?$GILD making new recent lows...now in the $85sRT @JustinPulitzer: $GILD getting close to some VERY key reference support ($81.89-$85). I think this will play out like $AAPL. Short term‚Ä¶$GILD getting close to some VERY key reference support ($81.89-$85). I think this will play out like $AAPL. Short term bounce to lower high.Therapy Focus - NASH Projects Set For Data In Dog Days Of Summer https://t.co/UFt0eFyG0U $GNFTF $TBRA $IMROY $GILDDumped $ILMN on the gap fill for a flat trade, still short $GILD and $REGNMAY 04 Wednesday, $GILD LOW was $86.09 and hit my BEARISH target $86.57 from MAY 02 Monday‚òïüí∞üôå@ben_levisohn @barronsonline $GILD shareholder mtg 5/114 traders on our negative surprise list $EL $GILD $EXPD  $HRS $BHI $PBI -at https://t.co/FZPcGSL2CYBuying some $GILD hereRT @outsizedreturn: Americas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/o1RAefAkX0 htt‚Ä¶Fuller &amp; Thaler Asset Management Inc. Has $1,002,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/jcRiUcJefZHow Fun Workplace Design Can Increase Productivity  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f $btu 3Happier Employees Make Companies Great  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 3@dsobek @bradloncar $MRK has a very high IV, suggests surprise.  @GantosJ could probably give better idea on price action. $GILD had same.Building a Powerful Brand by Creating More Value  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f 2@jjgiablue i meant $GILDVolume Alert - GILD 86.66 Gilead Sciences Inc $GILD Hit a high today of 86.99 Closing the day 10:29 at 86.66 - https://t.co/n1nO2Y20peGilead Stock: Analyzing 5 Key Suppliers $GILD https://t.co/NMst2UU6y2RT @AndyBiotech: $ICPT @adar170 @anachtomi Nope, $GILD has a safer and cleaner FXR agonist that could move into Ph3 soon in NASH
https://t.‚Ä¶$GILD Getting ready to buy some at 85.50 after patiently waiting and avoiding all the head fakes. #stocks #tradeideas #investingRT @outsizedreturn: #EconomicData $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/o1RAefAkX0 https‚Ä¶RT @outsizedreturn: #EconomicData $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/o1RAefAkX0 https‚Ä¶Recent Buy - $GILD https://t.co/tvVVP03LYt via @Div4SonRT @outsizedreturn: #EconomicData $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/o1RAefAkX0 https‚Ä¶RT @outsizedreturn: #EconomicData $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/o1RAefAkX0 https‚Ä¶RT @AndyBiotech: $ICPT @adar170 @anachtomi Nope, $GILD has a safer and cleaner FXR agonist that could move into Ph3 soon in NASH
https://t.‚Ä¶RT @outsizedreturn: #EconomicData $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/o1RAefAkX0 https‚Ä¶$GILD and $CElG raise heads above 1min VWAP .. cautiously optimistic#EconomicData $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/o1RAefAkX0 https://t.co/kT9hvDXwo9#GileadSciences Health Canada issues safety warning on Zydelig. Read more: https://t.co/GpscsgbW9l $GILDRT @ETFChannel: Health Care Select Sector SPDR Fund Experiences Big Inflow $XLV $GILD $UNH $AMGN #etfs: Symbols mentioned in ... https://t.‚Ä¶Sold $gild here, might want to buy $qure if it falls more or other stuffHealth Care Select Sector SPDR Fund Experiences Big Inflow $XLV $GILD $UNH $AMGN #etfs https://t.co/kSoekW90tJHealth Care Select Sector SPDR Fund Experiences Big Inflow $XLV $GILD $UNH $AMGN #etfs: Symbols mentioned in ... https://t.co/lRGQIKZ6jtHealth Care Select Sector SPDR Fund Experiences Big Inflow $XLV $GILD $UNH $AMGN #etfs: Symbols mentioned in ... https://t.co/lRGQIKHuUT#Global #Macro Movers $spy $vxx $yinn $aapl $crm $dia $oil $ge $f $t $gild $rth #hedgefund https://t.co/o1RAefAkX0 https://t.co/rf7Q7u8gU2RT @outsizedreturn: Americas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/o1RAefAkX0 htt‚Ä¶Don't Sell Gilead - Sell Options And Buy The Stock Instead: https://t.co/rzvKYBgaww $GILD https://t.co/9ZqPPHg5J5Americas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/o1RAefAkX0 https://t.co/YhOmWvFCETGILD Stock Forum
See Here ---&gt; https://t.co/ajuR9yFZ7N

$GILD $SHW $TCK #tradeideas$gild cheapest large cap, not $vrxRT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9I referenced 86.75 on $GILD to possibly trade against.  I did not buy $GILD as the stock &amp; sector been too choppy. That level now taken out.Technical action by S&amp;P 500 stocks to 10:15: Bearish. Breakout: $ICE. Breakdowns: $UA, $JWN, $M, $PCLN, $ILMN, $HSIC, $GILD, $EXPD, $RHT@bret_jensen Bret, is there a good argument for $GILD as the target of a major rather than an acquirer?How Fun Workplace Design Can Increase Productivity  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f $btu 2Happier Employees Make Companies Great  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 3$GILD:US Doheny Asset Management CA Raises Stake in Gilead Sciences, Inc. (GILD) #GILEAD SCIENCES INC  https://t.co/bpgo9bFhCq #SP500RT @tgtxdough: No change in CS top 3 bio pics $CELG $GILD $BMRN https://t.co/zXWoaRkRdbGILD Top news - May 4th, 2016 $GILD https://t.co/MV0ncabsa0B2O $GILD June 92.50 May 6 84.50 Put Spread Debit 7.12 per$GILD took a hit holding $GOOGL puts still but might take a hit soonCommented on 2 Attractive Possible Takeovers In Biotech https://t.co/HaY3ySFLyi $GILD $RLYP $IONSBuilding a Powerful Brand by Creating More Value  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f 2Long Gilead $GILD https://t.co/cMUaTCQCyR ~ via https://t.co/Kd2qwcsyit$gild wonder how many shares they are buying back nowPurchased 1000 shares of $Gild here at 86.51$ I'm slowly starting to accumulate from here down.Long Gilead $GILD https://t.co/ucagReuWJh$GILD  below  both  March  and  April  lowsGilead Sciences hits a 1 month low https://t.co/SFMrq46T3v $GILD #GileadSciences https://t.co/HwmsCi12IBlong more weekly puts $GILD $GOOGLGilead Sciences, Inc $GILD Vote proxy AGAINST pay, comp com, bonus plan. FOR written consent https://t.co/KAasujoJAJ https://t.co/NdNSKFcPR9Masterclass Watchlist 5/4

Gold: $VRX* $AAPL* $QCOM

Silver: $FB* $BA $GILD

Bronze: $CLong: $ZG, $Z, $MDVN, $TREE, $ETSY, $DVN, $EBIO, $OCLR, $CVC

Short: $PCLN, $CRAY, $ILMN, $EXPE, $RUBI, $RLYP, $WFC, $GILD, $GLUU, $SPY, $FBFavs: $Z over 29.5, $MDVN over 60.5, $ETSY over 10, $DVN over 34, $OCLR over 5.6, $CRAY und 30, $ILMN und 126.5, $WFC und 49, $GILD und 86.5$AAPL $FB $AMZN $PG $MCD $GS $C $GE $UTX $SLB $XOM $GOOGL $AGN $WMT $QQQ $IWM $GILD $HON $JPM $DIS #futures lower. https://t.co/Nt9Pz9DVnyCommented on Gilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move https://t.co/8kAWUZbk0R $GLPG $MDVN $GILDLongs Watches: $ZG, $Z, $MDVN, $TREE, $ETSY, $DVN, $EBIO, $OCLR, $CVC! Shorts: $PCLN, $CRAY, $ILMN, $EXPE, $RUBI, $RLYP, $WFC, $GILD, $GLUU!RT @tgtxdough: No change in CS top 3 bio pics $CELG $GILD $BMRN https://t.co/zXWoaRkRdbNo change in CS top 3 bio pics $CELG $GILD $BMRN https://t.co/zXWoaRkRdb$GILD - Wave 4 in Progress - https://t.co/rb142RLynF$GILD is this at 75 yet?   no.. then dont careRT @ebcapital: 3 Dirt-Cheap Biotech Stocks To Buy -- $UTHR $GILD $ENDP The Motley Fool https://t.co/PSvzPfTM5D3 Dirt-Cheap Biotech Stocks To Buy -- $UTHR $GILD $ENDP The Motley Fool https://t.co/PSvzPfTM5DRT @Benzinga: The Next Sector Rotation Will Be To Biotechs $BIIB $GILD $PFE  https://t.co/40jJM0mOZtA Prescription For High Risk Fever https://t.co/44BVuixFzD $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCI$GILD https://t.co/qYWK5GLPIj$GILD PT lowered to $116 from $120 at OppenheimerRT SeekingAlpha: A Portfolio Update That Includes Buying Shares Of Gilead https://t.co/ncHDPWOJOz $AGN $EV $GOOG $ORLY $PCLN $SWKS $GILDA Portfolio Update That Includes Buying Shares Of Gilead https://t.co/enFkl90z3n $AGN $EV $GOOG $ORLY $PCLN $SWKS $GILDA Portfolio Update That Includes Buying Shares Of Gilead https://t.co/OVmsgJyASq $AGN $EV $GOOG $ORLY $PCLN $SWKS $GILDThese #biopharma companies are the world's top shareholder value creators via @FortuneMagazine https://t.co/XTbhdmWmkU $BIIB $GILD #big3bio$GILD $STX $SPLS options have the largest change in price. Free options screener. https://t.co/YRdUp0plr2@megtirrell @HalftimeReport will $gild retrace its steps back above $100.00 this year ? Or is M&amp;A the only solution. Guidance was reiteratedJim Cramer Advises Viewers On Schlumberger, Gilead Sciences And Disney $DIS $GILD $SLB via @benzinga https://t.co/Qkec8jlXHm5 #Stocks to Buy for Growth, Value, and #Yield $F $GM $PEB $AMGN $ABBV Also $AAPL $GILD $MSFT $FB https://t.co/kinlWsNcbiJim Cramer Advises Viewers On Schlumberger, Gilead Sciences And Disney $DIS $GILD $SLB via @benzinga https://t.co/81qO88Zp1QRT @tgtxdough: @mikegoodma Stocks Where Sentiment Has Worsened
$ACRX $ANAC $CHMA $GILD $PTCTRT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9Wave 4 in Progress $GILD https://t.co/mD45Pmmk9URT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9RT @BioStockAddict: @GalapagosNV @GileadSciences $GILD / $GLPG should win. Highest upfront + equity deal. #Filgotinib https://t.co/00GC26I0‚Ä¶Gilead Sciences, Inc. $GILD Sees Large Drop in Short Interest https://t.co/ZJCwmKZ9e0Kyll√§ $GILD :in hinnassa on rutto ja kolera IMO. Mielet√∂n ROE ja bruttomarginaali, P/E kohta 7. Nousutriggeri tulee viel√§. Lis√§sin.@GalapagosNV @GileadSciences $GILD / $GLPG should win. Highest upfront + equity deal. #Filgotinib https://t.co/00GC26I0QLGilead Sciences, Inc. $GILD Sees Large Drop in Short Interest https://t.co/tG5CfLYgqXRT @JeaYu21: $CVS $UA $AIG $GILD chart https://t.co/21gPjUcIOYRT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9RT @dhovekamp42: $AZN $ALXN $BMS $CELG $GILD $GLPG $IPH $PFE $SNY $VRTX https://t.co/QKlAx6CiJl$AZN $ALXN $BMS $CELG $GILD $GLPG $IPH $PFE $SNY $VRTX https://t.co/QKlAx6CiJl$GILD:US Doheny Asset Management CA Raises Stake in Gilead Sciences, Inc. (GILD) #GILEAD SCIENCES INC  https://t.co/jovOdKyyVx #SP500These #Biopharma Companies Are the World's Top Shareholder Value Creators $REGN $GILD $BIIB 
https://t.co/ysSMjN0Sm3RT @JeaYu21: $CVS $UA $AIG $GILD chart https://t.co/21gPjUcIOYhttps://t.co/uAcamNRUPt alerted $PTX +45% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/OQCNEb9p9K $HOT $AMAT $ITUB $MT $GILD $HST $AART @Benzinga: #Biotech: The Next Sector Rotation $BIIB $GILD $PFE https://t.co/40jJM0mOZtCincinnati Insurance Co. Has $26,694,000 Position in Gilead Sciences, Inc. $GILD https://t.co/uTPudjBiXw$aapl, $dal, $abg, $gild, $uthr :)Doheny Asset Management CA Raises Stake in Gilead Sciences, Inc. $GILD https://t.co/bhtkLiEsCJDoheny Asset Management CA Raises Stake in Gilead Sciences, Inc. $GILD https://t.co/v2FVAw8nGqCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Gilead Sciences, Inc. $GILD Stake Raised by Family Management Corp https://t.co/4onK1WeFfg$GILD Gilead Seeks to Tame Merck Case -- WSJ‚Ä¶ https://t.co/HHXBYtFGHi#Biotech: The Next Sector Rotation $BIIB $GILD $PFE https://t.co/40jJM0mOZtRT @AndyBiotech: $ICPT @adar170 @anachtomi Nope, $GILD has a safer and cleaner FXR agonist that could move into Ph3 soon in NASH
https://t.‚Ä¶RT @HepCMe: The Gilead-Merck Hep C Drug Patent Case Takes A Surprising Turn https://t.co/SIv4hgMyoK $MRK $GILD$GILD looks a lot like early Feb here, but will we have the BOJ negative rate boost to bail the mkt out this time?RT @HepCMe: The Gilead-Merck Hep C Drug Patent Case Takes A Surprising Turn https://t.co/SIv4hgMyoK $MRK $GILDThe Gilead-Merck Hep C Drug Patent Case Takes A Surprising Turn https://t.co/SIv4hgMyoK $MRK $GILDToday`s #unusualprofits #options: $DPM $ETE $GILD $SLV $SSRI $STX $XRX via https://t.co/MBahY6U0fH https://t.co/vGmfkQitBp",2016-05-04,GILD,1
23,"@jimcramer Slap a Big Pharma PE of 15x on $GILD and discount earnings to $10.00 per year &amp; you get $150. CHEAPEST drug co. stock on earth!Unusual Call Activity https://t.co/XeFGNb5Tot  $TRIP $TLT $AA $MGM $WFM  $MDVN $LOW $KATE $XOP $COST $JCP $TSLA $DVN $DDD $PCLN $SCTY $GILD$GILD Merck Revenue Falls on Generic Competition‚Ä¶ https://t.co/RidJYQyfuhNR7-2 https://t.co/rg0MFscE8x $IWF $TSS $JCI $CENX $SEE $APH $PCY $AMAT $MSFT $SBUX $GILD $MWA $FLO $NWSA $BBBY $HIMX $ALKSVSLR Ex-Div Date
See Here ---&gt; https://t.co/q3zMJBSTMh

$VSLR $GILD $BMY #tradeideasRT: @biospace: Look Who‚Äôs Profiting from Gilead $GILD's Sky-High Hepatitis C Drug Prices https://t.co/X7OnQsSUlX https://t.co/CeigKNVVCoGilead Sciences, Inc. $GILD Stake Raised by Massachusetts Financial Services Co. MA https://t.co/enYCTIhLNBUnusual Call Activity https://t.co/XeFGNb5Tot $TRIP $TLT $AA $MGM $WFM  $MDVN $LOW $KATE $XOP $COST $JCP $TSLA $DVN $DDD $PCLN $SCTY $GILDRT @biospace: Look Who‚Äôs Profiting from Gilead $GILD's Sky-High Hepatitis C Drug Prices https://t.co/5QiGD8QEkS https://t.co/2TRd7FOpUiLook Who‚Äôs Profiting from Gilead $GILD's Sky-High Hepatitis C Drug Prices https://t.co/5QiGD8QEkS https://t.co/2TRd7FOpUi$GILD ticks the boxes as a dream üí∞ dividend üí∞ stock with 1.9% yield https://t.co/nHdTPPnqeu https://t.co/Ba8A4MQTSrRT @BPGAG: Higher lows in #biotech land. It looks good. #NFP on tap tomorrow. Market looks ripe for a strong bounce. $IBB $CELG $GILD $BIIB‚Ä¶Higher lows in #biotech land. It looks good. #NFP on tap tomorrow. Market looks ripe for a strong bounce. $IBB $CELG $GILD $BIIB #stocksXYL Volume
See Here ---&gt; https://t.co/RXFRKjAWbf

$XYL $GILD $DUST #tradeideas$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ Mix Day. https://t.co/fSBTkq1cjlUnusual Call Activity https://t.co/XeFGNb5Tot   $TRIP $TLT $AA $MGM $WFM  $MDVN $LOW $KATE $XOP $COST $JCP $TSLA $DVN $DDD $PCLN $SCTY $GILDClosed out $GILD trades. 4.2% gain.Gilead Sciences, Inc. $GILD Raised to ‚ÄúStrong-Buy‚Äù at Vetr Inc. https://t.co/YjbNueEy7s$GILD looks like it‚Äôs really trying hard to bottom[Trending] Central Bank Inaction Moves Markets https://t.co/EA1AdEsJpC #ETF $GILD $GLD https://t.co/d9qTKbfsM9GILD Bid
See Here ---&gt; https://t.co/ert5861yTA

$GILD $SBUX $LXU #financeRT @BPGAG: Looks like $IBB wants new highs on the day ... $CELG $GILD $BIIB #biotech #stocks@megtirrell @PopSci add the 10-15M #HCV infected in #China and try to quantify how undervalued $GILD isRT @BPGAG: Looks like $IBB wants new highs on the day ... $CELG $GILD $BIIB #biotech #stocksLooks like $IBB wants new highs on the day ... $CELG $GILD $BIIB #biotech #stocks$IBB $CELG $GILD How do you come to this opinion of yours?  https://t.co/c0uiKuAuyq$gild   the 8 day dip stats  on Gilead Science   $103.00s  /  $85.00s   =     - $18   /   - 18%RT @JeaYu21: $BABA $GILD $UVXY $WFM Thursday Trades Blog + $745 https://t.co/E6uxzx5fvIRT @JeaYu21: $BABA $GILD $UVXY $WFM Thursday Trades Blog + $745 https://t.co/E6uxzx5fvI$BABA $GILD $UVXY $WFM Thursday Trades Blog + $745 https://t.co/E6uxzx5fvI$GILD Gilead Sciences Inc SPECULATION - New IntraDAY LONG at 85.8X | Accumulating for SWING on Trend Change Reversal to Upsidehttps://t.co/p7tVeIZFvX Millionaire Road Map Trading top students win a Porsche for a yr! $LNKD $CVX $GILD $STX $P$MDVN two hours left for $GILD, $BIIB and $CELG to speak to their advisors on making a offer for $MDVNBiotech Bear Market: Another Bad Day IBB Down 2.9% $BMY $SNY $TMO $RHHBY $IBB $ILMN $MDVN $REGN $GILD $XBI... https://t.co/dBCnwrxljF#GileadSciences Look Who???s Profiting from Gilead's Sky-High Hepatitis C Drug Prices  . Read more: https://t.co/ec8bqy6NBe $GILDHow Fun Workplace Design Can Increase Productivity  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f $btu 4Happier Employees Make Companies Great  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 4Regeneron &amp; Merck both report mixed Q1s and raise guidance, but the devil is in the details: https://t.co/MZUk6gCc4r $REGN $MRK $GILD $BMYBuilding a Powerful Brand by Creating More Value  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f 4If wrong, stops already in place. #NFP always presents uncertainties so we'll see $MACRO. $IBB $CELG $GILD @Option_Addict #biotech #stocksAgree wholeheartedly w/ @Option_Addict on ""fat pitch"" &amp; #biotech #stocks as long as $IBB holds $255 area - new Hods for $CELG $GILD coming.#Clinicaltrials $SPY $ABBV $GILD $PFE Chronic ill Patients accept death over the cost of meds- #RealityCheck #LUPUS #RA #CrohnsDisease@jq1234t those were interesting comments re NASH from $GILD.  if this is true, bad for $ICPT?  thoughts?@Biotech2050 $GILD short % of float is 1,97%$GILD in weekly puts, risky trade$GILD #shorts #HCV is in higher numbers than you think
https://t.co/tO81emEHtv
Add the 10-15M in #China + #HBV #NASH + then #HIV #cure 
$IBB$gild   looking over sold and earliest chance of  first baby step higher would be exceeding 86.50 with force.Happier Employees Make Companies Great  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 4How Fun Workplace Design Can Increase Productivity  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f $btu 4Building a Powerful Brand by Creating More Value  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f 3$GILD stopped out 85.90 grrr added UVXY  16.50Volume Alert - GILD 85.85 Gilead Sciences Inc $GILD Hit a high today of 86.40 Closing the day 10:30 at 85.85 + https://t.co/BiMiPuheSz$GILD perfect storm breakout attempts$GILD showing a little life here https://t.co/PbCexd1eFG$GILD added 86.25RT @JeaYu21: $GILD REVERSED LONG  86.32 seed waveRT @JeaYu21: $GILD REVERSED LONG  86.32 seed waveRT @JeaYu21: $GILD REVERSED LONG  86.32 seed wave$GILD REVERSED LONG  86.32 seed wave$GILD REVERSED LONG@takingstock614 a lot of good bounce plays earlier on the morning $NFLX $AAL $GILD to name a fewBased on prior post, if $IBB does not push higher, will reconsider with end of day review. $CELG $GILDBig #biotech #stocks w/ program buys on w/ overlay intraday moving averages - $CELG $GILD - due for retracement; watch $IBB $260+ potential.RT @JeaYu21: $GILD added short 86.05$GILD added short 86.05Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @JeaYu21: $GILD ADDED 85.93 SHORT$GILD ADDED 85.93 SHORT$GILD: Citigroup Inc. Cuts Gilead Sciences, Inc. Price Target to $105.00 - Zolmax (5/4) https://t.co/AMQu0tYYpjSky-high price of hepatitis C drug produces profits for lawmakers https://t.co/FFJZFUqolj via @OpenSecretsDC $GILDRT @JeaYu21: $GILD added SHORT 86.77RT @JeaYu21: $GILD added SHORT 86.77RT @JeaYu21: $GILD added SHORT 86.77RT @JeaYu21: $GILD added SHORT 86.77$GILD added SHORT 86.77RT @JeaYu21: $GILD SHORT 85.65RT @JeaYu21: $GILD SHORT 85.65$GILD SHORT 85.65A Prescription For High Risk Fever https://t.co/Uu9lQOeTW0 $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCI$GILD finally showing some life again...about $1 off the low$GILD The 85.15 add limit buy missed by 5 cents. Note to self: ""Be more precise with trendlines."" We are trading against machines. #stocks$GILD In some Aug c on this downgrade. Still in chop modeRT @BPGAG: Last add to $GILD #trading L - bought down to $85.46 avg #biotech #stocks $IBBAs a trade, not excited about Gilead entering gap - meaningfully - in the short-term, but $90 or so is coming... $GILD $IBB #biotech #stocks@cek_cpa @financialbuzz @ryanwallace198 bought $gildGilead Sciences hits a 1 quarter low https://t.co/aE2bhADJXH $GILD #GileadSciences https://t.co/by8FrCjL11Happier Employees Make Companies Great  https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f $cbs $ual $pm $utx 4How Fun Workplace Design Can Increase Productivity  https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f $btu 3RT @BPGAG: Last add to $GILD #trading L - bought down to $85.46 avg #biotech #stocks $IBBBuilding a Powerful Brand by Creating More Value  https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f 3Last add to $GILD #trading L - bought down to $85.46 avg #biotech #stocks $IBBMrPrud's [#Watchlist] Que's | $GILD https://t.co/A1GXHdPZIg https://t.co/ZN9yCJ004rAdded to $GILD #trading L $85.63 avg $IBB #biotech #stocksStarted a #trading L in $GILD - liking $IBB at this $255 -$260 level - in at $85.60 avg$GILD Looks like Oppenheimer saw my chart. Sometimes I feel like these analysts are as technical as I am. #stocks #tradeideasWorst #sentiment for #SP1500 #stocks at market open: $MOH $ALL $GILD $AET $PXD (2016/05/05) #stocktrading #predictiveanalytics #bigdataWorst sentiment for SP1500 stocks at market open: $MOH $ALL $GILD $AET $PXD (2016/05/05) #sentiment #stock #alexandriaRT @AndyBiotech: $MRK saying on Q1 call that #HCV drug price will continue to be under pressure.  &lt;-- $GILD $ABBV  really grateful to you g‚Ä¶GILD Top news - May 5th, 2016 $GILD https://t.co/aF0B095Tc6RT @outsizedreturn: #Global #Macro $spy $vxx $aapl $dia $oil $ge $f $gild $rth #hedgefunds @mcorcelli 5/6/16 9am https://t.co/rCt021K8bY ht‚Ä¶RT @outsizedreturn: #Global #Macro $spy $vxx $aapl $dia $oil $ge $f $gild $rth #hedgefunds @mcorcelli 5/6/16 9am https://t.co/rCt021K8bY ht‚Ä¶#GileadSciences, Inc. To Pay $1.2 Billion For A Unit Of Nimbus. Read more: https://t.co/Zwc6btQ4nI $GILD#Global #Macro $spy $vxx $aapl $dia $oil $ge $f $gild $rth #hedgefunds @mcorcelli 5/6/16 9am https://t.co/rCt021K8bY https://t.co/LuINIMAKc1RT @AndyBiotech: $MRK saying on Q1 call that #HCV drug price will continue to be under pressure.  &lt;-- $GILD $ABBV  really grateful to you g‚Ä¶RT @AndyBiotech: $MRK saying on Q1 call that #HCV drug price will continue to be under pressure.  &lt;-- $GILD $ABBV  really grateful to you g‚Ä¶#GileadSciences, Inc. Confirms That It Is Not Exciting From Oncology Anytime Soon Despite T... Read more: https://t.co/LkCGBQWP7t $GILDRT @AndyBiotech: $MRK saying on Q1 call that #HCV drug price will continue to be under pressure.  &lt;-- $GILD $ABBV  really grateful to you g‚Ä¶RWC Daily  https://t.co/wxiChYzJgx $AAPL, $BAC, $C, $GILD, $JPM, $WFC$GILD spitting distance of FEB lows - gap fill/bounce watch$VRX $WFM $GILD $WTW chart https://t.co/EcqksgnrrV5/5 watch list: long $Z $KHC $BAX $QRVO $ARRS $TWTR  $CHK $SDRL short $TRIP $FOXA $FIT $UA $GILD5/5 watch list: long $Z $KHC $BAX $QRVO $ARRS $TWTR  $CHK $SDRL short $TRIP $FOXA $FIT $UA $GILDRT @AndyBiotech: $MRK saying on Q1 call that #HCV drug price will continue to be under pressure.  &lt;-- $GILD $ABBV  really grateful to you g‚Ä¶$MRK saying on Q1 call that #HCV drug price will continue to be under pressure.  &lt;-- $GILD $ABBV  really grateful to you guys...CDC: 2014 US Hepatitis C-related deaths hit record high - 19k+ More than all other infectious conditions $GILD https://t.co/jdqwXr3lFQ@Sport234a @AndyBiotech they'd have been smart to load up on puts ahead of $GILD Q1 EPS$GILD - Merck Revenue Falls on Generic Competition https://t.co/3kPqIl9kF7$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ #Market Analysis https://t.co/7eYOG1AuTu#GileadSciences Shares Slip as Judge Re-Opens Merck Patent Case: Bloomberg (NASDAQ:). Read more: https://t.co/jLKYrF03FX $GILD$MRK's Zepatier only brought in $50M in sales for Q1, compare to $3.02B for $GILD Harvoni, $414M for $ABBV Viekira https://t.co/QpAwQ28IyxBiotech Bear Market: Another Bad Day IBB Down 2.9% $BMY $SNY $TMO $RHHBY $IBB $ILMN $MDVN $REGN $GILD $XBI... https://t.co/vAxiLRP2o3Approval of the next gen HIV from the FDA gives hope to #GileadSciences, Inc (NASDAQ:). Read more: https://t.co/Xg5EnEJDRk $GILDRT @SquawkCNBC: Here's what top stock picker David Katz is betting onüìà

- $MSFT 
- $GILD
- $HPQ https://t.co/ID0xGdnW2NHere's what top stock picker David Katz is betting onüìà

- $MSFT 
- $GILD
- $HPQ https://t.co/ID0xGdnW2NZero chance $gild works as a stock in a election yearHere are my ticker ideas of making 10%+ by Monday. Buy only w/ (1)  $W $UAL $LB  $BWLD $GILD $UWTI $NUGT $LABU $UVXY $FAZ $NFLX $FMSA $GSSThe Next Sector Rotation Will Be To Biotechs $BIIB $GILD $PFE https://t.co/qAPTKuBLZm via @benzingaGilead Sciences, Inc. $GILD Price Target Lowered to $105.00 at Citigroup Inc. https://t.co/AuGwrpFdPB$GILD: Analyst action by Citigroup on Gilead Sciences: https://t.co/fW7rFvKdUd https://t.co/Lnx520otSnCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKjqBmDGilead Sciences, Inc. $GILD Downgraded by Maxim Group https://t.co/nFBCauGocKHow Argus Views $GILD After Earnings 
https://t.co/5yAOXcy1j1 via @247WallSt
#CHINA #HCVInteresting read on prevalence of #HCV in #USA
https://t.co/m5rMGUphIW
$GILD $MRK $ABBV
3.5M+ patients yet to be treatedRT @SA_MacroView: Stocks Slide; Muddy Waters At It Again - Bezek's Daily Briefing https://t.co/hM0b6gMMCv $BOFI $DIA $GDX $GILD $OZRK $QQQ‚Ä¶RT @SEEKINGALPHA_FS: Stocks Slide; Muddy Waters At It Again - Bezek's Daily Briefing https://t.co/T1Jw5WCWpk $BOFI $DIA $GDX $GILD $OZRK $Q‚Ä¶RT SeekingAlpha: Stocks Slide; Muddy Waters At It Again - Bezek's Daily Briefing https://t.co/6s4GvuRIO5 $BOFI $DIA $GDX $GILD $OZRK $QQQ ‚Ä¶Stocks Slide; Muddy Waters At It Again - Bezek's Daily Briefing https://t.co/T1Jw5WCWpk $BOFI $DIA $GDX $GILD $OZRK $QQQ $SPY $USO $WFCStocks Slide; Muddy Waters At It Again - Bezek's Daily Briefing https://t.co/hM0b6gMMCv $BOFI $DIA $GDX $GILD $OZRK $QQQ $SPY $USO $WFC@lhfang @MarieMyungOkLee bet $GILD is one of them. Greedy pigs! Have cure for epidemic disease &amp; priced it $84k+Connor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNRRT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO 5/1 $VIX $TLT $HYG $EWZ $IBB $GILD $ALKS $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $FCX ht‚Ä¶Biotech Bear Market: Another Bad Day IBB Down 2.9% $BMY $SNY $TMO $RHHBY $IBB $ILMN $MDVN $REGN $GILD $XBI... https://t.co/dBCnwrfJV5GSA Capital Partners LLP Sells 35,098 Shares of Gilead Sciences, Inc. $GILD https://t.co/seHO4QcrZD$GILD - Gilead Sciences, Inc. #GILD Stake Held by Amica Mutual Insurance Co. https://t.co/wh6zzp9WaP$GILD - Gilead Sciences, Inc. #GILD Stake Held by Amica Mutual Insurance Co. https://t.co/gRIsZoNF45Gilead Sciences, Inc. $GILD Stake Held by Amica Mutual Insurance Co. https://t.co/NN2S46vj29Meanwhile, $ESRX, other PBMs, $GILD, $ABBV $MRK play the warehousing game.  Something wrong with this picture. https://t.co/z1Qxu1LPzBRT @BioPharmaJosh: Good read: China medical tourism firms taking HCV patients to India for Sovaldi ... $GILD  https://t.co/LD0AltrOCaHRS Bid Size
See Here ---&gt; https://t.co/2PDPZ9Ztao

$HRS $MNOV $GILD #tradeideasRT @raymond10mm: $GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ Mix Day. https‚Ä¶RT @raymond10mm: $AAPL $FB $AMZN $PG $MCD $GS $C $GE $UTX $SLB $XOM $GOOGL $AGN $WMT $QQQ $IWM $GILD $HON $JPM $DIS #markets lower. https:/‚Ä¶$GILD: Analyst action by Citigroup on Gilead Sciences: https://t.co/fW7rFvsD2F https://t.co/9ry2b8Hdw9MAY 04 Wednesday, $GILD closed $85.60",2016-05-05,GILD,0
24,"$AAPL, $GILD :)Interesting story on why so many hep C positive patients are not getting treatment. $GILD https://t.co/Er2Bn0jeLmSlingshot Bearish https://t.co/Eh2azkO0z5 $HZNP $WBA $JWN $AGEN $ANF $PPC $DAL $ERIC $SMH $ALK $PANW $GILD $CSCO $CHKP $SWKS $BLUE $URBNS&amp;P100 #Stocks Performance $AGN $BIIB $CELG $ABBV $EMC $TGT $COST $AMGN $LLY $GILD $MO $SPG $WMT $KMI $MRK more@ https://t.co/cKkr8cKsjuGilead Sciences, Inc. $GILD Shares Sold by Axiom International Investors LLC DE https://t.co/3J5IrKCrQY$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ Mix Day. https://t.co/YE37G6hTpP@jimcramer good entry point for $GILD?$gild? https://t.co/4v6MbcML0sRT @pharm_specialty: #GileadSciences Gilead gets patent for Hepatitis C drug Solvadi. Read more: https://t.co/TQq9m6ql31 $GILDRT @Tootix: #NASH Therapeutics Market to Reach US$20.27 bn by 2025, #Elafibranor Projected to Spur Growth https://t.co/6rrqa34kXq $GNFT $IC‚Ä¶$GILD Gilead Sciences to Present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 1
From our Stock News Alerts App#GileadSciences Gilead gets patent for Hepatitis C drug Solvadi. Read more: https://t.co/TQq9m6ql31 $GILD$GILD - Gilead Sciences to Present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May https://t.co/Wyhow0CIyzCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @FiercePharma: 'Important deals' on the horizon for Gilead, new CEO says https://t.co/t5zYa8rzQF $GILD #pharma by @EmilyWFierce$GILD may targets cancer acquisitions with 21 million cash pile https://t.co/w0GUuEt5W4 by @BioSpaceCommented on Gilead: It Is Now Obvious, The Biotech Juggernaut Needs To Make A Major Move https://t.co/8kAWUZbk0R $GLPG $MDVN $GILD@Lin_ling_88 $GILD bought Pharmasset Nov 2011, Sovaldi approved 12/2013. A 2 yr wait 4 revenue to stem nose dive will be frustrating! $GILDRT @BPGAG: Speaking of elite #traders, shout out also to @tradingaddicts on his #biotech #stocks analyses last week. $IBB $GILD $CELG $CNCR‚Ä¶Gilead $GILD CEO Targets Cancer Acquisitions with $21 Billion Cash Pile https://t.co/daW3LfZJLF https://t.co/qDnqfOjQpP@WilliamGerber1 of the deal $GILD cud see extraordinary value in a company while others do not see. Their acq of pharmasset was receivedS&amp;P100 #Stocks Performance $AGN $BIIB $CELG $ABBV $AMGN $TGT $EMC $GILD $AMZN $COST $LLY $RTN $WMT $MO  more@ https://t.co/cKkr8cKsju@WilliamGerber1 @OMillionaires That's my personal opinion. I've owned $GILD since early 2014 b/f it arrived...feeling sorta of in syncSpeaking of elite #traders, shout out also to @tradingaddicts on his #biotech #stocks analyses last week. $IBB $GILD $CELG $CNCR LISTS@WilliamGerber1 @OMillionaires Either compli $GILD's core competence in liver dis. or in oncology- then needs 2/b 1st in class/best in breed@WilliamGerber1 @OMillionaires Simply put, I think $GILD wants a company with assets capable growing into a sizable franchise 1/2$GILD Second starter buy @ 85.77$GILD Max Pain = 87.50. Maturity = 05/13/2016. Previous close = 84.68. bullish https://t.co/OaCG2Dx6Tv https://t.co/SHfZqZMC0U@DewDiligence yep and the flip side the next big $GILD purchase will be called a ""flop"" no matter whatRT @Tootix: #NASH Therapeutics Market to Reach US$20.27 bn by 2025, #Elafibranor Projected to Spur Growth https://t.co/6rrqa34kXq $GNFT $IC‚Ä¶#NASH Therapeutics Market to Reach US$20.27 bn by 2025, #Elafibranor Projected to Spur Growth https://t.co/6rrqa34kXq $GNFT $ICPT $GILD@PowerTriggerTra how do you feel about $gild for a reversal bounce?Took a little bit of weekly $AAPL and $GILD - gonna hold overnight@WilliamGerber1 @OMillionaires $14B for $INCY? NO way Jose! BTW this idea has been kicked around for couple of yrs, obviously $GILD moved on@Lin_ling_88 @OMillionaires Listening 2 $INCY earnings call couldn't help think it could add a lot 2 $GILD's capabilities &amp; product offering$GILD Milligan John CEO reported a huge SALE to SEC on May 4th. I only BUY when a CEO buys on the open market. simple and easy strategycourtesy of @kevenv13 Arrowheads new digs! Why they NEED larger digs? hmm? opn lbl trials ARC520  HepB $ARWR $GILD ? https://t.co/kBBlkBe5j5Gilead Sciences: A Black Box of Uncertainty? https://t.co/FOWWPo3Q6t via @barronsonline $GILD $ABBV $MRK $JNJRT @Lin_ling_88: $GILD passed up $MDVN..wanted only first-in-class, best-in-breed marquee names 4 real match. $PFE, $MGN can have it https:‚Ä¶RT @Nvestly: RT @JustinPulitzer: Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $GPRO $‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $GPRO $FIT $‚Ä¶ #invest$GILD passed up $MDVN..wanted only first-in-class, best-in-breed marquee names 4 real match. $PFE, $MGN can have it https://t.co/JscY3y59ZpRT SeekingAlpha: Half-Million Dollar Income Project: It Has Been A While https://t.co/XjTfSipYnR $BHI $GILD $HCP $JNJ $KMI $NE $NLY $O $PT‚Ä¶$QQQ $AAPL $GOOG $GILD $MSFT https://t.co/54etHLuKFkHalf-Million Dollar Income Project: It Has Been A While https://t.co/6SsqmJpFlk $BHI, $GILD, $HCP, $JNJ, $KMI, $NE, $NLY, $O, $PTY, $XOMHalf-Million Dollar Income Project: It Has Been A While https://t.co/N3LIZOuhWY $BHI $GILD $HCP $JNJ $KMI $NE $NLY $O $PTY $RCS $TSM $UNHHalf-Million Dollar Income Project: It Has Been A While https://t.co/xXW7uAr8qG $BHI $GILD $HCP $JNJ $KMI $NE $NLY $O $PTY $RCS $TSM $UNH@PDRennert @cornel6m Since when has the ""Just Do It"" company become the ""Just Talk About It"" company? $GILD@PDRennert @cornel6m $GILD rev facing pressure no secret 4 yrs (thus fwd p/e 7x). Targets s/b lined up. Qtr call s/n/b psychotherapy session20 Stocks With A Billion Dollar Buyback Program And Yields Over 2% - https://t.co/G7DgXm5dIA - $BBY $CAH $GILD $K $M $MMM $HON $WYN $SYMC$GILD 'Important deals' on the horizon for Gilead, new CEO says https://t.co/i9oE7VS0hoRT @FiercePharma: 'Important deals' on the horizon for Gilead, new CEO says https://t.co/t5zYa8rzQF $GILD #pharma by @EmilyWFierce@cornel6m virus guy? (pharmasett)- maybe other therapeutic areas lie outside core comfort zone, cause hesitation? admit I'm puzzled by $GILD'Important deals' on the horizon for Gilead, new CEO says https://t.co/t5zYa8rzQF $GILD #pharma by @EmilyWFierce$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/XNX2HmPtmbRT @EmilyWFierce: 'Important deals' on the horizon for Gilead, new CEO says: https://t.co/zUddVaZods $GILD #pharmaRT @Toad: $GILD https://t.co/l7L3Ro4fME$GILD https://t.co/l7L3Ro4fMERT @R4inb0w_: $GILD : Gilead CEO Targets Cancer Acquisitions with 21 Billion Cash Pile https://t.co/13UvXlqJMQ$GILD : Gilead CEO Targets Cancer Acquisitions with 21 Billion Cash Pile https://t.co/13UvXlqJMQRT @VailshireCap: $GILD gets the most attention, but the management, pipeline &amp; vision of both $CELG and $REGN make them best buys for the‚Ä¶Nasdaq100 #Stocks Performance $CERN $REGN $TRIP $MYL $BMRN $DISH $VRTX $GILD $BIIB $ALXN $CELG $AMGN $COST  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Performance $AGN $EMC $GILD $BIIB $TGT $CELG $AMGN $LLY $COST $CVS $MRK $PFE $AAPL $MDT  more@ https://t.co/cKkr8cKsju#GileadSciences Gilead CEO Targets Cancer Acquisitions with $21 Billion Cash Pile  . Read more: https://t.co/eBPmk6dvoU $GILDRT @Taarriqq: Biotech stocks showing strength $GILD  $AMGN $ALXN $XBI $LABU $CELG $BIIB $MNK'Important deals' on the horizon for Gilead, new CEO says: https://t.co/zUddVaZods $GILD #pharmaBiotech stocks showing strength $GILD  $AMGN $ALXN $XBI $LABU $CELG $BIIB $MNK$GILD maturity 05/13/2016 oi CallPutRatio of 0.86 puts 5,311 &amp; calls 6,146 bullish. https://t.co/jALZfrkqQx https://t.co/B62Mzj03oR20 Stocks With A Billion Dollar Buyback Program And Yields Over 2% - https://t.co/G7DgXmmOA8 - $BBY $CAH $GILD $K $M $MMM $HON $WYN $SYMC.
94.57% Avg. Gain
100% Unbiased
 .
https://t.co/2qE8x3zfry 
 .
 .
$CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO https://t.co/G0F0Sawf4z89.32 Next support level or resistance? $GILD            
83.19 temporary support https://t.co/AREYElDJx7Volume Alert - GILD 85.86 Gilead Sciences Inc $GILD Hit a high today of 86.37 Closing the day 10:30 at 85.86 + https://t.co/7JkdZl2FN7$IBB bullish reversal candles on 60 min &amp; daily charts. now see if it can hold. $AMGN $BIIB $CELG $GILD $REGN $ALXN https://t.co/XEUx9LBY2Q@cek_cpa @financialbuzz @ryanwallace198 Long $AAPL $CY $UAL $GILD $KBHAlthough #Gilead has disappointed on sales and earnings, there are many reasons to be optimistic https://t.co/EWuG67OHAV $GILDRT @strictly_trades: Close half size $GILD @86.05 from 84.40 entry #winningtrade https://t.co/fFFiDPtffm +1.95% sharing timestamped entries‚Ä¶Close half size $GILD @86.05 from 84.40 entry #winningtrade https://t.co/fFFiDPtffm +1.95% sharing timestamped entries/exits$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/RNnaSg1m44HCV Killed Nearly 20,000 Americans in 2014 $GILD $RGLS $BMY MRK https://t.co/KMbI320xJCHope you didn't capitulate on Friday. $GILD $AAPLRT @JustinPulitzer: Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $GPRO $FIT $YELP htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $GPRO $FIT $YELP htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $GPRO $FIT $YELP htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $GPRO $FIT $YELP htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $GPRO $FIT $YELP htt‚Ä¶$GILD https://t.co/UUh0j02UTz@danwardbio what about $GBIM should hear about $Gild and $Celg drug before end of Q2GILD Top news - May 9th, 2016 $GILD https://t.co/WQfhIV35tART @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/MtQYNVpemK https:‚Ä¶Strong buy $AGN, $ AMGN, and $GILD today, all technical indicators confirmed signal. Long term play for these stocks, huge upside potential.RT @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/MtQYNVpemK https:‚Ä¶Discount on $GILD Share Price Will Not Last Long
https://t.co/fBjWI1Jwn2RT @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/MtQYNVpemK https:‚Ä¶After the $IBB bounce on Friday, still looking for that $255 lower bound area to provide support. $CELG $GILD #biotech #stocks#Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/MtQYNVpemK https://t.co/hdTQlv0dGFTracking The Parnassus Core Equity Fund - Q1 2016 Update https://t.co/ulvpdpRNkJ $AAPL $AGN $AMAT $CMP $CVS $DE $DHR $EBAY $GAS $GILDPharmalot.. Pharmalittle.. Good Morning.. coffee &amp; headlines are served..https://t.co/A45assNDZL #pharma$VRX $PFE $GILD $GSK #oxycontinWeekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $TSLA $GPRO $FIT $YELP https://t.co/jiwu9xLwy9Commented on Gilead Sciences: Not A Stock For 2016 https://t.co/E3pScNDw08 $GILD5/9 watch list: long $SSYS $HLF $SND short $GILD $SCTY $COP $RCL $LULU $FLR $LC $FCX5/9 watch list: long $SSYS $HLF $SND short $GILD $SCTY $COP $RCL $LULU $FLR $LC $FCXRT SeekingAlpha: Gilead Sciences: Not A Stock For 2016 https://t.co/QyPwqCo4eV $GILD$GILD gets the most attention, but the management, pipeline &amp; vision of both $CELG and $REGN make them best buys for the foreseeable future.Gilead Sciences: Not A Stock For 2016 https://t.co/Csu0SBG9TL $GILDGilead Sciences: Not A Stock For 2016 https://t.co/sa96aHTUkD $GILDRT @bnkinvest: Analysts Forecast 12% Upside For The Holdings of $OEF $GILD $BIIB $AAPL #etfs https://t.co/9HCjJIBQ65RT @ETFChannel: Analysts Forecast 12% Upside For The Holdings of $OEF $GILD $BIIB $AAPL #etfs: Looking at the underlying hold... https://t.‚Ä¶RT @fgusequity: $GILD https://t.co/dZWRGe19sM Pot. intermed bot in Downtrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co‚Ä¶RT @BioStockAddict: Kempen &amp; Co reiterates buy rating on Galapagos and 80 EUR price target. #Filgotinib $GLPG $GILD $ABBV$GILD https://t.co/dZWRGe19sM Pot. intermed bot in Downtrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/HTPBhfx5m6RT @SA_BioTech: Gilead: Hold For Now https://t.co/7MmFCyLrO6 $MRK $MDVN $GILDRT SeekingAlpha: Gilead: Hold For Now https://t.co/ptqxW8GCTg $MRK $MDVN $GILDGilead: Hold For Now https://t.co/7MmFCyLrO6 $MRK $MDVN $GILDGilead: Hold For Now https://t.co/RL3NxdulXz $MRK $MDVN $GILDGilead: Hold For Now https://t.co/z2hn1nNM7j $MRK $MDVN $GILDMy just for fun prediction sure to go wrong: $GILD buys $VRTX, proving all those earlier tumors to be true.$GILD initiated a Phase II trial (NCT02759562) to explore the effect of GS-5745 (anti-MMP9 antibody) on FEV1 adults withcystic fibrosis.MMP9RT @ETFChannel: Analysts Forecast 12% Upside For The Holdings of $OEF $GILD $BIIB $AAPL #etfs: Looking at the underlying hold... https://t.‚Ä¶$GILD high open interest range is 87.50 to 90.00 for option expiration 05/13/2016. bullish https://t.co/jALZfrkqQx https://t.co/rYbnBwkBbzAnalysts Forecast 12% Upside For The Holdings of $OEF $GILD $BIIB $AAPL #etfs https://t.co/9HCjJIBQ65Analysts Forecast 12% Upside For The Holdings of $OEF $GILD $BIIB $AAPL #etfs: Looking at the underlying hold... https://t.co/cUVVqO7UCf@ $GILD looking pretty darn fundamentally cheap here...they are about to buy another company for sure, but when...?? I bet very very soon...$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/v8NXzrWN5PKempen &amp; Co reiterates buy rating on Galapagos and 80 EUR price target. #Filgotinib $GLPG $GILD $ABBVRT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶Insider Selling: Gilead Sciences, Inc. $GILD Chairman Sells $8,782,000.00 in Stock https://t.co/8c31BisuKmRT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶With a yield of 2% Gilead Sciences is a üí∞ dividend üí∞ stock worth a look $GILD https://t.co/nHdTPPnqeu https://t.co/rbHXccywlCRT @R4inb0w_: NASH : ""Milligan is willing to be patient"" $GILD $GNFT Gilead Chief Has $21 Billion in Cash and an Itch to Do a Deal https://‚Ä¶Trading Rules - Discipline and staying strong: https://t.co/vVZZyIZdvD $GILD $TTWO $GM $SCO $REXX $YUM $ABBV $UCO $NXPI $USO $WPRT$GILD:US Allergan: A Better Valeant? An Analysis Coming Into Earnings #GILEAD SCIENCES INC  https://t.co/nnf6XSqIwJ #SP500BUY #Gilead Sciences, Inc., $GILD. Target: 85.25 (+0.67%).
 https://t.co/5e7Mz2Lxi6  #trading #stocks #investingGILD Message Board Posts
See Here ---&gt; https://t.co/QE4FPXQER5

$GILD $UFPI $FBP #financeRT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶RT @ETFdb: [Trending] Central Bank Inaction Moves Markets https://t.co/EA1AdEsJpC #ETF $GILD $GLD https://t.co/d9qTKbfsM9RT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $YELP htt‚Ä¶RT @JustinPulitzer: My Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $GPRO $FIT $YELP ht‚Ä¶RT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶RT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.co/TVCEkmC851RT @odibro: Analysts: Biotech Is Ripe for M&amp;A $RLYP $BIIB $ABBV $GILD $ICPT https://t.co/6v6lXwClhyRT @JustinPulitzer: #StockMarket Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $YELP htt‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $YELP htt‚Ä¶RT @JustinPulitzer: My Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $GPRO $FIT $YELP ht‚Ä¶My Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $GPRO $FIT $YELP https://t.co/jiwu9xLwy9RT @JustinPulitzer: #StockMarket Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $YELP htt‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $YELP htt‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $YELP htt‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $YELP htt‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $YELP htt‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $YELP htt‚Ä¶RT @JustinPulitzer: #StockMarket Weekend Review VIDEO 5/8: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $MSFT $YELP htt‚Ä¶",2016-05-09,GILD,1
25,"RT @raymond10mm: $GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $SPX $NASDAQ $QQQ Big Rally! https://‚Ä¶RT @BioPharmaDive: In reversal, India awards patent to $GILD hepatitis C drug https://t.co/HmksxvbQIwIn reversal, India awards patent to $GILD hepatitis C drug https://t.co/HmksxvbQIwRT @NatalieGrover: Finally: #India Patent Office approves #Gilead's #hepatitis C #drug #patent https://t.co/xhe2Z1xDb7 via @Reuters $GILD #‚Ä¶Finally: #India Patent Office approves #Gilead's #hepatitis C #drug #patent https://t.co/xhe2Z1xDb7 via @Reuters $GILD #Sovaldi$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/vVwW0LSpcHGilead: Hold For Now https://t.co/j6TCMqqPtr $MRK $MDVN $GILD - free #investing book &amp; newsletter= big profits - https://t.co/CzS5PYhx3W$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $SPX $NASDAQ $QQQ Big Rally! https://t.co/L2isOsW7Q8$GILD I&amp;#39;m putting 2/2 together.. Insider Buying heavy at the close then this --&amp;gt; News regarding India.$GILD just saw this. Wow! I&amp;#39;m not a fundamental trader. What does this mean guys? https://t.co/155RU31lQCFor 5 dollars up stocks and options 
$EEM
$EFA
$HYG
$JNK
$CROX
$AAL
$GILD
$XLB
Nice bottom#GileadSciences India Patent Office approves Gilead's hepatitis C drug patent. Read more: https://t.co/hukN57Vc30 $GILD#GileadSciences India Patent Office approves Gilead's hepatitis C drug patent. Read more: https://t.co/J10Xqd8H9Z $GILD$GILD Is Gilead a buy at current prices? https://t.co/uiSbtaQTJt""India has reversed course and granted approval to $GILD's patent for its hepatitis C drug Sovaldi"" https://t.co/iVLaArL8xB@TristanWakely tesla needs a few billion will have no problem getting it. I'm not sure what gilead will do. We're sticking with it. $gild$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/H5hgv3QlPlRT @pharmalot: Reversal of fortune: Gilead gets a big win as India issues #patent for Sovaldi, after all. read ruling https://t.co/cZvcY8Jf‚Ä¶RT @EPVantage: NASH projects set for data in dog days of summer https://t.co/15XZYZcvoM $GNFTF $ICPT $GILD https://t.co/2px3uRxpC9$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/tQHvoArzeu$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/JXhC5jNgZnRT @GeryDIVRY: $GNFT $ICPT $GILD $GLMD
#NASH 
Who is on cover ??
https://t.co/5LgqIgR65TRT @TristanWakely: @GerberKawasaki What's you're thoughts about capital raises needed by $Tsla destroying value? Will $Gild finally buy any‚Ä¶What Factors Will Drive Celgene‚Äôs Valuations in 2016? $ABBV $AMGN $CELG $GILD https://t.co/3qdqXsGZIs@GerberKawasaki What's you're thoughts about capital raises needed by $Tsla destroying value? Will $Gild finally buy anything?!? Ross = #1$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/hSyyZgJE3gGilead Sciences director just picked up 1,466 shares  https://t.co/TNJH5i1ENW $GILD$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/Px6ySJXuxa$GILD:

New Insider Transaction on GILD by Director:

https://t.co/TXKsffYLIF https://t.co/xj0Q8XYpgV$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/lfKAok3g5zCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @tpsnewsletter: Had the pleasure of discussing $AAPL &amp; $GILD on @CNBC today. Check out the replay here: https://t.co/d1QTMqmps1. https:/‚Ä¶Gilead Sciences director just picked up 1,047 shares  https://t.co/NtNISURL8f $GILD$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts App$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/Yglh61Oi6tHad the pleasure of discussing $AAPL &amp; $GILD on @CNBC today. Check out the replay here: https://t.co/d1QTMqmps1. https://t.co/ugh9E9RnT5Is #Gilead Stock A Buy At Current Price? $GILD Also $MRK $ABBV https://t.co/33bY8ExspA$GILD Daily, 20 sma looking to cross 50 sma down you can use this as a possible... https://t.co/JidDEdywcV https://t.co/5qqStneF8t#GileadSciences Gilead gets a big win as India upholds a Sovaldi patent after all. Read more: https://t.co/xRQxHBJrTi $GILDRT @pharmalot: Gilead gets a big win as India upholds a #Sovaldi patent, after all. read the ruling here. https://t.co/cZvcY8JfTJ #pharma $‚Ä¶RT @pharmalot: Reversal of fortune: Gilead gets a big win as India issues #patent for Sovaldi, after all. read ruling https://t.co/cZvcY8Jf‚Ä¶Top 5 right now: CASH, $PEP, $MSFT, $GILD, $GOOGL, $WFM ... saving some cash for $AAPLKA-CHING!! THANKS FOR PLAYING!! $DIA $DIS $GILD $GOOGL $HD $IBM $JNJ $MRK $MSFT $NFLX $PFE $QQQ $SBUX $SPY $UNH $V $XLKRT @pharmalot: Reversal of fortune: Gilead gets a big win as India issues #patent for Sovaldi, after all. read ruling https://t.co/cZvcY8Jf‚Ä¶@santiagoreba @litenpuppe @pricatti escuch√° a santiago,Ricatti! $GILD, $AMGN $BIIB $CELG $KITE $NVS $JNJ son un ej y mi pollo $JUNO tmb ser√°RT @pharmalot: Reversal of fortune: Gilead gets a big win as India issues #patent for Sovaldi, after all. read ruling https://t.co/cZvcY8Jf‚Ä¶RT @pharmalot: Reversal of fortune: Gilead gets a big win as India issues #patent for Sovaldi, after all. read ruling https://t.co/cZvcY8Jf‚Ä¶Reversal of fortune: Gilead gets a big win as India issues #patent for Sovaldi, after all. read ruling https://t.co/cZvcY8JfTJ #pharma $GILDImpressive turnaround day $IBB
w/some red2green

Top 10 holdings, 9/10 nHod
$AMGN $BIIB $CELG $GILD
$REGN $ALXN $VRTX $ILMN $BMRN

$MYL flatRT @jarredtrax: $GILD trying to bottom - I‚Äôd like to try a long over 86.50 https://t.co/dE3GoL4aJS$GILD trying to bottom - I‚Äôd like to try a long over 86.50 https://t.co/dE3GoL4aJS$GILD https://t.co/PSMDaY69n2RT SeekingAlpha: Gilead: The Question Is Not What Just Happened, But What Will Happen Next Quarter https://t.co/cZkO7cyJaa $GILDRT @HenryEChang: India's patent office reversed course &amp; upholds a Sovaldi patent (ruling document‚Üíhttps://t.co/U04h7u12ze) #HCV #HepC $GIL‚Ä¶Gilead: The Question Is Not What Just Happened, But What Will Happen Next Quarter https://t.co/DrntAK1aan $GILDRT @BioStockAddict: Theodoor Gilissen reiterates its buy rating on Galapagos and 75EUR price target. $GLPG $GILD $ABBV #filgotinib #CF http‚Ä¶Gilead: The Question Is Not What Just Happened, But What Will Happen Next Quarter https://t.co/j5BACfpszH $GILDGilead: The Question Is Not What Just Happened, But What Will Happen Next Quarter https://t.co/9ZIHClv7sU $GILDIndia's patent office reversed course &amp; upholds a Sovaldi patent (ruling document‚Üíhttps://t.co/U04h7u12ze) #HCV #HepC $GILD #India$GILD 86.83-86.99 close im looking for this week$GILD trade the chart not the news.. biotechs $LABU $LABD are getting a bad rap.. Go in/out U / D and mk the $$$RT @pharm_specialty: #GileadSciences Gilead's patent on Hep C drug set for a possible challenge. Read more: https://t.co/Aqd8CZv1ge $GILDRT @pharm_specialty: #GileadSciences Gilead's patent on Hep C drug set for a possible challenge. Read more: https://t.co/Aqd8CZv1ge $GILDRT @pharm_specialty: #GileadSciences Gilead's patent on Hep C drug set for a possible challenge. Read more: https://t.co/Aqd8CZv1ge $GILD$GILD $100 PT ALERT!!! #GILD@zerohedge He specified those with actual earnings and seemingly low valuations like $GILD$GILD here comes 86 :}@TVarmageddon @dave3com $GILD have room to get higher when it breaks$GILD here comes 36About to appear on @CNBC Power Lunch. Tune in now to hear my thoughts on $AAPL and $GILD.$GILD Just received a BOOST on CNBC #GILDRT @CarolineYLChen: $GILD's access chief tells me how he sells Sovaldi in poor countries. https://t.co/c62H0ETJ0LRT @CarolineYLChen: $GILD's access chief tells me how he sells Sovaldi in poor countries. https://t.co/c62H0ETJ0LRT @CarolineYLChen: $GILD's access chief tells me how he sells Sovaldi in poor countries. https://t.co/c62H0ETJ0L#GileadSciences Gilead's patent on Hep C drug set for a possible challenge. Read more: https://t.co/Aqd8CZv1ge $GILDAt these levels and below $GILD is cheap enough to start accumulating... Growth will return at some pointRT @toolbox87: It's very likely that $AAPL buy back program to kick in any minute. My TP Short term $102. $TSLA $AMZN $FB $TWTR $NFLX $GILD‚Ä¶$GILD 36.18 close is veryRT @toolbox87: It's very likely that $AAPL buy back program to kick in any minute. My TP Short term $102. $TSLA $AMZN $FB $TWTR $NFLX $GILD‚Ä¶RT @pharmalot: Gilead gets a big win as India upholds a #Sovaldi patent, after all. read the ruling here. https://t.co/cZvcY8JfTJ #pharma $‚Ä¶It's very likely that $AAPL buy back program to kick in any minute. My TP Short term $102. $TSLA $AMZN $FB $TWTR $NFLX $GILD $SNDK $SCTYYest made for a good trade in #biotech #stocks off the open $256 $IBB bounce. Today disappointing with $GILD early dump. Reevaluating, $CELGRT @pharmalot: Gilead gets a big win as India upholds a #Sovaldi patent, after all. read the ruling here. https://t.co/cZvcY8JfTJ #pharma $‚Ä¶RT @Logribel: ""#Elafibranor induces resolution of #NASH"" on the cover of Gastroenterology @AmerGastroAssn $GNFT $ICPT $GILD $GNFTF https://‚Ä¶RT @GeryDIVRY: $GNFT $ICPT $GILD $GLMD
#NASH 
Who is on cover ??
https://t.co/5LgqIgR65T$GILD only 12% of HCV patients have been treated. I can see $RGLS has still lots of potential market to take out. https://t.co/Z43P5ar6gYRT @BursatilBiotech: Notici√≥n para $GILD y tambi√©n para el mercado hind√∫. Atentis ac√°, Ojo. Ojo (para bien) 
@arielsbdar https://t.co/ccsrt‚Ä¶Gilead gets a big win as India upholds a #Sovaldi patent, after all. read the ruling here. https://t.co/cZvcY8JfTJ #pharma $GILD #hepatitisC$GILD AND $GLPG agreement sheds a light on value of anti inflammation drugs/targets.. $VTAE ,, and now $FATE watch https://t.co/X2b6kEeOn1$GILD areas of focus presented @BankofAmerica https://t.co/fIuvl1ESIsNotici√≥n para $GILD y tambi√©n para el mercado hind√∫. Atentis ac√°, Ojo. Ojo (para bien) 
@arielsbdar https://t.co/ccsrtwckrz$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/bqja0PGXe0RT @FiercePharma: India awards Gilead patent for Sovaldi, disappointing civic groups https://t.co/c6qgGHJVyD $GILDRT @FiercePharmAsia: India awards Gilead patent for Sovaldi, disappointing civic groups https://t.co/0EjIE2jNpp $GILDGENFIT $GNFT $ICPT $GILD $GALE GALMED #NASH  https://t.co/k5mIisD9sbRT @FiercePharma: India awards Gilead patent for Sovaldi, disappointing civic groups https://t.co/c6qgGHJVyD $GILDRT @FiercePharma: India awards Gilead patent for Sovaldi, disappointing civic groups https://t.co/c6qgGHJVyD $GILDIndia awards Gilead patent for Sovaldi, disappointing civic groups https://t.co/c6qgGHJVyD $GILDIndia awards Gilead patent for Sovaldi, disappointing civic groups https://t.co/0EjIE2jNpp $GILDVolume Alert - GILD 85.67 Gilead Sciences Inc $GILD Hit a high today of 86.48 Closing the day 10:30 at 85.67 u https://t.co/8s8vWJ6sHyRT @tpsnewsletter: I'll be live from New York on @CNBC Power Lunch today at 1:40pm ET! Tune in to hear my thoughts on $AAPL and $GILD.Did Regeneron Pharmaceuticals Beat Earnings Estimates in 1Q16? $AMGN $CELG $GILD $IBB https://t.co/or4bylE6jCI'll be live from New York on @CNBC Power Lunch today at 1:40pm ET! Tune in to hear my thoughts on $AAPL and $GILD.$AAPL $GOOGL $GILD $MSFT $PCLN etc. from last week https://t.co/gS3gZAcrAT$WFM @ $30.34 $GILD @ $86.04 $NFLX $90.25RT @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/3Ej08WoGPs https:‚Ä¶RT @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/3Ej08WoGPs https:‚Ä¶RT @outsizedreturn: Americas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/NzhTUzgR83 htt‚Ä¶RT @outsizedreturn: Americas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/NzhTUzgR83 htt‚Ä¶RT @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/3Ej08WoGPs https:‚Ä¶Connor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/DgrNThhkJM  $DIS $ALXN $NOAH $GILD $QUNRAmericas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/NzhTUzgR83 https://t.co/TGGMEKhfJeRT SeekingAlpha: Best And Worst Q2'16: Health Care ETFs, Mutual Funds And Key Holdings https://t.co/TjVWrSW9sS $LLY $GILD $SWHFX $AHSAX $B‚Ä¶RT @michael007here: courtesy of @kevenv13 Arrowheads new digs! Why they NEED larger digs? hmm? opn lbl trials ARC520  HepB $ARWR $GILD ? ht‚Ä¶#Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/3Ej08WoGPs https://t.co/Go9FNmr0S1Best And Worst Q2'16: Health Care ETFs, Mutual Funds And Key Holdings https://t.co/8Wj5wvoeES $LLY $GILD $SWHFX $AHSAX $BBP $IXJBest And Worst Q2'16: Health Care ETFs, Mutual Funds And Key Holdings https://t.co/MnDTW4ysuT $LLY $GILD $SWHFX $AHSAX $BBP $IXJtoday interesting presentation @BankofAmerica .. including $GILD and $JUNO. will  update if anything interesting$GILD continues to consolidate at $85s - looks good for an entry but you have some time for sureMichael brush says stocks can power out of a slump $http://on.mktw.net/1TCcJRV $STX $GT $GILD https://t.co/jNdTK2aQn7$GILD / $WFM Added a lot to both on this churn downwards TYDate  Time                 Last
5/9/20164:00:00 PM85.6700 Volume:797,420
$GILD Block TradeGILD Top news - May 10th, 2016 $GILD https://t.co/20cDWFIGGpRT @Logribel: ""#Elafibranor induces resolution of #NASH"" on the cover of Gastroenterology @AmerGastroAssn $GNFT $ICPT $GILD $GNFTF https://‚Ä¶@CT_Morrison @JohnCFierce what they have innovated lately?$celg follows $gild $amgn as it gets bigger and fatter.On our oversold list, $AAPL, $M, $GILD, $CCL, $HPE, $KR at https://t.co/FZPcGT2Duw https://t.co/S55mukhPc4On our oversold list, $AAPL, $M, $GILD, $CCL, $HPE, $KR at https://t.co/FZPcGSL2CYOn our oversold list, $AAPL, $M, $GILD, $CCL, $HPE, $KR at https://t.co/FZPcGT2DuwRT @Tootix: #NASH Therapeutics Market to Reach US$20.27 bn by 2025, #Elafibranor Projected to Spur Growth https://t.co/6rrqa34kXq $GNFT $IC‚Ä¶@JohnCFierce You feel only $PFE could afford?  You don't think $GILD could work out the financing?$GILD  (don't just talk!) $AGN $SNY $MRK $PFE https://t.co/XamAOWFOS6RT @Logribel: ""#Elafibranor induces resolution of #NASH"" on the cover of Gastroenterology @AmerGastroAssn $GNFT $ICPT $GILD $GNFTF https://‚Ä¶$MRK $PFE $GILD $AZN $AGN and many more.... https://t.co/5xmhct3z05$gild ~ accumulate and hold... https://t.co/Ql9xWaImH1$GILD PT ALERT! 94.22$WFM $GILD 10% Runner ALERT!!!@JasonHolman5 To recap DART license(not prtnr)prgms; $MGNX still potentially has $GILD w/1trgt,Boeh. Ing. w/1 trgt(preclin)&amp;Takeda w/3 trgts""#Elafibranor induces resolution of #NASH"" on the cover of Gastroenterology @AmerGastroAssn $GNFT $ICPT $GILD $GNFTF https://t.co/x9uNcDtn3j$GILD on the watchlist for a breakout above 86.50$ https://t.co/NOQDPEERazRT @TylerHCanalyst: $GILD GS-5745 in CF

https://t.co/KBSMNVcmXM$GILD GS-5745 in CF

https://t.co/KBSMNVcmXMRT @tgtxdough: @BioStocks come on $AGN and $GILD   Buy some companies also.@adamfeuerstein @brentlsaunders $gild said the same thing 2 years ago and stuck to their conclusion while some valuat cut in half since then$GILD looking nice this morning.@BioStocks come on $AGN and $GILD   Buy some companies also.A new PM high for $GILD was just reached.  GILD $86.48 @ 6:15:18 AM.  Found with MOMO Stock  app by Mometic. https://t.co/m3XDmR9AVcRT @BioStockAddict: Theodoor Gilissen reiterates its buy rating on Galapagos and 75EUR price target. $GLPG $GILD $ABBV #filgotinib #CF http‚Ä¶RT @Lin_ling_88: $GILD granted Sovaldi patent in India. Big deal. https://t.co/IAgq4PwrdE$GILD granted Sovaldi patent in India. Big deal. https://t.co/IAgq4PwrdERT @FiercePharma: 'Important deals' on the horizon for Gilead, new CEO says https://t.co/t5zYa8rzQF $GILD #pharma by @EmilyWFierceMOS Short Sales
See Here ---&gt; https://t.co/qIsDi3Atay

$MOS $CLUB $GILD #shareSCHW Day High
See Here ---&gt; https://t.co/mjCpmRh49A

$SCHW $GILD $PX #financeIs Gilead Stock A Buy At Current Price? $GILD https://t.co/uiSbtaQTJt https://t.co/jjcgtbVsUyRT @BioStockAddict: Theodoor Gilissen reiterates its buy rating on Galapagos and 75EUR price target. $GLPG $GILD $ABBV #filgotinib #CF http‚Ä¶Theodoor Gilissen reiterates its buy rating on Galapagos and 75EUR price target. $GLPG $GILD $ABBV #filgotinib #CF https://t.co/pKnE7YkM8Shttps://t.co/p7tVeIZFvX Millionaire Road Map Trading top students win a Porsche for a yr! $LNKD $CVX $GILD $STX $P#GileadSciences Gilead's $1,000 pill gets patent in India. Read more: https://t.co/z8ajzNS7b0 $GILD#GileadSciences Gileads US$ 1,000 pill gets patent in India and other top pharma news. Read more: https://t.co/cfpeJ4I668 $GILDCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5$GNFT $ICPT $GILD $GLMD
#NASH 
Who is on cover ??
https://t.co/5LgqIgR65TGILD Ideas
See Here ---&gt; https://t.co/szgNlwzfQX

$GILD $ROK $HTGM #tradeideasRT @Tootix: #NASH Therapeutics Market to Reach US$20.27 bn by 2025, #Elafibranor Projected to Spur Growth https://t.co/6rrqa34kXq $GNFT $IC‚Ä¶RBC video 
https://t.co/yYrnFfrTjA

1. $VRTX (5:58)
2. $GILD (10:31)
3. $BIIB (13:04)
4. $CELG (17:30)
5. $BMRN (19:07)
6. $ICPT (21:56)RT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpMUFG Americas Holdings Corp Has $13,291,000 Position in Gilead Sciences, Inc. $GILD https://t.co/0BS6mbcrc9MUFG Americas Holdings Corp Has $13,291,000 Position in Gilead Sciences, Inc. $GILD https://t.co/oC8HjTUofcGilead Sciences, Inc. $GILD Shares Sold by Deere &amp; Co. https://t.co/HIpgCmfFAPGilead Sciences, Inc. $GILD Shares Bought by Coho Partners Ltd. https://t.co/x0SC9NkSLbGilead Sciences, Inc. $GILD Shares Bought by Coho Partners Ltd. https://t.co/9WCmXUhqCUFort Washington Investment Advisors Inc. OH Has $5,985,000 Position in Gilead Sciences, Inc. $GILD https://t.co/G6Cj0dbZnfCommented on StockTwits: 3 buys tomorrow $UA (39) $GILD (86) $PLCE (72) https://t.co/xdYDFqSRnyRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @2020Investing: #Sovaldi is a $5B+ drug for $GILD.  Lots at stake in India https://t.co/7h63x7ge2BRT @2020Investing: #Sovaldi is a $5B+ drug for $GILD.  Lots at stake in India https://t.co/7h63x7ge2BCommented on Gilead: Hold For Now https://t.co/IcK4GSNTKJ $MRK $MDVN $GILD$LABU Bullish on BIOTECH but will be playing $GILD$GILD first time GILD didn't blow top off guidance in 5 qrtrs...GILD has no historical experience in global if u are counting on EX-USRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpSlowing hep c revenue on $GILD but higher volumes on lower margins. Doesn't that work against the bear theory of the stock? #biotech #stocksGilead Sciences: Not A Stock For 2016 https://t.co/5MlU4MHh3T $GILDRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfp#Sovaldi is a $5B+ drug for $GILD.  Lots at stake in India https://t.co/7h63x7ge2BRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfp$IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶",2016-05-10,GILD,0
26,"Below Price Channel https://t.co/XDn0RAREhX $ENDP $JCP $CJES $NKE $KSS $GILD $POTG $PTX $GDSI $BIDU $ZTS $CYTX $NVAX $VDRM $SGYP $KKR $NEIKRichard Bernstein Advisors LLC Has $5,619,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/MMnFdVls1Y$GILD:US Gilead patent to hit millions of patients outside India #GILEAD SCIENCES INC  https://t.co/UvNT71BBoG #NASDAQCharts of Interest - $IBB $CELG $REGN $ILMN $GILD https://t.co/8op6DlveWVGilead Sciences, Inc. $GILD Stake Raised by Great Lakes Advisors LLC https://t.co/VHTofXLKuvRT @stockspastor: Bio-tech stocks sold off today.  Expect a reversal tomorrow going to next week.  $IBB, $GILD, $AMGN $PFE, $MRK@jimcramer I bought $GILD at $107 and it's down in the 80's. Hold or sell...?India Patent Office reverse course and grants patent to $GILD's Sovaldi https://t.co/HmksxuUfjWRT @quack1612: $SPY #SPX $QQQ $GILD #Gilead Gets Approval in India https://t.co/w4oVSv9kSa https://t.co/p9hC9pKvZHRT @quack1612: $SPY #SPX $QQQ $GILD #Gilead Gets Approval in India https://t.co/w4oVSv9kSa https://t.co/p9hC9pKvZHRT @quack1612: $SPY #SPX $QQQ $GILD #Gilead Gets Approval in India https://t.co/w4oVSv9kSa https://t.co/p9hC9pKvZH$SPY #SPX $QQQ $GILD #Gilead Gets Approval in India https://t.co/w4oVSv9kSa https://t.co/p9hC9pKvZHBio-tech stocks sold off today.  Expect a reversal tomorrow going to next week.  $IBB, $GILD, $AMGN $PFE, $MRK@pawcio2009 @srqstockpicker at this point, only thing that will move us is if major firms like $gild $celg just go into the open marketAnother great day in room! All traders green -most hit daily goal in 30min &amp; were done for day. Traded $KORS $M $ADBE $PYPL $GILD $UVXYLarge Put Buying https://t.co/GtYP6kUHh9 $GPS $MGM $BEAV $WEN $WWE $HES $FCX $KGC $NFLX $GILD $AMZNRT @bigbear083: $SPX #StockMarket map at the close today $DIS $WMT $NFLX $AMZN $NKE $GOOGL $MSFT $GILD more@ https://t.co/jVWRiII5eu https:‚Ä¶@ $GILD Start buying up growth with the cash instead of repurchases. No real growth in repurchases besides inflating EPS.Need Revenue Growth$SPX #StockMarket map at the close today $DIS $WMT $NFLX $AMZN $NKE $GOOGL $MSFT $GILD more@ https://t.co/jVWRiII5eu https://t.co/V3ufGczKDd$GILD 84.13 Close it looks like.. I'll tk it$GILD $B 20 in cash, PEGilead Sciences hits a 1 quarter low https://t.co/aE2bhADJXH $GILD #GileadSciences https://t.co/ZFS3kcLFzE$IBB 4hr bear flag resolves at 230 $xbi $labu $gild $QQQ $SPY https://t.co/H3K89keebz$GILD Always tomorrow.10d of $GILD, Ugly wow $IBB $XBI https://t.co/P3CLMLL8xJ$GILD close over 84.01.$GILD its clarified GILD will not pass $84.01.. 2 day push coming$GILD 1 TIME! #TomDwan$GILD PT $84.44 CLOSE?!?!?$GILD $84.01 support, moved chart-line floor.. 5 day chart 86.26 resistance$IBB &amp; $GILD still look pretty bad.$GILD @bbear Give it a day or two and they'll disappear https://t.co/vtuoCqx0ehGilead Sciences Blessed with Victory as #India Approves #Sovaldi Patent $GILD  ‚ûú   https://t.co/OpOxcbfW7C https://t.co/gBBCJxCOkbWe calculated 63-day Expected Return of $GILD for you: 0.2% https://t.co/mTgAzTSiLDPatent not to affect hepatitis C drug price in India: #GileadSciences Inc. Read more: https://t.co/6aOqDwPnl5 $GILD#GileadSciences India approves Gilead's hepatitis C drug patent. Read more: https://t.co/zXqPxObNA8 $GILD$GILD one of the best companies in existence and a PE under 9??????????@NotaBubble @yusschr @gorechristophe2 @7wtc  See $GILD ? fm $96 to $84 in a blink. Guidance &amp; earnings didn't help. But still ? unwarrantedPopular: $ENDP, $GILD, $VRX, $ODP, $WMT, $ECA, $GOOGL#Options #maxpain chart for $GILD. #option #invest More with #OptionsPro FREE app at https://t.co/vmQaxw1x1K https://t.co/ZqOPpg5vwU$GILD nope 84.40-84.57 basing https://t.co/59NJ2NUADWLooks like $GILD has been making a steady move, as Bollingers have expanded. More to come? https://t.co/e0soWde8io‚Ä¶ https://t.co/1Kcp2nNxeG$GILD #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/rWU3El59cb$GILD And let the covering commence!!$GILD $84.60 is my EOD closing target$GILD 2% is congrats? C'mon we all know where Bio $IBB / $LABU will be by weeks end. Lets just hope y'all cover i... https://t.co/w7Mlv4C2xz$GILD $LABU $LABD Staying under $48.95 is very BULLISH for LABU &amp; $IBB$GILD trading at a 20% discount, time to grab a bargain? https://t.co/TcaGaeAbFl https://t.co/sWfiqwmmPr$GILD $IBB still above 258.60 is very strong.. Markets are cycling $LABU needs to cross over $26.20 by EOD to push higher tomorrow$GILD those that are short will be covering by EOD tomorrow.  Recovering to $86 Soon$GILD Broke thru but still holding thru till friday.$GILD Looking for $85 EOD#GileadSciences India Patent Office approves Gilead's hepatitis C drug patent. Read more: https://t.co/1vZtZzhrnv $GILD$GILD Forming a base around $84.37$GILD Should get bk to $86.27 soon$GILD Lets hold $84.33 baseSorry, $ADRO $MNTA $GILD You are no more able to reduce Intratumor Pressure and penetrate PDA w/o $HALO HA reduc'n than were $THLD &amp; $NLNKPatent not to affect #hepatitis C drug price in #India‚Üíhttps://t.co/YJY7k0HMUv via @timesofindia #HCV #HepC $GILD#GileadSciences Gilead Blessed with Victory as India Approves Sovaldi Patent. Read more: https://t.co/q2ORrdGKUH $GILD$GILD Don't see the reason why this is nearing Feb low's best in BIO block$CELG platforms .. a very different company than $GILD https://t.co/tJelEwWFge#GileadSciences Gilead Elated as India Upholds Sovaldi Patent  . Read more: https://t.co/pk4w5ZjAVs $GILDluckily out before earnings. Would give it a shot around $80 if dips that low. Good luck bulls. $GILD$PACB $IDTI My two spec plays are running today.. Added $MOBL to the spec list.. C'mon $GILD great news from India shouldve moved the niddle@bret_jensen Is $GILD @GileadSciences management ever going to make an acquisition and get this stock back to highs?ICYMI: Indian Patent Office overturns Sovaldi ruling https://t.co/zdQTKqMVfQ via @BioCentury $GILDRT @Biotech2050: Cytokine IL-12 + Veledimex as monotherapy 
Did you read this @gileadSciences $GILD $ZIOP $XON @Intrexon?
 https://t.co/eyR‚Ä¶RT @Biotech2050: Cytokine IL-12 + Veledimex as monotherapy 
Did you read this @gileadSciences $GILD $ZIOP $XON @Intrexon?
 https://t.co/eyR‚Ä¶Cytokine IL-12 + Veledimex as monotherapy 
Did you read this @gileadSciences $GILD $ZIOP $XON @Intrexon?
 https://t.co/eyRPb3gE7LRT @anky7544: Recap today's buy list: $BIDU, $TSLA, $GS, $AMGN, and $GILD.Recap today's buy list: $BIDU, $TSLA, $GS, $AMGN, and $GILD.RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Treating Hepatitis C Treatment https://t.co/kbPYBRoCzm‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Treating Hepatitis C Treatment https://t.co/kbPYBRoCzm‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Treating Hepatitis C Treatment https://t.co/kbPYBRoCzm‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Treating Hepatitis C Treatment https://t.co/kbPYBRoCzm‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Hepatitis C Treatment Sovaldi https://t.co/kbPYBRoCzm $‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Treating Hepatitis C Treatment https://t.co/kbPYBRoCzm‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Hepatitis C Treatment Sovaldi https://t.co/kbPYBRoCzm $‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Treating Hepatitis C Treatment https://t.co/kbPYBRoCzm‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Treating Hepatitis C Treatment https://t.co/kbPYBRoCzm‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Hepatitis C Treatment Sovaldi https://t.co/kbPYBRoCzm $‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Treating Hepatitis C Treatment https://t.co/kbPYBRoCzm‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Hepatitis C Treatment Sovaldi https://t.co/kbPYBRoCzm $‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Treating Hepatitis C Treatment https://t.co/kbPYBRoCzm‚Ä¶RT @marketexclusive: India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Hepatitis C Treatment Sovaldi https://t.co/kbPYBRoCzm $‚Ä¶India Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Hepatitis C Treatment Sovaldi https://t.co/kbPYBRoCzm $GILDIndia Grants Patent To Gilead Sciences, Inc. (NASDAQ:GILD) For Treating Hepatitis C Treatment https://t.co/kbPYBRoCzm $GILDI'm Still Buying Allergan In My Portfolio Despite The Increase In Price https://t.co/ncDa12QCAU $AGN, $SWKS, $GILD, $EVNext plays on Friday $ODP $UA Im watching here may sell 1/2 $GILD / $WFM and load in these two.. Someone will buy... https://t.co/gq2bS4kAJ620 Stocks With A Billion Dollar Buyback Program And Yields Over 2% - https://t.co/G7DgXm5dIA - $BBY $CAH $GILD $K $M $MMM $HON $WYN $SYMC$WFM $PACB $NFLX breaking even, EVEN with $GILD dropping here.. Always hedge your positions@jimcramer $AAPL, $GILD - Buying.$GILD has just reached a new high at 84.88.  Found with MOMO Stock Breakout App @ https://t.co/1WLje7D8rC@Stephanie_Link @karenfinerman @GuyAdami Buying $GILD. Way too cheap.Winton Capital Reduces Size of Several Top Holdings Entering Q2
$GT, $EBAY, $GILD, $AAPL, $IBM
https://t.co/L0DAkmoyjXWinton Capital Reduces Size of Several Top Holdings Entering Q2
$GT, $EBAY, $GILD, $AAPL, $IBM
https://t.co/Lz2wusIkKZBuy list to hold for next 2 weeks: $AMGN, $GILD, $GS, and $TSLA. More upside breakout potential. Very attractive entry level here.@JDR1024 @cek_cpa @ryanwallace198 does $GILD have a buyback program? they need it asap because its going to hit back 52 week low if not$GILD This HIV Drug maker is on the cheap. ‚öóüî¨üíä #stocks #onthecheap #MillennialMoney https://t.co/O3TozsqCNR@financialbuzz @cek_cpa @ryanwallace198 Bought $GILD here under $86.$MJTK BIG REVS/NEWS COMING... Check out DD here https://t.co/xDhS0mzelG

$FB $AAPL $GILD $AMZN $STJ $LNKD 
https://t.co/8AzYLxZly0Netflix, Apple, and Gilead have absolutely been forgotten by the market as stocks.  Are they shitty companies now??  $GILD $AAPL $NFLXGILD Top news - May 11th, 2016 $GILD https://t.co/rv2rSZwrgZ$gild - does she deserve to be trading down here at 85? On watchIn reversal, India awards patent to $GILD hepatitis C drug https://t.co/HmksxuUfjWRT @AshishSPatel: India Patent Office approves Gilead's hepatitis C drug patent https://t.co/zO77BQfDQJ $GILD #GileadRT @GeryDIVRY: $GNFT $ICPT $GILD $GLMD
#NASH 
Who is on cover ??
https://t.co/5LgqIgR65TThe $5000 Question: What One Stock Is Buy And Hold Forever? https://t.co/yyFqC6McB1 $AAPL $AXP $COST $F $GILD $IBB $INVN $MRK $NXPI $PFERT @Logribel: ""#Elafibranor induces resolution of #NASH"" on the cover of Gastroenterology @AmerGastroAssn $GNFT $ICPT $GILD $GNFTF https://‚Ä¶RT @GeryDIVRY: $GNFT $ICPT $GILD $GLMD
#NASH 
Who is on cover ??
https://t.co/5LgqIgR65TRT @optionalarmchat: $GILD has my attention, $87-$87.50 could be a spot to try calls.  $IBB looks ready to stretch its legs a bit.RT @HenryEChang: India's patent office reversed course &amp; upholds a Sovaldi patent (ruling document‚Üíhttps://t.co/U04h7u12ze) #HCV #HepC $GIL‚Ä¶RT @fgusequity: $GILD https://t.co/dZWRGe19sM Pot. pullback in Downtrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/dv4‚Ä¶$GILD https://t.co/dZWRGe19sM Pot. pullback in Downtrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/dv4fEyyyTUBUY #Gilead Sciences, Inc., $GILD. Target: 87.30 (+1.30%).
 https://t.co/5e7Mz2Lxi6  #trading #stocks #investing$GILD has my attention, $87-$87.50 could be a spot to try calls.  $IBB looks ready to stretch its legs a bit.RT @MikeF_trading: $GILD still a good long on the break of 86.50$ resistance https://t.co/hMnWcG7SmWAnyone follow $GILD closely? If so, what are your thoughts?RT @MikeF_trading: $GILD still a good long on the break of 86.50$ resistance https://t.co/hMnWcG7SmW$GILD still a good long on the break of 86.50$ resistance https://t.co/hMnWcG7SmW$GILD $CELG $BIIB $ALXN $AMGN https://t.co/I2gajuKKdoCommented on Merck May Need More Than Just Bolt-On Acquisitions https://t.co/rP6RvFuDZe $ABBV $BMY $GILD $PFE $MRKRT @GeryDIVRY: $GNFT $ICPT $GILD $GLMD
#NASH 
Who is on cover ??
https://t.co/5LgqIgR65TRT @R4inb0w_: $GILD : Gilead CEO Targets Cancer Acquisitions with 21 Billion Cash Pile https://t.co/13UvXlqJMQRT @Moneyflipp: Trades ideas May 11 $SPX $EA $SWHC $PII $CP $TSN $FISV $RCL $CTRP $GILD $WFM $BA $RAI By: Moneyflip @watchhimtrade https://‚Ä¶$GILD CC: onco strategy is kinase combs for B-cell cancers: BTK, JAK1/2, SYK, PI3K. With purchase of Nimbus ACC program, v bullish on NASH$SPX $EA $SWHC $PII $CP $TSN $FISV $RCL $CTRP $GILD $WFM $BA $RAI https://t.co/WhQmFvFyVOThe $5000 Question: What One Stock Is Buy And Hold Forever? https://t.co/9e1ZTuIOLE $AAPL $AXP $COST $F $GILD $IBB $INVN $MRK $NXPI $PFERT @AshishSPatel: India Patent Office approves Gilead's hepatitis C drug patent https://t.co/zO77BQfDQJ $GILD #GileadRT @techwhitepapers: $GILD AND $GLPG agreement sheds a light on value of anti inflammation drugs/targets.. $VTAE ,, and now $FATE watch htt‚Ä¶India Patent Office approves Gilead's hepatitis C drug patent https://t.co/zO77BQfDQJ $GILD #GileadTop Buy Stocks: $DE, $GILD, $HLT, $INTC, $JPM, $MDLZ  https://t.co/aADT5jrD5BRT @Roboviper: Last month we took profits and closed out our position in $CHRW. 
We added to our positions in $FB $GILD $CTSH and $BWLDLast month we took profits and closed out our position in $CHRW. 
We added to our positions in $FB $GILD $CTSH and $BWLDintriguing to see #Sovaldi patent ""granted"" in India after $GILD had already effectively surrendered earnable economic rent on its IP.RT @toolbox87: $AAPL Chart of the week analysis, Have a look below. $TSLA $AMZN $FB $TWTR $NFLX $GILD $SNDK $SCTY, Long $AAPL https://t.co/‚Ä¶Is #Gilead Stock A Buy At Current Price? $GILD Also $MRK $ABBV https://t.co/33bY8ExspA$AAPL Chart of the week analysis, Have a look below. $TSLA $AMZN $FB $TWTR $NFLX $GILD $SNDK $SCTY, Long $AAPL https://t.co/MxTquAO1EnConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNRCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v510 Potential Dividend Champs With An Impressing Outperformance - https://t.co/oPmuhyTgGY - $DIS $NKE $RAI $SBUX $V $COST $GILD@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/mMiqzR3mnBRT @pharmalot: Reversal of fortune: Gilead gets a big win as India issues #patent for Sovaldi, after all. read ruling https://t.co/cZvcY8Jf‚Ä¶RT @SA_HealthInvest: I'm Still Buying Allergan In My Portfolio Despite The Increase In Price https://t.co/EVvCoXnoA7 $SWKS $GILD $EV $AGNRT @SA_HealthInvest: Merck May Need More Than Just Bolt-On Acquisitions https://t.co/1WuxWVPABq $ABBV $BMY $GILD $PFE $MRKRT @pharmalot: Reversal of fortune: Gilead gets a big win as India issues #patent for Sovaldi, after all. read ruling https://t.co/cZvcY8Jf‚Ä¶RT @Logribel: ""#Elafibranor induces resolution of #NASH"" on the cover of Gastroenterology @AmerGastroAssn $GNFT $ICPT $GILD $GNFTF https://‚Ä¶HYGS P/E Ratio
See Here ---&gt; https://t.co/tYoBQqGm4e

$HYGS $GILD $APDN #finance$GILD:US Gilead patent to hit millions of patients outside India #GILEAD SCIENCES INC  https://t.co/g9KuxaSd1m #NASDAQRT SeekingAlpha: Merck May Need More Than Just Bolt-On Acquisitions https://t.co/M4HWXdb8j6 $ABBV $BMY $GILD $PFE $MRKMerck May Need More Than Just Bolt-On Acquisitions https://t.co/1WuxWVPABq $ABBV $BMY $GILD $PFE $MRK$IMUC ImmunoCellular Therapeutics news: $GILD Gilead CEO Targets Cancer Acquisitions with $21.0 Billion Cash Pile https://t.co/dRV4iMMlVaRT SeekingAlpha: I'm Still Buying Allergan In My Portfolio Despite The Increase In Price https://t.co/aMnDp2Ia3p $SWKS $GILD $EV $AGNI'm Still Buying Allergan In My Portfolio Despite The Increase In Price https://t.co/gogjLRLG4g $SWKS $GILD $EV $AGNI'm Still Buying Allergan In My Portfolio Despite The Increase In Price https://t.co/EVvCoXnoA7 $SWKS $GILD $EV $AGNI'm Still Buying Allergan In My Portfolio Despite The Increase In Price https://t.co/bBuSxj62i3 $SWKS $GILD $EV $AGNI'm Still Buying Allergan In My Portfolio Despite The Increase In Price https://t.co/isdxKgaAbb $SWKS $GILD $EV $AGN@BioBoyScout straegic investor may be better. If $GILD too dumb to invest-Baker brothers fine. They r buying. Look at $ACAD 3billion$. $ARWR#GileadSciences Indian Patent Office overturns Sovaldi ruling. Read more: https://t.co/a7h0AMr5gh $GILDEmployees Retirement System of Texas Lowers Position in Gilead Sciences, Inc. $GILD https://t.co/c6ybIFhauVRoosevelt Investment Group Inc. Sells 4,424 Shares of Gilead Sciences, Inc. $GILD https://t.co/BQmjiFwDcQIs #Gilead Stock A Buy At Current Price? $GILD Also $MRK $ABBV https://t.co/8owgzrVfQl$GILD Should you buy Gilead here? https://t.co/uiSbtaQTJtGilead Sciences, Inc. $GILD Shares Sold by Hartford Investment Management Co. https://t.co/70d9MTX68iRT @George323818: $GILD Gilead gets Indian patent for #hepatitis #drug #Sofosbuvir #biotech #biopharma  https://t.co/8GBnCyDha1Trades ideas May 11 $SPX $EA $SWHC $PII $CP $TSN $FISV $RCL $CTRP $GILD $WFM $BA $RAI By: Moneyflip @watchhimtrade https://t.co/Mf4OulcFlwRT @NatalieGrover: Finally: #India Patent Office approves #Gilead's #hepatitis C #drug #patent https://t.co/xhe2Z1xDb7 via @Reuters $GILD #‚Ä¶RT @ChinaInvest: RT SeekingAlpha: The $5000 Question: What One Stock Is Buy And Hold Forever? https://t.co/DfmVfBNU8u $AAPL #APPLE $AXP $CO‚Ä¶Our DCF has $GILD available at a 20% discount - why the sale??: https://t.co/jomgDzQJfF https://t.co/ZqYpZwM09dRT @HenryEChang: India's patent office reversed course &amp; upholds a Sovaldi patent (ruling document‚Üíhttps://t.co/U04h7u12ze) #HCV #HepC $GIL‚Ä¶$GILD Gilead gets Indian patent for #hepatitis #drug #Sofosbuvir #biotech #biopharma  https://t.co/8GBnCyDha1WMT Current Price
See Here ---&gt; https://t.co/5CGlWnRa44

$WMT $GILD $FITX #investRT SeekingAlpha: The $5000 Question: What One Stock Is Buy And Hold Forever? https://t.co/DfmVfBNU8u $AAPL #APPLE $AXP $COST $F $GILD $IBB‚Ä¶https://t.co/uAcamNRUPt alerted $BIND +49% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/F8iKSLizL2 $HOT $AMAT $ITUB $MT $GILD $HST $AAGILD Tick
See Here ---&gt; https://t.co/9DpZN5sM6Q

$GILD $ENTA $KS #investingRT @BioPharmaDive: In reversal, India awards patent to $GILD hepatitis C drug https://t.co/HmksxvbQIwACRX Financials
See Here ---&gt; https://t.co/Lb7Ehgj0id

$ACRX $GILD $NGG #tradeideasRT @biotechinvstr: $GILD CEO re: CAR-T - ""very labor intensive... expensive/akin to BMT/lot of costs... make me nervous"" $KITE $JUNO https:‚Ä¶Today`s #unusualprofits #options: $DIS $ENDP $ERIC $FIS $GILD $HRB $SCTY via https://t.co/MBahY6U0fH https://t.co/3oeI97IzNKGilead Sciences, Inc. $GILD Position Boosted by Federated Investors Inc. PA https://t.co/1UMTaSAsAIBull Sig Reversal https://t.co/RStVWrvphC $CHKP $CLMS $CYRN $EZA $FOLD $GILD $IMDZ $MLNX $MMYT $OMEX $SMCI $XPO$GILD A Biotech Giant Goes on Sale-Kiplinger https://t.co/HeFBDK8qNS via @po_st",2016-05-11,GILD,0
27,"@NickBarillaro clearly you have not looked at a 5 year chart. I've been doing this longer than year to date. $dis $aapl $gildWhy now's the time to buy shares of Gilead Sciences https://t.co/dNtbq0C1LR $GILD check out the ROE figures...$GILD $WFM $NFLX $MOBL Happy to see $DIA $SPY Raising the HAMMER doji and striking bk at close tomorrow SPY 2080 PT DIA 17855 PT@DewDiligence Both $ACHN and $GILD nuc had 14-day monotherapy in HCV patients before.RT @bostonbiomed: At this point $GILD could load the boat with 2015 high flying smid biotechs. Maybe they are waiting until they are all BK.@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/LS5cm9bqrS@GerberKawasaki why would anyone take your picks as you were wrong about 3 of the 4 you suggested $AAPL $DIS $GILD$GILD:US Stocks falter for a second day as Apple drags down tech #GILEAD SCIENCES INC  https://t.co/JIlpSICm4J #SP500Got alerts at work today. $abt $ua $gild $himx $agn $aapl &amp; $ions time for a little spit shine, dinner with my queen &amp; some stock huntingRT @GantosJ: $CELG is the one who start the recovery faster than the $IBB .. look how $IBB $XBI &amp; $GILD going almost tick by tick https://t‚Ä¶$GILD Crossed so hard she broker her ankles https://t.co/KriI3rc0pLWatch Out: Barbarians At The Gate For Gilead $GILD $GILD https://t.co/h3dnFk5M1D@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/N0Dr5FEN61@RonnieMoas not wrong at all. What happened to $gild. That was your top pic. You pick 100 stocks. Something will go up.RT @raymond10mm: $GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ Mix Day. https‚Ä¶$GILD $CYDY  https://t.co/xBmxLcKSRDGilead Sciences, Inc. $GILD Shares Bought by Cubist Systematic Strategies LLC https://t.co/7zu9BVDzBw$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $PFE $SPX $NASDAQ $QQQ Mix Day. https://t.co/MmFhZmaLa2RT @GerberKawasaki: Amazes me the companies with the most cash. Are performing miserably. Yet the CEOs don't do anything. Sitting on cash i‚Ä¶RT @R4inb0w_: #Elafibranor via NEJM !! ""Elafibranor for the Treatment of Nonalcoholic Steatohepatitis"" $GNFT $ICPT $GILD #NASH https://t.co‚Ä¶@Mazmasta it's name is $gildWill this be a classic &amp; significant double bottom in $GILD or will markets completely give up on #biotech and send it down to new 2Y lows?CC @adamfeuerstein @AndyBiotech $GILD@SusanCTShore @StockCats interesting that $NFLX, $GILD, $AAPL at/near 52 week lows while S&amp;P near all time highs.  Must be bad companies...RT @king_option1: #GILD
$GILD https://t.co/OafavOovIjRT @LostDiva: Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/EIm76w8HCM $ABBV $MRK $GILDRT @mbrookstaylor: my dumb little spreadsheet model shows $gild priced for zero growth =). i'm long one share.my dumb little spreadsheet model shows $gild priced for zero growth =). i'm long one share.$spy flat like my account, missed 20k daytrade of $spxs at open then same for $gild under 82. One of those weeks#GILD
$GILD https://t.co/OafavOovIj@GerberKawasaki $AAPL P/E x6.9 (ex-cash) $GILD P/E x6.5 üò≥RT @GerberKawasaki: Amazes me the companies with the most cash. Are performing miserably. Yet the CEOs don't do anything. Sitting on cash i‚Ä¶Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/EIm76w8HCM $ABBV $MRK $GILDBernie Sanders, California Dropped A Grenade On Gilead https://t.co/qHrJqBdMGZ $ABBV $MRK $GILD  #feelthebern!!!Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/qHrJqBdMGZ $ABBV $MRK $GILD  READ!$CELG is the one who start the recovery faster than the $IBB .. look how $IBB $XBI &amp; $GILD going almost tick by tick https://t.co/a9LP5Fzws9RT @OpenOutcrier: $GILD May 80 / 85 Put Spread trading actively in small lots$GILD May 80 / 85 Put Spread trading actively in small lotsRT SeekingAlpha: Monthly Review Of DivGro: April 2016 https://t.co/qYynUqMlN7 $GPS $NIE $PM $OHI $TRV $AAPL $GILD $IBM $JNJ $XOMMonthly Review Of DivGro: April 2016 https://t.co/VBFGtmEeW5 $GPS $NIE $PM $OHI $TRV $AAPL $GILD $IBM $JNJ $XOMMonthly Review Of DivGro: April 2016 https://t.co/rP8NZfaXfO $GPS $NIE $PM $OHI $TRV $AAPL $GILD $IBM $JNJ $XOMMonthly Review Of DivGro: April 2016 https://t.co/MdhQlOJa0c $GPS $NIE $PM $OHI $TRV $AAPL $GILD $IBM $JNJ $XOMRT @R4inb0w_: #Elafibranor via NEJM !! ""Elafibranor for the Treatment of Nonalcoholic Steatohepatitis"" $GNFT $ICPT $GILD #NASH https://t.co‚Ä¶@zipjet lol, certainly and in this case for the shareholders capital tax loss ! $gild @GileadSciencesBiotechs Enter Pocket of Turbulence. https://t.co/bwiuA59c65
$gild $incy $regn $vrtx $celg $regn $mdvn $nbix $jazz $juno #biotech #stocksRT @GerberKawasaki: @tinaloehmann19 I think the market is now penalizing CEO's who can't figure out how to use their capital. $aapl $gildRT @R4inb0w_: #Elafibranor via NEJM !! ""Elafibranor for the Treatment of Nonalcoholic Steatohepatitis"" $GNFT $ICPT $GILD #NASH https://t.co‚Ä¶@tinaloehmann19 I think the market is now penalizing CEO's who can't figure out how to use their capital. $aapl $gildNotable Thursday Option Activity: $GILD  $NVDA  $AET #stockoptions https://t.co/VzRAm5RlEN#news #feelthebern #crazybernie #BernieSanders #California Dropped A Grenade On Gilead https://t.co/Pzaukqzd1J $ABBV $MRK $GILDAlright $SPY, Youre just toying with me now. I sell $SDS u tank, I go to buy $GILD at 81.85 &amp; u do this b4 Im in! https://t.co/8GbTEOzJeHAlso $TWTR for a flip. Luck with $ATVI $EXPE AND believe it or not $GILD today / Now $GPRO and $TWTR@traderstu2 Can u believe what $GILD just did to me? Seriously!@ColfaxCapital At least redistribute all the cream (divi) Who needs MS, HC, MP to sink the sector $gild respected managent is best at it imoMy luck in a chart, tried to buy $GILD at 81.85... https://t.co/a1pgRnS185Is $GILD on the road to recovery? https://t.co/txK51Hb0lT via @TheStreetRT @ShockExchange: Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/bQO5jF918M #FeelTheBern @MassAGO @AGSchneiderman $GI‚Ä¶Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/bQO5jF918M #FeelTheBern @MassAGO @AGSchneiderman $GILD $MRK $ABBV $VRX$GILD short under 82.50 if it fades....Tried to get my $GILD order in sub $82. Just missed, Whoops!MAY 12 Thursday, $GILD LOW was $81.70 and hit that $82.05 that I've seen on MAY 04 Wednesdayüëç‚òï
.$gild PE below 7$Is $GILD on the road to recovery? https://t.co/TsMZgOkaA9 https://t.co/t5bnUsNnbXRT SeekingAlpha: Large-Cap Stocks Primed For Big Returns https://t.co/Z8FBxV1OtS $AAPL #APPLE $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $TRI‚Ä¶Why Now's the Time to Buy Shares of #GileadSciences. Read more: https://t.co/xoep4zmvrc $GILDRT @SA_Portfolio: Large-Cap Stocks Primed For Big Returns https://t.co/M2XA8LU6B9 $AAPL #APPLE $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $TRI‚Ä¶RT @SEEKINGALPHA_FS: Large-Cap Stocks Primed For Big Returns https://t.co/kim5l4IOlz $AAPL #APPLE $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $‚Ä¶Large-Cap Stocks Primed For Big Returns https://t.co/kim5l4IOlz $AAPL #APPLE $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $TRIP $ULTA $VMWLarge-Cap Stocks Primed For Big Returns https://t.co/M2XA8LU6B9 $AAPL #APPLE $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $TRIP $ULTA $VMWRT @R4inb0w_: #Elafibranor via NEJM !! ""Elafibranor for the Treatment of Nonalcoholic Steatohepatitis"" $GNFT $ICPT $GILD #NASH https://t.co‚Ä¶@SukhramPal send me an email, I will send you some thoughts on $GILDRT @ChinaInvest: RT SeekingAlpha: Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/St6K60aq71 $ABBV $MRK $GILDSome #unusualactivity #options: $AMBA $BBBY $CREE $GILD $GLW $MON $MYL $SEAS $SINA $SSYS via https://t.co/AyoJORKy1x https://t.co/FkS6rWKdlx#Options #maxpain chart for $GILD. #option #invest More with #OptionsPro FREE app at https://t.co/vmQaxw1x1K https://t.co/UebeMcKx1P$GILD on support line here.RT @LindaCa28647460: Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/qHrJqBdMGZ $ABBV $MRK $GILD  #CAPrimary #ORPrimary‚Ä¶At this point $GILD could load the boat with 2015 high flying smid biotechs. Maybe they are waiting until they are all BK.@JarmoFriman Tulee mieleen $Gild$GILD just crushing 52 week lows.. yearly chart shows room to 65.. crazy if bios keep getting hammered ...https://t.co/p9HM6MgJQk $GILD, $ABBV, $MRKBernie Sanders, California Dropped A Grenade On Gilead $GILD https://t.co/6UlvZjxiptRT @MissElllly: $SPY $AAPL $PCLN $AMZN $FB $USO $GILD $PFE $IBB Fed‚Äôs Rosengren says rate hikes should resume https://t.co/nrKD60HRLp$GILD Is Gilead a buy now? https://t.co/uiSbtaQTJt$SPY $AAPL $PCLN $AMZN $FB $USO $GILD $PFE $IBB Fed‚Äôs Rosengren says rate hikes should resume https://t.co/nrKD60HRLp@SconnieTrader Still own $GILD ?? Kind of starting to look at it myselfLike $AAPL around ""92"", here at strong\u2026 $GILD https://t.co/i4vcIBGdGaRT @GodandtheBear: Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/YuZKFA4c8a $ABBV $MRK $GILD@HalftimeReport @jimcramer I bought $GILD under $82. I bought $TWTR @ $14. $AAPL I'll add by the end of the day. I sold out of all my dogsüí∞üí∞Biotech Giant Gilead Sciences Goes on Sale https://t.co/eUO7M03gjJ $GILD https://t.co/utfy6ww0gaCommented on Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/Y1ffiYLAcY $ABBV $MRK $GILDBy this point I am considering this trendline on $GILD, but the O/S RSI stress on Daily could make it hard. #stocks https://t.co/310CumgpZM$GILD so cheap, but in a downtrendRT @LindaCa28647460: Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/qHrJqBdMGZ $ABBV $MRK $GILD  #CAPrimary #ORPrimary‚Ä¶@GantosJ @dan_smithey No better investment than our own shares $gild said... since then, all their their buyback ended up undewater.Interestingly, $GILD has also had great bounces at The 40 Level on Monthly RSI just like $AAPL. I swear these two are cousins. #stocksBernie Sanders, California Dropped A Grenade On Gilead https://t.co/qHrJqBdMGZ $ABBV $MRK $GILD  #CAPrimary #ORPrimary #KYPrimary #MTPrimaryBernie Sanders, California Dropped A Grenade On Gilead https://t.co/qHrJqBdMGZ $ABBV $MRK $GILD  #BernieSandersBernie Sanders, California Dropped A Grenade On Gilead https://t.co/qHrJqBdMGZ $ABBV $MRK $GILD  Go #Bernie #feelthebernBernie Sanders, California Dropped A Grenade On Gilead https://t.co/qHrJqBdMGZ $ABBV $MRK $GILD #feelthebern$GILD Under The 50 Monthly RSI I consider it to be on its own Bear Market. Dead to me until I find a good setup. No position. #tradeideasBernie Sanders, California Dropped A Grenade On Gilead https://t.co/qHrJqBdMGZ $ABBV $MRK $GILD$GILD also way way way oversold. Balance sheet and cash reserve is too good for this stock to be hammered this way.RT @GodandtheBear: Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/YuZKFA4c8a $ABBV $MRK $GILD$AAL American Airlines 52 week low today... $GILD also made a 52 week low today $NFLX getting much closer to its 52 week low...and $AAPLTo the people complaining about $GILD sitting on cash...
Why are you mad that they can now acquire co's and buyback own stock at 52 wk lows?RT @GodandtheBear: Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/YuZKFA4c8a $ABBV $MRK $GILDRT @GodandtheBear: Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/YuZKFA4c8a $ABBV $MRK $GILDBernie Sanders, California Dropped A Grenade On Gilead https://t.co/YuZKFA4c8a $ABBV $MRK $GILDIf you're bullish $GILD they're RIGHT at a double bottom, worth taking a stab. If it goes below $81.50, get out.Staring hard at $GILD $IONS for LT buy #gettingchubbyHow are those PE Ratio's working out for ya? $AMZN $GILD https://t.co/eVYy1Yl4gYCommented on Gilead Will Go Lower And Lower Unless It Changes Course https://t.co/hfWU2sK5Ad $MRK $GILD@dan_smithey Yeah... and even ASCO need help, maybe a BIG deal like $GILD M&amp;A $BMY or $CELG$GILD breaks Feb lows, trying to stay above now. https://t.co/Jc3XBJE9nGRT @GerberKawasaki: Amazes me the companies with the most cash. Are performing miserably. Yet the CEOs don't do anything. Sitting on cash i‚Ä¶RT @GerberKawasaki: Amazes me the companies with the most cash. Are performing miserably. Yet the CEOs don't do anything. Sitting on cash i‚Ä¶$SPY $GILD new low 52 weekwatching close here on $GILD...81.54 another level to watch$GILD please buy $IONS. Why? No clue, I'm just tired of looking at it in my BAOther stocks just getting shot $AAL $AMBA $GILD $IBB $AAPL etcAllstate Corp Takes Position in Gilead Sciences, Inc. $GILD https://t.co/YdPo9Scag411:08 New 52wk Lows: $GILD$GILD at 52 week low
Congratulations @GileadSciences management for the leadership - shareholders really looking forward to your shr optionsVolume Alert - GILD 82.66 Gilead Sciences Inc $GILD Hit a high today of 84.30 Closing the day 10:30 at 82.66 - https://t.co/0p6dK9Yr3t$aapl into 80's soon. $gild $ions making fresh lows.RT @GerberKawasaki: Amazes me the companies with the most cash. Are performing miserably. Yet the CEOs don't do anything. Sitting on cash i‚Ä¶Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5""Later stage"" meaning on the chart -- already up huge during the past couple of years  $NFLX $AAPL $GILDRT @ARKgenome: India upholds $GILD's Solvaldi patent over generic made within the company https://t.co/Mt135bsn2m by @Pharmalot https://t.c‚Ä¶RT @IncredibleTrade: Added some $GBIM $1 and 1.09 - They can survive till 2017 and still have ties with $CEGL and $GILD. CEO did a F lousy‚Ä¶$ICPT - can mkt cap be sustained if $GILD hits with any of its 3 drug candidates for NASH? Reason for concern in my view.RT SeekingAlpha: Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/St6K60aq71 $ABBV $MRK $GILDRT @GerberKawasaki: Amazes me the companies with the most cash. Are performing miserably. Yet the CEOs don't do anything. Sitting on cash i‚Ä¶RT @zbiotech: $GILD approaching new yr lowRT @WarrenofWallSt: $GILD Gilead Sciences is a 5 star üí∞ dividend üí∞ stock with a 2.2% yield: https://t.co/ktWdCnEz0K https://t.co/traJBDpn3rRT @Biotech2050: Dear @GileadSciences $GILD
Two options:
A. Either make a couple of mega deals from $IBB $XBI; or
B. All top management res‚Ä¶RT @GerberKawasaki: Amazes me the companies with the most cash. Are performing miserably. Yet the CEOs don't do anything. Sitting on cash i‚Ä¶$GILD #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/1u4tyjELB8$GILD Gilead Sciences is a 5 star üí∞ dividend üí∞ stock with a 2.2% yield: https://t.co/ktWdCnEz0K https://t.co/traJBDpn3rRT @outsizedreturn: Americas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/NzhTUzgR83 htt‚Ä¶Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/3q46d7B3F4 $ABBV $MRK $GILDBernie Sanders, California Dropped A Grenade On Gilead https://t.co/V9bBv4IwiJ $ABBV $MRK $GILD$GILD &amp; $IBB helping keep $SPY from falling but it will need $AAPL to hold https://t.co/RgClwqk8n1$LABU $IBB Coming alive! $GILDIndia upholds $GILD's Solvaldi patent over generic made within the company https://t.co/Mt135bsn2m by @Pharmalot https://t.co/w79ZFHYMp2$GILD seems like its resisting doing down IF $SPY would a brotha out https://t.co/LIcemGosvQWondering about #sentiment indicator for $GILD? The Short Ratio is 2.5% https://t.co/aGOMONHc1URT @outsizedreturn: Americas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/NzhTUzgR83 htt‚Ä¶Incredibly difficult to sit on cash in my account...Realize it is smart portfolio strategy, but burning a hole in my pocket $GILD $DIS $JNJMay 12 Biotech Update $cpxx $GILD $ZIOP https://t.co/fquqvt9X2nAmericas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/NzhTUzgR83 https://t.co/W8PN8pDpP6RT @BioStocks: #Pharma's Game of (Hep C) Thrones 
https://t.co/8s4Bpz9TRM $GILD $ABBV $MRKRT @Biotech2050: Dear @GileadSciences $GILD
Two options:
A. Either make a couple of mega deals from $IBB $XBI; or
B. All top management res‚Ä¶GILD Top news - May 12th, 2016 $GILD https://t.co/BW31aqngCJRT @DrSManian: $gild
$alny
$tsro
...
Quite a few amazing blue chip bargains out thereThe statistically cheap stocks seem to be cracking daily now. Yesterday was retail. Today is $AAPL and $GILDGILD Investor Opinions
See Here ---&gt; https://t.co/wtYkDAsfFD

$GILD $TWTR $UNT #nasdaqRT @IncredibleTrade: Added some $GBIM $1 and 1.09 - They can survive till 2017 and still have ties with $CEGL and $GILD. CEO did a F lousy‚Ä¶$gild
$alny
$tsro
...
Quite a few amazing blue chip bargains out there@commodoredfw $GILD $81.89 is ref low. Can try RORO, but I‚Äôm not a big fan of $IBB pattern. $M is right into 61.8% Fib, but not loving‚Äô it.$GILD continues.
94.57% Average Gain
100% Unbiased
 .
https://t.co/2qE8x3QQQ8 
 .
 .
$CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO https://t.co/aWwwjwQf2U$GILD approaching new yr lowDear @GileadSciences $GILD
Two options:
A. Either make a couple of mega deals from $IBB $XBI; or
B. All top management resigns &amp; be replaced$GILD $82.05 is still on the way. I've stopped watching it.$GILD touching the low in feb may find some support here if biotech makes U turn to the upside. https://t.co/63g2Zif3XKRT @tradingonfire: $GILD Prints a scary chart if neckline is breached. #trading #stocks https://t.co/yzScxWjD9B@adar170 @Bfly Still unlikely to grab a ton of share from $GILD. Also not till late 2017 probably@Melikeitalot @LTbioinvestor Yes. $GILD trying to get the group down so they can buy stuff cheap. LOL$GILD - that was hilarious$GILD approaching 52 week low...within 50 centsAmazes me the companies with the most cash. Are performing miserably. Yet the CEOs don't do anything. Sitting on cash is absurd. $aapl $gildGilead Sciences hits a 1 quarter low https://t.co/aE2bhADJXH $GILD #GileadSciences https://t.co/ZRoUEBfgVC$GILD deathExcepting $AAPL and $GILD to continue trading in tandem, same owner base@JustinPulitzer thoughts on $GILD and $M todayJust wait until $AAPL, $GILD, &amp; $NFLX join this rally - should shoot S&amp;P right to 3000!  #bullish  @carlquintanilla https://t.co/PmoZEiH6aoRT @R4inb0w_: #Elafibranor via NEJM !! ""Elafibranor for the Treatment of Nonalcoholic Steatohepatitis"" $GNFT $ICPT $GILD #NASH https://t.co‚Ä¶$AAPL &amp; $GILD are the story of your markets today folks, $AAPL is BELOW any low levels of Aug flash or FebWeakness in $GILD continues.....Is there anything more bullish than owning $GILD $AAPL and $NFLX right now??  #diversifiedAdded some $GBIM $1 and 1.09 - They can survive till 2017 and still have ties with $CEGL and $GILD. CEO did a F lousy job with PR.$GILD couldn't hold the May 6th lows, so damn weak $IBB $XBIRT @R4inb0w_: #Elafibranor via NEJM !! ""Elafibranor for the Treatment of Nonalcoholic Steatohepatitis"" $GNFT $ICPT $GILD #NASH https://t.co‚Ä¶RT @R4inb0w_: #Elafibranor via NEJM !! ""Elafibranor for the Treatment of Nonalcoholic Steatohepatitis"" $GNFT $ICPT $GILD #NASH https://t.co‚Ä¶$GILD dominates the HCV market with #Harvoni and #Sovaldi, but will it last? https://t.co/i6AeZubX2kRT @BioStocks: #Pharma's Game of (Hep C) Thrones 
https://t.co/8s4Bpz9TRM $GILD $ABBV $MRK#Elafibranor via NEJM !! ""Elafibranor for the Treatment of Nonalcoholic Steatohepatitis"" $GNFT $ICPT $GILD #NASH https://t.co/Quk2bZ28r5RT @BioStocks: #Pharma's Game of (Hep C) Thrones 
https://t.co/8s4Bpz9TRM $GILD $ABBV $MRKWatch list $JBLU $AAPL $ADBE $GILD $ATW $CA $TERP $JACK $SINA $TRMB $TWO $WFT $FEYE $WNR $HBI $EL $KSS $YY $GE $LGCY $WB $ORIG $MON#Pharma's Game of (Hep C) Thrones 
https://t.co/8s4Bpz9TRM $GILD $ABBV $MRKGilead Will Go Lower And Lower Unless It Changes Course https://t.co/rLlMNatkyz $MRK $GILD@christ1c  $GILD should mke it bk to $86 by EOD. Keep ur eyes on $IBB $XBI $LABU $LABDPharma's Game of (#HepC) Thrones - https://t.co/TLxpSM5NlG via @bfly $GILD $ABBV $MRKRT @DrSManian: Bios near 52w low
Avg vol &gt;100K

Large
$gild $azn $teva

Mid
$prgo $vrx
$alny $blue $ipxl

Small
$rgls $cnce 
$infi $ardx
$a‚Ä¶@BioStocks active pipeline and licensing agreements with $Gild &amp; $Celg also cash through Q1 of 2017. Not like they will be closing doorsBio-tech stocks sold off today.  Expect a reversal tomorrow going to next week.  $IBB, $GILD, $AMGN $PFE, $MRKRT @bigbear083: $SPX #StockMarket map at the close today $DIS $WMT $NFLX $AMZN $NKE $GOOGL $MSFT $GILD more@ https://t.co/jVWRiII5eu https:‚Ä¶RT @quack1612: $SPY #SPX $QQQ $NTRA $CA $KGC $CAS $GILD $EFOI $CCXI Earnings Reports and News https://t.co/U6iNqVz7k8 https://t.co/iXedxMS1‚Ä¶RT @quack1612: $SPY #SPX $QQQ $NTRA $CA $KGC $CAS $GILD $EFOI $CCXI Earnings Reports and News https://t.co/U6iNqVz7k8 https://t.co/iXedxMS1‚Ä¶RT @quack1612: $SPY #SPX $QQQ $NTRA $CA $KGC $CAS $GILD $EFOI $CCXI Earnings Reports and News https://t.co/U6iNqVz7k8 https://t.co/iXedxMS1‚Ä¶$SPY #SPX $QQQ $NTRA $CA $KGC $CAS $GILD $EFOI $CCXI Earnings Reports and News https://t.co/U6iNqVz7k8 https://t.co/iXedxMS1sRBUY #Gilead Sciences, Inc., $GILD. Target: 87.09 (+3.80%).
 https://t.co/5e7Mz2Lxi6  #trading #stocks #investingGilead Sciences, Inc. $GILD Sees Significant Growth in Short Interest https://t.co/u7SAjf2ZziGilead Sciences, Inc. $GILD Sees Significant Growth in Short Interest https://t.co/46hKEM6UpGPNRA Last Price
See Here ---&gt; https://t.co/jdNwZv3uf2

$PNRA $GILD $ERIC #pennystocksRT @chproperties: $SPY $DIA $LABU $GILD $UWTI It&amp;#39;s early but so far so good for a green open. $DWTI  $NUGT $LABD $UVXY  $TVIX https://t‚Ä¶$SPY $DIA $LABU $GILD $UWTI It&amp;#39;s early but so far so good for a green open. $DWTI  $NUGT $LABD $UVXY  $TVIX https://t.co/vAxoniMTePGILD Last Trade
See Here ---&gt; https://t.co/XWm5tudonM

$GILD $UVXY $KLDX #share$IBB interestingly enough also at support on daily. w large accumulations end of day say $GILD or even $ENDP ! https://t.co/0ZiaqX3TLHhttps://t.co/uAcamNRUPt alerted $BIND +49% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/F8iKSLizL2 $HOT $AMAT $ITUB $MT $GILD $HST $AA$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB $AAPL $V $JPM $WMT $DIS $SPX $NASDAQ $QQQ Big drop! https://t.co/bF3BgnGrAkRT @BioPharmaJosh: ICYMI: Indian Patent Office overturns Sovaldi ruling https://t.co/zdQTKqMVfQ via @BioCentury $GILDRT @tphedgegroup: We re more concerned about $GILD than $VRXWe re more concerned about $GILD than $VRXCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5$TVIX $SPY  $DIA  $GILD  $LABU  $LABD  $DWTI  $UWTI looks like #GOLD / #CRUDE Headed lower &amp;amp; #ASIA coming bk indices futures r GREEN!RT @DrSManian: Bios near 52w low
Avg vol &gt;100K

Large
$gild $azn $teva

Mid
$prgo $vrx
$alny $blue $ipxl

Small
$rgls $cnce 
$infi $ardx
$a‚Ä¶RT @DrSManian: Bios near 52w low
Avg vol &gt;100K

Large
$gild $azn $teva

Mid
$prgo $vrx
$alny $blue $ipxl

Small
$rgls $cnce 
$infi $ardx
$a‚Ä¶@alwaysbull4ever @pricatti @FSantamarina @ezequielhalfon ojo, hay un prod q est√° trabajando $GILD q se llama gs9620.Lo desc de pp pero worksRT @tradingonfire: $GILD Prints a scary chart if neckline is breached. #trading #stocks https://t.co/yzScxWjD9BBios near 52w low
Avg vol &gt;100K

Large
$gild $azn $teva

Mid
$prgo $vrx
$alny $blue $ipxl

Small
$rgls $cnce 
$infi $ardx
$arlz $kmph $drnaRT @tradingonfire: $GILD Prints a scary chart if neckline is breached. #trading #stocks https://t.co/yzScxWjD9B$GILD Prints a scary chart if neckline is breached. #trading #stocks https://t.co/yzScxWjD9B",2016-05-12,GILD,0
28,"Gilead Sciences, Inc. $GILD Stake Lowered by Tanaka Capital Management Inc. https://t.co/UPb8PkfTFw$IBB $CELG $GILD $AMGN $BIIB https://t.co/Hn58lZIBiCGilead Sciences, Inc. $GILD is South Street Advisors LLC‚Äôs 3rd Largest Position https://t.co/siZK8zkfD0#GileadSciences Breaking down barriers to HIV/Aids treatment - afternoon seminar. Read more: https://t.co/lIQzrtAURI $GILDWLL Stock Forum
See Here ---&gt; https://t.co/yrqRXr9cMh

$WLL $TRQ $GILD #nasdaq41,159 Shares in Gilead Sciences, Inc. $GILD Acquired by Pacer Advisors Inc. https://t.co/h3YL58AmY341,159 Shares in Gilead Sciences, Inc. $GILD Acquired by Pacer Advisors Inc. https://t.co/ghWio3d8ytSLW Ask
See Here ---&gt; https://t.co/Y0xGJKS94F

$SLW $GILD $VRNT #stockmarket@AnthonyMaceroni it could easily see that...take a look at $GILD's P/E right now hahaCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5GILD Ask Size
See Here ---&gt; https://t.co/IVmUKPOdsU

$GILD $EWG $BMO #nasdaqRT @sssvenky: Watching $GILD closely. Bear flag but potential reversal candle too today. Early to say but watching. https://t.co/LfpYfbwl3F$GILD shares look bloody cheap right now but the returns on Buharinomics make so much more sense.Definitely early but worth a watch $GILD. https://t.co/dpyk4t0zP7Watching $GILD closely. Bear flag but potential reversal candle too today. Early to say but watching. https://t.co/LfpYfbwl3FGilead Sciences, Inc. $GILD Position Reduced by Cambridge Financial Group Inc. https://t.co/7A59YRx9dmRT @FREDERICDJA: Genfit's NASH Phase 2b Results Are Published And Confirm The Biotech's Lead https://t.co/moSiyFU5I6 $CNAT $GILD $GLMD $ICP‚Ä¶Mariner Investment‚Äôs Top Healthcare Picks
$BXLT, $JAZZ, $BMRN, $CELG, $GILD
https://t.co/WU5zUp9v6mMariner Investment‚Äôs Top Healthcare Picks
$BXLT, $JAZZ, $BMRN, $CELG, $GILD
https://t.co/2sIiMNoRWaRT @JavierHasse: Leon Cooperman Buys 227,000 Apple Shares, Adds More Microsoft $AAPL $ETP $GILD $UNH $PYPL $MSFT $TGRP  https://t.co/BFKmD0‚Ä¶Leon Cooperman Buys 227,000 Apple Shares, Adds More Microsoft $AAPL $ETP $GILD $UNH $PYPL $MSFT $TGRP  https://t.co/BFKmD0LvWs via @benzingaRT @bob56300: # ICPT Genfit's NASH Phase 2b Results Are Published &amp; Confirm The  Biotech's Lead https://t.co/0uAxPcaG0D $CNAT $GILD $GLMD $‚Ä¶$GILD barely moved, neither did $CELGI've been saying for weeks that once $AAPL, $GILD, and $NFLX join the rally, S&amp;P will be at 250 in no time.  Today is part 1 of that! #study$GILD    supply/demand challenges estimated bearish/bullish borderline 83.87Commented on 2 Attractive Possible Takeovers In Biotech https://t.co/HaY3ySFLyi $GILD $RLYP $IONS$PFE made an acquisition 2day. BP is hungry 4 growth &amp; lot of biotechs r @ bargain level. IMO $GILD will make a move soon. $ARWR $ABUS $EXASRT @StockTwits: And here's a list of stocks that Leon Cooperman has been buying. According to his 13f: https://t.co/3j73hkBUQw

$AAPL $GILD‚Ä¶RT @DividendHawk: Recent Buy (Tax Deferred) - $GILD https://t.co/vswpFAlKpz via @Div4SonRT @sspencer_smb: cooperman files his 13Fs. he likes to buy leaders that pull back. $GILDRT @AAP_Global: $GILD @petenajarian @HalftimeReport @markets @WSJmarkets  https://t.co/ZL9uO3RcOPRT @TomSilver39: Barclays:"" Payor/PBM Survey:decrease in restrictions should drive continued new patient starts (5-15% y/y) ‚Äì potentially g‚Ä¶RT @TV_TradingIdeas: If you like dip buying this i\u2026 $GILD https://t.co/8AaakW4dqWRT @JDR1024: @ScottWapnerCNBC Tremendous value in $AAPL and $GILD. Buying here.RT @tgtxdough: $GILD CFO GILD has $21billion cash Priorities for capital allocation are: 1) Pipeline development, 2) M&amp;A, 3) Shareholder re‚Ä¶RT @tgtxdough: $GILD Phase I GS-5829 (a BET inhibitor) in adults with advanced solid tumors &amp;lymphomas has increased recruitment from 48 to‚Ä¶RT @OpenOutcrier: Cooperman Omega Advisors 13F
New $AAPL $AZO $BLL $EA $ETP $GILD $PYPL $SPKE $TSE $UNH $WPZ
Increased: $ASPS $FDC $MSFT $O‚Ä¶RT @hedgefundclone: Billionaire Leon Copperman also takes new position in $GILD, trend here with Buffett Copperman low P/E wide moat stocksCMLviz: RT Oldie_Records: $IBB $GILD $CELG $AMGN $BIIB $REGN $KITE
Get #Bullish--#BioTech #Stocks?
#StockMarket #T‚Ä¶ https://t.co/P6oQgOZJjTRT @Oldie_Records: $IBB $GILD $CELG $AMGN $BIIB $REGN $KITE
Get #Bullish--#BioTech #Stocks?
#StockMarket #Trading #SwingTrade #Daytrade htt‚Ä¶Connor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNRRT @bob56300: # ICPT Genfit's NASH Phase 2b Results Are Published &amp; Confirm The  Biotech's Lead https://t.co/0uAxPcaG0D $CNAT $GILD $GLMD $‚Ä¶RT @FREDERICDJA: Genfit's NASH Phase 2b Results Are Published And Confirm The Biotech's Lead https://t.co/moSiyFU5I6 $CNAT $GILD $GLMD $ICP‚Ä¶RT @StockTwits: And here's a list of stocks that Leon Cooperman has been buying. According to his 13f: https://t.co/3j73hkBUQw

$AAPL $GILD‚Ä¶StockTwits: And here's a list of stocks that Leon Cooperman has been buying. According to his 13f: https://t.co/WEuTUK2U8h

$AAPL $GILD $P‚Ä¶StockTwits: And here's a list of stocks that Leon Cooperman has been buying. According to his 13f: https://t.co/5KYtjYb9kP

$AAPL $GILD $P‚Ä¶And here's a list of stocks that Leon Cooperman has been buying. According to his 13f: https://t.co/3j73hkBUQw

$AAPL $GILD $PYPL $EA$GILD ignored HA in PDA x2- Failed mAb &amp; JAK inhibitor (see Jakafi) &amp; $MNTA w novel heparin- $HALO using LMW heparin w success-finished P2#GileadSciences Vermont to Require Drug Makes to Explain Price Increases. Read more: https://t.co/JV2rvOSFyt $GILD@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $REGN $CELG https://t.co/3IUcVhGIx2@bret_jensen $GILD - tremendous value. Adding.@petenajarian @jonnajarian Tremendous value here in $AAPL, $GILD, $CY. Buying.@ScottWapnerCNBC Tremendous value in $AAPL and $GILD. Buying here.If you like dip buying this i\u2026 $GILD https://t.co/8AaakW4dqW$GILD chart: If you like dip buying this is a good place to try. https://t.co/lw5fqvsYNXBarclays:"" Payor/PBM Survey:decrease in restrictions should drive continued new patient starts (5-15% y/y) ‚Äì potentially greater for $GILD.""@CortesSteve Buying more $AAPL, $CY and $GILD. Tremendous value there.$GILD @exquisimagic #AnotherOne https://t.co/F2RQHHjLhC$gild   Chance of sentiment shift as  sideline bulls  may be effected by shares trading above  Mondays high $83.40 and Fridays high $83.87I don't trust this market. Indicators look wobbly. I'm out! $DIS $GILD $GOOGL $HD $IBM $JNJ $MRK $MSFT $NFLX $PFE $SBUX $SPY $UNH $V $XLK$GILD @petenajarian @HalftimeReport @markets @WSJmarkets  https://t.co/ZL9uO3RcOPHey $GILD move ur ass; look at $OPHT, else $PFE may look at you @ 7x PE mkts may like it :)Gabalex Capital Management‚Äôs Top Stock Picks for Q2
$GILD, $BRK.B, $SLB, $HD, $GWW
https://t.co/waUlAxefpSGabalex Capital Management‚Äôs Top Stock Picks for Q2
$GILD, $BRK.B, $SLB, $HD, $GWW
https://t.co/jGCkGv2gUKVolume Alert - GILD 82.71 Gilead Sciences Inc $GILD Hit a high today of 83.40 Closing the day 10:30 at 82.71 + https://t.co/ZYKYm0vDvt@jimcramer $AAPL, $GILD should both be trading $200.cooperman files his 13Fs. he likes to buy leaders that pull back. $GILDCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @OpenOutcrier: Cooperman Omega Advisors 13F
New $AAPL $AZO $BLL $EA $ETP $GILD $PYPL $SPKE $TSE $UNH $WPZ
Increased: $ASPS $FDC $MSFT $O‚Ä¶@hedgefundclone $GILD management strategy of hoarding cash, buying back shares not working imo. Stock keeps drifting lower and lowerRecent Buy (Tax Deferred) - $GILD https://t.co/vswpFAlKpz via @Div4Son$AAPL $GILD and more just got the Cooperman Kiss of DeathRT @hedgefundclone: Billionaire Leon Copperman also takes new position in $GILD, trend here with Buffett Copperman low P/E wide moat stocksBillionaire Leon Copperman also takes new position in $GILD, trend here with Buffett Copperman low P/E wide moat stocks#BernieSanders , #California Dropped A Grenade On Gilead https://t.co/l9RR2gKT7W ‚Ä¶ ‚Ä¶ ‚Ä¶ $GILD $ABBV $MRKRT @OpenOutcrier: Cooperman Omega Advisors 13F
New $AAPL $AZO $BLL $EA $ETP $GILD $PYPL $SPKE $TSE $UNH $WPZ
Increased: $ASPS $FDC $MSFT $O‚Ä¶Cooperman Omega Advisors 13F
New $AAPL $AZO $BLL $EA $ETP $GILD $PYPL $SPKE $TSE $UNH $WPZ
Increased: $ASPS $FDC $MSFT $OMF $TRGP $TRCO $SYFRT @bob56300: # ICPT Genfit's NASH Phase 2b Results Are Published &amp; Confirm The  Biotech's Lead https://t.co/0uAxPcaG0D $CNAT $GILD $GLMD $‚Ä¶RT @outsizedreturn: Americas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/nraWgiv32g htt‚Ä¶# ICPT Genfit's NASH Phase 2b Results Are Published &amp; Confirm The  Biotech's Lead https://t.co/0uAxPcaG0D $CNAT $GILD $GLMD $ICPT $NVO $TBRA| $PRED | Predictive Biotech, Inc. Completes Development of Allograft Stem Cell Liquid Suspension Product https://t.co/J4AKnX2yTP $GILD $VRXRT @outsizedreturn: Americas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/nraWgiv32g htt‚Ä¶On $PFE-AGN deal brk-up &amp; BO speculation, $IBB shot 6% in a day, &amp; to 288(am). Now it's actually happening $PFE I m sure $GILD is thinkingRT @outsizedreturn: Americas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/nraWgiv32g htt‚Ä¶$GILD Phase I GS-5829 (a BET inhibitor) in adults with advanced solid tumors &amp;lymphomas has increased recruitment from 48 to 120 patients.RT @tgtxdough: $GILD CFO GILD has $21billion cash Priorities for capital allocation are: 1) Pipeline development, 2) M&amp;A, 3) Shareholder re‚Ä¶81.50 is the number that $GILD needs to hold all week...or its 77RT @tgtxdough: $GILD CFO GILD has $21billion cash Priorities for capital allocation are: 1) Pipeline development, 2) M&amp;A, 3) Shareholder re‚Ä¶Live at #moomoc ‚Äì MOO long i.E. ooBLUEBELL $TGT $GILD ooDELTAFORCE $BK #Trading #Investing #Stocks https://t.co/OWPaLSnw9oLive at #moomoc ‚Äì MOO long i.E. ooBLUEBELL $TGT $GILD ooDELTAFORCE $BK #Trading #Investing #Stocks https://t.co/JKvayxfHygAmericas #Macro $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/nraWgiv32g https://t.co/YgJrY0vWGCRT @JustinPulitzer: My #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $YELP $SHAK http‚Ä¶Genfit's NASH Phase 2b Results Are Published And Confirm The Biotech's Lead https://t.co/moSiyFU5I6 $CNAT $GILD $GLMD $ICPT $NVO $TBRART @Falcon_Stocks: .
94.57% Avg Gain
100% Unbiased
 .
https://t.co/mNVCwocg7V 
 .
 .
$CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO https://t.co/BX‚Ä¶RT @tgtxdough: $GILD CFO GILD has $21billion cash Priorities for capital allocation are: 1) Pipeline development, 2) M&amp;A, 3) Shareholder re‚Ä¶$GILD CFO GILD has $21billion cash Priorities for capital allocation are: 1) Pipeline development, 2) M&amp;A, 3) Shareholder returns..
94.57% Avg Gain
100% Unbiased
 .
https://t.co/mNVCwocg7V 
 .
 .
$CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO https://t.co/BXGk5F518lRT @GantosJ: $GILD Double bottom at the $81.89 support line, Indicators are DEEP in Over-Sold territories, time to load the boat! https://t‚Ä¶GILD Top news - May 16th, 2016 $GILD https://t.co/x46qpHmEGsRT @GantosJ: $GILD Double bottom at the $81.89 support line, Indicators are DEEP in Over-Sold territories, time to load the boat! https://t‚Ä¶RT @23aloha: ICYMI Biotech Tweets of the Week with @BioDueDiligence - the Rainy Edition https://t.co/chPAlmeqcw $BIIB $CLVS $GILD $MDVN $TT‚Ä¶My #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $YELP $SHAK https://t.co/XwJTuvSqrO$REGN should lift $IBB early.  Bios due for a bounce. $BIIB $GILD https://t.co/2CNIooQ7KlRT @GantosJ: $GILD Double bottom at the $81.89 support line, Indicators are DEEP in Over-Sold territories, time to load the boat! https://t‚Ä¶Interesting Monday morning factoid. Donald Rumsfeld was once the Chairman of the Board at $GILD.$GILD Temasek Holdings raises share stake in Gilead Sciences Inc  by 8.1 percent to 13.83  million sharesRT @fgusequity: $GILD https://t.co/dZWRGe19sM Pot. cont. Downtrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/Axh4miHiY7$GILD https://t.co/dZWRGe19sM Pot. cont. Downtrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/Axh4miHiY7$GILD $MRK $BMY $RGLS https://t.co/QXkPLahos4$gild oversold https://t.co/g4wdCFdvKTRT @GantosJ: $GILD Double bottom at the $81.89 support line, Indicators are DEEP in Over-Sold territories, time to load the boat! https://t‚Ä¶$GILD Double bottom at the $81.89 support line, Indicators are DEEP in Over-Sold territories, time to load the boat! https://t.co/u1H5Rpd0D6Not considering a position on $GILD until strong support &gt;$84. Possible entry around $86.5 https://t.co/OjD5j8qtUVRT @JustinPulitzer: Weekend Review VIDEO (5/15): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $YELP $ZG $SHAK $GPRO htt‚Ä¶RT @GantosJ: $IBB &amp; $XBI bouncing in the PM ... the #biotech sector need good news &amp; Today's $PFE acquiring $ANAC for $5.2B is good one, $G‚Ä¶@super_calls $XBI needs to break $60 soon so the Bulls come back to the game . Big bounce coming $GILD let's see a buyout ! Do it $IBBRT @GantosJ: $IBB &amp; $XBI bouncing in the PM ... the #biotech sector need good news &amp; Today's $PFE acquiring $ANAC for $5.2B is good one, $G‚Ä¶$IBB &amp; $XBI bouncing in the PM ... the #biotech sector need good news &amp; Today's $PFE acquiring $ANAC for $5.2B is good one, $GILD next move!#GileadSciences : Breaking down barriers to HIV/Aids treatment - afternoon seminar. Read more: https://t.co/O6a2FCkqDc $GILD$IBB $GILD $CELG $AMGN $BIIB $REGN $KITE
Get #Bullish--#BioTech #Stocks?
#StockMarket #Trading #SwingTrade #Daytrade https://t.co/9XMROfJix4RT @JustinPulitzer: Weekend Review VIDEO (5/15): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $YELP $ZG $SHAK $GPRO htt‚Ä¶Live at #moomoc ‚Äì MOO long i.E. ooBLUEBELL $TGT $GILD ooDELTAFORCE $BK #Trading #Geldanlage #Aktien https://t.co/d7roNX20zOLive at #moomoc ‚Äì MOO long i.E. ooBLUEBELL $TGT $GILD ooDELTAFORCE $BK #Trading #Geldanlage #Aktien https://t.co/UvtXx3DsYpSZYM Shares
See Here ---&gt; https://t.co/ToHcIm40hL

$SZYM $GILD $AMP #stocksRT @23aloha: ICYMI Biotech Tweets of the Week with @BioDueDiligence - the Rainy Edition https://t.co/chPAlmeqcw $BIIB $CLVS $GILD $MDVN $TT‚Ä¶BUY #Gilead Sciences, Inc., $GILD. Target: 89.74 (+8.51%).
 https://t.co/5e7Mz2Lxi6  #trading #stocks #investingRT @2waystrading: New post: New $IWM, $UA, $X, $TCK, $AAPL, $GILD and $RL Technical Notes Posted https://t.co/Gr2cmjNepJNew post: New $IWM, $UA, $X, $TCK, $AAPL, $GILD and $RL Technical Notes Posted https://t.co/Gr2cmjNepJCUBN % Change
See Here ---&gt; https://t.co/LNpbTHvI3Z

$CUBN $HBAN $GILD #investRT @livetradepro: Many (quality) stocks like $COST $AAPL $NFLX $GS $TSLA $JBLU $GILD $FSLR continue to show signs of weakness (under their‚Ä¶$GILD looses title to $AMGN https://t.co/zmSAigPGOxRT @JustinPulitzer: Weekend Review VIDEO (5/15): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $YELP $ZG $SHAK $GPRO htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (5/15): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $YELP $ZG $SHAK $GPRO htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (5/15): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $YELP $ZG $SHAK $GPRO htt‚Ä¶Looking for bargains? Gilead Sciences is available for 19% off its SP $GILD - https://t.co/jomgDzQJfF https://t.co/1ZnQaSB5yOGilead Sciences Reiterated Rating by JP Morgan (Ranked 32nd) to Buy $GILD #GILD https://t.co/nyq7xJnbR7Gilead Sciences's buy rating reiterated at JPMorgan Chase  &amp; Co.. https://t.co/XS8lPxeSwt $GILD #GILDRT @JustinPulitzer: Weekend Review VIDEO (5/15): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $YELP $ZG $SHAK $GPRO htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (5/15): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $YELP $ZG $SHAK $GPRO htt‚Ä¶Weekend Review VIDEO (5/15): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $YELP $ZG $SHAK $GPRO https://t.co/XwJTuvSqrOCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @MargaretDudley1: Gilead Sciences withdraws writ petition in support of consolidating hearings over patent rights https://t.co/5fcUdtuBi‚Ä¶RT @MargaretDudley1: Gilead Sciences withdraws writ petition in support of consolidating hearings over patent rights https://t.co/5fcUdtuBi‚Ä¶GILD Quotes
See Here ---&gt; https://t.co/D0UGqQXVIi

$GILD $SQNS $ONCS #stockGilead Sciences withdraws writ petition in support of consolidating hearings over patent rights https://t.co/5fcUdtuBit #hepC #HCV $GILDhttps://t.co/uAcamNRUPt alerted $BIND +49% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/F8iKSLizL2 $ITUB $MT $GILD $HST $AA $GM $EMCRT @BursatilBiotech: $GILD GS9883 que lindo, y pensar q estuvieron x venderlo a $AMGN 
Mira @arielsbdar https://t.co/RKj3W9R4qk",2016-05-16,GILD,0
29,"RT @TradeWithSuper: Benzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/c4tS24SE4QRT @Benzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/KshODCHP0nBenzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/c4tS24SE4QHas A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/KshODCHP0n#GileadSciences Ferozsons Laboratories : IGI Securities Limited - Investor Kit . Read more: https://t.co/8pwRS6XM9J $GILD#GileadSciences Ferozsons Laboratories : IGI Securities Limited - Investor Kit. Read more: https://t.co/ww4yl1qK82 $GILDRT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶180 Bearish https://t.co/d6619kf7gT $HEZU $LVLT $HEDJ $UPS $ERIC $ABT $SWKS $BRKR $SCHF $CERS $JNPR $QLD $EIX $EWG $GILD $ACWI $EWPRT @StockTwits: And here's a list of stocks that Leon Cooperman has been buying. According to his 13f: https://t.co/3j73hkBUQw

$AAPL $GILD‚Ä¶RT @TalkMarkets: ?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/3efj‚Ä¶$GILD Current Report Filing (8-k)‚Ä¶ https://t.co/idO6fH2ALV?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/3efjKHeDGQ.@ebcapital Great article! I'm especially interested in $GILD &amp; $CELG for the long-term.EMC % Change
See Here ---&gt; https://t.co/ukaA7LxitB

$EMC $GILD $SRPT #investBought $GILD at $83.17.@truthtracer $GILD not totally cleared in US/EU for TAF Nuc &amp; no completion/data presentation on GS9-9620-TLR7, yet.Gilead Sciences‚Äô $GILD ‚ÄúBuy‚Äù Rating Reaffirmed at Robert W. Baird https://t.co/SYXZQKMtXFGilead Sciences‚Äô $GILD ‚ÄúBuy‚Äù Rating Reaffirmed at Robert W. Baird https://t.co/UX0d7Tr3jg$GILD, $VRX, $ED, $VXX, $SPG, $DDS, $AMZN, trade updates posted. Have a nice dayGilead Sciences‚Äô $GILD ‚ÄúBuy‚Äù Rating Reaffirmed at Robert W. Baird https://t.co/ruVY2hcPGaPost Edited: May Portfolio Updated ($AAPL, $GILD, $ED, $AMZN and $DDS) https://t.co/OrKXgDcUpIRT @TraderHQdotcom: The 22 Most Oversold Stocks This Week https://t.co/rvrRoSDg2i $TSLA $GILD $CS #InvestingRT @TraderHQdotcom: The 22 Most Oversold Stocks This Week https://t.co/rvrRoSDg2i $TSLA $GILD $CS #InvestingThe 22 Most Oversold Stocks This Week https://t.co/rvrRoSDg2i $TSLA $GILD $CS #Investing#GileadSciences : US drug maker Gilead Sciences withdrew a writ petition filed in Delhi Hig... Read more: https://t.co/B4Bv6fMlHD $GILDGILD - WEEKLY - SHORT $GILD https://t.co/NY6PhsUOeX@Stephanie_Link tremendous value at $GILD. Is management ever going to make acquisitions?  Buyback hasn't done anything for the stock.Gilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Robert W. Baird https://t.co/rI5NRR1qlR@aztecs99 Thanks. Tremendous value there. Same with $AAPL $GILD and $BAC. Buy.Gilead Sciences Reiterated Rating by Robert W. Baird (Ranked 19th) to Buy $GILD #GILD https://t.co/nyq7xJnbR7$GILD:

New SEC Filing for GILD: Form 8-K (No. 0001193125-16-593013):

https://t.co/KL1kAOF7Sc https://t.co/NeQSJmEBPyRT @Lichartin: $GILD took a hit holding $GOOGL puts still but might take a hit soon#GileadSciences GILEAD SCIENCES INC FILES (8-K) Disclosing Change in Directors or Principal... Read more: https://t.co/VN767t9C6k $GILD$GILD ""Our new model estimates 2016 US HCV sales at $8.9B vs. $8.4B previous."" - Citi https://t.co/MqcG8zwV8k$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts AppWhat a cheap stock! $GILD https://t.co/OKtGYHyv3a#GileadSciences Nimbus Therapeutics Announces Closing Of Gilead??? Acquisition Of  And Its ... Read more: https://t.co/6OvgZmLky3 $GILD$GILD - Current Report Filing (8-k) https://t.co/xlx2yDLfDlDeparture of Directors or Certain  https://t.co/ZKPca9ZBWe $GILDRT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶And every one with FCF trending up strongly except $GILD dropping by 1/3. https://t.co/hcOpavkdPZRT @csresearch: Estimated impact of US drug price rises on 2015 net income: $VRTX, $BMRN, $GSK, $MRK and $GILD were least reliant https://t‚Ä¶Disclosing over the past week I've continually accumulated $Tril $Ozm $Gild and $Vrx they are all undervalued IMORT @csresearch: Estimated impact of US drug price rises on 2015 net income: $VRTX, $BMRN, $GSK, $MRK and $GILD were least reliant https://t‚Ä¶GILD E.P.S.
See Here ---&gt; https://t.co/IQizfVHabP

$GILD $CMC $UHS #financeRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @csresearch: Estimated impact of US drug price rises on 2015 net income: $VRTX, $BMRN, $GSK, $MRK and $GILD were least reliant https://t‚Ä¶Estimated impact of US drug price rises on 2015 net income: $VRTX, $BMRN, $GSK, $MRK and $GILD were least reliant https://t.co/hAfuOKfjoaTook a #trading S $GILD $83.61 avgNimbus Therapeutics Announces Closing of #GileadSciences' Acquisition of Nimbus Apollo, Inc... Read more: https://t.co/y3Bnj6pxnE $GILDNimbus Therapeutics Announces Closing of #GileadSciences' Acquisition of Nimbus Apollo, Inc... Read more: https://t.co/9ZOF3mAQIJ $GILDNimbus Therapeutics Announces Closing of #GileadSciences' Acquisition of Nimbus Apollo, Inc... Read more: https://t.co/UrGe6I0pxn $GILDVolume Alert - GILD 83.37 Gilead Sciences Inc $GILD Hit a high today of 83.74 Closing the day 10:30 at 83.37 - https://t.co/aCN9NJVJWThttps://t.co/uAcamNRUPt alerted $BIND +49% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/F8iKSLizL2 $MT $GILD $HST $AA $GM $EMC $AALIntrexon Appoints Geno Germano to New Role of President https://t.co/3q2rfX2KTy via @YahooFinance  $XON $PFE $FB $GILD $VRX #ZIKA@NotaBubble @SusanCTShore $GILD $FB $SBUX $DIS $AAPL will make money in any type of market or economy - until something better comes alonghttps://t.co/uAcamNRUPt members have an advantage. SEE TRACK RECORD &amp; JOIN https://t.co/fqtC8LvhLY $HOT $AMAT $ITUB $MT $GILD $HST $AAMy core holdings: $AAPL, $GILD, $BX, $VRX, $NVAX. Love the value in the first 3 (VRX cheap but...) and big upside potential in the last 2I like $GILD again at this $83 level. Added. Also liking $AAPL now that it has regained support at $93Sold some $GILD. Added to $WBAhttps://t.co/uAcamNRUPt members have an advantage. SEE TRACK RECORD &amp; JOIN https://t.co/fqtC8LvhLY $HPQ $HOT $AMAT $ITUB $MT $GILD $HST@NotaBubble @7wtc 7 Stocks I'm staying long: $FB , $AAPL , $DIS , $SBUX , $TSLA , $MSFT , $GILD. But I do have Puts to protect any sell offsCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/yDkokYeIuj https:‚Ä¶Looking forward to the next clinical trial for NASH patients, under $GILD leadership! https://t.co/Or9xJPqdL4@cek_cpa @financialbuzz @wandy922 @ryanwallace198 I'm building positions in $AAPL and $GILD here also. Like these for LT.Gilead Sciences: Is There Upside in Hepatitis C? $GILD https://t.co/vecgoUSCwx via @barronsonlineGilead Sciences: Is There Upside in Hepatitis C? $GILD https://t.co/S6DviHMrfm https://t.co/3ovnb3OnVXDave-Trading ‚Äì May edition $ABBV $AGN $GILD https://t.co/deVoyKOfPgGilead Sciences: Is There Upside in Hepatitis C? Citi thinks there is. https://t.co/oJFifvVDMi via @barronsonline $GILD $IBBRT @mikegoodma: @fezziwig2008 True about $GILD, but I was just looking back 1 year. Pancreatic Cancer is graveyard of failed drugs.Gilead will be able to maintain its dominant position in the market despite competition, says Citigroup
https://t.co/7Qkxo01oSV $GILD@fezziwig2008 True about $GILD, but I was just looking back 1 year. Pancreatic Cancer is graveyard of failed drugs.RT @JustinPulitzer: Weekend Review VIDEO (5/15): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $YELP $ZG $SHAK $GPRO htt‚Ä¶@megtirrell @bret_jensen Did Soros buy into $GILD during q1?@jimcramer Did Soros buy into $GILD in last q?@karenfinerman Is Soros buying $GILD?GILD Top news - May 17th, 2016 $GILD https://t.co/uMO7lpO1MQLarge-Cap Stocks Primed For Big Returns https://t.co/hlt2Ailncm $AAPL $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $TRIP $ULTA $VMW $YELP$GILD (Weekly) Parabolic Arc Pattern https://t.co/mY4qMnHvCIRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/yDkokYeIuj https:‚Ä¶#Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/yDkokYeIuj https://t.co/sVCbLTxy8aRT @hedgefundclone: Billionaire Leon Copperman also takes new position in $GILD, trend here with Buffett Copperman low P/E wide moat stocksGILD back at support $GILD #thinkorswim #tradestation #fibonacci
https://t.co/BEfMpxG1RL$GILD What I'm seeing. cc: @scheplick https://t.co/s6h63q3VQAWatching today: 
$HD
$FDX
$AAPL
$BRK.B
$DNR
$GILD
$DIS
$SBUX
$CMG
$LEA
$FLWS$GILD UPDATES N REPORTS https://t.co/CfKiRnUTjCSAlphaTrending: More Bad Decisions At Berkshire: Time To Sell? - Bezek's Daily Briefing https://t.co/lLFKKyz9uX $AAPL #APPLE $DIA $GILD $G‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶More Bad Decisions At Berkshire: Time To Sell? - Bezek's Daily Briefing https://t.co/aK1ntxuuN8 $AAPL #APPLE $DIA $GILD $GM $IBM $KMI $KOhttps://t.co/G9pMgSr1JY &lt; Review of this fantastic traders teaching service! Try it for FREE! $GILD $CMG $XON $FRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT SeekingAlpha: Top 10 Net Payout Yields For May 2016 https://t.co/sOTuGaNRic $AAL $AIG $AMP $BBBY $BBY $GILD $M $MSI $NTAP $QCOM $STX $U‚Ä¶SeekingAlpha: Top 10 Net Payout Yields For May 2016 https://t.co/FHt212XBAL $AAL $AIG $AMP $BBBY $BBY $GILD $M $MSI $NTAP $QCOM $STX $UAL ‚Ä¶Top 10 Net Payout Yields For May 2016 https://t.co/TTShYn7cLA $AAL $AIG $AMP $BBBY $BBY $GILD $M $MSI $NTAP $QCOM $STX $UAL $UTXTop 10 Net Payout Yields For May 2016 https://t.co/CwkVpRp5Xk $AAL $AIG $AMP $BBBY $BBY $GILD $M $MSI $NTAP $QCOM $STX $UAL $UTXTop 10 Net Payout Yields For May 2016 https://t.co/XwttM20oUt $AAL $AIG $AMP $BBBY $BBY $GILD $M $MSI $NTAP $QCOM $STX $UAL $UTXRT @RTRRTcoach: $AGG $BND $BOND $PTY $SPY $TLT $IMGN $SAN $FXA $AAPL $VTI $VIX $GOOGL $IDRA $CTIX $SDS $EFA $ITB $HGU $AXN $ACAD $GILD $IWM‚Ä¶RT @lancejepsen: Gilead Sciences Phase 3 Study Will Be Unblinded Early $GILD https://t.co/9F9Nm67PRE https://t.co/afgTquOqY2RT @RTRRTcoach: $AGG $BND $BOND $PTY $SPY $TLT $IMGN $SAN $FXA $AAPL $VTI $VIX $GOOGL $IDRA $CTIX $SDS $EFA $ITB $HGU $AXN $ACAD $GILD $IWM‚Ä¶Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKjqBmD$AGG $BND $BOND $PTY $SPY $TLT $IMGN $SAN $FXA $AAPL $VTI $VIX $GOOGL $IDRA $CTIX $SDS $EFA $ITB $HGU $AXN $ACAD $GILD $IWM $BND $JBLU $VNQ‚Ä¶BUY #Gilead Sciences, Inc., $GILD. Target: 88.49 (+5.84%).
 https://t.co/5e7Mz2Lxi6  #trading #stocks #investingRT @InvestorsLive4U: SeekingAlpha: More Bad Decisions At Berkshire: Time To Sell? - Bezek's Daily Briefing https://t.co/XWjDJiMMTP $AAPL #A‚Ä¶RT @ChinaInvest: RT SeekingAlpha: More Bad Decisions At Berkshire: Time To Sell? - Bezek's Daily Briefing https://t.co/oY6iQb5NKW $AAPL #AP‚Ä¶RT @ChinaInvest: RT SeekingAlpha: More Bad Decisions At Berkshire: Time To Sell? - Bezek's Daily Briefing https://t.co/oY6iQb5NKW $AAPL #AP‚Ä¶RT SeekingAlpha: More Bad Decisions At Berkshire: Time To Sell? - Bezek's Daily Briefing https://t.co/oY6iQb5NKW $AAPL #APPLE $DIA $GILD $‚Ä¶SeekingAlpha: More Bad Decisions At Berkshire: Time To Sell? - Bezek's Daily Briefing https://t.co/XWjDJiMMTP $AAPL #APPLE $DIA $GILD $GM ‚Ä¶More Bad Decisions At Berkshire: Time To Sell? - Bezek's Daily Briefing https://t.co/c4EIaNwsKE $AAPL #APPLE $DIA $GILD $GM $IBM $KMI $KORT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @FREDERICDJA: Genfit's NASH Phase 2b Results Are Published And Confirm The Biotech's Lead https://t.co/moSiyFU5I6 $CNAT $GILD $GLMD $ICP‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶With a yield of 2.2% Gilead Sciences is a üí∞ dividend üí∞ stock worth a look $GILD https://t.co/nHdTPPnqeu https://t.co/3h35KVCrhyAMT E.P.S.
See Here ---&gt; https://t.co/R5K0szypGq

$AMT $FC $GILD #tradeideasRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶New post: $GILD Trade Update https://t.co/D9l6Y5my6tRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @StocksThatDoubl: Need help finding momentum stocks? https://t.co/uAcamNRUPt https://t.co/qTR8WWxoW5 $ $MT $GILD $HST $AA $GM $EMC $AAL‚Ä¶Need help finding momentum stocks? https://t.co/uAcamNRUPt https://t.co/qTR8WWxoW5 $ $MT $GILD $HST $AA $GM $EMC $AAL $EBAY $JDRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶Trading Rules - Discipline and staying strong: https://t.co/vVZZyIZdvD $GILD $TTWO $GM $SCO $REXX $YUM $ABBV $UCO $NXPI $USO $WPRT@ramlan61 simple no growth on tap, give top line 5% yoy growth and multiple expands to 12-13x and stock moves higher quickly. $GILD HBV NASHRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶Castleark Management LLC Has $37,751,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/PDgGiGkH2pCastleark Management LLC Has $37,751,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/zxEdUUf2LfRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @scalpthatstock: Stock Market Stock Chart Technical Analysis 
  https://t.co/BelvWfhEFf
  $SPY $AAPL $NFLX $TWTR $GPRO $GOOGL $FB $GILDRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶@BioTecIsFuture Reminds me of $AAPL before Carl Icahn got involved. Looks like $GILD management strategy is a no go per the marketRT @scalpthatstock: Stock Market Stock Chart Technical Analysis 
  https://t.co/BelvWfhEFf
  $SPY $AAPL $NFLX $TWTR $GPRO $GOOGL $FB $GILDRT @tgtxdough: $GILD CFO GILD has $21billion cash Priorities for capital allocation are: 1) Pipeline development, 2) M&amp;A, 3) Shareholder re‚Ä¶RT @scalpthatstock: Stock Market Stock Chart Technical Analysis 
  https://t.co/BelvWfhEFf
  $SPY $AAPL $NFLX $TWTR $GPRO $GOOGL $FB $GILDStock Market Stock Chart Technical Analysis 
  https://t.co/BelvWfhEFf
  $SPY $AAPL $NFLX $TWTR $GPRO $GOOGL $FB $GILDRT @Trading_Analyst: {NEW} ANALYSIS + TRADE IDEAS: $SPY $AAPL $NFLX $TWTR $GPRO $GOOGL $FB $GILD - click link &gt; https://t.co/ny7RRhgGVI htt‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶{NEW} ANALYSIS + TRADE IDEAS: $SPY $AAPL $NFLX $TWTR $GPRO $GOOGL $FB $GILD - click link &gt; https://t.co/ny7RRhgGVI https://t.co/eMLJ5sCd1SVTAE Bid Size
See Here ---&gt; https://t.co/gPo3vc4giw

$VTAE $MCO $GILD #investingBig #Biotech What‚Äôs the Worst Case Scenario? This doesn't sound too bad to me #stocks $CELG $GILD $BIIB $REGN
https://t.co/cPj7OmLhTrRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶@mikegoodma Add $GILD to list of recent PDA Failures - looks like a job for $HALORT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE‚Ä¶BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE $AGIO $BLUERT @raymond10mm: $GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB  $V $JPM $WMT $DIS $SPX $NASDAQ $QQQ $AAPL Apple Rally! https‚Ä¶$GILD $UTX $NKE $KO $MO $SYY $AMZN $TXN $CSCO $ORCL $CRM $FB  $V $JPM $WMT $DIS $SPX $NASDAQ $QQQ $AAPL Apple Rally! https://t.co/rlxyOAZ5DvBull Sig Reversal https://t.co/s4DxAU8W1B $CHAU $CLMS $CRUS $DRII $FCX $FIVE $GILD $JLL $MCRB $MMYT $OMEX $SAIA $TMST $XPOToday`s #unusualprofits #options: $ENDP $ERIC $FOSL $GILD $UA $XRX via https://t.co/MBahY6U0fH https://t.co/MZHdY2DIMVGilead Sciences, Inc. $GILD Stake Lowered by Tanaka Capital Management Inc. https://t.co/HtnZMRn5XVRT @WarriorNewsFeed: $IBB $CELG $GILD $AMGN $BIIB https://t.co/Hn58lZIBiC",2016-05-17,GILD,1
30,"$GILD  Double bottom? https://t.co/hPVcU7FmscRT @Biotech2050: @DrSManian $GILD is not interested in CAR-T because of cost consideration. I belief $ZIOP has a solution to this. @pharmam‚Ä¶NR7-2 https://t.co/9zgFmiHGug $FDC $ZIOP $DNR $CSIQ $GILD $GPRO $GRPN $FNSR $FIT $PRGN $SAGE $ARG $SZMK $BSTG $VLRS $EQGP $KMPHRT @Biotech2050: @DrSManian $GILD is not interested in CAR-T because of cost consideration. I belief $ZIOP has a solution to this. @pharmam‚Ä¶RT @Biotech2050: @DrSManian $GILD is not interested in CAR-T because of cost consideration. I belief $ZIOP has a solution to this. @pharmam‚Ä¶RT @Biotech2050: @DrSManian $GILD is not interested in CAR-T because of cost consideration. I belief $ZIOP has a solution to this. @pharmam‚Ä¶RT @Biotech2050: @DrSManian $GILD is not interested in CAR-T because of cost consideration. I belief $ZIOP has a solution to this. @pharmam‚Ä¶Double Bottom Perfect Doji Trigge\u2026 $GILD https://t.co/L5Ga5XbZCzLoaded up on $HSY and $GILD today - weakness due to #fedspeak. #dividend #investing #retirementCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @livesquawk: $GILD Gilead Outlook Revised To Stable From Positive By Moody'sRT @livesquawk: $GILD Gilead Outlook Revised To Stable From Positive By Moody's$GILD Gilead Outlook Revised To Stable From Positive By Moody'sHas A #Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD$CELG $REGN  https://t.co/RmLjOqsBNY via @benzinga #stocks@BursatilBiotech es q viene cagado a palos ese sector, $gild en pe de 7@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/m83pkEcmYWLong $GILD &lt;83 hit this one for a trade earlier this year.  #RT @DailyStockPlays: Below Price Channel https://t.co/XDn0RAREhX $ENDP $JCP $CJES $NKE $KSS $GILD $POTG $PTX $GDSI $BIDU $ZTS $CYTX $NVAX $‚Ä¶i bot some $GILD calls cuz they has alotter moniesRT @finboxio: An Undervalued Gem: AbbVie $ABBV @ideagenerator01 https://t.co/epZLSeLS7H $GILD $CHRS $GSK https://t.co/AZMAvcbkcu@AndyBiotech @Loftus What $MRK and $ABBV should have done following $GILD. The masters teach the students!An Undervalued Gem: AbbVie $ABBV @ideagenerator01 https://t.co/epZLSeLS7H $GILD $CHRS $GSK https://t.co/AZMAvcbkcu$CELG Showing a bit more buyers than $GILD recently. Still $GILD cheaper for value tradersRT @Logribel: ""#NAFLD and Risk of Incident Cardiovascular Disease: A Meta-Analysis"" in Hepatology $GNFT $GILD $ICPT @JHepatology https://t.‚Ä¶@tgtxdough Metabolic Immuno-oncology Competitive Landscape $INCY $GILD $CELG https://t.co/0dlocdheWMSAlphaTrending: The Celgene-Agios Partnership Strategy https://t.co/CxDJsg6PgL $AGIO $AZN $GILD $JUNO $NVO $REGN $CELG@financialbuzz @cek_cpa @wandy922 @ryanwallace198 Giddy up $aapl $cy $gild $bac.$GILD ticks the boxes as a dream üí∞ dividend üí∞ stock with 2.2% yield https://t.co/nHdTPP5PmW https://t.co/AM6n0Ngu0nThe Celgene-Agios Partnership Strategy https://t.co/LVXqXjpJa2 $AGIO $AZN $GILD $JUNO $NVO $REGN $CELG$IBB $XBI breaking down . . $CELG $GILD $BIIB $REGN way off today's highs.RT @MacaoChina: Goldman Sachs just downgraded stocks all over the world https://t.co/Ww0jhJJHhg $VXX $VIX $TVIX $UVXY $AAPL $TSLA $GILD $BI‚Ä¶RT @MacaoChina: Goldman Sachs just downgraded stocks all over the world https://t.co/Ww0jhJJHhg $VXX $VIX $TVIX $UVXY $AAPL $TSLA $GILD $BI‚Ä¶RT @MacaoChina: Goldman Sachs just downgraded stocks all over the world https://t.co/Ww0jhJJHhg $VXX $VIX $TVIX $UVXY $AAPL $TSLA $GILD $BI‚Ä¶RT @MacaoChina: Goldman Sachs just downgraded stocks all over the world https://t.co/Ww0jhJJHhg $VXX $VIX $TVIX $UVXY $AAPL $TSLA $GILD $BI‚Ä¶RT @buysellshort: $GBIM $1.70 cash per share subtle change in filing language could mean deal - partner with $GILD and $CELGRT @buysellshort: $GBIM $1.70 cash per share subtle change in filing language could mean deal - partner with $GILD and $CELGRT @buysellshort: $GBIM $1.70 cash per share subtle change in filing language could mean deal - partner with $GILD and $CELGRT @buysellshort: $GBIM $1.70 cash per share subtle change in filing language could mean deal - partner with $GILD and $CELGRT @buysellshort: $GBIM $1.70 cash per share subtle change in filing language could mean deal - partner with $GILD and $CELGRT @buysellshort: $GBIM $1.70 cash per share subtle change in filing language could mean deal - partner with $GILD and $CELG$GBIM $1.70 cash per share subtle change in filing language could mean deal - partner with $GILD and $CELGRT SeekingAlpha: Does Recent Patent Ruling Make AbbVie A Sell? https://t.co/jbgiC0hfZT $CHRS $GILD $GSK $ABBVSeekingAlpha: Does Recent Patent Ruling Make AbbVie A Sell? https://t.co/fMylULcXLb $CHRS $GILD $GSK $ABBV@roo5guy16 Gotta be quick on the feet, I missed this on $GILD last week. Same setup, falling knife, reddog reversal &amp; go. Im learning stillGilead Sciences Should Turn to Acquisitions to Drive Future Growth $GILD ‚ûú https://t.co/W2hDoPPXkD https://t.co/MWhUszZ9C7Gilead Sciences: Advantages Of Net Payout Yields $GILD https://t.co/LHleilKr7eDoes Recent Patent Ruling Make AbbVie A Sell? https://t.co/dBs4c92WuW $CHRS $GILD $GSK $ABBVDoes Recent Patent Ruling Make AbbVie A Sell? https://t.co/FCaDHtnBCZ $CHRS $GILD $GSK $ABBVDoes Recent Patent Ruling Make AbbVie A Sell? https://t.co/3HIpvNkGB8 $CHRS $GILD $GSK $ABBVDoes Recent Patent Ruling Make AbbVie A Sell? https://t.co/y3HyIp9DsJ $CHRS $GILD $GSK $ABBVVolume Alert - GILD 83.18 Gilead Sciences Inc $GILD Hit a high today of 83.33 Closing the day 10:30 at 83.18 + https://t.co/FRJk8HSSoI20 Stocks With A Billion Dollar Buyback Program And Yields Over 2% - https://t.co/G7DgXmmOA8 - $BBY $CAH $GILD $K $M $MMM $HON $WYN $SYMCCommented on Gilead Sciences: Advantages Of Net Payout Yields https://t.co/zg5s79sLfa $GILD$SBUX $NKE These two are cousins just like $AAPL and $GILD. These are some trends that would catch my attention. https://t.co/O0IIMSSq8FRT @DavidBautz: Commented on Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/518JooPvmr $ALXN $ENUM $GILD $REGN $‚Ä¶Pieris Pharmaceuticals: The Paradigm Shift That Antibodies Need https://t.co/RVCpEanG5L $PIRS, $ALXN, $ENUM, $GILD, $REGN, $SNYRT @DavidBautz: Commented on Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/518JooPvmr $ALXN $ENUM $GILD $REGN $‚Ä¶RT @MrAdamsIDF: Four off the Masterclass Watchlist immediately Boomed this morning $BABA $TSLA $GILD $TWTR‚Ä¶ https://t.co/W6d73UWPwaFour off the Masterclass Watchlist immediately Boomed this morning $BABA $TSLA $GILD $TWTR‚Ä¶ https://t.co/W6d73UWPwaTop 25 drugs in 2015 1. $ABBV 2. $GILD 3. $AMGN https://t.co/DnV9uuW55r$GILD:US Gilead Sciences Is A Long-Term Buy #GILEAD SCIENCES INC  https://t.co/Fli4aGcyUA #NASDAQCommented on Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/518JooPvmr $ALXN $ENUM $GILD $REGN $SNY $PIRSRT @MacaoChina: Goldman Sachs just downgraded stocks all over the world https://t.co/Ww0jhJJHhg $VXX $VIX $TVIX $UVXY $AAPL $TSLA $GILD $BI‚Ä¶Goldman Sachs just downgraded stocks all over the world https://t.co/Ww0jhJJHhg $VXX $VIX $TVIX $UVXY $AAPL $TSLA $GILD $BIIB $GOOG $FB #mkt@cek_cpa @financialbuzz @wandy922 @ryanwallace198 $CY $BAC $AAPL $GILD - Buy.RT SeekingAlpha: Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/XnI9dWqP6U $ALXN $ENUM $GILD $REGN $SNY $PIRS$BABA $TSLA $TWTR $GILD Boomin off the WatchlistRT @OpenOutcrier: Cooperman Omega Advisors 13F
New $AAPL $AZO $BLL $EA $ETP $GILD $PYPL $SPKE $TSE $UNH $WPZ
Increased: $ASPS $FDC $MSFT $O‚Ä¶SeekingAlpha: Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/pGFtpN9Oqj $ALXN $ENUM $GILD $REGN $SNY $PIRSRT @SA_BioTech: Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/1KRWatsdjb $ALXN $ENUM $GILD $REGN $SNY $PIRSPieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/1KRWatsdjb $ALXN $ENUM $GILD $REGN $SNY $PIRSPieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/yTGcv6TKHH $ALXN $ENUM $GILD $REGN $SNY $PIRSWill not take a loss on the remaining trading position in $GILD after locking in earlier profits on 1/2. Not much more to say.RT @dhovekamp42: $PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SN‚Ä¶Commented on Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/Y1ffiYLAcY $ABBV $MRK $GILDRT @dhovekamp42: $PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SN‚Ä¶RT @dhovekamp42: $PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SN‚Ä¶$PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SNY $PIRS$GILD has just reached a new low at $82.39.  Found with MOMO Stock Breakout App @ https://t.co/1WLje7D8rC$GILD So now a 1/2 position in S with BTC $82.50 avg from $83.61 avg  https://t.co/m1nXDPxWFWTook some off of #trading S $GILD at $82.50 avg from yesterdayMasterclass Watchlist 5/18

$BABA $FB* $GILD $HD $MCD $TWTR $TSLA $AMZN* $NFLXGILD Top news - May 18th, 2016 $GILD https://t.co/M398VUUzFgRT SeekingAlpha: Gilead Sciences: Advantages Of Net Payout Yields https://t.co/3NTrsHiASB $GILDSeekingAlpha: Gilead Sciences: Advantages Of Net Payout Yields https://t.co/8K87y9hjro $GILDGilead Sciences: Advantages Of Net Payout Yields https://t.co/TiMoyISbg0 $GILDGilead Sciences: Advantages Of Net Payout Yields https://t.co/xgAfal9EnY $GILDGilead Sciences: Advantages Of Net Payout Yields https://t.co/Cvy3Wu9WLH $GILDGilead Sciences: Advantages Of Net Payout Yields https://t.co/Lv0gqxpt4j $GILDGilead Sciences: Advantages Of Net Payout Yields https://t.co/K9SUessMxw $GILDGILD Filings
See Here ---&gt; https://t.co/Ctn74LGL8a

$GILD $DEPO $STEV #investRT @Logribel: ""#NAFLD and Risk of Incident Cardiovascular Disease: A Meta-Analysis"" in Hepatology $GNFT $GILD $ICPT @JHepatology https://t.‚Ä¶RT @TalkMarkets: ?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/3efj‚Ä¶?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/3efjKHeDGQ6 oversold stocks that aren't as ugly as they look. $nflx $gild $swks $tif $abt $lam https://t.co/YIxegkSUo0RT @GeryDIVRY: $GNFT $ICPT $GILD 
https://t.co/EmwCRfbLqVRT @GeryDIVRY: $GNFT $ICPT $GILD 
https://t.co/EmwCRfbLqV""#NAFLD and Risk of Incident Cardiovascular Disease: A Meta-Analysis"" in Hepatology $GNFT $GILD $ICPT @JHepatology https://t.co/AdE4V9Mh9n#NAFLD and Risk of Incident Cardiovascular Disease - A Meta-Analysis of Observational Studies $GNFT $ICPT $GILD https://t.co/R5hmKKP5XV$GNFT $ICPT $GILD 
https://t.co/EmwCRfbLqVhttps://t.co/uAcamNRUPt alerted $BIND +49% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/F8iKSLizL2 $MT $GILD $HST $AA $GM $EMC $AALGilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Robert W. Baird https://t.co/VkMXaz22uvRT SeekingAlpha: Skyworks Is A Name I Continue To Add To My Portfolio https://t.co/N0wutlcco5 $AGN $EV $GILD $GOOG $ORLY $PCLN $SPGI $SWKSSeekingAlpha: Skyworks Is A Name I Continue To Add To My Portfolio https://t.co/TfVUb27k5J $AGN $EV $GILD $GOOG $ORLY $PCLN $SPGI $SWKSSkyworks Is A Name I Continue To Add To My Portfolio https://t.co/QlmyLSsngT $AGN $EV $GILD $GOOG $ORLY $PCLN $SPGI $SWKSSkyworks Is A Name I Continue To Add To My Portfolio https://t.co/aUDSQ0FrBT $AGN $EV $GILD $GOOG $ORLY $PCLN $SPGI $SWKSSkyworks Is A Name I Continue To Add To My Portfolio https://t.co/M6N5SvWTwT $AGN $EV $GILD $GOOG $ORLY $PCLN $SPGI $SWKSSkyworks Is A Name I Continue To Add To My Portfolio https://t.co/zCvLwip8gC $AGN $EV $GILD $GOOG $ORLY $PCLN $SPGI $SWKShttps://t.co/uAcamNRUPt members have an advantage. SEE TRACK RECORD &amp; JOIN https://t.co/fqtC8LvhLY $HOT $AMAT $ITUB $MT $GILD $HST $AAHCA Market Cap
See Here ---&gt; https://t.co/CAaAO37oP6

$HCA $GILD $SAM #investhttps://t.co/uAcamNRUPt members have an advantage. SEE TRACK RECORD &amp; JOIN https://t.co/fqtC8LvhLY $HPQ $HOT $AMAT $ITUB $MT $GILD $HSTACH Last Trade
See Here ---&gt; https://t.co/fQxwh4wzxK

$ACH $GILD $TSM #tradeideasRT @MarketsRecap: ?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/moZ‚Ä¶?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/moZw8CefgxLLL 52Wk High
See Here ---&gt; https://t.co/m6MFIQH4fS

$LLL $MT $GILD #financeCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5$GILD is prolly waiting for 07-08 correction to go shopping,PE 7 or 5 will hardly matter, w $AAPL type cash. But $REGN shud raise some dough$GILD https://t.co/94ah0AqfH0$GILD https://t.co/ftAsuKbfyv@BorisB2 just because the price goes down doesn't mean the underlying business has gone bad. $GILD is undervalued. I'll hold for about 1 yr.Gilead Sciences, Inc. $GILD Shares Bought by CCM Investment Advisers LLC https://t.co/zDJ89MWRNOPossible Long Setup $GILD https://t.co/xp7Cw3LsGWRT @ben_levisohn: Gilead Sciences: Is There Upside in Hepatitis C? Citi thinks there is. https://t.co/oJFifvVDMi via @barronsonline $GILD $‚Ä¶Psagot Investment House Ltd. Has $19,069,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/zBDZ4I7AWHRT @UOTApp: Today`s #unusualprofits #options: $ERIC $FOSL $GILD $JWN $UA $XRX via https://t.co/MBahY6U0fH https://t.co/6ja3BNTTjzRT @UOTApp: Today`s #unusualprofits #options: $ERIC $FOSL $GILD $JWN $UA $XRX via https://t.co/MBahY6U0fH https://t.co/6ja3BNTTjzToday`s #unusualprofits #options: $ERIC $FOSL $GILD $JWN $UA $XRX via https://t.co/MBahY6U0fH https://t.co/6ja3BNTTjz$FAS put diagonals and $GILD call diagonals is what I have left.",2016-05-18,GILD,0
31,"Could've sworn I saw a $14 spike in $GILD after hours. I blinked and it was gone. Too bad for my May 27 call spreads.@RiskReversal @megtirrell @CNBCFastMoney Not sure where $GILD will go, but, I think we can agree that @megtirrell is indeed fabulous.@RiskReversal @megtirrell dan no way $gild can be looked at with tech analysis. Company generates enough cash to be a small country.RT @RiskReversal: With the fab @megtirrell we just discussed $GILD, one of the worst 6 P/E charts I've ever seen. #TriangleOfDeath https://‚Ä¶RT @aktionaer: $NFLX, $GILD and four other #oversold #stocks where the charts do not signal buy. /SO https://t.co/n5Jlcf0Btm via @TheStreetWith the fab megtirrell we just discussed $GILD, one of the worst 6 P/E charts I've ever seen. #TriangleOfDeath https://t.co/WETRTptWeRRiskReversal: With the fab megtirrell we just discussed $GILD, one of the worst 6 P/E charts I've ever seen. #Tria‚Ä¶ https://t.co/yxYkcWex41RT @RiskReversal: With the fab @megtirrell we just discussed $GILD, one of the worst 6 P/E charts I've ever seen. #TriangleOfDeath https://‚Ä¶RiskReversal: With the fab megtirrell we just discussed $GILD, one of the worst 6 P/E charts I've ever seen. #Tria‚Ä¶ https://t.co/RNKLJgz9jymegtirrell: RT RiskReversal: With the fab megtirrell we just discussed $GILD, one of the worst 6 P/E charts I've e‚Ä¶ https://t.co/0BuZE3CMCERT @tysonclaytonmti: $GILD is setting up to be a major trade! Watch my full #profit strategy in today‚Äôs #DailyEquitiesOutlook: https://t.co‚Ä¶RT @RiskReversal: With the fab @megtirrell we just discussed $GILD, one of the worst 6 P/E charts I've ever seen. #TriangleOfDeath https://‚Ä¶$GILD is setting up to be a major trade! Watch my full #profit strategy in today‚Äôs #DailyEquitiesOutlook: https://t.co/HdggsUdjPsRT @RiskReversal: With the fab @megtirrell we just discussed $GILD, one of the worst 6 P/E charts I've ever seen. #TriangleOfDeath https://‚Ä¶With the fab @megtirrell we just discussed $GILD, one of the worst 6 P/E charts I've ever seen. #TriangleOfDeath https://t.co/2bjGLWDNom@ZenTrends I may go short if that happens.  $GILD{NEW POST} ANALYSIS + TRADE IDEAS: $AAPL $NFLX $TSLA $TWTR $GPRO $GILD $VRX $CMG click link&gt; https://t.co/EzZyh0R7Lg https://t.co/iUf4kX9VrTRT @outsizedreturn: #EconomicData $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/Fn1XYkxmV9 https‚Ä¶RT @outsizedreturn: #EconomicData $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/Fn1XYkxmV9 https‚Ä¶#EconomicData $spy $vxx $yinn $nky $oil $uso $amzn $msft $crm $ko $gild $aapl #hedgefunds https://t.co/Fn1XYkxmV9 https://t.co/EHeYbr0izoWould be nice. $GILD https://t.co/avzczk1dSERT @TaxHavens: $GILD $4.2 to $4.8B in quarterly HCV  revs going to continue for years. Nearest competition is $440M from Viekira. Nobody ha‚Ä¶$GILD has just reached a new high at $97.0424.  Found with MOMO Stock Breakout App @ https://t.co/1WLje7lx32Found some support today $GILD https://t.co/x1o9ME6OpW$GILD chart: Found some support today. https://t.co/ugQbXiJWC0RT @BioStockAddict: Galapagos' new pipeline update and timeline. $GLPG $GILD $ABBV #RA #Crohn #CF https://t.co/kA0X6L76dTRT @Benzinga: 5 Reasons Arrowhead Pharma Is A Hepatitis B Leader $ARWR $GILD $JNJ https://t.co/D70ZD70w0mRT @BioStockAddict: Galapagos' new pipeline update and timeline. $GLPG $GILD $ABBV #RA #Crohn #CF https://t.co/kA0X6L76dTInvestment Analysts‚Äô Recent Ratings Updates for Gilead Sciences $GILD https://t.co/eocpTAzYoCInvestment Analysts‚Äô Recent Ratings Updates for Gilead Sciences $GILD https://t.co/hMwn07zBi7Four stocks making new 52-week lows in Thursday‚Äôs session:
$LB, $GILD, $SPLS, $GPS
https://t.co/SqMjtdrcnPGalapagos' new pipeline update and timeline. $GLPG $GILD $ABBV #RA #Crohn #CF https://t.co/kA0X6L76dThammer in $GILD.. long term trend point..@SheffStation @SheffStation $TGTX have a poison pill preventing a hostile #buyout.
#shorts manipulating in the meanwhile
$GILD should buy itRT @TV_TradingIdeas: GILD - Valuation bargain\u2026 $GILD https://t.co/5xAqPidGG4GILD - Valuation bargain\u2026 $GILD https://t.co/5xAqPidGG4RT @Biotech2050: Will @GileadSciences $GILD explain to #shareholders in the next #AGM that they are working in their best interest 
Do a #b‚Ä¶RT @Biotech2050: $GILD &amp; $TGTX at 52 week low today. If @GileadSciences #buysout @TGTherapeutics both will explode both in value &amp; in scien‚Ä¶$GILD $GILD https://t.co/COasNnzFRC ~ via https://t.co/Kd2qwcsyit$GILD $GILD https://t.co/JvrOCqhUVB$GILD chart: $GILD. https://t.co/4ppgqf7Sam$GILD $4.2 to $4.8B in quarterly HCV  revs going to continue for years. Nearest competition is $440M from Viekira. Nobody has this kina cashRT @Benzinga: 5 Reasons Arrowhead Pharma Is A Hepatitis B Leader $ARWR $GILD $JNJ https://t.co/D70ZD70w0mRT @ramlan61: @Biotech2050 @GileadSciences They need a good activist involved to set them right b/c nothing they are doing is working right‚Ä¶@Biotech2050 @GileadSciences They need a good activist involved to set them right b/c nothing they are doing is working right now imo $GILDhttps://t.co/p7tVeIZFvX Millionaire Road Map Trading top students win a Porsche for a yr! $LNKD $CVX $GILD $STX $PBenzinga: 5 Reasons Arrowhead Pharma Is A Hepatitis B Leader $ARWR $GILD $JNJ https://t.co/fuhRm5W1ZSWill @GileadSciences $GILD explain to #shareholders in the next #AGM that they are working in their best interest 
Do a #buyout or #resignRT @Benzinga: 5 Reasons Arrowhead Pharma Is A Hepatitis B Leader $ARWR $GILD $JNJ https://t.co/D70ZD70w0m5 Reasons Arrowhead Pharma Is A Hepatitis B Leader $ARWR $GILD $JNJ https://t.co/D70ZD70w0mKeeping an eye on $GILD as it continues to break down [needs to consolidate before an entry]Don't get why solid co. like $GILD is going down! Sometimes #stockmarket makes no sense!$GILD~ Couldn't resist, added 600 shares at $81.33...https://t.co/uAcamNRUPt alerted $BIND +49% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/F8iKSLizL2 $HOT $AMAT $ITUB $MT $GILD $HST $AA$GILD if your short cover and get out of the way.RT @fezziwig2008: W/Recent PDA Failures by $GILD (HR&gt;1) $THLD, $NLNK, &amp; $ADRO -Not surprising The Street can't recognize a successful HR in‚Ä¶RT @ZenTrends: $GILD Clear sell signal...BTFD right? https://t.co/DkvtKVJUAsOversold $NFLX $GILD $ABT $LAZ  watching not pulling any triggers$GILD Clear sell signal...BTFD right? https://t.co/DkvtKVJUAsStockConsultant: $GILD (Gilead) stock uh oh, sliding with a breakdown https://t.co/4mA5bD2pZS https://t.co/0TITAvNMBo$GILD (Gilead) stock uh oh, sliding with a breakdown https://t.co/tlB9IYqUTj https://t.co/H5mjTZIJY5RT @DividendSheet: 10 Companies With The Biggest Share Buybacks - https://t.co/0l5YWFCQ4Q - $GE $GILD $UTX $V $MON $AIG10 Companies With The Biggest Share Buybacks - https://t.co/0l5YWFCQ4Q - $GE $GILD $UTX $V $MON $AIG@HalftimeReport $GILD hit a 52 week low today $81.28 and they have a great BS,CF, and pipeline.$BIIB is nearing its 52 week low too.The value in $GILD is insane on an EARNINGS basis (no bubble, actual earnings) https://t.co/RUdNpYqcNVFREE LUNCH TIME WEBINAR 12:45 est. Covering: $GLD $USO $NFLX $FB $CMG $GS $GILD - Register: https://t.co/CwNrdUIud5 https://t.co/QgTy6yDXBG$XLV  $UNH  $GILD  $AMGN  ETF Outflow Alert #etfs https://t.co/q22lxcbeUo$XLV  $UNH  $GILD  $AMGN  ETF Outflow Alert #etfs: Symbols mentioned in this story:  XLV, UNH, GILD, AMGN
 
 ... https://t.co/yEwjIY5M9PWhich one is Gilead $GILD and which one is the snail mail company Pitney Bowes $PBI .  Hint- Gilead worse. https://t.co/vMLf0lA2SSStrong buy watchlist: $TSLA, $NFLX, $GILD and $DIS. ¬†Very attractive oversold price level. ¬†Huge rebound upside potential in coming weeks.https://t.co/uAcamNRUPt members have an advantage. SEE TRACK RECORD &amp; JOIN https://t.co/fqtC8LvhLY $HOT $AMAT $ITUB $MT $GILD $HST $AA$GILD touch 52W lowhttps://t.co/uAcamNRUPt members have an advantage. SEE TRACK RECORD &amp; JOIN https://t.co/fqtC8LvhLY $HPQ $HOT $AMAT $ITUB $MT $GILD $HST$GILD ROI 45% stock ytd -19.41%  vs $DUK ROI 4.9% stock ytd +7.17%.  Apparently, ROI is a bad measure.Volume Alert - GILD 81.79 Gilead Sciences Inc $GILD Hit a high today of 82.59 Closing the day 10:30 at 81.79 - https://t.co/Vqge94lHVk@bret_jensen Is $GILD management ever going to get this together?  Why isn't the board doing its fiduciary duty?$NFLX, $GILD and four other #oversold #stocks where the charts do not signal buy. /SO https://t.co/n5Jlcf0Btm via @TheStreet$GILD Inside wk &amp; month. No bottom yetW/Recent PDA Failures by $GILD (HR&gt;1) $THLD, $NLNK, &amp; $ADRO -Not surprising The Street can't recognize a successful HR in $HALO better in Q4Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Skyworks Is A Name I Continue To Add To My Portfolio https://t.co/jE36ICVNb2 $AGN $EV $GILD $GOOG $ORLY $PCLN $SPGI $SWKSMy #buyback expectation out of $GILD @GileadSciences is that exhaust the full $12B available for all shares &lt; $82
$IBB $XBI$GILD &amp; $TGTX at 52 week low today. If @GileadSciences #buysout @TGTherapeutics both will explode both in value &amp; in scientific pipelineAnalyst Actions and Breaking News $AAPL $AA $LMT $GILD $MNK #stocks https://t.co/n82tlsOOjaRT @portefeuillefun: Added 100 $GILD at $81.77, now 200 #zzporte shares, cost basis $85.27. @zzlangerhans$GILD I see $XBI going to 40s no joke. Recent rejection of The 50 RSI on Weekly on that not adding much conviction to buy this right now.$GILD Plus it gave 0 f-cks about a Candle Support Trend I drew on The Weekly.RT @bostonbiomed: Buying $GILD here$GILD Got alerted again on this. But not catching much of my interest because i still see risk when I look at an $XBI or $IBB.$GILD Gilead Sciences NEW SHORT at 81.5X | Executed on break of monthly support &amp; weakening IBB &amp; weak broad market conditionsBuying $GILD hereI hope there is a ""no one ever got fired for buying $GILD shares"" rule :) @zzlangerhansAdded 100 $GILD at $81.77, now 200 #zzporte shares, cost basis $85.27. @zzlangerhans$GILD 3mo Breaking lows of 5y ago https://t.co/du7t9a2brwRT @BPGAG: $GILD Moved to 1/4 pos on #trading S at $81.95 avg from $83.61 avg #biotech #stocks  https://t.co/WstblMZ0sl@jimcramer @_JackMohr $BAC $AAPL $GILD feel like gifts at these levels.@petenajarian $AAPL and $GILD at current levels is a gift.$GILD Moved to 1/4 pos on #trading S at $81.95 avg from $83.61 avg #biotech #stocks  https://t.co/WstblMZ0sl@Stephanie_Link Are you a buyer of $GILD here?  Ridiculously undervalued like $AAPL.@financialbuzz @cek_cpa @wandy922 @ryanwallace198 I'm averaged into $GILD under $84.@JDR1024 @cek_cpa @wandy922 @ryanwallace198 biotechs are going to heat up because of ASCO June 3rd, so $GILD is good the IBB should heat up$GILD looks ripe for Activist involvement! $21B in cash with a ridiculously low mult. Mgmt needs a catalyst!RT @BPGAG: $GILD 2/3 covered on trade for nice profit from near $83.50 - see earlier posts; 1/3 rides to $83 area #biotech #stocksOkay $GILD, it's officially time for you to announce that you are making a game-changing acquisition in the immuno-oncology space.@cek_cpa @financialbuzz @wandy922 @ryanwallace198 Anyone here own $CY $BAC $GILD or $AAPL besides me?$GILD 2/3 covered on trade for nice profit from near $83.50 - see earlier posts; 1/3 rides to $83 area #biotech #stocksTook $GILD #trading S to 1/3 at BTC $82.08 avgGilead Sciences‚Äô $GILD Buy Rating Reiterated at Robert W. Baird https://t.co/goBIvon4k2GILD Top news - May 19th, 2016 $GILD https://t.co/ZgMbsTTktFRT @tgtxdough: LR $GILD Encouraging Phase I PFS Data for GILD‚Äôs anti-MMP9 Ab GS5745 in Chemotherapy Na√Øve Gastric Cancer PatientsLR $GILD Encouraging Phase I PFS Data for GILD‚Äôs anti-MMP9 Ab GS5745 in Chemotherapy Na√Øve Gastric Cancer Patients$GILD:US HM Payson &amp; Co. Purchases 29,278 Shares of Gilead Sciences, Inc. (GILD) #GILEAD SCIENCES INC  https://t.co/QvDfT8abiZ #SP500AXDX Stock Message Board
See Here ---&gt; https://t.co/tEZlKkchRP

$AXDX $RGEN $GILD #nasdaqRT @csresearch: Estimated impact of US drug price rises on 2015 net income: $VRTX, $BMRN, $GSK, $MRK and $GILD were least reliant https://t‚Ä¶Trading Rules - Discipline and staying strong: https://t.co/vVZZyIZdvD $GILD $TTWO $GM $SCO $REXX $YUM $ABBV $UCO $NXPI $USO $WPRTBCS Last Trade
See Here ---&gt; https://t.co/bD3DNyfDeQ

$BCS $BEL $GILD #investingVCEL Last Trade
See Here ---&gt; https://t.co/UkcDsx976t

$VCEL $GILD $ISRG #stocksGilead Sciences, Inc. $GILD Sees Significant Growth in Short Interest https://t.co/cXkWGsTGXCGilead Sciences, Inc. $GILD Sees Significant Growth in Short Interest https://t.co/lkGSU9v7jjGilead Sciences, Inc. $GILD Sees Significant Growth in Short Interest https://t.co/EjI9rfjNd4RT @fgusequity: $GILD https://t.co/dZWRGe19sM Pot. cont. Downtrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/dyelL0qhSd$GILD https://t.co/dZWRGe19sM Pot. cont. Downtrend INTRAWEEK 60m-15m-4m combo chart #trading #stocks https://t.co/dyelL0qhSdRT @goldrush201617: POT Market Cap
See Here ---&gt; https://t.co/F2ilzwxhPK

$POT $AXE $GILD #stocksPOT Market Cap
See Here ---&gt; https://t.co/F2ilzwxhPK

$POT $AXE $GILD #stocksGILD Day High
See Here ---&gt; https://t.co/Kb639cDvbl

$GILD $NJ $SWX #shareGilead Sciences, Inc. $GILD Position Increased by Albion Financial Group UT https://t.co/UY0xZAQ5WbGilead Sciences, Inc. $GILD Stake Boosted by Highbridge Capital Management LLC https://t.co/9P45aUY74cGilead Sciences, Inc. $GILD Stake Boosted by Highbridge Capital Management LLC https://t.co/G0luaEAx8FKentucky Retirement Systems Insurance Trust Fund Invests $5,462,000 in Gilead Sciences, Inc. $GILD https://t.co/zopRzUnK4FGilead Sciences: Advantages Of Net Payout Yields $GILD https://t.co/yBPvlpc3KPHM Payson &amp; Co. Purchases 29,278 Shares of Gilead Sciences, Inc. $GILD https://t.co/lLn3CmyFI1HM Payson &amp; Co. Purchases 29,278 Shares of Gilead Sciences, Inc. $GILD https://t.co/ztxaVhg27mMeyer Handelman Co. Sells 1,500 Shares of Gilead Sciences, Inc. $GILD https://t.co/JyJDw3shS0CalPERS awards $4.9 billion PBM contract to @OptumRx, as it scrambles to control Rx drug costs‚Üíhttps://t.co/lgRfLK9lpp #HCV #HepC $UNH $GILDCalPERS Picks OptumRx as New Pharmacy Benefits Manager‚Üíhttps://t.co/gs0AKNLKTk @CalPERS @OptumRx #HCV #HepC $UNH $GILD",2016-05-19,GILD,1
32,"RT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶Stillwater Investment Management LLC Decreases Stake in Gilead Sciences, Inc. $GILD https://t.co/wodalddzPZRT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶Gilead Sciences, Inc. $GILD Position Decreased by First American Trust FSB https://t.co/JCM8g1INBMStillwater Investment Management LLC Decreases Stake in Gilead Sciences, Inc. $GILD https://t.co/KplwTzDBlUGilead Sciences, Inc. $GILD Position Decreased by First American Trust FSB https://t.co/e475h8WIMSRT @eriehner101: RT https://t.co/q6vFOsSCBm : Competition may threaten Gilead as market leader. $GILD #HepC #antibiotics #pharma ‚Ä¶ https://‚Ä¶RT https://t.co/q6vFOsSCBm : Competition may threaten Gilead as market leader. $GILD #HepC #antibiotics #pharma ‚Ä¶ https://t.co/y4RV0fADThCompetition may threaten Gilead as market leader. $GILD #HepC #antibiotics #pharma https://t.co/9lWITstcAX https://t.co/mb0nw7CLVxS&amp;P100 #Stocks Performance $MON $DD $DOW $HAL $AAPL $GILD $CAT $MMM $GS $C $BIIB $MO $TXN $SPG $PEP $INTC  more@ https://t.co/cKkr8cKsju#GileadSciences Activists challenge granting of Sovaldi patent in India. Read more: https://t.co/xr9iVsPEIo $GILDParabolic SAR Buy https://t.co/DFZK6wIEKQ $VOE $ANSS $GILD $RSP $TREE $ESRX $ODFL $PRXL $DDS $TNA $APH $WCC $TUP $BURL $DOW $SCHA $PENWhat To Make Of Gilead And Its Buybacks https://t.co/voaNuTvG4Z $GILD#GileadSciences Gilead To Present At The UBS Global Healthcare Conference On Monday, May 23  . Read more: https://t.co/jc95dkuVga $GILDWhat's moving? Crunch by #Bloomberg Social Velocity #hegdefunds $fb $twtr $aapl $ge $gild $f https://t.co/kdNS5oGAZe https://t.co/c87RetueEbA block of $GILD did trade for $98.4725...1026 shares...no news, sum1 got ripped off...use limit orders AH kids$GILD chart w/w https://t.co/1lqzpxqsfzGood moves in $FB S $GILD L. If you're taking early bird home, don't let this happen https://t.co/jYvLT0ZImv #MondayMotivation Good Night!Money Flows: Selling on Strength: Among stocks that were up today, these had the largest outflow of $$$: $INTC $MCD $HAL $GILD $PPG $PG top6RT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶@jimcramer do you know what's happening with $GILD?RT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶@cnbc $gild up 18+% and CNBC doesn't mention it?Just saw $gild at $98 AH fan across the bottom on CNBC,  must be a mistake.https://t.co/KkHg4O78J2 &lt;&lt; 5 lessons for FREE from Tim https://t.co/KkHg4O78J2 TimSykes millionaire trader on $SPY $INO $SLV $GILD $CRUS$GILD Gilead Sciences is a 5 star üí∞ dividend üí∞ stock with a 2.3% yield: https://t.co/nHdTPP5PmW https://t.co/5uIWd0zqGsFor the 2 on our daytrade lists: $GILD (multiple profits taken today on #trading L from $82.18); $FB closes on the lows and is eyeing $114.RT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶RT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶S&amp;P100 #Stocks Performance $MON $DOW $DD $HAL $AAPL $CAT $GILD $MMM $TXN $GS $CMCSA $FOXA $BIIB $MO $INTC  more@ https://t.co/cKkr8cKsjuGilead: Is Vermont The ""Canary In The Coal Mine?"" https://t.co/xw2l0hyuer ‚Ä¶ ‚Ä¶ $ABBV $GILD @BernieSanders #FeelRT @hedgefundclone: Goldman Sach $GS says these are the 20 stocks hedge funds are betting against: $DIS    $XOM $GE $BA $NFLX $F $TGT $CAT‚Ä¶RT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶RT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶RT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶Your 2016 Guide to Investing in #GileadSciences Stock. Read more: https://t.co/yThQt6mrgC $GILDThere are many reasons to be optimistic about #Gilead's prospects
 https://t.co/J32hXfwAOa $GILD#Stocks hugging the flat line. Apple up on hope for the #iPhone7 Some movement on Netflix higher and Gilead a little higher. $NFLX $GILDRT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GILD $ABBV@sassyoptions $GILD looks to be in the final stages of a pennant; you tempted to add to the 85 calls on a possible breakout?Goldman Sach $GS says these are the 20 stocks hedge funds are betting against: $DIS    $XOM $GE $BA $NFLX $F $TGT $CAT $ESRX $IBM $GILD $TRT @HenryEChang: Activists challenge granting of Sovaldi patent in #India‚Üíhttps://t.co/A0Hwuoabie via @ThePharmaLetter #HCV #HepC #Hepatiti‚Ä¶Activists challenge granting of Sovaldi patent in #India‚Üíhttps://t.co/A0Hwuoabie via @ThePharmaLetter #HCV #HepC #HepatitisC $GILDRT @JustinPulitzer: Weekend Review VIDEO (5/22): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB #StockM‚Ä¶ #investRT @Tootix: #GFT505 Presents an Array of Hope in Nonalcoholic Steatohepatitis (#NASH) $GNFT $ICPT $GILD Therapeutics Market https://t.co/HO‚Ä¶RT https://t.co/Lq7ENZz15z : Here are the top 25 #infectiousdisease products in 2015. #pharma $GILD $BMS $PFE $MR‚Ä¶ https://t.co/nm9zpFiXK7$VIX curve flattens, small gains in #equities like $GILD, $IBB-- rather mixed picture. @elerianm spins #FED move for Jun/Sep. What next?Here are the top 25 #infectiousdisease products in 2015. #pharma $GILD $BMS $PFE $MRK $JNJ https://t.co/9RjN5FZTqG https://t.co/uGrdkfWEFIBuying $GILD today, holding into retirement account.  Options possibly at the Jul exp on 85 or 90 strikes.SAlphaTrending: Gilead Sciences (GILD) Presents at UBS Global Healthcare Conference (Transcript) https://t.co/uBisqfpO9r $GILD@SunriseTrader you are stop on $GILD . looks like it will move over 85 near term..RT @SunriseTrader: Looking for a dumpster dive trade? $GILD https://t.co/yp3dQ8Q7ZhSAlphaTrending: Gilead Sciences (GILD) Presents at UBS Global Healthcare Conference (Transcript) https://t.co/TgQYvboJGB $GILDRT @BioStockAddict: I still stand by my idea. By the end of the year Galapagos will be (one of) the biggest European biotech companies. $GL‚Ä¶Gilead Sciences (GILD) Presents at UBS Global Healthcare Conference (Transcript) https://t.co/iPPwaDVlR4 $GILD$GILD trade working tight stopRT @The__Slayer: Generation Portfolio: Wish List https://t.co/fQlqBXli44 $AAPL $HD $ADI $GILD $SPY $IWM $QQQ $RUT $DJIA $DIA@JDR1024 @cek_cpa @wandy922 @ryanwallace198 guys loving my $GILD right now, easily back to $100 in a bull market and biotechs heating upCompetition may threaten Gilead as market leader. $GILD #HepC #antibiotics #pharma https://t.co/9lWITstcAX https://t.co/VdLLOyoY9XGilead: Et Tu Vermont? $GILD https://t.co/DDb57LU8V7RT @SunriseTrader: Looking for a dumpster dive trade? $GILD https://t.co/yp3dQ8Q7Zh#GileadSciences Gilead HIV Franchise Can Perform Better Than Expected. Read more: https://t.co/oDDi6K1GZo $GILDGuTA: Bought $GILD 6/17 86c @ .85 - GuTA https://t.co/C9xaB1JcRnGeneration Portfolio: Wish List https://t.co/fQlqBXli44 $AAPL $HD $ADI $GILD $SPY $IWM $QQQ $RUT $DJIA $DIART @SunriseTrader: Looking for a dumpster dive trade? $GILD https://t.co/yp3dQ8Q7ZhLooking for a dumpster dive trade? $GILD https://t.co/yp3dQ8Q7Zh$gild having a rare strong dayStockConsultant: $GILD (Gilead Sciences) stock attempting to bounce off 82.59 support area, bullish stats ‚Ä¶ https://t.co/qauEwwhUPeS&amp;P100 #Stocks Performance $MON $DOW $AAPL $DD $FOXA $BIIB $CAT $GILD $CSCO $MCD $INTC $CMCSA $TXN $BA  more@ https://t.co/cKkr8cKsju$GILD (Gilead Sciences) stock attempting to bounce off 82.59 support area, bullish stats https://t.co/tlB9IYqUTj https://t.co/TfCEsdWNMS$GILD @1simpletrader yup https://t.co/l3S6JWXAp7$AAPL $NFLX $GILD ALL look stellar into Gap Fills!Volume Alert - GILD 83.77 Gilead Sciences Inc $GILD Hit a high today of 84.03 Closing the day 10:30 at 83.77 + https://t.co/cgOTz8jg2jRT @ShockExchange: Gilead: Et Tu Vermont? https://t.co/xw2l0hyuer ‚Ä¶ $ABBV $GILD @RepCP @progparty @SusanHatchDavis @GovPeterShumlin https:/‚Ä¶RT @R4inb0w_: Gilead CSO Bischofberger Speaks At Investor Conference. Gilead Says Will Be Pursuing M&amp;A, Collaboration Opportuinities $GILD‚Ä¶Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Sold $GILD 0527 83C @ 1.12 from 0.90. Holding seeply red $AGN 230C lots from 2.40 to 1.65#Gilead HIV Franchise Can Perform Better Than Expected $GILD ‚ûú https://t.co/UV57OnXr8o https://t.co/03tZhozEcNThe buy biotech $IBB trade into ASCO seems poised to work again $CELG $GILDSmall position $GILD call 83.5 @ 1.06$GILD back over $84? Hmmmmm?@cek_cpa @financialbuzz @wandy922 @ryanwallace198 Long $CY $AAPL $GILD $BAC $MAR and $IMNP.Long $GILD $83.95RT @jonathanrockoff: Most cash-rich drug cos, per Moody's: $PFE ($39bn), $JNJ (38), $AMGN (31), $MRK (27), $GILD (26), $BMY (9), $ABBV (9),‚Ä¶$GILD seller might have finally cleaned up right near $82 support.  They have to be buying back stock hand over fist here.Potential Risks Which Gilead Sciences Should Address $GILD https://t.co/zXUfAfE1CQ@jimcramer Buying more $CY, $BAC, $GILD and $AAPL.$ICPT nice move. PDUFA coming - 150-170 in cards - then buyout from $GILD??!Went to 20% on $GILD #trading L at $83.60 avgRT @JustinPulitzer: My #StockMarket Weekend Review VIDEO $VIX $UUP $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB ht‚Ä¶$GILD 1/3 position L at $83.39 avgRT @R4inb0w_: Gilead CSO Bischofberger Speaks At Investor Conference. Gilead Says Will Be Pursuing M&amp;A, Collaboration Opportuinities $GILD‚Ä¶RT @R4inb0w_: Gilead CSO Bischofberger Speaks At Investor Conference. Gilead Says Will Be Pursuing M&amp;A, Collaboration Opportuinities $GILD‚Ä¶Took some off $GILD L $83.25 avgGilead CSO Bischofberger Speaks At Investor Conference. Gilead Says Will Be Pursuing M&amp;A, Collaboration Opportuinities $GILD (Bloomberg)BUY $GILD üëçAlso glad I bought $GILD at close on Friday. #ThatsAlsoRightPartTwoGilead Sciences: The Qualitative Long Case https://t.co/NibCUPIY1h $GILD""We will be pursuing acquisitions that are attractive to us."" UBS $GILDCommented on Gilead Sciences: The Qualitative Long Case https://t.co/I1QjIIcMbA $ABBV $MRK $GILDGarbage stocks return to rising, Quality languishes.  $gildInvestorsLive4U: SeekingAlpha: What To Make Of Gilead And Its Buybacks https://t.co/oPbSd68kcF $GILDRT SeekingAlpha: What To Make Of Gilead And Its Buybacks https://t.co/rpOGEc15vV $GILD@carlquintanilla @jimcramer Co's w great balance sheets &amp; strong, but slowing, sales, get hammered most. $GILD is another. Herd mentality.RT @JustinPulitzer: My #StockMarket Weekend Review VIDEO $VIX $UUP $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB ht‚Ä¶SeekingAlpha: What To Make Of Gilead And Its Buybacks https://t.co/0v7ANskdO5 $GILDGILD Top news - May 23rd, 2016 $GILD https://t.co/jEOmiYwvIqWhat To Make Of Gilead And Its Buybacks https://t.co/CwwZKtyswG $GILDWhat To Make Of Gilead And Its Buybacks https://t.co/VSr43wmhHb $GILDRT @Tootix: #Elafibranor Could be Just the Thing to Boost the Global #NASH Market $GNFT $ICPT $GILD https://t.co/6zkypYa6eoGeneration Portfolio: Wish List https://t.co/Yw7mfYb7do $AAPL $ABR $ADI $AGNC $BMY $CLDT $CPB $CVX $CYS $DIS $GILD $HD $HSY $JPM $KMI $KORT @JustinPulitzer: My #StockMarket Weekend Review VIDEO $VIX $UUP $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB ht‚Ä¶RT @Tootix: #Elafibranor Could be Just the Thing to Boost the Global #NASH Market $GNFT $ICPT $GILD https://t.co/6zkypYa6eo#Elafibranor Could be Just the Thing to Boost the Global #NASH Market $GNFT $ICPT $GILD https://t.co/6zkypYa6eoCommented on 2 Attractive Possible Takeovers In Biotech https://t.co/HaY3ySFLyi $GILD $RLYP $IONSRT @JustinPulitzer: My #StockMarket Weekend Review VIDEO $VIX $UUP $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB ht‚Ä¶RT @JustinPulitzer: My #StockMarket Weekend Review VIDEO $VIX $UUP $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB ht‚Ä¶My #StockMarket Weekend Review VIDEO $VIX $UUP $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB https://t.co/QifceATXSFRT @GantosJ: $GILD sofosbuvir / velpatasvir EMA Accelerated assessment treatment of chronic hepatitis C virus in European union https://t.c‚Ä¶RT @danwardbio: (3/5) Wild $GBIM action continues w move today. I dont think $GILD has given up on GS-4774. That said, GBIM execution has b‚Ä¶RT @outsizedreturn: World #Equity Mkts Futures $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/kjOSvygfJ7 https‚Ä¶RT @outsizedreturn: Americas #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/nraWgiv32g https://t.co/OKQ‚Ä¶RT @BioStockAddict: @BioStockAddict so. Here we are now. Galapagos back where it belongs: over 50EUR. Still cheap. $GLPG $ABBV $GILD #Filgo‚Ä¶$GILD sofosbuvir / velpatasvir EMA Accelerated assessment treatment of chronic hepatitis C virus in European union https://t.co/EbFoEYo2YhRT @BioStockAddict: I still stand by my idea. By the end of the year Galapagos will be (one of) the biggest European biotech companies. $GL‚Ä¶RT @BioStockAddict: I still stand by my idea. By the end of the year Galapagos will be (one of) the biggest European biotech companies. $GL‚Ä¶Your 2016 Guide to Investing in Gilead Sciences Stock -- $GILD #HCV #HIV #INVESTING #STOCKS The Motley Fool https://t.co/3AXXlFreDLRT @outsizedreturn: World #Equity Mkts Futures $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/kjOSvygfJ7 https‚Ä¶RT @outsizedreturn: Americas #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/nraWgiv32g https://t.co/OKQ‚Ä¶EMA CHMP May mtg agenda
https://t.co/1Qsu9QrXja

On deck for opinion:
$MRK Zepatier
$GILD sof/vel 
$PTCT Translarna for nm #CysticFibrosisGilead: Et Tu Vermont? https://t.co/xw2l0hyuer ‚Ä¶ $ABBV $MRK $GILD @SenSanders @MassAGO @AGSchneiderman @MassAGO https://t.co/3fzMr77meeWorld #Equity Mkts Futures $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/kjOSvygfJ7 https://t.co/3u3sidTIHoGilead: Et Tu Vermont? https://t.co/xw2l0hyuer ‚Ä¶ $ABBV $GILD @RepCP @progparty @SusanHatchDavis @GovPeterShumlin https://t.co/dPoOp2EpZ0Americas #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/nraWgiv32g https://t.co/OKQPUzuRwjNoteworthy Analysts Suggestions Gilead Sciences Inc $GILD #GILD https://t.co/YlZjD3H63D @ShareStockNewsInvestorsLive4U: SeekingAlpha: Gilead Sciences: The Qualitative Long Case https://t.co/gyBGtwzQdi $ABBV $MRK $GILDSeekingAlpha: Gilead Sciences: The Qualitative Long Case https://t.co/gQw4fOoctO $ABBV $MRK $GILDInvestorsLive4U: SeekingAlpha: Gilead: Et Tu Vermont? https://t.co/JXc86WL4TJ $ABBV $MRK $GILDRT SeekingAlpha: Gilead Sciences: The Qualitative Long Case https://t.co/LLlLlA87BJ $ABBV $MRK $GILDRT SeekingAlpha: Gilead: Et Tu Vermont? https://t.co/1obxjevG5j $ABBV $MRK $GILDRT @SA_HealthInvest: Gilead Sciences: The Qualitative Long Case https://t.co/QAhrpd8eO2 $ABBV $MRK $GILDGilead Sciences: The Qualitative Long Case https://t.co/0RQGnV1zYg $ABBV $MRK $GILDGilead Sciences: The Qualitative Long Case https://t.co/QAhrpd8eO2 $ABBV $MRK $GILDRT @SA_HealthInvest: Gilead: Et Tu Vermont? https://t.co/8yGsPKHEkf $ABBV $MRK $GILDSeekingAlpha: Gilead: Et Tu Vermont? https://t.co/XXig63AaPJ $ABBV $MRK $GILDGilead: Et Tu Vermont? https://t.co/GGKLh1u9M4 $ABBV $MRK $GILDGilead: Et Tu Vermont? https://t.co/8yGsPKHEkf $ABBV $MRK $GILD$INSM oral and HCV decisions this week as well $MRK $GILD https://t.co/Ja102ayMF2I still stand by my idea. By the end of the year Galapagos will be (one of) the biggest European biotech companies. $GLPG $GILD $ABBV@BioStockAddict so. Here we are now. Galapagos back where it belongs: over 50EUR. Still cheap. $GLPG $ABBV $GILD #Filgotinib #RA #Crohn #CFRT @R4inb0w_: GENFIT ""Elafibranor has a potential of USD 10 billion a year in revenue!"" CEO JF  Mouney #NASH #PBC $GNFT $GILD $ICPT $TBRA $‚Ä¶RT @R4inb0w_: GENFIT ""Elafibranor has a potential of USD 10 billion a year in revenue!"" CEO JF  Mouney #NASH #PBC $GNFT $GILD $ICPT $TBRA $‚Ä¶Gilead Has Great Value Now; No Need For It To Make A Big Deal $GILD https://t.co/eT3szqkUqRRT @lancejepsen: Analyst Actions and Breaking News $AAPL $AA $LMT $GILD $MNK #stocks https://t.co/n82tlsOOjaNoteworthy Analysts Suggestions Gilead Sciences Inc $GILD #GILD https://t.co/c7zbyOkuBd @ShareStockNewsRT @R4inb0w_: GENFIT ""We are expected to capture more than 50% of the potential market"" CEO JF  Mouney #NASH $GNFT $GILD $ICPT https://t.co‚Ä¶RT @R4inb0w_: GENFIT ""Elafibranor has a potential of USD 10 billion a year in revenue!"" CEO JF  Mouney #NASH #PBC $GNFT $GILD $ICPT $TBRA $‚Ä¶RT @R4inb0w_: GENFIT ""We are expected to capture more than 50% of the potential market"" CEO JF  Mouney #NASH $GNFT $GILD $ICPT https://t.co‚Ä¶RT @R4inb0w_: GENFIT ""Elafibranor has a potential of USD 10 billion a year in revenue!"" CEO JF  Mouney #NASH #PBC $GNFT $GILD $ICPT $TBRA $‚Ä¶RT @R4inb0w_: GENFIT ""Elafibranor has a potential of USD 10 billion a year in revenue!"" CEO JF  Mouney #NASH #PBC $GNFT $GILD $ICPT $TBRA $‚Ä¶RT @Tootix: #GFT505 Presents an Array of Hope in Nonalcoholic Steatohepatitis (#NASH) $GNFT $ICPT $GILD Therapeutics Market https://t.co/HO‚Ä¶WFC Ex-Div Date
See Here ---&gt; https://t.co/UrXTASBC9h

$WFC $GILD $TMH #nasdaqRT @jonathanrockoff: Most cash-rich drug cos, per Moody's: $PFE ($39bn), $JNJ (38), $AMGN (31), $MRK (27), $GILD (26), $BMY (9), $ABBV (9),‚Ä¶@kyleprohaska  Yeah I am looking for some news as there is talk of a deal with $GILD or $CELG.  It may not happen, but I will ride this up.RT @jonathanrockoff: Most cash-rich drug cos, per Moody's: $PFE ($39bn), $JNJ (38), $AMGN (31), $MRK (27), $GILD (26), $BMY (9), $ABBV (9),‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (5/22): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB #StockMarket ht‚Ä¶RT @jonathanrockoff: Most cash-rich drug cos, per Moody's: $PFE ($39bn), $JNJ (38), $AMGN (31), $MRK (27), $GILD (26), $BMY (9), $ABBV (9),‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (5/22): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB #StockMarket ht‚Ä¶Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @JustinPulitzer: Weekend Review VIDEO (5/22): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB #StockMarket ht‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (5/22): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB #StockMarket ht‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (5/22): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB #StockMarket ht‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (5/22): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB #StockMarket ht‚Ä¶Weekend Review VIDEO (5/22): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB #StockMarket https://t.co/QifceATXSFPrepare for a red day in the market tomorrow $TVIX $VIX $AAPL $NFLX $GILD $SPY $QQQhttps://t.co/p7tVeJhgUx Millionaire Road Map Trading top students win a Porsche for a yr! $LNKD $CVX $GILD $STX $PRT @tgtxdough: BMO Latest coverage and price target $CELG $GILD $AFMD $IONS $INCY $IBB https://t.co/mtafR6Q13j$GILD I WILL BUY WHEN THE MILLIGAN BUYS !Milligan John FPres, CEOS - Sale+OE$87.71-112,0001,058,963-10%-$9,823,95",2016-05-23,GILD,1
33,"Unusual Call Activity https://t.co/9iGiScMHpg  $BBY $FEYE $GPS $XLF $DIA $BMY $AMD $V $TNA $EBAY $AMAT $PBR $NFLX $QCOM $GPRO $GS $XBI $GILDRT @outsizedreturn: #Bloomberg #News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f $c $v #hedgefunds https://t.co/qldGKzCzi3 ht‚Ä¶RT @outsizedreturn: #Bloomberg #News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f $c $v #hedgefunds https://t.co/qldGKzCzi3 ht‚Ä¶$GILD up over 5% since we bought it last Thursday. Forward P/E is below 8 even on the most bearish analyst estimates https://t.co/PIaj6zhcMrMACD Bull Crossover: $C, $DHI, $DOW, $GILD, $HPQ, $IVZ,$KBH  https://t.co/2E9ZO8qEPK#GileadSciences Gilead Brings Back Kevin Young Former Commercial Exec As New COO. Read more: https://t.co/3C9WoOYjYS $GILDRT @outsizedreturn: #Bloomberg #News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f $c $v #hedgefunds https://t.co/qldGKzCzi3 ht‚Ä¶PTEN Stock Forum
See Here ---&gt; https://t.co/yoDbFwBO8V

$PTEN $GILD $CPF #stockRT @outsizedreturn: #Bloomberg #News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f $c $v #hedgefunds https://t.co/qldGKzCzi3 ht‚Ä¶Gilead Sciences, Inc. $GILD Shares Sold by Fulton Bank N.A. https://t.co/qNcWXOJYZNGilead Sciences, Inc. $GILD Stake Increased by Indiana Trust &amp; Investment Management CO https://t.co/CYIt0d43Di#GileadSciences Announces Appointment of Kevin Young CBE as Chief Operating Officer and Mar... Read more: https://t.co/Qq5mcl8Ojl $GILDSome Unique Ratios That Can Make You A Better Investor https://t.co/1QamWJ34yA $AAPL $BRK.A $BRK.B $GILD $MA#Bloomberg #News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f $c $v #hedgefunds https://t.co/qldGKzCzi3 https://t.co/qIPnz3zsQ9First Financial Bank N.A. Trust Division Has $2,112,000 Position in Gilead Sciences, Inc. $GILD https://t.co/YEskC3uNdSCMLviz: RT adamfeuerstein: $GILD ‚Äî I love Porges' description of Kevin Young‚Äôs return from ‚Äúreportedly comfortable retirement.‚Äù 

If only h‚Ä¶Chevy Chase Trust Holdings Inc. Cuts Position in Gilead Sciences, Inc. $GILD https://t.co/u2cKPjo0QgRT @adamfeuerstein: $GILD ‚Äî I love Porges' description of Kevin Young‚Äôs return from ‚Äúreportedly comfortable retirement.‚Äù 

If only half the‚Ä¶adamfeuerstein: $GILD ‚Äî I love Porges' description of Kevin Young‚Äôs return from ‚Äúreportedly comfortable retirement.‚Äù 

If only half the sto‚Ä¶RT @adamfeuerstein: $GILD Kevin Young is back!! Just named COO. He left company in 2014 as SVP Commercial. 

Paul Cater, current SVP Commer‚Ä¶$GILD ‚Äî I love Porges' description of Kevin Young‚Äôs return from ‚Äúreportedly comfortable retirement.‚Äù 

If only half the stories are true...Nasdaq100 #Stocks Performance $CTRP $NTES $XLNX $VRTX $WDC $BIDU $GILD $ATVI $VIAB $LLTC $CHKP $LRCX $NFLX  more@ https://t.co/YdSIjFJqHfAIR Change
See Here ---&gt; https://t.co/rNlr6blGtV

$AIR $ACGL $GILD #stockS&amp;P100 #Stocks Performance $GILD $MSFT $MON $BIIB $V $INTC $CELG $QCOM $ACN $ABBV $TXN $AMGN $MDLZ $GOOGL  more@ https://t.co/cKkr8cKsju#GileadSciences : Names New Operating Chief. Read more: https://t.co/omI62SsgdZ $GILD1234 Bearish https://t.co/iJRaqizqat $EQR $TGNA $ANF $GPRO $GGP $HIMX $FXI $LHO $TGT $PSX $GILD $SSYS $MBI $GPS $VWO $ASX $XPORT https://t.co/x9fc3cxwdf : Here are the top 25 #infectiousdisease products in 2015. #pharma $GILD $BMS $PFE $MR‚Ä¶ https://t.co/cCtoeBI0ob#GileadSciences Names Kevin Young COO. Read more: https://t.co/rJvcnTpg6m $GILDFor 4ema cross 8ema stocks 
$SPY
$IWM
$MSFT
$FXI
$EFA
$WFC
$GILD
$VEA
$XLV
$ORCL
$YHOO
$VGK
$HYSR - penny
$GPRO
$BRCD
$GM
Nice cross upHere are the top 25 #infectiousdisease products in 2015. #pharma $GILD $BMS $PFE $MRK $JNJ https://t.co/9RjN5FZTqG https://t.co/gDcZG9NCHrBot $GILD at $83.52. Upward trend confirmed$GILD names Kevin Young COO https://t.co/IbYga2pfvjRT @BiotechRadar: so $GILD / $GLPG will perform the RA phase 3 with 100/200mg daily - more comprehensive than forecasted but better chances‚Ä¶$GILD - Gilead Names New Operating Chief https://t.co/BW4oBXfVbbRT @jonathanrockoff: $GILD names a commander of the British empire its COO &amp; ex-$ANTH exec its strategy chief, as commercial head leaves: h‚Ä¶SeekingAlpha: Western Digital: NASDAQ Top Dog Fetches Broker Love In May https://t.co/jQGuKb1jNR $AAPL #APPLE $AMGN $AVGO $CSCO $CSX $GILD‚Ä¶RT @BiotechRadar: so $GILD / $GLPG will perform the RA phase 3 with 100/200mg daily - more comprehensive than forecasted but better chances‚Ä¶Western Digital: NASDAQ Top Dog Fetches Broker Love In May https://t.co/JAvesTwt31 $AAPL #APPLE $AMGN $AVGO $CSCO $CSX $GILD $INTC $KHCWestern Digital: NASDAQ Top Dog Fetches Broker Love In May https://t.co/4g6B4snWoc $AAPL #APPLE $AMGN $AVGO $CSCO $CSX $GILD $INTC $KHCWestern Digital: NASDAQ Top Dog Fetches Broker Love In May https://t.co/PY7NmmW1IR $AAPL #APPLE $AMGN $AVGO $CSCO $CSX $GILD $INTC $KHCRT @Carine1111111: @genfit_pharma  @genfit #ELAFIBRANOR $GILD $ICPT #NASH $GNFTF https://t.co/qpRGOmdCrBGilead Sciences appointed former EVP of Commercial Operations Kevin Young as the Chief Operating Officer $GILD#GileadSciences names Kevin Young COO. Read more: https://t.co/LCdsDVaE7Q $GILDRT @adamfeuerstein: $GILD Kevin Young is back!! Just named COO. He left company in 2014 as SVP Commercial. 

Paul Cater, current SVP Commer‚Ä¶#GileadSciences Announces Appointment of Kevin Young CBE as Chief Operating Officer and Mar... Read more: https://t.co/jOACWhadQG $GILD#GileadSciences Announces Appointment of Kevin Young CBE as Chief Operating Officer and Mar... Read more: https://t.co/2NX6o0ULFD $GILDRT @theflynews: BREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHN$GILD üòÄüòÄRT @canuck2usa: $GILD Weekly Doji B signal and ripperRT @theflynews: BREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHNGilead Sciences Announces Appointment of Kevin Young CBE as Chief Operating Officer and Martin...  https://t.co/8faGWUY1Ni $GILDThe stocks fighting Zika $GILD $IBB $XBI https://t.co/S6DviHMrfm https://t.co/5gHhkagFIb https://t.co/0SXLPEFtd4RT @ScripMandy: $GILD Young returns, EVP of commercial Paul Carter leaving to pursue other opportunities. #biotech #HCV  https://t.co/W7Giv‚Ä¶https://t.co/uC9PBw4ARk
The stocks fighting Zika via @YahooFinance $GILD $IBB $XBIRT @ScripMandy: $GILD Young returns, EVP of commercial Paul Carter leaving to pursue other opportunities. #biotech #HCV  https://t.co/W7Giv‚Ä¶RT @adamfeuerstein: $GILD Kevin Young is back!! Just named COO. He left company in 2014 as SVP Commercial. 

Paul Cater, current SVP Commer‚Ä¶RT @adamfeuerstein: $GILD Kevin Young is back!! Just named COO. He left company in 2014 as SVP Commercial. 

Paul Cater, current SVP Commer‚Ä¶RT @theflynews: BREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHNRT @WarriorNewsFeed: $500 off #DayTrading Course Sale Ends Tonight! | Get started today: https://t.co/ciNNMPXfFR | $OXGN $VRX $GILD $SRPT h‚Ä¶#StockNews ‚Äï BREAKING: Gilead Sciences appoints Kevin Young as COO: $GILD‚Ä¶ https://t.co/TblCOvUWpk ‚Üí via @AlertTrade https://t.co/BFfScwnvRRRT @theflynews: BREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHNRT @adamfeuerstein: $GILD Kevin Young is back!! Just named COO. He left company in 2014 as SVP Commercial. 

Paul Cater, current SVP Commer‚Ä¶RT @adamfeuerstein: @DewDiligence Seriously, not sure anyone is buying incremental $GILD on Kevin Young‚Äôs return. But his re-hire is defini‚Ä¶RT @theflynews: BREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHNBREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHNRT @BioStockAddict: @BioStockAddict all good news with an extra positive surprise: Phase 2/3 study in ulcerative colitis in Q3'16. $GLPG $G‚Ä¶@BioStockAddict all good news with an extra positive surprise: Phase 2/3 study in ulcerative colitis in Q3'16. $GLPG $GILD #saybingo@genfit_pharma  @genfit #ELAFIBRANOR $GILD $ICPT #NASH $GNFTF https://t.co/qpRGOmdCrBGilead names new operating chief and new strategy chief https://t.co/KfTRz5Gh7c $GILD $ANTMGilead names new operating chief and new strategy chief https://t.co/nIsAtjWLAU $GILD $ANTMGilead names new operating chief and new strategy chief https://t.co/yzGiuLPPSC $GILD $ANTMRT @adamfeuerstein: $GILD Kevin Young is back!! Just named COO. He left company in 2014 as SVP Commercial. 

Paul Cater, current SVP Commer‚Ä¶RT @BiotechRadar: so $GILD / $GLPG will perform the RA phase 3 with 100/200mg daily - more comprehensive than forecasted but better chances‚Ä¶adamfeuerstein: DewDiligence Seriously, not sure anyone is buying incremental $GILD on Kevin Young‚Äôs return. But his re-hire is definitely ‚Ä¶$GILD Young returns, EVP of commercial Paul Carter leaving to pursue other opportunities. #biotech #HCV  https://t.co/W7GivtQpfW@DewDiligence Seriously, not sure anyone is buying incremental $GILD on Kevin Young‚Äôs return. But his re-hire is definitely a + for the co.RT @adamfeuerstein: $GILD Kevin Young is back!! Just named COO. He left company in 2014 as SVP Commercial. 

Paul Cater, current SVP Commer‚Ä¶RT @DewDiligence: $GILD CCO is leaving company:

https://t.co/IU8TKnEBve@adamfeuerstein Haha. Seriously,if $GILD were sports team, Milligan &amp;Bischopberger would get max contracts &amp;every1one else would get scraps.RT @jonathanrockoff: $GILD names a commander of the British empire its COO &amp; ex-$ANTH exec its strategy chief, as commercial head leaves: h‚Ä¶$GILD names a commander of the British empire its COO &amp; ex-$ANTH exec its strategy chief, as commercial head leaves: https://t.co/wUeShhVF7Dadamfeuerstein: $GILD Kevin Young is back!! Just named COO. He left company in 2014 as SVP Commercial. 

Paul Cater, current SVP Commercial‚Ä¶$GILD Paul Carter ""decided to depart...and pursue other opportunities"" -- Kevin Young is back as COO. Martin Silverstein is EVP strategy.RT @adamfeuerstein: $GILD Kevin Young is back!! Just named COO. He left company in 2014 as SVP Commercial. 

Paul Cater, current SVP Commer‚Ä¶RT @DewDiligence: $GILD CCO is leaving company:

https://t.co/IU8TKnEBveRT @adamfeuerstein: $GILD Kevin Young is back!! Just named COO. He left company in 2014 as SVP Commercial. 

Paul Cater, current SVP Commer‚Ä¶$GILD Kevin Young is back!! Just named COO. He left company in 2014 as SVP Commercial. 

Paul Cater, current SVP Commercial, is out.$GILD CCO is leaving company:

https://t.co/IU8TKnEBve$GILD Gilead Sciences Announces Appointment of Kevin Young CBE as Chief Operating Officer and Martin Silverst
From our Stock News Alerts App$GILD Gilead Sciences Announces Appointment of Kevin Young CBE as Chief Operating Officer and Martin Silve... - https://t.co/0pFDLlLjRcGilead Sciences names Kevin Young CBE as COO, Martin Silverstein, MD as EVP-Strategy. https://t.co/YEUxY68AEx $GILD close: 86.22 (+3.47%)$GILD - Gilead Sciences Announces Appointment of Kevin Young CBE as Chief Operating Officer &amp; Martin https://t.co/bZuKiCC4rr$GLPG Successful completion of End-of-Phase 2 FDA and EMA consultations in #RA #Galapagos $GILD https://t.co/dT0Y6l9Z70so $GILD / $GLPG will perform the RA phase 3 with 100/200mg daily - more comprehensive than forecasted but better chances for the reg. pathNasdaq100 #Stocks Performance $CTRP $NTES $WDC $NFLX $BIDU $MSFT $GILD $VRTX $LRCX $VIAB $DLTR $ATVI $ADBE  more@ https://t.co/YdSIjG11yNS&amp;P100 #Stocks Performance $MSFT $GILD $INTC $CELG $MS $V $ABBV $BIIB $AMGN $AXP $CSCO $ORCL $MDLZ $QCOM  more@ https://t.co/cKkr8csQUUUnusual Call Activity https://t.co/9iGiScMHpg  $BBY $FEYE $GPS $XLF $DIA $BMY $AMD $V $TNA $EBAY $AMAT $PBR $NFLX $QCOM $GPRO $GS $XBI $GILD$500 off #DayTrading Course Sale Ends Tonight! | Get started today: https://t.co/ciNNMPXfFR | $OXGN $VRX $GILD $SRPT https://t.co/xRSdcexrJERT @ta4u_stocks: I scan 4U: some of the technically best looking #US #Stocks 4 short term : $AA $GE $NOK $F $JD $GILD  (DourDD.)Just wait until $AAPL, $GILD, $NFLX, $LNKD, $PCLN etc join the rally and make all time highs.  Dow will shoot past 20K then!Took first rung of the ladder $GILD +$3.10 per share profit holding most stop raised will make coin on total tradeInteresting price action in $GILD today, up 3.6% on volume... any news coming soon? https://t.co/x49JyPi8EPRT @eTrading_Emilia: Dia de #TDOM #WallStreet alcista. De compras en las acciones de $NOK $GILD $MU $APPL https://t.co/iotur5C1wNDia de #TDOM #WallStreet alcista. De compras en las acciones de $NOK $GILD $MU $APPL https://t.co/iotur5C1wNDia de #TDOM #WallStreet alcista. De compras en las acciones de $NOK $GILD $MU $APPL https://t.co/K2OuidmQZNRT @canuck2usa: $GILD Weekly Doji B signal and ripperRT @Nicole1515: $GILD like a champ. Not even a single dip. #Strong$GILD like a champ. Not even a single dip. #Strong$GILD is one outbreak/breakthrough away from sincere follow through, perhaps.$GILD Weekly Doji B signal and ripper$GILD Norbert Bischofberger on UBS webcast: SOF/VEL mainly4 GT3 patients. (Confirms what we already knew.)3 Safe Dividend Stocks with Pristine Balance Sheets https://t.co/b7HH2TPieb $AAPL $AMGN $GILD $M via @InvestorsAlleyTarget Short Term $GILD https://t.co/Sm3XE3hKCh% off high
$CLVS 86,7%
$BLUE 78,6%
$HALO 61,6%
$RLYP 57,8%
$JUNO 41,8%
$REGN 34,5%
$ONCE 30,8%
$GILD 30,2%
$BIIB 25,3%
$AMGN 15,9%RT @SA_Portfolio: Some Unique Ratios That Can Make You A Better Investor https://t.co/dooOIzR6rE $AAPL #APPLE $BRK.A $BRK.B $GILD $MA$lci, $gild, $xbi :)RT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶RT @portefeuillefun: Sold 100 $GILD at $85.96, now 100 #zzporte shares, cost basis $85.27. @zzlangerhans$GILD make first steps to break out from conso https://t.co/8I78qEDvp0Here are the top 25 #infectiousdisease products in 2015. #pharma $GILD $BMS $PFE $MRK $JNJ https://t.co/9RjN5FZTqG https://t.co/eaJe2QsvnMGILD $GILD https://t.co/pJbllrX3B1RT https://t.co/YUAk5gjwu8 : Competition may threaten Gilead as market leader. $GILD #HepC #antibiotics #pharma ‚Ä¶ https://t.co/D935R1flUHUnusual Call Activity https://t.co/9iGiScv6xI  $BBY $FEYE $GPS $XLF $DIA $BMY $AMD $V $TNA $EBAY $AMAT $PBR $NFLX $QCOM $GPRO $GS $XBI $GILDCompetition may threaten Gilead as market leader. $GILD #HepC #antibiotics #pharma https://t.co/9lWITstcAX https://t.co/ZBXt2lUKbo43,000+ contracts traded on $GILD

72% calls.RT @bpmulvaney: @swat_premium Unbelievable!  This is awesome $GILD $FEYESwatOptions: RT bpmulvaney: swat_premium Unbelievable!  This is awesome $GILD $FEYE$GILD sweet breakout.. Hope to reach 89-90. 55EMASold 100 $GILD at $85.96, now 100 #zzporte shares, cost basis $85.27. @zzlangerhans$GILD at $0.00.Now the MACD crossover happened in $GILD  https://t.co/x49JyPi8EP#Options #maxpain chart for $GILD. #option #invest More with #OptionsPro FREE app at https://t.co/vmQaxw1x1K https://t.co/QliHGMXlZXRT @bpmulvaney: @swat_premium Unbelievable!  This is awesome $GILD $FEYERT @bpmulvaney: @swat_premium Unbelievable!  This is awesome $GILD $FEYERT @bpmulvaney: @swat_premium Unbelievable!  This is awesome $GILD $FEYERemind myself a little of @WallStreetBean with $GILD on this one  ;)  $SEDG https://t.co/zfptnliQyS$GILD  Nice push off support (potential double bottom setup)I scan 4U: some of the technically best looking #US #Stocks 4 short term : $AA $GE $NOK $F $JD $GILD  (DourDD.)RT @MarginHunt: Is It Time To Sell Gilead Sciences $GILD? @ideagenerator01 https://t.co/jWa0iC1eVF $AAPL $ABBV $AMGN $BIIB #stocks https://‚Ä¶$GILD #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/ShOPPLUwlGcan $GILD take out 20 ema ?Wondering about risks of $GILD? The 21-day volatility is 10.08% https://t.co/YrfwPBdUuUUnusual Call Activity https://t.co/9iGiScMHpg $BBY $FEYE $GPS $XLF $DIA $BMY $AMD $V $TNA $EBAY $AMAT $PBR $NFLX $QCOM $GPRO $GS $XBI $GILDSAlphaTrending: The No. 1 Stock In The World (Revisited) https://t.co/vCMaPLhXBD $AAPL #APPLE $BRK.B $CCP $CTSH $CVX $DIS $GILD $HON $HRL ‚Ä¶Is Shorting Stocks Wise If You Aren‚Äôt Jim #Chanos? $XOM $NFLX $GILD https://t.co/VJ7USbqurc via @barronsonlineThe No. 1 Stock In The World (Revisited) https://t.co/aYQdBmUkSJ $AAPL #APPLE $BRK.B $CCP $CTSH $CVX $DIS $GILD $HON $HRL $JNJ $KMI $KORT SeekingAlpha: The No. 1 Stock In The World (Revisited) https://t.co/squkWNaWsR $AAPL #APPLE $BRK.B $CCP $CTSH $CVX $DIS $GILD $HON $HRL‚Ä¶$GILD kicking today not sure whySeekingAlpha: The No. 1 Stock In The World (Revisited) https://t.co/WcECOeglj0 $AAPL #APPLE $BRK.B $CCP $CTSH $CVX $DIS $GILD $HON $HRL $J‚Ä¶The No. 1 Stock In The World (Revisited) https://t.co/qO5zuA4po3 $AAPL #APPLE $BRK.B $CCP $CTSH $CVX $DIS $GILD $HON $HRL $JNJ $KMI $KOThe No. 1 Stock In The World (Revisited) https://t.co/Y2NV0r4qt2 $AAPL #APPLE $BRK.B $CCP $CTSH $CVX $DIS $GILD $HON $HRL $JNJ $KMI $KOThe No. 1 Stock In The World (Revisited) https://t.co/aEBaixOCWV $AAPL #APPLE $BRK.B $CCP $CTSH $CVX $DIS $GILD $HON $HRL $JNJ $KMI $KO@swat_premium Unbelievable!  This is awesome $GILD $FEYE@RNAiAnalyst other question of course is whether such deal will bring in cash or is pretty much cashless+ name recognition $ARWR $GILD $MRK@Nicole1515 $GILD- great stock but Maxim makes good point about rev tied to HCV-is that sustainable? Enough growth beyond HCV? Likely yes.$GILD up almost 6% since its 52 Week low since last Thursday. @CNBCFastMoney https://t.co/cSyi8u1m2l$TRIP $DHI $GILD options have the largest change in volume. Free options screener. https://t.co/VNabeKV6sU$GILD is on a mission today$GILD #AnotherOne for the kids @1simpletrader https://t.co/dh4zcqfMUmAnd... $GILD is off! towards $87Everyone shorting or waiting for the 200 week moving average is S.O.L. $GILD$GILD to vault over $86?Nasdaq100 #Stocks Performance $CTRP $WDC $NTES $BIDU $NFLX $BMRN $LRCX $NXPI $GILD $ADBE $ATVI $MSFT $INTC  more@ https://t.co/YdSIjFJqHfSafety/Efficacy of SOF/VEL/VOX for 8 Weeks &amp; SOF/VEL for 12 Weeks in Adults GT-3 #HCV Infection &amp; Cirrhosis‚Üíhttps://t.co/0UUuhOUrGu $GILDS&amp;P100 #Stocks Performance $GILD $MSFT $INTC $CELG $BIIB $V $MS $QCOM $C $ORCL $ABBV $MDLZ $AXP $GOOGL  more@ https://t.co/cKkr8cKsjuSector names working today $CHK $MUR$SWN $WHR $GT $HAR $AMG $MS $GILD $VRTX $BIIB $LEN $DHI $PHM $NFLX $RHI $MCO https://t.co/fitokVqJwE$GILD is simply beasting. Well-deserved.$GILD calls doing nicely.. but frankly i dont get any of this.. scratching head.RT @BPGAG: Out for day. Shorts decapitated in the #stockmarket. https://t.co/8EILs27fWX Earlier posts on $GILD $IBB $FB $AMZN $NFLX $AAPL $‚Ä¶Out for day. Shorts decapitated in the #stockmarket. https://t.co/8EILs27fWX Earlier posts on $GILD $IBB $FB $AMZN $NFLX $AAPL $SPY #stocksVolume Alert - GILD 85.45 Gilead Sciences Inc $GILD Hit a high today of 85.46 Closing the day 10:30 at 85.45 + https://t.co/EjIlIJUxB8RT @DAMSConsulting: $ICPT $138.36 Rumor that $GILD will make a $300 Cash bid for company, plenty of room on this one, good luck$ICPT $138.36 Rumor that $GILD will make a $300 Cash bid for company, plenty of room on this one, good luckI'm sure many more today... $IBB $GILD $AMGN $BIIB $REGN $CELGRT @outsizedreturn: Bloomberg #News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/UqWr7lpaiX https://t‚Ä¶#Gilead Sciences Shares Have #LongTermPotential: Analyst - https://t.co/rQnmpQ4vTi $GILD https://t.co/Jap8Py6vLDI wonder if $GILD is ever going to make it back over $100$GILD to $86? Come on!$GILD is a monster@Bandinellosaul similar float, below cash, shorted shares, irrational pricing as $AQXP. $GILD has not returned drug to GlobeImmune.@SunriseTrader Nice call on $GILD :)RT @outsizedreturn: World #Equity Mkts Futures $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/kjOSvygfJ7 https‚Ä¶RT @GerberKawasaki: #stocks start higher in full rally. Strong new home sales numbers. Strong moves in $aapl $gild and $nflx today. Lots of‚Ä¶@swat_premium Nice early movement, I bailed early for a tidy profit $GILD$GILD first resist that matters much to me is 86.40ish area. Intraday needs some basing, daily looks greatGuTA: Sold $GILD 6/17 86c @ 1.51 from yesterday's - GuTA https://t.co/fPOvGda26iRT @GerberKawasaki: #stocks start higher in full rally. Strong new home sales numbers. Strong moves in $aapl $gild and $nflx today. Lots of‚Ä¶RT @AndyBiotech: EMA CHMP May mtg agenda
https://t.co/1Qsu9QrXja

On deck for opinion:
$MRK Zepatier
$GILD sof/vel 
$PTCT Translarna for nm‚Ä¶#stocks start higher in full rally. Strong new home sales numbers. Strong moves in $aapl $gild and $nflx today. Lots of love out there.$gild double bottom (FEB/MAY), held earnings low from Feb, MACD bull cross and above 10dma...Run to the 50dma may be in store around $92TTI Message Board Posts
See Here ---&gt; https://t.co/JAJdfKFLIz

$TTI $GILD $MERC #shareRT @GantosJ: And the breakout is here.. $GILD ‚Üë2.4% breaking out the $84.88 line..looking for the closing above it &amp; continuation https://t‚Ä¶Commented on Bernie Sanders, California Dropped A Grenade On Gilead https://t.co/Y1ffiYLAcY $ABBV $MRK $GILDAnd the breakout is here.. $GILD ‚Üë2.4% breaking out the $84.88 line..looking for the closing above it &amp; continuation https://t.co/VHaconZ3RwI'm starting to think they might want to add Gilead $GILD to the Millennial ETF (h/t @Nonrelatedsense)  https://t.co/xp3Qy0QYV3RT @BPGAG: $GILD Cleared last of #trading L at $85.40 from $82.18 - will revisit on attempt to $90  https://t.co/nGyWcGdJ8KRT @contraryguy: Wish I had the cash to chase $GILD here... low $80s didn't suit it. Decent strength in bios today.Wish I had the cash to chase $GILD here... low $80s didn't suit it. Decent strength in bios today.$GILD Cleared last of #trading L at $85.40 from $82.18 - will revisit on attempt to $90  https://t.co/nGyWcGdJ8K@canuck2usa long 2 of the top 4 holdings so no complaints here ü§ë $GILD $BIIB$FEYE $GILD $DAL $RLYP all ww long side$GILD : Gilead Sciences primed for gap up today! #hotstocks #stockpicks@financialbuzz @cek_cpa @wandy922 @ryanwallace198 Long $GILD $CY $BAC $AAPL $MAR $IMNP.@JDR1024 @cek_cpa @wandy922 @ryanwallace198 go Jared! $GILD NO BRAINER here, will add on any major dips until getting at least $92 on it$GILD mastery today. Grabbed some $82s Fri@financialbuzz @cek_cpa @wandy922 @ryanwallace198 Long $GILD.$GILD  https://t.co/vwIKo6RUKN$GILD Looks like found that floorRT @BPGAG: Only holding 5% $GILD #trading L selling at $85 from $82.18 #biotech #stocks@cek_cpa @JDR1024 @wandy922 @ryanwallace198 also $GILD on fire up 100% on that too, and its just the start should go back to $90s easyRT @BPGAG: Only holding 5% $GILD #trading L selling at $85 from $82.18 #biotech #stocks$GILD 60 min oscillators at overbought may need to base some here to gain more momentum. Looking for first rung of ladder.RT @outsizedreturn: World #Equity Mkts Futures $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/kjOSvygfJ7 https‚Ä¶RT @outsizedreturn: Bloomberg #News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/UqWr7lpaiX https://t‚Ä¶RT @blarsonbrf: Safe to say $GILD has a bottom around $82.RT @outsizedreturn: Americas #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/nraWgiv32g https://t.co/EN3‚Ä¶RT @outsizedreturn: World #Equity Mkts Futures $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/kjOSvygfJ7 https‚Ä¶RT @outsizedreturn: Bloomberg #News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/UqWr7lpaiX https://t‚Ä¶Commented on StockTwits: Added $GILD https://t.co/yex1SkGHMdRT @realcommonking: $IBB over the 50dma and $GILD rippingGILD Top news - May 24th, 2016 $GILD https://t.co/VpozWRx9TROnly holding 5% $GILD #trading L selling at $85 from $82.18 #biotech #stocksSafe to say $GILD has a bottom around $82.$IBB over the 50dma and $GILD rippingRT @anky7544: Strong buy on $GILD,$AMGN, and $MCD today. all technical indicators confirmed signal. 5% short term upside potential..@GantosJ A ""textbook bottom"", I guess. $GILD #chartsRT @GantosJ: $GILD start moving upward after testing $81.89 support line, RSI is out of the Over-Sold area &amp; $84.88 next to break https://t‚Ä¶RT @GantosJ: $GILD start moving upward after testing $81.89 support line, RSI is out of the Over-Sold area &amp; $84.88 next to break https://t‚Ä¶RT @GantosJ: $GILD start moving upward after testing $81.89 support line, RSI is out of the Over-Sold area &amp; $84.88 next to break https://t‚Ä¶$GILD start moving upward after testing $81.89 support line, RSI is out of the Over-Sold area &amp; $84.88 next to break https://t.co/4DePzctxS9$gild $gs nice pops@SunriseTrader out of $GILD for now.. It may be too early but just out for now.. It is nearing that resistance.. I may revisitStrong buy on $GILD,$AMGN, and $MCD today. all technical indicators confirmed signal. 5% short term upside potential.$GILD $GPRO @TradeIdeas1 https://t.co/76fmEsH3Xunice gap up in $GILD and $SBUX no green to red now on those trades@JDR1024 @cek_cpa @wandy922 @ryanwallace198 lets gooo $GILD monster!!!!!$GILD - this is where we short right? ;)RT SeekingAlpha: Hundred Thousand Dollars Of Income Portfolio - May Update https://t.co/gVewCjIbtr $BRK.B $CVX $ED $GILD $HCP $JNJ $O $PHK‚Ä¶$GILD nice gap up üëçRT @MMMnews: Competition may threaten Gilead as market leader. $GILD #HepC #antibiotics #pharma https://t.co/9lWITstcAX https://t.co/fQVegY‚Ä¶SeekingAlpha: Hundred Thousand Dollars Of Income Portfolio - May Update https://t.co/8Y4URkL0K7 $BRK.B $CVX $ED $GILD $HCP $JNJ $O $PHK $R‚Ä¶RT @outsizedreturn: Americas #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/nraWgiv32g https://t.co/EN3‚Ä¶Competition may threaten Gilead as market leader. $GILD #HepC #antibiotics #pharma https://t.co/9lWITstcAX https://t.co/fQVegYM9uXHundred Thousand Dollars Of Income Portfolio - May Update https://t.co/HsdaLRyGMi $BRK.B $CVX $ED $GILD $HCP $JNJ $O $PHK $RCS $SPY $THundred Thousand Dollars Of Income Portfolio - May Update https://t.co/MQZEJdbvxK $BRK.B $CVX $ED $GILD $HCP $JNJ $O $PHK $RCS $SPY $THundred Thousand Dollars Of Income Portfolio - May Update https://t.co/9Hr3Ro0Kiy $BRK.B $CVX $ED $GILD $HCP $JNJ $O $PHK $RCS $SPY $TAmericas #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/nraWgiv32g https://t.co/EN3hH4TJIx@mckeevjm I see you removed some of the turds, nice job. Add $GILD &amp; $NFLXWorld #Equity Mkts Futures $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/kjOSvygfJ7 https://t.co/1Io2R1bgHLBloomberg #News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/UqWr7lpaiX https://t.co/sz1aVQO8V2https://t.co/p7tVeIZFvX Millionaire Road Map Trading top students win a Porsche for a yr! $LNKD $CVX $GILD $STX $PRT @InvestorsLive4U: SeekingAlpha: Some Unique Ratios That Can Make You A Better Investor https://t.co/WpTUpWi5Bo $AAPL #APPLE $BRK.A $BRK.‚Ä¶Commented on Gilead Sciences: The Qualitative Long Case https://t.co/I1QjIIcMbA $ABBV $MRK $GILDRT SeekingAlpha: Some Unique Ratios That Can Make You A Better Investor https://t.co/UK77jAJdZ9 $AAPL #APPLE $BRK.A $BRK.B $GILD $MAWatchlist $FSLR, $GILD, $SWHC  https://t.co/RaC3dCQoKnSeekingAlpha: Some Unique Ratios That Can Make You A Better Investor https://t.co/WpTUpWi5Bo $AAPL #APPLE $BRK.A $BRK.B $GILD $MASome Unique Ratios That Can Make You A Better Investor https://t.co/HicBee94Nc $AAPL #APPLE $BRK.A $BRK.B $GILD $MASome Unique Ratios That Can Make You A Better Investor https://t.co/dooOIzR6rE $AAPL #APPLE $BRK.A $BRK.B $GILD $MART @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶https://t.co/KkHg4O78J2 &lt;&lt; 5 lessons for FREE from Tim https://t.co/KkHg4O78J2 TimSykes millionaire trader on $SPY $INO $SLV $GILD $CRUS#GileadSciences Spinning Its Wheels. Read more: https://t.co/lccxF2r29q $GILDRT @R4inb0w_: GENFIT ""We are expected to capture more than 50% of the potential market"" CEO JF  Mouney #NASH $GNFT $GILD $ICPT https://t.co‚Ä¶RT @R4inb0w_: GENFIT ""Elafibranor has a potential of USD 10 billion a year in revenue!"" CEO JF  Mouney #NASH #PBC $GNFT $GILD $ICPT $TBRA $‚Ä¶Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Trading Rules - Discipline and staying strong: https://t.co/vVZZyIZdvD $GILD $TTWO $GM $SCO $REXX $YUM $ABBV $UCO $NXPI $USO $WPRTSalkun halvat j√§tit, jotka moukaroitiin monttuun, osoittavat yl√∂snousemuksen merkkej√§.
$AAPL, $GILDRT @Carine1111111: #NASH #elafibranor $GILD $ICPT https://t.co/1rShcalolV#NASH #elafibranor $GILD $ICPT https://t.co/1rShcalolVperformance update. @zzlangerhans #zzporte $ABBV $ALXN $AMGN $BIIB $BMY $CELG $FPRX $GILD $IBB $INO $REGN $VRX $XBI https://t.co/mKJWA9ohcTConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNRRT @hedgefundclone: Goldman Sach $GS says these are the 20 stocks hedge funds are betting against: $DIS    $XOM $GE $BA $NFLX $F $TGT $CAT‚Ä¶RT @scalpthatstock: Stock Market Chart Technical Analysis Video
https://t.co/wQHNigIK8u
$SPY $AAPL $GPRO $TWTR $TSLA $GILD $VRX https://t.c‚Ä¶$GILD (Gilead Science) is at $83.33, below its Chandelier Exit of $96.19 https://t.co/mzYDAAfZsT #GILDIs It Time To Sell Gilead Sciences $GILD? @ideagenerator01 https://t.co/jWa0iC1eVF $AAPL $ABBV $AMGN $BIIB #stocks https://t.co/Nq26RlR5aFRT @scalpthatstock: Stock Market Chart Technical Analysis Video
https://t.co/wQHNigIK8u
$SPY $AAPL $GPRO $TWTR $TSLA $GILD $VRX https://t.c‚Ä¶Is It Time To Sell Gilead Sciences? $GILD https://t.co/H7AQSElUz1https://t.co/uAcamNRUPt alerted $BIND +49% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/F8iKSLizL2 $HOT $AMAT $ITUB $MT $GILD $HST $AAFirst up: $GILD Trying to hold its Feb lows. Use #MNM to request the next chart! https://t.co/McXDMxe0nVRT @scalpthatstock: Stock Market Chart Technical Analysis Video
https://t.co/wQHNigIK8u
$SPY $AAPL $GPRO $TWTR $TSLA $GILD $VRX https://t.c‚Ä¶RT https://t.co/JAzUiivGlI : Here are the top 25 #infectiousdisease products in 2015. #pharma $GILD $BMS $PFE $MR‚Ä¶ https://t.co/QhdIkt73rMStock Market Chart Technical Analysis Video
https://t.co/wQHNigIK8u
$SPY $AAPL $GPRO $TWTR $TSLA $GILD $VRX https://t.co/SKJGvDNA61RT @GerberKawasaki: #Stocks hugging the flat line. Apple up on hope for the #iPhone7 Some movement on Netflix higher and Gilead a little hi‚Ä¶{NEW} 5/23/16 ANALYSIS + TRADE IDEAS: $SPY $AAPL $TSLA $GPRO $TWTR $GILD $VRX - click link&gt; https://t.co/Vi6nUIh4hU https://t.co/fFIiEku9npHere are the top 25 #infectiousdisease products in 2015. #pharma $GILD $BMS $PFE $MRK $JNJ https://t.co/9RjN5FZTqG https://t.co/myrVIOJDYu@SolarMelt He also bought $ibb $gild and $nvax.",2016-05-24,GILD,1
34,"#GileadSciences appoints chief operating officer and strategy head. Read more: https://t.co/g409HsJwXR $GILD$FL perfect place to bottom fish for those that didn't gamble on Earnings like myself.  2 more $GILD $GPRO,  Every stock green, so, LE LOYClosed Positions: $IBB, $BAC, $GILD https://t.co/vGqgGQ1UTmCount Celgene $CELG and Gilead $GILD as New Suitors to Acquire the Popular Medivation $MDVN https://t.co/UbXZQ7rA9L https://t.co/ozicUDnG2VRT @TheStreet: $GILD shares spike after exec. board appointment https://t.co/keFRQF4CVoRT @DougKass: Real Money: Added to longs yesterday: $HIG $OAK. Established new $IBB longs: $GILD $XON $CELG $AGN
Added to $XLP short
@jimcr‚Ä¶1234 Bearish https://t.co/3Giwf2l4jZ $EDC $MOH $SPWR $GERN $GILD $STNG $ROST $GPS $OZRK $WDR $EXAS $AAPL $MRVL $PANW $FSLR $MCD $TGNA#GileadSciences The commercial carousel continues to spin: Gilead's head of commercial depa... Read more: https://t.co/faU2id3w0H $GILDNew long positions this month in $GILD, $NAT, $NNA, $PLOW, $SEP, $SKM, &amp; $VIAB$GOOGL #SEO #SearchEngineOptimization #bots #like #retweeting #blogs from https://t.co/qwnNd0PP0F $gild $qcom $f$GILD #gild / Gilead Sciences Inc (US). Positive score +3.  Signal (+2), Correlation (+1). https://t.co/VpYFiA3ls5 #stocks #stockaction#GileadSciences Gilead reshuffles senior leadership team. Read more: https://t.co/h8UHgAJOta $GILD#GileadSciences Gilead names new COO EVP strategy. Read more: https://t.co/acxSmKXXY1 $GILDRT @DougKass: Real Money: Added to longs yesterday: $HIG $OAK. Established new $IBB longs: $GILD $XON $CELG $AGN
Added to $XLP short
@jimcr‚Ä¶The #stocks *seeing the most volume in after hours*: $YHOO $QQQ $SYMC $INTC and $GILD.Retired Gilead $GILD Exec Returns as His Replacement Exits https://t.co/NTSYoGqHJH https://t.co/yivizeqk5N#GileadSciences Celgene, Gilead Rumored to Be Considering Bids for Medivation  . Read more: https://t.co/8mD37y0ltp $GILDRT @TheStreet: $GILD shares spike after exec. board appointment https://t.co/keFRQF4CVo$GILD shares spike after exec. board appointment https://t.co/keFRQF4CVo$INTC $GILD are the Most Active in After Hours as seen on SpeculatingStocks After-Hours, https://t.co/0sHRjqRl7f #stocksCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5CMLviz: RT adamfeuerstein: . DewDiligence Thank you. I would also be very surprised to see $GILD buy $MDVN. $CELG might but still a strateg‚Ä¶adamfeuerstein: . DewDiligence Thank you. I would also be very surprised to see $GILD buy $MDVN. $CELG might but still a strategic leap for‚Ä¶RT @adamfeuerstein: . @DewDiligence Thank you. I would also be very surprised to see $GILD buy $MDVN. $CELG might but still a strategic lea‚Ä¶CMLviz: RT adamfeuerstein: . EdenRahim Again, NOT question asked. Based on what you know about $GILD $CELG, would they pay $Bs to share an ‚Ä¶RT @adamfeuerstein: . @DewDiligence Thank you. I would also be very surprised to see $GILD buy $MDVN. $CELG might but still a strategic lea‚Ä¶@adamfeuerstein @DewDiligence maybe $GILD buys both Astellas &amp; $MDVN??@adamfeuerstein re $GILD new guy at the helm. And for both GILD and $CELG not 2 many AR inh around + 2 other fully owned assets.RT @adamfeuerstein: . @DewDiligence Thank you. I would also be very surprised to see $GILD buy $MDVN. $CELG might but still a strategic lea‚Ä¶. @DewDiligence Thank you. I would also be very surprised to see $GILD buy $MDVN. $CELG might but still a strategic leap for them.@adamfeuerstein based ON $celg $juno deal i say they would be open as opppsed to $GILD no wayadamfeuerstein: . EdenRahim Again, NOT question asked. Based on what you know about $GILD $CELG, would they pay $Bs to share an asset?@adamfeuerstein Ok‚Äîmy 2 cents: $GILD probably wouldn't, but $CELG probably would (assuming the numbers worked, of course).RT @adamfeuerstein: . @EdenRahim Again, NOT question asked. Based on what you know about $GILD $CELG, would they pay $Bs to share an asset?Nice and might run more part 2
$EWU
$DOW
$MRK
$SYF
$MAS
$LABU
$NTAP
$HOV
$AXP
$SPY
$IWM
$MSFT
$FXI
$EFA
$WFC
$GILD
$VEA
$XLV
$ORCL
$VGK. @EdenRahim Again, NOT question asked. Based on what you know about $GILD $CELG, would they pay $Bs to share an asset?RT @adamfeuerstein: A LOT of wiggle room in this ‚Äògraph from Bloomberg story on $CELG $GILD interest in $MDVN. 

https://t.co/ZpKZIgvkgU ht‚Ä¶@SunriseTrader very nice play x play for this trade, ty. I took my $GILD profits today, but if powers above today's high, I was too early.RT @theflynews: On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.‚Ä¶RT @theflynews: On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.‚Ä¶RT @theflynews: On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.‚Ä¶On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.co/wRJ4jcgHCNCMLviz: RT adamfeuerstein: Would $GILD or $CELG buy an asset ‚Äî $MDVN Xtandi ‚Äî they can‚Äôt wholly control?https://t.co/qwnNd0PP0F is the #online #source for #marketing and #corporate #intelligence #strategy $xlv $xlp $gildadamfeuerstein: Would $GILD or $CELG buy an asset ‚Äî $MDVN Xtandi ‚Äî they can‚Äôt wholly control?RT @adamfeuerstein: Would $GILD or $CELG buy an asset ‚Äî $MDVN Xtandi ‚Äî they can‚Äôt wholly control?RT @SunriseTrader: $GILD took another piece off +3.29 per share profit stop raised and holding the restRT @BioStockAddict: Goldman Sachs company update on Galapagos. Price target 55 EUR. $GLPG $GILD https://t.co/RV7Ap85d3iRT @adamfeuerstein: Would $GILD or $CELG buy an asset ‚Äî $MDVN Xtandi ‚Äî they can‚Äôt wholly control?RT @adamfeuerstein: Would $GILD or $CELG buy an asset ‚Äî $MDVN Xtandi ‚Äî they can‚Äôt wholly control?Would $GILD or $CELG buy an asset ‚Äî $MDVN Xtandi ‚Äî they can‚Äôt wholly control?RT @SmoothPooh: $GILD CNBC Kevin O'Leary says biotech bring it on $GILD... Man with Horsesence.RT @MaisaCorp: $MDVN according to sources that $GILD $CELG are joining to bid for $MDVN ... $SNY please raise the bid to $70+ ...hehe$GILD took another piece off +3.29 per share profit stop raised and holding the rest@PVBTrader remember there was a rumor before it became to public. $SNY  was mentioned one of them. $GILD $CELG has money to outbid $SNYConcomitant PI3KŒ¥ and SYK inhibition resulted in treatment-emergent pneumonitis,early study termination
idelalisib and entospletinib
$GILD$MDVN according to sources that $GILD $CELG are joining to bid for $MDVN ... $SNY please raise the bid to $70+ ...hehe$ICPT  rumor $GILD will make a $300 bid for company, maybe a hint Gilead Sciences: Goodbye Buybacks, Hello M&amp;A?at https://t.co/pXYkscWv9v$GILD https://t.co/JVF4Hx6QC9Commented on Gilead Sciences: The Qualitative Long Case https://t.co/I1QjIIcMbA $ABBV $MRK $GILD#GileadSciences Gilead names new COO, EVP strategy. Read more: https://t.co/rXbMVky7fu $GILDRT @BioStockAddict: Kempen company update on Galapagos. Price target: 80 EUR. $GLPG $GILD https://t.co/5RlyckUlNRRT @BioStockAddict: Credit Suisse company update on Galapagos. Target price: 48 EUR. $GLPG $GILD https://t.co/36D7SGtVtXRT @BioStockAddict: Jefferies Company update on Galapagos. Buy, target 69 EUR. $GLPG $GILD $ABBV https://t.co/tPRjzGnIW8RT @BioStockAddict: Goldman Sachs company update on Galapagos. Price target 55 EUR. $GLPG $GILD https://t.co/RV7Ap85d3iRT @BioStockAddict: Kempen company update on Galapagos. Price target: 80 EUR. $GLPG $GILD https://t.co/5RlyckUlNRRT @BioStockAddict: Credit Suisse company update on Galapagos. Target price: 48 EUR. $GLPG $GILD https://t.co/36D7SGtVtXCredit Suisse company update on Galapagos. Target price: 48 EUR. $GLPG $GILD https://t.co/36D7SGtVtXCMLviz: RT adamfeuerstein: A LOT of wiggle room in this ‚Äògraph from Bloomberg story on $CELG $GILD interest in $MD‚Ä¶ https://t.co/OlGN6ZEYYqKempen company update on Galapagos. Price target: 80 EUR. $GLPG $GILD https://t.co/5RlyckUlNRRT @BioStockAddict: Goldman Sachs company update on Galapagos. Price target 55 EUR. $GLPG $GILD https://t.co/RV7Ap85d3iGoldman Sachs company update on Galapagos. Price target 55 EUR. $GLPG $GILD https://t.co/RV7Ap85d3iRT @FiercePharma: Hostile Sanofi puts forth its slate of Medivation directors as Gilead, Celgene weigh their own bids https://t.co/Ay0VOMor‚Ä¶Jefferies Company update on Galapagos. Buy, target 69 EUR. $GLPG $GILD $ABBV https://t.co/tPRjzGnIW8This is such a great rally that $DIS, $AAPL, $NFLX, and $GILD don't even have to participate for markets to hit all time highs, it appearsRT @adamfeuerstein: A LOT of wiggle room in this ‚Äògraph from Bloomberg story on $CELG $GILD interest in $MDVN. 

https://t.co/ZpKZIgvkgU ht‚Ä¶RT @FiercePharma: Hostile Sanofi puts forth its slate of Medivation directors as Gilead, Celgene weigh their own bids https://t.co/Ay0VOMor‚Ä¶adamfeuerstein: A LOT of wiggle room in this ‚Äògraph from Bloomberg story on $CELG $GILD interest in $MDVN. 

‚Ä¶ https://t.co/xeyj8CemF4@adamfeuerstein very different from the earlier report that both $GILD and $PFE made offers.  This sounds more likely but its all rumorFY2016 Earnings Forecast for Gilead Sciences, Inc. Issued By Leerink Swann $GILD https://t.co/FmYrhdongXFY2016 Earnings Forecast for Gilead Sciences, Inc. Issued By Leerink Swann $GILD https://t.co/m3aM5Dh7tWA LOT of wiggle room in this ‚Äògraph from Bloomberg story on $CELG $GILD interest in $MDVN. 

https://t.co/ZpKZIgvkgU https://t.co/71DhxePXGPRT @FiercePharma: Hostile Sanofi puts forth its slate of Medivation directors as Gilead, Celgene weigh their own bids https://t.co/Ay0VOMor‚Ä¶Galapagos, Gilead include high dose in PhIII RA trial following talk with FDA $GLPG $GILD https://t.co/NKRRE6BUQt@jq1234t Were you surprised they didn't at least have a BID induction dose arm? Seems less details since $GILD deal. Hopefully more 6/15 R&amp;D$GILD should be looking for $97 on big reversal if we are right from 82.xx https://t.co/THl8jVpprPRT @BioStockAddict: Rabobank full report on Galapagos (50 pages). Starts as a buy and 60 EUR price target. $GLPG $GILD $ABBV #RA #CF  https‚Ä¶Rabobank full report on Galapagos (50 pages). Starts as a buy and 60 EUR price target. $GLPG $GILD $ABBV #RA #CF  https://t.co/FScjCro2Bx$GILD #GileadSciences Shocks With Unlikely Executive Appointments Following Weak Q1 - https://t.co/DlEP0I3x6Q#imagination and #creativity will grow $cah $ba $c $amzn $wfc - https://t.co/HCoDDJTWVd $xlv $xlp $gild $qcom $f#GileadSciences Retired Gilead Exec Returns as His Replacement Exits. Read more: https://t.co/v5hSuf1fJM $GILD#imagination and #creativity will grow $cah $ba $c $amzn $wfc - https://t.co/1zLoF8mgQG $xlv $xlp $gild $qcom $f#imagination and #creativity will grow $cah $ba $c $amzn $wfc - https://t.co/qwnNd0PP0F $xlv $xlp $gild $qcom $f@NOLAquidity $gild is cheap on earnings basis...they have the cash and track record to grow through acquisition...less risk than others pal#imagination and #creativity will grow $cah $ba $c $amzn $wfc - https://t.co/g2vV8lXi5W $xlv $xlp $gild $qcom $f#imagination and #creativity will grow $cah $ba $c $amzn $wfc - https://t.co/vV6iH1XEiA $xlv $xlp $gild $qcom $f#imagination and #creativity will grow $cah $ba $c $amzn $wfc - https://t.co/QQbAjoICSw $xlv $xlp $gild $qcom $fRT @rileymcd: Key exec returns to @GileadSciences as his replacement departs https://t.co/Mdk0RlPmpL $GILD #biotech https://t.co/sEMvkS3qz3@GileadSciences just hired its first Head of Strategy who used to be a @BCG Partner. Should be interesting! $GILDRT @ScripMandy: Nice work if you can get it: $GILD 8K says new COO Kevin Young will make $1.05m +up to 95% performance-based bonus &amp; up to‚Ä¶Milligan shakes things up at Gilead in moves seen as reassuring to investors https://t.co/YF58vtKTSF $GILD #pharma by @EricPFierce$GILD shares spike after exec. board appointment https://t.co/GeKykX3hBO via @TheStreet$incy 200dma 93.78 long way to run. $gild might be looking to buy too. Chart hotI'm not intimate with these companies but recent history seems to expose the huge risk in their plan. $CELG $GILD https://t.co/AqTj10suyNGilead: Here's what $GILD needs to bounce back https://t.co/SBzfjuvyb3 via @CGrantWSJ @WSJheardRT @outsizedreturn: What's moving in the Americas today #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds @Scoopnest ht‚Ä¶RT @outsizedreturn: What's moving in the Americas today #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds @Scoopnest ht‚Ä¶RT @svKatface: Baird and CS analysts think new $GILD Board appt points to acquisition in the works, $ICPT and $INCY as candidates. https://‚Ä¶RT @outsizedreturn: What's moving in the Americas today #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds @Scoopnest ht‚Ä¶RT @oobiewpb: want to see $GILD run like a bansheeHostile Sanofi puts forth its slate of Medivation directors as Gilead, Celgene weigh their own bids https://t.co/Ay0VOMorX8 $SNY $MDVN $GILDwant to see $GILD run like a bansheeRT @IBD_Areeves: Seems like pharma's new bumper sticker is ""Honk if you want to buy Medivation"": https://t.co/LARnmwQk1h $SNY $MDVN $CELG $‚Ä¶$AAPL I will take on them Apple boat-missing sorrows and buy its cousin $GILD instead. #stocks #tradeideas #investingRT @svKatface: Baird and CS analysts think new $GILD Board appt points to acquisition in the works, $ICPT and $INCY as candidates. https://‚Ä¶What's moving in the Americas today #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds @Scoopnest https://t.co/zokvW0y1GyRT @ldbvua: @Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.‚Ä¶@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/5l3FSjGjknPursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/0i4z5D1D8D $qcom $f $gild$GILD:

New SEC Filing for GILD: Form 8-K (No. 0001193125-16-601852):

https://t.co/yWPKJtDuDn https://t.co/dJdnDTGGO3Pursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/2BPAOdPnyu $qcom $f $gildRT @SFBusinessTimes: Key exec returns to @GileadSciences as his replacement departs https://t.co/b1q4kOmYRq $GILD #biotech https://t.co/12l‚Ä¶Pursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/s1u5uocbbz $qcom $f $gildRT @theflynews: On The Fly: Top stock stories at midday $BABA $HPE $CSC $MDVN $SNY $CELG $GILD $PFE $AZN $NVS $AMGN $SRPT $DY... https://t.‚Ä¶Pursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/RLON4b1kmc $qcom $f $gildOn The Fly: Top stock stories at midday $BABA $HPE $CSC $MDVN $SNY $CELG $GILD $PFE $AZN $NVS $AMGN $SRPT $DY... https://t.co/afVrd5VSYoNice work if you can get it: $GILD 8K says new COO Kevin Young will make $1.05m +up to 95% performance-based bonus &amp; up to $3.5 in stock.#GileadSciences Gilead reshuffles senior leadership team. Read more: https://t.co/JUScC6KpE8 $GILD@ahaskett8 I believe recent  $ADRO $NLNK $THLD &amp; $GILD PDA fails Give Politically motivated FDA reason to Accelerate +++ $HALO PFS P2 dataPursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/ygsv9MZjpu $qcom $f $gild$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts AppBaird and CS analysts think new $GILD Board appt points to acquisition in the works, $ICPT and $INCY as candidates. https://t.co/g32PEjjX82Pursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/leHTqvzHV4 $qcom $f $gildKey exec returns to @GileadSciences as his replacement departs https://t.co/wLDyU8yp2B $GILD #biotech https://t.co/1z2S4o5Fp7Key exec returns to @GileadSciences as his replacement departs https://t.co/Mdk0RlPmpL $GILD #biotech https://t.co/sEMvkS3qz3Key exec returns to @GileadSciences as his replacement departs https://t.co/b1q4kOmYRq $GILD #biotech https://t.co/12lBG0frqcRT @TheStreet: $GILD shares spike after exec. board appointment https://t.co/9z6eTgdlri https://t.co/VdbkJqterC$GILD - Current Report Filing (8-k) https://t.co/vffWlEbSUdDeparture of Directors or Certain  https://t.co/kWXQb9pn2B $GILDMay 25: Gilead's New Execs; Large SSF Project; More on Santa Cruz Biotech https://t.co/6boxGZEBAX  Stories on $GILD $MDVN  $SNSSPursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/HCoDDJTWVd $qcom $f $gildRT @SunriseTrader: $GILD updated chart with notes. Still holding most. End of day print will be interesting and may pull some more https://‚Ä¶$GILD updated chart with notes. Still holding most. End of day print will be interesting and may pull some more https://t.co/W2qhNqOM6HPursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/1zLoF8mgQG $qcom $f $gild#GileadSciences Gilead Names a New COO and Executive VP of Strategy  . Read more: https://t.co/iGpp4Qwz42 $GILDGalapagos and Gilead on go to start late-stage filgotinib development in RA https://t.co/tv7xLH4yg6 $GLPG $GILD $ABBVPursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/qwnNd0PP0F $qcom $f $gildRT @FierceBiotech: Galapagos, Gilead include high dose in PhIII RA trial following talk with FDA: https://t.co/CSkHn1JRE1 $GILD $GLPGRT @TheStreet: $GILD shares spike after exec. board appointment https://t.co/9z6eTgdlri https://t.co/VdbkJqterCGalapagos and Gilead on go to start late-stage filgotinib development in RA https://t.co/01yBjWoX8c $GLPG $GILD $ABBVPursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/g2vV8lXi5W $qcom $f $gildSeems like pharma's new bumper sticker is ""Honk if you want to buy Medivation"": https://t.co/LARnmwQk1h $SNY $MDVN $CELG $GILD $PFE $AMGNPursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/vV6iH1XEiA $qcom $f $gildSanofi seeks to replace Medivation board amid reports of competing offers $SNY $MDVN $CELG $GILD $PFE $AMGN $... https://t.co/8Uc8Moqm6HRecap strong buy list for today: $KO, $CVS, and $GILD. Great entry at current price level. Can also be long term play on these stocks.RT @CarlyHFierce: Should I bid for Medivation, too? https://t.co/Os5NuVfShY $CELG $GILD $MDVN #pharmaPursue your dreams. All the great #entrepreneurs and #business #barons did. https://t.co/QQbAjoICSw $qcom $f $gildBillionaires Are Bailing on #GileadSciences -- Should You, Too?. Read more: https://t.co/T5P32Xyit7 $GILDRT @TheStreet: $GILD shares spike after exec. board appointment https://t.co/9z6eTgdlri https://t.co/VdbkJqterCTaking final run of $GOOGL calls...Can go higher but without me. Also $GILD the trailer - took it off. Could have waited but trimming down.RT @BioStockAddict: Rabobank starts Galapagos with a buy rating and a 60EUR price target. $GLPG $GILD $ABBVGalapagos, Gilead include high dose in PhIII RA trial following talk with FDA: https://t.co/StmtwQTFw6 $GILD $GLPG story from FierceBiotec‚Ä¶Gilead Sciences: Executive Changes are ‚ÄòNegative Signals‚Äô But‚Ä¶ https://t.co/YjcYuBNDs3 via @barronsonline $GILD $VRX $ANTM $CI#GileadSciences, Inc. Appoints New Execs; Can a Strategy Change Be Expected?. Read more: https://t.co/pB1Szp4WXl $GILDRT @TheStreet: $GILD shares spike after exec. board appointment https://t.co/9z6eTgdlri https://t.co/VdbkJqterCThe No. 1 Stock In The World (Revisited) https://t.co/OWiB7hpk6q $AAPL $BRK.B $CCP $CTSH $CVX $DIS $GILD $HON $HRL $JNJ $KMI $KO $MDT $MOGalapagos, Gilead include high dose in PhIII RA trial following talk with FDA: https://t.co/CSkHn1JRE1 $GILD $GLPG@RampCapitalLLC yeah, really helpful to those who bought it in the $110s and $120s.  Just like $GILD, $DIS, $NFLX.  Such a great rally!!RT @TheStreet: $GILD shares spike after exec. board appointment https://t.co/9z6eTgdlri https://t.co/VdbkJqterCVolume Alert - GILD 86.30 Gilead Sciences Inc $GILD Hit a high today of 87.00 Closing the day 10:30 at 86.30 + https://t.co/2Tyedrex8h$GILD Sciences: Executive Changes are ‚ÄòNegative Signals‚Äô But‚Ä¶ https://t.co/KhyPN27hOc via @barronsonlineRT @TheStreet: $GILD shares spike after exec. board appointment https://t.co/9z6eTgdlri https://t.co/VdbkJqterC$GILD ""Milligan and the company‚Äôs board of directors are starting to feel the pressure from investors"" - Leerink https://t.co/Rq9WYuBMp7Shorting $GILD again using August puts. https://t.co/IUtAJb6sEx$GILD shares spike after exec. board appointment https://t.co/9z6eTgdlri https://t.co/VdbkJqterCStrong buy on $KO and $GILD today, all technical indicators confirmed signal.RT SeekingAlpha: Best And Worst Q2'16: All Cap Growth ETFs, Mutual Funds And Key Holdings https://t.co/fDqnCxXr2O $GILD $DXCM $ESEIX $ADOA‚Ä¶SeekingAlpha: Best And Worst Q2'16: All Cap Growth ETFs, Mutual Funds And Key Holdings https://t.co/Pp351oYgey $GILD $DXCM $ESEIX $ADOAX $‚Ä¶@oobiewpb ....grabbed some common under $86 for a swing $GILDBest And Worst Q2'16: All Cap Growth ETFs, Mutual Funds And Key Holdings https://t.co/3fD98PsWh4 $GILD $DXCM $ESEIX $ADOAX $CFGE $IUSGBest And Worst Q2'16: All Cap Growth ETFs, Mutual Funds And Key Holdings https://t.co/Va6af2TJwh $GILD $DXCM $ESEIX $ADOAX $CFGE $IUSG#validate #organic #strategies at https://t.co/0i4z5D1D8D stay #focused on #success $xlv $xlp $gild $qcom $fSeekingAlpha: Delta Leads A List Of Buys For This Portfolio Which Is Beating The Market https://t.co/bEbYUGxH2i $AGN $AVGO $EA $EV $GILD $‚Ä¶#validate #organic #strategies at https://t.co/2BPAOdPnyu stay #focused on #success $xlv $xlp $gild $qcom $fSo $GILD had official offer 'substantially higher' and then $PFE came in, probably higher, and now $CELG might take part. Awesome for longs.#validate #organic #strategies at https://t.co/s1u5uocbbz stay #focused on #success $xlv $xlp $gild $qcom $fREPORT: Celgene and Gilead weighing offers for Medivation, pitting them against Sanofi: https://t.co/MDt5O1Ljn4 $CELG $GILD $MDVN $SNYThis week's rally has been an absolute Godsend for everyone holding $AAPL, $NFLX, $GILD, $DIS in the $110s and $120s.... Wait, what?#validate #organic #strategies at https://t.co/RLON4b1kmc stay #focused on #success $xlv $xlp $gild $qcom $fRT @Street_Insider: Medivation's $MDVN Board Split Over Support for Gilead $GILD, Pfizer $PFE Proposals - Source https://t.co/BUqH588limDelta Leads A List Of Buys For This Portfolio Which Is Beating The Market https://t.co/5PHLivXZZy $AGN $AVGO $EA $EV $GILD $GOOG $ORLYDelta Leads A List Of Buys For This Portfolio Which Is Beating The Market https://t.co/zRLggJpikt $AGN $AVGO $EA $EV $GILD $GOOG $ORLY$GILD -Leerink argues that exec turnover (COO role) puts $GILD in ""penalty box"", maybe reflecting issues in HCV franchise.HCV sales at risk?Delta Leads A List Of Buys For This Portfolio Which Is Beating The Market https://t.co/SYbfmRYAOt $AGN $AVGO $EA $EV $GILD $GOOG $ORLYStocks With The Most Cash On Hands - https://t.co/p62NkTgOd7 - $AAPL $QCOM $V $INTC $KO $MDT $ORCL $MSFT $MRK $CSCO $AMGN $EMC $F $FB $GILDCelgene and Gilead are considering bids for Medivation; Sanofi remains the most serious bidder
https://t.co/sVQWFCIKYJ $CELG $GILD $MDVNRT @CarlyHFierce: Should I bid for Medivation, too? https://t.co/Os5NuVfShY $CELG $GILD $MDVN #pharma#validate #organic #strategies at https://t.co/ygsv9MHI0U stay #focused on #success $xlv $xlp $gild $qcom $f$GILD $GLPG Completion of End-of-Phase 2 FDA and EMA in RA, 100mg and 200mg QD dosing in males and females worldwide https://t.co/AySSaLvnAZRT @OpenOutcrier: Celgene $CELG, Gilead $GILD Said to Join Suitors Weighing Medivation $MDVN Offers - Bloomberg

https://t.co/H4CglyOvHfRT @srqstockpicker: I like yo see $gild involved in $mdvn chatter even if they don't buy... good for bio#validate #organic #strategies at https://t.co/leHTqvzHV4 stay #focused on #success $xlv $xlp $gild $qcom $f#GILD
$gild https://t.co/4kCRjpQpF3#validate #organic #strategies at https://t.co/HCoDDJTWVd stay #focused on #success $xlv $xlp $gild $qcom $fRT @SellSideSource: $MDVN  $GILD https://t.co/dIB7HwD7TAI like yo see $gild involved in $mdvn chatter even if they don't buy... good for bioRT @SellSideSource: $MDVN  $GILD https://t.co/dIB7HwD7TART @OpenOutcrier: Medivation's $MDVN Board Split Over Support for Gilead $GILD, Pfizer $PFE Proposals - Source - Street Insider

https://t.‚Ä¶Medivation's $MDVN Board Split Over Support for Gilead $GILD, Pfizer $PFE Proposals - Source https://t.co/BUqH588lim#validate #organic #strategies at https://t.co/1zLoF8mgQG stay #focused on #success $xlv $xlp $gild $qcom $fMedivation's $MDVN Board Split Over Support for Gilead $GILD, Pfizer $PFE Proposals - Source - Street Insider

https://t.co/E1dAQTUEH7Should I bid for Medivation, too? https://t.co/Os5NuVfShY $CELG $GILD $MDVN #pharma$NVS LJN452, non-bile acid FXR agonist with supposedly improved efficacy and safety over OCA $ICPT $GILD https://t.co/pxFrgz3t1Z$MDVN  $GILD https://t.co/dIB7HwD7TAThe unique thing about $GBIM R/M is the fact they have ongoing collabs with $CELG + $GILD. $BIOD was valued at cash and canned programs.#validate #organic #strategies at https://t.co/qwnNd0PP0F stay #focused on #success $xlv $xlp $gild $qcom $fRT @tgtxdough: COWEN filgotinib will be a competitive agent in RA and potentially other areas of autoimmunity.remain at Outperform for both‚Ä¶RT @Drchik23: Leerink reiterates outperform &amp; $123 PT for $gildRT @KSSMDPhD: Pubbed today: GS-5745 shines in phase 1 UC/ Drug is mAb anti-MMP-9. 14 pc remission. 43 pc clin response. $GILD.RT @outsizedreturn: #EconomicData Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/UqWr7lpaiX https://t.c‚Ä¶Connor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/DgrNThhkJM  $DIS $ALXN $NOAH $GILD $QUNRWeak shakeout, $87 b4 long.  $gildBillionaires Are Bailing on Gilead Sciences -- Should You, Too? -- $GILD #HCV #HEPC  The Motley Fool https://t.co/JzmheGpjiJ#validate #organic #strategies at https://t.co/g2vV8lXi5W stay #focused on #success $xlv $xlp $gild $qcom $f#validate #organic #strategies at https://t.co/vV6iH1XEiA stay #focused on #success $xlv $xlp $gild $qcom $fRT @outsizedreturn: #EconomicData Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/UqWr7lpaiX https://t.c‚Ä¶#validate #organic #strategies at https://t.co/QQbAjoICSw stay #focused on #success $xlv $xlp $gild $qcom $fRT SeekingAlpha: Achillion's Pipeline Strengthens, With Near-Term Potential Catalysts https://t.co/IvkaP53cGa $ABBV $ALXN $BMY $GILD $JNJ ‚Ä¶$GILD appoints new COO &amp; EVP, Strategy https://t.co/60tZeNlsiy by @YahooFinanceSeekingAlpha: Achillion's Pipeline Strengthens, With Near-Term Potential Catalysts https://t.co/OLhrqkrDrn $ABBV $ALXN $BMY $GILD $JNJ $AC‚Ä¶$GILD 87.5's .3 avg yoloAchillion's Pipeline Strengthens, With Near-Term Potential Catalysts https://t.co/9q9VR19PDN $ABBV $ALXN $BMY $GILD $JNJ $ACHNAchillion's Pipeline Strengthens, With Near-Term Potential Catalysts https://t.co/quqsuMPoAh $ABBV $ALXN $BMY $GILD $JNJ $ACHNRT @AmericanBanking: Gilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Leerink Swann https://t.co/i7dfRSsklWRT @OpenOutcrier: Celgene $CELG, Gilead $GILD Said to Join Suitors Weighing Medivation $MDVN Offers - Bloomberg

https://t.co/H4CglyOvHf$GILD GS-9620-TLR7 'immune enhancer"" data release when, August?$GILD $ARWR https://t.co/CBYZjoAyqDGilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Leerink Swann https://t.co/jX5jcAdAPGRT @DougKass: Real Money: Added to longs yesterday: $HIG $OAK. Established new $IBB longs: $GILD $XON $CELG $AGN
Added to $XLP short
@jimcr‚Ä¶Gilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Leerink Swann https://t.co/i7dfRSsklWRT @outsizedreturn: Americas #Macro Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/UqWr7lpaiX https://t‚Ä¶@WiltonPark @TheDohertyInst HBV 'heavy hitters' Locarnini &amp; Yuen talking this week at ACHA $ARWR, next week again in HK $GILD UCSF.GILD Top news - May 25th, 2016 $GILD https://t.co/IVQaIjnakF$TRIP $DHI $GILD options have the largest change in volume. Free options screener. https://t.co/VNabeKV6sU$GILD sentiment rise to: 0.78, change: +0.59, sdr: 1.11, 1H, 9:00 AM, #nasdaq $SPY $NDXRT @outsizedreturn: #Bloomberg News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/Fn1XYkxmV9 https://t‚Ä¶Wondering about #sentiment indicator for $GILD? The Short Ratio is 2.5% https://t.co/aGOMONHc1URT @OpenOutcrier: Celgene $CELG, Gilead $GILD Said to Join Suitors Weighing Medivation $MDVN Offers - Bloomberg

https://t.co/H4CglyOvHfRT @OpenOutcrier: Celgene $CELG, Gilead $GILD Said to Join Suitors Weighing Medivation $MDVN Offers - Bloomberg

https://t.co/H4CglyOvHfRT @chartsmarter: ChartSmarter Wed Game Plan: https://t.co/nbpTYV4qE6 ""Nasdaq sporting bullish inverse head and shoulders"" $NDAQ $GILD http‚Ä¶RT @DougKass: Real Money: Added to longs yesterday: $HIG $OAK. Established new $IBB longs: $GILD $XON $CELG $AGN
Added to $XLP short
@jimcr‚Ä¶RT @outsizedreturn: #EconomicData Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/UqWr7lpaiX https://t.c‚Ä¶RT @outsizedreturn: Americas #Macro Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/UqWr7lpaiX https://t‚Ä¶RT @outsizedreturn: #Bloomberg News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/Fn1XYkxmV9 https://t‚Ä¶@princetongb @bradloncar $MDVN courting dance keeps getter more suitors... looks like $GILD/$CELG may join the fray -https://t.co/FRhKfPmoBC$celg and $gild now also among buyers for $mdvnRT @OpenOutcrier: Celgene $CELG, Gilead $GILD Said to Join Suitors Weighing Medivation $MDVN Offers - Bloomberg

https://t.co/H4CglyOvHfRT @DougKass: Real Money: Added to longs yesterday: $HIG $OAK. Established new $IBB longs: $GILD $XON $CELG $AGN
Added to $XLP short
@jimcr‚Ä¶RT @DougKass: Real Money: Added to longs yesterday: $HIG $OAK. Established new $IBB longs: $GILD $XON $CELG $AGN
Added to $XLP short
@jimcr‚Ä¶RT @OpenOutcrier: Celgene $CELG, Gilead $GILD Said to Join Suitors Weighing Medivation $MDVN Offers - Bloomberg

https://t.co/H4CglyOvHfRT @OpenOutcrier: Celgene $CELG, Gilead $GILD Said to Join Suitors Weighing Medivation $MDVN Offers - Bloomberg

https://t.co/H4CglyOvHfRT @OpenOutcrier: Celgene $CELG, Gilead $GILD Said to Join Suitors Weighing Medivation $MDVN Offers - Bloomberg

https://t.co/H4CglyOvHf#EconomicData Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/UqWr7lpaiX https://t.co/XT1G4iOpWxCelgene $CELG, Gilead $GILD Said to Join Suitors Weighing Medivation $MDVN Offers - Bloomberg

https://t.co/H4CglyOvHfAmericas #Macro Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/UqWr7lpaiX https://t.co/cELvZGwvky#Bloomberg News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/Fn1XYkxmV9 https://t.co/4uDKnRx2k3Real Money: Added to longs yesterday: $HIG $OAK. Established new $IBB longs: $GILD $XON $CELG $AGN
Added to $XLP short
@jimcramer$GILD and $GLPD conclude discussions with regulators on design of filgotinib Phase 3 study in¬†RA https://t.co/aOjaOdmelGChartSmarter Wed Game Plan: https://t.co/nbpTYV4qE6 ""Nasdaq sporting bullish inverse head and shoulders"" $NDAQ $GILD https://t.co/M0yfThqRkb@OpenOutcrier @WrigleyTom $GILD needs   ItRumor: $GILD, $CELG mulling bid for $MDVNNasdaq listed stocks that saw short interest decrease by &gt;$100m: $GILD $WYNN $SWKS $FAST $GLPI https://t.co/bAUVWJqWiPRT @OpenOutcrier: $MDVN (+1.0% pre) Premarket chatter $CELG and $GILD still looking at possible bidsWhat to Watch at ASCO: $GILD $CELG
https://t.co/aFQw5JDJLuRT @OpenOutcrier: $MDVN (+1.0% pre) Premarket chatter $CELG and $GILD still looking at possible bidsRT @OpenOutcrier: $MDVN (+1.0% pre) Premarket chatter $CELG and $GILD still looking at possible bidsRT @OpenOutcrier: $MDVN (+1.0% pre) Premarket chatter $CELG and $GILD still looking at possible bidsRT @HumbleBioTrader: $CELG, $GILD Said to Join Suitors Weighing Medivation (MDVN) Offers - Bloomberg https://t.co/KjQqEXhcAT via @Street_In‚Ä¶$MDVN (+1.0% pre) Premarket chatter $CELG and $GILD still looking at possible bids$CELG, $GILD Said to Join Suitors Weighing Medivation (MDVN) Offers - Bloomberg https://t.co/KjQqEXhcAT via @Street_InsiderGilead Sciences Announces Appointment of Kevin Young CBE as Chief Operating Officer $GILD https://t.co/36KHz9Qb3lRT @KSSMDPhD: Pubbed today: GS-5745 shines in phase 1 UC/ Drug is mAb anti-MMP-9. 14 pc remission. 43 pc clin response. $GILD.The #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/0i4z5D1D8D  $gild $qcomThe #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/2BPAOdPnyu  $gild $qcomPubbed today: GS-5745 shines in phase 1 UC/ Drug is mAb anti-MMP-9. 14 pc remission. 43 pc clin response. $GILD.@Drchik23 LR Bottom Line: $GILD announced 2 surprising new executive appointments that raise short-term??but provide long-term reassurance.The #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/s1u5uocbbz  $gild $qcomThe #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/RLON4b1kmc  $gild $qcomOpem Positions Update: $FSLR, $GILD,$SWHC, $BAC,$TAN,$IBB https://t.co/2v3kqQOb7c$ICPT rumor on St of a deal with $GILD around $300 per share. around late yesterdayThe #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/ygsv9MZjpu  $gild $qcomThe #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/leHTqvzHV4  $gild $qcomThe #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/HCoDDJTWVd  $gild $qcomThe #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/1zLoF8mgQG  $gild $qcomThe #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/qwnNd0PP0F  $gild $qcomRT @Drchik23: Leerink reiterates outperform &amp; $123 PT for $gildThe #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/g2vV8lXi5W  $gild $qcom$GILD: Gilead Sciences appoints Kevin Young as COO https://t.co/ZS5TprqXoPRT @BioStockAddict: Rabobank starts Galapagos with a buy rating and a 60EUR price target. $GLPG $GILD $ABBVThe #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/vV6iH1XEiA  $gild $qcom@TheDomino to piggy back off your report on @SquawkCNBC this morning, $GILD up over 5% since its 52 Week Low last Thursday.The #hashtag #theory of #seo #searchengineoptimization was #developed here - https://t.co/QQbAjoICSw  $gild $qcomExec Turnover Puts Gilead Sciences $GILD In The Penalty Box- Leerink https://t.co/4EbNtVLTLzGalapagos and Gilead on go to start late-stage filgotinib development in RA https://t.co/WHtFTSHwpp #premarket $GLPG $GILD $ABBVGalapagos and Gilead on go to start late-stage filgotinib development in RA https://t.co/kSdDN5u60J #premarket $GLPG $GILD $ABBVGalapagos and Gilead on go to start late-stage filgotinib development in RA https://t.co/vMqHYPOo06 #premarket $GLPG $GILD $ABBVRT @JustinPulitzer: Weekend Review VIDEO (5/22): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $DB #StockMarket ht‚Ä¶RT @Carine1111111: @genfit_pharma  @genfit #ELAFIBRANOR $GILD $ICPT #NASH $GNFTF https://t.co/qpRGOmdCrBRT @MarketsRecap: 3 Safe Dividend Stocks With Pristine Balance Sheets $AAPL $AMGN $GILD Also $GPS $JWN $M $TGT $AMZN https://t.co/NcW1nE1jL5RT @MarketsRecap: 3 Safe Dividend Stocks With Pristine Balance Sheets $AAPL $AMGN $GILD Also $GPS $JWN $M $TGT $AMZN https://t.co/NcW1nE1jL5Leerink reiterates outperform &amp; $123 PT for $gildhttps://t.co/0i4z5D1D8D has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $fRT @BioStockAddict: Rabobank starts Galapagos with a buy rating and a 60EUR price target. $GLPG $GILD $ABBVhttps://t.co/2BPAOdPnyu has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $fGoing to the office soon, but before I do: $GILD!Gilead Sciences's outperform rating reiterated at Leerink Swann. $123.00 PT. https://t.co/mUZ9iNpJDa $GILD #GILDhttps://t.co/s1u5uocbbz has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $fGilead Sciences's outperform rating reiterated at Leerink Swann. $123.00 PT. https://t.co/3C2nJJgYg4 $GILD #GILDhttps://t.co/RLON4b1kmc has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $fhttps://t.co/ygsv9MZjpu has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $fhttps://t.co/leHTqvzHV4 has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $f3 Safe Dividend Stocks With Pristine Balance Sheets $AAPL $AMGN $GILD Also $GPS $JWN $M $TGT $AMZN https://t.co/NcW1nE1jL5https://t.co/HCoDDJTWVd has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $fRT @BiotechRadar: so $GILD / $GLPG will perform the RA phase 3 with 100/200mg daily - more comprehensive than forecasted but better chances‚Ä¶https://t.co/1zLoF8mgQG has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $fhttps://t.co/qwnNd0PP0F has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $fhttps://t.co/g2vV8lXi5W has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $fhttps://t.co/vV6iH1XEiA has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $fhttps://t.co/QQbAjoICSw has the #elite #strategyconsultants that will #strengthen your #brand $mon $gild $qcom $fRT @SunriseTrader: Looking for a dumpster dive trade? $GILD https://t.co/yp3dQ8Q7Zh$GILD def needs a strategy https://t.co/Ivcc5ZDLfu and it works on it but still early and slow.RT @tgtxdough: COWEN filgotinib will be a competitive agent in RA and potentially other areas of autoimmunity.remain at Outperform for both‚Ä¶RT @BioStockAddict: Rabobank starts Galapagos with a buy rating and a 60EUR price target. $GLPG $GILD $ABBVRabobank starts Galapagos with a buy rating and a 60EUR price target. $GLPG $GILD $ABBVRT @tgtxdough: COWEN filgotinib will be a competitive agent in RA and potentially other areas of autoimmunity.remain at Outperform for both‚Ä¶RT @bmwnewchic: GOLDMAN: Hedge funds' biggest shorts:

$dis
$xom
$ge
$ba
$nflx
$esrx
$tgt
$cat
$cvx
$ibm
$t
$gild
$jnj
$intc
$wmt
$F https:‚Ä¶RT @BiotechRadar: so $GILD / $GLPG will perform the RA phase 3 with 100/200mg daily - more comprehensive than forecasted but better chances‚Ä¶RT @adamfeuerstein: $GILD ‚Äî I love Porges' description of Kevin Young‚Äôs return from ‚Äúreportedly comfortable retirement.‚Äù 

If only half the‚Ä¶$GILD Gilead Sciences is a 5 star üí∞ dividend üí∞ stock with a 2.3% yield: https://t.co/nHdTPP5PmW https://t.co/ZTnijYoC7zRT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶RT @tgtxdough: COWEN filgotinib will be a competitive agent in RA and potentially other areas of autoimmunity.remain at Outperform for both‚Ä¶RT @tgtxdough: COWEN filgotinib will be a competitive agent in RA and potentially other areas of autoimmunity.remain at Outperform for both‚Ä¶$GILD $V $BRKB $IBB all looking Good!Gilead Sciences(PBR107) names Kevin Young CBE as COO, Martin Silverstein, MD, as EVP-Strategy. https://t.co/TzJuHHe1R1 $GILD #ThePBR1000Commented on Gilead Sciences: The Qualitative Long Case https://t.co/I1QjIIunAa $ABBV $MRK $GILDRT @BioStockAddict: $GLPG Successful completion of End-of-Phase 2 FDA and EMA consultations in #RA #Galapagos $GILD https://t.co/dT0Y6l9Z70Unusual Call Activity https://t.co/9iGiScv6xI  $BBY $FEYE $GPS $XLF $DIA $BMY $AMD $V $TNA $EBAY $AMAT $PBR $NFLX $QCOM $GPRO $GS $XBI $GILD3 Safe Dividend Stocks With Pristine Balance Sheets $AAPL $AMGN $GILD Also $GPS $JWN $M $TGT $AMZN https://t.co/i8yHDBF9VtI own $GILD currently and will be the first to tell you that it may be cheap for good reason, and the best days are over.Examples: there definitely were statistically cheap energy/commodities related stuff. There's things like $GILD , $JWN ..but there are validMEMBER VIDEO POSTED! Covering $SPY $BABA $BIDU $AKAM $GILD $EXPE $AGN $EXPE $APC click link&gt; https://t.co/Io03uadOS1 https://t.co/eGWgrDOxjgCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5#GileadSciences Names COO and Executive VP of Strategy (NASDAQ:). Read more: https://t.co/n84atZ3cQi $GILDSome Unique Ratios That Can Make You A Better Investor https://t.co/aTlbYunCsy $AAPL $BRK.A $BRK.B $GILD $MART @iviewmarkets: Sector names working today $CHK $MUR$SWN $WHR $GT $HAR $AMG $MS $GILD $VRTX $BIIB $LEN $DHI $PHM $NFLX $RHI $MCO https://‚Ä¶Kevin Young is a machine... $gild

https://t.co/yvgmuFZ6xNCOWEN filgotinib will be a competitive agent in RA and potentially other areas of autoimmunity.remain at Outperform for both $GLPG &amp; $GILD.#GileadSciences Young returning to Gilead as COO. Read more: https://t.co/YP3J4cqG8R $GILDOpen Positions - $FSLR, $GILD, $SWHC, $BAC, $IBB https://t.co/zOlHpCRzDnRT @adamfeuerstein: $GILD ‚Äî I love Porges' description of Kevin Young‚Äôs return from ‚Äúreportedly comfortable retirement.‚Äù 

If only half the‚Ä¶RT @R4inb0w_: GENFIT ""Elafibranor has a potential of USD 10 billion a year in revenue!"" CEO JF  Mouney #NASH #PBC $GNFT $GILD $ICPT $TBRA $‚Ä¶#GileadSciences Key exec returns to Gilead as his replacement departs. Read more: https://t.co/aWa6z0PgDa $GILD#GileadSciences Key exec returns to Gilead as his replacement departs. Read more: https://t.co/OUjn1SD8lV $GILDRT @adamfeuerstein: $GILD ‚Äî I love Porges' description of Kevin Young‚Äôs return from ‚Äúreportedly comfortable retirement.‚Äù 

If only half the‚Ä¶",2016-05-25,GILD,0
35,"RT @HenryEChang: Combination Therapy With TDF and PEG-IFN May Not Be Translated Into
Current Clinical Practice‚Üíhttps://t.co/eRSPGzihzv #HBV‚Ä¶Combination Therapy With TDF and PEG-IFN May Not Be Translated Into
Current Clinical Practice‚Üíhttps://t.co/eRSPGzihzv #HBV #HepB $GILDEqis Capital Management Inc. Has $6,068,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/S0dFtk1vpL#GileadSciences -- Strong Buy Despite Management Shakeup: Barrons. Read more: https://t.co/3GT28MEYja $GILDStochastic OB https://t.co/RKFM6ikG4U $SWN $COP $PLCM $FLS $STWD $OAS $MMM $CBG $HES $GILD $HSBC $KKR $OLN $HON $TSLA $IBM $SIRIRT https://t.co/h36rmy0f8Q : Commercial carousel continues to spin: Gilead's head of commercial departs. $GILD #p‚Ä¶ https://t.co/EFNWt8ybmTCommercial carousel continues to spin: Gilead's head of commercial departs. $GILD #pharma https://t.co/C4nyL2o7Z3 https://t.co/7ltdotNY2aRT @DrPaulyDeSantis: TME=Tumor Microenvironment for those that dont know the acronym, key target for $GILD $JUNO $KITE and many others http‚Ä¶RT @DrPaulyDeSantis: TME=Tumor Microenvironment for those that dont know the acronym, key target for $GILD $JUNO $KITE and many others http‚Ä¶@cek_cpa @wandy922 @ryanwallace198 I'm glad I didn't tough it. Rather play long $GILD.RT @SAlphaTrending: Trouble Strikes Ionis; Will It Get Bought Out? By Gilead? https://t.co/VMLvH85gq6 $ALNY $BAYRY $BIIB $GILD $GSK $IBB $P‚Ä¶RT @Top5Traders: SAlphaTrending: Trouble Strikes Ionis; Will It Get Bought Out? By Gilead? https://t.co/ZUJRASvpZP $ALNY $BAYRY $BIIB $GILD‚Ä¶RT @Top5Traders: InvestorsLive4U: SeekingAlpha: Trouble Strikes Ionis; Will It Get Bought Out? By Gilead? https://t.co/8taOlH45l6 $ALNY $BA‚Ä¶RT @barronsonline: Gilead a Buy Amid a Big Management Shake-Up https://t.co/SOpSrVfIc5 $GILD https://t.co/wCZVQG8SGU#GileadSciences Gilead and Celgene Among Biotechnology Stocks to Buy. Read more: https://t.co/FW0feLMs73 $GILDGilead a Buy Amid a Big Management Shake-Up https://t.co/SOpSrVfIc5 $GILD https://t.co/wCZVQG8SGURT @outsizedreturn: Americas #Macro Update $klac $yinn $oil $spy $tbt $gpro $ntfl $t $aapl $gild $pg #hedgefunds https://t.co/DlyX2Fg2zj ht‚Ä¶SAlphaTrending: Trouble Strikes Ionis; Will It Get Bought Out? By Gilead? https://t.co/ZUJRASvpZP $ALNY $BAYRY $BIIB $GILD $GSK $IBB $PTLA‚Ä¶InvestorsLive4U: SeekingAlpha: Trouble Strikes Ionis; Will It Get Bought Out? By Gilead? https://t.co/8taOlH45l6 $ALNY $BAYRY $BIIB $GILD ‚Ä¶Trouble Strikes Ionis; Will It Get Bought Out? By Gilead? https://t.co/VMLvH85gq6 $ALNY $BAYRY $BIIB $GILD $GSK $IBB $PTLA $SPY $IONSRT @BioStockAddict: Rabobank full report on Galapagos (50 pages). Starts as a buy and 60 EUR price target. $GLPG $GILD $ABBV #RA #CF  https‚Ä¶Trouble Strikes Ionis; Will It Get Bought Out? By Gilead? https://t.co/FnCHNcywbw $ALNY $BAYRY $BIIB $GILD $GSK $IBB $PTLA $SPY $IONSTrouble Strikes Ionis; Will It Get Bought Out? By Gilead? https://t.co/3PRvLFwOBu $ALNY $BAYRY $BIIB $GILD $GSK $IBB $PTLA $SPY $IONSGilead Sciences Doesn‚Äôt Have Many Fans on Wall Street: Jim Cramer
  https://t.co/V45lBymo8d
  $GILD https://t.co/OPFYi7hVVQRT @outsizedreturn: Americas #Macro Update $klac $yinn $oil $spy $tbt $gpro $ntfl $t $aapl $gild $pg #hedgefunds https://t.co/DlyX2Fg2zj ht‚Ä¶RT @outsizedreturn: Americas #Macro Update $klac $yinn $oil $spy $tbt $gpro $ntfl $t $aapl $gild $pg #hedgefunds https://t.co/DlyX2Fg2zj ht‚Ä¶Americas #Macro Update $klac $yinn $oil $spy $tbt $gpro $ntfl $t $aapl $gild $pg #hedgefunds https://t.co/DlyX2Fg2zj https://t.co/KwEqtYywsxRT @hedgefundclone: $GILD What a Young Buffett Would Buy Today, P/E of 7, High Return on Capital, Great Balance Sheet, and near low! https:‚Ä¶$GILD: Analyst action by Morgan Stanley on Gilead Sciences: https://t.co/0ifWPrunlp https://t.co/j24my9dNct.@GileadSciences reappoints former Exec VP Kevin Young as new COO, Martin Silverstein, MD as Exec VP, Strategy $GILD ‚Ä¶RT @TipRanks: Analysts Cautious on $VRX and $GILD; Here‚Äôs Why
https://t.co/mtvXnN19rAThe Next Grenade For Gilead Gilead: Et Tu Vermont? https://t.co/o6FTdiRKO6 ‚Ä¶ $ABBV $MRK $GILD https://t.co/yZx3EZy0BMBetter Buy: #GileadSciences Inc. vs. Johnson &amp; Johnson. Read more: https://t.co/ZqoHow9fCt $GILDTME=Tumor Microenvironment for those that dont know the acronym, key target for $GILD $JUNO $KITE and many others https://t.co/NpkBGihhiL@WilliamGerber1 @PRB51 @Ogut_Ozgur realistically, $7B/yr PS wud hav $MDVN at $GILD val, but is MILES away. That's not val-gap.Just lousy estStock Trading Quiz: https://t.co/wzVrn8s6bO | $PTX $VRX $IONS $SRPT $MNKD $BIOD $MSTX $BIOC $XOMA $GILD $CELG $SGPY https://t.co/B2g8FswJ2qGILD % Change
See Here ---&gt; https://t.co/MNLHF3vKpW

$GILD $EXPE $VALE #shareRT @FredrikRydlun: NASDAQ Dogs refine treasures of technology. Do brokers get it? https://t.co/59oxKunoIP $AAPL $AMGN $AVGO $CSCO $CSX $GIL‚Ä¶NASDAQ Dogs refine treasures of technology. Do brokers get it? https://t.co/59oxKunoIP $AAPL $AMGN $AVGO $CSCO $CSX $GILD $INTC $KHC $MSFTBetter Buy: Gilead Sciences Inc. vs. Johnson &amp; Johnson $GILD $JNJ https://t.co/KN6RiizqS5 #Dividend #Investing https://t.co/t35Ah3hxZeJim Cramer: Wall Street Doesn't Like $GILD Gilead https://t.co/MFdYYxBovC via @TheStreetRT @techwhitepapers: Gilead a Buy Amid a Big Management Shake-Up https://t.co/WOF7PXnnxI via @barronsonline - I said here that $GILD needs‚Ä¶@go2sleepjj invested in $GILDICYMI: Kevin Young to return to $GILD as COO https://t.co/YoKS48nuKVRT @TipRanks: Analysts Cautious on $VRX and $GILD; Here‚Äôs Why
https://t.co/mtvXnN19rA$GILD: Analyst action by Morgan Stanley on Gilead Sciences: https://t.co/0ifWPrunlp https://t.co/Vbtc2nLeBGRT @hedgefundclone: $GILD What a Young Buffett Would Buy Today, P/E of 7, High Return on Capital, Great Balance Sheet, and near low! https:‚Ä¶$GILD is consolidating on its 8d EMA. Open gap targets $98. Currently at $85.RT @247WallSt: As US opens #ZikaVirus purse for a vaccine, 7 companies leading fight against Zika $GILD $INO $XON $SPB $NLNK $DGX https://t‚Ä¶$IONS, formerly ISIS, got beheaded today. Down 40%, it shows dangers of ""investing"" in #SpecBios. Stick w big guns $CELG $GILD $BIIB $AMGN@moctavio No te Gusta $GILD largo plazo?I'm going all in on a LT position of $gild if it breaks today's low $85.05. Major key would be a 84.5 cost basis @ScalpEm23Is Best Biotech Stock Buy Now, GILD Or ? You Pick https://t.co/4ioKJfv2wm $LGND $GILDIs Best Biotech Stock Buy Now, GILD Or ? You Pick https://t.co/Oy9S2GOHnU $LGND $GILDRT @hedgefundclone: $GILD What a Young Buffett Would Buy Today, P/E of 7, High Return on Capital, Great Balance Sheet, and near low! https:‚Ä¶$GILD What a Young Buffett Would Buy Today, P/E of 7, High Return on Capital, Great Balance Sheet, and near low! https://t.co/FMiGmmvvoENice article on Gilead and what it needs to do from the @WSJ $GILD https://t.co/bgVgFISaWnGilead needs to do something with its cash. We know that the market punishes management that does not execute a vision for growth. $gildKey exec returns to @GileadSciences as his replacement departs https://t.co/b1q4kOmYRq $GILD #biotech https://t.co/12lBG0frqcStockSpotify: M&amp;A Chatter $CELG $GILD $MDVN $SNY $AMGN $MON $BAYRY $NYRT $AAPL $AXLL https://t.co/YWU07klZDj https://t.co/DYmW4ztQD4RT @HenryEChang: New drug names joining the #HepC lexicon: Voxilaprevir (GS-9857), Glecaprevir (ABT-493) &amp; Pibrentasvir (ABT-530). #HCV $GI‚Ä¶Quite a ""V8"" moment for all those selling today- but $GILD, $THLD, $INCY, &amp; $NLNK did so well in Panc Ca- I understand $HALO skepticism...RT @Tootix: #OCA for the Treatment of #PBC: Comparative Clinical Effectiveness and Value $ICPT $GNFT $GILD
https://t.co/lC7Kx1wt4F#OCA for the Treatment of #PBC: Comparative Clinical Effectiveness and Value $ICPT $GNFT $GILD
https://t.co/lC7Kx1wt4FAnalysts Cautious on $VRX and $GILD; Here‚Äôs Why
https://t.co/mtvXnN19rAVolume Alert - GILD 85.44 Gilead Sciences Inc $GILD Hit a high today of 86.50 Closing the day 10:30 at 85.44 - https://t.co/vfszmzsA6pCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Is It Time To Worry About Debt Levels Again? - Bret Jensen | Seeking Alpha https://t.co/H88G9KA8E7 via @salphatrending $AAPL $AMGN $GILDRBC‚Äôs Michael Yee and team writes that $MDVN purchase ‚Äúmay not be the best value creation‚Äù for $AMGN $GILD &amp; $CELG https://t.co/0TJGJU6nRxRT @scutify: StockSpotify: Merger &amp; Acquisition Chatter $YDKN $CELG $GILD $MON $BAYRY $NYRT $AAPL $AXLL https://t.co/SxeydMQVNZ https://t.c‚Ä¶$GILD ...having issues getting over $85.60.... Think once thru back over $86$GILD:US Gilead Sciences, Inc. (GILD) Stock Rating Reaffirmed by Morgan Stanley #GILEAD SCIENCES INC  https://t.co/9tkNamiAoV #NASDAQCommercial carousel continues to spin: Gilead's head of commercial departs. $GILD #pharma https://t.co/C4nyL2o7Z3 https://t.co/lcBw54fjlNGilead Has Great Value Now; No Need For It To Make A Big Deal $GILD https://t.co/EM4xiRM6OqGILD Top news - May 26th, 2016 $GILD https://t.co/GwpswjWljm$AAPL $AMGN $GILD Is It Time To Worry About Debt Levels Again? https://t.co/BRT4iGa1ds https://t.co/210q5HWxqHRT @jonogg: As US opens #ZikaVirus purse for a vaccine, 7 companies leading fight against Zika $GILD $INO $XON $SPB $NLNK $DGX
https://t.co‚Ä¶RT @247WallSt: As US opens #ZikaVirus purse for a vaccine, 7 companies leading fight against Zika $GILD $INO $XON $SPB $NLNK $DGX https://t‚Ä¶May 26 Biotech Update $CELG $GILD $GSK $ions $MDVN https://t.co/GLnBrPAZIfAs US opens #ZikaVirus purse for a vaccine, 7 companies leading fight against Zika $GILD $INO $XON $SPB $NLNK $DGX https://t.co/HAiyvYHcG2XLV Has Rebounded And Is Ready To Break Out https://t.co/eITCQvyECs $AMGN $GILD $JNJ $PFE $XLVXLV Has Rebounded And Is Ready To Break Out https://t.co/hXKfK71UXR $AMGN $GILD $JNJ $PFE $XLVXLV Has Rebounded And Is Ready To Break Out https://t.co/3nrO6lVkdw $AMGN $GILD $JNJ $PFE $XLVHighest rated in the past week: $AAPL $RRR $GILD $AMAT $NFLX https://t.co/esqNms1Oix #stocksRT @MrLobble: Patiently  waiting to back the truck up on $gild this morningStrong buy on $CVS, $GILD, $MCD and $KO today. Current price is at oversold level. Great entry point here, 10% to 15% upside potential.Patiently  waiting to back the truck up on $gild this morningRT @outsizedreturn: Social Velocity on #Bloomberg $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/nraWgiv32g ht‚Ä¶As US opens #ZikaVirus purse for a vaccine, 7 companies leading fight against Zika $GILD $INO $XON $SPB $NLNK $DGX
https://t.co/vvxUWiYhrCTrimming profitable $GILD at this O/B Hourly on $XBI. #stocks #tradeideas #investingGilead Sciences: The Qualitative Long Case $GILD https://t.co/7tR1eOovTf.@GileadSciences reappoints former Exec VP Kevin Young as new COO, Martin Silverstein, MD as Exec VP, Strategy $GILD https://t.co/zhX2xrELXl@jimcramer I do have tinnitis!  Sorry but you were NEGATIVE on $GILD. Why wait for them to do a deal - it will POP after it does! BUY NOW!RT @outsizedreturn: Social Velocity on #Bloomberg $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/nraWgiv32g ht‚Ä¶Social Velocity on #Bloomberg $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/nraWgiv32g https://t.co/PLiqjsl7lC@jimcramer says ""don't buy, dont buy"" when a caller asked him about $GILD last night. Everyone hates the BEST DRUG company in the world! BUYRT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶Gilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Morgan Stanley https://t.co/12zZAwXHj1Gilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Morgan Stanley https://t.co/5eFVL2Ot16$GILD 2nd largest($) short position of HF's at $2.5B.Pharmalot.. Pharmalittle.. Good Morning.. coffee, sunshine &amp; headlines.. https://t.co/bYAXeMziMS #pharma $MDVN $CELG $GILD $VRX $WBASanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN $AMGN $PFE $GILD $NVSMrPrud's [#Watchlist] Que's | $GILD https://t.co/A1GXHdPZIg https://t.co/lyArrYl7IBRT @BioBounce: Longtime leaders of large cap biotech ($IBB), $CELG $GILD $BIIB $ALXN $VRTX &amp; $ILMN all triggered potential breakouts yester‚Ä¶$GILD maintains Equal-weight at Morgan Stanley- PT cut $103 from $107Gilead Sciences Reiterated Rating by Morgan Stanley (Ranked 34th) to Hold with 103 PT $GILD #GILD https://t.co/nyq7xJnbR7Gilead Sciences's hold rating reiterated at Morgan Stanley. $103.00 PT. https://t.co/5ERYaA4a9R $GILD #GILDCommented on Gilead Sciences: In The Catbird's Seat https://t.co/uuhPPF3rQj $MACK $RLYP $IBB $GILDLongtime leaders of large cap biotech ($IBB), $CELG $GILD $BIIB $ALXN $VRTX &amp; $ILMN all triggered potential breakouts yesterday.Biotech Trade Alerts Archive -2016-05-25- $PTX, $MDVN, $NVAX, $SNGX, $SPPI, $EYEG, $SRPT, $GILD,¬†$VRX https://t.co/OjHwQit7UCRT @tgtxdough: CITI $GILD Share Buybacks to
decrease as the co turns to
Pipeline. Is M&amp;A coming?RT @tgtxdough: CITI $GILD Share Buybacks to
decrease as the co turns to
Pipeline. Is M&amp;A coming?CITI $GILD Share Buybacks to
decrease as the co turns to
Pipeline. Is M&amp;A coming?$GILD: Analyst action by Morgan Stanley on Gilead Sciences: https://t.co/0ifWPrunlp https://t.co/ahekICoCP7$MDVN: Three Biotech Giants Enter. Which One Leaves? - Report Suggests $GILD has joined $AMGN $SNY $CELG  #Barron's https://t.co/snCUn6NkOB$GILD Current Report Filing (8-k)‚Ä¶ https://t.co/C8aiosWJv7Weekly S&amp;P100 #Stocks Performance $MON $WMT $CSCO $DD $SLB $QCOM $BIIB $HAL $AAPL $KMI $INTC $GILD $TXN  more@ https://t.co/cKkr8csQUUCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKjqBmDFeelin' froggy want HUGE $OIL, $UWTI dmp, $NUGT, $JNUG, $GDJJ, $GDXX small. $NFLX, $GILD, $GPRO, $CRM, $LOW 2 https://t.co/a6mRowLoKrGilead a Buy Amid a Big Management Shake-Up https://t.co/WOF7PXnnxI via @barronsonline - I said here that $GILD needs a new strategy. well.!$CELG have a plan as to how to manage #revlimid patent cliff and have revenue growth thro 2030 (&gt;14 yrs)
$GILD @GileadSciences wake up!
$IBB#GileadSciences appoints COO and strategy head. Read more: https://t.co/5Tw3i7rrZ5 $GILDRT @adamfeuerstein: A LOT of wiggle room in this ‚Äògraph from Bloomberg story on $CELG $GILD interest in $MDVN. 

https://t.co/ZpKZIgvkgU ht‚Ä¶RT @scutify: StockSpotify: Merger &amp; Acquisition Chatter $YDKN $CELG $GILD $MON $BAYRY $NYRT $AAPL $AXLL https://t.co/SxeydMQVNZ https://t.c‚Ä¶Billionaire George Soros' Fund Bought These Stocks: Should You? --  The Motley Fool https://t.co/qOXskY6tFM $IBB $GILD $NVAX #InvestRT @scutify: StockSpotify: Merger &amp; Acquisition Chatter $YDKN $CELG $GILD $MON $BAYRY $NYRT $AAPL $AXLL https://t.co/SxeydMQVNZ https://t.c‚Ä¶StockSpotify: Merger &amp; Acquisition Chatter $YDKN $CELG $GILD $MON $BAYRY $NYRT $AAPL $AXLL https://t.co/SxeydMQVNZ https://t.co/22zHd2gI91RT @FierceBiotech: Galapagos, Gilead include high dose in PhIII RA trial following talk with FDA: https://t.co/CSkHn1JRE1 $GILD $GLPGRT @theflynews: On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.‚Ä¶RT @lancejepsen: Analyst Actions and Breaking News $ASYS $BA $BEAT $EVHC $GILD $ODP $SAIC https://t.co/VzSdWujWrv https://t.co/tFE4OECe0ERT @theflynews: On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.‚Ä¶RT @vxx46: Gilead a Buy Amid a Big Management Shake-Up https://t.co/T9NS4dSQsF $GILDBuy-signal detected for 4 stocks: $STZ $GILD $ORLY $PSA$MDVN- As Sanofi's bid and Bd strategy is rejected, it seems $GILD and $PFE have the upper hand. Expect Sanofi to up their price in responseRT @investalert: $GILD (Gilead Science) is below its Chandelier Exit https://t.co/mzYDAAfZsT #GILD$GILD (Gilead Science) is below its Chandelier Exit https://t.co/mzYDAAfZsT #GILD#GileadSciences appoints chief operating officer and strategy head. Read more: https://t.co/o4zQxejYlX $GILD$GILD $GILD should be looking for $97 on big reversal if we are right from 82.xx https://t.co/MkhvBGsQaoGilead a Buy Amid a Big Management Shake-Up https://t.co/T9NS4dSQsF $GILDGILD Financials
See Here ---&gt; https://t.co/Ua8lEQ3ZQx

$GILD $EQIX $MYRG #pennystocksRT @megtirrell: Good morning SF! Tune in to @CNBCClosingBell for our interview w $GILD CEO John Milligan. What do you want to know? https:/‚Ä¶Burns J W &amp; Co. Inc. NY Has $5,739,000 Position in Gilead Sciences, Inc. $GILD https://t.co/3B4lCUavOLRathbone Brothers plc Sells 138,270 Shares of Gilead Sciences, Inc. $GILD https://t.co/kx9Dm4z02m",2016-05-26,GILD,1
36,"RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @actaestfabulaXX: Agree! $GILD would be wise to take a closer look! Long $RGLS @GileadSciences  https://t.co/Z4q6hGwivaRT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @HenryEChang: Nominal &amp; PPP-adjusted prices of SOF &amp; LDV/SOF, with &amp; without a 23% rebate via @WHO @PLOSONE #HCV #HepC $GILD https://t.c‚Ä¶StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/m61awOvF0c

$CELG $GILD $I‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/YnYP414T9d

$CELG $GILD $I‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/MNNqNps50p

$CELG $GILD $I‚Ä¶Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD $INCY $REGNRT @OphirGottlieb: (1/3) 

Tweet Storm

1. Phase III Trials: $GILD $PFE $CELG $LLY $AMGN $MRK

--&gt; https://t.co/MrZeDP0miW https://t.co/H6e‚Ä¶S&amp;P100 #Stocks Performance $MON $BIIB $AMZN $UNP $GILD $MSFT $KMI $ABT $AMGN $CAT $CMCSA $IBM $SO $VZ $BMY more@ https://t.co/cKkr8cKsju(3/3) 

Tweet Storm

3. R&amp;D per $1 of OpEx: $ALNY $ALKS $GILD $CELG $BMY $BIIB $ALXN

--&gt; https://t.co/MrZeDP0miW https://t.co/h9abFqOo1j(1/3) 

Tweet Storm

1. Phase III Trials: $GILD $PFE $CELG $LLY $AMGN $MRK

--&gt; https://t.co/MrZeDP0miW https://t.co/H6exjPP3qF$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts AppRT @GantosJ: $GILD after bouncing from the $81.89 bottom, today breaking out the $86.85 resistance line &amp; printing a higher high https://t.‚Ä¶$GILD - Initial Statement of Beneficial Ownership (3) https://t.co/ppoYsLFCASAgree! $GILD would be wise to take a closer look! Long $RGLS @GileadSciences  https://t.co/Z4q6hGwivaRT @RatingsNetwork: Gilead Sciences's buy rating reiterated at Citigroup Inc.. $105.00 PT. https://t.co/tNus1prD0T $GILD #GILDCitigroup Inc. Reiterates ‚ÄúBuy‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/7uAII6HFaxICYMI: $GILD, $MRK hepatitis C drugs win backing of EMA https://t.co/hjThevGz8RRT @pharmalot: ICYMI: Washington state told to lift restrictions on hepatitis C medicines.. read opinion here.. https://t.co/WoQbHnoOzV #ph‚Ä¶RT @ZacharyBrennan: New analysis from WHO researchers finds $GILD hep c drug prices vary widely country to country/are not affordable: http‚Ä¶@BellTimeTrading stack those chips! üí∞ Im still long $GILD equity. Almost took profit today as well but decided to hold.Citigroup Inc. Reiterates ‚ÄúBuy‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/L90UQbsaLoCitigroup Inc. Reiterates ‚ÄúBuy‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/VWJiCSubhVCitigroup Inc. Reiterates ‚ÄúBuy‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/LZ413hzA36Gilead Sciences Reiterated Rating by Citigroup (Ranked 28th) to Buy with 105 PT $GILD #GILD https://t.co/nyq7xJnbR7Gilead Sciences's buy rating reiterated at Citigroup Inc.. $105.00 PT. https://t.co/Tafwuaxklt $GILD #GILDGilead Sciences's buy rating reiterated at Citigroup Inc.. $105.00 PT. https://t.co/tNus1prD0T $GILD #GILDRT @R4inb0w_: @R4inb0w_ JF Mouney : ""Elafibranor sera la premi√®re th√©rapie sur le march√© pour la prise en charge de la NASH"" $GNFT $ICPT $G‚Ä¶Seeking Alpha now has my note on $AAPL $BUD $CSCO $INTC $JPM $QCOM $SBUX $GILD $WFC $M $JWN Pls. follow me @brocado https://t.co/3phr0DuHkWRT @pharmalot: Hepatitis C drugs remain unaffordable in many countries, says WHO study.. 'it's a global problem'.. https://t.co/KmUwZ2t6rb‚Ä¶RT @R4inb0w_: @R4inb0w_ JF Mouney : ""Elafibranor sera la premi√®re th√©rapie sur le march√© pour la prise en charge de la NASH"" $GNFT $ICPT $G‚Ä¶#GileadSciences Ready to Move Higher, This Chart Shows. Read more: https://t.co/6KNK7yl5lJ $GILD@AndyBiotech 3 of them supposedly de-risked! The best buys had been those not quite de-risked $GILD-$VRUS $BMY-$MEDX $GILD-$VIRS $VRTX-$ABSCRT @pharmalot: Hepatitis C drugs remain unaffordable in many countries, says WHO study.. 'it's a global problem'.. https://t.co/KmUwZ2t6rb‚Ä¶Young Investor Dividend Growth Portfolio - 25% YOY Growth https://t.co/9MsgmToWTW $AAPL #APPLE $BAX $BXLT $CVX $DPS $DUK $GE $GILD $GMYoung Investor Dividend Growth Portfolio - 25% YOY Growth https://t.co/BKcbhoYjvH $AAPL #APPLE $BAX $BXLT $CVX $DPS $DUK $GE $GILD $GMYoung Investor Dividend Growth Portfolio - 25% YOY Growth https://t.co/OyQVT50Kvn $AAPL #APPLE $BAX $BXLT $CVX $DPS $DUK $GE $GILD $GM$GILD inverse head and shoulders forming..  Long...  How's everybody?!   :)RT @HenryEChang: Nominal &amp; PPP-adjusted prices of SOF &amp; LDV/SOF, with &amp; without a 23% rebate via @WHO @PLOSONE #HCV #HepC $GILD https://t.c‚Ä¶$XBI $AMGN $GILD $CPXX $JAZZ $IBB Biotech Sector breaks huge downtrend today! https://t.co/pgRbb4WmOrRT @Financial_Orbit: And I wondered why $GILD was popping back up above the US$85s... https://t.co/o0D5I7KfN1Webster Bank N. A. Has $2,463,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/UuREBAl00eCapital Impact Advisors LLC Decreases Position in Gilead Sciences, Inc. $GILD https://t.co/EuYDqzyzfNRT @BellTimeTrading: @BellTimeTrading Oh and forgot $GILD from options port. More upside there.@BellTimeTrading Oh and forgot $GILD from options port. More upside there.@AndyBiotech &amp; sell-side keep bashing $GILD for not doing deals....Still have $BABA, $WYNN $GILD longs$GILD - Capital Impact Advisors LLC Decreases Position in Gilead Sciences, Inc. #GILD https://t.co/i9MGxoH6Is$GILD - Capital Impact Advisors LLC Decreases Position in Gilead Sciences, Inc. #GILD https://t.co/W285sDfbBdRT @HenryEChang: Burden of pricey #hepatitis C drugs heaviest in eastern Europe‚Üíhttps://t.co/w9sAP3VZkO @Reuters_Health @WHO #HCV #HepC $GI‚Ä¶$GILD as I wrote last week have an eye on that https://t.co/hrYifo43gfNasdaq100 #Stocks Performance $STX $VRTX $BIIB $WDC $MU $DLTR $ENDP $NVDA $DISH $CSX $NTES $EA $AMZN $GILD  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Performance $MON $BIIB $AMZN $UNP $GILD $KMI $ABT $VZ $AMGN $FDX $TWX $ABBV $CMCSA $NEE  more@ https://t.co/cKkr8cKsjuRT @HenryEChang: Burden of pricey #hepatitis C drugs heaviest in eastern Europe‚Üíhttps://t.co/w9sAP3VZkO @Reuters_Health @WHO #HCV #HepC $GI‚Ä¶@cek_cpa @wandy922 @ryanwallace198 Bought more $AAPL $BAC $GILD $IMNP and $GPS.RT @pharmalot: Hepatitis C drugs remain unaffordable in many countries, says WHO study.. 'it's a global problem'.. https://t.co/KmUwZ2t6rb‚Ä¶Burden of pricey #hepatitis C drugs heaviest in eastern Europe‚Üíhttps://t.co/w9sAP3VZkO @Reuters_Health @WHO #HCV #HepC $GILDNew analysis from WHO researchers finds $GILD hep c drug prices vary widely country to country/are not affordable: https://t.co/vdzQtX8UjZRT @Top5Traders: SAlphaTrending: Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/f3Mg6btXz0 $IBM $GILD $MO $PSE‚Ä¶RT @Top5Traders: SAlphaTrending: Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/f3Mg6btXz0 $IBM $GILD $MO $PSE‚Ä¶Our DCF has $GILD available at a 13% discount - why the sale??: https://t.co/jomgDzQJfF https://t.co/MzKbgXNLBJNominal &amp; PPP-adjusted prices of SOF &amp; LDV/SOF, with &amp; without a 23% rebate via @WHO @PLOSONE #HCV #HepC $GILD https://t.co/qfw1X0HylaYes bought it a week ago about $10 lower - sticking with it. Alos small positions in $CELG $GILD and $XON. https://t.co/nfPSdw1dyLSAlphaTrending: Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/f3Mg6btXz0 $IBM $GILD $MO $PSEC $TGT $XLU $UTG‚Ä¶Benzinga: Solid Potential For Gilead To Beat Estimates And Raise Guidance: Here's How $GILD https://t.co/JpFgtoM59pRT @SAlphaTrending: Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/J2So83WKBu $IBM $GILD $MO $PSEC $TGT $XLU $‚Ä¶SAlphaTrending: Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/iqRyNspEar $IBM $GILD $MO $PSEC $TGT $XLU $UTG‚Ä¶Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/J2So83WKBu $IBM $GILD $MO $PSEC $TGT $XLU $UTG $IDU $CSAL $VPU$ASPX $ZSPH CRLs are enuf to put doubts in $GILD/big-boys for $4-5B buy-outs, especially thru July-Nov &amp; T-presidency :)RT @pharmalot: Hepatitis C drugs remain unaffordable in many countries, says WHO study.. 'it's a global problem'.. https://t.co/KmUwZ2t6rb‚Ä¶Benzinga: Solid Potential For Gilead To Beat Estimates And Raise Guidance: Here's How $GILD https://t.co/CWoIgtOqUdSolid Potential For Gilead To Beat Estimates And Raise Guidance: Here's How $GILD https://t.co/3rpUu0Ghcc$BIIB $GILD &amp; $ADMA Oppenheimer also dropped due to reallocation of analyst resources.RT @R4inb0w_: @R4inb0w_ JF Mouney : ""Elafibranor sera la premi√®re th√©rapie sur le march√© pour la prise en charge de la NASH"" $GNFT $ICPT $G‚Ä¶RT @SpeedyCalls: $GILD 77.5 Puts BUYING Activity expiring on 20th Jan, Vol 1000$GILD 77.5 Puts BUYING Activity expiring on 20th Jan, Vol 1000RT @SunriseTrader: Still have $AAPL $GILD $TWTR swing longs with lots of cushion. No micromanage letting them manage themselves and looking‚Ä¶#GileadSciences Lawsuit Claims Gilead Could Have Created Safer HIV Drug Sooner But Didn't D... Read more: https://t.co/FveEH0Vnym $GILDHepatitis C drugs remain unaffordable in many countries, says WHO study.. 'it's a global problem'.. https://t.co/KmUwZ2t6rb #pharma $GILD$GILD and $GLD trading in tandem today. May I buy a vowel...Still have $AAPL $GILD $TWTR swing longs with lots of cushion. No micromanage letting them manage themselves and looking at stops onlyRT @Logribel: With $69k pricing &amp; 10mg max dosing there's officially ZERO chance that #Ocaliva will get off-label prescriptions for NASH $I‚Ä¶EMA recommends approval for hepatitis C meds from $GILD, $MRK https://t.co/hjThevoXKhHave to admit so many bullish consolidating charts (potentially) -- $GILD seems to putting a diamond like on cupish attempt. Break up possRT @laildesours: ""Real potential partners are the ones that already work on NASH or Diabetes"" $GNFT $ICPT $GILD  https://t.co/kT8iCtv8OmGILD $GILD https://t.co/umIuKwr8GpRT @R4inb0w_: @R4inb0w_ JF Mouney : ""Elafibranor sera la premi√®re th√©rapie sur le march√© pour la prise en charge de la NASH"" $GNFT $ICPT $G‚Ä¶RT @laildesours: Good new for Intercept, 3 good news for Genfit !. $GNFT $ICPT $GILD  https://t.co/7EfXtK7YwsRT @laildesours: ""Real potential partners are the ones that already work on NASH or Diabetes"" $GNFT $ICPT $GILD  https://t.co/kT8iCtv8OmRT @laildesours: ""Elafibranor 'll be the first therapy on NASH market"" $GNFT $ICPT $GILD  https://t.co/CwvArf3Cf8RT @R4inb0w_: @R4inb0w_ JF Mouney : ""Elafibranor sera la premi√®re th√©rapie sur le march√© pour la prise en charge de la NASH"" $GNFT $ICPT $G‚Ä¶RT @Tootix: $ICPT #OCA OK for #PBC but only for 10mg in combination with UDCA... a boulevard in #NASH for $GNFT @Logribel $GILD https://t.c‚Ä¶$CELG $IBB $XBI
https://t.co/8UfylLdn7Q
Is $CELG a #buyout target of $GILD $BMY $RHHBY $PFE @GileadSciences @pfizer @rocheRT @HenryEChang: Top 25 infectious disease products in 2005 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶RT @Logribel: With $69k pricing &amp; 10mg max dosing there's officially ZERO chance that #Ocaliva will get off-label prescriptions for NASH $I‚Ä¶RT @HenryEChang: Top 25 infectious disease products in 2015 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶RT @hedgefundclone: These are the stocks just deleted from Goldman's VIP Hedge Fund List!  $ENDP $VRX $NFLX $GILD $CFG $CI $WBA $QVCA $LVLT‚Ä¶RT @R4inb0w_: @R4inb0w_ JF Mouney : ""Elafibranor sera la premi√®re th√©rapie sur le march√© pour la prise en charge de la NASH"" $GNFT $ICPT $G‚Ä¶I had always thought $GILD could buy $CPXX...RT @R4inb0w_: @R4inb0w_ JF Mouney : ""Elafibranor sera la premi√®re th√©rapie sur le march√© pour la prise en charge de la NASH"" $GNFT $ICPT $G‚Ä¶RT @HenryEChang: Top 25 infectious disease products in 2015 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶AHF Calls on FDA Congress to Investigate #GileadSciences Over HIVAIDS Drug Patent Manipulat... Read more: https://t.co/15l3DR0BAQ $GILDAHF Calls on FDA, Congress to Investigate #GileadSciences Over HIV/AIDS Drug Patent Manipul... Read more: https://t.co/CF4rl9NFlv $GILDRT @Tootix: $ICPT #OCA OK for #PBC but only for 10mg in combination with UDCA... a boulevard in #NASH for $GNFT @Logribel $GILD https://t.c‚Ä¶AHF Calls on FDA, Congress to Investigate #GileadSciences Over HIV/AIDS Drug Patent Manipul... Read more: https://t.co/Hwe69eT7pz $GILDAHF Calls on FDA, Congress to Investigate #GileadSciences Over HIV/AIDS Drug Patent Manipul... Read more: https://t.co/gwnWhCH7gq $GILDGood new for Intercept, 3 good news for Genfit !. $GNFT $ICPT $GILD  https://t.co/7EfXtK7YwsFavorite current long positions: $ATAX $CMRE $EURN $FBR $FRO $GILD $GM $GMLP $HSBC $NNA $PRU $SDLP $SEP $SKM $SSW $STNG $TAX $TNP $UAN $WDRTop 25 infectious disease products in 2015 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://t.co/W3Oebq9SlI""Real potential partners are the ones that already work on NASH or Diabetes"" $GNFT $ICPT $GILD  https://t.co/kT8iCtv8OmThese are the stocks just deleted from Goldman's VIP Hedge Fund List!  $ENDP $VRX $NFLX $GILD $CFG $CI $WBA $QVCA $LVLT $SYF $AET  $TWC $CAM""Elafibranor 'll be the first therapy on NASH market"" $GNFT $ICPT $GILD  https://t.co/CwvArf3Cf8@R4inb0w_ JF Mouney : ""Elafibranor sera la premi√®re th√©rapie sur le march√© pour la prise en charge de la NASH"" $GNFT $ICPT $GILDRT @Logribel: With $69k pricing &amp; 10mg max dosing there's officially ZERO chance that #Ocaliva will get off-label prescriptions for NASH $I‚Ä¶Key exec returns to @GileadSciences as his replacement departs https://t.co/b1q4kOmYRq $GILD #biotech https://t.co/12lBG0frqc$SPY nice dump so far today. Strongest names today $AMZN $GILD. Had some $GOOGL calls this morning, sold for 50%$GILD

June 10 89 calls94.57% Average Gain
100% Unbiased
 .
https://t.co/2qE8x3QQQ8 
 .
 .
$CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO https://t.co/cT1r8faHZu$RGLS up 5.5%. I wouldn't be surprised if it is on $GILD's short list of acquisition, anti mRNA approach has broad prospects other than HCVNasdaq100 #Stocks Performance $ENDP $VRTX $MU $CSX $BIIB $STX $AMZN $INCY $DLTR $GILD $DISCA $WDC $BMRN  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Performance $BIIB $KMI $AMZN $MON $UNP $GILD $CAT $AGN $GS $VZ $FDX $MS $AMGN $ABBV $CELG  more@ https://t.co/cKkr8cKsju$GILD HOD - need $QQQ over 110.32Biotech stocks showing strength. Valuations are reasonable $BIIB $GILD $CELGSAlphaTrending: How Much More Time Will Investors Give Gilead? https://t.co/8fcGIt19G1 $ACAD $GLPG $IONS $GILDSAlphaTrending: How Much More Time Will Investors Give Gilead? https://t.co/U2mBmAkDdl $ACAD $GLPG $IONS $GILDhttps://t.co/G9pMgSr1JY &lt; Review of this fantastic traders teaching service! Try it for FREE! $GILD $CMG $XON $FHow Much More Time Will Investors Give Gilead? https://t.co/y02H6FkPBH $ACAD $GLPG $IONS $GILD$GILD + $IBB about to lead market back to greenGPL Summary
See Here ---&gt; https://t.co/Qu1BdYaKPZ

$GPL $AMG $GILD #investingVolume Alert - GILD 86.96 Gilead Sciences Inc $GILD Hit a high today of 87.15 Closing the day 10:30 at 86.96 + https://t.co/YbDPjS1oZGRT @GantosJ: $GILD after bouncing from the $81.89 bottom, today breaking out the $86.85 resistance line &amp; printing a higher high https://t.‚Ä¶Open
$GILD May17 86.50 Calls@HCPG $GILD$gild hanging tough, holding 86 from .72 grabbed $uvxy 10.50's from .45 for protection. Looks good so far.RT @HenryEChang: Top 25 infectious disease products in 2005 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶What does $SFY not understand about their price being too low for $MDVN?  Now $CELG $GILD and $AMGN may bid  https://t.co/JsOJwsWdMr $MnA#GileadSciences European CHMP adopts positive opinion for Gilead's Epclusa to treat all gen... Read more: https://t.co/Ztf5HykP76 $GILD#GileadSciences EMA Adopts Positive Opinion for Gilead's Epclusa. Read more: https://t.co/r3SclESxcC $GILDGilead: Citigroup says $GILD's hepatitis-C business was weak during Q1, but expects a beat-and-raise for Q2
https://t.co/OgUfB3QGjFCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @JustinPulitzer: Weekend Review VIDEO (5/30): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $V #StockMarket htt‚Ä¶And I wondered why $GILD was popping back up above the US$85s... https://t.co/o0D5I7KfN1. @lalaruza74 still riding both $gild and $biibRT @pharmalot: ICYMI: Washington state told to lift restrictions on hepatitis C medicines.. read opinion here.. https://t.co/WoQbHnoOzV #ph‚Ä¶$GILD keep an eye though for the inverted H&amp;S on daily.$GILD long from breakout https://t.co/BJBdNcMfkCRT @SunriseTrader: $GILD move and hold over 87 = bullish. long day ahead see how it ends. Still holding$GILD - possible to test gap -  https://t.co/IlPCUYmJKG$GILD after bouncing from the $81.89 bottom, today breaking out the $86.85 resistance line &amp; printing a higher high https://t.co/AcG6h84xwA$GILD up 1.4% and breaking out with EMA10 (blue line) as support. Buy if price dips and forms higher low above EMA10 https://t.co/NvNOiqT0lMRT @HenryEChang: Top 25 infectious disease products in 2005 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶$GILD watch 87.17 area firstIf it doesn't #challenge you, it will not #change you. $CPXX $SQI $TTM $WR $MKTO $DE $AGN $MON $GILD $CLF $AEE $WMB $CLF $DVN$GILD move and hold over 87 = bullish. long day ahead see how it ends. Still holdingnice looking $GILD chart imho.
@RedDogT3 @SperlsT3$GILD's #buyback #cash machine must have been working non stop in the last few weeks! Is it $12B or $15B authorized to be executed?Be long, major squeeze coming over 87. $GILD$GILD: Analyst action by Morgan Stanley on Gilead Sciences: https://t.co/0ifWPrunlp https://t.co/z87FgkQpaJ$GILD moving nicelyRT @Logribel: With $69k pricing &amp; 10mg max dosing there's officially ZERO chance that #Ocaliva will get off-label prescriptions for NASH $I‚Ä¶RT @Logribel: With $69k pricing &amp; 10mg max dosing there's officially ZERO chance that #Ocaliva will get off-label prescriptions for NASH $I‚Ä¶Nice spike from $GILD through 86.50XBI Tops the Biotechnology ETFs in the Last Week of May $AMGN $GILD $IBB $JNJ https://t.co/IQKXCetaxhSomewhat expecting a rally-all-day-day for $GILDRT @JustinPulitzer: My #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $V https:/‚Ä¶RT @pharmalot: Washington state told to lift coverage restrictions on Hep C drugs.. read opinion here.. https://t.co/WoQbHnoOzV #pharma $GI‚Ä¶GILD Top news - May 31st, 2016 $GILD https://t.co/ITbJImMc9YWith $69k pricing &amp; 10mg max dosing there's officially ZERO chance that #Ocaliva will get off-label prescriptions for NASH $ICPT $GILD $GNFT#GileadSciences Gilead, Merck get CHMP backing for new hep C combinations. Read more: https://t.co/5momzj4iCo $GILD#GileadSciences Gilead Merck get CHMP backing for new hep C combinations. Read more: https://t.co/cdWp6PdyM8 $GILD@ramlan61 @SpartanBiotech Market sentiment will change very fast after the next M&amp;A that $GILD r looking for..they know everyone are waiting@SpartanBiotech Good luck to us all $GILD :)RT @contraryguy: ton of biotech news today.
Good: $JAZZ to buy $CPXX
Bad: $TEVA drug rejected, $STEM halts ph2 trial
The rest: trials start‚Ä¶RT @contraryguy: ton of biotech news today.
Good: $JAZZ to buy $CPXX
Bad: $TEVA drug rejected, $STEM halts ph2 trial
The rest: trials start‚Ä¶RT @contraryguy: ton of biotech news today.
Good: $JAZZ to buy $CPXX
Bad: $TEVA drug rejected, $STEM halts ph2 trial
The rest: trials start‚Ä¶RT @JustinPulitzer: My #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $V https:/‚Ä¶RT @pharmalot: ICYMI: Washington state told to lift restrictions on hepatitis C medicines.. read opinion here.. https://t.co/WoQbHnoOzV #ph‚Ä¶RT @JustinPulitzer: My #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $V https:/‚Ä¶RT @JustinPulitzer: My #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $V https:/‚Ä¶My #StockMarket Weekend Review VIDEO: $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $V https://t.co/16rUgMMOjXton of biotech news today.
Good: $JAZZ to buy $CPXX
Bad: $TEVA drug rejected, $STEM halts ph2 trial
The rest: trials started at $GILD, $BIIBRT @outsizedreturn: What's moving in the Americas today #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds @Scoopnest ht‚Ä¶RT @biotech_forum: The question is while Gilead remains patient, will its stockholders?https://t.co/OMtylpzsFU $ACAD $GLPG $IONS $GILD http‚Ä¶RT @biotech_forum: The question is while Gilead remains patient, will its stockholders?https://t.co/OMtylpzsFU $ACAD $GLPG $IONS $GILD http‚Ä¶RT @Tootix: $ICPT #OCA OK for #PBC but only for 10mg in combination with UDCA... a boulevard in #NASH for $GNFT @Logribel $GILD https://t.c‚Ä¶$GILD $NASDAQ #nasdaq #compq $comp #nasd100 #nas100 #nyse #stocks #investing #markets https://t.co/CamOz3tvvI https://t.co/sw9zBMndDERT @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl $f #hedgefunds https://t.co/vXy8K8ZmWv htt‚Ä¶RT @outsizedreturn: What's moving in the Americas today #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds @Scoopnest ht‚Ä¶RT @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl $f #hedgefunds https://t.co/vXy8K8ZmWv htt‚Ä¶RT @pelias01: Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/jeXroeQbaC $IBM $GILD $MO $PSEC $TGT $XLU $UTG $I‚Ä¶Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/jeXroeQbaC $IBM $GILD $MO $PSEC $TGT $XLU $UTG $IDU $CSAL $VPUWhat's moving in the Americas today #Macro $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds @Scoopnest https://t.co/iHXwPO4229#Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl $f #hedgefunds https://t.co/vXy8K8ZmWv https://t.co/rpIrOiCNvPRT @Tootix: $ICPT #OCA OK for #PBC but only for 10mg in combination with UDCA... a boulevard in #NASH for $GNFT @Logribel $GILD https://t.c‚Ä¶The question is while Gilead remains patient, will its stockholders?https://t.co/OMtylpzsFU $ACAD $GLPG $IONS $GILD https://t.co/j0qI8efU6nRT @tgtxdough: Citi $GILD see beat and raise in 2QRT @Tootix: $ICPT #OCA OK for #PBC but only for 10mg in combination with UDCA... a boulevard in #NASH for $GNFT @Logribel $GILD https://t.c‚Ä¶$ICPT #OCA OK for #PBC but only for 10mg in combination with UDCA... a boulevard in #NASH for $GNFT @Logribel $GILD https://t.co/5u0RZx9fXVRT @tgtxdough: $GILD started a new Phase II trial (NCT02781584) for GS-4997 in patients with Hepatic Steatosis and Elevated Liver Stiffness.Citi $GILD see beat and raise in 2QRT @tgtxdough: $GILD started a new Phase II trial (NCT02781584) for GS-4997 in patients with Hepatic Steatosis and Elevated Liver Stiffness.ICYMI: Washington state told to lift restrictions on hepatitis C medicines.. read opinion here.. https://t.co/WoQbHnoOzV #pharma $GILD $ABBVRT @tgtxdough: $GILD started a new Phase II trial (NCT02781584) for GS-4997 in patients with Hepatic Steatosis and Elevated Liver Stiffness.RT @tgtxdough: $GILD started a new Phase II trial (NCT02781584) for GS-4997 in patients with Hepatic Steatosis and Elevated Liver Stiffness.$GILD started a new Phase II trial (NCT02781584) for GS-4997 in patients with Hepatic Steatosis and Elevated Liver Stiffness.Biotech Trade Alerts Archive -2016-05-27- $PTLA, $ABBV, $MRK, $GILD, $AMGN, $RHHBY, $CANF, $SHPG,¬†$ALDX https://t.co/kLnWoLw3PHRT @HenryEChang: Top 25 infectious disease products in 2005 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶RT SeekingAlpha: Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/r2Rn63iVZ1 $IBM $GILD $MO $PSEC $TGT $XLU $UT‚Ä¶RT @SA_EditorPicks: Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/dt35M7orpt $IBM $GILD $MO $PSEC $TGT $XLU $‚Ä¶RT @SA_IncomeInvest: Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/WhOYPUyqc7 $IBM $GILD $MO $PSEC $TGT $XLU‚Ä¶RT @SEEKINGALPHA_FS: Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/lt06h2P61x $IBM $GILD $MO $PSEC $TGT $XLU‚Ä¶RT @SA_IncomeInvest: Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/WhOYPUyqc7 $IBM $GILD $MO $PSEC $TGT $XLU‚Ä¶Dividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/lt06h2P61x $IBM $GILD $MO $PSEC $TGT $XLU $UTG $IDU $CSAL $VPUDividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/WhOYPUyqc7 $IBM $GILD $MO $PSEC $TGT $XLU $UTG $IDU $CSAL $VPUDividends &amp; Income Digest: Shaping Up To Be An Exciting Summer https://t.co/dt35M7orpt $IBM $GILD $MO $PSEC $TGT $XLU $UTG $IDU $CSAL $VPU$ICPT looking up at least $20,, rumor of $GILD deal should keep it going higher after FDA approval friday night, deal price around $3002/ Our team's #AheadOfTheCurve report on the BTK inhibitor market includes discussion of $ABBV $JNJ $AZN $BGNE $CELG $GILD $RHHBYRT @HenryEChang: Top 25 infectious disease products in 2005 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶$GILD Gilead Sciences by Vladimir Zernov https://t.co/lRUByVmmmK https://t.co/0G4Uw72HRECheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKjqBmDHow Much More Time Will #Investors Give #Gilead $GILD ?  https://t.co/MWMJJNa8MO$GILD has just reached a new high at $86.41.  Found with MOMO Stock Breakout App @ https://t.co/1WLje7lx32Gilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Jefferies Group https://t.co/6mp4Sa7HBO$GILD: Analyst action by Morgan Stanley on Gilead Sciences: https://t.co/0ifWPrLYcX https://t.co/on7lNYC25Q@SpartanBiotech They can buy back stock all the stock they want, but market telling them it doesn't care imo $GILD@SpartanBiotech Yeah! Stock buyback sure had worked out very well for $GILD so far lol$icpt - pay attention $gild to premium paid on $cpxx - better get wheelin and a dealin soonRT @ramlan61: @bradloncar @2015Stalog17 Would love to see a big activist get involved with $GILD like Carl Icahn did with $AAPL@tgtxdough if $GILD's pipeline for #HIV #cure works than this could be double #HCV #cure. Add #NASH + #HBV
Grossly understated pipeline@bradloncar @2015Stalog17 Would love to see a big activist get involved with $GILD like Carl Icahn did with $AAPL@2015Stalog17 If $GILD management is waiting for valuations to go down further b4 acquisition, they better realize they're going down tooRT @HenryEChang: Top 25 infectious disease products in 2005 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶@bradloncar $GILD management strategy of using their cash to buy back stock rather than a major acquisition has failed miserably so far imo.Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @JustinPulitzer: Weekend Review VIDEO (5/30): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $V #StockMarket htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (5/30): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $V #StockMarket htt‚Ä¶@bradloncar Hope so Brad! Wonder when $GILD pulls the trigger on a major deal? :)RT @HenryEChang: Top 25 infectious disease products in 2005 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶C'mon $GILD, you know you want $CPXX. Better get a better offer ready quickly.https://t.co/p7tVeIZFvX Millionaire Road Map Trading top students win a Porsche for a yr! $LNKD $CVX $GILD $STX $PBetter Buy: Gilead Sciences Inc. vs. Johnson &amp; Johnson $GILD $JNJ https://t.co/Fa2ouKvnNN #Dividend #Investing https://t.co/VfjN8uLXdHRT @JustinPulitzer: Weekend Review VIDEO (5/30): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $V #StockMarket htt‚Ä¶Weekend Review VIDEO (5/30): $VIX $TLT $IBB $GILD $SPY $IWM $QQQ $AAPL $FB $AMZN $NFLX $GOOGL $TSLA $V #StockMarket https://t.co/16rUgMMOjXMS $GILD est pipeline could contribute ~$7B in rev 2020E&amp; ~$15B in rev by 2025E.such rev would only yield a ~3% topline CAGR from 2016-2025ECommented on How Much More Time Will Investors Give Gilead? https://t.co/GfUoRnOOGs $ACAD $GLPG $IONS $GILD",2016-05-31,GILD,0
37,"$CTRV Phase 2a study comparing its CMX157 to tenofovir DF, marketed by Gilead Sciences $GILD as Viread.---uhmm RESULTS are in 4thQ2016@GuyAdami @megtirrell @CNBCFastMoney I think I'll stick with a proven cash machine over the long run - $GILD. I speculate at casino!$GILD getting ready for inverse head and shoulders? https://t.co/6FVCDiV7nJRT @HenryEChang: Number of years of average wage required to pay for a 12-week course of SOF or LDV/SOF via @WHO #HCV #HepC $GILD https://t‚Ä¶$GILD looking good again5 things for #pharma #marketers to know: Wed., June 1 $GILD #hepC $BMRN $TEVA #cancer #FDA https://t.co/0LJrX1Ze2q https://t.co/StKLk3atM8RT @delawemon: „ÇÆ„É™„Ç¢„Éâ„ÅåÊúÄ„ÇÇÂâ≤ÂÆâ„Å™„Éê„Ç§„Ç™„ÉÜ„ÇØ‰ºÅÊ•≠„Åß„ÅÇ„ÇãÁêÜÁî±„ÄÇ
1)CÂûãËÇùÁÇéÂ∏ÇÂ†¥„Åß„ÅÆÂÑ™‰Ωç
2)HIVÂ∏ÇÂ†¥„Åß„ÅÆ„É™„Éº„ÉÄ„Éº„Ç∑„ÉÉ„Éó
3)Ëá™Á§æÊ†™Ë≤∑Âèä„Å≥M&amp;A
 https://t.co/OM1KRDtFNN
via Barron‚Äôs
$GILD„ÄÄ#„ÇÆ„É™„Ç¢„Éâ„ÄÄ#„Éê„É≠„É≥„Ç∫Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @delawemon: „ÇÆ„É™„Ç¢„Éâ„ÅåÊúÄ„ÇÇÂâ≤ÂÆâ„Å™„Éê„Ç§„Ç™„ÉÜ„ÇØ‰ºÅÊ•≠„Åß„ÅÇ„ÇãÁêÜÁî±„ÄÇ
1)CÂûãËÇùÁÇéÂ∏ÇÂ†¥„Åß„ÅÆÂÑ™‰Ωç
2)HIVÂ∏ÇÂ†¥„Åß„ÅÆ„É™„Éº„ÉÄ„Éº„Ç∑„ÉÉ„Éó
3)Ëá™Á§æÊ†™Ë≤∑Âèä„Å≥M&amp;A
 https://t.co/OM1KRDtFNN
via Barron‚Äôs
$GILD„ÄÄ#„ÇÆ„É™„Ç¢„Éâ„ÄÄ#„Éê„É≠„É≥„Ç∫@NotaBubble @jimcramer @7wtc Agree $SBUX $GILD $WFM &amp; $UA also stocks punished for no really good reason. I like $BOX biz model Lterm @BoxHQRT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶https://t.co/uAcamNRUPt alerted $BIND +49% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/F8iKSLizL2 $AMAT $ITUB $MT $GILD $HST $AA $GMRT @barronsonline: Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiX‚Ä¶RT @barronsonline: Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiX‚Ä¶RT @HenryEChang: Burden of pricey #hepatitis C drugs heaviest in eastern Europe‚Üíhttps://t.co/w9sAP3VZkO @Reuters_Health @WHO #HCV #HepC $GI‚Ä¶RT SeekingAlpha: Diplomat Pharmacy: Fundamentals Strong Enough To Shrug Off Sector Concerns https://t.co/9hZWvgKOxu $EXEL $GILD $MRK $TARO‚Ä¶Bath Savings Trust Co Has $3,464,000 Position in Gilead Sciences, Inc. $GILD https://t.co/w2Ws846JX5Bath Savings Trust Co Has $3,464,000 Position in Gilead Sciences, Inc. $GILD https://t.co/OyeGkolj5wDiplomat Pharmacy: Fundamentals Strong Enough To Shrug Off Sector Concerns https://t.co/MqoO7lOwjj $EXEL $GILD $MRK $TARO $TEVA $VRX $DPLOF&amp;V Capital Management LLC Cuts Position in Gilead Sciences, Inc. $GILD https://t.co/3hAZIkCaDIGradient Investments LLC Has $312,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/vVz7Vo0aw2Independent Portfolio Consultants Inc. Boosts Position in Gilead Sciences, Inc. $GILD https://t.co/rkxUUCAQ4YGradient Investments LLC Has $312,000 Stake in Gilead Sciences, Inc. $GILD https://t.co/PTEKF9C57DIndependent Portfolio Consultants Inc. Boosts Position in Gilead Sciences, Inc. $GILD https://t.co/q3tpmtdEyA@stockassassin74 $ICPT From Feb, what's the holdup $GILD?? https://t.co/jrfx74AiM5RT @SA_IncomeInvest: May I Receive Some Dividends? https://t.co/gIM6lpVBJQ $AMZN $CLX $DIS $DUK $GD $GILD $GLW $HCP $HD $HMN $MO $MSFT $NKE‚Ä¶RT SeekingAlpha: May I Receive Some Dividends? https://t.co/JDMJzHdbvi $AMZN $CLX $DIS $DUK $GD $GILD $GLW $HCP $HD $HMN $MO $MSFT $NKE $O‚Ä¶May I Receive Some Dividends? https://t.co/B68ZgZ0tlx $AMZN $CLX $DIS $DUK $GD $GILD $GLW $HCP $HD $HMN $MO $MSFT $NKE $O $ORCL $OXY $PRUMay I Receive Some Dividends? https://t.co/gIM6lpVBJQ $AMZN $CLX $DIS $DUK $GD $GILD $GLW $HCP $HD $HMN $MO $MSFT $NKE $O $ORCL $OXY $PRU$GILD breaking out of that 2-day pattern late day$SPY $AAPL $AMZN $XOM $GE $GILD How rate hike could send S&amp;P 500 into summer tailspin https://t.co/6WqgrGm1FvJune bullish bets: $INO, $ALIM, $CERU, $PBYI, $GILD, $AMH, $MEIP... Bearish: $EWQ, $QIWI, @HBCP, @AMDA. Neutral, but more positive $LPCN.RT @NelsonThought: Three Reasons Gilead Sciences is the Most Undervalued Stock in Biotech: #biotech $GILD via @barronsonline  https://t.co/‚Ä¶Three Reasons Gilead Sciences is the Most Undervalued Stock in Biotech: #biotech $GILD via @barronsonline  https://t.co/uCFoNF7PpV@adamfeuerstein and some of them didn't fail but suck. #Zydelig $GILDRT @barronsonline: Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiX‚Ä¶RT @R4inb0w_: Intercept: Upon PBC Approval, Ocaliva's Prospects In NASH Are Getting Dimmer, By @Logribel $ICPT $GNFT GENFIT $GILD https://t‚Ä¶RT SeekingAlpha: I'm Looking For V.F. Corp To Dress My Portfolio With Some Gains https://t.co/JWJ6okeeFe $AGN $AVGO $DAL $EA $GILD $GOOG $‚Ä¶$gild has the best line-up of commercial HIV drugs so far. https://t.co/mA5W9B3Ju8 https://t.co/So6BB0pV60I'm Looking For V.F. Corp To Dress My Portfolio With Some Gains https://t.co/LcoT2ohMNZ $AGN $AVGO $DAL $EA $GILD $GOOG $ORLY $PCLN $SWKSI'm Looking For V.F. Corp To Dress My Portfolio With Some Gains https://t.co/52NZA6dfUo $AGN $AVGO $DAL $EA $GILD $GOOG $ORLY $PCLN $SWKSI'm Looking For V.F. Corp To Dress My Portfolio With Some Gains https://t.co/hzraifLODk $AGN $AVGO $DAL $EA $GILD $GOOG $ORLY $PCLN $SWKSMedicaid programs may be violating federal law by restricting access to hepatitis C medicines. $GILD $MRK $ABBV #HepatitisC #CureJudge: Evidence establishes consensus among medical experts &amp; providers that the lifesaving drugs are medically necessary for HepC pts $GILDRT @HenryEChang: Number of years of average wage required to pay for a 12-week course of SOF or LDV/SOF via @WHO #HCV #HepC $GILD https://t‚Ä¶RT @HenryEChang: Number of years of average wage required to pay for a 12-week course of SOF or LDV/SOF via @WHO #HCV #HepC $GILD https://t‚Ä¶RT @HenryEChang: Number of years of average wage required to pay for a 12-week course of SOF or LDV/SOF via @WHO #HCV #HepC $GILD https://t‚Ä¶Number of years of average wage required to pay for a 12-week course of SOF or LDV/SOF via @WHO #HCV #HepC $GILD https://t.co/M5moJQcxo6RT @HenryEChang: Top 25 infectious disease products in 2005 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶RT @CarlyHFierce: AIDS foundation asks Congress, FDA to investigate Gilead over HIV patent: https://t.co/RZkRF4on4m $GILD #pharmaRT @laildesours: ""Elafibranor 'll be the first therapy on NASH market"" $GNFT $ICPT $GILD  https://t.co/CwvArf3Cf8barronsonline: Three Reasons GileadSciences is the Most Undervalued Stock in Biotech https://t.co/0ukuotVuuW $GILD https://t.co/PnjcQ2XZuKRT @WrigleyTom: $ICPT 155 fwiw
looks like Baird &amp; Needham joining party
reit. PT $332 &amp; $350, respectively

icymi (spec. w/ $GILD)
https://‚Ä¶$ICPT 155 fwiw
looks like Baird &amp; Needham joining party
reit. PT $332 &amp; $350, respectively

icymi (spec. w/ $GILD)
https://t.co/xylPnrYq2u@Chub519 I'm long $GILD and $AKRX so yesRT @barronsonline: Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiX‚Ä¶RT @barronsonline: Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiX‚Ä¶RT @barronsonline: Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiX‚Ä¶@barronsonline @GileadSciences oh god.. End of $GILD run.. I sold yesterday. @ReformedBroker @sssvenky @traderstewieRT @barronsonline: Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiX‚Ä¶$GILD https://t.co/n0zC2Sfk7vRT @barronsonline: Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiX‚Ä¶RT @barronsonline: Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiX‚Ä¶Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiXuKnX„ÇÆ„É™„Ç¢„Éâ„ÅåÊúÄ„ÇÇÂâ≤ÂÆâ„Å™„Éê„Ç§„Ç™„ÉÜ„ÇØ‰ºÅÊ•≠„Åß„ÅÇ„ÇãÁêÜÁî±„ÄÇ
1)CÂûãËÇùÁÇéÂ∏ÇÂ†¥„Åß„ÅÆÂÑ™‰Ωç
2)HIVÂ∏ÇÂ†¥„Åß„ÅÆ„É™„Éº„ÉÄ„Éº„Ç∑„ÉÉ„Éó
3)Ëá™Á§æÊ†™Ë≤∑Âèä„Å≥M&amp;A
 https://t.co/OM1KRDtFNN
via Barron‚Äôs
$GILD„ÄÄ#„ÇÆ„É™„Ç¢„Éâ„ÄÄ#„Éê„É≠„É≥„Ç∫Commented on GILD: Any Takers On 30% Upside? https://t.co/2imNmfQSVu $GILDAIDS foundation asks Congress, FDA to investigate Gilead over HIV patent https://t.co/8l5ZmAfaTf $GILD #pharma by @CarlyHFierce$GILD looks really interestingRT @hedgefundclone: Sounds Familiar? $GILD Three Reasons Gilead Sciences is the Most Undervalued Stock in Biotech https://t.co/tyRLUxst5gRT @BPGAG: Will look at $GILD again either with support at $84ish support or $87.50ish. $IBB #biotech #stocksWill look at $GILD again either with support at $84ish support or $87.50ish. $IBB #biotech #stocksGlad to make good $$ on $GILD day trade, but disappointing action into market bounce, Gabelli u/g. Big $87 seller; UOA puts. $IBB #biotech$GILD: Analyst action by Gabelli &amp; Co on Gilead Sciences: https://t.co/yorThNV9Ug https://t.co/dWPQMgspVnRT @HenryEChang: Top 25 infectious disease products in 2005 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶AIDS foundation asks Congress, FDA to investigate Gilead over HIV patent: https://t.co/RZkRF4on4m $GILD #pharmaRT @hedgefundclone: Sounds Familiar? $GILD Three Reasons Gilead Sciences is the Most Undervalued Stock in Biotech https://t.co/tyRLUxst5gWhy The S&amp;P 500 And The Dow Are Getting An 'F' Grade In My Research https://t.co/5r74VlSfGo $AAPL #APPLE $AMZN $BRK.A $BRK.B $DIA $GILDWhy The S&amp;P 500 And The Dow Are Getting An 'F' Grade In My Research https://t.co/Jq0xLLRCBx $AAPL #APPLE $AMZN $BRK.A $BRK.B $DIA $GILD#GileadSciences appoints Kevin Young COO, Martin Silverstein EVP. Read more: https://t.co/Uz5ao0FJWL $GILD$icpt with all buyouts lately $anac $cpxx $mdvn $mon - $icpt a must own and insane to be short over the weekend $gildRT @DAMSConsulting: $ICPT rumor on street $GILD will make a $300 Cash bid for company.. recent FDA approval makes a strong case for dealRT @VonnieQuinn: Some stock picks from @BobDollNuveen: $WMT, $TGT, $HD, $LOW, $QCOM , $GILDRT @BPGAG: Stopped last piece of $GILD #trading L at $86.70 breakeven after cashing in 2/3 87s calls at $87.20 - said it needs $87.50+ #bio‚Ä¶RT @DrSManian: $INSM üöÄüöÄ
 $INSM oral and HCV decisions this week as well $MRK $GILD https://t.co/l3Nt0SYC3x‚Ä¶
h/t @bio_clouseau 
üëáüëáüëá
https://‚Ä¶@cek_cpa @wandy922 @ryanwallace198 @JDR1024 guys $AGN happy with this today $GILD happy, this week and next biotechs are going to explode$INSM üöÄüöÄ
 $INSM oral and HCV decisions this week as well $MRK $GILD https://t.co/l3Nt0SYC3x‚Ä¶
h/t @bio_clouseau 
üëáüëáüëá
https://t.co/rUdEygf9G2RT @BPGAG: Stopped last piece of $GILD #trading L at $86.70 breakeven after cashing in 2/3 87s calls at $87.20 - said it needs $87.50+ #bio‚Ä¶RT @Logribel: New Seeking Alpha article: ""Intercept: #Ocaliva's #NASH Prospects Post #PBC Approval"" - https://t.co/f1TmEHMT6T $ICPT $GNFT $‚Ä¶$GILD will get limited valuation until they demonstrate a positive GR and how they are going to use the FCF. https://t.co/m819aetOJW$gild trades like a micro capStopped last piece of $GILD #trading L at $86.70 breakeven after cashing in 2/3 87s calls at $87.20 - said it needs $87.50+ #biotech #stocksRT @HenryEChang: Nominal &amp; PPP-adjusted prices of SOF &amp; LDV/SOF, with &amp; without a 23% rebate via @WHO @PLOSONE #HCV #HepC $GILD https://t.c‚Ä¶Volume Alert - GILD 86.77 Gilead Sciences Inc $GILD Hit a high today of 87.30 Closing the day 10:30 at 86.77 - https://t.co/HWu0UzT9l9Commented on StockTwits: I don't like the Twitter BUT I love the $GILD! https://t.co/GnFVTantqPRT @Drchik23: Jing He from Gabelli initiated $gild w/ $109 PT today.  Very undervalued, in his opinion.Jing He from Gabelli initiated $gild w/ $109 PT today.  Very undervalued, in his opinion.Holding 1/3 #trading L $GILD from $86.70 avgTook some options off $GILD #trading L w/ stock at $87.20 (87s)I have 4 swing longs not 5 $AAPL, $COST, $GILD, $TWTRSounds Familiar? $GILD Three Reasons Gilead Sciences is the Most Undervalued Stock in Biotech https://t.co/tyRLUxst5gRT @R4inb0w_: Intercept: Upon PBC Approval, Ocaliva's Prospects In NASH Are Getting Dimmer, By @Logribel $ICPT $GNFT GENFIT $GILD https://t‚Ä¶$GILD over yesterdays highs5 things for #pharma #marketers to know: Wed., June 1 $GILD #hepC $BMRN $TEVA #breastcancer https://t.co/0LJrX1HDaS https://t.co/aYF4QBVpXT@hedgefundclone Can't recall -- have you mentioned $GILD in this cheap, down and out category?Analyst Actions and Breaking News $AAPL $GILD $LULU $OA #stocks https://t.co/IUdj4dYPhs$GILD L 86.99$GILD I might buy this guy soon as a swing tradeRT @BPGAG: $CELG shaking off negative comments and pretty intraday cup in $GILD - $IBB still in accumulation mode. #biotech #stocks@moon_shine15 $gild r/g$CELG shaking off negative comments and pretty intraday cup in $GILD - $IBB still in accumulation mode. #biotech #stocksRT @BPGAG: Above $87.50 in $GILD and gliding to test $88-$90. Not a huge fan long term anymore but it's likely testing $90's again in the g‚Ä¶Commented on StockTwits: $GILD ""plans to repurchase $12 billion worth of stock in 2016 (10% of shares)"" https://t.co/QAW6NrL6daCommented on StockTwits: $GILD's ""HIV franchise generated $13.5 billion of sales in 2015, 60% of the HIV market"" https://t.co/S016nvlWbDAbove $87.50 in $GILD and gliding to test $88-$90. Not a huge fan long term anymore but it's likely testing $90's again in the gap.$GILD ""we believe the future cash flow generated by Hep C is still worth over $40 billion."" https://t.co/sMy6OkJKVNRT @BioStocks: $GILD the most undervalued stock in the #biotech industry - Gabelli 
https://t.co/YPWXSbwO0eTrading L $GILD $86.70 avg$GILD might be the one to buy ICPT they are most likely  imo. wow $WYNN screaming today #stocks #investing #tradeideasRT @BioStocks: $GILD the most undervalued stock in the #biotech industry - Gabelli 
https://t.co/YPWXSbwO0eGILD: Any Takers On 30% Upside? $GILD #investing  https://t.co/H7kBdtc6DD$GILD 77.5 Puts BUYING Activity expiring on 17th Jun, Vol 2500RT SeekingAlpha: GILD: Any Takers On 30% Upside? https://t.co/pFBz79O90r $GILDGILD: Any Takers On 30% Upside? https://t.co/7ZEioHCBXY $GILDGILD: Any Takers On 30% Upside? https://t.co/rB6rmTYQ4Z $GILDRT @financialbuzz: @OptionPicker89 in $AGN after @Carl_C_Icahn got in. Company had news today, also in $GILD both are monstersRT @BioStocks: $GILD the most undervalued stock in the #biotech industry - Gabelli 
https://t.co/YPWXSbwO0e$GILD the most undervalued stock in the #biotech industry - Gabelli 
https://t.co/YPWXSbwO0e@OptionPicker89 in $AGN after @Carl_C_Icahn got in. Company had news today, also in $GILD both are monsters$ICPT rumor on street $GILD will make a $300 Cash bid for company.. recent FDA approval makes a strong case for dealRT @Logribel: New Seeking Alpha article: ""Intercept: #Ocaliva's #NASH Prospects Post #PBC Approval"" - https://t.co/f1TmEHMT6T $ICPT $GNFT $‚Ä¶RT @R4inb0w_: Intercept: Upon PBC Approval, Ocaliva's Prospects In NASH Are Getting Dimmer, By @Logribel $ICPT $GNFT GENFIT $GILD https://t‚Ä¶#StockNews ‚Äï On The Fly: Top five analyst initiations $GILD $PINC $GWRE $ZEN $DLR: Full Story https://t.co/7WWIpN7UUX ‚Üí via @AlertTrade$GILD 8sma support is just under $85.50RT @theflynews: On The Fly: Top five analyst initiations  $GILD $PINC $GWRE $ZEN $DLR: Full Story https://t.co/leGIRidbtjRT @theflynews: On The Fly: Top five analyst initiations  $GILD $PINC $GWRE $ZEN $DLR: Full Story https://t.co/leGIRidbtjRT @theflynews: On The Fly: Top five analyst initiations  $GILD $PINC $GWRE $ZEN $DLR: Full Story https://t.co/leGIRidbtjRT @theflynews: On The Fly: Top five analyst initiations  $GILD $PINC $GWRE $ZEN $DLR: Full Story https://t.co/leGIRidbtjRT @theflynews: On The Fly: Top five analyst initiations  $GILD $PINC $GWRE $ZEN $DLR: Full Story https://t.co/leGIRidbtjOn The Fly: Top five analyst initiations  $GILD $PINC $GWRE $ZEN $DLR: Full Story https://t.co/leGIRidbtj#TrendReversalUp $GILD - GILEAD SCIENCES ‚Äï Via ‚û° https://t.co/LUJOH84uLu For Free #TradingEDU$GILD at a crucial level -- if we gain support my first upside target is $91 https://t.co/zgPkbA6mTLSold for a loss
$GILD May17 86.50 Calls 
Stop hit....it happens. NextOpen from 5/31
$GILD May17 86.50 Calls 
My stop is yesterdays lowGILD Top news - Jun 1st, 2016 $GILD https://t.co/T5252NfKfe–¢–æ—Ä–≥–æ–≤—ã–µ –∏–¥–µ–∏ –Ω–∞ —Å–µ–≥–æ–¥–Ω—è, 1 –∏—é–Ω—è. /  / –ò–¥–µ–∏ long / $TEX $GILD $MOS $KORS $MON $TRI.. https://t.co/OgRaWlXXQ6RT @R4inb0w_: Intercept: Upon PBC Approval, Ocaliva's Prospects In NASH Are Getting Dimmer, By @Logribel $ICPT $GNFT GENFIT $GILD https://t‚Ä¶$GILD initiated with a Buy at Gabelli. PT $109OpenOutcrier: Top + Inits 6/1: $ACXM $BLDR $CCE $CONE $CRME $DLR $DWRE $GILD $GWRE $HMSY $HUBS $NGVT $PGTI $PINC $QTS $SNCR $STCK $ULTI $WS‚Ä¶Top + Inits 6/1: $ACXM $BLDR $CCE $CONE $CRME $DLR $DWRE $GILD $GWRE $HMSY $HUBS $NGVT $PGTI $PINC $QTS $SNCR $STCK $ULTI $WSO $ZEN $ZTSSold $GILD for 3.5%. https://t.co/CwA6ueKFxsRT @WrigleyTom: $GILD 87.06
Initiated Buy, PT $109 -Gabelli https://t.co/mkfdXe12czRT @WrigleyTom: $GILD 87.06
Initiated Buy, PT $109 -Gabelli https://t.co/mkfdXe12czRT @hedgefundclone: Goldman Sach $GS says these are the 20 stocks hedge funds are betting against: $DIS    $XOM $GE $BA $NFLX $F $TGT $CAT‚Ä¶RT @WrigleyTom: $GILD 87.06
Initiated Buy, PT $109 -Gabelli https://t.co/mkfdXe12czRT @WrigleyTom: $GILD 87.06
Initiated Buy, PT $109 -Gabelli https://t.co/mkfdXe12cz$GILD 87.06
Initiated Buy, PT $109 -Gabelli https://t.co/mkfdXe12czGilead Sciences Initiated Coverage by Gabelli &amp; Co (Ranked 63rd) to Buy with 109 PT $GILD #GILD https://t.co/nyq7xJnbR7Gilead Sciences initiated by Gabelli at buy. $109.00 PT. https://t.co/2coq6ENa7R $GILD #GILDRT @InvestVerified: $GILD put in a bottoming tail yesterday. Strong up move today confirms it. Likely a move back to $90 coming. https://t.‚Ä¶RT @Logribel: New Seeking Alpha article: ""Intercept: #Ocaliva's #NASH Prospects Post #PBC Approval"" - https://t.co/f1TmEHMT6T $ICPT $GNFT $‚Ä¶Intercept: Upon PBC Approval, Ocaliva's Prospects In NASH Are Getting Dimmer, By @Logribel $ICPT $GNFT GENFIT $GILD https://t.co/uKXte8yXxpGilead Sciences initiated by Gabelli at buy. $109.00 PT. https://t.co/RzHuoK0ydZ $GILD #GILDTop Holdings ending May 2016 - $M, $LB, $WFM, $AAPL, $GILD, $GOOGL, $MSFT, $IBM, $MA https://t.co/HymTK5R4A5$GILD: Gabelli &amp; Co starts at Buy@JNapodano Do you see $ATNM being a target of @GileadSciences $GILD?RT @Logribel: New Seeking Alpha article: ""Intercept: #Ocaliva's #NASH Prospects Post #PBC Approval"" - https://t.co/f1TmEHMT6T $ICPT $GNFT $‚Ä¶RT @Logribel: New Seeking Alpha article: ""Intercept: #Ocaliva's #NASH Prospects Post #PBC Approval"" - https://t.co/f1TmEHMT6T $ICPT $GNFT $‚Ä¶RT @Logribel: New Seeking Alpha article: ""Intercept: #Ocaliva's #NASH Prospects Post #PBC Approval"" - https://t.co/f1TmEHMT6T $ICPT $GNFT $‚Ä¶New Seeking Alpha article: ""Intercept: #Ocaliva's #NASH Prospects Post #PBC Approval"" - https://t.co/f1TmEHMT6T $ICPT $GNFT $GILDRT @OphirGottlieb: (1/3) 

Tweet Storm

1. Phase III Trials: $GILD $PFE $CELG $LLY $AMGN $MRK

--&gt; https://t.co/MrZeDP0miW https://t.co/H6e‚Ä¶Commented on How Much More Time Will Investors Give Gilead? https://t.co/GfUoRnOOGs $ACAD $GLPG $IONS $GILDRT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @pharmalot: Hepatitis C drugs remain unaffordable in many countries, says WHO study.. 'it's a global problem'.. https://t.co/KmUwZ2t6rb‚Ä¶RT @laildesours: ""Elafibranor 'll be the first therapy on NASH market"" $GNFT $ICPT $GILD  https://t.co/CwvArf3Cf8ContraVir Pharma initiates mid-stage study comparing CMX157 to Gilead's Viread https://t.co/yXt8l600nr #premarket $CTRV $GILDContraVir Pharma initiates mid-stage study comparing CMX157 to Gilead's Viread https://t.co/xTYTeSmstg #premarket $CTRV $GILDRT @laildesours: ""Elafibranor 'll be the first therapy on NASH market"" $GNFT $ICPT $GILD  https://t.co/CwvArf3Cf8ContraVir Pharma initiates mid-stage study comparing CMX157 to Gilead's Viread https://t.co/DGgoT4MDK8 #premarket $CTRV $GILDRT @laildesours: Good new for Intercept, 3 good news for Genfit !. $GNFT $ICPT $GILD  https://t.co/7EfXtK7Yws$GILD: Analyst action by Morgan Stanley on Gilead Sciences: https://t.co/0ifWPrunlp https://t.co/vfsUK5wHq1RT @HenryEChang: Burden of pricey #hepatitis C drugs heaviest in eastern Europe‚Üíhttps://t.co/w9sAP3VZkO @Reuters_Health @WHO #HCV #HepC $GI‚Ä¶RT @HenryEChang: Burden of pricey #hepatitis C drugs heaviest in eastern Europe‚Üíhttps://t.co/w9sAP3VZkO @Reuters_Health @WHO #HCV #HepC $GI‚Ä¶Zika Stocks $SPB $DGX $INO $XON $GILD $CERS $NLNK $SNY $LAKERT @RatingsNetwork: Gilead Sciences's buy rating reiterated at Citigroup Inc.. $105.00 PT. https://t.co/tNus1prD0T $GILD #GILDSome stock picks from @BobDollNuveen: $WMT, $TGT, $HD, $LOW, $QCOM , $GILDGilead Sciences Buy - Immer noch eine gute Biotech Firma $GILD #aktien #NASDAQ100 https://t.co/pS2DOlaMuIRT @lancejepsen: Analyst Actions and Breaking News $ASYS $BA $BEAT $EVHC $GILD $ODP $SAIC https://t.co/VzSdWujWrv https://t.co/tFE4OECe0ERT @HenryEChang: Burden of pricey #hepatitis C drugs heaviest in eastern Europe‚Üíhttps://t.co/w9sAP3VZkO @Reuters_Health @WHO #HCV #HepC $GI‚Ä¶Gilead Sciences, Inc. $GILD Short Interest Down 16.8% in May https://t.co/SBxTzBrbyychartguy89: 2016 Trending Stocks: GILD 87.06 Stock Charts $GILD Gilead Sciences https://t.co/bQ5lMbAjmdchartguy89: GILD 87.06 Stock Charts $GILD Gilead Sciences https://t.co/LzKpZb8QnvSort term #bearish candidates (for day or quick swing trades) - $AAPL $CMG $DIS $GILD $GLD $SBUX $UAL $XOM  #trading #stock #optionsRT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @HenryEChang: Burden of pricey #hepatitis C drugs heaviest in eastern Europe‚Üíhttps://t.co/w9sAP3VZkO @Reuters_Health @WHO #HCV #HepC $GI‚Ä¶Gilead Sciences, Inc. $GILD Shares Gap Up to $85.82 https://t.co/ra9Mjt4mEKGilead Sciences, Inc. $GILD Shares Gap Up to $85.82 https://t.co/kmRbQm4CZgJefferies Group Reaffirms ‚ÄúHold‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/hHW073udheJefferies Group Reaffirms ‚ÄúHold‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/Vv5oUje6pnGilead Sciences‚Äô $GILD ‚ÄúBuy‚Äù Rating Reaffirmed at Citigroup Inc. https://t.co/sgzjRqGjHGMorgan Stanley Lowers Gilead Sciences, Inc. $GILD Price Target to $103.00 https://t.co/cO3em1ixo7$GILD trading at a 13% discount, time to grab a bargain? https://t.co/jomgDzQJfF https://t.co/L3XB235vQeJefferies Group Reaffirms ‚ÄúHold‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/bo6zHKmRx9Jefferies Group Reaffirms ‚ÄúHold‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/MYmn2VsOedhttps://t.co/GUSfxc4QBa. $GILD$GILD could wait and see the kind of data $EPZM has and make a play by EOY, IMO. Believe $GILD wants to be a player in epigentics.https://t.co/dhXXigI2rp [Free Trial] Give Jason Bond 90 days and he will make u a better trader!!! $gild $gld $hou.to$GILD - Gilead Sciences, Inc. #GILD Given Buy Rating at Oppenheimer https://t.co/NyclIQQMOjRT @HenryEChang: Top 25 infectious disease products in 2015 ranked by U.S. sales &amp; journal spend. #HCV #HepC #HIV $GILD $ABBV $BMS https://‚Ä¶RT @pharmalot: Hepatitis C drugs remain unaffordable in many countries, says WHO study.. 'it's a global problem'.. https://t.co/KmUwZ2t6rb‚Ä¶RT @HenryEChang: Nominal &amp; PPP-adjusted prices of SOF &amp; LDV/SOF, with &amp; without a 23% rebate via @WHO @PLOSONE #HCV #HepC $GILD https://t.c‚Ä¶RT @scutify: StockSpotify: Merger &amp; Acquisition Chatter $YDKN $CELG $GILD $MON $BAYRY $NYRT $AAPL $AXLL https://t.co/SxeydMQVNZ https://t.c‚Ä¶https://t.co/uAcamNRUPt alerted $BIND +49% MUST SEE TRACK RECORD &amp; SUBSCRIBE https://t.co/F8iKSLizL2 $AMAT $ITUB $MT $GILD $HST $AA $GMCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Buy-signal detected for 6 stocks: $TSN $STZ $GILD $PGR $SYY $EQRThese blood transfusion HIV-infections in India are depressing https://t.co/aMiGdxsxjG Prompts qs: should $GILD get more hands-on in Asia?RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @pharmalot: Hepatitis C drugs remain unaffordable in many countries, says WHO study.. 'it's a global problem'.. https://t.co/KmUwZ2t6rb‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @pharmalot: ICYMI: Washington state told to lift restrictions on hepatitis C medicines.. read opinion here.. https://t.co/WoQbHnoOzV #ph‚Ä¶https://t.co/uAcamNRUPt members have an advantage. SEE TRACK RECORD &amp; JOIN https://t.co/fqtC8LvhLY $FOXA $HPQ $HOT $AMAT $ITUB $MT $GILDRT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶$GILD: Analyst action by Morgan Stanley on Gilead Sciences: https://t.co/0ifWPrunlp https://t.co/RNa9HeSV3sRT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶",2016-06-01,GILD,1
38,"RT @PuruSaxenaWMgt: #Biotech stocks breaking out after period of base building; quality names look interesting. $BIIB $CELG $GILD $IBBRT @PuruSaxenaWMgt: #Biotech stocks breaking out after period of base building; quality names look interesting. $BIIB $CELG $GILD $IBB#Biotech stocks breaking out after period of base building; quality names look interesting. $BIIB $CELG $GILD $IBBRT @MBATMann: 6 for 6 @StockSwipe generated trades in option gains. $FCEL $GILD $BURL $WUBA $PANW . https://t.co/hMSrbGTYkD https://t.co/dE‚Ä¶. @lalaruza74 same with $biib and $gild. The latter gotta buy someone!!$GILD Insider Trading

Latest insider trasanction of Carter Paul Rutherford (EVP  Commercial Ops).

 https://t.co/R5E9IQ10LbRT @pharm_specialty: #GileadSciences, Inc: Most Undervalued Biotech?. Read more: https://t.co/8rM1WaT5xD $GILDToday`s #call buying action #options: $EWU $GILD $MRK $MT $WLL. via https://t.co/P6hp2rTDE8 https://t.co/07XCVAYIdtCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts App$GILD:

New Insider Transaction on GILD by EVP  Commercial Ops:

https://t.co/J4DdARbS1d https://t.co/M7Js6HbCBv$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/X8pDJCxOMC@BellTimeTrading @Chub519 $GILD pissed me off...... I took a 15% on that sucker...... I'll wait it out since it's one of the cheapestNice close for $CELG - even $GILD flipped green@evan_danca @avidresearch @BikeRieder $ARWR last man standing? only if u ignore $ALNY $GILD $ABUS $CTRV $JNJ $BNTC Replicor Enyo, etc#GileadSciences, Inc: Most Undervalued Biotech?. Read more: https://t.co/8rM1WaT5xD $GILDRNC Capital Management LLC Sells 94 Shares of Gilead Sciences, Inc. $GILD https://t.co/Koxc1MczrRSkylands Capital LLC Decreases Position in Gilead Sciences, Inc. $GILD https://t.co/2ySn4nz0fZ6 for 6 @StockSwipe generated trades in option gains. $FCEL $GILD $BURL $WUBA $PANW . https://t.co/hMSrbGTYkD https://t.co/dELK9s66QKRNC Capital Management LLC Sells 94 Shares of Gilead Sciences, Inc. $GILD https://t.co/wHDDMB7WWJ$GILD - Skylands Capital LLC Decreases Position in Gilead Sciences, Inc. #GILD https://t.co/yu4SntcQqV$GILD - Skylands Capital LLC Decreases Position in Gilead Sciences, Inc. #GILD https://t.co/XSxVFSkT2lSelz Capital LLC Increases Stake in Gilead Sciences, Inc. $GILD https://t.co/yCGJ7wrJi6RT @stockassassin74: Who will $gild buy? $incy $vrtx $icptWho will $gild buy? $incy $vrtx $icpt@rick_decard $GILD que opina?$GILD green@moon_shine15 $gild goes green$GILD https://t.co/l17wClPs3T 1 Hr chart, wants to higher along with $XLV, watch outRT @PearlF: Hiring at #BIO2016 in SF: @Alnylam, @regeneron, @portola_pharma, @myokardia, @SutroBioInc, $GILD, $MRK $LLY, $RARE https://t.co‚Ä¶Why The S&amp;P 500 And The Dow Are Getting An 'F' Grade In My Research https://t.co/fu7txSaauS $AAPL $AMZN $BRK.A $BRK.B $DIA $GILD $SPY.@GileadSciences reappoints former Exec VP Kevin Young as new COO, Martin Silverstein, MD as Exec VP, Strategy $GILD https://t.co/zhX2xrELXl$GILD going for afternoon red to green#Healthcare Lets live in a world where people don't need 'Go Fund Me"" to not die....... $GILD $PFE $AGN$GILD Pop to $100+++Looks like $gild wants to join the partyperformance update. @zzlangerhans #zzporte $ABBV $ALXN $AMGN $BIIB $CELG $FPRX $GILD $IBB $INO $MDVN $REGN $VRX $XBI https://t.co/wnL9Sfqd3p$GILD: Analyst action by Gabelli &amp; Co on Gilead Sciences: https://t.co/yorThNV9Ug https://t.co/2mlqmITgdl$GILD falling wedge on 15. POC 87s https://t.co/fVsGspGrMIRT @PearlF: Hiring at #BIO2016 in SF: @Alnylam, @regeneron, @portola_pharma, @myokardia, @SutroBioInc, $GILD, $MRK $LLY, $RARE https://t.co‚Ä¶Hiring at #BIO2016 in SF: @Alnylam, @regeneron, @portola_pharma, @myokardia, @SutroBioInc, $GILD, $MRK $LLY, $RARE https://t.co/PvOPbCFiOB$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/J753ayJve8$GILD at 86 seems crazy to me.  I'm betting a bounce to mid-90s w/in 30 days.RT @laildesours: ""Elafibranor 'll be the first therapy on NASH market"" $GNFT $ICPT $GILD  https://t.co/CwvArf3Cf8$XBI https://t.co/jsvSPloY1b breaking Biotechs, I like $GILD $REGN in this space@GangLeader time for $GILD to step up?Why so little progress has been made in solving the soaring drug prices problem via @hiltzikm #HCV #HepC @CMSGov $GILD $ABBV $MRK $BMSVolume Alert - GILD 86.27 Gilead Sciences Inc $GILD Hit a high today of 87.07 Closing the day 10:30 at 86.27 - https://t.co/1SWIrerhIsRT @FireTimCook: $ICPT is in play. My guess $GILD bids big over $300 per share.Not sure about $GILD.  Good enough entry to give it some slack but buying the names already through congestion has worked better. We'll see.RT @Lin_ling_88: $GILD: Three Reasons Gilead Sciences is the Most Undervalued Stock in Biotech - Barron's https://t.co/OQRSA4PldR@financialbuzz @cek_cpa @wandy922 @ryanwallace198 I don't understand why $GILD is below $100.@JDR1024 @cek_cpa @wandy922 @ryanwallace198 cashed out on $GILD new to reset new calls but waiting for a dip@financialbuzz @cek_cpa @wandy922 @ryanwallace198 Long $GILD and $IMNP.$ICPT not bad gave it to you at $138 last week, now $160+  $GILD rumor is $300, plenty of room  to goRT @FireTimCook: $ICPT is in play. My guess $GILD bids big over $300 per share.Hating how strong Biotech $IBB $XBI is versus my only real play in the space $GILDCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKjqBmD$ICPT is in play. My guess $GILD bids big over $300 per share.Biotech Stocks: Don‚Äôt Expect a ‚ÄòMiraculous Recovery‚Äô $XBI $IBB $GILD $BIIB $REGN https://t.co/S6DviHMrfm https://t.co/wujiBQkSmnBiotech Stocks: Don‚Äôt Expect a ‚ÄòMiraculous Recovery‚Äô https://t.co/UxjxbX15fm via @barronsonline $XBI $IBB $GILD $BIIB $REGN$GILD near LOD with $IBB at HOD... meh...After good trade in $GILD yesterday on thrust to $87.20, the big $87 sellers reemerge - I want $84ish or $87.50ish #trading #biotech #stocks@SquawkStreet @jimcramer Agree w him. Ignore June swoon talk; look at individual stocks
https://t.co/QZMz0mUhBH $AAPL $AMZN $BUD $CSCO $GILDGILD Top news - Jun 2nd, 2016 $GILD https://t.co/FDUkDjEgBiRT @Lin_ling_88: $GILD: Three Reasons Gilead Sciences is the Most Undervalued Stock in Biotech - Barron's https://t.co/OQRSA4PldRRT @SA_HealthInvest: GILD: Any Takers On 30% Upside? https://t.co/rB6rmTYQ4Z $GILDRT @MBATMann: Discovered $GILD #StockSwipe $86 Calls 6/17/16 suggestion up 50%. Should have more gains. https://t.co/wqfl1ndObm https://t.c‚Ä¶Jobless claims drop 1,000 to 267,000 https://t.co/ILA0XrA9uJ $SPY $AMZN $AAPL $PCLN $GILD $GE $GM$GILD: Analyst action by Gabelli &amp; Co on Gilead Sciences: https://t.co/yorThNV9Ug https://t.co/ncdO2yfxfaRT https://t.co/He2rzY2zC7 : Missed yesterday's news? Here's what to know #pharma $GILD #hepC $BMRN $TEVA #cancer‚Ä¶ https://t.co/rrMXhG2GafRT @MMMnews: Missed yesterday's news? Here's what to know #pharma $GILD #hepC $BMRN $TEVA #cancer #FDA https://t.co/0LJrX1Ze2q https://t.co‚Ä¶Discovered $GILD #StockSwipe $86 Calls 6/17/16 suggestion up 50%. Should have more gains. https://t.co/wqfl1ndObm https://t.co/QVvEhtkgIuMissed yesterday's news? Here's what to know #pharma $GILD #hepC $BMRN $TEVA #cancer #FDA https://t.co/0LJrX1Ze2q https://t.co/0ROfHtN7UVUnicorn Bay rating for $GILD is 3.73 out of 5. https://t.co/jD70zGcNYE$GILD Buy and hold does not work‚Ä¶here‚Äôs what does.RT @hedgefundclone: Sounds Familiar? $GILD Three Reasons Gilead Sciences is the Most Undervalued Stock in Biotech https://t.co/tyRLUxst5gPopular: $AAPL, $GILD, $JOY, $KERX, $ADI, $AKRX, $MPC, $NAV, $ZUMZ, $WNR, $BUDExplore #fundamental numbers and pros and cons for $GILD https://t.co/IFnkAQiwhERT @HenryEChang: Efficacy of SOF/VEL/VOX (GS-9857) in Treatment-Na√Øve or Previously Treated Pts with #HCV GT-1 or 3‚Üíhttps://t.co/HCKEFA50MV‚Ä¶Cheap call option upside: $CRM calls cheaper than 100% of history, $DAL 99%, $MNST 99%, $DIS 99%, $GILD 97%, $CSCO 97%, $INTC 96%RT @barronsonline: Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiX‚Ä¶RT @AndyBiotech: $GILD BTKi --&gt; Updated survival data for the 26 pts treated w ONO/GS-4059 in NEJM
https://t.co/nwJG3ZMTGk
@jq1234t https:/‚Ä¶RT @AndyBiotech: $GILD BTKi --&gt; Updated survival data for the 26 pts treated w ONO/GS-4059 in NEJM
https://t.co/nwJG3ZMTGk
@jq1234t https:/‚Ä¶RT @lancejepsen: Analyst Actions and Breaking News $AAPL $GILD $LULU $OA #stocks https://t.co/IUdj4dYPhsCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5Efficacy of SOF/VEL/VOX (GS-9857) in Treatment-Na√Øve or Previously Treated Pts with #HCV GT-1 or 3‚Üíhttps://t.co/HCKEFA50MV #HepC $GILD$GILD Such a great company, I'm often confused why it's not at 120+ https://t.co/8zd03rAwpq$GILD: Three Reasons Gilead Sciences is the Most Undervalued Stock in Biotech - Barron's https://t.co/OQRSA4PldRRT @AndyBiotech: NEJM Editorial suggests idelalisib+ibrutinib combo; $TGTX should try it as $GILD won't pursue. http://t.co/rStAStDdYi http‚Ä¶RT @AndyBiotech: $GILD BTKi --&gt; Updated survival data for the 26 pts treated w ONO/GS-4059 in NEJM
https://t.co/nwJG3ZMTGk
@jq1234t https:/‚Ä¶RT @AndyBiotech: $GILD BTKi --&gt; Updated survival data for the 26 pts treated w ONO/GS-4059 in NEJM
https://t.co/nwJG3ZMTGk
@jq1234t https:/‚Ä¶Commented on GILD: Any Takers On 30% Upside? https://t.co/2imNmfQSVu $GILDRT https://t.co/2xD7vUmbv6 : 5 things for #pharma #marketers to know:Wed, June 1 $GILD #hepC $BMRN $TEVA #Duchenn‚Ä¶ https://t.co/oIZFijyYqEhttps://t.co/uAcamNRUPt members have an advantage. SEE TRACK RECORD &amp; JOIN https://t.co/fqtC8LvhLY $FOXA $HPQ $HOT $AMAT $ITUB $MT $GILD5 things for #pharma #marketers to know:Wed, June 1 $GILD #hepC $BMRN $TEVA #Duchenne #FDA https://t.co/0LJrX1Ze2q https://t.co/cjUPiHrZ1KRT @AndyBiotech: NEJM Editorial suggests idelalisib+ibrutinib combo; $TGTX should try it as $GILD won't pursue. http://t.co/rStAStDdYi http‚Ä¶RT @pharmalot: Hepatitis C drugs remain unaffordable in many countries, says WHO study.. 'it's a global problem'.. https://t.co/KmUwZ2t6rb‚Ä¶$GILD: Analyst action by Morgan Stanley on Gilead Sciences: https://t.co/0ifWPrunlp https://t.co/A0jTfTZBDRCCI Over 100 https://t.co/uz2kggnMqD $UHS $IHF $KWR $GILD $BMI $BMY $RGR $OXM $ACHC $SCAI $CATM $SHOO $CRAY $RLGY $HCI $FTD $HQY@AndyBiotech Acerta went all out for ACP196, including combo with PD1 $GILD had 2 studies

https://t.co/0hiCZmX2Cr

https://t.co/8BQo8BEaw1RT @HigherLowz: $GILD interesting above the support https://t.co/Pod2atDlv9$GILD BTKi --&gt; Updated survival data for the 26 pts treated w ONO/GS-4059 in NEJM
https://t.co/nwJG3ZMTGk
@jq1234t https://t.co/Tmc06gvT5jRT @HigherLowz: $GILD interesting above the support https://t.co/Pod2atDlv9$GILD interesting above the support https://t.co/Pod2atDlv9RT @tgtxdough: $GILD IMS reported April Harvoni sales of $896mn and Sovaldi sales of $260mn,RT @tgtxdough: $GILD r GS-4997 in adults with Pulmonary Arterial Hypertension has increased patient recruitment from 120 to 151 patients.$GILD r GS-4997 in adults with Pulmonary Arterial Hypertension has increased patient recruitment from 120 to 151 patients.$GILD IMS reported April Harvoni sales of $896mn and Sovaldi sales of $260mn,$EXPE , $LLY , $KORS , $GILD , $FSLR , $AAPL , $M
seems like good investment these year , wait for $SPY to get a little lower first",2016-06-02,GILD,0
39,"Invest Like Ray Dalio: $AAPL $GILD and $MCD https://t.co/xnzUBGSHnnRT @bradloncar: IMO this slide illustrates why you have to own a PD-L(1) to be a leader in oncology. $GILD $ABBV missing out. https://t.co/‚Ä¶OGXI Oncothyreon Inc. Dividend
https://t.co/vGreLd006c

$OGXI $MUX $GILD $CDE  #pennystocks #investingMIDU 3M Co. Bid Size
https://t.co/KKSlDrVkpV

$MIDU $KRA $GILD $QBR/B.TO  #share #nasdaqRT @SA_Retirement: Average American Retirement Portfolio - Retiring With $100,000 https://t.co/wtm0Yi2q1W $AAPL #APPLE $CVX $GILD $HCP $RCS‚Ä¶Average American Retirement Portfolio - Retiring With $100,000 https://t.co/SidTrItss8 $AAPL #APPLE $CVX $GILD $HCP $RCS $UHT $VCLT $VOXAverage American Retirement Portfolio - Retiring With $100,000 https://t.co/wtm0Yi2q1W $AAPL #APPLE $CVX $GILD $HCP $RCS $UHT $VCLT $VOXAverage American Retirement Portfolio - Retiring With $100,000 https://t.co/QXz1hrijz3 $AAPL #APPLE $CVX $GILD $HCP $RCS $UHT $VCLT $VOXCAO.TO Cara Operations Limited Bid
https://t.co/MoUouXQcc1

$CAO.TO $CLF $ARIA $GILD  #pennystocks #stockmarketAVXL Anavex Life Sciences Corp. Quotes
https://t.co/7x7UREZUuR

$AVXL $GILD $FTK $GBTC  #pennystocks #investingGILD SPDR Gold Shares Last Price
https://t.co/qJLs6LyFGy

$GILD $ZUMZ $FXY $AXP  #tradeideas #investRT @CashRocket: TOP UPCOMING EVENTS IN 2016: $BIIB $VRTX $ESPR $MDCO $SCYX $PRTA $AMGN $CELG $KITE $INFI $GILD $ACOR $PTI $FGEN https://t.c‚Ä¶RT @bradloncar: IMO this slide illustrates why you have to own a PD-L(1) to be a leader in oncology. $GILD $ABBV missing out. https://t.co/‚Ä¶@FirstAidKitBand 
38:25LONG 
1123/16um39 
66/14 $GILD
#STEPHENOBEIRNE 
#criminalHIV 
#princeCarlPhilip 
@fbi 
RIC https://t.co/dweqIdcrUMRT @stockfollower4u: GILD Gilead Sciences, Inc. Bid
https://t.co/IJd6Hrbyf5

$GILD $CHK $BRZU $CSC  #pennystocks #shareGILD Gilead Sciences, Inc. Bid
https://t.co/IJd6Hrbyf5

$GILD $CHK $BRZU $CSC  #pennystocks #shareGilead Sciences, Inc. $GILD Receives $113.34 Average Target Price from Analysts https://t.co/fcQa0328zDJust one of many big alerts $AQXP  https://t.co/uAcamNRUPt https://t.co/zHAvlEkA1M $AMAT $ITUB $MT $GILD $HST $AA $GM $EMCRT @DrPaulyDeSantis: $GILD solid commercialexecution navigating price wars &amp; 2 new competitors since Sovaldi. Maintains ~90% mkt share, htt‚Ä¶RT @tgtxdough: Key upcoming regulatory catalysts $CLVS $GILD $VRTX $RDUS https://t.co/68AtryYBpdRT @bradloncar: IMO this slide illustrates why you have to own a PD-L(1) to be a leader in oncology. $GILD $ABBV missing out. https://t.co/‚Ä¶$GILD: Analyst action by Gabelli &amp; Co on Gilead Sciences: https://t.co/yorThNV9Ug https://t.co/O2JvfpDkCaGILD Volume
See Here ---&gt; https://t.co/SF2YnvHzjM

$GILD $MNOV $PKD #shareRT @bradloncar: IMO this slide illustrates why you have to own a PD-L(1) to be a leader in oncology. $GILD $ABBV missing out. https://t.co/‚Ä¶RT @AndysCycles: $IBB biotech index components. $ENDP $VRTX $MYL $BIIB $ALXN $AMGN $ILMN $REGN $CELG $BMRN $INCY $JAZZ $GILD $MDVN https://‚Ä¶$XLV health care sector index components. $AGN $ABBV $BMY $UNH $MDT $JNJ $CELG $GILD $MRK $PFE $LLY https://t.co/zO9kxTSFCTRT @bradloncar: IMO this slide illustrates why you have to own a PD-L(1) to be a leader in oncology. $GILD $ABBV missing out. https://t.co/‚Ä¶RT @tgtxdough: Key upcoming regulatory catalysts $CLVS $GILD $VRTX $RDUS https://t.co/68AtryYBpd$IBB biotech index components. $ENDP $VRTX $MYL $BIIB $ALXN $AMGN $ILMN $REGN $CELG $BMRN $INCY $JAZZ $GILD $MDVN https://t.co/EdsQv7PvjxCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @bradloncar: IMO this slide illustrates why you have to own a PD-L(1) to be a leader in oncology. $GILD $ABBV missing out. https://t.co/‚Ä¶Stocks to hold for 25 years. A few interesting names $ILMN $GILD
https://t.co/b69Yy5paETGet to know the main five #Biotech stocks in the US $GILD $AMGN $CELG $BIIB $REGN https://t.co/2ufHFlwWMh https://t.co/BTfEluIMZXRT @DrPaulyDeSantis: $GILD solid commercialexecution navigating price wars &amp; 2 new competitors since Sovaldi. Maintains ~90% mkt share, htt‚Ä¶Key upcoming regulatory catalysts $CLVS $GILD $VRTX $RDUS https://t.co/68AtryYBpdRT @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl $ge #hedgefunds https://t.co/MSf3m8r01N ht‚Ä¶@DrPaulyDeSantis $GILD $MRK $Abbv also worth noting that $MRK WAS a bigger competitive threat to ABBV NOT $GILD as stated ahead of launch.RT @DrPaulyDeSantis: $GILD solid commercialexecution navigating price wars &amp; 2 new competitors since Sovaldi. Maintains ~90% mkt share, htt‚Ä¶#Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl $ge #hedgefunds https://t.co/MSf3m8r01N https://t.co/Ny33jPbPRURT @bradloncar: IMO this slide illustrates why you have to own a PD-L(1) to be a leader in oncology. $GILD $ABBV missing out. https://t.co/‚Ä¶@BioAcumen yes, I think if no counter bid from $AMGN $CELG $GILD etc then $SNY offer is actually good.$18B for 100% $MDVN is nothing cheap.RT @bradloncar: IMO this slide illustrates why you have to own a PD-L(1) to be a leader in oncology. $GILD $ABBV missing out. https://t.co/‚Ä¶RT @bradloncar: IMO this slide illustrates why you have to own a PD-L(1) to be a leader in oncology. $GILD $ABBV missing out. https://t.co/‚Ä¶RT @bradloncar: IMO this slide illustrates why you have to own a PD-L(1) to be a leader in oncology. $GILD $ABBV missing out. https://t.co/‚Ä¶RT @HenryEChang: Nominal &amp; PPP-adjusted prices of SOF &amp; LDV/SOF, with &amp; without a 23% rebate via @WHO @PLOSONE #HCV #HepC $GILD https://t.c‚Ä¶",2016-06-06,GILD,0
40,"@adamfeuerstein everyone loves $GILD but it's about time to back up all this optimismRT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶RT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶RT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶RT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶RT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶RT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶#GileadSciences Gilead freed of having to pay Merck &amp; Co $200 million in hep C patent dispute. Read more: https://t.co/gtesRED7AN $GILDAUY Yamana Gold Inc. Filings
https://t.co/Fi84dZLOjY

$AUY $JNK $ACTG $GILD  #tradeideas #finance$GILD $MRK https://t.co/38mMDH9qNMRT @pharmalot: Gilead won't have to pay $200M in hepatitis c patent case because Merck lawyer lied. read ruling: https://t.co/a2uZahYiw1 #p‚Ä¶RT @SA_Dividends: Top 10 Net Payout Yields For June 2016 https://t.co/ixvJtCQiNd $AAL $AIG $AMP $BBY $GILD $M $MSI $NTAP $QCOM $UAL""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CELG $GILD$MRK barely budged on $GILD patent ruling, but as usual bear attack on $IONS, sinking stock by over 8%! Break above 24.3 can take it to 26.7#GileadSciences to Present at the Goldman Sachs 37th Annual Global Healthcare Conference on... Read more: https://t.co/EtK2od94wu $GILD#GileadSciences to Present at the Goldman Sachs 37th Annual Global Healthcare Conference on... Read more: https://t.co/JJKNnQV3Ud $GILDRT @barronsonline: Three Reasons @GileadSciences is the Most Undervalued Stock in Biotech https://t.co/bkCLB05IdR $GILD https://t.co/djKEiX‚Ä¶RT @manzoorsohail: Great News For Gilead https://t.co/houkzG342t $MRK $GILD$GILD - BUY Signal at 88.1599 on Jun 07, 16 By https://t.co/6PpjiKmc9G, Trading Robot#Stockstowatch #Stockmarket #trading #trade #investingBearish Doji https://t.co/rZsZkjTU5N $KKR $GNW $CVS $LM $HMY $VALE $ETSY $BLL $HUN $AEE $QEP $INFY $GILD $SYRG $MXL $XRAY $ADSK$GILD could see 90 by FridayRT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶RY.TO Sibanye Gold Ltd. Market Cap
https://t.co/7CZ9Pk2Pct

$RY.TO $CSCO $GILD $TSLA  #stockmarket #stocks$GILD - Gilead Sciences, Inc. #GILD Stock Rating Reaffirmed by Morgan Stanley https://t.co/SXVsnnNwit$GILD: Analyst action by Gabelli &amp; Co on Gilead Sciences: https://t.co/yorThNV9Ug https://t.co/6CeK6AvmX3Gilead Sciences: ‚ÄòEgregious Misconduct‚Äô as Merck Hepatitis C Decision Reversed $GILD https://t.co/duo4oH5675 via @barronsonlineRT @ScripDonnaDC: Judge: Merck's A Liar, Has Dirty Hands; Gilead Won't Have To Pay 
https://t.co/53pHxcoXCq
$MRK $GILD #hepC #Sovaldi #Harv‚Ä¶RT @ScripDonnaDC: Judge: Merck's A Liar, Has Dirty Hands; Gilead Won't Have To Pay 
https://t.co/53pHxcoXCq
$MRK $GILD #hepC #Sovaldi #Harv‚Ä¶Top 10 Net Payout Yields For June 2016 https://t.co/JpJyE8T6Bo $AAL $AIG $AMP $BBY $GILD $M $MSI $NTAP $QCOM $UALTop 10 Net Payout Yields For June 2016 https://t.co/ixvJtCQiNd $AAL $AIG $AMP $BBY $GILD $M $MSI $NTAP $QCOM $UALTop 10 Net Payout Yields For June 2016 https://t.co/EP0cSSN9t1 $AAL $AIG $AMP $BBY $GILD $M $MSI $NTAP $QCOM $UALRT @ScripDonnaDC: Judge: Merck's A Liar, Has Dirty Hands; Gilead Won't Have To Pay 
https://t.co/53pHxcoXCq
$MRK $GILD #hepC #Sovaldi #Harv‚Ä¶Judge: Merck's A Liar, Has Dirty Hands; Gilead Won't Have To Pay 
https://t.co/53pHxcoXCq
$MRK $GILD #hepC #Sovaldi #Harvoni #pharmaRT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶GILD Globus Maritime Ltd. Message Board Posts
https://t.co/Og1I5Kso6y

$GILD $SLV $TNA $V  #pennystocks #invest@adamfeuerstein  who is left to buy $GILD after that survey?RT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶RT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶RT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶RT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶RT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶1631 #BMV  #TRMX $GILD * - Min. Act. 1600 - Min. Est. 1618.32-  Max Act 1635.28  - Max Est 1651.42#GileadSciences Gilead faces pressure on Hep C. Read more: https://t.co/qsmMgVtNDv $GILDRT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶RT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WSJ $MRK $GILDGilead: Ninety-Nine Problems But Merck Ain't One $GILD https://t.co/tEXGede5sl1631 #BMV  #TRMX $GILD * - Min. Act. 1600 - Min. Est. 1618.32-  Max Act 1635.28  - Max Est 1651.42RT @adamfeuerstein: Response to my big-cap biotech turnaround poll question. $GILD by wide margin. https://t.co/wlOqZAs6pV#GileadSciences Gilead freed of having to pay Merck &amp; Co $200 million in hep C patent dispute. Read more: https://t.co/yj8gxuYKQI $GILD#GileadSciences Gilead wont have to pay $200 million in patent case because Merck lawyer lied. Read more: https://t.co/cKoEg8MewB $GILD#GileadSciences Why Gilead May Not Have to Pay Merck $200 Million After All. Read more: https://t.co/i5qR4z5Ssc $GILDCommented on Gilead: Ninety-Nine Problems But Merck Ain't One https://t.co/R8LIMehgFn $MRK $VRX $GILDRT @adamfeuerstein: Response to my big-cap biotech turnaround poll question. $GILD by wide margin. https://t.co/wlOqZAs6pVRT @adamfeuerstein: Response to my big-cap biotech turnaround poll question. $GILD by wide margin. https://t.co/wlOqZAs6pV$GILD Gilead Sciences to Present at the Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday, J... https://t.co/K6kOfuSYEbRT @SA_BioTech: Gilead: Ninety-Nine Problems But Merck Ain't One https://t.co/Qm6vEwFdtM $MRK $VRX $GILDadamfeuerstein: Response to my big-cap biotech turnaround poll question. $GILD by wide margin. https://t.co/1O79fzT6y9Gilead: Ninety-Nine Problems But Merck Ain't One https://t.co/Qm6vEwFdtM $MRK $VRX $GILDGilead: Ninety-Nine Problems But Merck Ain't One https://t.co/6N2Rg4yVrx $MRK $VRX $GILDRT @adamfeuerstein: Response to my big-cap biotech turnaround poll question. $GILD by wide margin. https://t.co/wlOqZAs6pVRT @adamfeuerstein: Response to my big-cap biotech turnaround poll question. $GILD by wide margin. https://t.co/wlOqZAs6pVRT @adamfeuerstein: Response to my big-cap biotech turnaround poll question. $GILD by wide margin. https://t.co/wlOqZAs6pVGabelli Research Says Gilead's HCV Sales To Crash Badly And Soon: Analysis https://t.co/C1ixgIQc1x $ACHN $ESRX $JNJ $GILDResponse to my big-cap biotech turnaround poll question. $GILD by wide margin. https://t.co/wlOqZAs6pV$GILD Gilead Sciences to Present at the Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday, 
From our Stock News Alerts App@adamfeuerstein $Gild b/c it's undervaluedRT @pharmalot: Gilead won't have to pay $200M in hepatitis c patent case because Merck lawyer lied. read ruling: https://t.co/a2uZahYiw1 #p‚Ä¶$GILD - Gilead Sciences to Present at the Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday https://t.co/9lFjT5X7WCCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKjqBmD$GILD - Judge Sides With Gilead Against Merck in Hepatitis C Case https://t.co/eMrcDmMyV7Judge throws out Merck‚Äôs $200 million verdict over Gilead https://t.co/Pwj54I7Slj / $GILD#GileadSciences Judge Sides With Gilead Against Merck in Hepatitis C Case. Read more: https://t.co/WDv4eCMb4L $GILD$GILD - Judge Sides With Gilead Against Merck in Case Over Hepatitis C Drug Patents https://t.co/7nnxTuIsaLRT @Big3BioSF: June 7: Verily's Breakthrough #Biotech Goals; Genentech Settles Suit; SFBay Life Sci #Startup Report  https://t.co/51xuwUrJv‚Ä¶RT @HenryEChang: Gilead escapes liability in #hepatitis C patent fight with Merck‚Üíhttps://t.co/6j4eyz5QLd via @Reuters_Health #HCV #HepC $G‚Ä¶PANW Petroleo Brasileiro (Petrobras) Dividend
https://t.co/q2iuPtPVXa

$PANW $GBTC $ORCL $GILD  #investing #shareGILD short $GILD https://t.co/lPyP6HByA5RT @pharmalot: Gilead won't have to pay $200M in hepatitis c patent case because Merck lawyer lied. read ruling: https://t.co/a2uZahYiw1 #p‚Ä¶June 07 Tuesday, $GILD closed $87.50RT @MarginHunt: Great News For Gilead $GILD https://t.co/j8i4gOvTZ8 #trading at very low #valuation $ABBV $AMGN $BIIB $CELG #stocks https:/‚Ä¶Great News For Gilead $GILD https://t.co/j8i4gOvTZ8 #trading at very low #valuation $ABBV $AMGN $BIIB $CELG #stocks https://t.co/jq3mBvdZ7UDIA Diana Shipping Inc. Day Low
https://t.co/d1zaoMrdsq

$DIA $F $GILD $LVS  #stockmarket #pennystocksGilead escapes liability in hepatitis C patent fight https://t.co/HBnQtAfvwy $MRK $GILD@adamfeuerstein $GILD with a gun to my headRT @pharmalot: Gilead won't have to pay $200M in hepatitis c patent case because Merck lawyer lied. read ruling: https://t.co/a2uZahYiw1 #p‚Ä¶Bot more $GILD trading at 7x P/E simply ludicrous. Sill have some $82'sRT @WallStreetBean: ""Last night, a judge ruled in favor of $GILD in a lawsuit brought by $MRK"" https://t.co/PUvOUB7m08$GILD I feel like I'm posting the same chart, over and over.  But surely, this is a coincidence?  (hint: it's not) https://t.co/tOUfWMeQPxGilead Sciences, Inc. $GILD Shares Bought by Stralem &amp; Co. Inc. https://t.co/CQHlBGYuzdGilead Sciences, Inc. $GILD Shares Bought by Stralem &amp; Co. Inc. https://t.co/OpAuFTZdFxFirst Financial Corp IN Has $682,000 Position in Gilead Sciences, Inc. $GILD https://t.co/miHfDCbG89Gilead Sciences, Inc. $GILD Position Reduced by Cohen Klingenstein LLC https://t.co/iX5AURjBsWLaurel Grove Capital LLC Purchases 4,750 Shares of Gilead Sciences, Inc. $GILD https://t.co/5t97dnW4c2""Last night, a judge ruled in favor of $GILD in a lawsuit brought by $MRK"" https://t.co/PUvOUB7m08RT @AndysCycles: $IBB #Biotech top components sorted by 1month chg. $MDVN $INCY $VRTX $ILMN $BMRN $REGN $BIIB $CELG $AMGN $MYL $GILD https:‚Ä¶@afortunetraders still holding $gild?TZA ProShares Ultra Bloomberg Crude Oil Short Sales
https://t.co/rr38b12GZM

$TZA $SPXS $SRPT $GILD  #investing #investRT @pharm_specialty: #GileadSciences Merck &amp; Co.'s $200 Million Win Against Gilead Voided Due to False Testimony  . Read more: https://t.co‚Ä¶RT @SA_BioTech: Great News For Gilead https://t.co/LNhqTGHDpX $MRK $GILD#GileadSciences Merck &amp; Co.'s $200 Million Win Against Gilead Voided Due to False Testimony  . Read more: https://t.co/FALP7Ht8xO $GILD#GileadSciences Federal Judge Reverses Merck &amp; Co.'s $200 Million Patent Win Against Gilead... Read more: https://t.co/PIx64CCzP4 $GILDRT @GantosJ: $GILD a ""Cup &amp; Handle"" pattern in the intraday chart, the breakout just happening now.. &amp; daily continuation candle https://t.‚Ä¶Gilead escapes liability in hepatitis C patent fight https://t.co/vNiU2fr5Ko $MRK $GILDHere's How #GileadSciences, Inc. New CEO Plans To Maintain HCV Dominance. Read more: https://t.co/egfRIIbOQB $GILDGreat News For Gilead https://t.co/LNhqTGHDpX $MRK $GILDGreat News For Gilead https://t.co/MJ1D9HYbqU $MRK $GILDRT @pharmalot: Gilead won't have to pay $200M in hepatitis c patent case because Merck lawyer lied. read ruling: https://t.co/a2uZahYiw1 #p‚Ä¶RT @pharmalot: Gilead won't have to pay $200M in hepatitis c patent case because Merck lawyer lied. read ruling: https://t.co/a2uZahYiw1 #p‚Ä¶Has A Biotech Recovery Started Yet? Avery Schumer answers: https://t.co/thzkjA5lDg $GILD@RudyHavenstein he clearly must think this rally is happening without any help from $aapl, $dis, $NKE, $GILD, $CAT, $GS, $IBM...RT @pharmalot: Gilead won't have to pay $200M in hepatitis c patent case because Merck lawyer lied. read ruling: https://t.co/a2uZahYiw1 #p‚Ä¶Gilead won't have to pay $200M in hepatitis c patent case because Merck lawyer lied. read ruling: https://t.co/a2uZahYiw1 #pharma $MRK $GILDThinking on loading on $GILD 91.50 call expiring June 17th for $0.09.I raised my stops on $COST and $GILD today. I kept the stops on $AAPL and $TWTR the same. All have great cushion and letting them work$RGLS Regulus' four-week HCV regimen achieves cure rates as high as 100% in mid-stage study https://t.co/T6plHkUBKK $RGLS, $GILD, $JNJ, $BMYGreat News For Gilead https://t.co/houkzG342t $MRK $GILDGILD Alphabet Inc. Day Low
https://t.co/qrFAKUa2oj

$GILD $HXD.TO $EWZ $ANF  #invest #nasdaqRT @Fibonacciqueen: $GILD I spy some weekly support at those last lows....still investigating https://t.co/46m7w7U2WJRT @GantosJ: $GILD a ""Cup &amp; Handle"" pattern in the intraday chart, the breakout just happening now.. &amp; daily continuation candle https://t.‚Ä¶A judge ruled in favor of  $GILD in lawsuit brought by $MRK related to Gilead's hepatitis-C drugs Harvoni &amp; Sovaldi https://t.co/8TWkFTS8KcRT @canuck2usa: $GILD new highs on the moveGilead Sciences: About that Hepatitis C Lawsuit‚Ä¶ https://t.co/B6e41H6y3Z via @barronsonline $GILD $MRK $IONSRT @fwpharma: US judge overturns Merck &amp; Co.'s hepatitis C drug patent award against Gilead https://t.co/UXsq1Dn5nz $MRK $GILD #pharmaGILD $GILD https://t.co/uTUA3dRrg1RT @GantosJ: $GILD a ""Cup &amp; Handle"" pattern in the intraday chart, the breakout just happening now.. &amp; daily continuation candle https://t.‚Ä¶All out of $GILD calls for profit. Decent trade. Out after seeing neg divergence on 240. Will likely revisit. https://t.co/XdHbXJwp6e$TSLA extremely overbought and overpriced. Sell this beast to $80. $SPY $TWTR $HMNY $FB $AMGN $GILD $USORT @afortunetraders: @afortunetraders $gild running now@afortunetraders $gild running now@abscgc not $nflx .. in  $gildRT @canuck2usa: $GILD new highs on the move$GILD a ""Cup &amp; Handle"" pattern in the intraday chart, the breakout just happening now.. &amp; daily continuation candle https://t.co/hcFEi5vJvD$GILD July 1  calls moving for me, but really this is too little too late.June 07 Tuesday, $My 3rd BULLISH target for $GILD is $92.40$GILD Could move to $92 from here.$GILD hod$GILD new highs on the move$GILD still strong in a weak $IBB tapeDo I have that right: $IONS patents valid, but $MRK legal team messes up, so $IONS ends up with nothing? Malpractice suit in order? $GILD$GILD https://t.co/FthNZf2eT9@Weeb644 $gild will keep $ibb off lows and grinding higher - so if $aapl theory plays - could be good close yesRT @FiercePharma: Judge nixes Merck's $200M hep C patent win, citing 'fabricated' testimony, 'pervasive' misconduct https://t.co/QOGkWS1o2R‚Ä¶#GileadSciences Wins The Lost Patent Battle Against Merck and Co. Read more: https://t.co/UWdlFACiz2 $GILDRT @afortunetraders: Its just Tuesday and we have multiple multi-baggers. $pcln, $tsla, $agn, $spx ...coming soon at a screen near you $gil‚Ä¶$GILD - Gilead Sciences, Inc. #GILD Rating Reiterated by Morgan Stanley https://t.co/yPzBlsrwPZRT @afortunetraders: @afortunetraders I still like $gild and it moves slow but moves... $90 by end of week will give you 300% return$GILD - Gilead Sciences, Inc. #GILD Rating Reiterated by Morgan Stanley https://t.co/t11THMx8i8Its just Tuesday and we have multiple multi-baggers. $pcln, $tsla, $agn, $spx ...coming soon at a screen near you $gild / $nflx multi-baggerRT @Fibonacciqueen: $GILD I spy some weekly support at those last lows....still investigating https://t.co/46m7w7U2WJ@afortunetraders I still like $gild and it moves slow but moves... $90 by end of week will give you 300% returnXLV SPDR S&amp;P Retail ETF Shares
https://t.co/ymlBK9J6y9

$XLV $GE $GILD $GILD  #stockmarket #invest$GILD - Gilead Sciences, Inc. #GILD Rating Reiterated by Morgan Stanley https://t.co/2yIENeq0yi$GILD escapes liability in hepatitis C patent fight because of $MRK's dishonesty! https://t.co/fCvMNLf1Lf by @SeekingAlphaRT @Fibonacciqueen: $GILD I spy some weekly support at those last lows....still investigating https://t.co/46m7w7U2WJGilead Sciences Reiterated Rating by Morgan Stanley (Ranked 33rd) to Hold $GILD #GILD https://t.co/nyq7xJnbR7RT @stocktrader300: @CraigScott31 already figured that out without using a chart #obionekenobi $GILD https://t.co/2gR5chqbyvRT @CraigScott31: Earlier purchase of $gild https://t.co/llV6tcpfx5@CraigScott31 already figured that out without using a chart #obionekenobi $GILD https://t.co/2gR5chqbyvRT @FiercePharma: Judge nixes Merck's $200M hep C patent win, citing 'fabricated' testimony, 'pervasive' misconduct https://t.co/QOGkWS1o2R‚Ä¶$GILD I spy some weekly support at those last lows....still investigating https://t.co/46m7w7U2WJJune 07 Tuesday, $GILD is $88.00. My 2nd BULLISH target is $91.50RT @FiercePharma: Judge nixes Merck's $200M hep C patent win, citing 'fabricated' testimony, 'pervasive' misconduct https://t.co/QOGkWS1o2R‚Ä¶RT @FiercePharma: Judge nixes Merck's $200M hep C patent win, citing 'fabricated' testimony, 'pervasive' misconduct https://t.co/QOGkWS1o2R‚Ä¶$GILD strong like bull. Highlighting a strong $IBB divergence off non-liability settlement result. When $IBB bounces it goes $90+RT @FiercePharma: Judge nixes Merck's $200M hep C patent win, citing 'fabricated' testimony, 'pervasive' misconduct https://t.co/QOGkWS1o2R‚Ä¶Judge nixes Merck's $200M hep C patent win, citing 'fabricated' testimony, 'pervasive' misconduct https://t.co/QOGkWS1o2R $MRK $GILD #pharmaSWKS iShares 20+ Year Treasury Bond ETF Yield
https://t.co/lC7WFAiJ3X

$SWKS $PHM.V $GILD $ABX.TO  #nasdaq #investRT @CraigScott31: Earlier purchase of $gild https://t.co/llV6tcpfx5Earlier purchase of $gild https://t.co/llV6tcpfx5TMC members our $BEAV took off nicely today. $GILD could breakout. Watching $JWN and $BAX and $KRValuation Dashboard: Healthcare https://t.co/m5E8DEMPKL $ABBV $ABC $AKRX $AMGN $BIIB $BSX $CRL $GILD $IBB $MCK $PFE $SPY $STJ $UTHR $VARValuation Dashboard: Healthcare https://t.co/czT3eBBzpc $ABBV $ABC $AKRX $AMGN $BIIB $BSX $CRL $GILD $IBB $MCK $PFE $SPY $STJ $UTHR $VARValuation Dashboard: Healthcare https://t.co/BGgvWzNlLt $ABBV $ABC $AKRX $AMGN $BIIB $BSX $CRL $GILD $IBB $MCK $PFE $SPY $STJ $UTHR $VARRT @jonathanrockoff: As $GILD looks beyond HIV &amp; HCV, new CEO Milligan aims to keep it close to the science: https://t.co/i8BS8lLSuv Under‚Ä¶Wall Street Breakfast: World Shares Higher As Fed Rethinks Rate Hike https://t.co/PsgUkhpZrp $SPY $QQQ $DDAIY $GILD $GS $MRK $SSNLF $VRXRay Dalio is #investing the McRight way! $AAPL $GILD $MCD #tuesdaymotivation https://t.co/i3U5m2wmPt https://t.co/KWKZMXgKCVJust seen $GILD $91.69 and that would be great for my BULLISH target $90.00.$GILD looking sweet!JO Michael Kors Holdings Ltd. Dividend
https://t.co/5jiN0pTpAY

$JO $CVX $JDST $GILD  #pennystocks #pennystocksGILD Alphabet Inc. Open
https://t.co/6DU7aGqT6Y

$GILD $CPG.TO $DUST $HOD.TO  #tradeideas #stockFF.V First Solar Inc. Shares
https://t.co/wJD4HMYL4P

$FF.V $GILD $TZA $ABX.TO  #stockmarket #nasdaqIonis Shareholders Cannot Catch A Break https://t.co/RhScQ7WYZU $GILD $MRK $IONSDUST EnCana Corp. Open
https://t.co/2GG3MChpe4

$DUST $DDD $CVX $GILD  #finance #nasdaqRT @BPGAG: $GILD shook some quick pounces on $87.50 area this morning with quick move to test $86. $89+ ? #biotech #stocks #trading $IBB $C‚Ä¶$GILD needs a company like $ARWR if they can produce FCs for HBV. While it seems a bit crazy, $15B+ buyout would still be a bargain.$GILD shook some quick pounces on $87.50 area this morning with quick move to test $86. $89+ ? #biotech #stocks #trading $IBB $CELG $AMGNJune 7: Verily's Breakthrough #Biotech Goals; Genentech Settles Suit; SFBay Life Sci #Startup Report  https://t.co/51xuwUrJvl $GILD #BIO2016Here‚Äôs How Gilead Sciences, Inc. New CEO Plans To Maintain HCV Dominance $GILD https://t.co/ksA7qvjmMBVolume Alert - GILD 88.08 Gilead Sciences Inc $GILD Hit a high today of 88.12 Closing the day 10:30 at 88.08 + https://t.co/gCBcOVXC7zThe drug industry is a bit of a mess.. Watch for $GILD to cut prices on Harvoni am sureRT @afortunetraders: Trade idea: $gild $88.50 for $0.50 looks good for a trade@afortunetraders $GILD (W) $$88.50C in  @  .44 for the train ride!$BIIB $GILD need new assets to support their growth. just do it.RT @jonathanrockoff: As $GILD looks beyond HIV &amp; HCV, new CEO Milligan aims to keep it close to the science: https://t.co/i8BS8lLSuv Under‚Ä¶RT @ArtSlott: $RGLS $IONS $GILD $MRK $IBB #biotech @HepCentral #HepC  4-week of RG-101 plus Harvoni: 10/10 SVRs at 24 weeks https://t.co/WI‚Ä¶Trade idea: $gild $88.50 for $0.50 looks good for a tradeRT @Carine1111111: $icpt $GILD #genfit #GNFTF https://t.co/qyGbspDIaJ$GILD said it was being picked up at support, now above pre market highs$icpt $GILD #genfit #GNFTF https://t.co/qyGbspDIaJRegulus' four-week HCV regimen achieves cure rates as high as 100% in mid-stage study, inve... https://t.co/m2tZ6KOLQL $RGLS $GILD $JNJ $BMYRegulus' four-week HCV regimen achieves cure rates as high as 100% in mid-stage study, inve... https://t.co/lHcLEKYwEN $RGLS $GILD $JNJ $BMYRegulus' four-week HCV regimen achieves cure rates as high as 100% in mid-stage study, inve... https://t.co/Bje1HhFmn7 $RGLS $GILD $JNJ $BMYRegulus' four-week HCV regimen achieves cure rates as high as 100% in mid-stage study, inve... https://t.co/GEEDWzztAe $RGLS $GILD $JNJ $BMYRT @jonathanrockoff: As $GILD looks beyond HIV &amp; HCV, new CEO Milligan aims to keep it close to the science: https://t.co/i8BS8lLSuv Under‚Ä¶RT @jonathanrockoff: As $GILD looks beyond HIV &amp; HCV, new CEO Milligan aims to keep it close to the science: https://t.co/i8BS8lLSuv Under‚Ä¶@CraigScott31 I am with you on $GILD  - just a lot less shares$GILD freed from paying damages for infringing $MRK¬†patents https://t.co/1Un0KkghRcGabelli Research Says Gilead's HCV Sales To Crash Badly And Soon: Analysis https://t.co/uoOvgoT24r $ACHN $ESRX $JNJ $GILDRT @jonathanrockoff: As $GILD looks beyond HIV &amp; HCV, new CEO Milligan aims to keep it close to the science: https://t.co/i8BS8lLSuv Under‚Ä¶Swing Trading Watch-List - June 6, 2016 $DOW $MMM $SEE $GILD $RLGY https://t.co/BeckFZKSMSAdded 8,000 shares of $GILD.#asco16 losers pulling down the winners today. $biib $gild $celg $agioI am still waiting for $GILD hit bottom then buy$RGLS $IONS $GILD $MRK $IBB #biotech @HepCentral #HepC  4-week of RG-101 plus Harvoni: 10/10 SVRs at 24 weeks https://t.co/WIQs2omUfiHas A Biotech Recovery Started Yet? $GILD BIIB $VRX $AMGN 
https://t.co/TzVGl2earI@RNAiAnalyst Worth noting he was a witness for $GILD not $MRK $IONS.GILD Top news - Jun 7th, 2016 $GILD https://t.co/w8cSCarzjTRT @outsizedreturn: #Bloomberg News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/Fn1XYkxmV9 https://t‚Ä¶RT @Benzinga: TD Ameritrade's IMX Growth Hits Record High In May: Check Out Clients' Picks &amp; Pans $AAPL $NFLX $TWTR $FB $GILD $VRX https://‚Ä¶RT @jonathanrockoff: As $GILD looks beyond HIV &amp; HCV, new CEO Milligan aims to keep it close to the science: https://t.co/i8BS8lLSuv Under‚Ä¶$GILD: Analyst action by Gabelli &amp; Co on Gilead Sciences: https://t.co/yorThNV9Ug https://t.co/P5M7GaAWpw$GILD

Took 1/2 calls off for gains.We calculated 21-day Expected Return of $GILD for you: 2.02% https://t.co/mTgAzTSiLD$GILD With their new windfall, Management should plan additional $300M in buybacks for the rest of the week.RT @outsizedreturn: #Bloomberg News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/Fn1XYkxmV9 https://t‚Ä¶#Bloomberg News Update $aapl $fb $goog $amzn $gild $gs $intc $jpm $bac $f #hedgefunds https://t.co/Fn1XYkxmV9 https://t.co/bDrfSBeWEnRT @HenryEChang: Gilead escapes liability in #hepatitis C patent fight with Merck‚Üíhttps://t.co/6j4eyz5QLd via @Reuters_Health #HCV #HepC $G‚Ä¶RT @datamonitor_MH: Judge rules $GILD not liable for $200m damages + royalties for SOF patent infringement as $MRK attorney gave ""untruthfu‚Ä¶RT @ScripDonnaDC: WIn for $GILD: Judge: $MRK has unclean hands; not entitled to enforce 2 HCV patents b/c dishonest conduct by patent attor‚Ä¶RT @redacre: $GILd vs $MRK jury award overturned due to witness lying - never a dull moment - this affair seems far from overWall Street Breakfast: World Shares Higher As Fed Rethinks Rate Hike https://t.co/uGG4Pc6hMF $SPY $QQQ $DDAIY $GILD $GS $MRK $SSNLF $VRXRT @jonathanrockoff: As $GILD looks beyond HIV &amp; HCV, new CEO Milligan aims to keep it close to the science: https://t.co/i8BS8lLSuv Under‚Ä¶RT @SA_WallStreetBr: Wall Street Breakfast: World Shares Higher As Fed Rethinks Rate Hike https://t.co/U81vB1gZrP $SPY $QQQ $DDAIY $GILD $G‚Ä¶@GangLeader sold $GILD in pre market, just in case $BIIB drags the bio sector down$GILd vs $MRK jury award overturned due to witness lying - never a dull moment - this affair seems far from overRT @ScripDonnaDC: WIn for $GILD: Judge: $MRK has unclean hands; not entitled to enforce 2 HCV patents b/c dishonest conduct by patent attor‚Ä¶SAlphaTrending: Wall Street Breakfast: World Shares Higher As Fed Rethinks Rate Hike https://t.co/p4dbcdMYoX $SPY $QQQ $DDAIY $GILD $GS $M‚Ä¶KBE SPDR S&amp;P Bank ETF Yield
https://t.co/0bwVuIWqsE

$KBE $GILD $UUP $QLD  #stocks #invest$GILD It looks like all the analysts who rate this as a BUY, don't buy it themselves. #stocks #investing #tradeideas@redacre Sort of yes and no. The top five securities are given an 8% weight every time it rebalances. $BIIB $REGN $AMGN $GILD, and $CELG.GILD Gilead Sciences, Inc. Filings
https://t.co/PGFjcVHoEv

$GILD $NEM $NTRA $XLU  #nasdaq #stockmarket$vrx can't handle it's massive debt and $biib down 27 bucks hitting my main man $gild who reversed a big royalty ruling with $mrk last nightSAlphaTrending: Wall Street Breakfast: World Shares Higher As Fed Rethinks Rate Hike https://t.co/IjRR0frERH $SPY $QQQ $DDAIY $GILD $GS $M‚Ä¶",2016-06-07,GILD,0
41,"@actaestfabulaXX  Got my attention! Why are they selling here? But been watching CEO's of both $GILD, $VRTX sell every Q during boom! $ALDRRT @SashaDamouni: In cash you missed, $GILD said earlier at Goldman they don't have a need for external NASH opportunities now, more focuse‚Ä¶CHK Chesapeake Energy Corp. Company Info
https://t.co/xtDdYnCXSH

$CHK $USA.TO $XOM $GILD  #stock #stockUnusual Call Option Activity Today (in order of volume to open interest): $TLRD $LULU $CHK $SLV $MRO $CLF $GDX  $TSLA $COP $X $EWZ $GILDAG First Majestic Silver Corp. Prev Close
https://t.co/XA5xEAjDlp

$AG $USLV $GILD $IEF  #stocks #nasdaqGilead Sciences' (GILD) Management Presents at 2016 Goldman Sachs Annual Global Healthcare ... https://t.co/qHE5ZV4Xus $GILDRT @BiotechRadar: Bischofberger at Goldman Sachs GHC: $GILD also has an FXR agonist for NASH but according to him OCA safety profile is not‚Ä¶#HCV $GILD $ABBV  https://t.co/CDYR38WMqt$GILD:

New Insider Transaction on GILD by President and CEO:

https://t.co/a2kW5gnl02 https://t.co/e0GIn0T3cA$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts AppVTI Vanguard Total Stock Market ETF Prev Close
https://t.co/kPjWxljWbr

$VTI $FB $GILD $BABA  #stocks #finance$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/2Xzitumlh8Gilead Sciences's President and CEO just cashed-in 112,000 options  https://t.co/z7brNFaLpq $GILDFor 8ema cross 21ema stocks 
$CHK
$EWZ
$GE
$X
$AA
$KGC
$OREX - penny
$VALE/P
$ESV
$GILD
$SYRG
$GFI
$BAX
$FTI
$BTG
$MUX
$PWE
Nice cross upRT @SashaDamouni: In cash you missed, $GILD said earlier at Goldman they don't have a need for external NASH opportunities now, more focuse‚Ä¶PFE Pfizer, Inc. News
https://t.co/u6EBu4xZxp

$PFE $WLL $LL $GILD  #nasdaq #financeRT @DailyStockPlays: Unusual Call Activity https://t.co/zeWdrIVRSR $LULU $NEM $FXI $CHK $MGM $WYNN $GILD $GLD $GG $SLW $GDXJ $BABA $SLV $TS‚Ä¶GILD $GILD https://t.co/ckA8O86YQkEffectiveness of SOF, LDV/SOF, or PTV/OMV/RTV/+DSV Regimens for Tx of #HCV Patients in VA System‚Üíhttps://t.co/HrBlOnDcFC $GILD $ABBV #HepCUnusual Call Activity https://t.co/zeWdrIVRSR $LULU $NEM $FXI $CHK $MGM $WYNN $GILD $GLD $GG $SLW $GDXJ $BABA $SLV $TSLA $AAL $CLF $DE $CATGILD Gilead Sciences, Inc. Summary
https://t.co/VqQI2QHdeG

$GILD $MUX $RAI $SCO  #investing #shareGG Goldcorp, Inc. Market Cap
https://t.co/YXs5bc7wCB

$GG $BHP $TRTC $GILD  #stockmarket #shareRT @BioWorld: $GLPG, $GILD deal had ""lots of moving parts"": equity investment, co-development, co-promote option; closed in 3 mos. #Allicen‚Ä¶RT @BiotechRadar: Bischofberger at Goldman Sachs GHC: $GILD also has an FXR agonist for NASH but according to him OCA safety profile is not‚Ä¶$GLPG, $GILD deal had ""lots of moving parts"": equity investment, co-development, co-promote option; closed in 3 mos. #Allicense2016 #BIO2016$GLPG quips that $2.075B $GILD deal ""was third time we should have been nominated"" for filgotinib, dropped by other partners #Allicense2016RT @HenryEChang: #Hepatitis B in Pregnancy‚Üíhttps://t.co/X0PvQCVvvp @IDSAInfo @HIVMA @CedarsSinai @cdchep $GILD #HBV #HepBCommented on GILD: Any Takers On 30% Upside? https://t.co/2imNmfQSVu $GILDRT @BiotechRadar: Bischofberger at Goldman Sachs GHC: $GILD also has an FXR agonist for NASH but according to him OCA safety profile is not‚Ä¶RT @BiotechRadar: Bischofberger at Goldman Sachs GHC: $GILD also has an FXR agonist for NASH but according to him OCA safety profile is not‚Ä¶1621 #BMV  #TRMX $GILD * - Min. Act. 1580 - Min. Est. 1591.9-  Max Act 1611  - Max Est 1611Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5SOXX Direxion Daily S&amp;P 500 Bull 3x Shares EOD Data
https://t.co/RYhfRlJ5uo

$SOXX $OIH $GILD $BTE  #stock #pennystocks@insidermonkey $PFE $GILD @HedgeMind @novuspartners  https://t.co/qkK24MNZFgSAlphaTrending: Gilead Slam Dunks Merck In Federal Court Ruling https://t.co/bH5OhunBhU $GILD $MRKSAlphaTrending: Gilead Slam Dunks Merck In Federal Court Ruling https://t.co/dkTtqk7hqw $GILD $MRK@SashaDamouni $GILD already has every NASH MoA covered!RT @SashaDamouni: In cash you missed, $GILD said earlier at Goldman they don't have a need for external NASH opportunities now, more focuse‚Ä¶In cash you missed, $GILD said earlier at Goldman they don't have a need for external NASH opportunities now, more focused on oncology $ICPTPBR https://t.co/Cd8iZd0ZAh Inc. Ask
https://t.co/EW2TriyX0a

$PBR $MRO $GILD $SLW  #investing #stocksGilead Slam Dunks Merck In Federal Court Ruling https://t.co/f4VzrG5HAZ $GILD $MRKGilead Slam Dunks Merck In Federal Court Ruling https://t.co/zBA80fioip $GILD $MRKGilead Slam Dunks Merck In Federal Court Ruling https://t.co/SsJ1TY88u9 $GILD $MRKOpenOutcrier: RECAP 6/8 Chatter:
$GILD + Ubben Stake
$SIG + CEO buy
$CTRP - Air commissions
$VRX + Asset Sale
$NETE + $MA
$VRX + $AGNDon't Get Caught With These 5 Stocks Ahead of #Earnings Season $AA $CMG $GPS $AAPL $GILD https://t.co/RsgsUHn9WC@BiotechRadar @portefeuillefun Would you expect $GILD to admit $ICPT best?RT @BiotechRadar: $GILD Bischofberger at Goldman Sachs GHC: filgotinib safety database is extensive, oral formulation is OK for this produc‚Ä¶Don‚Äôt Get Caught With These 5 Stocks Ahead of Earnings Season https://t.co/Gpy4aAi4ub via @estimize $CMG $GPS $AAPL $AA $GILDRT @afortunetraders: What a million dollar week $tsla $googl $agn $pcln $gild $nflx $gs $spy $spx making a fortune every week if you follow‚Ä¶$GILD was so flat after that initial crazy move up.  Any thoughts? @jonnajarian You still in it? I added yesterday.RECAP 6/8 Chatter:
$GILD + Ubben Stake
$SIG + CEO buy
$CTRP - Air commissions
$VRX + Asset Sale
$NETE + $MA
$VRX + $AGNTLP Current Price
See Here ---&gt; https://t.co/30bJ6VjfoH

$TLP $GILD $WATT #investGILD SPDR Gold Shares E.P.S.
https://t.co/6meXMkrmB0

$GILD $NEM $VRX $CF  #investing #stockRT @CBOE: #optionstrading @jonnajarian $GILD &amp; $WFT trades on @CNBC @HalftimeReport portfolio #TeamJon https://t.co/km4MlJmDki https://t.co‚Ä¶#GileadSciences Merck &amp; Company Little Changed After Federal Judge Says Gilead Doesn't Have... Read more: https://t.co/iKTgpNGkf3 $GILDRT @CBOE: #optionstrading @jonnajarian $GILD &amp; $WFT trades on @CNBC @HalftimeReport portfolio #TeamJon https://t.co/km4MlJmDki https://t.co‚Ä¶V Wealth Management LLC Buys New Position in Gilead Sciences, Inc. $GILD https://t.co/10ereMjmUyGilead Sciences, Inc. $GILD is Rhenman &amp; Partners Asset Management AB‚Äôs 2nd Largest Position https://t.co/LbVTCwDPDB#optionstrading @jonnajarian $GILD &amp; $WFT trades on @CNBC @HalftimeReport portfolio #TeamJon https://t.co/km4MlJmDki https://t.co/jNExnXg9ELSigma Planning Corp Purchases 404 Shares of Gilead Sciences, Inc. $GILD https://t.co/bVOyKm81AKRT @afortunetraders: What a million dollar week $tsla $googl $agn $pcln $gild $nflx $gs $spy $spx making a fortune every week if you follow‚Ä¶Private Trust Co. NA Purchases 147 Shares of Gilead Sciences, Inc. $GILD https://t.co/wAPsvVGpdFWhat a million dollar week $tsla $googl $agn $pcln $gild $nflx $gs $spy $spx making a fortune every week if you follow me @afortunetradersRT @BiotechRadar: Bischofberger at Goldman Sachs GHC: $GILD also has an FXR agonist for NASH but according to him OCA safety profile is not‚Ä¶RT @BiotechRadar: $GILD Bischofberger at Goldman Sachs GHC: filgotinib safety database is extensive, oral formulation is OK for this produc‚Ä¶RT @BiotechRadar: Bischofberger at Goldman Sachs GHC: $GILD also has an FXR agonist for NASH but according to him OCA safety profile is not‚Ä¶RT @BiotechRadar: $GILD Bischofberger at Goldman Sachs GHC: filgotinib safety database is extensive, oral formulation is OK for this produc‚Ä¶$PRHL Huge company DD  ~ https://t.co/HGyR3FAvmv

$VPCO $ZINC $REXX $MNKD $CNAT $CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO $BP $XOM $KORS $GOOG@swat_premium now if we can get $GILD to join party!RT @HenryEChang: ~30,000 U.S. veterans received #HCV tx in FY15 with drug costs btw $25,000 &amp; $124,000 per regimen @USGAO #HepC $GILD https‚Ä¶RT @HenryEChang: ~30,000 U.S. veterans received #HCV tx in FY15 with drug costs btw $25,000 &amp; $124,000 per regimen @USGAO #HepC $GILD https‚Ä¶~30,000 U.S. veterans received #HCV tx in FY15 with drug costs btw $25,000 &amp; $124,000 per regimen @USGAO #HepC $GILD https://t.co/Tq5pJauyZwRT @TraderDaily: Will Gilead $GILD Stock Be Helped by Hepatitis C Drug Patents Case Win? https://t.co/rDTXRCCuMHRT @StockAction: Will Gilead $GILD Stock Be Helped by Hepatitis C Drug Patents Case Win? https://t.co/x0Fm9oj42u #StockActionRT @BiotechRadar: Bischofberger at Goldman Sachs GHC: $GILD also has an FXR agonist for NASH but according to him OCA safety profile is not‚Ä¶RT @BiotechRadar: Bischofberger at Goldman Sachs GHC: $GILD also has an FXR agonist for NASH but according to him OCA safety profile is not‚Ä¶RT @BiotechRadar: $GILD Bischofberger at Goldman Sachs GHC: filgotinib safety database is extensive, oral formulation is OK for this produc‚Ä¶$GILD Bischofberger at Goldman Sachs GHC: filgotinib safety database is extensive, oral formulation is OK for this product $GLPGBischofberger at Goldman Sachs GHC: $GILD also has an FXR agonist for NASH but according to him OCA safety profile is not so good (rash,hdl)#Hepatitis B in Pregnancy‚Üíhttps://t.co/X0PvQCVvvp @IDSAInfo @HIVMA @CedarsSinai @cdchep $GILD #HBV #HepBWill Gilead $GILD Stock Be Helped by Hepatitis C Drug Patents Case Win? https://t.co/rDTXRCCuMHWill Gilead $GILD Stock Be Helped by Hepatitis C Drug Patents Case Win? https://t.co/x0Fm9oj42u #StockActionGilead: We believe the company is the most undervalued stock in the biotechnology industry, says Gabelli &amp; Co.
https://t.co/cZd0pwlFhE $GILDGreat News For Gilead https://t.co/OubRgo9nU1 $MRK $GILD - free #investing book &amp; newsletter = big profits - https://t.co/CzS5PYhx3WHGD.TO Horizons BetaPro NYMEX Crude Oil Bear Plus ETF Company Info
https://t.co/1ErZYBjfro

$HGD.TO $XME $GILD $NEM  #nasdaq #investGOOGL Goldman Sachs Group, Inc. EOD Data
https://t.co/qXMwItvLGh

$GOOGL $VXX $GILD $JAMN  #tradeideas #stockLong $GILD agree with Barons most undervalued bioGILD Global X Gold Explorers ETF Filings
https://t.co/ZDMCHVB73j

$GILD $ABX.TO $CXO $MDY  #stockmarket #pennystocksTrading Rules - Discipline and staying strong: https://t.co/vVZZyIZdvD $GILD $TTWO $GM $SCO $REXX $YUM $ABBV $UCO $NXPI $USO $WPRTRT @ApproTrade: $GILD running higher on bullish ""unusual options activity"" touted by Dr. J Jon Najarian on CNBC Halftime.RT @SA_BioTech: Great News For Gilead https://t.co/LNhqTGHDpX $MRK $GILDXME SPDR S&amp;P Oil &amp; Gas Exploration &amp; Production ETF E.P.S.
https://t.co/s2mhjoT3PM

$XME $GILD $XLU $NGD.TO  #invest #nasdaq$GILD running higher on bullish ""unusual options activity"" touted by Dr. J Jon Najarian on CNBC Halftime.@jonnajarian you know $GILD multi-bagger for short term!Imagine if you go LONG!Politics can't walk&amp;chew gum! @HalftimeReport @petenajarian#FastMoneyEspresso
FINAL CALLS:
Dr J ‚Äî&gt; buy $GILD $WFTUVXY Visa Inc. Day Low
https://t.co/KtKMe6BdWg

$UVXY $DIS $GILD $TZA  #pennystocks #share$GILD such bull shit yea activity in his assRT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶SLV Silver Wheaton Corp. Open
https://t.co/Ipz1yzTL3D

$SLV $XLK $VXX $GILD  #invest #investingWant to see who ranks as a top generic company? $JNJ $GILD #SNY $GSK https://t.co/Pwmok24z2cRT @BioStockAddict: Nice spike and volume in Galapagos. Looks like a Bull Flag breakout. On our way to 60EUR imo. $GLPG $GILD $ABBVRT @MarginHunt: Great News For Gilead $GILD https://t.co/j8i4gOvTZ8 #trading at very low #valuation $ABBV $AMGN $BIIB $CELG #stocks https:/‚Ä¶RT @outsizedreturn: #Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl $goog $fb $v $csco #hedgefunds #grains htt‚Ä¶Hold the Phone on Biotech: $VRX and $GILD
https://t.co/eo9ONk53EQ#GileadSciences New Gilead CEO's Game Plan to Maintain HCV Dominance  . Read more: https://t.co/oS8rNYoKNU $GILDLooking for $GILD + $IBB to breakout here and help $QQQ $SPYGILD SPDR Gold Shares Short Sales
https://t.co/17SzraLJT9

$GILD $SBUX $UUP $KMI  #nasdaq #financeGDX VanEck Vectors Junior Gold Miners ETF % Change
https://t.co/INmja7lzh7

$GDX $NEM $BTE.TO $GILD  #stocks #nasdaq#Commodity Update $spy $vxx $yinn $oil $uso $amzn $msft $crm $ko $gild $aapl $goog $fb $v $csco #hedgefunds #grains https://t.co/BbH8vfZygKBiotech Stocks: Much Ado About Nothing at ASCO? $CELG $GILD $REGN $AMGN https://t.co/ujBtmgfS5qWant to see who ranks as a top generic company? $JNJ $GILD #SNY $GSK https://t.co/X0lxRADL35Hold the Phone on Biotech: $VRX and $GILD https://t.co/rG32fKEsDIVolume Alert - GILD 87.26 Gilead Sciences Inc $GILD Hit a high today of 88.09 Closing the day 10:30 at 87.26 - https://t.co/cTWiPjhmowMassive call buying in June for $GILD 

#GILD #WallStreet #Stocks #Options@jimcramer $GILD, buy now or sit on the sideline for couple of months?RT @OpenOutcrier: $GILD Activist chatter making rounds with Value Act mentioned94.57% Average Gain
100% Unbiased
 .
https://t.co/mNVCwocg7V 
 .
 .
$CMCSA $GM $MRK $TSLA $SMG $GILD $YHOO https://t.co/M6L6bFymISGILD Summary
See Here ---&gt; https://t.co/G93ZQ7KPUw

$GILD $MNKD $ADHD #financePAY https://t.co/RnFsTN4CQg Inc. Filings
https://t.co/MCmHGPiLmn

$PAY $WYNN $GILD $VYM  #nasdaq #shareONVO Pacific Drilling SA Ex-Div Date
https://t.co/p340FQN8rB

$ONVO $GILD $KGC $JO  #finance #pennystocksMDT MannKind Corp. Filings
https://t.co/lw1lK5vDTx

$MDT $GILD $CCJ $GS  #finance #share$GILD little ss https://t.co/LZgP9SnGnGRT @afortunetraders: Market pulling be careful ... Mentioned earlier to get out of $tsla ... $gild... $googl went to $3.50 gave you 75% pro‚Ä¶Market pulling be careful ... Mentioned earlier to get out of $tsla ... $gild... $googl went to $3.50 gave you 75% profit.. Manage ur tradesOpenOutcrier: $GILD Activist chatter making rounds with Value Act mentioned#GileadSciences The Wall Street Journal: Judge throws out Merck's $200 million verdict over... Read more: https://t.co/M7WfO2ggfI $GILDRT @afortunetraders: @afortunetraders $tsla now $11+ ..  $gild if you don't want to hold, sell and you should break even .. Things that don‚Ä¶@Biotechnology $GILD is in runoff mode. Mgmt had years 2 funnel cash flow 2 next act product lines but ignored the  inevitable (mkt forces)GILD SPDR Gold Shares Bid
https://t.co/eKd8nuyxec

$GILD $HAL $CCJ $PLAY  #share #stockmarketRT @OpenOutcrier: $GILD Activist chatter making rounds with Value Act mentionedRT @afortunetraders: @afortunetraders $tsla now $11+ ..  $gild if you don't want to hold, sell and you should break even .. Things that don‚Ä¶RT @OpenOutcrier: $GILD Activist chatter making rounds with Value Act mentioned@afortunetraders $tsla now $11+ ..  $gild if you don't want to hold, sell and you should break even .. Things that don't work get outRT @OpenOutcrier: $GILD Activist chatter making rounds with Value Act mentionedRT @OpenOutcrier: $GILD Activist chatter making rounds with Value Act mentioned@OpenOutcrier @SpartanBiotech Seriously, WTF is wrong with $GILD? They think it's OK to go into runoff mode?RT @GantosJ: It's about time !!! $GILD Gilead Shares Spiking, Traders Passing Around Comments Of Possible ValueAct Stake$GILD finally!$GILD chart looks ready to run https://t.co/W4Aaw97iLd via https://t.co/11Wpw9y7t1It's about time !!! $GILD Gilead Shares Spiking, Traders Passing Around Comments Of Possible ValueAct StakeRT @OpenOutcrier: $GILD Activist chatter making rounds with Value Act mentionedRT @OpenOutcrier: $GILD Activist chatter making rounds with Value Act mentioned$GILD
Gilead Shares Spiking, Traders Passing Around Comments Of Possible ValueAct StakeRT @OpenOutcrier: $GILD Activist chatter making rounds with Value Act mentioned$GILD is pissed now$GILD Activist chatter making rounds with Value Act mentionedGILD Top news - Jun 8th, 2016 $GILD https://t.co/OnrrVu75GsACIA Acacia Communications, Inc. Exchange
https://t.co/15jEtbK3vf

$ACIA $CCJ $GILD $PBR  #pennystocks #pennystocksRT @WrigleyTom: Some Presenting at ...

Goldman
$GWPH
$CELG
$MYGN
$BLCM
$TEVA
$ACAD
$GILD
$JNJ

Jefferies
$EGRX
$NERV

Baird
$FFIV https://‚Ä¶RT @w_biltmore85: $GILD NOT looking for the next big thing like the Pharmasset deal https://t.co/Ei3oSqalNWJust one of many big alerts $AQXP  https://t.co/uAcamNRUPt https://t.co/zHAvlEkA1M $AMAT $ITUB $MT $GILD $HST $AA $GM $EMCValuation Dashboard: Healthcare https://t.co/13UYs6F7cI $ABBV $ABC $AKRX $AMGN $BIIB $BSX $CRL $GILD $IBB $MCK $PFE $SPY $STJ $UTHR $VAR$88.5 $gild calls$gild #bullishHow #Regulus Therapeutics Inc Four-Week HCV Data Can Interest #Gilead $RGLS , $GILD ‚ûú https://t.co/xWT2UB3YZQ https://t.co/SCkMIdyYisRELCAPITAL.IN Reliance Capital Ltd. Message Board Posts
https://t.co/UlTQB8IvW0

$RELCAPITAL.IN $SQQQ $GILD $ITW  #stock #stockRT @GantosJ: Federal judge reversed a jury's verdict that $GILD should pay $200M to $MRK in a drug-patent dispute  https://t.co/elHJ5YwTx2RT @WrigleyTom: Some Presenting at ...

Goldman
$GWPH
$CELG
$MYGN
$BLCM
$TEVA
$ACAD
$GILD
$JNJ

Jefferies
$EGRX
$NERV

Baird
$FFIV https://‚Ä¶RT @GantosJ: Federal judge reversed a jury's verdict that $GILD should pay $200M to $MRK in a drug-patent dispute  https://t.co/elHJ5YwTx2RT @WrigleyTom: Some Presenting at ...

Goldman
$GWPH
$CELG
$MYGN
$BLCM
$TEVA
$ACAD
$GILD
$JNJ

Jefferies
$EGRX
$NERV

Baird
$FFIV https://‚Ä¶PACD Pacific Drilling SA Stock Forum
https://t.co/KcCTOlH8hF

$PACD $XLI $GILD $T  #share #investing=tweet $ACHN $ESRX $JNJ $GILD
Is Gabelli the same person who was convicted for fraud and felony?RT @WrigleyTom: Some Presenting at ...

Goldman
$GWPH
$CELG
$MYGN
$BLCM
$TEVA
$ACAD
$GILD
$JNJ

Jefferies
$EGRX
$NERV

Baird
$FFIV https://‚Ä¶Wall Street Breakfast: World Shares Higher As Fed Rethinks Rate Hike https://t.co/xD2DfNWkmh $SPY $QQQ $DDAIY $GILD $GS $MRK $SSNLF $VRXBiotech Trade Alerts Archive -2016-06-07- $RGLS, $RARE, $BIIB, $PFE, $IMUC, $VRX,¬†$GILD, https://t.co/wMuk1QYlneHYG iShares iBoxx $ High Yield Corporate Bond ETF Volume
https://t.co/q7swpDEOkE

$HYG $CHK $XLY $GILD  #stocks #investRT @WrigleyTom: Some Presenting at ...

Goldman
$GWPH
$CELG
$MYGN
$BLCM
$TEVA
$ACAD
$GILD
$JNJ

Jefferies
$EGRX
$NERV

Baird
$FFIV https://‚Ä¶OpenOutcrier: RT WrigleyTom: Some Presenting at ...

Goldman
$GWPH
$CELG
$MYGN
$BLCM
$TEVA
$ACAD
$GILD
$JNJ

Jeffe‚Ä¶ https://t.co/eFgg9jGzRVGILD Gilead Sciences, Inc. Company Info
https://t.co/RRpeD7eldq

$GILD $WYNN $USLV $SH  #tradeideas #financeRT @WrigleyTom: Some Presenting at ...

Goldman
$GWPH
$CELG
$MYGN
$BLCM
$TEVA
$ACAD
$GILD
$JNJ

Jefferies
$EGRX
$NERV

Baird
$FFIV https://‚Ä¶RT @GantosJ: Federal judge reversed a jury's verdict that $GILD should pay $200M to $MRK in a drug-patent dispute  https://t.co/elHJ5YwTx2RT @WrigleyTom: Some Presenting at ...

Goldman
$GWPH
$CELG
$MYGN
$BLCM
$TEVA
$ACAD
$GILD
$JNJ

Jefferies
$EGRX
$NERV

Baird
$FFIV https://‚Ä¶RT @WrigleyTom: Some Presenting at ...

Goldman
$GWPH
$CELG
$MYGN
$BLCM
$TEVA
$ACAD
$GILD
$JNJ

Jefferies
$EGRX
$NERV

Baird
$FFIV https://‚Ä¶Some Presenting at ...

Goldman
$GWPH
$CELG
$MYGN
$BLCM
$TEVA
$ACAD
$GILD
$JNJ

Jefferies
$EGRX
$NERV

Baird
$FFIV https://t.co/YfAD1RFovXFEZ SPDR EURO STOXX 50 ETF 52Wk Low
https://t.co/iKhDESMw41

$FEZ $XLP $GILD $ITRK.L  #finance #invest$GILD #Gilead Sciences, Break Out https://t.co/tnU9yRsbNU FOLLOW ME https://t.co/uatmy7vSVBGilead Sciences, Inc. $GILD Rating Reiterated by Robert W. Baird https://t.co/gHHaFxYn0sGilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Morgan Stanley https://t.co/ZnxriVIM07Federal judge reversed a jury's verdict that $GILD should pay $200M to $MRK in a drug-patent dispute  https://t.co/elHJ5YwTx2CDE Coeur D Alene Mines Corp. % Change
https://t.co/ToyDrnXkMk

$CDE $SLV $GILD $FDC  #tradeideas #pennystocksFair value screening candidates via @MorningstarInc $FCAU $SWGAY $GILD $AGN $RH  https://t.co/NvPX6bzszGRT @TradeWithSuper: SA_QuickIdeas: 5 Top Large-Cap Stocks For Greenblatt's Magic Formula https://t.co/INwzedVlyS $AAPL #APPLE $GILD $HPQ $R‚Ä¶RT @pharm_specialty: #GileadSciences Judge Sides With Gilead in Drug-Patent Dispute -- WSJ. Read more: https://t.co/7IRTzmThf9 $GILDICYMI: Judge: Merck's A Liar, Has Dirty Hands; Gilead Won't Have To Pay
https://t.co/53pHxcoXCq
$MRK $GILD #pharma #biotech #HCV #patentsRT @w_biltmore85: $GILD NOT looking for the next big thing like the Pharmasset deal https://t.co/Ei3oSqalNWQuick summary for #ASCO16 heavyweights $AMGN $CELG $GILD $REGN

Biotech Stocks: Much Ado About Nothing at ASCO? https://t.co/QoBhNa3tB1$GILD: Analyst action by Gabelli &amp; Co on Gilead Sciences: https://t.co/yorThNV9Ug https://t.co/pnQHsqOjta#GileadSciences Judge Sides With Gilead in Drug-Patent Dispute -- WSJ. Read more: https://t.co/7IRTzmThf9 $GILDTBF Teck Resources Ltd. EOD Data
https://t.co/hyrZTvaTGp

$TBF $CVX $GILD $CBT  #nasdaq #investingSLW Direxion Daily Semiconductor Bull 3x Shares Change
https://t.co/yE5HqQjgjG

$SLW $BTE.TO $GILD $UPLMQ  #investing #investingRRPIX Guggenheim S&amp;P 500 Equal Weight ETF Ideas
https://t.co/WNFuKCnF3H

$RRPIX $XRM $GILD $FXI  #stocks #shareGilead Sciences, Inc. $GILD EVP Sells $174,040.00 in Stock https://t.co/bpcx7tzWl8Gilead Sciences, Inc. $GILD EVP Sells $174,040.00 in Stock https://t.co/JdsY0CiuC0SA_QuickIdeas: 5 Top Large-Cap Stocks For Greenblatt's Magic Formula https://t.co/INwzedVlyS $AAPL #APPLE $GILD $HPQ $RAI $VIAJNUG Direxion Daily Junior Gold Miners Index Bull 3x Shares Shares
https://t.co/l1y75nbFq4

$JNUG $IWM $JDST $GILD  #nasdaq #stockmarketIWM iShares Russell 2000 ETF Ask
https://t.co/XRS42TmXAW

$IWM $GILD $XLNX $FXI  #pennystocks #stocksITEK Inotek Pharmaceuticals Corp. Stock Message Board
https://t.co/fOjeCbNYaY

$ITEK $HBM.TO $GILD $DIS  #stocks #investGNCA Genocea Biosciences, Inc. Yield
https://t.co/UH2cQYSNVQ

$GNCA $BGS $DIS $GILD  #investing #nasdaqGILD Gilead Sciences, Inc. 52Wk High
https://t.co/zVmdX0M8mx

$GILD $AEM $ITEK $AAPL  #pennystocks #investingThese companies churn out cash like crazy $AAPL $JPM $BAC $C $MSFT $MS $VZ $GILD $WMT $WFC https://t.co/Htg4qWbu8G #stocks #investing@TheStalwart $GILD Baker Bros. are probably happy! @HedgeMind @novuspartnersGilead Sciences, Inc. $GILD Receives $113.34 Average PT from Analysts https://t.co/7aqoeBQgPXNFLX Nemaska Lithium, Inc. Volume
https://t.co/iguQjzr98a

$NFLX $GILD $CVX $ENPH  #finance #stockmarketGilead Sciences, Inc. $GILD Receives $113.34 Average PT from Analysts https://t.co/kGhhPFIPqC@megtirrell @SashaDamouni @matthewherper what are your thoughts on $GILD now? I think it's time to go LONG! @HedgeMind @CNBC @FierceBiotechRT @intowin2017: AAPL Apple, Inc. Filings
https://t.co/xtGfoml18a

$AAPL $IEF $GILD $SPWR  #share #tradeideasAfter reading through $MRK- $GILD, latest ruling serves $MRK. A reminder for small biotechs talking to Big Pharma: they're out to screw you.Gilead Sciences, Inc. $GILD Receives $113.34 Average PT from Analysts https://t.co/EU9RXfZvuvGreat News For #Gilead https://t.co/Hz3yXDrJuR $GILD, $MRKFDC SPDR EURO STOXX 50 ETF Stock Forum
https://t.co/uBWNm10BrX

$FDC $EEM $FXY $GILD  #nasdaq #investingAAPL Apple, Inc. Filings
https://t.co/xtGfoml18a

$AAPL $IEF $GILD $SPWR  #share #tradeideasRT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶$GILD - BUY Signal at 87.51 on Jun 07, 16 By https://t.co/6PpjiKmc9G, Trading Robot#Stockstowatch #Stockmarket #trading #trade #investing#GileadSciences Judge overturns HCV patent ruling in Merck-Gilead case. Read more: https://t.co/wjn6xSeIJK $GILDRT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶$GILD - Judge Sides With Gilead in Drug-Patent Dispute -- WSJ https://t.co/ksIrwMTPbp$BIIB seuraa $GILD :in j√§lki√§, fw. P/E l√§hestyy kymppi√§. Meni ostotutkaan. https://t.co/vPDJaAOPoy@w_biltmore85 ""But I reserve the right to change my mind"" Dr Milligan said. $GILD $GNFT $ICPTINTC iShares Russell 2000 ETF % Change
https://t.co/ygvfHs3xjT

$INTC $PRTS $GILD $XBI  #pennystocks #pennystocksGILD Globus Maritime Ltd. Ask Size
https://t.co/epRiXX2DZ7

$GILD $BTE.TO $PRTS $AVL.TO  #stocks #stockmarketRT @RNAiAnalyst: Do I have that right: $IONS patents valid, but $MRK legal team messes up, so $IONS ends up with nothing? Malpractice suit‚Ä¶RT @w_biltmore85: $GILD NOT looking for the next big thing like the Pharmasset deal https://t.co/Ei3oSqalNWCDE Central Garden &amp; Pet Co. Market Cap
https://t.co/ZE541VTljf

$CDE $EL $GILD $EWG  #stockmarket #shareInvestors Sell Gilead Sciences, Inc. $GILD on Strength Following Insider Selling https://t.co/L2btjmzEN0RT @pharmalot: Gilead won't have to pay $200M in hepatitis c patent case because Merck lawyer lied. read ruling: https://t.co/a2uZahYiw1 #p‚Ä¶RT @w_biltmore85: $GILD NOT looking for the next big thing like the Pharmasset deal https://t.co/Ei3oSqalNW$GILD seems to be taking too long to go FWIW@CraigScott31 Love $GILD. Markets wants them to put their money to work beyond buy backs. A deal or two and it should be back on track.RT @adamfeuerstein: Response to my big-cap biotech turnaround poll question. $GILD by wide margin. https://t.co/wlOqZAs6pVRT @w_biltmore85: $GILD NOT looking for the next big thing like the Pharmasset deal https://t.co/Ei3oSqalNWLegal Dispute Puts #IonisPharmaceuticals' Payday on Hold $IONS $GILD $MRK https://t.co/vkYrcAX5OXRT @w_biltmore85: $GILD NOT looking for the next big thing like the Pharmasset deal https://t.co/Ei3oSqalNWRT @w_biltmore85: $GILD NOT looking for the next big thing like the Pharmasset deal https://t.co/Ei3oSqalNWRT @w_biltmore85: $GILD NOT looking for the next big thing like the Pharmasset deal https://t.co/Ei3oSqalNW$GILD NOT looking for the next big thing like the Pharmasset deal https://t.co/Ei3oSqalNWRT @Biotech2050: #EHA2016 $TGTX
https://t.co/Q8Ns3yPrjA
#ibrutinib $ABBV $GILD #cornerstone pipeline #buyout candidate$GILD: Analyst action by Gabelli &amp; Co on Gilead Sciences: https://t.co/yorThNV9Ug https://t.co/u6VQ8efyE2#EHA2016 $TGTX
https://t.co/Q8Ns3yPrjA
#ibrutinib $ABBV $GILD #cornerstone pipeline #buyout candidateGILD Globus Maritime Ltd. Yield
https://t.co/jffZU9imFP

$GILD $WB $UWTI $WNC  #nasdaq #tradeideasRT @pharmalot: Gilead won't have to pay $200M in hepatitis c patent case because Merck lawyer lied. read ruling: https://t.co/a2uZahYiw1 #p‚Ä¶@adamfeuerstein definitely depends on $gild strategy going forward. hopefully it doesn't become aapl of biotechs: good dividend slow growthABX Barrick Gold Corp. News
https://t.co/MKMNPhDa1l

$ABX $XLF $GILD $UAL  #finance #shareCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶Top 10 Net Payout Yields For June 2016 https://t.co/iGw56XR3UK $AAL $AIG $AMP $BBY $GILD $M $MSI $NTAP $QCOM $UALRT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶EMES Emerge Energy Services LP Bid Size
https://t.co/YdvH08B54k

$EMES $SPWR $GILD $NOV  #stock #investseeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/WpFdFTLfP3  by OphirGottlieb  $CELG $GILD $AMGN‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $AMGN $BIIB $REGNLegal Dispute Puts Ionis Pharmaceuticals' Payday on Hold -- $ions $gild $mrk The Motley Fool https://t.co/96EjlCxOJ3XLK Consumer Staples Select Sector SPDR Fund News
https://t.co/vJke9puzqL

$XLK $USO $PYPL $GILD  #nasdaq #nasdaq@pt117cool I tend to agree, however, $GILD will pay through the nose to acquire the entire company if $ARWR can produce FCs for HBV.RT @adamfeuerstein: Response to my big-cap biotech turnaround poll question. $GILD by wide margin. https://t.co/wlOqZAs6pVRT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶LABD Lending Club Corp. Ask
https://t.co/F9EMBsANVa

$LABD $IYT $JNUG $GILD  #share #stockmarketITB iShares Russell 2000 ETF News
https://t.co/kzi2NlwO8B

$ITB $EEM $IBB $GILD  #stockmarket #investingRT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶RT @Loftus: Judge sides with Gilead against Merck in hepatitis C drug patent dispute, blasts Merck conduct: https://t.co/cqkibrdTwO via @WS‚Ä¶GILD Globus Maritime Ltd. Quotes
https://t.co/OZsh8mfkJw

$GILD $DSX $HYG $HL  #stocks #stockmarketRT @SA_Portfolio: Valuation Dashboard: Healthcare https://t.co/czT3eBBzpc $ABBV $ABC $AKRX $AMGN $BIIB $BSX $CRL $GILD $IBB $MCK $PFE $SPY‚Ä¶",2016-06-08,GILD,0
42,"Stochastic Sell https://t.co/9ehYFreSPQ $CNHI $XHB $HLX $HYG $VEA $XRT $HMY $CYH $AXP $VLY $IBN $GNTX $EMR $MTDR $GILD $CPN $AERCBK Company Info
See Here ---&gt; https://t.co/SFrxFDpZAh

$CBK $GILD $NSAM #pennystocks$GILD:US 5 Stocks To Dump Ahead Of Q2 Earnings Season #GILEAD SCIENCES INC  https://t.co/VuN9CDDwsQ #SP500RT @SharonAConklin: $GILD Looking for autoimmune oral combination assets  S1P1 $ARNA APD-334  ?LIFE Lumber Liquidators Holdings, Inc. Exchange
https://t.co/BybFcoWBLX

$LIFE $STX $GILD $FXG  #finance #investing@musicandwork Pair trade Seymour recommended. $GILDGMO Alphabet Inc. % Change
https://t.co/9t8F0KX7Xv

$GMO $GILD $UWTI $NPC.TO  #tradeideas #stockGILD SPDR Gold Shares Stock Message Board
https://t.co/utGzFSqmgP

$GILD $CENT $GLD $XLI  #stock #pennystocksGE Gilead Sciences, Inc. Open
https://t.co/WSFSb5lO1L

$GE $GILD $SVXY $IWM  #stocks #stocksAAII Blog: MoneyLife Radio Sell of the Week: Gilead Sciences, Inc. $GILD https://t.co/DxLcgbUcTW https://t.co/FBC5J9ZjLwAAII Blog: MoneyLife Radio Sell of the Week: Gilead Sciences, Inc. $GILD https://t.co/bkwlkdFbh4 https://t.co/KAsefaWrPi$GILD Looking for $85... Tomorrow?Tim Seymour: Buy $GILD on valuation (and sell $CELG).J Rae Chipera placed an order to buy 20 shares of Gilead Sciences Inc.  $GILD
https://t.co/UwFrvZueQ1$GILD Gilead Sciences to Present at the Jefferies 2016 Healthcare Conference on Friday, June 10
From our Stock News Alerts App$GILD - Gilead Sciences to Present at the Jefferies 2016 Healthcare Conference on Friday, June 10 https://t.co/vfVRSjKgAVTPLM ProShares UltraPro QQQ Last Trade
https://t.co/1NJ3EscdTL

$TPLM $FB $CHK $GILD  #stock #stockSLW VanEck Vectors Semiconductor ETF P/E Ratio
https://t.co/BYiTDQTxYp

$SLW $WFM $GILD $HRB  #invest #stocksStory of the highest paid research scientist in drug industry. https://t.co/2B5SdXxCVs $REGN $IBB $AMGN $PG $CELG $GILDRT @ZachHurwitz: $GILD is a simple biotech company, doing simple things like failing at the VWAP during a downtrend.  No big deal. https://‚Ä¶$GILD is a simple biotech company, doing simple things like failing at the VWAP during a downtrend.  No big deal. https://t.co/0kKagKW84f$GILD Rejected! #VWAP https://t.co/GCk2pDc7TDHXD.TO iShares iBoxx $ High Yield Corporate Bond ETF Ask
https://t.co/MIi7AitJ3a

$HXD.TO $AG $HGD.TO $GILD  #nasdaq #shareGILD SPDR Gold Shares Message Board Posts
https://t.co/vHO3WWZqMD

$GILD $RELIANCE.IN $ASTID $POU.TO  #pennystocks #tradeideasAAII Blog: @MoneyLifeShow Sell of the Week: Gilead Sciences, Inc. $GILD https://t.co/tmSK3mhnAN https://t.co/pcjugij8rhAAII Blog: @MoneyLifeShow Sell of the Week: Gilead Sciences, Inc. $GILD https://t.co/Kw45JSK0DP https://t.co/V0oqTwOIpJGibraltar Capital Management Inc. Purchases 13,267 Shares of Gilead Sciences, Inc. $GILD https://t.co/QvotTJrkqqQUANTRES ASSET MANAGEMENT Ltd Buys Shares of 11,300 Gilead Sciences, Inc. $GILD https://t.co/3IkcXxiVgaPeddock Capital Advisors LLC Acquires 434 Shares of Gilead Sciences, Inc. $GILD https://t.co/Mcdof4cvLcWendell David Associates Inc. Has $5,379,000 Position in Gilead Sciences, Inc. $GILD https://t.co/9IERXPv0lX$GILD my bearish alert triggered watching price actionShould You Buy Gilead Sciences Inc? $GILD Also $MRK $MDVN $GSK $SNY $VRX $ADAP https://t.co/JzIEGYG7lBMU Message Board Posts
See Here ---&gt; https://t.co/Aq3ihmMhkm

$MU $GILD $BBD #pennystocks@musicandwork Wish I knew. Looks like manipulation to me. Why? Who knows. $GILDLol. Just precious. I've seen less spin on a Clayton Kershaw curveball. #HBV $ARWR $GILD  https://t.co/sfccTKhVEQFor those of you looking for the $MRK v. $GILD #patent unenforceability decision, I've got you covered: https://t.co/qpSijpdxUqGLD Randgold Resources Ltd. Last Trade
https://t.co/AmlsZtJu0i

$GLD $GILD $LUV $VLTC  #pennystocks #investingGILD SPDR Gold Shares Bid
https://t.co/ptJ8eYt1X5

$GILD $STZ $WFM $DWTI  #investing #stocksRT @ConsumerFeed: Gilead Sciences's buy rating reiterated at Leerink Swann. https://t.co/qZJwT96ORv $GILD #GILDHolding $abbv, $bac, $gild, $msft, $wfc &amp; some good 'ol $spy 208P for good measureGilead Sciences Reiterated Rating by Leerink Swann (Ranked 70th) to Buy $GILD #GILD https://t.co/nyq7xJnbR7Gilead Sciences‚Äô $GILD ‚ÄúBuy‚Äù Rating Reaffirmed at Leerink Swann https://t.co/iLmzmygXB8Gilead Sciences's buy rating reiterated at Leerink Swann. https://t.co/qZJwT96ORv $GILD #GILD$GILD price action is reaction to mgmt playing the fiddle... https://t.co/HthUofO9oa$FB $AAPL $NKE $SPY $GILD $GLD $USO $BABA $JNUG  Here's the fear n greed index updated a few mins ago https://t.co/Gr0NN1B8R2WWAV USX-US Steel Group, Inc. Last Price
https://t.co/y9mpMzBZgm

$WWAV $NEM $ERX $GILD  #invest #tradeideas@GerberKawasaki I bet it's some smart HF buying into them! $SBUX expanding &amp; $GILD w/ patent...both winners!@AdamSinger Sure, no one wants $GILD 2 do stupid acquisition but doing nothing major 2 build another leg of the stool #@#!!!% frustrating.@AdamSinger Didn't / doesn't have 2 b that way tho. $GILD cash flow ginormous but dallied (share buy backs etc) when c/h lined up next act.GILD Chart
See Here ---&gt; https://t.co/CbkV2LyDs2

$GILD $SBR $RH #stock$GILD - love this cartoon of little Dutch Boy trying to keep sand from falling in the hour glass. #StateOfDenial https://t.co/FUlPf4fJ6iGILD $GILD https://t.co/11E5TVmJ06RT @cfromhertz: Biotech $IBB $XBI very weak after we saw a HUGE put buyer:
&gt; 8,719 IBB Sep 250p @ $6.20   OPENING /   $5.4mm trade
$CELG $A‚Ä¶Biotech $IBB $XBI very weak after we saw a HUGE put buyer:
&gt; 8,719 IBB Sep 250p @ $6.20   OPENING /   $5.4mm trade
$CELG $AMGN $BIIB $GILDbl: $GILD-premkt news sells it off -2 to its - bl https://t.co/NaKKNEdBrV$GILD happy with that exit. Actually considering puts as we could see weekly wedge demand touch again. https://t.co/XiJ3kGWpDSRT @Escells: Will Gilead $GILD Stock Be Helped by Hepatitis C Drug Patents Case Win? https://t.co/HJq1ytAbu5Biotech stocks breaking low  $IBB $GILD $IBB $XBI $LABU $AMGN bearish options flowGabelli Research Says Gilead's HCV Sales To Crash Badly And Soon: Analysis https://t.co/A5aQ9mlAz3 $ACHN $ESRX $JNJ $GILDGILD Alphabet Inc. - Class C Chart
https://t.co/U2R8eexzzj

$GILD $MUX $RHS $ITB  #stocks #stocksMFC 52Wk High
See Here ---&gt; https://t.co/Mz9RMwD8Z1

$MFC $GILD $GIFI #investRT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶$GILD AddWho Will Win The Zika Wars? $GILD $XON $SNY 
https://t.co/bMWfl5178PRT @Escells: Will Gilead $GILD Stock Be Helped by Hepatitis C Drug Patents Case Win? https://t.co/HJq1ytAbu5RT @Escells: Will Gilead $GILD Stock Be Helped by Hepatitis C Drug Patents Case Win? https://t.co/HJq1ytAbu5$GILD might be on my chopping block today. Still holding some of the swing. The close will tell me. Stop set emotions out.RT @Escells: Will Gilead $GILD Stock Be Helped by Hepatitis C Drug Patents Case Win? https://t.co/HJq1ytAbu5$GILD way oversold. Buy $GILD.Volume Alert - GILD 86.06 Gilead Sciences Inc $GILD Hit a high today of 87.25 Closing the day 10:30 at 86.06 - https://t.co/MmckPzCCmrWill Gilead $GILD Stock Be Helped by Hepatitis C Drug Patents Case Win? https://t.co/HJq1ytAbu5Ex-Dividend Stocks Of The Next Week June 13 - 19, 2016 - https://t.co/ihGgGunjvT - $KO $MRK $UNH $MO $GILD $SNP $AVGO $TMO $ORGAN $AMT $FDXGood for my $GILD position https://t.co/eK7W24UHSaSLW VanEck Vectors Semiconductor ETF Ask
https://t.co/uCob4ySVzy

$SLW $WMT $GOOGL $GILD  #share #pennystocksMNOV Stock Message Board
See Here ---&gt; https://t.co/PWgbopNjQi

$MNOV $GILD $MKC #investingBANK BIOTECH ALL DOWN  AS EXPECTED  $GILD $SSYS $BABA  , look what we told our premium members yestrday, https://t.co/TJKZMHmSmQPeople have asked us for current portfolio in size order. $AAPL $JPM $SBNY $SBUX $CFRUY $GILD $HCA $ILMN $QCOM $AC. Sold most else early '16RT @BrandenMuhl: Amen. 5yrs ago ppl criticized industry 4 only treatments (esp $GILD HIV) &amp; no cures. Now üò¢ abt $ 4 cure. Some ppl. https:/‚Ä¶RT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶RT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶Amen. 5yrs ago ppl criticized industry 4 only treatments (esp $GILD HIV) &amp; no cures. Now üò¢ abt $ 4 cure. Some ppl. https://t.co/vXnihhAGCbGILD SPDR Gold Shares Stock Message Board
https://t.co/GbrUl6hDdQ

$GILD $VIXY $XLE $LIFE  #pennystocks #stocksWeekly Investment Analysts‚Äô Ratings Updates for Gilead Sciences $GILD https://t.co/gl9o289ngHWeekly Investment Analysts‚Äô Ratings Updates for Gilead Sciences $GILD https://t.co/X7Lj7yZBLKWeekly Investment Analysts‚Äô Ratings Updates for Gilead Sciences $GILD https://t.co/pJH6Ez2rksWeekly Investment Analysts‚Äô Ratings Updates for Gilead Sciences $GILD https://t.co/XMEer9NcqnRT @intercooleronli: Gilead Sciences, Inc. $GILD Earns ‚ÄúHold‚Äù Rating from Morgan Stanley https://t.co/KsSCZiUl8BRT @murphym45: ""I want to go on the record -- I think that Sovaldi was underpriced for what it does.""
-Mark Alles, Celgene CEO
#BIO2016 $CE‚Ä¶RT @BiotechRadar: Bischofberger at Goldman Sachs GHC: $GILD also has an FXR agonist for NASH but according to him OCA safety profile is not‚Ä¶XLK Technology Select Sector SPDR Fund Quotes
https://t.co/6VgtYtNmyC

$XLK $GILD $ABX $KORS  #tradeideas #stocksGilead Sciences, Inc. $GILD Earns ‚ÄúHold‚Äù Rating from Morgan Stanley https://t.co/KsSCZiUl8BGilead Sciences, Inc. $GILD Earns ‚ÄúHold‚Äù Rating from Morgan Stanley https://t.co/4vLY9T7ffyGilead Sciences, Inc. $GILD Earns ‚ÄúHold‚Äù Rating from Morgan Stanley https://t.co/3nds7zyklBGilead Sciences, Inc. $GILD Earns ‚ÄúHold‚Äù Rating from Morgan Stanley https://t.co/GqCM3sjhsu@SuprunaMans $GILD is looking for oral autoimmune and $ARNA has a good unpartnered one.SVM.TO Silvercorp Metals Inc. Short Sales
https://t.co/nKN7dLRulp

$SVM.TO $TAHO $IYR $GILD  #stockmarket #stocksGILD Top news - Jun 9th, 2016 $GILD https://t.co/F3ywxjboPX$GILD - few months back did they not say they want to grow core, now its oncology, hard to tell mgt thinking ... https://t.co/rQCx6BVAVtRT @SharonAConklin: $GILD Looking for autoimmune oral combination assets  S1P1 $ARNA APD-334  ?RT @HenryEChang: ~30,000 U.S. veterans received #HCV tx in FY15 with drug costs btw $25,000 &amp; $124,000 per regimen @USGAO #HepC $GILD https‚Ä¶NKE Nike Inc. Volume
https://t.co/VVoTQ0HW3K

$NKE $VIXY $GILD $MU  #finance #stockmarket$GILD should buy $TWTRGILD Gilead Sciences, Inc. Company Info
https://t.co/5QpUVDtfBP

$GILD $HD $SVM.TO $NUGT  #share #tradeideas$GILD problems ahead - it tried to breakout above down TL &amp; failed now resistance again, Down side risk lower  60's https://t.co/5lmVlZMWxe$GILD Looking for autoimmune oral combination assets  S1P1 $ARNA APD-334  ?RT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶RT @SashaDamouni: In cash you missed, $GILD said earlier at Goldman they don't have a need for external NASH opportunities now, more focuse‚Ä¶Morning Alert Gilead Sciences $GILD Advanced Micro Devices‚Ä¶ https://t.co/SqdJ5w8RMu @ShareStockNewshttps://t.co/p7tVeJhgUx Millionaire Road Map Trading top students win a Porsche for a yr! $LNKD $CVX $GILD $STX $PGILD Gilead Sciences, Inc. % Change
https://t.co/rrKUipvd7b

$GILD $ZSL $GLD $ULE  #stock #shareDividend Growth Theme Should Continue 2 Work Long-Term-see also https://t.co/QZMz0mUhBH $AAPL $AMZN $BUD $CSCO $GILD https://t.co/2TG73eSHT6RT @SashaDamouni: In cash you missed, $GILD said earlier at Goldman they don't have a need for external NASH opportunities now, more focuse‚Ä¶RT @SashaDamouni: In cash you missed, $GILD said earlier at Goldman they don't have a need for external NASH opportunities now, more focuse‚Ä¶CTIB CTI Industries Corp. Day Low
https://t.co/AjXHDz2VwF

$CTIB $GILD $WB $FMSA  #pennystocks #investingEx-Dividend Stocks Of The Next Week June 13 - 19, 2016 - https://t.co/ihGgGuEUUt - $KO $MRK $UNH $MO $GILD $SNP $AVGO $TMO $ORGAN $AMT $FDXDon't Get Caught With These 5 Stocks Ahead of #Earnings Season $AA $CMG $GPS $AAPL $GILD https://t.co/RsgsUHn9WCCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5SSRI Silver Standard Resources, Inc. Change
https://t.co/dkWnJlHZZP

$SSRI $TLT $FB $GILD  #stockmarket #pennystocks#Gilead $GILD Ninety-Nine Problems But #Merck $MRK Ain't One  https://t.co/uvRAXhxOr4Gilead Says Doesn‚Äôt Have Need for External NASH Opportunities... $GILD $ICPT $GNFT $GLMD $TBRA https://t.co/TzqIuHKHsmhttps://t.co/G9pMgSID8y &lt; Review of this fantastic traders teaching service! Try it for FREE! $GILD $CMG $XON $FGILD Gilead Sciences, Inc. Tick
https://t.co/rkA0k7jWWF

$GILD $LQD $K.TO $SBB.TO  #finance #stocksShould You Buy Gilead Sciences Inc? $GILD https://t.co/VcDk5ndhv7 https://t.co/FaUsLwuCBzRT @SashaDamouni: In cash you missed, $GILD said earlier at Goldman they don't have a need for external NASH opportunities now, more focuse‚Ä¶RT @Carine1111111: $GNFTF @genfit_pharma $GILD #ELAFIBRANOR 
https://t.co/QELzYomFE8RT @Carine1111111: #NASH #genfit #GNFT #GNFTF $GILD $ICPT https://t.co/BmCPZp6cjI#GileadSciences Gilead To Present At The Goldman, Sachs &amp; Co. 37th Annual Global Healthcare... Read more: https://t.co/it6MyoU1BW $GILD#GileadSciences Hydra Biosciences to Present at the JMP Securities Life Sciences       Conf... Read more: https://t.co/jTbfV1hlIE $GILDGilead Sciences‚Äô $GILD Hold Rating Reaffirmed at Maxim Group https://t.co/7poW0JaulHSIG PureFunds ISE Junior Silver ETF Shares
https://t.co/2KnFaLwHmR

$SIG $SNPS $GILD $XLV  #invest #stocksRT @FREDERICDJA: Genfit's NASH Phase 2b Results Are Published And Confirm The Biotech's Lead https://t.co/moSiyFU5I6 $CNAT $GILD $GLMD $ICP‚Ä¶RT @FREDERICDJA: Therapy Focus - NASH Projects Set For Data In Dog Days Of Summer https://t.co/qQg9bKiUz7 $GNFTF $TBRA $IMROY $GILD$GILD trading at a 13% discount, time to grab a bargain? https://t.co/TcaGaeAbFl https://t.co/Qsy1ppKoXz$GNFTF @genfit_pharma $GILD #ELAFIBRANOR 
https://t.co/QELzYomFE8#NASH #genfit #GNFT #GNFTF $GILD $ICPT https://t.co/BmCPZp6cjIRT @BioWorld: $GLPG, $GILD deal had ""lots of moving parts"": equity investment, co-development, co-promote option; closed in 3 mos. #Allicen‚Ä¶RT @BiotechRadar: Bischofberger at Goldman Sachs GHC: $GILD also has an FXR agonist for NASH but according to him OCA safety profile is not‚Ä¶$GILD Gilead Sciences Inc at Goldman Sachs Global Healthcare Conference Transcript is now available #earnings https://t.co/pZXkWDF8wkHRL Hormel Foods Corp. 52Wk High
https://t.co/PzF3GH3jD3

$HRL $SHW $DNR $GILD  #nasdaq #investGILD Gilead Sciences, Inc. Prev Close
https://t.co/lCBpQlKeyE

$GILD $SLW.TO $TAP $AMGN  #stockmarket #financeRT @CashRocket: TOP UPCOMING EVENTS IN 2016: $BIIB $VRTX $ESPR $MDCO $SCYX $PRTA $AMGN $CELG $KITE $INFI $GILD $ACOR $PTI $FGEN https://t.c‚Ä¶Maxim Group Reiterates ‚ÄúHold‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/jr0gSOb1ZVWondering about risks of $GILD? The 63-day volatility is 14.29% https://t.co/YrfwPBvvTuGilead Sciences Reiterated Rating by Maxim Group (Ranked 76th) to Hold $GILD #GILD https://t.co/nyq7xJENfHWe calculated 63-day Expected Return of $GILD for you: -0.1% https://t.co/mTgAzU9UadWe calculated 21-day Expected Return of $GILD for you: 3.35% https://t.co/mTgAzU9Uad$GILD $89.95 is doableGLD SPDR Gold Shares Bid
https://t.co/tko3DKbegD

$GLD $VRX $NTRA $GILD  #invest #stocksGILD Gilead Sciences, Inc. Prev Close
https://t.co/HyYnfg0rHb

$GILD $UUP $ONE $WFT  #tradeideas #stocksConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNRGILD Quotes
See Here ---&gt; https://t.co/jXa9EGSsli

$GILD $SFUN $DYN #investingDon't Get Caught With These 5 Stocks Ahead of #Earnings Season $AA $CMG $GPS $AAPL $GILD https://t.co/PEn43ZLcvYGilead Sciences, Inc. $GILD CEO John F. Milligan Sells 112,000 Shares https://t.co/HFkJPzNOwNGilead Sciences, Inc. $GILD CEO John F. Milligan Sells 112,000 Shares https://t.co/sMaiYQrRmVPOT.TO Potash Corp. of Saskatchewan, Inc. Ask Size
https://t.co/CrkBJkIlVn

$POT.TO $GILD $TRKK $UNG  #stock #investNG NovaGold Resources Inc Stock Message Board
https://t.co/x5bBRZ4sf0

$NG $XLE $MLPY $GILD  #nasdaq #stockmarketRT @CBOE: #optionstrading @jonnajarian $GILD &amp; $WFT trades on @CNBC @HalftimeReport portfolio #TeamJon https://t.co/km4MlJmDki https://t.co‚Ä¶GILD Gilead Sciences, Inc. Stock Forum
https://t.co/tRlgj2cTp1

$GILD $WFT $XLB $ONE  #invest #stocks$GILD - BUY Signal at 87.51 on Jun 07, 16 By https://t.co/6PpjiKmc9G, Trading Robot#Stockstowatch #Stockmarket #trading #trade #investingTLT iShares 20+ Year Treasury Bond ETF 52Wk High
https://t.co/40JpoNrUIR

$TLT $USO $GILD $SLV  #pennystocks #stockmarket$GILD 2016 Goldman Sachs. Note HBV language (&amp; GILD use of woodchucks üòâ). https://t.co/aOXvGRxxKnPOU.TO Paramount Resources Ltd. Stock Forum
https://t.co/ITE4ML8Adv

$POU.TO $GILD $EEM $NOC  #pennystocks #financeJune 08 Wednesday, $GILD closed $87.42RT @BioWorld: $GLPG, $GILD deal had ""lots of moving parts"": equity investment, co-development, co-promote option; closed in 3 mos. #Allicen‚Ä¶@RyanEGerry @BiotechPays ryan one point I agree small caps more riskier than companies like $celg $bmy $gild. crap data stock gets killedGILD Gilead Sciences, Inc. Ideas
https://t.co/U9XY5UyDzY

$GILD $FDC $LABU $MNKD  #stockmarket #stocks",2016-06-09,GILD,0
43,"ABMD ABIOMED, Inc. Ask
https://t.co/D3EGnxQ9JC

$ABMD $IYT $GILD $XIV  #investing #stockmarketRT @Allstocknews: $GILD Gilead Sciences to Present at the 36th Annual William Blair Growth Stock Conference on Tuesday, June 14
From our St‚Ä¶XLF Industrial Select Sector SPDR Fund Chart
https://t.co/xpMsQ4s3hH

$XLF $AEM $NFLX $GILD  #finance #stockTQQQ Trupanion, Inc. Bid
https://t.co/1QNO24xqdF

$TQQQ $_SPY $IBM $GILD  #pennystocks #invest@jimcramer Dont know why $GILD is so down either!But when its raining gold, $GILD will b there w/HUGETUB,not tbsp.w/all that cash #madtweetsNR7-2 https://t.co/jD1v0BWBLh $AXLL $SLCA $WEC $GILD $AWK $PAGP $CMC $KKD $NERV $RVNC $EDIT $HHC $TGTX $DLTH $EPZM $AMBA $NWNSVXY Smith &amp; Wesson Holding Corp. Short Sales
https://t.co/wDCtdOAhu9

$SVXY $DBA $GILD $NEM  #stockmarket #investingSSO Silver Standard Resources, Inc. Exchange
https://t.co/FpgArT5ZIz

$SSO $SH $GILD $XBI  #investing #investRH Transocean, Inc. Market Cap
https://t.co/SUznFPfvCK

$RH $GILD $TNA $HYG  #share #finance$GILD:US Gilead Sciences, Inc. (GILD) To Go Ex-Dividend on June 14th #GILEAD SCIENCES INC  https://t.co/en3YuebTv2 #NASDAQ$GILD:US Gilead Sciences, Inc. (GILD) To Go Ex-Dividend on June 14th #GILEAD SCIENCES INC  https://t.co/rEzm7oXl77 #SP500GILD SPDR Gold Shares Ex-Div Date
https://t.co/tAkb0SEHXq

$GILD $GS $CHK $CERE  #stock #tradeideasEW Endeavour Silver Corp. P/E Ratio
https://t.co/Xtnu1Rd9MN

$EW $GILD $WB $SN  #stockmarket #shareRT @HenryEChang: Gilead says Medicaid price for Harvoni: ~$31,000 for 12-wks; 40% can be treated with 8-wks regimen. @jamie_love #a2mharvar‚Ä¶Bloomberg: 'Everything's A Buy' Really? https://t.co/yZfg0uTOg6 $SPY $GILDThe Best Stocks By Shareholder Yield As Of June 2016 - https://t.co/I8zjKvrr7c - $AAL $AIG $AMP $GILD $M $NTAP $QCOM $DAL $BBY $MSI@CGrantWSJ Snail mail company Pitney Bowes Inc. $PBI (9.4 p/e) is viewed by the market as having higher growth potential than $GILD !!!!Did $GILD receive the invite by accident?  LOL https://t.co/GyE1c6AZwM https://t.co/Yt27IxGr1l$GILD Gilead Sciences to Present at the 36th Annual William Blair Growth Stock Conference on Tuesday, June 14
From our Stock News Alerts App$GILD - Gilead Sciences to Present at the 36th Annual William Blair Growth Stock Conference on Tuesday, June 14 https://t.co/JjGu4Qp2C8Check out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5UNG United States Oil Fund, LP Day High
https://t.co/FbgJV1rRmS

$UNG $IBM $LULU $GILD  #investing #pennystocksRT @HenryEChang: Gilead says Medicaid price for Harvoni: ~$31,000 for 12-wks; 40% can be treated with 8-wks regimen. @jamie_love #a2mharvar‚Ä¶@JFinDallas of them. &amp; by they should be priced (latter on)by the way their work on CarT. That is $JUNO trading like $GILD (or more) and (3)$GILD - Gilead Sciences' #GILD ""Hold"" Rating Reiterated at Jefferies Group https://t.co/kWQZA03w2HMCD Marathon Oil Prev Close
https://t.co/FARj51MygX

$MCD $DUST $GILD $ERX  #invest #investLULU SPDR S&amp;P MIDCAP 400 ETF Stock Forum
https://t.co/8OMNYU7oac

$LULU $GILD $WFM $SSO  #stockmarket #nasdaqJune 13 Monday, $GILD closed $83.98GILD Alphabet Inc. - Class C Ask Size
https://t.co/MM7cbS3CEr

$GILD $VRX.TO $EDIT $IWM  #invest #invest$GILD $HCP:

Why Abbott Laboratories Is The Next High-Yield Health Care ‚Ä¶:

https://t.co/tPpJsNTipSGilead Sciences's hold rating reiterated at Jefferies Group. https://t.co/TJWrqApcEw $GILD #GILDBAC Baidu, Inc. Quotes
https://t.co/SLUW0WRhM1

$BAC $LMT $SWHC $GILD  #pennystocks #pennystocksRT @HenryEChang: Gilead says Medicaid price for Harvoni: ~$31,000 for 12-wks; 40% can be treated with 8-wks regimen. @jamie_love #a2mharvar‚Ä¶RT @Benzinga: Gilead's HCV Franchise Erosion Here To Stay; Leerink Cuts Price Target $GILD https://t.co/uNXb4JvcqfBenzinga: Gilead's HCV Franchise Erosion Here To Stay; Leerink Cuts Price Target $GILD https://t.co/g6d5wxNTRRST Germain D J Co. Inc. Increases Position in Gilead Sciences, Inc. $GILD https://t.co/RYrDMwimaOBenzinga: Gilead's HCV Franchise Erosion Here To Stay; Leerink Cuts Price Target $GILD https://t.co/DiVhRls4KmOLD National Bancorp IN Sells 1,026 Shares of Gilead Sciences, Inc. $GILD https://t.co/j0joNRxQ4vGilead's HCV Franchise Erosion Here To Stay; Leerink Cuts Price Target $GILD https://t.co/uNXb4JvcqfRT @Biotech2050: RBC Capital Markets #biotech #video
$CELG #Revlimid #TopPick #Abraxane
$BIIB $GILD $VRTX 
#buyouts 
$IBB $XBI https://t.co‚Ä¶$GILD - Legacy Private Trust Co. Has $2,291,000 Position in Gilead Sciences, Inc. #GILD https://t.co/2E0osJfs7N$GILD - Bridges Investment Management Inc. Lowers Stake in Gilead Sciences, Inc. #GILD https://t.co/bO2ylrfHerTBT iShares 20+ Year Treasury Bond ETF Investor Opinions
https://t.co/bzbOE6xWwv

$TBT $BIB $MGT $GILD  #invest #investGilead Sciences, Inc. $GILD Shares Bought by Saddle Road Partners LLC https://t.co/YcShcJ7xJkLarge Call Trades https://t.co/wxPJ1z7TaC $NFLX $ASNA $ETE $KGC $KMI $FEYE $SPY $C $SYMC $MGM $TRQ $ATVI $AAPL $GILD $UTX $ACM $FB $SQQQRT @RisingTideER: $CYDY $GILD $JNJ https://t.co/2hmewP1NL4  Read our newest equity report #investing #biotech #Stocks #pharmaThe Best Stocks By Shareholder Yield As Of June 2016 - https://t.co/I8zjKvJ1YK - $AAL $AIG $AMP $GILD $M $NTAP $QCOM $DAL $BBY $MSIRT @HenryEChang: Gilead says Medicaid price for Harvoni: ~$31,000 for 12-wks; 40% can be treated with 8-wks regimen. @jamie_love #a2mharvar‚Ä¶Gilead says Medicaid price for Harvoni: ~$31,000 for 12-wks; 40% can be treated with 8-wks regimen. @jamie_love #a2mharvard #HCV #HepC $GILDCVS Deutsche Bank AG Prev Close
https://t.co/juvFQSmunx

$CVS $MCD $GILD $BABA  #tradeideas #investHFWA EOD Data
See Here ---&gt; https://t.co/6GdtPWZXmY

$HFWA $GILD $MRCY #stocks$120PT trading at 6.5x 2016 EPS estimates $GILD https://t.co/YZGKrit6f6$GILD investor worries how to rescue his deep in the money naked put positions. Here's some repair and rescue ideas https://t.co/ATotvfv2sz$INTC remains 1 of my top picks. Yet, I also like $AAPL $QCOM..
https://t.co/QZMz0mUhBH $AAPL $AMZN $BUD $CSCO $GILD https://t.co/lkktZVQNVzUGAZ ProShares UltraPro S&amp;P500 Shares
https://t.co/9QRMu5hKeN

$UGAZ $DB $GILD $GDX  #invest #stockLast Week Was a Mixed Bag for the Biotech Sector $AMGN $BIIB $GILD $IBB https://t.co/wrXxghxk9iGilead: One Down, Two To Go https://t.co/xsfD7JMoTK $GILDFor those looking for a good short in the healthcare/bio space, look at $gild. LT downtrend and close to testing support againRT @CashRocket: TOP UPCOMING EVENTS IN 2016: $BIIB $VRTX $ESPR $MDCO $SCYX $PRTA $AMGN $CELG $KITE $INFI $GILD $ACOR $PTI $FGEN https://t.c‚Ä¶SwingWarrior: Gilead | $GILD | Slowing Sales, Shares Slide https://t.co/SzBabC7dyf | #News #Stocks #Market #NYSE ‚Ä¶ https://t.co/eTq821ju6kGilead | $GILD | Slowing Sales, Shares Slide https://t.co/7roJwvtht4 | #News #Stocks #Market #NYSE #NASDAQ $SPY https://t.co/EcRP3CNSWKGilead | $GILD | Slowing Sales, Shares Slide https://t.co/y5xsa8TYmJ | #News #Stocks #Market #NYSE #NASDAQ $SPY https://t.co/UymrajuRNaGilead | $GILD | Slowing Sales, Shares Slide https://t.co/wr8s7jOzKO | #News #Stocks #Market #NYSE #NASDAQ $SPY https://t.co/n0JrUE5voyGilead | $GILD | Slowing Sales, Shares Slide https://t.co/gAgptgEmah | #News #Stocks #Market #NYSE #NASDAQ $SPY https://t.co/8l5l8U0tFoRT @HenryEChang: Gilead's #HCV drug discovery effort ended ~2 years ago; shifted resources to #HBV drug development says $GILD's CSO. https‚Ä¶RT @Tootix: VIDEO: Prevalence of #NASH -induced cirrhosis more than doubled between 1999 and 2012 https://t.co/vrSpUwdt5U $GNFT $ICPT $GILDGILD Alphabet Inc. - Class C Summary
https://t.co/tDqAr0QnRt

$GILD $COP $YELP $XRT  #nasdaq #nasdaq@SharpMango Bare bones around $3.85 a share. $CELG + $GILD programs likely worth a lot more.RT @ScalpMaster1: Long Watches: $AGIO, $SAIC, $TSLA, $SWHC, $EBIO, $SYMC, $TWTR, $NVDA! Short Watches: $CMG, $BIDU, $CRM, $CCL, $GILD, $SCT‚Ä¶RT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶VIDEO: Prevalence of #NASH -induced cirrhosis more than doubled between 1999 and 2012 https://t.co/vrSpUwdt5U $GNFT $ICPT $GILDCP.TO Cisco Systems, Inc. Financials
https://t.co/tVZptFJ0L5

$CP.TO $NKE $CHK $GILD  #stockmarket #stocksVolume Alert - GILD 84.37 Gilead Sciences Inc $GILD Hit a high today of 84.81 Closing the day 10:30 at 84.37 - https://t.co/kkZaEKZzTLRT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶RT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶$TGTX for you to grab a huge position @GileadSciences $GILD then make a mega offer for the shares u do not own to make it acceptable to mngtLarge Cap Growth Stocks ‚Äì a study by Ruben Satink ‚Äì $AMGN $GILD $MYL¬†$TEVA https://t.co/U0VKUdbZQ8 https://t.co/944QWUEEwwRT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶RT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶$GILD sitting right at it's 880d MAVGRT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD $GILD $SRPT@greggalton at $GILD move access programs from commercial group, give company people stronger incentives for global access #a2mHarvardRT @finboxio: Can Pfizer's Outperformance Continue? $PFE @ideagenerator01 https://t.co/3cdiQYzXps $AGN $GILD $AZN #trading #stocks https://‚Ä¶RT @MarginHunt: Gilead Sciences Is On The Cusp Of A Breakthrough In NASH @ideagenerator01 https://t.co/kXrwvN7CkX $GILD #investing https://‚Ä¶Assessing Gilead's Prospects In HIV/AIDS, With Comments On HCV As Well https://t.co/v2oLue6ZNN $ABBV $BMY $GSK $JNJ $MRK $SPY $GILDCan Pfizer's Outperformance Continue? $PFE @ideagenerator01 https://t.co/3cdiQYzXps $AGN $GILD $AZN #trading #stocks https://t.co/RLQL38ByV9@cafepharma These seekingalpha pieces should be considered w/ caution but if $GILD emerges in NASH, bad for $ICPT valuation$GILD:US Gilead Sciences, Inc. (GILD) To Go Ex-Dividend on June 14th #GILEAD SCIENCES INC  https://t.co/j7tGS00oth #NASDAQGilead Sciences‚Äô $GILD ‚ÄúHold‚Äù Rating Reiterated at Maxim Group https://t.co/D17rrnMprwPrice Target Alert: Trading the Zacks price target change for GILEAD SCIENCES¬†$GILD https://t.co/rJkJBEAoKC https://t.co/UvLSFEA02KGilead Sciences Is On The Cusp Of A Breakthrough In NASH @ideagenerator01 https://t.co/kXrwvN7CkX $GILD #investing https://t.co/ChWKFl2sYY$GILD:US Gilead Sciences, Inc. (GILD) To Go Ex-Dividend on June 14th #GILEAD SCIENCES INC  https://t.co/04BkEVrafH #SP500$GILD:

Assessing Gilead‚Äôs Prospects In HIV/AIDS, With Comments On HCV ‚Ä¶:

https://t.co/m5msz9aNPPAssessing Gilead's Prospects In HIV/AIDS, With Comments On HCV As Well https://t.co/UPnBHRAeN4 $ABBV $BMY $GSK $JNJ $MRK $SPY $GILDAssessing Gilead's Prospects In HIV/AIDS, With Comments On HCV As Well https://t.co/nLWIfOPjy1 $ABBV $BMY $GSK $JNJ $MRK $SPY $GILDAssessing Gilead's Prospects In HIV/AIDS, With Comments On HCV As Well https://t.co/NoBDUuSoui $ABBV $BMY $GSK $JNJ $MRK $SPY $GILDDWTI Eleven Biotherapeutics Inc. Stock Message Board
https://t.co/eoIjfhScxp

$DWTI $GILD $RSP $POT.TO  #invest #pennystocksGilead Sciences, Inc. $GILD Cut to Sell at Zacks Investment Research https://t.co/GaB7UKPl85GILD Top news - Jun 13th, 2016 $GILD https://t.co/DJK5O9prB9Gilead Sciences downgraded by Zacks Investment Research to sell. https://t.co/e9VbJj7dkH $GILD #GILDGilead Sciences, Inc. $GILD Cut to Sell at Zacks Investment Research https://t.co/qWkIujL44PARGS Argos Therapeutics, Inc. Financials
https://t.co/Vt2xpCZtLN

$ARGS $PGLC $VTI $GILD  #tradeideas #financeAMZN https://t.co/sYi72hSCKd, Inc. Ideas
https://t.co/rsfobaNigH

$AMZN $LNKD $NGVT $GILD  #stock #nasdaqRT @bob56300: #genfit Gilead: One Down, Two To Go https://t.co/lmd7ddfAdW $GILD$CYDY $GILD $JNJ https://t.co/2hmewP1NL4  Read our newest equity report #investing #biotech #Stocks #pharmaSAlphaTrending: Gilead: One Down, Two To Go https://t.co/920bFqEmvO $GILDStocks with strong double-bottom pattern: $TLRD, $GEN, $GILD, $ABYSAlphaTrending: Gilead: One Down, Two To Go https://t.co/GKzVMFNcmc $GILD#genfit Gilead: One Down, Two To Go https://t.co/lmd7ddfAdW $GILD#CBC member market overview is out $SPY $SPX $IWM $QQQ $AAPL $UVXY $CHK $MU $DDD $TWTR $IBB $GILDMy #StockMarket Weekend Review VIDEO: $VIX $TLT $XLE $XOM $FXI $IBB $GILD $SPY $XLF $GS $IWM $QQQ $AAPL $FB $RH $PAY https://t.co/ebxdKvtMCWLong Watches: $AGIO, $SAIC, $TSLA, $SWHC, $EBIO, $SYMC, $TWTR, $NVDA! Short Watches: $CMG, $BIDU, $CRM, $CCL, $GILD, $SCTY!Gilead: One Down, Two To Go https://t.co/2Ne8tjd0zu ‚Ä¶ $GILD https://t.co/rmksqwQIsATomorrow's ex-dividend dates $XCEL $BACHY $GILD $SNP $FIS and 36 more https://t.co/8K76LaiyrB $$Gilead: One Down, Two To Go https://t.co/7fQn8PfEiD $GILD@bradloncar Perhaps $CELG, $BIIB or $GILD can pull off something similar...$GILD:

Gilead: One Down, Two To Go:

https://t.co/qtM5wLU7QBGilead: One Down, Two To Go https://t.co/H3YLArVJow $GILDGilead: One Down, Two To Go https://t.co/qXZY4XQWYh $GILDThis is the tech equivalent of a big $GILD deal. Our turn next?RSP Guggenheim S&amp;P 500 Equal Weight ETF Change
https://t.co/nl6JGNo8UN

$RSP $GILD $CNC $SBUX  #investing #pennystocksGilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Leerink Swann https://t.co/ufSgkrzMFlGILD Gilead Sciences, Inc. Last Trade
https://t.co/yjh5HZyuqE

$GILD $AXTI $TLT $AAPL  #stockmarket #pennystocksFNMA Federal National Mortgage Current Price
https://t.co/HkkTINxlg4

$FNMA $GDX $GILD $CHK  #investing #stockmarketSwingWarrior: Gilead | $GILD Stock | Slowing Sales, Shares Slide https://t.co/zNXGV4UZvY #gild #gileadRT @SwingWarrior: Gilead | $GILD Stock | Slowing Sales, Shares Slide https://t.co/1m9EEy7Zp6 #gild #gileadGilead | $GILD Stock | Slowing Sales, Shares Slide https://t.co/ycs3wYSgdL #gild #gileadGilead | $GILD Stock | Slowing Sales, Shares Slide https://t.co/1m9EEy7Zp6 #gild #gileadGilead | $GILD Stock | Slowing Sales, Shares Slide https://t.co/OyG2dxtajQ #gild #gileadGilead | $GILD Stock | Slowing Sales, Shares Slide https://t.co/x3gxK5x74l #gild #gileadDB Deutsche Bank AG Tick
https://t.co/5RLgrHWmvc

$DB $GILD $AMG $CNC  #finance #financeCan Pfizer's Outperformance Continue? https://t.co/4Tu6bjvzLe $AGN $ANAC $AZN $GILD $IBB $MDVN $REGN $PFERT @Top5Traders: Benzinga: Biogen And Gilead Sciences Buck #Biotech Short Interest Trend $BIIB $GILD https://t.co/yfatvdku13RT @TradeWithSuper: Benzinga: Biogen And Gilead Sciences Buck #Biotech Short Interest Trend $BIIB $GILD https://t.co/U3tzzFSbCpBenzinga: Biogen And Gilead Sciences Buck #Biotech Short Interest Trend $BIIB $GILD https://t.co/yfatvdku13Benzinga: Biogen And Gilead Sciences Buck #Biotech Short Interest Trend $BIIB $GILD https://t.co/U3tzzFSbCpBiogen And Gilead Sciences Buck #Biotech Short Interest Trend $BIIB $GILD https://t.co/XeX8SzupyjCan Pfizer's Outperformance Continue? https://t.co/1y03ffxU9j $AGN $ANAC $AZN $GILD $IBB $MDVN $REGN $PFECan Pfizer's Outperformance Continue? https://t.co/5B5BuvHTEe $AGN $ANAC $AZN $GILD $IBB $MDVN $REGN $PFECan Pfizer's Outperformance Continue? https://t.co/GhE0Tba8nL $AGN $ANAC $AZN $GILD $IBB $MDVN $REGN $PFECan Pfizer's Outperformance Continue? https://t.co/VlyVyYE5CE $AGN $ANAC $AZN $GILD $IBB $MDVN $REGN $PFEGDXS ProShares UltraShort Gold Miners Ex-Div Date
https://t.co/VeJXu1oqJg

$GDXS $GILD $MU $NATI  #stock #pennystocks$GILD:

Gilead Sciences Is On The Cusp Of A Breakthrough In NASH.:

https://t.co/TCLFKnlnrPGilead Sciences Is On The Cusp Of A Breakthrough In NASH. https://t.co/1NILI2DVTw $BIIB $ESRX $IBB $ICPT $MDVN $VRTX $GILDGilead Sciences Is On The Cusp Of A Breakthrough In NASH. https://t.co/iMej3HWgNE $BIIB $ESRX $IBB $ICPT $MDVN $VRTX $GILDCCGI Car Charging Group Inc. Prev Close
https://t.co/zEIXeoTLGN

$CCGI $DD $COD.L $GILD  #invest #investRT @markcarson161: XLE Energy Select Sector SPDR Fund E.P.S.
https://t.co/h9oTz3ItM3

$XLE $XLK $GILD $CLIR  #stocks #stocksXLE Energy Select Sector SPDR Fund E.P.S.
https://t.co/h9oTz3ItM3

$XLE $XLK $GILD $CLIR  #stocks #stocksCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5#Biogen $BIIB And #Gilead Sciences $GILD Buck #Biotech Short Interest Trend  https://t.co/AVad7GyfsJNII.TO Norsat Intl, Inc. Quotes
https://t.co/i5aRe3LpXN

$NII.TO $AEPI $GILD $IBM  #share #nasdaqMDVN Quotes
See Here ---&gt; https://t.co/XLUrAPXI76

$MDVN $IO $GILD #shareGILD Gilead Sciences, Inc. E.P.S.
https://t.co/DzguWuKS3o

$GILD $XLK $CTRV $CNP  #investing #stockGilead Sciences, Inc. $GILD CEO Sells $9,737,280.00 in Stock https://t.co/insTRLV7GbGilead Sciences, Inc. $GILD CEO Sells $9,737,280.00 in Stock https://t.co/v2x5Yfn9PYSLV iShares Silver Trust Stock Message Board
https://t.co/pK6c6Pmet3

$SLV $GILD $ONVO $NATI  #share #investRBC Capital Markets #biotech #video
$CELG #Revlimid #TopPick #Abraxane
$BIIB $GILD $VRTX 
#buyouts 
$IBB $XBI https://t.co/OOovdhn1gvNEM Newmont Mining Corp. Ask
https://t.co/Lu3AeHnA8d

$NEM $GILD $USO $USO  #finance #stockHigh-Quality Ex-Dividend Stocks For Tuesday, June 14, 2016 - https://t.co/awIQsZdpZh - $GILD $SNP $FIS $XEL $HES $AME $FNF $WU $LAMR $ENH$GILD:US Gilead Sciences, Inc. (GILD) To Go Ex-Dividend on June 14th #GILEAD SCIENCES INC  https://t.co/cozjRdxgcL #NASDAQGILD Gilead Sciences, Inc. Bid Size
https://t.co/gpjGyOgeqf

$GILD $LOW $OSG $IBM  #stocks #nasdaq$GILD:US Gilead Sciences, Inc. (GILD) To Go Ex-Dividend on June 14th #GILEAD SCIENCES INC  https://t.co/hDZp6Rjas8 #SP500Gilead Sciences, Inc. $GILD To Go Ex-Dividend on June 14th https://t.co/EvLcuZ4jdYGilead Sciences, Inc. $GILD To Go Ex-Dividend on June 14th https://t.co/r8E5PTbOkEBABA Alibaba Group Holding Ltd. Bid Size
https://t.co/9WEj6e11yd

$BABA $GRPN $RAI $GILD  #pennystocks #financeGilead Sciences, Inc. $GILD To Go Ex-Dividend on June 14th https://t.co/Xan1MvmyJaGilead Sciences, Inc. $GILD To Go Ex-Dividend on June 14th https://t.co/jtxQDFRVeyGILD Gilead Sciences, Inc. Yield
https://t.co/SjMyCxU6Rp

$GILD $GRCU $ALXN $AAPL  #nasdaq #stocksGILD 52Wk High
See Here ---&gt; https://t.co/VyYyc6yPTq

$GILD $MCIG $RGA #stockmarketBiogen And Gilead Sciences Buck Biotech Short Interest Trend $BIIB $GILD https://t.co/UbFXV2JvI0 via @benzingaVRX.TO Vanguard Total Stock Market ETF Open
https://t.co/LTI4RFS4a2

$VRX.TO $GILD $ECA $EWU  #stock #shareRT @JustinPulitzer: Weekend Review VIDEO (6/12): #StockMarket $VIX $TLT $XLE $XOM $FXI $IBB $GILD $SPY $GS $IWM $QQQ $AAPL $FB $RH $PAY htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (6/12): #StockMarket $VIX $TLT $XLE $XOM $FXI $IBB $GILD $SPY $GS $IWM $QQQ $AAPL $FB $RH $PAY htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (6/12): #StockMarket $VIX $TLT $XLE $XOM $FXI $IBB $GILD $SPY $GS $IWM $QQQ $AAPL $FB $RH $PAY htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (6/12): #StockMarket $VIX $TLT $XLE $XOM $FXI $IBB $GILD $SPY $GS $IWM $QQQ $AAPL $FB $RH $PAY htt‚Ä¶RT @JustinPulitzer: Weekend Review VIDEO (6/12): #StockMarket $VIX $TLT $XLE $XOM $FXI $IBB $GILD $SPY $GS $IWM $QQQ $AAPL $FB $RH $PAY htt‚Ä¶Weekend Review VIDEO (6/12): #StockMarket $VIX $TLT $XLE $XOM $FXI $IBB $GILD $SPY $GS $IWM $QQQ $AAPL $FB $RH $PAY https://t.co/ebxdKvtMCWWith Valeant's assets valued this low, rumors of a hostile buyout are being heard.  $GILD or $AGN possible suitors.   $VRX to $37?J Rae Chipera placed an order to sell 20 shares of Gilead Sciences Inc.  $GILD
https://t.co/ZEJn189l0VSYY Sysco Corp. Company Info
https://t.co/UhYQve2aJV

$SYY $HYD $COST $GILD  #stocks #stocksMU Micron Technology, Inc. Last Price
https://t.co/lr7EHiwZt8

$MU $UNG $GILD $LQD  #share #stockRT @hedgefundclone: Stocks with biggest insider selling last week: $WDAY $FB $GILD $ABBV $IRM $BBYGILD Gilead Sciences, Inc. Chart
https://t.co/bYebXYmkFr

$GILD $NUGT $DXJF $HZN  #stocks #pennystocks",2016-06-13,GILD,0
44,"RT @LongShortTrader: Two Ebola Patients Cured by Gilead ? Is this true? Maybe not all is wrong with the world... 

$GILD https://t.co/gOpLS‚Ä¶RT @LongShortTrader: Two Ebola Patients Cured by Gilead ? Is this true? Maybe not all is wrong with the world... 

$GILD https://t.co/gOpLS‚Ä¶DWTI VelocityShares 3x Inverse Crude Oil ETN % Change
https://t.co/nUmHr3Dczn

$DWTI $EWY $GILD $IYR  #pennystocks #investing$GILD:

New Insider Filing on

Chief Operating Officer

KEVIN YOUNG:

https://t.co/VTECETwP3y https://t.co/GfnHyGHnPWAVXL Anavex Life Sciences Corp. Ideas
https://t.co/X6ghkqQCb0

$AVXL $GILD $STX $DIS  #pennystocks #stockRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILD$GILD ALERT: New Gilead Sciences SEC Filing
From our Stock News Alerts App$GILD - Statement of Changes in Beneficial Ownership (4) https://t.co/RK7QftYfysGilead Sciences's Chief Operating Officer was just granted 83,880 options  https://t.co/omK9O2g4Dd $GILD$CELG False breakout, just like $GILD in April. Dirty. https://t.co/gjdvnikRI4XLU Health Care Select Sector SPDR Fund Bid
https://t.co/Pp188YG6Lr

$XLU $WATT $GILD $AGN  #invest #pennystocks$GILD:US PGGM Investments Has $99,820,000 Position in Gilead Sciences, Inc. (GILD) #GILEAD SCIENCES INC  https://t.co/BCjh1zZj16 #NASDAQTraveling this week but picked up a little $GILD $NFLX $WFC &amp; sold 1/2 $UVXY today@HumbleBioTrader In San Diego we have suspected M&amp;A for about 2 years. $GILD? But see: https://t.co/GhuJ7wCjtgRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDFMC FMC Corp. 52Wk High
https://t.co/bUzGvXnHzK

$FMC $GPRO $GLD $GILD  #tradeideas #investingRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @LongShortTrader: Two Ebola Patients Cured by Gilead ? Is this true? Maybe not all is wrong with the world... 

$GILD https://t.co/gOpLS‚Ä¶RT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDTwo Ebola Patients Cured by Gilead ? Is this true? Maybe not all is wrong with the world... 

$GILD https://t.co/gOpLSvvdbJhttps://t.co/G9pMgSr1JY &lt; Review of this fantastic traders teaching service! Try it for FREE! $GILD $CMG $XON $FAssessing Gilead's Prospects In HIV/AIDS, With Comments On HCV As Well https://t.co/65Mnvi7NrK $ABBV $BMY $GSK $JNJ $MRK $GILDGilead Sciences, Inc: Why More Price Cuts Can Follow https://t.co/03VMRaNrrm $GILD https://t.co/aNCySHclxW$GILD $SGMO https://t.co/4HNgFrVjYr#GileadSciences Judge overturns ruling on patent after finding Merck lied to court. Read more: https://t.co/xm5qrXTqHc $GILDRT @psuvafan007: Nice review. ""New Therapies for Chronic HBV"" $GILD $ARWR $ABUS et al. Feel like I'm seeing more of these reviews ü§î https:/‚Ä¶3 Biotech Stocks to Buy If the Market Crashes -- $CELG $GILD $REGN #STOCKS  The Motley Fool https://t.co/7SQRjQ23NCJune 14 Tuesday, $GILD closed $83.57RT @psuvafan007: Nice review. ""New Therapies for Chronic HBV"" $GILD $ARWR $ABUS et al. Feel like I'm seeing more of these reviews ü§î https:/‚Ä¶GILD Gilead Sciences, Inc. E.P.S.
https://t.co/VoHp8KJzT6

$GILD $CELG $HYG $MCD  #finance #stockmarketFXI iShares China Large-Cap ETF Stock Forum
https://t.co/qntXmdF9Z7

$FXI $RSX $FCX $GILD  #invest #stocksRT @psuvafan007: Nice review. ""New Therapies for Chronic HBV"" $GILD $ARWR $ABUS et al. Feel like I'm seeing more of these reviews ü§î https:/‚Ä¶Nice review. ""New Therapies for Chronic HBV"" $GILD $ARWR $ABUS et al. Feel like I'm seeing more of these reviews ü§î https://t.co/QoqfiiLmq5$GILD continues to be one of the most frustrating stocks I've ever owned. It's just waiting for mom and pop to throw in the towel. #crowdedGilead Sciences, Inc. $GILD Stake Cut by Forte Capital LLC ADV https://t.co/z0ALcRV2A3The bottom fishing in $GILD has to pay. Its been quite a lot of workAdded to $FB $GILD $AIMTKeep an eye on $SPPI $LXRX $VRX $GILD and $REGN over next few months.  #FDA news coming.#GileadSciences Gilead To Present At The 36th Annual Stock Conference On Tuesday, June 14
  . Read more: https://t.co/87k66ojl2j $GILDGILD Bid
See Here ---&gt; https://t.co/Ay0o3fg579

$GILD $CHGG $MAR #financescaling in long side VERY lightly in $CELG and $GILD...by lightly i mean like, REAL lightly lol...$gild management are geniuses. Thxs to their skills, they will be able to buy back more cheap share at 52L @BagholderQuotes $ibb $xbi#Gilead Sciences, Inc: Why More Price Cuts Can Follow $GILD ‚ûúhttps://t.co/eVnks3JUGC https://t.co/CAX0K1EWsP@JustinPulitzer $GILD closed lower than premarket lows several times in recent days. Ex-date today. I believe you see it going lower, right?RT @TomSilver39: GS:"" M&amp;A: $ALXN, $CELG, $GILD and $VRTX =late stage smid-caps are most likely targets...""We've Updated Our Reports on Firms in the #Pharmaceuticals Industry
https://t.co/Pg59CM91fh $GILD $VRX $ZTSRT @BentheFidler: Infinity Closes Research Ops as Blood Cancer Drug Comes Up Short https://t.co/GRltmpbrfn $INFI $GILD@GantosJ: $GILD 2 patients that have been treated with GS-5734 for Ebola, both of those patients have recovered, &amp; were cured. https://t....RT @TipRanks: Healthcare Analysts Weigh In on $GILD and $INCY Following Management Meetings https://t.co/p5yrcm4KulRT @mikegoodma: First $GILD stops 6 trials of Zydelig - toxicity. Now $ABBV pulls plug on duvelisib for lack of efficacy. The last PI3K sta‚Ä¶RT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @TomSilver39: GS:"" M&amp;A: $GILD noted a need to build in cancer, but not NASH. $BMRN search for early-stage with peak revenue potential &gt;$‚Ä¶#GileadSciences, Inc: Why More Price Cuts Can Follow. Read more: https://t.co/MlI0XWhqFZ $GILDOIH iPath S&amp;P GSCI Crude Oil Total Return Index ETN Volume
https://t.co/N5VNSJoWPc

$OIH $SVXY $CCO.TO $GILD  #tradeideas #pennystocksLABD Direxion Daily S&amp;P Biotech Bull 3x Shares Ask Size
https://t.co/IT1Z0i09g3

$LABD $FXE $GILD $BAC  #finance #stocksRT @mikegoodma: First $GILD stops 6 trials of Zydelig - toxicity. Now $ABBV pulls plug on duvelisib for lack of efficacy. The last PI3K sta‚Ä¶GS:"" M&amp;A: $ALXN, $CELG, $GILD and $VRTX =late stage smid-caps are most likely targets...""GS:"" M&amp;A: $GILD noted a need to build in cancer, but not NASH. $BMRN search for early-stage with peak revenue potential &gt;$500mn.""GILD Gilead Sciences, Inc. Ask
https://t.co/Tv2SALOyih

$GILD $AMD $BTE.TO $SSO  #nasdaq #investingGG Goldcorp, Inc. Bid Size
https://t.co/zoIBm8ZoJX

$GG $GILD $CELG $AKS  #invest #stockmarketRT @mikegoodma: First $GILD stops 6 trials of Zydelig - toxicity. Now $ABBV pulls plug on duvelisib for lack of efficacy. The last PI3K sta‚Ä¶Is Dividend Growth Doomed To Slow? What You Can Do About It $SPY $IBB $AMGN $GILD $CELG $AAPL $CSCO $GOOG $FB $NKE https://t.co/ROB0yBMXyU$GILD Presents at William Blair
https://t.co/N8N5QcJ60H #HBV https://t.co/69wZXKbkGL$GILD 2 patients that have been treated with GS-5734 for Ebola, both of those patients have recovered, &amp; were cured. https://t.co/WnBiD4X8E1ADTM Adaptive Media, Inc. Filings
https://t.co/BB1XKjtMuF

$ADTM $GILD $PCLN $COP  #nasdaq #nasdaqRT @SAlphaTrending: Gilead Sciences' (GILD) Management Presents at William Blair Growth Stock Brokers Conferenc... https://t.co/IGKg6zyqqO‚Ä¶RT @72olds: June 14 Tuesday, $GILD LOW was $82.93 and hit my BEARISH target $82.96 from June 07 Tuesday‚òïüí∞‚úåGilead Sciences' (GILD) Management Presents at William Blair Growth Stock Brokers Conferenc... https://t.co/IGKg6zyqqO $GILDVolume Alert - GILD 83.74 Gilead Sciences Inc $GILD Hit a high today of 84.56 Closing the day 10:30 at 83.74 - https://t.co/KZ15eV1MNmJune 14 Tuesday, $GILD LOW was $82.93 and hit my BEARISH target $82.96 from June 07 Tuesday‚òïüí∞‚úåHealthcare Analysts Weigh In on $GILD and $INCY Following Management Meetings
https://t.co/6BKhDbefym@gbar43 Think you mean CFO change. Sold ICPT over a week ago. Street waiting on Ocaliva script #s &amp; $GILD is focused on its own NASH drugHealthcare Analysts Weigh In on $GILD and $INCY Following Management Meetings https://t.co/p5yrcm4Kul$GILD @GileadSciences approaching 52 week low once again. 
Hope the $12B #buyback executed &amp; they announce a new $15B at these low pricesuniformly down day in bio land - notably, $INFI's NHL drug is essentially done. 46% response rate is below $GILD's drug which is bit of dudRT @Logribel: Victoza has impressive CVOT results and good potential in #NASH - https://t.co/362AGytfdm - $NVO $ICPT $GNFT $GILD https://t.‚Ä¶$GILD https://t.co/hOkXvEUTDf 3:20 - CFO states two Ebola victims treated and curedJune 14 Biotech Update $ABBV $DEPO $egrx $GILD $INFI https://t.co/s12tCgz1G0Yah plus $GILD ~ HARVONI~cures HEP-C https://t.co/TKsunmrokthttps://t.co/p7tVeIZFvX Millionaire Road Map Trading top students win a Porsche for a yr! $LNKD $CVX $GILD $STX $PJPM Direxion Daily S&amp;P Biotech Bear 3x Shares Exchange
https://t.co/4YhME11Iwh

$JPM $YANG $AMBA $GILD  #tradeideas #share@STRATTrading Took $GILD long 83.85Analysts Observing Stocks: Gilead Sciences, Inc. (NASDAQ: $GILD ) , Baxter International Inc. (NYSE: $BAX ) https://t.co/FOSqf3hhr5 $IBBHMNY Horizons BetaPro S&amp;P 500 VIX Short-Term Futures Bull Plus ETF Exchange
https://t.co/UofR4Gq54c

$HMNY $EBIO $GILD $MOV  #pennystocks‚Ä¶RT @mikegoodma: First $GILD stops 6 trials of Zydelig - toxicity. Now $ABBV pulls plug on duvelisib for lack of efficacy. The last PI3K sta‚Ä¶Gilead: One Down, Two To Go https://t.co/oxSRyz9EBX $GILDRT @mikegoodma: First $GILD stops 6 trials of Zydelig - toxicity. Now $ABBV pulls plug on duvelisib for lack of efficacy. The last PI3K sta‚Ä¶GLD Alphabet Inc. Stock Message Board
https://t.co/NKbWJQ8B53

$GLD $VRX $SKLN $GILD  #investing #investGILD Alphabet Inc. - Class C Prev Close
https://t.co/iwF4SSJ3II

$GILD $F $FCX $JNJ  #stocks #stocksThomson Reuters Recognizes Bristol-Myers Squibb/Cardioxyl and $GILD/Galapagos as Top BioPharma Deals o/t Year $GLPG https://t.co/Okz33Dd5RM?RT @The_Real_Fly: $GILD claims two patients with Ebola were cured taking their clinical drugEEM Eldorado Gold Corp. Exchange
https://t.co/TC579kmqWW

$EEM $UNG $SLV $GILD  #finance #financeGILD Top news - Jun 14th, 2016 $GILD https://t.co/O5UtDGdzdt$GILD on long watch with healthcare set to bounceRT @mikegoodma: First $GILD stops 6 trials of Zydelig - toxicity. Now $ABBV pulls plug on duvelisib for lack of efficacy. The last PI3K sta‚Ä¶OpenOutcrier: $GILD Jun 85.5 Calls bought small ~2500 for $0.33-0.40RT @The_Real_Fly: $GILD claims two patients with Ebola were cured taking their clinical drugRT @The_Real_Fly: $GILD claims two patients with Ebola were cured taking their clinical drugRT @GantosJ: At William Blair Growth Conference, Gilead Says They Cured 2 People With Ebola Treated With GS-5734 $GILDRT @GantosJ: At William Blair Growth Conference, Gilead Says They Cured 2 People With Ebola Treated With GS-5734 $GILD$GILD claims two patients with Ebola were cured taking their clinical drug$GILD claims two patients with Ebola were cured taking their clinical drug$GILD Jun 85.5 Calls bought small ~2500 for $0.33-0.40RT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @mikegoodma: First $GILD stops 6 trials of Zydelig - toxicity. Now $ABBV pulls plug on duvelisib for lack of efficacy. The last PI3K sta‚Ä¶At William Blair Growth Conference, Gilead Says They Cured 2 People With Ebola Treated With GS-5734 $GILDRT @mikegoodma: First $GILD stops 6 trials of Zydelig - toxicity. Now $ABBV pulls plug on duvelisib for lack of efficacy. The last PI3K sta‚Ä¶RT @Vegastrader66: $GILD
At William Blair Growth Conference, Gilead Says They Cured 2 People With Ebola Treated With GS-5734RT @outsizedreturn: What's moving in Americas today #Macro $aapl $fb $goog $amzn $gild $f #hedgefunds @Scoopnest https://t.co/YdfH3yWWrl ht‚Ä¶RT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILD$GILD
At William Blair Growth Conference, Gilead Says They Cured 2 People With Ebola Treated With GS-5734RT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILD*GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @outsizedreturn: What's moving in Americas today #Macro $aapl $fb $goog $amzn $gild $f #hedgefunds @Scoopnest https://t.co/YdfH3yWWrl ht‚Ä¶gild cures ebola? $GILDWhat's moving in Americas today #Macro $aapl $fb $goog $amzn $gild $f #hedgefunds @Scoopnest https://t.co/YdfH3yWWrl https://t.co/sFiD3E6YuTOur DCF has $GILD available at a 17% discount - why the sale??: https://t.co/jomgDzQJfF https://t.co/hbbHJKuxjeRT @BentheFidler: Infinity Closes Research Ops as Blood Cancer Drug Comes Up Short https://t.co/GRltmpbrfn $INFI $GILDInfinity Closes Research Ops as Blood Cancer Drug Comes Up Short https://t.co/GRltmpbrfn $INFI $GILDRT @mikegoodma: First $GILD stops 6 trials of Zydelig - toxicity. Now $ABBV pulls plug on duvelisib for lack of efficacy. The last PI3K sta‚Ä¶GILD Gilead Sciences, Inc. Prev Close
https://t.co/wf2izCFWU4

$GILD $AA $ARIA $TNA  #invest #stocksFirst $GILD stops 6 trials of Zydelig - toxicity. Now $ABBV pulls plug on duvelisib for lack of efficacy. The last PI3K standing wins. $TGTXRT @PDRennert: ouch $INFI looks at it's cards, folds.  https://t.co/e3RAlJe4nl

#duvelisib $ABBV partnered

follows $GILD pullback on #idel‚Ä¶RT @PDRennert: ouch $INFI looks at it's cards, folds.  https://t.co/e3RAlJe4nl

#duvelisib $ABBV partnered

follows $GILD pullback on #idel‚Ä¶RT @PDRennert: ouch $INFI looks at it's cards, folds.  https://t.co/e3RAlJe4nl

#duvelisib $ABBV partnered

follows $GILD pullback on #idel‚Ä¶RT @PDRennert: ouch $INFI looks at it's cards, folds.  https://t.co/e3RAlJe4nl

#duvelisib $ABBV partnered

follows $GILD pullback on #idel‚Ä¶ouch $INFI looks at it's cards, folds.  https://t.co/e3RAlJe4nl

#duvelisib $ABBV partnered

follows $GILD pullback on #idelalisib

#PI3KIs $TGTX a @GileadSciences $GILD #buyout target? $IBB $XBI $ABBV #CLL  https://t.co/zaprvhoSI3EUM ProShares Short MSCI Emerging Markets News
https://t.co/MaV0K9rMEG

$EUM $RLYP $RLYP $GILD  #stock #nasdaqAbbVie - European Ombudsman Report Moot https://t.co/UnnoHCyLRc $ABBV, $ABT, $AMGN, $BMY, $GILD, $GSK, $JNJ, $LLY, $MRK, $NVS, $PFEAbbVie - European Ombudsman Report Moot https://t.co/AbpTu6Gom2 $ABT $AMGN $BMY $GILD $GSK $JNJ $LLY $MRK $NVS $PFE $ABBVCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5IBOC International Bancshares Corp. Exchange
https://t.co/A7t95yhUm1

$IBOC $WGP $GILD $TQQQ  #tradeideas #shareGILD Gilead Sciences, Inc. Market Cap
https://t.co/CA9QiYfhR2

$GILD $IYR $V $PICO  #finance #invest#GileadSciences to Present at the 36th       Annual William Blair Growth Stock Conference o... Read more: https://t.co/ZmZ2wghYwA $GILDSHPG Shire Ltd. Ex-Div Date
https://t.co/n4voKOURnW

$SHPG $GILD $GOOGL $FB  #finance #investingVictoza has impressive CVOT results and good potential in #NASH - https://t.co/362AGytfdm - $NVO $ICPT $GNFT $GILD https://t.co/KPR4HZwxs0OIH VanEck Vectors Oil Services ETF Tick
https://t.co/UdHdvWyK9G

$OIH $GDX $TCK/B.TO $GILD  #investing #stock#genfit Gilead Sciences Is On The Cusp Of A Breakthrough In NASH. https://t.co/4jkLnGBNYE $BIIB $ESRX $IBB $ICPT $MDVN $VRTX $GILDGILD Gilead Sciences, Inc. Company Info
https://t.co/rjIJppX7SD

$GILD $SWHC $BND $GDX  #invest #stockRT @bigbluecup721: CELG Celgene Corp. Ex-Div Date
https://t.co/TIQHHLFNXx

$CELG $CSCO $BIDU $GILD  #pennystocks #shareCELG Celgene Corp. Ex-Div Date
https://t.co/TIQHHLFNXx

$CELG $CSCO $BIDU $GILD  #pennystocks #share$GILD Company GILEAD SCIENCES INC just submited new SEC filing https://t.co/CuBCBdUURP #gilead #sciencesGilead Sciences, Inc. $GILD Stock Rating Reaffirmed by Maxim Group https://t.co/cTxj6UPevzABX Barrick Gold Corp. Summary
https://t.co/lWbDOOUSvm

$ABX $SN $VRSN $GILD  #nasdaq #stockmarketRGLD Sturm Ruger &amp; Co., Inc. Volume
https://t.co/ncC8TtdDqF

$RGLD $NVDA $GILD $JNJ  #tradeideas #nasdaqI feel stock buybacks are not the most efficient use of capital for Gilead.  $GILD #GILD Prefer R&amp;D and M&amp;A.EDC Direxion Daily Emerging Markets Bull 3x Shares P/E Ratio
https://t.co/pdxlP9wY70

$EDC $XOP $GILD $CY  #pennystocks #shareRT @WilliamGerber1: @CGrantWSJ Snail mail company Pitney Bowes Inc. $PBI (9.4 p/e) is viewed by the market as having higher growth potentia‚Ä¶$GILD is looking to acquire an oncology asset: Per its CFO at the Jefferies conference the company has the ba... https://t.co/2tD4TPJJFJ$IBB monthly $GILD $CELG $BIIB $REGN $CELG $ALXN $AGN https://t.co/HwAS0vZjv3RT @bn201612: XIV Materials Select Sector SPDR Fund Quotes
https://t.co/7LcX5chjp1

$XIV $HD $XLK $GILD  #stocks #stockXIV Materials Select Sector SPDR Fund Quotes
https://t.co/7LcX5chjp1

$XIV $HD $XLK $GILD  #stocks #stockMy M&amp;A list
$aapl should buy $ twtr
$gild buy $mnkd and its drug system
$csco buy $ Ericsson
$amzn buy $grpn
$ MT buy $X
Or$x buys $aksRT @jsherkow: I'm Q"" in this @latimes @hiltzikm piece on the $MRK v $GILD #patent saga. $ could have been huge. https://t.co/7eUsWOm1Rk #ph‚Ä¶GDX VanEck Vectors Gold Miners ETF Ask Size
https://t.co/BPa0AyQB4Y

$GDX $BKF $TNA $GILD  #stockmarket #investingBBBY Bed Bath &amp; Beyond, Inc. Ideas
https://t.co/cGnhoqV5IL

$BBBY $NUGT $PAAS $GILD  #finance #financeSQQQ Supernus Pharmaceuticals, Inc. Investor Opinions
https://t.co/dgRHHOUVao

$SQQQ $GILD $TAHO $DWTI  #tradeideas #nasdaqSA ProShares UltraShort S&amp;P500 Chart
https://t.co/9CQWXBFUrb

$SA $BAX $XHB $GILD  #share #pennystocks#GileadSciences to Present at the 36th Annual William Blair Growth Stock Conference on Tues... Read more: https://t.co/Fo2JpRrZx0 $GILD#GileadSciences to Present at the 36th Annual William Blair Growth Stock Conference on Tues... Read more: https://t.co/AnOtrpPDJt $GILDJJG iPath Bloomberg Grains Subindex Total Return ETN Open
https://t.co/zNjDmfHbFp

$JJG $FCX $MRO $GILD  #stock #investingGILD Gilead Sciences, Inc. Change
https://t.co/gQzEjHmfrh

$GILD $PANW $AGG $GOOG  #stockmarket #nasdaqGDXJ VanEck Vectors Junior Gold Miners ETF Chart
https://t.co/TIyynCkLmv

$GDXJ $DIA $JJG $GILD  #investing #pennystocks",2016-06-14,GILD,0
45,"Bristol-Myers Squibb's Takeover Premium May Be Building https://t.co/Va35Q4U1bn $ABBV $GILD $MRK $PFE $BMYBristol-Myers Squibb's Takeover Premium May Be Building https://t.co/tTc87GbYmf $ABBV $GILD $MRK $PFE $BMYBristol-Myers Squibb's Takeover Premium May Be Building https://t.co/ddwOrGiSqf $ABBV $GILD $MRK $PFE $BMYLeerink Swann Reaffirms ‚ÄúBuy‚Äù Rating for Gilead Sciences, Inc. $GILD https://t.co/QCRifyHr6sRT @bradloncar: This is the tech equivalent of a big $GILD deal. Our turn next?Investors Sell Gilead Sciences, Inc. $GILD on Strength $GILD https://t.co/t7ObOhLXhFInvestors Sell Gilead Sciences, Inc. $GILD on Strength $GILD https://t.co/dbmApEy2tVGILD SPDR Gold Shares 52Wk High
https://t.co/ATw0eo7ckf

$GILD $EWU $IWM $MTD  #stock #stockGalapagos' R&amp;D Update 2016. $GLPG $GILD $ABBV #RA #CF #CROHN  https://t.co/VAsiOu8IpTERY Direxion Daily Energy Bear 3x Shares News
https://t.co/WfTVCWjXc4

$ERY $GILD $LNKD $HXU.TO  #stocks #financeCNC Centene Corp. Stock Forum
https://t.co/8Qciw6HTQp

$CNC $HZNP $GILD $NEM  #pennystocks #investV Vista Gold Corp. E.P.S.
https://t.co/KuhP8aDhcZ

$V $BARC.L $HNU.TO $GILD  #investing #shareRT @BentheFidler: Infinity Closes Research Ops as Blood Cancer Drug Comes Up Short https://t.co/GRltmpbrfn $INFI $GILDGILD SPDR Gold Shares Summary
https://t.co/hcYXkklR7y

$GILD $UBNT $BLK $EEM  #finance #pennystocksRT @TomSilver39: MS:"" $GILD Treating all state Medicaid HCV patients could lead to an additional ~$18B in revenue for Gilead.Medicaid &amp; ST‚Ä¶MS:"" $GILD Treating all state Medicaid HCV patients could lead to an additional ~$18B in revenue for Gilead.Medicaid &amp; ST ~1M HCV patients.""VXX iPath S&amp;P 500 VIX Short-Term Futures ETN Stock Message Board
https://t.co/2TlO09LOx1

$VXX $MCD $GILD $XLP  #pennystocks #stockmarket$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/n0u1iP7r2xSLW Silver Wheaton Corp. Exchange
https://t.co/oHeVFXMZqi

$SLW $GILD $RWM $CTRP  #stockmarket #shareRT @BiotechGems: 3 Safe Dividend Stocks with Pristine Balance Sheets https://t.co/b7HH2TPieb $AAPL $AMGN $GILD $M via @InvestorsAlley$GILD Gilead Sciences Inc at William Blair Growth Stock Conference Transcript is now available #earnings https://t.co/BE029WIN1uRT @DrPaulyDeSantis: $GILD solid commercialexecution navigating price wars &amp; 2 new competitors since Sovaldi. Maintains ~90% mkt share, htt‚Ä¶Dang it, I was away for a few updates, and bang, I held $GILD from 87. Duh!!! Nobody beats the queen @Fibonacciqueen https://t.co/B7fwWhRtolDB Deutsche Bank AG Dividend
https://t.co/Tr9GOnzh20

$DB $SQQQ $GILD $QRVO  #stock #stockmarketCXRX Concordia Healthcare Corp. Yield
https://t.co/1dh820dtJb

$CXRX $EWJ $GILD $SLAB  #pennystocks #nasdaqRT @masterofstocks1: AUY Yamana Gold Inc. Dividend
https://t.co/ANouaizsU0

$AUY $GILD $QQEW $MU  #stocks #nasdaqAUY Yamana Gold Inc. Dividend
https://t.co/ANouaizsU0

$AUY $GILD $QQEW $MU  #stocks #nasdaqCheck out the free Friday Biotech Breakdown! $IBB $COMP $BIIB $GILD $ICPT https://t.co/aDtIKj90v5RT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDI Long to-see-the-day where I can stop cursing my Long $GILD position every morningAMGN Amgen, Inc. Quotes
https://t.co/gjMZEcFnZT

$AMGN $DBC $GILD $XLE  #pennystocks #pennystocksRT @mikegoodma: First $GILD stops 6 trials of Zydelig - toxicity. Now $ABBV pulls plug on duvelisib for lack of efficacy. The last PI3K sta‚Ä¶XLB Materials Select Sector SPDR Fund Filings
https://t.co/q52pMQ4tAz

$XLB $GILD $SPXS $TVIX  #pennystocks #tradeideasSWC Stillwater Mining Co. Exchange
https://t.co/1lpLMwc1B5

$SWC $FXI $GILD $AVXL  #pennystocks #investingStock Chart Technical Analysis Video
  https://t.co/D17dlZBWR6
  $AAPL $TSLA $NFLX $AMZN $TWTR $GPRO $GILD https://t.co/cPqtxkpwEKRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDEROS Day High
See Here ---&gt; https://t.co/eoQRAPuCzo

$EROS $GILD $BVN #pennystocksGILD Gilead Sciences, Inc. Day High
https://t.co/tjhPe8xJEV

$GILD $WATT $NEOT $XLE  #stockmarket #pennystocksRT @zbiotech: *GILEAD SAYS TWO EBOLA PATIENTS TREATED WITH GS-5734, BOTH CURED

long-term growth...solved $GILDRT @LongShortTrader: Two Ebola Patients Cured by Gilead ? Is this true? Maybe not all is wrong with the world... 

$GILD https://t.co/gOpLS‚Ä¶",2016-06-15,GILD,1
